ACVRL1 	
ADAMTS1 	
AKT1
AKT2
ANGPT1 	
ANGPT2 	
556 	
ARHGAP5 
BMP2 	
BMP4 	
BMP6 	
BMP7 	
BMPR1A 	
BMPR2 	
CCBE1 	
CCM2 	
CCM3 	
CDC42 	
CDH5 	
CDKN2A 	
COL4A1 	
COL4A2 	
COL4A3 	
COL4A4 	
CCN2 	
CTNNB1 	
CUL3 	
ENG 	
EPAS1 	
ETS1 	
ETS2 	
FGF1 	
FGF17 	
FGF18 	
FGF19 	
FGF2 	
FGF21 	
FGF23 	
FGF4 	
FGF6 	
FGF9 	
FLT1 	
FN1 	
GJA4 	GJA4 (Gap Junction Protein Alpha 4) is a Protein Coding gene. Diseases associated with GJA4 include  GJA1	This gene encodes a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene have been associated with atherosclerosis and a higher risk of myocardial infarction. This gene encodes a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene have been associated with atherosclerosis and a higher risk of myocardial infarction. no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Increased shRNA abundance (Z-score &gt; 2), Decreased cell number, increased S DNA content, 	GO:0001568 GO:0003158 GO:0003158 GO:0003158 GO:0006816 GO:0006816 GO:0006816 GO:0007043 GO:0007043 GO:0007043
ADGRF5 	ADGRF5 (Adhesion G Protein-Coupled Receptor F5) is a Protein Coding gene. Diseases associated with ADGRF5 include  ADGRF1	Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and cell surface receptor signaling pathway. Predicted to act upstream of or within several processes, including glomerular filtration; pharyngeal arch artery morphogenesis; and surfactant homeostasis. Located in cell surface and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and cell surface receptor signaling pathway. Predicted to act upstream of or within several processes, including glomerular filtration; pharyngeal arch artery morphogenesis; and surfactant homeostasis. Located in cell surface and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]	and  ADGRF1	     
&quot;:" GO:0003094 3 5 involved_in IEA 3 5 involved_in IBA 5 IEA 3 5 involved_in IEA 3 5 involved_in TAS	 
HEG1 	HEG1 (Heart Development Protein With EGF Like Domains 1) is a Protein Coding gene. Diseases associated with HEG1 include 	Predicted to enable calcium ion binding activity. Involved in several processes, including negative regulation of Rho protein signal transduction; negative regulation of Rho-dependent protein serine/threonine kinase activity; and negative regulation of membrane permeability. Located in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable calcium ion binding activity. Involved in several processes, including negative regulation of Rho protein signal transduction; negative regulation of Rho-dependent protein serine/threonine kinase activity; and negative regulation of membrane permeability. Located in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, FOXO1 nuclear localization, Decreased viability with paclitaxel, Decreased influenza A/WSN/33 replication, 	 
HIF1A 	HIF1A (Hypoxia Inducible Factor 1 Subunit Alpha) is a Protein Coding gene. Diseases associated with HIF1A include  EPAS1	This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]	This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased shRNA abundance, Decreased caspase 3/7 activity, 	GO:0000302 GO:0001525 GO:0001568 GO:0001568 GO:0001568 GO:0001666 GO:0001666 GO:0001666 GO:0001678
ITGA2 	ITGA2 (Integrin Subunit Alpha 2) is a Protein Coding gene. Diseases associated with ITGA2 include  ITGA1	This gene encodes the alpha subunit of a transmembrane receptor for collagens and related proteins. The encoded protein forms a heterodimer with a beta subunit and mediates the adhesion of platelets and other cell types to the extracellular matrix. Loss of the encoded protein is associated with bleeding disorder platelet-type 9. Antibodies against this protein are found in several immune disorders, including neonatal alloimmune thrombocytopenia. This gene is located adjacent to a related alpha subunit gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	This gene encodes the alpha subunit of a transmembrane receptor for collagens and related proteins. The encoded protein forms a heterodimer with a beta subunit and mediates the adhesion of platelets and other cell types to the extracellular matrix. Loss of the encoded protein is associated with bleeding disorder platelet-type 9. Antibodies against this protein are found in several immune disorders, including neonatal alloimmune thrombocytopenia. This gene is located adjacent to a related alpha subunit gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	no effect, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Decreased viability, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased cell migration, Decreased shRNA abundance, 	GO:0001666 GO:0002687 GO:0002687 GO:0002687 GO:0006929 GO:0006929 GO:0006929 GO:0006971 GO:0007155 GO:0007155 GO:0007155
ITGA2B 	ITGA2B (Integrin Subunit Alpha 2b) is a Protein Coding gene. Diseases associated with ITGA2B include  ITGA8	This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]	This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Inconclusive, Increased circadian period length, Dynamic nuclei (hole, folded or small irregular), 	GO:0001525 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229 GO:0033627
ITGA5 	ITGA5 (Integrin Subunit Alpha 5) is a Protein Coding gene. Diseases associated with ITGA5 include  ITGA8	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 5 subunit. This subunit associates with the beta 1 subunit to form a fibronectin receptor. This integrin may promote tumor invasion, and higher expression of this gene may be correlated with shorter survival time in lung cancer patients. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 5 subunit. This subunit associates with the beta 1 subunit to form a fibronectin receptor. This integrin may promote tumor invasion, and higher expression of this gene may be correlated with shorter survival time in lung cancer patients. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell number in G1, small nuclei in G1, 	GO:0001525 GO:0007044 GO:0007155 GO:0007155 GO:0007155
ITGA6 	ITGA6 (Integrin Subunit Alpha 6) is a Protein Coding gene. Diseases associated with ITGA6 include  ITGA7	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased homologous recombination repair frequency, Negative genetic interaction between BLM-/- and BLM+/+, Increased S DNA content, Weakly decreased NFAT1-GFP nuclear translocation, S arrest, Increased cilium length after serum starvation, Increased cell number in G1, small nuclei in G1, Decreased focal adhesion (FA) area, decreased FA length, increased number of small and round FAs, decreased cell spreading, 	GO:0007044 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229 GO:0010668
ITGAV 	ITGAV (Integrin Subunit Alpha V) is a Protein Coding gene. Diseases associated with ITGAV include  ITGA8	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, FOXO1 nuclear localization, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Dynamic nuclei (hole, folded or small irregular), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased homologous recombination repair frequency, Reduced shRNA abundance in FBW7 KO line, Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Decreased viability of wild-type and TP53 knockout cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased nuclear migration speed, Increased Salmonella enterica Typhimurium binding, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0001525 GO:0001568 GO:0001570 GO:0001570 GO:0001570 GO:0007155 GO:0007155 GO:0007155 GO:0007160
ITGB1 	ITGB1 (Integrin Subunit Beta 1) is a Protein Coding gene. Diseases associated with ITGB1 include  ITGB2	Integrins are heterodimeric proteins made up of alpha and beta subunits. At least 18 alpha and 8 beta subunits have been described in mammals. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. This gene encodes a beta subunit. Multiple alternatively spliced transcript variants which encode different protein isoforms have been found for this gene. Integrins are heterodimeric proteins made up of alpha and beta subunits. At least 18 alpha and 8 beta subunits have been described in mammals. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. This gene encodes a beta subunit. Multiple alternatively spliced transcript variants which encode different protein isoforms have been found for this gene. no effect, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Increased G2M DNA content, increased 8N DNA content, Increased number of mitotic cells, Increased ionizing radiation sensitivity, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Salmonella enterica Typhimurium invasion, Increased the percentage of infected cells, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with imatinib mesylate, 	GO:0000082 GO:0000132 GO:0000132 GO:0000132
ITGB3 	ITGB3 (Integrin Subunit Beta 3) is a Protein Coding gene. Diseases associated with ITGB3 include  ITGB5	The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. no effect, Decreased viability, shRNA abundance &lt;= 50%, Dynamic nuclei (hole, folded or small irregular), Decreased replication of vaccinia virus (VACV), Increased shRNA abundance, Increased G2M DNA content, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased cell spreading, 	GO:0001934 GO:0001938
ITGB5 	ITGB5 (Integrin Subunit Beta 5) is a Protein Coding gene. Diseases associated with ITGB5 include  ITGB3	This gene encodes a beta subunit of integrin, which can combine with different alpha chains to form a variety of integrin heterodimers. Integrins are integral cell-surface receptors that participate in cell adhesion as well as cell-surface mediated signaling. The alphav beta5 integrin is involved in adhesion to vitronectin. [provided by RefSeq, Aug 2017]	This gene encodes a beta subunit of integrin, which can combine with different alpha chains to form a variety of integrin heterodimers. Integrins are integral cell-surface receptors that participate in cell adhesion as well as cell-surface mediated signaling. The alphav beta5 integrin is involved in adhesion to vitronectin. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Dynamic nuclei (hole, folded or small irregular), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Increased nuclear migration distance, increased nuclear migration speed, Increased Salmonella enterica Typhimurium binding, Decreased viability, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007179 GO:0007229 GO:0016477
JAG1 	JAG1 (Jagged Canonical Notch Ligand 1) is a Protein Coding gene. Diseases associated with JAG1 include  JAG2	The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. no effect, Decreased viability ratio, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased G1 DNA content, Strongly decreased CFP-tsO45G cell surface transport, Decreased vaccinia virus (VACV-LREV ) gene expression, 	GO:0001525 GO:0001709 GO:0001953
KDR 	KDR (Kinase Insert Domain Receptor) is a Protein Coding gene. Diseases associated with KDR include  FLT1	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased substrate adherent cell growth, Weakly decreased NFAT1-GFP nuclear translocation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, 	GO:0001525 GO:0001541 GO:0001569 GO:0001569 GO:0001569 GO:0001570 GO:0001934 GO:0001934 GO:0001934
KLF2 	KLF2 (KLF Transcription Factor 2) is a Protein Coding gene. Diseases associated with KLF2 include  KLF4	This gene encodes a protein that belongs to the Kruppel family of transcription factors. The encoded zinc finger protein is expressed early in mammalian development and is found in many different cell types. The protein acts to bind the CACCC box found in the promoter of target genes to activate their transcription. It plays a role in many processes during development and disease including adipogenesis, embryonic erythropoiesis, epithelial integrity, inflammation and t-cell viability. [provided by RefSeq, Mar 2017]	This gene encodes a protein that belongs to the Kruppel family of transcription factors. The encoded zinc finger protein is expressed early in mammalian development and is found in many different cell types. The protein acts to bind the CACCC box found in the promoter of target genes to activate their transcription. It plays a role in many processes during development and disease including adipogenesis, embryonic erythropoiesis, epithelial integrity, inflammation and t-cell viability. [provided by RefSeq, Mar 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased Nanog expression, Decreased HIV-LTR-beta-galactosidase protein expression, Negative genetic interaction between BLM-/- and BLM+/+, Decreased replication of vaccinia virus (VACV), Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0000122 GO:0000902 GO:0001701 GO:0001701 GO:0001701 GO:0006357 GO:0006357 GO:0006357
KRAS 	KRAS (KRAS Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with KRAS include  NRAS	This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. Decreased viability, Increased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased replication of vaccinia virus (VACV), Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased shRNA abundance, Decreased viability in colon lineage; decreased viability in pancreas lineage, 	GO:0000165 GO:0001934 GO:0001934 GO:0001934 GO:0007165 GO:0007265 GO:0007265 GO:0007265
KRIT1 	KRIT1 (KRIT1 Ankyrin Repeat Containing) is a Protein Coding gene. Diseases associated with KRIT1 include  FRMD8	This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]	This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased replication of vaccinia virus (VACV), Decreased shRNA abundance, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0001525 GO:0001937 GO:0001937 GO:0001937 GO:0003158 GO:0007264 GO:0010596
LATS1 	LATS1 (Large Tumor Suppressor Kinase 1) is a Protein Coding gene. Diseases associated with LATS1 include  Tetraploidy LATS2	The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]	The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased substrate adherent cell growth, Decreased cell migration, Decreased viability, Increased CFP-tsO45G cell surface transport, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Decreased sensitivity to paclitaxel, 	GO:0000082 GO:0000086 GO:0000278 GO:0000819 GO:0000819 GO:0000819
LATS2 	LATS2 (Large Tumor Suppressor Kinase 2) is a Protein Coding gene. Diseases associated with LATS2 include  DYRK1A LATS1	This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression. This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased epidermal growth factor (EGF) endocytosis, Decreased viability, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased viability after TNF/CHX stimulation, Increased ID2::GFP protein expression, Increased apoptosis, Decreased viability (cell death), increased nuclear migration distance, 	GO:0000082 GO:0001827 GO:0001828 GO:0001828 GO:0001828 GO:0006468 GO:0006468 GO:0006468
MADH4 	SMAD4 (SMAD Family Member 4) is a Protein Coding gene. Diseases associated with SMAD4 include  SMAD5	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in colon lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Increased transcriptional activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased S DNA content, increased G2M DNA content, S arrest, Increased mitotic index, Downregulation of NFkappaB pathway, Synthetic lethal with gemcitabine, Increased sensitivity to paclitaxel, 	GO:0000122 GO:0001541 GO:0001541 GO:0001541 GO:0001649 GO:0001649 GO:0001649 GO:0001658 GO:0001658 GO:0001658 GO:0001666 GO:0001666 GO:0001666
MAML2 	MAML2 (Mastermind Like Transcriptional Coactivator 2) is a Protein Coding gene. Diseases associated with MAML2 include  Hidradenoma MAML3	The protein encoded by this gene is a member of the Mastermind-like family of proteins. All family members are proline and glutamine-rich, and contain a conserved basic domain that binds the ankyrin repeat domain of the intracellular domain of the Notch receptors (ICN1-4) in their N-terminus, and a transcriptional activation domain in their C-terminus. This protein binds to an extended groove that is formed by the interaction of CBF1, Suppressor of Hairless, LAG-1 (CSL) with ICN, and positively regulates Notch signaling. High levels of expression of this gene have been observed in several B cell-derived lymphomas. Translocations resulting in fusion proteins with both CRTC1 and CRTC3 have been implicated in the development of mucoepidermoid carcinomas, while a translocation event with CXCR4 has been linked with chronic lymphocytic leukemia (CLL). Copy number variation in the polyglutamine tract has been observed. [provided by RefSeq, Jan 2015]	The protein encoded by this gene is a member of the Mastermind-like family of proteins. All family members are proline and glutamine-rich, and contain a conserved basic domain that binds the ankyrin repeat domain of the intracellular domain of the Notch receptors (ICN1-4) in their N-terminus, and a transcriptional activation domain in their C-terminus. This protein binds to an extended groove that is formed by the interaction of CBF1, Suppressor of Hairless, LAG-1 (CSL) with ICN, and positively regulates Notch signaling. High levels of expression of this gene have been observed in several B cell-derived lymphomas. Translocations resulting in fusion proteins with both CRTC1 and CRTC3 have been implicated in the development of mucoepidermoid carcinomas, while a translocation event with CXCR4 has been linked with chronic lymphocytic leukemia (CLL). Copy number variation in the polyglutamine tract has been observed. [provided by RefSeq, Jan 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Inconclusive, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased interferon-beta reporter expression, 	GO:0007219 GO:0007221 GO:0045944
MAP2K1 	MAP2K1 (Mitogen-Activated Protein Kinase Kinase 1) is a Protein Coding gene. Diseases associated with MAP2K1 include  MAP2K2	The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased vesicular stomatitis virus (VSV) infection, Decreased viability, Increased nuclear migration distance, increased nuclear migration speed, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Increased viability, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, Transferrin accumulation in small spots in the cell periphery, polarized transferrin accumulation in plasma membrane protrusions, 	GO:0000165 GO:0006468 GO:0006935 GO:0007165
MAP2K2 	MAP2K2 (Mitogen-Activated Protein Kinase Kinase 2) is a Protein Coding gene. Diseases associated with MAP2K2 include  MAP2K1	The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. no effect, Decreased viability ratio, shRNA abundance &lt;= 25%, Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000165 GO:0006468 GO:0007507 GO:0007507 GO:0007507 GO:0010628 GO:0010628 GO:0010628
MAP3K3 	MAP3K3 (Mitogen-Activated Protein Kinase Kinase Kinase 3) is a Protein Coding gene. Diseases associated with MAP3K3 include  MAP3K2	This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. no effect, Decreased viability, Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased substrate adherent cell growth, Decreased viability in pancreas lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Decreased cell proliferation, Increased cell death in DLD-1 cells, Decreased cell viability after pRB stimulation, 	GO:0000165 GO:0001568 GO:0006468 GO:0006468 GO:0006468 GO:0016310 GO:0016310 GO:0016310 GO:0035556 GO:0035556 GO:0035556
MAP3K7 	MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7) is a Protein Coding gene. Diseases associated with MAP3K7 include  PKDCC	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Decreased HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with gemcitabine, Increased cell number in G1, small nuclei in G1, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, 	GO:0000165 GO:0002223 GO:0002726 GO:0002726 GO:0002726
MAP4K4 	MAP4K4 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4) is a Protein Coding gene. Diseases associated with MAP4K4 include  TNIK	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Large nuclei, Increased cell transformation, 	GO:0000165 GO:0001953 GO:0006468 GO:0016310 GO:0030033 GO:0030033 GO:0030033
MAPK1 	MAPK1 (Mitogen-Activated Protein Kinase 1) is a Protein Coding gene. Diseases associated with MAPK1 include  MAPK3	This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]	This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased cell death in HCT116 cells, Decreased cell migration, Increased viability, Decreased viability with carboplatin, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0006915 GO:0006935 GO:0006935 GO:0006935
MAPK10 	MAPK10 (Mitogen-Activated Protein Kinase 10) is a Protein Coding gene. Diseases associated with MAPK10 include  Pheochromocytoma MAPK8	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability ratio, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Dynamic nuclei (hole, folded or small irregular), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell viability after pRB stimulation, Increased viability with TRAIL, Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Synthetic lethal with gemcitabine, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007254
MAPK11 	MAPK11 (Mitogen-Activated Protein Kinase 11) is a Protein Coding gene. Diseases associated with MAPK11 include  MAPK14	This gene encodes a member of a family of protein kinases that are involved in the integration of biochemical signals for a wide variety of cellular processes, including cell proliferation, differentiation, transcriptional regulation, and development. The encoded protein can be activated by proinflammatory cytokines and environmental stresses through phosphorylation by mitogen activated protein kinase kinases (MKKs). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	This gene encodes a member of a family of protein kinases that are involved in the integration of biochemical signals for a wide variety of cellular processes, including cell proliferation, differentiation, transcriptional regulation, and development. The encoded protein can be activated by proinflammatory cytokines and environmental stresses through phosphorylation by mitogen activated protein kinase kinases (MKKs). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	Increased vaccinia virus (VACV) infection, no effect, Increased Nanog expression, Decreased viability in glioblastoma multiforme (GBM) lineage, Strongly decreased CFP-tsO45G cell surface transport, Increased epidermal growth factor (EGF) endocytosis, Decreased cell migration, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased human cytomegalovirus (HCMV) strain AD169 replication, Synthetic lethal with imatinib mesylate, Fragmented cis-Golgi, fragmented trans-Golgi, Decreased viability with RAF265, 	GO:0000165 GO:0001649 GO:0001649 GO:0001649 GO:0006468 GO:0006468 GO:0006468 GO:0010628 GO:0010628 GO:0010628
MAPK12 	MAPK12 (Mitogen-Activated Protein Kinase 12) is a Protein Coding gene. Diseases associated with MAPK12 include  MAPK13	Activation of members of the mitogen-activated protein kinase family is a major mechanism for transduction of extracellular signals. Stress-activated protein kinases are one subclass of MAP kinases. The protein encoded by this gene functions as a signal transducer during differentiation of myoblasts to myotubes. Activation of members of the mitogen-activated protein kinase family is a major mechanism for transduction of extracellular signals. Stress-activated protein kinases are one subclass of MAP kinases. The protein encoded by this gene functions as a signal transducer during differentiation of myoblasts to myotubes. Increased vaccinia virus (VACV) infection, Increased viability, no effect, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007049 GO:0007049 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0007517
MAPK14 	MAPK14 (Mitogen-Activated Protein Kinase 14) is a Protein Coding gene. Diseases associated with MAPK14 include  Chlamydia MAPK11	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased ionizing radiation sensitivity, Increased cell migration, Increased cell viability after pRB stimulation, Decreased telomerase activity, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, High actin ratio cells, Decreased viability in colon lineage; decreased viability in pancreas lineage, toxic, 	 
MAPK3 	MAPK3 (Mitogen-Activated Protein Kinase 3) is a Protein Coding gene. Diseases associated with MAPK3 include  MAPK1	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. Increased gamma-H2AX phosphorylation, Increased viability, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased substrate adherent cell growth, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Increased CFP-tsO45G cell surface transport, Decreased viability with paclitaxel, Decreased focal adhesion (FA) abundance, increased cell elongation, decreased cell spreading, 	GO:0000165 GO:0001934 GO:0006351 GO:0006468 GO:0006468 GO:0006468
MAPK8 	MAPK8 (Mitogen-Activated Protein Kinase 8) is a Protein Coding gene. Diseases associated with MAPK8 include  MAPK10	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrom c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Apr 2016]	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrom c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Apr 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased vesicular stomatitis virus (VSV) infection, Increased circadian period length, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased homologous recombination repair frequency, Decreased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased Hepatitis C virus replication, Increased S DNA content, Increased mitotic index, Decreased cell viability after pRB stimulation, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Increased viability after TNF/CHX stimulation, Increased telomerase activity, Increased IL-13 protein expression, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0006979 GO:0007165 GO:0007254 GO:0007254 GO:0007254
MGC4607 	CCM2 (CCM2 Scaffold Protein) is a Protein Coding gene. Diseases associated with CCM2 include  CCM2L	This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]	This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability after Maraba virus infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased transcriptional activity, 	GO:0001568 GO:0001570 GO:0001570 GO:0001570
MMP2 	MMP2 (Matrix Metallopeptidase 2) is a Protein Coding gene. Diseases associated with MMP2 include  MMP9	This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	Increased gamma-H2AX phosphorylation, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), Decreased nuclei size in G2M, 	GO:0001525 GO:0001541 GO:0001541 GO:0001541 GO:0001542 GO:0001542 GO:0001542 GO:0001553 GO:0001553 GO:0001553 GO:0001666 GO:0001666 GO:0001666
MMP9 	MMP9 (Matrix Metallopeptidase 9) is a Protein Coding gene. Diseases associated with MMP9 include  MMP2	Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased Nanog expression, Decreased HIV-LTR-beta-galactosidase protein expression, Increased NF-kappaB reporter expression, Decreased shRNA abundance, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0001501 GO:0001503 GO:0001503 GO:0001503 GO:0001934 GO:0001934 GO:0001934 GO:0006508
MYL9 	MYL9 (Myosin Light Chain 9) is a Protein Coding gene. Diseases associated with MYL9 include  Microcolon MYL12B	Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene. Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene. no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased replication of vaccinia virus (VACV), 	GO:0006937 GO:0030239 GO:0070527
NEDD4L 	NEDD4L (NEDD4 Like E3 Ubiquitin Protein Ligase) is a Protein Coding gene. Diseases associated with NEDD4L include  NEDD4	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased replication of vaccinia virus (VACV), Two nuclei (binuclear), Decreased viability, 	GO:0000209 GO:0003254 GO:0003254 GO:0003254 GO:0006511 GO:0016567
NF1 	NF1 (Neurofibromin 1) is a Protein Coding gene. Diseases associated with NF1 include  binding RASA3	This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA&gt;UGA-&gt;Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA&gt;UGA-&gt;Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Increased cell migration, Increased shRNA abundance with PLX4720, Decreased shRNA abundance (Z-score &lt; -2), Increased cell number in G1, small nuclei in G1, Decreased sensitivity to paclitaxel, 	 
NF2 	NF2 (NF2, Moesin-Ezrin-Radixin Like (MERLIN) Tumor Suppressor) is a Protein Coding gene. Diseases associated with NF2 include  EZR	This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein\'s function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]	This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein\'s function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Increased viability, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, Decreased cell migration, Decreased Tat-dependent transcription, Increased proliferation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Decreased p24 protein expression, Synthetic lethal with cisplatin, 	GO:0000165 GO:0001707 GO:0001707 GO:0001707 GO:0001953 GO:0001953 GO:0001953
NOTCH4 	NOTCH4 (Notch Receptor 4) is a Protein Coding gene. Diseases associated with NOTCH4 include  Schizophrenia JAG1	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor may play a role in vascular, renal and hepatic development. Mutations in this gene may be associated with schizophrenia. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor may play a role in vascular, renal and hepatic development. Mutations in this gene may be associated with schizophrenia. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	no effect, Decreased viability, Decreased viability ratio, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability (cell death), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0000122 GO:0001569 GO:0001709 GO:0001709 GO:0001709 GO:0001763 GO:0001837 GO:0001837 GO:0001837
PDCD10 	PDCD10 (Programmed Cell Death 10) is a Protein Coding gene. Diseases associated with PDCD10 include 	This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), 	GO:0001525 GO:0003158 GO:0003158 GO:0003158 GO:0006915 GO:0008284 GO:0008284 GO:0008284 GO:0010628
PDGFB 	PDGFB (Platelet Derived Growth Factor Subunit B) is a Protein Coding gene. Diseases associated with PDGFB include  PDGFA	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased substrate adherent cell growth, Increased cell death HMECs cells, 	GO:0001892 GO:0001938 GO:0001938 GO:0001938 GO:0002548 GO:0003104 GO:0006468 GO:0006468 GO:0006468
PDGFRA 	PDGFRA (Platelet Derived Growth Factor Receptor Alpha) is a Protein Coding gene. Diseases associated with PDGFRA include  PDGFRB	This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]	This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Diffuse trans-Golgi, Decreased viability in ovarian lineage; decreased viability in pancreas lineage, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0001553 GO:0001701 GO:0001701 GO:0001701 GO:0001775 GO:0001775 GO:0001775
PDGFRB 	PDGFRB (Platelet Derived Growth Factor Receptor Beta) is a Protein Coding gene. Diseases associated with PDGFRB include  PDGFRA	The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased NF-kappaB reporter expression, Decreased viability in pancreas lineage, Increased cell death HMECs cells, Decreased cell migration, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Decreased cell viability after pRB stimulation, Decreased viability with RAF265, 	GO:0001525 GO:0006024 GO:0006468 GO:0006468 GO:0006468 GO:0006935 GO:0006935 GO:0006935 GO:0007165 GO:0007165 GO:0007165
PIK3C2A 	PIK3C2A (Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Alpha) is a Protein Coding gene. Diseases associated with PIK3C2A include  PIK3C2B	The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is not sensitive to nanomolar levels of the inhibitor wortmanin. This protein was shown to be able to be activated by insulin and may be involved in integrin-dependent signaling. The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is not sensitive to nanomolar levels of the inhibitor wortmanin. This protein was shown to be able to be activated by insulin and may be involved in integrin-dependent signaling. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability, Reduced mammosphere formation, Increased Nanog expression, Increased cell death HMECs cells, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with paclitaxel, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased viability after gemcitabine stimulation, 	GO:0006629 GO:0006661 GO:0006661 GO:0006661 GO:0006887 GO:0006897 GO:0007173
PIK3CA 	PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha) is a Protein Coding gene. Diseases associated with PIK3CA include  PIK3CD	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]	Increased viability, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Decreased HPV16-GFP infection, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Increased cell death in HCT116 cells, Decreased cell migration, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0001525 GO:0001889 GO:0001889 GO:0001889 GO:0001932 GO:0001932 GO:0001932 GO:0001944 GO:0001944 GO:0001944
PIK3CB 	PIK3CB (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta) is a Protein Coding gene. Diseases associated with PIK3CB include  PIK3CD	This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K). These kinases are important in signaling pathways involving receptors on the outer membrane of eukaryotic cells and are named for their catalytic subunit. The encoded protein is the catalytic subunit for PI3Kbeta (PI3KB). PI3KB has been shown to be part of the activation pathway in neutrophils which have bound immune complexes at sites of injury or infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]	This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K). These kinases are important in signaling pathways involving receptors on the outer membrane of eukaryotic cells and are named for their catalytic subunit. The encoded protein is the catalytic subunit for PI3Kbeta (PI3KB). PI3KB has been shown to be part of the activation pathway in neutrophils which have bound immune complexes at sites of injury or infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased IL-8 secretion, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Increased HPV18 LCR reporter activity, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased influenza A/WSN/33 replication, Strongly decreased NFAT1-GFP nuclear translocation, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased cilium length after serum starvation, Decreased cell viability after pRB stimulation, 	GO:0001935 GO:0001952 GO:0001952 GO:0001952 GO:0002931 GO:0003376
PIK3CD 	PIK3CD (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta) is a Protein Coding gene. Diseases associated with PIK3CD include  PIK3CB	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Decreased Sindbis virus (SINV) infection, Decreased cell proliferation, Decreased viability after gemcitabine stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001779 GO:0001819 GO:0001938 GO:0002250
PIK3CG 	PIK3CG (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma) is a Protein Coding gene. Diseases associated with PIK3CG include  binding PIK3CA	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I catalytic subunit of PI3K. Like other class I catalytic subunits (p110-alpha p110-beta, and p110-delta), the encoded protein binds a p85 regulatory subunit to form PI3K. This gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2015]	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I catalytic subunit of PI3K. Like other class I catalytic subunits (p110-alpha p110-beta, and p110-delta), the encoded protein binds a p85 regulatory subunit to form PI3K. This gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2015]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Two nuclei (binuclear), Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Increased cell death HMECs cells, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, Decreased cilium length after serum starvation, Decreased viability after gemcitabine stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Decreased cilium length, 	GO:0001525 GO:0001819 GO:0001819 GO:0001819 GO:0001932 GO:0002250 GO:0002250 GO:0002250
PKNOX1 	PKNOX1 (PBX/Knotted 1 Homeobox 1) is a Protein Coding gene. Diseases associated with PKNOX1 include  PKNOX2	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in angiogenesis and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within camera-type eye development; hemopoiesis; and positive regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasm and nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in angiogenesis and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within camera-type eye development; hemopoiesis; and positive regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasm and nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, 	GO:0001525 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006366
PLCD4 	PLCD4 (Phospholipase C Delta 4) is a Protein Coding gene. Diseases associated with PLCD4 include  PLCD1	This gene encodes a member of the delta class of phospholipase C enzymes. Phospholipase C enzymes play a critical role in many cellular processes by hydrolyzing phosphatidylinositol 4,5-bisphosphate into two intracellular second messengers, inositol 1,4,5-trisphosphate and diacylglycerol. Expression of this gene may be a marker for cancer. [provided by RefSeq, Jan 2011]	This gene encodes a member of the delta class of phospholipase C enzymes. Phospholipase C enzymes play a critical role in many cellular processes by hydrolyzing phosphatidylinositol 4,5-bisphosphate into two intracellular second messengers, inositol 1,4,5-trisphosphate and diacylglycerol. Expression of this gene may be a marker for cancer. [provided by RefSeq, Jan 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance, Decreased viability, 	 
PRKCG 	PRKCG (Protein Kinase C Gamma) is a Protein Coding gene. Diseases associated with PRKCG include  PRKCA	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	no effect, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased substrate adherent cell growth, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Decreased cell viability after pRB stimulation, Increased viability, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	GO:0006468
PRKG1 	PRKG1 (Protein Kinase CGMP-Dependent 1) is a Protein Coding gene. Diseases associated with PRKG1 include  PRKG2	Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]	Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased viability in ovarian lineage, Decreased substrate adherent cell growth, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Increased simian virus 40 (SV40) infection, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased shRNA abundance (Z-score &lt; -2), Decreased nuclei size in G2M, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased viability after gemcitabine stimulation, Transferrin accumulation in small spots in the cell periphery, Many micronuclei (grape), decreased viability (cell death), 	GO:0001764 GO:0006468 GO:0006468 GO:0006468 GO:0007165
PTEN 	PTEN (Phosphatase And Tensin Homolog) is a Protein Coding gene. Diseases associated with PTEN include  TNS1	This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]	This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]	no effect, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased NF-kappaB reporter expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Decreased shRNA abundance (Z-score &lt; -2), Condensed cis-Golgi, condensed medial Golgi, condensed trans-Golgi, Decreased viability in non-small-cell lung cancer (NSCLC) lineage; decreased viability in ovarian lineage, Increased apoptosis, Increased Akt phosphorylation after EGF stimulation, Decreased sensitivity to paclitaxel, Increased resistance to Trastuzumab, 	GO:0001933 GO:0006470 GO:0006470 GO:0006470
PTK2 	PTK2 (Protein Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with PTK2 include  PTK2B	This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Decreased substrate adherent cell growth, Increased circadian period length, Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased simian virus 40 (SV40) infection, Diffuse trans-Golgi, Decreased viability with paclitaxel, Decreased viability in HMC1.1 cells, Decreased viability in CMK cells, 	GO:0001525 GO:0001890 GO:0001932 GO:0001934 GO:0003007
PTPN14 	PTPN14 (Protein Tyrosine Phosphatase Non-Receptor Type 14) is a Protein Coding gene. Diseases associated with PTPN14 include  PTPN21	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, Decreased epidermal growth factor (EGF) endocytosis, Fragmented trans-Golgi, 	GO:0001946 GO:0006351 GO:0006470 GO:0006470 GO:0006470 GO:0008285 GO:0008285 GO:0008285
PTPRB 	PTPRB (Protein Tyrosine Phosphatase Receptor Type B) is a Protein Coding gene. Diseases associated with PTPRB include  PTPRJ	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in ovarian lineage, Decreased viability after Maraba virus infection, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased Akt phosphorylation after EGF stimulation, 	GO:0001525 GO:0006470 GO:0006796 GO:0008347 GO:0016311 GO:0016311 GO:0016311
RAP1A 	RAP1A (RAP1A, Member Of RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAP1A include  RAP1B	This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased viability with SS1P at EC30, Synthetic lethal with imatinib mesylate, 	 
RAP1B 	RAP1B (RAP1B, Member Of RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAP1B include  RAP1A	This gene encodes a member of the RAS-like small GTP-binding protein superfamily. Members of this family regulate multiple cellular processes including cell adhesion and growth and differentiation. This protein localizes to cellular membranes and has been shown to regulate integrin-mediated cell signaling. This protein also plays a role in regulating outside-in signaling in platelets. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 5, 6 and 9. [provided by RefSeq, Oct 2011]	This gene encodes a member of the RAS-like small GTP-binding protein superfamily. Members of this family regulate multiple cellular processes including cell adhesion and growth and differentiation. This protein localizes to cellular membranes and has been shown to regulate integrin-mediated cell signaling. This protein also plays a role in regulating outside-in signaling in platelets. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 5, 6 and 9. [provided by RefSeq, Oct 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), Decreased Tat-dependent transcription, Decreased p24 protein expression, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0008283 GO:0008283 GO:0008283 GO:0017156 GO:0017156 GO:0017156 GO:0030033 GO:0030033 GO:0030033
RASA1 	RASA1 (RAS P21 Protein Activator 1) is a Protein Coding gene. Diseases associated with RASA1 include  SYNGAP1	The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]	The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased cell number and increased metaphase cell number, 	GO:0000281 GO:0001570 GO:0001570 GO:0001570 GO:0001953 GO:0001953 GO:0001953 GO:0007162 GO:0007165
RHOA 	RHOA (Ras Homolog Family Member A) is a Protein Coding gene. Diseases associated with RHOA include  RHOC	This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. Overexpression of this gene is associated with tumor cell proliferation and metastasis. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. Overexpression of this gene is associated with tumor cell proliferation and metastasis. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	Increased gamma-H2AX phosphorylation, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased homologous recombination repair frequency, Increased cell migration, Increased Salmonella enterica Typhimurium invasion, Decreased OCT4 protein expression, Decreased NANOG protein expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased nuclear migration speed, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	 
ROCK1 	ROCK1 (Rho Associated Coiled-Coil Containing Protein Kinase 1) is a Protein Coding gene. Diseases associated with ROCK1 include  ROCK2	This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]	This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]	Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Decreased cell migration, Increased Nanog expression, Decreased viability, Increased cell viability after pRB stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased homologous recombination repair frequency, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Condensed cis-Golgi, Increased telomerase activity, 	GO:0000281 GO:0001837 GO:0003180 GO:0003180 GO:0003180 GO:0003383 GO:0003383 GO:0003383 GO:0006468 GO:0006468 GO:0006468
ROCK2 	ROCK2 (Rho Associated Coiled-Coil Containing Protein Kinase 2) is a Protein Coding gene. Diseases associated with ROCK2 include  ROCK1	The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased viability (proliferation), Increased HPV18 LCR reporter activity, Increased cell death HMECs cells, Decreased viability, Decreased telomerase activity, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased shRNA abundance (Z-score &gt; 2), Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased cell viability after pRB stimulation, toxic, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell spreading, 	GO:0000281 GO:0001837 GO:0001934 GO:0001934 GO:0001934
SERPINI1 	SERPINI1 (Serpin Family I Member 1) is a Protein Coding gene. Diseases associated with SERPINI1 include  SERPINI2	This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Reduced mammosphere formation, Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0007417 GO:0007422 GO:0010466 GO:0010951 GO:0010951 GO:0010951
SH3RF1 	SH3RF1 (SH3 Domain Containing Ring Finger 1) is a Protein Coding gene.  Among its related pathways are  SH3RF3	This gene encodes a protein containing an N-terminus RING-finger, four SH3 domains, and a region implicated in binding of the Rho GTPase Rac. Via the RING-finger, the encoded protein has been shown to function as an ubiquitin-protein ligase involved in protein sorting at the trans-Golgi network. The encoded protein may also act as a scaffold for the c-Jun N-terminal kinase signaling pathway, facilitating the formation of a functional signaling module. This gene encodes a protein containing an N-terminus RING-finger, four SH3 domains, and a region implicated in binding of the Rho GTPase Rac. Via the RING-finger, the encoded protein has been shown to function as an ubiquitin-protein ligase involved in protein sorting at the trans-Golgi network. The encoded protein may also act as a scaffold for the c-Jun N-terminal kinase signaling pathway, facilitating the formation of a functional signaling module. Increased vaccinia virus (VACV) infection, no effect, Increased homologous recombination repair frequency, 	GO:0001764 GO:0009966 GO:0009966 GO:0009966 GO:0016567 GO:0016567 GO:0016567 GO:0032436 GO:0043066
SMAD1 	SMAD1 (SMAD Family Member 1) is a Protein Coding gene. Diseases associated with SMAD1 include  Osteopoikilosis SMAD5	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased viability in pancreas lineage, Increased transcriptional activity, Increased homologous recombination repair frequency, Increased shRNA abundance, Increased cell number in S, High actin ratio cells, 	GO:0000165 GO:0001649 GO:0001649 GO:0001649
SMAD2 	SMAD2 (SMAD Family Member 2) is a Protein Coding gene. Diseases associated with SMAD2 include  SMAD3	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Decreased NF-kappaB reporter expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Moderately decreased NFAT1-GFP nuclear translocation, Synthetic lethal with vaccinia virus (VACV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic index, Decreased vesicular stomatitis virus (VSV) infection, 	 
SMAD4 	SMAD4 (SMAD Family Member 4) is a Protein Coding gene. Diseases associated with SMAD4 include  SMAD5	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in colon lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Increased transcriptional activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased S DNA content, increased G2M DNA content, S arrest, Increased mitotic index, Downregulation of NFkappaB pathway, Synthetic lethal with gemcitabine, Increased sensitivity to paclitaxel, 	GO:0000122 GO:0001541 GO:0001541 GO:0001541 GO:0001649 GO:0001649 GO:0001649 GO:0001658 GO:0001658 GO:0001658 GO:0001666 GO:0001666 GO:0001666
SMAD5 	SMAD5 (SMAD Family Member 5) is a Protein Coding gene. Diseases associated with SMAD5 include  SMAD1	The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased nuclear migration distance, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased vesicular stomatitis virus (VSV) infection, 	 
SMAD6 	SMAD6 (SMAD Family Member 6) is a Protein Coding gene. Diseases associated with SMAD6 include  SMAD7	The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila \'mothers against decapentaplegic\' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]	The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila \'mothers against decapentaplegic\' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0001657 GO:0003148 GO:0003148 GO:0003148 GO:0003170 GO:0003170 GO:0003170 GO:0003180 GO:0003180 GO:0003180
SMAD7 	SMAD7 (SMAD Family Member 7) is a Protein Coding gene. Diseases associated with SMAD7 include  SMAD6	The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]	The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]	Increased vaccinia virus (VACV) infection, no effect, Increased hepcidin::fluc mRNA expression, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Increased Nanog expression, Proliferating cells, 	GO:0000122 GO:0001657 GO:0002725 GO:0002725 GO:0002725 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
SMAD9 	SMAD9 (SMAD Family Member 9) is a Protein Coding gene. Diseases associated with SMAD9 include  SMAD1	The protein encoded by this gene is a member of the SMAD family, which transduces signals from TGF-beta family members. The encoded protein is activated by bone morphogenetic proteins and interacts with SMAD4. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	The protein encoded by this gene is a member of the SMAD family, which transduces signals from TGF-beta family members. The encoded protein is activated by bone morphogenetic proteins and interacts with SMAD4. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased NF-kappaB reporter expression, Decreased shRNA abundance, Increased S DNA content, increased G2M DNA content, Increased CFP-tsO45G cell surface transport, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007179 GO:0009653 GO:0030154
SPRED1 	SPRED1 (Sprouty Related EVH1 Domain Containing 1) is a Protein Coding gene. Diseases associated with SPRED1 include  Neurofibromatosis SPRED2	The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced shRNA abundance in FBW7 KO line, 	GO:0006469 GO:0007275 GO:0009966 GO:0009966 GO:0009966 GO:0010719 GO:0010719 GO:0010719 GO:0010801 GO:0010801 GO:0010801
STAMBP 	STAMBP (STAM Binding Protein) is a Protein Coding gene. Diseases associated with STAMBP include  Deubiquitination STAMBPL1	Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Synthetic lethal with c-Myc after tamoxifen stimulation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0000281 GO:0006508 GO:0007259 GO:0007259 GO:0007259 GO:0008284 GO:0014067
STK11 	STK11 (Serine/Threonine Kinase 11) is a Protein Coding gene. Diseases associated with STK11 include  DCLK2	The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]	The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability, Wnt reporter downregulated, Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased caspase activity, Increased mitotic index, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Increased viability with 4OH tamoxifen, 	GO:0001558 GO:0001894 GO:0001894 GO:0001894 GO:0001944 GO:0001944 GO:0001944 GO:0006468 GO:0006468 GO:0006468 GO:0006470
TEK 	TEK (TEK Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with TEK include  TIE1	This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]	This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Increased mitotic index, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased viability after gemcitabine stimulation, 	GO:0001525 GO:0001934 GO:0001934 GO:0001934 GO:0001935 GO:0001938 GO:0001938 GO:0001938 GO:0002040
TGFBR1 	TGFBR1 (Transforming Growth Factor Beta Receptor 1) is a Protein Coding gene. Diseases associated with TGFBR1 include  ACVR1B	The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased G1 DNA content, G0/1 arrest, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Downregulation of Wnt pathway after Wnt3A stimulation, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased Salmonella proliferation, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Transferrin accumulation in small spots in the cell periphery, Increased vesicular stomatitis virus (VSV) infection, Condensed cis-Golgi, condensed trans-Golgi, 	 
TGFBR2 	TGFBR2 (Transforming Growth Factor Beta Receptor 2) is a Protein Coding gene. Diseases associated with TGFBR2 include  ACVR2A	The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased viability in pancreas lineage, Increased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Increased mitotic index, Decreased viability after gemcitabine stimulation, Increased apoptosis, 	GO:0001568
TIE1 	TIE1 (Tyrosine Kinase With Immunoglobulin Like And EGF Like Domains 1) is a Protein Coding gene. Diseases associated with TIE1 include  Angiosarcoma TEK	This gene encodes a member of the tyrosine protein kinase family. The encoded protein plays a critical role in angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Ectodomain cleavage of the encoded protein relieves inhibition of Tie2 and is mediated by multiple factors including vascular endothelial growth factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	This gene encodes a member of the tyrosine protein kinase family. The encoded protein plays a critical role in angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Ectodomain cleavage of the encoded protein relieves inhibition of Tie2 and is mediated by multiple factors including vascular endothelial growth factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased vesicular stomatitis virus (VSV) infection, Decreased cell migration, Decreased interferon-beta reporter expression, Decreased viability, Increased cell death in HCC-1954 cells, Decreased Hepatitis C virus replication, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	 
TIMP1 	TIMP1 (TIMP Metallopeptidase Inhibitor 1) is a Protein Coding gene. Diseases associated with TIMP1 include  Conjunctivochalasis TIMP2	This gene belongs to the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases (MMPs), a group of peptidases involved in degradation of the extracellular matrix. In addition to its inhibitory role against most of the known MMPs, the encoded protein is able to promote cell proliferation in a wide range of cell types, and may also have an anti-apoptotic function. Transcription of this gene is highly inducible in response to many cytokines and hormones. In addition, the expression from some but not all inactive X chromosomes suggests that this gene inactivation is polymorphic in human females. This gene is located within intron 6 of the synapsin I gene and is transcribed in the opposite direction. This gene belongs to the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases (MMPs), a group of peptidases involved in degradation of the extracellular matrix. In addition to its inhibitory role against most of the known MMPs, the encoded protein is able to promote cell proliferation in a wide range of cell types, and may also have an anti-apoptotic function. Transcription of this gene is highly inducible in response to many cytokines and hormones. In addition, the expression from some but not all inactive X chromosomes suggests that this gene inactivation is polymorphic in human females. This gene is located within intron 6 of the synapsin I gene and is transcribed in the opposite direction. no effect, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, 	GO:0001775 GO:0002248 GO:0002248 GO:0002248 GO:0007165 GO:0007165 GO:0007165 GO:0007568 GO:0007568 GO:0007568 GO:0008284 GO:0008284 GO:0008284
TIMP2 	TIMP2 (TIMP Metallopeptidase Inhibitor 2) is a Protein Coding gene. Diseases associated with TIMP2 include  Conjunctivochalasis Fibrosarcoma TIMP4	This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased cell migration, Decreased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell death in HCT116 cells, Increased focal adhesion (FA) area, decreased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, 	GO:0009725 GO:0010033 GO:0010466 GO:0010466 GO:0010466 GO:0010951 GO:0010951 GO:0010951 GO:0034097
TIMP3 	TIMP3 (TIMP Metallopeptidase Inhibitor 3) is a Protein Coding gene. Diseases associated with TIMP3 include  TIMP4	This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby\'s fundus dystrophy. This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby\'s fundus dystrophy. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased virus production, 	GO:0007601 GO:0009725 GO:0009725 GO:0009725 GO:0010033 GO:0010466 GO:0010466 GO:0010466 GO:0010951 GO:0010951 GO:0010951
VEGFA 	VEGFA (Vascular Endothelial Growth Factor A) is a Protein Coding gene. Diseases associated with VEGFA include  PGF	This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]	This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased Nanog expression, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0000122 GO:0001525 GO:0001541 GO:0001569 GO:0001569 GO:0001569 GO:0001570
VEGFB 	VEGFB (Vascular Endothelial Growth Factor B) is a Protein Coding gene. Diseases associated with VEGFB include  VEGFA	This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011]	This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Decreased cell migration, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Altered focal adhesion (FA) or cell shape morphology, 	GO:0001666 GO:0001934 GO:0001938 GO:0002040
VEGFC 	VEGFC (Vascular Endothelial Growth Factor C) is a Protein Coding gene. Diseases associated with VEGFC include  VEGFD	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors. [provided by RefSeq, Apr 2014]	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors. [provided by RefSeq, Apr 2014]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Decreased viability (cell death), Increased cell migration, Increased CFP-tsO45G cell surface transport, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0001934 GO:0001938 GO:0002040
VEGFR2 	KDR (Kinase Insert Domain Receptor) is a Protein Coding gene. Diseases associated with KDR include  FLT1	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased substrate adherent cell growth, Weakly decreased NFAT1-GFP nuclear translocation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, 	GO:0001525 GO:0001541 GO:0001569 GO:0001569 GO:0001569 GO:0001570 GO:0001934 GO:0001934 GO:0001934
HEYL 	HEYL (Hes Related Family BHLH Transcription Factor With YRPW Motif Like) is a Protein Coding gene. Diseases associated with HEYL include  HEY1	This gene encodes a member of the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcription factors. The sequence of the encoded protein contains a conserved bHLH and orange domain, but its YRPW motif has diverged from other HESR family members. It is thought to be an effector of Notch signaling and a regulator of cell fate decisions. Alternatively spliced transcript variants have been found, but their biological validity has not been determined. This gene encodes a member of the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcription factors. The sequence of the encoded protein contains a conserved bHLH and orange domain, but its YRPW motif has diverged from other HESR family members. It is thought to be an effector of Notch signaling and a regulator of cell fate decisions. Alternatively spliced transcript variants have been found, but their biological validity has not been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, 	GO:0000122 GO:0003151 GO:0003151 GO:0003151 GO:0003180 GO:0003180 GO:0003180
FKBP1A 	FKBP1A (FKBP Prolyl Isomerase 1A) is a Protein Coding gene. Diseases associated with FKBP1A include  FKBP1C	The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The protein is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 and rapamycin. It interacts with several intracellular signal transduction proteins including type I TGF-beta receptor. It also interacts with multiple intracellular calcium release channels, and coordinates multi-protein complex formation of the tetrameric skeletal muscle ryanodine receptor. In mouse, deletion of this homologous gene causes congenital heart disorder known as noncompaction of left ventricular myocardium. Multiple alternatively spliced variants, encoding the same protein, have been identified. The human genome contains five pseudogenes related to this gene, at least one of which is transcribed. [provided by RefSeq, Sep 2008]	The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The protein is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 and rapamycin. It interacts with several intracellular signal transduction proteins including type I TGF-beta receptor. It also interacts with multiple intracellular calcium release channels, and coordinates multi-protein complex formation of the tetrameric skeletal muscle ryanodine receptor. In mouse, deletion of this homologous gene causes congenital heart disorder known as noncompaction of left ventricular myocardium. Multiple alternatively spliced variants, encoding the same protein, have been identified. The human genome contains five pseudogenes related to this gene, at least one of which is transcribed. [provided by RefSeq, Sep 2008]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Decreased viability with paclitaxel, Increased CDKN1A mRNA expression, 	GO:0000413 GO:0003007 GO:0006457 GO:0006457 GO:0006457 GO:0006458 GO:0007183
MYO5A 	MYO5A (Myosin VA) is a Protein Coding gene. Diseases associated with MYO5A include  MYO5B	This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1), Griscelli syndrome type-3 (GS3) and neuroectodermal melanolysosomal disease, or Elejalde disease. Multiple alternatively spliced transcript variants encoding different isoforms have been reported, but the full-length nature of some variants has not been determined. [provided by RefSeq, Dec 2008]	This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1), Griscelli syndrome type-3 (GS3) and neuroectodermal melanolysosomal disease, or Elejalde disease. Multiple alternatively spliced transcript variants encoding different isoforms have been reported, but the full-length nature of some variants has not been determined. [provided by RefSeq, Dec 2008]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Increased shRNA abundance, 	GO:0006892 GO:0007015 GO:0015031 GO:0016192 GO:0016192 GO:0016192 GO:0030048 GO:0030048 GO:0030048
CDC42BPA 	CDC42BPA (CDC42 Binding Protein Kinase Alpha) is a Protein Coding gene. Diseases associated with CDC42BPA include  CDC42BPB	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase contains multiple functional domains. Its kinase domain is highly similar to that of the myotonic dystrophy protein kinase (DMPK). This kinase also contains a Rac interactive binding (CRIB) domain, and has been shown to bind CDC42. It may function as a CDC42 downstream effector mediating CDC42 induced peripheral actin formation, and promoting cytoskeletal reorganization. Multiple alternatively spliced transcript variants have been described. [provided by RefSeq, Sep 2018]	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase contains multiple functional domains. Its kinase domain is highly similar to that of the myotonic dystrophy protein kinase (DMPK). This kinase also contains a Rac interactive binding (CRIB) domain, and has been shown to bind CDC42. It may function as a CDC42 downstream effector mediating CDC42 induced peripheral actin formation, and promoting cytoskeletal reorganization. Multiple alternatively spliced transcript variants have been described. [provided by RefSeq, Sep 2018]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Increased Nanog expression, Decreased vesicular stomatitis virus (VSV) infection, Transferrin accumulation in the perinuclear area, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Decreased interferon-beta reporter expression, Increased cell viability after pRB stimulation, Decreased substrate adherent cell growth, Increased mitotic index, Synthetic lethal with gemcitabine, Condensed medial Golgi, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased apoptosis, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, 	GO:0006468 GO:0007010 GO:0016310 GO:0016310 GO:0016310 GO:0016477 GO:0016477 GO:0016477 GO:0018107
HACE1 	HACE1 (HECT Domain And Ankyrin Repeat Containing E3 Ubiquitin Protein Ligase 1) is a Protein Coding gene. Diseases associated with HACE1 include  Neuroblastoma HUWE1	This gene encodes a HECT domain and ankyrin repeat-containing ubiquitin ligase. The encoded protein is involved in specific tagging of target proteins, leading to their subcellular localization or proteasomal degradation. The protein is a potential tumor suppressor and is involved in the pathophysiology of several tumors, including Wilm\'s tumor. [provided by RefSeq, Mar 2016]	This gene encodes a HECT domain and ankyrin repeat-containing ubiquitin ligase. The encoded protein is involved in specific tagging of target proteins, leading to their subcellular localization or proteasomal degradation. The protein is a potential tumor suppressor and is involved in the pathophysiology of several tumors, including Wilm\'s tumor. [provided by RefSeq, Mar 2016]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Synthetic lethal with Ras, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Synthetic lethal with paclitaxel, 	GO:0000209 GO:0006511 GO:0007030 GO:0007049 GO:0016567 GO:0016567 GO:0016567
PPP1R15A 	PPP1R15A (Protein Phosphatase 1 Regulatory Subunit 15A) is a Protein Coding gene. Diseases associated with PPP1R15A include  PPP1R15B	This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The induction of this gene by ionizing radiation occurs in certain cell lines regardless of p53 status, and its protein response is correlated with apoptosis following ionizing radiation. This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The induction of this gene by ionizing radiation occurs in certain cell lines regardless of p53 status, and its protein response is correlated with apoptosis following ionizing radiation. no effect, shRNA abundance &lt;= 50%, Decreased melanin production, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased homologous recombination repair frequency, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0006417 GO:0006915 GO:0006915 GO:0006915 GO:0006974 GO:0031400 GO:0032058 GO:0032058 GO:0032058
TRIO 	TRIO (Trio Rho Guanine Nucleotide Exchange Factor) is a Protein Coding gene. Diseases associated with TRIO include  KALRN	This gene encodes a large protein that functions as a GDP to GTP exchange factor. This protein promotes the reorganization of the actin cytoskeleton, thereby playing a role in cell migration and growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	This gene encodes a large protein that functions as a GDP to GTP exchange factor. This protein promotes the reorganization of the actin cytoskeleton, thereby playing a role in cell migration and growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased vesicular stomatitis virus (VSV) infection, Decreased NF-kappaB reporter expression, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased simian virus 40 (SV40) infection, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0006468 GO:0007185 GO:0007185 GO:0007185 GO:0007411
PTN 	PTN (Pleiotrophin) is a Protein Coding gene. Diseases associated with PTN include  MDK	The protein encoded by this gene is a secreted heparin-binding growth factor. The protein has significant roles in cell growth and survival, cell migration, angiogenesis and tumorigenesis. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]	The protein encoded by this gene is a secreted heparin-binding growth factor. The protein has significant roles in cell growth and survival, cell migration, angiogenesis and tumorigenesis. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]	no effect, Decreased vaccinia virus (VACV) infection, 	GO:0001503 GO:0002232 GO:0002232 GO:0002232 GO:0002690 GO:0002690 GO:0002690 GO:0007165 GO:0007165 GO:0007165 GO:0007185 GO:0007185 GO:0007185
CSK 	CSK (C-Terminal Src Kinase) is a Protein Coding gene. Diseases associated with CSK include  Osteopetrosis MATK	The protein encoded by this gene is involved in multiple pathways, including the regulation of Src family kinases. It plays an important role in T-cell activation through its association with the protein encoded by the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene. This protein also phosphorylates C-terminal tyrosine residues on multiple substrates, including the protein encoded by the SRC proto-oncogene, non-receptor tyrosine kinase gene. Phosphorylation suppresses the kinase activity of the Src family tyrosine kinases. An intronic polymorphism (rs34933034) in this gene has been found to affect B-cell activation and is associated with systemic lupus erythematosus (SLE). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is involved in multiple pathways, including the regulation of Src family kinases. It plays an important role in T-cell activation through its association with the protein encoded by the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene. This protein also phosphorylates C-terminal tyrosine residues on multiple substrates, including the protein encoded by the SRC proto-oncogene, non-receptor tyrosine kinase gene. Phosphorylation suppresses the kinase activity of the Src family tyrosine kinases. An intronic polymorphism (rs34933034) in this gene has been found to affect B-cell activation and is associated with systemic lupus erythematosus (SLE). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]	no effect, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Wnt reporter downregulated, Decreased NF-kappaB reporter expression, Increased viability (proliferation), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Salmonella enterica Typhimurium effector injection, Decreased Salmonella enterica Typhimurium ruffling, Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased S DNA content, Decreased substrate adherent cell growth, Proliferating cells, Cell division defect, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, Increased mitotic index, Synthetic lethal with gemcitabine, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, decreased cell elongation, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0006468 GO:0006468 GO:0006468
TRPC6 	TRPC6 (Transient Receptor Potential Cation Channel Subfamily C Member 6) is a Protein Coding gene. Diseases associated with TRPC6 include  binding TRPC3	The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]	The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]     
carddis" GO:0006811 5 IEA 3 5 involved_in TAS 5 IEA 3 5 involved_in IEA 3 5 involved_in IBA	 
ZBTB16 	ZBTB16 (Zinc Finger And BTB Domain Containing 16) is a Protein Coding gene. Diseases associated with ZBTB16 include  ZBTB32	This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL). Alternate transcriptional splice variants have been characterized. This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL). Alternate transcriptional splice variants have been characterized.  Gene Ontology (GO) annotations related to this gene include  ZBTB32Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage; decreased viability in ovarian lineage, Increased Salmonella proliferation, 	GO:0000122 GO:0001501 GO:0001823 GO:0001823 GO:0001823 GO:0006355 GO:0006357 GO:0006357 GO:0006357
JUNB 	JUNB (JunB Proto-Oncogene, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with JUNB include  Lymphoma JUN	Enables sequence-specific double-stranded DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription factor AP-1 complex. Biomarker of Hodgkin\'s lymphoma and anaplastic large cell lymphoma. [provided by Alliance of Genome Resources, Apr 2022]	Enables sequence-specific double-stranded DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription factor AP-1 complex. Biomarker of Hodgkin\'s lymphoma and anaplastic large cell lymphoma. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability in pancreas lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), 	 
NRP1 	NRP1 (Neuropilin 1) is a Protein Coding gene. Diseases associated with NRP1 include  NRP2	This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Nov 2020]	This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Nov 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased cell migration, Increased resistance to Trastuzumab, Increased peripheral focal adhesion (FA) formation, increased cell elongation, decreased cell spreading, 	GO:0001525 GO:0001569 GO:0001570 GO:0001755
BCL2L1 	BCL2L1 (BCL2 Like 1) is a Protein Coding gene. Diseases associated with BCL2L1 include  BCL2	The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Alternative splicing results in multiple transcript variants encoding two different isoforms. The longer isoform acts as an apoptotic inhibitor and the shorter isoform acts as an apoptotic activator. [provided by RefSeq, Dec 2015]	The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Alternative splicing results in multiple transcript variants encoding two different isoforms. The longer isoform acts as an apoptotic inhibitor and the shorter isoform acts as an apoptotic activator. [provided by RefSeq, Dec 2015]	no effect, Synthetic lethal with Ras, Lamellipodia cells, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased viability (cell death), Increased epidermal growth factor (EGF) endocytosis, Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased Sindbis virus (SINV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with cisplatin, Decreased viability with paclitaxel, 	GO:0001541 GO:0001701 GO:0001701 GO:0001701 GO:0001836 GO:0001836 GO:0001836
NGF 	NGF (Nerve Growth Factor) is a Protein Coding gene. Diseases associated with NGF include  NTF3	This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene\'s expression is associated with allergic rhinitis. This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene\'s expression is associated with allergic rhinitis. Decreased hepcidin::fluc mRNA expression, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, 	GO:0007169 GO:0007422 GO:0007613 GO:0007613 GO:0007613 GO:0008285 GO:0008625
BDKRB2 	BDKRB2 (Bradykinin Receptor B2) is a Protein Coding gene. Diseases associated with BDKRB2 include  BDKRB1	This gene encodes a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. Bradykinin is released upon activation by pathophysiologic conditions such as trauma and inflammation, and binds to its kinin receptors, B1 and B2. The B2 receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system. [provided by RefSeq, Apr 2020]	This gene encodes a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. Bradykinin is released upon activation by pathophysiologic conditions such as trauma and inflammation, and binds to its kinin receptors, B1 and B2. The B2 receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system. [provided by RefSeq, Apr 2020]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Increased G1 DNA content, G0/1 arrest, Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased telomerase activity, Increased cell transformation, 	GO:0006939 GO:0006954 GO:0007165 GO:0007166 GO:0007166 GO:0007166 GO:0007169
THBS1 	THBS1 (Thrombospondin 1) is a Protein Coding gene. Diseases associated with THBS1 include  Pseudoachondroplasia THBS2	The protein encoded by this gene is a subunit of a disulfide-linked homotrimeric protein. This protein is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. This protein can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1. This protein has been shown to play roles in platelet aggregation, angiogenesis, and tumorigenesis. The protein encoded by this gene is a subunit of a disulfide-linked homotrimeric protein. This protein is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. This protein can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1. This protein has been shown to play roles in platelet aggregation, angiogenesis, and tumorigenesis. /strong view P07996 ENSP00000260356 UniProtKB STRING IID Symbol Details CD36 P16671 4 118 ENSP00000399421 19 FN1 P02751 4 118 ENSP00000346839 19 HTRA1 Q92743 4 118 ENSP00000357980 19	 
t=""_bla" 	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased epidermal growth factor (EGF) endocytosis, GO:0001666 3 5 involved_in NAS 3 5 involved_in 3 5 involved_in IDA 3 5 involved_in IMP 3 5 involved_in IEP 
EDF1 	EDF1 (Endothelial Differentiation Related Factor 1) is a Protein Coding gene. Diseases associated with EDF1 include 	This gene encodes a protein that may regulate endothelial cell differentiation, lipid metabolism, and hormone-induced cardiomyocyte hypertrophy. The encoded protein has also been found to act as a transcriptional coactivator by interconnecting the general transcription factor TATA element-binding protein (TBP) and gene-specific activators. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	This gene encodes a protein that may regulate endothelial cell differentiation, lipid metabolism, and hormone-induced cardiomyocyte hypertrophy. The encoded protein has also been found to act as a transcriptional coactivator by interconnecting the general transcription factor TATA element-binding protein (TBP) and gene-specific activators. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Decreased POU5F1-GFP protein expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased OCT4 protein expression, Decreased NANOG protein expression, Synthetic lethal with imatinib mesylate, Increased shRNA abundance (Z-score &gt; 2), 	GO:0006355 GO:0019216 GO:0030154 GO:0043388 GO:0043388 GO:0043388 GO:0045446
CTTNBP2 	CTTNBP2 (Cortactin Binding Protein 2) is a Protein Coding gene. Diseases associated with CTTNBP2 include  TANC1	This gene encodes a protein with six ankyrin repeats and several proline-rich regions. A similar gene in rat interacts with a central regulator of the actin cytoskeleton. This gene encodes a protein with six ankyrin repeats and several proline-rich regions. A similar gene in rat interacts with a central regulator of the actin cytoskeleton. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Synthetic lethal with Ras, Decreased viability ratio, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0007420 GO:0050807 GO:0050807 GO:0050807
MYL12B 	MYL12B (Myosin Light Chain 12B) is a Protein Coding gene. Diseases associated with MYL12B include  MYL12A	The activity of nonmuscle myosin II (see MYH9; MIM 160775) is regulated by phosphorylation of a regulatory light chain, such as MRLC2. This phosphorylation results in higher MgATPase activity and the assembly of myosin II filaments (Iwasaki et al., 2001 [PubMed 11942626]).[supplied by OMIM, Mar 2008]	The activity of nonmuscle myosin II (see MYH9; MIM 160775) is regulated by phosphorylation of a regulatory light chain, such as MRLC2. This phosphorylation results in higher MgATPase activity and the assembly of myosin II filaments (Iwasaki et al., 2001 [PubMed 11942626]).[supplied by OMIM, Mar 2008]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	 
GAB2 	GAB2 (GRB2 Associated Binding Protein 2) is a Protein Coding gene. Diseases associated with GAB2 include  GAB4	This gene is a member of the GRB2-associated binding protein (GAB) gene family. These proteins contain pleckstrin homology (PH) domain, and bind SHP2 tyrosine phosphatase and GRB2 adapter protein. They act as adapters for transmitting various signals in response to stimuli through cytokine and growth factor receptors, and T- and B-cell antigen receptors. The protein encoded by this gene is the principal activator of phosphatidylinositol-3 kinase in response to activation of the high affinity IgE receptor. Two alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2009]	This gene is a member of the GRB2-associated binding protein (GAB) gene family. These proteins contain pleckstrin homology (PH) domain, and bind SHP2 tyrosine phosphatase and GRB2 adapter protein. They act as adapters for transmitting various signals in response to stimuli through cytokine and growth factor receptors, and T- and B-cell antigen receptors. The protein encoded by this gene is the principal activator of phosphatidylinositol-3 kinase in response to activation of the high affinity IgE receptor. Two alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased homologous recombination repair frequency, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0007165 GO:0007169 GO:0008284 GO:0008284 GO:0008284 GO:0030316
MAPK8IP3 	MAPK8IP3 (Mitogen-Activated Protein Kinase 8 Interacting Protein 3) is a Protein Coding gene. Diseases associated with MAPK8IP3 include  SPAG9	The protein encoded by this gene shares similarity with the product of Drosophila syd gene, required for the functional interaction of kinesin I with axonal cargo. Studies of the similar gene in mouse suggested that this protein may interact with, and regulate the activity of numerous protein kinases of the JNK signaling pathway, and thus function as a scaffold protein in neuronal cells. The C. elegans counterpart of this gene is found to regulate synaptic vesicle transport possibly by integrating JNK signaling and kinesin-1 transport. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. The protein encoded by this gene shares similarity with the product of Drosophila syd gene, required for the functional interaction of kinesin I with axonal cargo. Studies of the similar gene in mouse suggested that this protein may interact with, and regulate the activity of numerous protein kinases of the JNK signaling pathway, and thus function as a scaffold protein in neuronal cells. The C. elegans counterpart of this gene is found to regulate synaptic vesicle transport possibly by integrating JNK signaling and kinesin-1 transport. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, 	GO:0016192 GO:0031103 GO:0031103 GO:0031103 GO:0043066 GO:0043066 GO:0043066
HIF3A 	HIF3A (Hypoxia Inducible Factor 3 Subunit Alpha) is a Protein Coding gene. Diseases associated with HIF3A include  EPAS1	The protein encoded by this gene is the alpha-3 subunit of one of several alpha/beta-subunit heterodimeric transcription factors that regulate many adaptive responses to low oxygen tension (hypoxia). The alpha-3 subunit lacks the transactivation domain found in factors containing either the alpha-1 or alpha-2 subunits. It is thought that factors containing the alpha-3 subunit are negative regulators of hypoxia-inducible gene expression. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2011]	The protein encoded by this gene is the alpha-3 subunit of one of several alpha/beta-subunit heterodimeric transcription factors that regulate many adaptive responses to low oxygen tension (hypoxia). The alpha-3 subunit lacks the transactivation domain found in factors containing either the alpha-1 or alpha-2 subunits. It is thought that factors containing the alpha-3 subunit are negative regulators of hypoxia-inducible gene expression. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2011]	no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with imatinib mesylate, Increased HPV16-GFP infection, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
RGL2 	RGL2 (Ral Guanine Nucleotide Dissociation Stimulator Like 2) is a Protein Coding gene. Diseases associated with RGL2 include  Calcinosis RALGDS	Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity and small GTPase mediated signal transduction. Predicted to act upstream of or within negative regulation of cardiac muscle cell apoptotic process; positive regulation of phosphatidylinositol 3-kinase signaling; and regulation of Ral protein signal transduction. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity and small GTPase mediated signal transduction. Predicted to act upstream of or within negative regulation of cardiac muscle cell apoptotic process; positive regulation of phosphatidylinositol 3-kinase signaling; and regulation of Ral protein signal transduction. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Increased HPV18 LCR reporter activity, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with vaccinia virus (VACV) infection, Decreased nuclei size in G2M, Multipolar spindles, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0007265 GO:0007265 GO:0007265
IGFBP7 	IGFBP7 (Insulin Like Growth Factor Binding Protein 7) is a Protein Coding gene. Diseases associated with IGFBP7 include  IGFBPL1	This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm (PMID:21835307). [provided by RefSeq, Dec 2011]	This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm (PMID:21835307). [provided by RefSeq, Dec 2011]	no effect, Decreased ionizing radiation sensitivity, Negative genetic interaction between MUS81-/- and MUS81+/+, Low eccentricity cells, Increased proliferation, 	GO:0001558 GO:0007155 GO:0007155 GO:0007155 GO:0007566 GO:0008285 GO:0008285 GO:0008285
S100B 	S100B (S100 Calcium Binding Protein B) is a Protein Coding gene. Diseases associated with S100B include  Syringoma Neurofibroma S100A1	The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer\'s disease, Down\'s syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer\'s disease, Down\'s syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0007409 GO:0007417 GO:0007611 GO:0007613 GO:0007613 GO:0007613 GO:0008284 GO:0008284 GO:0008284
RAP1B 	RAP1B (RAP1B, Member Of RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAP1B include  RAP1A	This gene encodes a member of the RAS-like small GTP-binding protein superfamily. Members of this family regulate multiple cellular processes including cell adhesion and growth and differentiation. This protein localizes to cellular membranes and has been shown to regulate integrin-mediated cell signaling. This protein also plays a role in regulating outside-in signaling in platelets. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 5, 6 and 9. [provided by RefSeq, Oct 2011]	This gene encodes a member of the RAS-like small GTP-binding protein superfamily. Members of this family regulate multiple cellular processes including cell adhesion and growth and differentiation. This protein localizes to cellular membranes and has been shown to regulate integrin-mediated cell signaling. This protein also plays a role in regulating outside-in signaling in platelets. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 5, 6 and 9. [provided by RefSeq, Oct 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), Decreased Tat-dependent transcription, Decreased p24 protein expression, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0008283 GO:0008283 GO:0008283 GO:0017156 GO:0017156 GO:0017156 GO:0030033 GO:0030033 GO:0030033
CORO1A 	CORO1A (Coronin 1A) is a Protein Coding gene. Diseases associated with CORO1A include  Disease CORO1B	This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Alternative splicing results in multiple transcript variants. A related pseudogene has been defined on chromosome 16. [provided by RefSeq, Sep 2010]	This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Alternative splicing results in multiple transcript variants. A related pseudogene has been defined on chromosome 16. [provided by RefSeq, Sep 2010]	no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Negative genetic interaction between BLM-/- and BLM+/+, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, 	GO:0001771 GO:0001845 GO:0006816 GO:0006906 GO:0006906 GO:0006906 GO:0006909 GO:0006909 GO:0006909
RASA1 	RASA1 (RAS P21 Protein Activator 1) is a Protein Coding gene. Diseases associated with RASA1 include  SYNGAP1	The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]	The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased cell number and increased metaphase cell number, 	GO:0000281 GO:0001570 GO:0001570 GO:0001570 GO:0001953 GO:0001953 GO:0001953 GO:0007162 GO:0007165
ARHGEF28 	ARHGEF28 (Rho Guanine Nucleotide Exchange Factor 28) is a Protein Coding gene. Diseases associated with ARHGEF28 include  ARHGEF18	This gene encodes a member of the Rho guanine nucleotide exchange factor family. The encoded protein interacts with low molecular weight neurofilament mRNA and may be involved in the formation of amyotrophic lateral sclerosis neurofilament aggregates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]	This gene encodes a member of the Rho guanine nucleotide exchange factor family. The encoded protein interacts with low molecular weight neurofilament mRNA and may be involved in the formation of amyotrophic lateral sclerosis neurofilament aggregates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]	Decreased viability, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, 	GO:0000902 GO:0030154 GO:0035023 GO:0035023 GO:0035023
INHBA 	INHBA (Inhibin Subunit Beta A) is a Protein Coding gene. Diseases associated with INHBA include  INHBB	This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate a subunit of the dimeric activin and inhibin protein complexes. These complexes activate and inhibit, respectively, follicle stimulating hormone secretion from the pituitary gland. The encoded protein also plays a role in eye, tooth and testis development. Elevated expression of this gene may be associated with cancer cachexia in human patients. [provided by RefSeq, Aug 2016]	This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate a subunit of the dimeric activin and inhibin protein complexes. These complexes activate and inhibit, respectively, follicle stimulating hormone secretion from the pituitary gland. The encoded protein also plays a role in eye, tooth and testis development. Elevated expression of this gene may be associated with cancer cachexia in human patients. [provided by RefSeq, Aug 2016]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased HPV16-GFP infection, Polylobed nuclei, large nuclei, 	GO:0001541 GO:0001707 GO:0001934 GO:0001934 GO:0001934 GO:0001942 GO:0001942 GO:0001942 GO:0002244
WASF3 	WASF3 (WASP Family Member 3) is a Protein Coding gene. Diseases associated with WASF3 include  Ganglioneuroblastoma WASF1	This gene encodes a member of the Wiskott-Aldrich syndrome protein family. The gene product is a protein that forms a multiprotein complex that links receptor kinases and actin. Binding to actin occurs through a C-terminal verprolin homology domain in all family members. The multiprotein complex serves to tranduce signals that involve changes in cell shape, motility or function. A pseudogene of this gene have been defined on chromosome 6. Alternative splicing results in multiple transcript variants [provided by RefSeq, May 2014]	This gene encodes a member of the Wiskott-Aldrich syndrome protein family. The gene product is a protein that forms a multiprotein complex that links receptor kinases and actin. Binding to actin occurs through a C-terminal verprolin homology domain in all family members. The multiprotein complex serves to tranduce signals that involve changes in cell shape, motility or function. A pseudogene of this gene have been defined on chromosome 6. Alternative splicing results in multiple transcript variants [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, Decreased vaccinia virus (VACV) infection, no effect, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased the percentage of infected cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0007010 GO:0008360 GO:0014003 GO:0030032 GO:0030032 GO:0030032 GO:0030036 GO:0030036 GO:0030036
IL33 	IL33 (Interleukin 33) is a Protein Coding gene. Diseases associated with IL33 include 	The protein encoded by this gene is a cytokine that binds to the IL1RL1/ST2 receptor. The encoded protein is involved in the maturation of Th2 cells and the activation of mast cells, basophils, eosinophils and natural killer cells. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]	The protein encoded by this gene is a cytokine that binds to the IL1RL1/ST2 receptor. The encoded protein is involved in the maturation of Th2 cells and the activation of mast cells, basophils, eosinophils and natural killer cells. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased NF-kappaB reporter expression, 	GO:0000122 GO:0001819
ADAMTS14 	ADAMTS14 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 14) is a Protein Coding gene. Diseases associated with ADAMTS14 include  ADAMTS3	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme cleaves amino-terminal propeptides from type I procollagen, a necessary step in the formation of collagen fibers. Mutations in this gene may be associated with osteoarthritis in human patients. [provided by RefSeq, May 2016]	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme cleaves amino-terminal propeptides from type I procollagen, a necessary step in the formation of collagen fibers. Mutations in this gene may be associated with osteoarthritis in human patients. [provided by RefSeq, May 2016]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Decreased cell number, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006508 GO:0030198 GO:0030198 GO:0030198
LMX1A 	LMX1A (LIM Homeobox Transcription Factor 1 Alpha) is a Protein Coding gene. Diseases associated with LMX1A include  LMX1B	This gene encodes a homeodomain and LIM-domain containing protein. The encoded protein is a transcription factor that acts as a positive regulator of insulin gene transcription. This gene also plays a role in the development of dopamine producing neurons during embryogenesis. Mutations in this gene are associated with an increased risk of developing Parkinson\'s disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]	This gene encodes a homeodomain and LIM-domain containing protein. The encoded protein is a transcription factor that acts as a positive regulator of insulin gene transcription. This gene also plays a role in the development of dopamine producing neurons during embryogenesis. Mutations in this gene are associated with an increased risk of developing Parkinson\'s disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Two nuclei (binuclear), Decreased NF-kappaB reporter expression, Decreased viability in pancreas lineage, Decreased viability of wild-type and TP53 knockout cells, 	GO:0001558 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
SYNJ2BP 	SYNJ2BP (Synaptojanin 2 Binding Protein) is a Protein Coding gene. Diseases associated with SYNJ2BP include  Brucellosis KIAA1614	Predicted to enable type II activin receptor binding activity. Involved in several processes, including negative regulation of endothelial cell migration; negative regulation of sprouting angiogenesis; and regulation of signal transduction. Located in mitochondrion. Is integral component of mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable type II activin receptor binding activity. Involved in several processes, including negative regulation of endothelial cell migration; negative regulation of sprouting angiogenesis; and regulation of signal transduction. Located in mitochondrion. Is integral component of mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Inconclusive, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, 	GO:0001937 GO:0006605 GO:0007266 GO:0007266 GO:0007266 GO:0007268 GO:0007268 GO:0007268 GO:0008593 GO:0008593 GO:0008593
KCNJ1 	KCNJ1 (Potassium Inwardly Rectifying Channel Subfamily J Member 1) is a Protein Coding gene. Diseases associated with KCNJ1 include  KCNJ10	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. It is activated by internal ATP and probably plays an important role in potassium homeostasis. The encoded protein has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Mutations in this gene have been associated with antenatal Bartter syndrome, which is characterized by salt wasting, hypokalemic alkalosis, hypercalciuria, and low blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. It is activated by internal ATP and probably plays an important role in potassium homeostasis. The encoded protein has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Mutations in this gene have been associated with antenatal Bartter syndrome, which is characterized by salt wasting, hypokalemic alkalosis, hypercalciuria, and low blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased circadian period length, 	GO:0006811 GO:0006813 GO:0006813 GO:0006813 GO:0034220 GO:0034220 GO:0034220 GO:0034765 GO:0034765 GO:0034765
SCNN1A 	SCNN1A (Sodium Channel Epithelial 1 Subunit Alpha) is a Protein Coding gene. Diseases associated with SCNN1A include  SCNN1D	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009]	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0006811 GO:0006814 GO:0006814 GO:0006814 GO:0006883 GO:0006883 GO:0006883 GO:0008217 GO:0035725
IV 	IV (Inversus Situs, Viscerum) is a Genetic Locus.     
FOXM1 	FOXM1 (Forkhead Box M1) is a Protein Coding gene. Diseases associated with FOXM1 include  FOXN1	The protein encoded by this gene is a transcriptional activator involved in cell proliferation. The encoded protein is phosphorylated in M phase and regulates the expression of several cell cycle genes, such as cyclin B1 and cyclin D1. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]	The protein encoded by this gene is a transcriptional activator involved in cell proliferation. The encoded protein is phosphorylated in M phase and regulates the expression of several cell cycle genes, such as cyclin B1 and cyclin D1. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Inconclusive, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with TRAIL, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), 	GO:0000086 GO:0000122
MAPK12 	MAPK12 (Mitogen-Activated Protein Kinase 12) is a Protein Coding gene. Diseases associated with MAPK12 include  MAPK13	Activation of members of the mitogen-activated protein kinase family is a major mechanism for transduction of extracellular signals. Stress-activated protein kinases are one subclass of MAP kinases. The protein encoded by this gene functions as a signal transducer during differentiation of myoblasts to myotubes. Activation of members of the mitogen-activated protein kinase family is a major mechanism for transduction of extracellular signals. Stress-activated protein kinases are one subclass of MAP kinases. The protein encoded by this gene functions as a signal transducer during differentiation of myoblasts to myotubes. Increased vaccinia virus (VACV) infection, Increased viability, no effect, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007049 GO:0007049 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0007517
GRK2 	GRK2 (G Protein-Coupled Receptor Kinase 2) is a Protein Coding gene. Diseases associated with GRK2 include  GRK3	This gene encodes a member of the G protein-coupled receptor kinase family of proteins. The encoded protein phosphorylates the beta-adrenergic receptor as well as a wide range of other substrates including non-GPCR cell surface receptors, and cytoskeletal, mitochondrial, and transcription factor proteins. Data from rodent models supports a role for this gene in embryonic development, heart function and metabolism. Elevated expression of this gene has been observed in human patients with heart failure and Alzheimer\'s disease. [provided by RefSeq, Sep 2017]	This gene encodes a member of the G protein-coupled receptor kinase family of proteins. The encoded protein phosphorylates the beta-adrenergic receptor as well as a wide range of other substrates including non-GPCR cell surface receptors, and cytoskeletal, mitochondrial, and transcription factor proteins. Data from rodent models supports a role for this gene in embryonic development, heart function and metabolism. Elevated expression of this gene has been observed in human patients with heart failure and Alzheimer\'s disease. [provided by RefSeq, Sep 2017]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased HIV-LTR-beta-galactosidase protein expression, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Downregulation of Wnt pathway after Wnt3A stimulation, Small cells, Decreased HIV-1 infection, Decreased cell migration, Increased mitotic index, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Increased cell number in G2M, increased nuclei size in G2M, Decreased viability after gemcitabine stimulation, Misorientated spindle, 	GO:0002026 GO:0002029 GO:0003108 GO:0003108 GO:0003108 GO:0006468
PRKAR2B 	PRKAR2B (Protein Kinase CAMP-Dependent Type II Regulatory Subunit Beta) is a Protein Coding gene. Diseases associated with PRKAR2B include  PRKAR2A	cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol. cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. This subunit has been shown to interact with and suppress the transcriptional activity of the cAMP responsive element binding protein 1 (CREB1) in activated T cells. Knockout studies in mice suggest that this subunit may play an important role in regulating energy balance and adiposity. The studies also suggest that this subunit may mediate the gene induction and cataleptic behavior induced by haloperidol. no effect, Synthetic lethal with Ras, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Decreased cell migration, Paclitaxel antagonistic effect, Decreased viability after gemcitabine stimulation, 	GO:0001932 GO:0006631 GO:0006631 GO:0006631 GO:0007612 GO:0007612 GO:0007612 GO:0016310 GO:0016310 GO:0016310 GO:0035556 GO:0035556 GO:0035556
ARC 	ARC (Activity Regulated Cytoskeleton Associated Protein) is a Protein Coding gene. Diseases associated with ARC include 	Predicted to enable mRNA binding activity. Involved in cell migration; cytoskeleton organization; and regulation of cell morphogenesis. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable mRNA binding activity. Involved in cell migration; cytoskeleton organization; and regulation of cell morphogenesis. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance, Decreased homologous recombination repair frequency, Decreased viability with paclitaxel, 	GO:0006897 GO:0007010 GO:0007010 GO:0007010 GO:0007492 GO:0007612 GO:0007612 GO:0007612 GO:0007616 GO:0007616 GO:0007616
PIK3R2 	PIK3R2 (Phosphoinositide-3-Kinase Regulatory Subunit 2) is a Protein Coding gene. Diseases associated with PIK3R2 include  PIK3R1	Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Three transcript variants, one protein coding and the other two non-protein coding, have been found for this gene. [provided by RefSeq, Apr 2019]	Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Three transcript variants, one protein coding and the other two non-protein coding, have been found for this gene. [provided by RefSeq, Apr 2019]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased cell migration, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Nanog expression, Decreased homologous recombination repair frequency, Strongly decreased NFAT1-GFP nuclear translocation, Decreased viability after gemcitabine stimulation, Increased apoptosis, 	GO:0001678 GO:0006955 GO:0006955 GO:0006955 GO:0007165 GO:0008286 GO:0008286 GO:0008286 GO:0010506
STRIP1 	STRIP1 (Striatin Interacting Protein 1) is a Protein Coding gene. Diseases associated with STRIP1 include  STRIP2	This gene encodes a member of the striatin-interacting phosphatase and kinase complex, which is involved in localization of the Golgi body. The encoded protein participates in cytosketelal organization. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	This gene encodes a member of the striatin-interacting phosphatase and kinase complex, which is involved in localization of the Golgi body. The encoded protein participates in cytosketelal organization. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	no effect, Increased IL-8 secretion, Increased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0007010 GO:0022604 GO:0030866
CFL1 	CFL1 (Cofilin 1) is a Protein Coding gene. Diseases associated with CFL1 include  CFL2	The protein encoded by this gene can polymerize and depolymerize F-actin and G-actin in a pH-dependent manner. Increased phosphorylation of this protein by LIM kinase aids in Rho-induced reorganization of the actin cytoskeleton. Cofilin is a widely distributed intracellular actin-modulating protein that binds and depolymerizes filamentous F-actin and inhibits the polymerization of monomeric G-actin in a pH-dependent manner. It is involved in the translocation of actin-cofilin complex from cytoplasm to nucleus.[supplied by OMIM, Apr 2004]	The protein encoded by this gene can polymerize and depolymerize F-actin and G-actin in a pH-dependent manner. Increased phosphorylation of this protein by LIM kinase aids in Rho-induced reorganization of the actin cytoskeleton. Cofilin is a widely distributed intracellular actin-modulating protein that binds and depolymerizes filamentous F-actin and inhibits the polymerization of monomeric G-actin in a pH-dependent manner. It is involved in the translocation of actin-cofilin complex from cytoplasm to nucleus.[supplied by OMIM, Apr 2004]	no effect, Synthetic lethal with Ras, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, shRNA abundance &lt;= 25%, Abundance of large cells with protrusions and bright nuclei, Increased ionizing radiation sensitivity, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance, Increased cell migration, Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Increased Salmonella enterica Typhimurium binding, Decreased viability, Decreased viability after ionizing radiation, Bright nuclei, 	GO:0000281 GO:0007010 GO:0007266 GO:0009615 GO:0022604
ZNF143 	ZNF143 (Zinc Finger Protein 143) is a Protein Coding gene. Diseases associated with ZNF143 include  ZNF76	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of snRNA transcription by RNA polymerase II. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of snRNA transcription by RNA polymerase II. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased shRNA abundance (Z-score &gt; 2), Moderately decreased NFAT1-GFP nuclear translocation, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0006355 GO:0006357 GO:0006359 GO:0045944 GO:0045945
RNF126 	RNF126 (Ring Finger Protein 126) is a Protein Coding gene.  Among its related pathways are  RNF115	The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. The protein encoded by this gene contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased epidermal growth factor (EGF) endocytosis, Increased NF-kappaB reporter expression, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0006511 GO:0006513 GO:0016567 GO:0042059 GO:0042127
ITGA6 	ITGA6 (Integrin Subunit Alpha 6) is a Protein Coding gene. Diseases associated with ITGA6 include  ITGA7	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased homologous recombination repair frequency, Negative genetic interaction between BLM-/- and BLM+/+, Increased S DNA content, Weakly decreased NFAT1-GFP nuclear translocation, S arrest, Increased cilium length after serum starvation, Increased cell number in G1, small nuclei in G1, Decreased focal adhesion (FA) area, decreased FA length, increased number of small and round FAs, decreased cell spreading, 	GO:0007044 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229 GO:0010668
RAB5A 	RAB5A (RAB5A, Member RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAB5A include  RAB5C	Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in several processes, including amyloid-beta clearance by transcytosis; early endosome to late endosome transport; and regulation of exocytosis. Located in several cellular components, including cytoplasmic side of early endosome membrane; nucleoplasm; and terminal bouton. [provided by Alliance of Genome Resources, Apr 2022]	Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in several processes, including amyloid-beta clearance by transcytosis; early endosome to late endosome transport; and regulation of exocytosis. Located in several cellular components, including cytoplasmic side of early endosome membrane; nucleoplasm; and terminal bouton. [provided by Alliance of Genome Resources, Apr 2022]	no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased IL-8 secretion, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased influenza A virus infection, 	GO:0006886 GO:0006897
CDH5 	CDH5 (Cadherin 5) is a Protein Coding gene. Diseases associated with CDH5 include  CDH7	This gene encodes a classical cadherin of the cadherin superfamily. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Functioning as a classical cadherin by imparting to cells the ability to adhere in a homophilic manner, this protein plays a role in endothelial adherens junction assembly and maintenance. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. [provided by RefSeq, Nov 2015]	This gene encodes a classical cadherin of the cadherin superfamily. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Functioning as a classical cadherin by imparting to cells the ability to adhere in a homophilic manner, this protein plays a role in endothelial adherens junction assembly and maintenance. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. [provided by RefSeq, Nov 2015]	no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Multipolar spindles, Inhibition of centrosomal clustering, Decreased viability with paclitaxel, Decreased viability with carboplatin, 	GO:0000902 GO:0001932 GO:0001944 GO:0001955 GO:0006874 GO:0006874 GO:0006874
NEDD8 	NEDD8 (NEDD8 Ubiquitin Like Modifier) is a Protein Coding gene. Diseases associated with NEDD8 include  UBA52	Enables ubiquitin protein ligase binding activity. Acts upstream of or within protein neddylation. Located in cytosol and nucleoplasm. Biomarker of Parkinson\'s disease and malignant astrocytoma. [provided by Alliance of Genome Resources, Apr 2022]	Enables ubiquitin protein ligase binding activity. Acts upstream of or within protein neddylation. Located in cytosol and nucleoplasm. Biomarker of Parkinson\'s disease and malignant astrocytoma. [provided by Alliance of Genome Resources, Apr 2022]	Mitotic spindle defects, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0006357 GO:0006508 GO:0006508 GO:0006508 GO:0006511 GO:0008104 GO:0009653 GO:0009653 GO:0009653
LRP6 	LRP6 (LDL Receptor Related Protein 6) is a Protein Coding gene. Diseases associated with LRP6 include  LRP5	This gene encodes a member of the low density lipoprotein (LDL) receptor gene family. LDL receptors are transmembrane cell surface proteins involved in receptor-mediated endocytosis of lipoprotein and protein ligands. The protein encoded by this gene functions as a receptor or, with Frizzled, a co-receptor for Wnt and thereby transmits the canonical Wnt/beta-catenin signaling cascade. Through its interaction with the Wnt/beta-catenin signaling cascade this gene plays a role in the regulation of cell differentiation, proliferation, and migration and the development of many cancer types. This protein undergoes gamma-secretase dependent RIP- (regulated intramembrane proteolysis) processing but the precise locations of the cleavage sites have not been determined.[provided by RefSeq, Dec 2009]	This gene encodes a member of the low density lipoprotein (LDL) receptor gene family. LDL receptors are transmembrane cell surface proteins involved in receptor-mediated endocytosis of lipoprotein and protein ligands. The protein encoded by this gene functions as a receptor or, with Frizzled, a co-receptor for Wnt and thereby transmits the canonical Wnt/beta-catenin signaling cascade. Through its interaction with the Wnt/beta-catenin signaling cascade this gene plays a role in the regulation of cell differentiation, proliferation, and migration and the development of many cancer types. This protein undergoes gamma-secretase dependent RIP- (regulated intramembrane proteolysis) processing but the precise locations of the cleavage sites have not been determined.[provided by RefSeq, Dec 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Increased HPV18 LCR reporter activity, Decreased shRNA abundance (Z-score &lt; -2), Decreased BPV1 E2 protein expression, 	GO:0001933 GO:0006355 GO:0006469 GO:0006469 GO:0006469
WWTR1 	WWTR1 (WW Domain Containing Transcription Regulator 1) is a Protein Coding gene. Diseases associated with WWTR1 include  YAP1	Enables transcription coactivator activity. Involved in several processes, including hippo signaling; positive regulation of cell differentiation; and regulation of signal transduction. Located in cytosol and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Enables transcription coactivator activity. Involved in several processes, including hippo signaling; positive regulation of cell differentiation; and regulation of signal transduction. Located in cytosol and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased viability of wild-type and TP53 knockout cells, Increased S DNA content, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000122 GO:0001649 GO:0001649 GO:0001649 GO:0001894 GO:0001894 GO:0001894 GO:0001933 GO:0001933 GO:0001933
FNDC5 	FNDC5 (Fibronectin Type III Domain Containing 5) is a Protein Coding gene. Diseases associated with FNDC5 include  FNDC4	This gene encodes a secreted protein that is released from muscle cells during exercise. The encoded protein may participate in the development of brown fat. Translation of the precursor protein initiates at a non-AUG start codon at a position that is conserved as an AUG start codon in other organisms. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]	This gene encodes a secreted protein that is released from muscle cells during exercise. The encoded protein may participate in the development of brown fat. Translation of the precursor protein initiates at a non-AUG start codon at a position that is conserved as an AUG start codon in other organisms. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance, Increased S DNA content, 	 
CCN1 	CCN1 (Cellular Communication Network Factor 1) is a Protein Coding gene. Diseases associated with CCN1 include  CCN2	The secreted protein encoded by this gene is growth factor-inducible and promotes the adhesion of endothelial cells. The encoded protein interacts with several integrins and with heparan sulfate proteoglycan. This protein also plays a role in cell proliferation, differentiation, angiogenesis, apoptosis, and extracellular matrix formation. [provided by RefSeq, Sep 2011]	The secreted protein encoded by this gene is growth factor-inducible and promotes the adhesion of endothelial cells. The encoded protein interacts with several integrins and with heparan sulfate proteoglycan. This protein also plays a role in cell proliferation, differentiation, angiogenesis, apoptosis, and extracellular matrix formation. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell number and increased metaphase cell number, Decreased viability with paclitaxel, 	GO:0001649 GO:0001934 GO:0001934 GO:0001934
MEF2A 	MEF2A (Myocyte Enhancer Factor 2A) is a Protein Coding gene. Diseases associated with MEF2A include  MEF2C	The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased homologous recombination repair frequency, Weakly decreased NFAT1-GFP nuclear translocation, Elongated cells, 	GO:0000002 GO:0000122 GO:0000122 GO:0000122 GO:0000165 GO:0006351
MAPK1 	MAPK1 (Mitogen-Activated Protein Kinase 1) is a Protein Coding gene. Diseases associated with MAPK1 include  MAPK3	This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]	This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased cell death in HCT116 cells, Decreased cell migration, Increased viability, Decreased viability with carboplatin, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0006915 GO:0006935 GO:0006935 GO:0006935
PHLPP2 	PHLPP2 (PH Domain And Leucine Rich Repeat Protein Phosphatase 2) is a Protein Coding gene. Diseases associated with PHLPP2 include  PHLPP1	Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in signal transduction. Located in several cellular components, including intercellular bridge; mitotic spindle; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in signal transduction. Located in several cellular components, including intercellular bridge; mitotic spindle; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), 	 
ACVRL1 	ACVRL1 (Activin A Receptor Like Type 1) is a Protein Coding gene. Diseases associated with ACVRL1 include  ACVR1	This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. Increased viability, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Decreased shRNA abundance, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased cell viability after pRB stimulation, Decreased viability with TRAIL, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Upregulation of RLR pathway after Sendai virus (SeV) infection, Increased apoptosis, Misorientated spindle, 	GO:0001525 GO:0001666 GO:0001701 GO:0001701 GO:0001701 GO:0001936 GO:0001936 GO:0001936
FOXP1 	FOXP1 (Forkhead Box P1) is a Protein Coding gene. Diseases associated with FOXP1 include  FOXP3	This gene belongs to subfamily P of the forkhead box (FOX) transcription factor family. Forkhead box transcription factors play important roles in the regulation of tissue- and cell type-specific gene transcription during both development and adulthood. Forkhead box P1 protein contains both DNA-binding- and protein-protein binding-domains. This gene may act as a tumor suppressor as it is lost in several tumor types and maps to a chromosomal region (3p14.1) reported to contain a tumor suppressor gene(s). Alternative splicing results in multiple transcript variants encoding different isoforms. This gene belongs to subfamily P of the forkhead box (FOX) transcription factor family. Forkhead box transcription factors play important roles in the regulation of tissue- and cell type-specific gene transcription during both development and adulthood. Forkhead box P1 protein contains both DNA-binding- and protein-protein binding-domains. This gene may act as a tumor suppressor as it is lost in several tumor types and maps to a chromosomal region (3p14.1) reported to contain a tumor suppressor gene(s). Alternative splicing results in multiple transcript variants encoding different isoforms. no effect, Small cells, 	GO:0000122 GO:0002903 GO:0002903 GO:0002903 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006974
CCR5 	CCR5 (C-C Motif Chemokine Receptor 5) is a Protein Coding gene. Diseases associated with CCR5 include  CCR2	This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]	This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Strongly decreased CFP-tsO45G cell surface transport, Increased HPV18 LCR reporter activity, 	GO:0000165 GO:0002407 GO:0006816 GO:0006935 GO:0006954
MVB12B 	MVB12B (Multivesicular Body Subunit 12B) is a Protein Coding gene. Diseases associated with MVB12B include 	The protein encoded by this gene is a component of the ESCRT-I complex, a heterotetramer, which mediates the sorting of ubiquitinated cargo protein from the plasma membrane to the endosomal vesicle. ESCRT-I complex plays an essential role in HIV budding and endosomal protein sorting. Depletion and overexpression of this and related protein (MVB12A) inhibit HIV-1 infectivity and induce unusual viral assembly defects, indicating a role for MVB12 subunits in regulating ESCRT-mediated virus budding. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	The protein encoded by this gene is a component of the ESCRT-I complex, a heterotetramer, which mediates the sorting of ubiquitinated cargo protein from the plasma membrane to the endosomal vesicle. ESCRT-I complex plays an essential role in HIV budding and endosomal protein sorting. Depletion and overexpression of this and related protein (MVB12A) inhibit HIV-1 infectivity and induce unusual viral assembly defects, indicating a role for MVB12 subunits in regulating ESCRT-mediated virus budding. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased melanin production, Increased epidermal growth factor (EGF) endocytosis, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0015031 GO:0019075 GO:0019075 GO:0019075 GO:0036258 GO:0042058 GO:0042058 GO:0042058 GO:0043162
HERC2 	HERC2 (HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2) is a Protein Coding gene. Diseases associated with HERC2 include  HECTD4	This gene belongs to the HERC gene family that encodes a group of unusually large proteins, which contain multiple structural domains. All members have at least 1 copy of an N-terminal region showing homology to the cell cycle regulator RCC1 and a C-terminal HECT (homologous to E6-AP C terminus) domain found in a number of E3 ubiquitin protein ligases. Genetic variations in this gene are associated with skin/hair/eye pigmentation variability. Multiple pseudogenes of this gene are located on chromosomes 15 and 16. [provided by RefSeq, Mar 2012]	This gene belongs to the HERC gene family that encodes a group of unusually large proteins, which contain multiple structural domains. All members have at least 1 copy of an N-terminal region showing homology to the cell cycle regulator RCC1 and a C-terminal HECT (homologous to E6-AP C terminus) domain found in a number of E3 ubiquitin protein ligases. Genetic variations in this gene are associated with skin/hair/eye pigmentation variability. Multiple pseudogenes of this gene are located on chromosomes 15 and 16. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, no effect, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with vaccinia virus (VACV) infection, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cilium length after serum starvation, Decreased cilium length, 	GO:0006281 GO:0006886 GO:0006886 GO:0006886 GO:0006974
KCP 	KCP (Kielin Cysteine Rich BMP Regulator) is a Protein Coding gene. Diseases associated with KCP include  FCGBP	Predicted to act upstream of or within hematopoietic progenitor cell differentiation and positive regulation of BMP signaling pathway. Predicted to be located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to act upstream of or within hematopoietic progenitor cell differentiation and positive regulation of BMP signaling pathway. Predicted to be located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Decreased vaccinia virus (VACV) infection, Decreased viability, Increased cell number in G2M, increased number of polyploid cells, 	GO:0002244 GO:0030513 GO:0030513 GO:0030513
CTNNA1 	CTNNA1 (Catenin Alpha 1) is a Protein Coding gene. Diseases associated with CTNNA1 include  CTNNA2	This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy. [provided by RefSeq, May 2016]	This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy. [provided by RefSeq, May 2016]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance, Increased cell migration, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Altered focal adhesion (FA) or cell shape morphology, 	GO:0001541 GO:0006915 GO:0006915 GO:0006915 GO:0007015 GO:0007015 GO:0007015 GO:0007155 GO:0007155 GO:0007155
ADM2 	ADM2 (Adrenomedullin 2) is a Protein Coding gene. Diseases associated with ADM2 include  ADM	This gene encodes a member of the calcitonin gene-related peptide (CGRP)/calcitonin family of hormones that play a role in the regulation of cardiovascular homeostasis, prolactin release, anti-diuresis, anti-natriuresis, and regulation of food and water intake. The encoded protein is proteolytically processed to generate one or more biologically active peptides. [provided by RefSeq, Jul 2015]	This gene encodes a member of the calcitonin gene-related peptide (CGRP)/calcitonin family of hormones that play a role in the regulation of cardiovascular homeostasis, prolactin release, anti-diuresis, anti-natriuresis, and regulation of food and water intake. The encoded protein is proteolytically processed to generate one or more biologically active peptides. [provided by RefSeq, Jul 2015]	Increased vaccinia virus (VACV) infection, no effect, Increased NF-kappaB reporter expression, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001525 GO:0003073 GO:0006468 GO:0007189
ARHGAP35 	ARHGAP35 (Rho GTPase Activating Protein 35) is a Protein Coding gene. Diseases associated with ARHGAP35 include  SYDE2	The human glucocorticoid receptor DNA binding factor, which associates with the promoter region of the glucocorticoid receptor gene (hGR gene), is a repressor of glucocorticoid receptor transcription. The amino acid sequence deduced from the cDNA sequences show the presence of three sequence motifs characteristic of a zinc finger and one motif suggestive of a leucine zipper in which 1 cysteine is found instead of all leucines. The GRLF1 enhances the homologous down-regulation of wild-type hGR gene expression. Biochemical analysis suggests that GRLF1 interaction is sequence specific and that transcriptional efficacy of GRLF1 is regulated through its interaction with specific sequence motif. The level of expression is regulated by glucocorticoids. The human glucocorticoid receptor DNA binding factor, which associates with the promoter region of the glucocorticoid receptor gene (hGR gene), is a repressor of glucocorticoid receptor transcription. The amino acid sequence deduced from the cDNA sequences show the presence of three sequence motifs characteristic of a zinc finger and one motif suggestive of a leucine zipper in which 1 cysteine is found instead of all leucines. The GRLF1 enhances the homologous down-regulation of wild-type hGR gene expression. Biochemical analysis suggests that GRLF1 interaction is sequence specific and that transcriptional efficacy of GRLF1 is regulated through its interaction with specific sequence motif. The level of expression is regulated by glucocorticoids. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Strongly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Downregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0001843 GO:0007165 GO:0007165 GO:0007165 GO:0007266 GO:0007266 GO:0007266
CDKN1A 	CDKN1A (Cyclin Dependent Kinase Inhibitor 1A) is a Protein Coding gene. Diseases associated with CDKN1A include  CDKN1B	This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]	This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), Decreased nuclei size in G2M, Decreased simian virus 40 (SV40) infection, 	GO:0000079 GO:0000082 GO:0001933 GO:0001933 GO:0001933 GO:0001934
EP300 	EP300 (E1A Binding Protein P300) is a Protein Coding gene. Diseases associated with EP300 include  CREBBP	This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased POU5F1-GFP protein expression, Dynamic nuclei (hole, folded or small irregular), Increased shRNA abundance (Z-score &gt; 2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased HIV-1 infection, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Increased virus production, Increased CDKN1A mRNA expression, Increased BBC3 mRNA expression, 	GO:0000122 GO:0001666
USP15 	USP15 (Ubiquitin Specific Peptidase 15) is a Protein Coding gene. Diseases associated with USP15 include  Deubiquitination USP4	This gene encodes a member of the ubiquitin specific protease (USP) family of deubiquitinating enzymes. USP enzymes play critical roles in ubiquitin-dependent processes through polyubiquitin chain disassembly and hydrolysis of ubiquitin-substrate bonds. The encoded protein associates with the COP9 signalosome, and also plays a role in transforming growth factor beta signalling through deubiquitination of receptor-activated SMAD transcription factors. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 2. [provided by RefSeq, Nov 2011]	This gene encodes a member of the ubiquitin specific protease (USP) family of deubiquitinating enzymes. USP enzymes play critical roles in ubiquitin-dependent processes through polyubiquitin chain disassembly and hydrolysis of ubiquitin-substrate bonds. The encoded protein associates with the COP9 signalosome, and also plays a role in transforming growth factor beta signalling through deubiquitination of receptor-activated SMAD transcription factors. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 2. [provided by RefSeq, Nov 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0006508 GO:0006511 GO:0006511 GO:0006511 GO:0007179 GO:0007179 GO:0007179 GO:0016579 GO:0030509 GO:0030509 GO:0030509
EEF2K 	EEF2K (Eukaryotic Elongation Factor 2 Kinase) is a Protein Coding gene. Diseases associated with EEF2K include  ALPK2	This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, shRNA abundance &lt;= 25%, Strongly decreased CFP-tsO45G cell surface transport, Decreased vesicular stomatitis virus (VSV) infection, Transferrin accumulation in the perinuclear area, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased simian virus 40 (SV40) infection, Paclitaxel antagonistic effect, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, decreased cell elongation, 	GO:0002931 GO:0006414 GO:0006414 GO:0006414 GO:0006468 GO:0016310 GO:0016310 GO:0016310 GO:0031037 GO:0031037 GO:0031037
DCX 	DCX (Doublecortin) is a Protein Coding gene. Diseases associated with DCX include  MAPKAPK2	This gene encodes a member of the doublecortin family. The protein encoded by this gene is a cytoplasmic protein and contains two doublecortin domains, which bind microtubules. In the developing cortex, cortical neurons must migrate over long distances to reach the site of their final differentiation. The encoded protein appears to direct neuronal migration by regulating the organization and stability of microtubules. In addition, the encoded protein interacts with LIS1, the regulatory gamma subunit of platelet activating factor acetylhydrolase, and this interaction is important to proper microtubule function in the developing cortex. Mutations in this gene cause abnormal migration of neurons during development and disrupt the layering of the cortex, leading to epilepsy, cognitive disability, subcortical band heterotopia ("double cortex" syndrome) in females and lissencephaly ("smooth brain" syndrome) in males. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2010]	This gene encodes a member of the doublecortin family. The protein encoded by this gene is a cytoplasmic protein and contains two doublecortin domains, which bind microtubules. In the developing cortex, cortical neurons must migrate over long distances to reach the site of their final differentiation. The encoded protein appears to direct neuronal migration by regulating the organization and stability of microtubules. In addition, the encoded protein interacts with LIS1, the regulatory gamma subunit of platelet activating factor acetylhydrolase, and this interaction is important to proper microtubule function in the developing cortex. Mutations in this gene cause abnormal migration of neurons during development and disrupt the layering of the cortex, leading to epilepsy, cognitive disability, subcortical band heterotopia ("double cortex" syndrome) in females and lissencephaly ("smooth brain" syndrome) in males. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2010]	no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased viability with cisplatin, 	GO:0001764 GO:0007399 GO:0007417
SMAD7 	SMAD7 (SMAD Family Member 7) is a Protein Coding gene. Diseases associated with SMAD7 include  SMAD6	The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]	The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]	Increased vaccinia virus (VACV) infection, no effect, Increased hepcidin::fluc mRNA expression, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Increased Nanog expression, Proliferating cells, 	GO:0000122 GO:0001657 GO:0002725 GO:0002725 GO:0002725 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
KCNJ11 	KCNJ11 (Potassium Inwardly Rectifying Channel Subfamily J Member 11) is a Protein Coding gene. Diseases associated with KCNJ11 include  KCNJ8	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009]	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, Decreased HIV-1 infection, 	GO:0006006 GO:0006811 GO:0006813 GO:0006813 GO:0006813 GO:0009410 GO:0009410 GO:0009410 GO:0033198
AXL 	AXL (AXL Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with AXL include  MERTK	The protein encoded by this gene is a member of the Tyro3-Axl-Mer (TAM) receptor tyrosine kinase subfamily. The encoded protein possesses an extracellular domain which is composed of two immunoglobulin-like motifs at the N-terminal, followed by two fibronectin type-III motifs. It transduces signals from the extracellular matrix into the cytoplasm by binding to the vitamin K-dependent protein growth arrest-specific 6 (Gas6). This gene may be involved in several cellular functions including growth, migration, aggregation and anti-inflammation in multiple cell types. The encoded protein acts as a host cell receptor for multiple viruses, including Marburg, Ebola and Lassa viruses and is a candidate receptor for the SARS-CoV2 virus. [provided by RefSeq, Sep 2021]	The protein encoded by this gene is a member of the Tyro3-Axl-Mer (TAM) receptor tyrosine kinase subfamily. The encoded protein possesses an extracellular domain which is composed of two immunoglobulin-like motifs at the N-terminal, followed by two fibronectin type-III motifs. It transduces signals from the extracellular matrix into the cytoplasm by binding to the vitamin K-dependent protein growth arrest-specific 6 (Gas6). This gene may be involved in several cellular functions including growth, migration, aggregation and anti-inflammation in multiple cell types. The encoded protein acts as a host cell receptor for multiple viruses, including Marburg, Ebola and Lassa viruses and is a candidate receptor for the SARS-CoV2 virus. [provided by RefSeq, Sep 2021]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Increased transferrin (TF) endocytosis, Increased Nanog expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic index, Condensed cis-Golgi, condensed medial Golgi, condensed trans-Golgi, 	GO:0001764 GO:0001779 GO:0001779 GO:0001779 GO:0001818 GO:0001961 GO:0001961 GO:0001961
DNER 	DNER (Delta/Notch Like EGF Repeat Containing) is a Protein Coding gene. Diseases associated with DNER include  JAG1	Predicted to enable Notch binding activity. Involved in central nervous system development. Located in dendrite; early endosome; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable Notch binding activity. Involved in central nervous system development. Located in dendrite; early endosome; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Increased caspase activity, 	GO:0001764 GO:0006897 GO:0007219 GO:0007220 GO:0007220 GO:0007220 GO:0007416 GO:0007416 GO:0007416
GJC2 	GJC2 (Gap Junction Protein Gamma 2) is a Protein Coding gene. Diseases associated with GJC2 include  GJC1	This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. no effect, Decreased vaccinia virus (VACV) infection, 	 
ANLN 	ANLN (Anillin, Actin Binding Protein) is a Protein Coding gene. Diseases associated with ANLN include  RTKN	This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Decreased cell number, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Cell division defect, Increased epidermal growth factor receptor (EGFR) surface abundance, Multipolar spindles, Inhibition of centrosomal clustering, Increased cell number in G2M, increased number of polyploid cells, increased number of cells with high perimeter-to-area ratio nuclei, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), two nuclei (binuclear), polylobed nuclei, Decreased cell number, increased 8N DNA content, 	GO:0000281 GO:0000915 GO:0000921
AKT3 	AKT3 (AKT Serine/Threonine Kinase 3) is a Protein Coding gene. Diseases associated with AKT3 include  AKT1	The protein encoded by this gene is a member of the AKT, also called PKB,  serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1). Alternatively splice transcript variants encoding distinct isoforms have been described. The protein encoded by this gene is a member of the AKT, also called PKB,  serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1). Alternatively splice transcript variants encoding distinct isoforms have been described. Mitotic spindle defects, Increased viability, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Decreased cell migration, Decreased viability, Increased cell viability after pRB stimulation, Decreased cell proliferation, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0000002 GO:0001938 GO:0006468 GO:0007165
IRS1 	IRS1 (Insulin Receptor Substrate 1) is a Protein Coding gene. Diseases associated with IRS1 include  IRS2	This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]	This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability ratio, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased HPV16-GFP infection, Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Salmonella enterica Typhimurium invasion, Increased cell death HMECs cells, Decreased Sindbis virus (SINV) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Decreased nuclei size in G2M, 	GO:0007165 GO:0008284 GO:0008286 GO:0010907 GO:0014065
DLL1 	DLL1 (Delta Like Canonical Notch Ligand 1) is a Protein Coding gene. Diseases associated with DLL1 include  DLL4	 DLL1 is a human homolog of the Notch Delta ligand and is a member of the delta/serrate/jagged family.  It plays a role in mediating cell fate decisions during hematopoiesis. It may play a role in cell-to-cell communication.  DLL1 is a human homolog of the Notch Delta ligand and is a member of the delta/serrate/jagged family.  It plays a role in mediating cell fate decisions during hematopoiesis. It may play a role in cell-to-cell communication. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Increased ionizing radiation sensitivity, Increased NF-kappaB reporter expression, 	GO:0001709
TXNIP 	TXNIP (Thioredoxin Interacting Protein) is a Protein Coding gene. Diseases associated with TXNIP include  Leukostasis Hyperglycemia Inflammasomes ARRDC4	This gene encodes a thioredoxin-binding protein that is a member of the alpha arrestin protein family. Thioredoxin is a thiol-oxidoreductase that is a major regulator of cellular redox signaling which protects cells from oxidative stress. This protein inhibits the antioxidative function of thioredoxin resulting in the accumulation of reactive oxygen species and cellular stress. This protein also functions as a regulator of cellular metabolism and of endoplasmic reticulum (ER) stress. This protein may also function as a tumor suppressor. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]	This gene encodes a thioredoxin-binding protein that is a member of the alpha arrestin protein family. Thioredoxin is a thiol-oxidoreductase that is a major regulator of cellular redox signaling which protects cells from oxidative stress. This protein inhibits the antioxidative function of thioredoxin resulting in the accumulation of reactive oxygen species and cellular stress. This protein also functions as a regulator of cellular metabolism and of endoplasmic reticulum (ER) stress. This protein may also function as a tumor suppressor. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased G1 DNA content, G0/1 arrest, Inconclusive, Large nuclei, 	 
PLAU 	PLAU (Plasminogen Activator, Urokinase) is a Protein Coding gene. Diseases associated with PLAU include  PRSS1	This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer\'s disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer\'s disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Increased cell death HMECs cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0001666 GO:0006508 GO:0006508 GO:0006508 GO:0006935 GO:0006935 GO:0006935 GO:0007165
LMTK2 	LMTK2 (Lemur Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with LMTK2 include  Azoospermia EPHA3	The protein encoded by this gene belongs to the protein kinase superfamily and the protein tyrosine kinase family. It contains N-terminal transmembrane helices and a long C-terminal cytoplasmic tail with serine/threonine/tyrosine kinase activity. This protein interacts with several other proteins, such as Inhibitor-2 (Inh2), protein phosphatase-1 (PP1C), p35, and myosin VI. It phosporylates other proteins, and is itself also phosporylated when interacting with cyclin-dependent kinase 5 (cdk5)/p35 complex. This protein involves in nerve growth factor (NGF)-TrkA signalling, and also plays a critical role in endosomal membrane trafficking. Mouse studies suggested an essential role of this protein in spermatogenesis. [provided by RefSeq, Oct 2009]	The protein encoded by this gene belongs to the protein kinase superfamily and the protein tyrosine kinase family. It contains N-terminal transmembrane helices and a long C-terminal cytoplasmic tail with serine/threonine/tyrosine kinase activity. This protein interacts with several other proteins, such as Inhibitor-2 (Inh2), protein phosphatase-1 (PP1C), p35, and myosin VI. It phosporylates other proteins, and is itself also phosporylated when interacting with cyclin-dependent kinase 5 (cdk5)/p35 complex. This protein involves in nerve growth factor (NGF)-TrkA signalling, and also plays a critical role in endosomal membrane trafficking. Mouse studies suggested an essential role of this protein in spermatogenesis. [provided by RefSeq, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased HPV16-GFP infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased cell proliferation, Increased epidermal growth factor (EGF) endosome number, increased epidermal growth factor (EGF) endosome elongation, Decreased viability, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, Decreased CYP1A1 activity after TCDD stimulation, 	GO:0001881 GO:0006468
GNB1 	GNB1 (G Protein Subunit Beta 1) is a Protein Coding gene. Diseases associated with GNB1 include  GNB4	Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]	Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]	no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased viability with SS1P at EC90, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased Salmonella proliferation, 	GO:0007165 GO:0007186 GO:0007191 GO:0007200 GO:0007200 GO:0007200 GO:0007213 GO:0007213 GO:0007213
GLI3 	GLI3 (GLI Family Zinc Finger 3) is a Protein Coding gene. Diseases associated with GLI3 include  GLI2	This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased Nanog expression, Decreased HPV16-GFP infection, Decreased IL-8 secretion, Increased ionizing radiation sensitivity, Decreased Aire reporter expression, 	GO:0000122
ARAP3 	ARAP3 (ArfGAP With RhoGAP Domain, Ankyrin Repeat And PH Domain 3) is a Protein Coding gene. Diseases associated with ARAP3 include  ARAP2	This gene encodes a phosphoinositide binding protein containing ARF-GAP, RHO-GAP, RAS-associating, and pleckstrin homology domains. The ARF-GAP and RHO-GAP domains cooperate in mediating rearrangements in the cell cytoskeleton and cell shape. It is a specific PtdIns(3,4,5)P3/PtdIns(3,4)P2-stimulated Arf6-GAP protein. An alternatively spliced transcript has been found for this gene, but its biological validity has not been determined. [provided by RefSeq, Sep 2015]	This gene encodes a phosphoinositide binding protein containing ARF-GAP, RHO-GAP, RAS-associating, and pleckstrin homology domains. The ARF-GAP and RHO-GAP domains cooperate in mediating rearrangements in the cell cytoskeleton and cell shape. It is a specific PtdIns(3,4,5)P3/PtdIns(3,4)P2-stimulated Arf6-GAP protein. An alternatively spliced transcript has been found for this gene, but its biological validity has not been determined. [provided by RefSeq, Sep 2015]	no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability (cell death), Increased ionizing radiation sensitivity, Decreased shRNA abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0007010 GO:0007165 GO:0016192 GO:0016192 GO:0016192
SERPINE1 	SERPINE1 (Serpin Family E Member 1) is a Protein Coding gene. Diseases associated with SERPINE1 include  SERPINE2	This gene encodes a member of the serine proteinase inhibitor (serpin) superfamily. This member is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. The protein also functions as a component of innate antiviral immunity. Defects in this gene are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency), and high concentrations of the gene product are associated with thrombophilia. [provided by RefSeq, Aug 2020]	This gene encodes a member of the serine proteinase inhibitor (serpin) superfamily. This member is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. The protein also functions as a component of innate antiviral immunity. Defects in this gene are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency), and high concentrations of the gene product are associated with thrombophilia. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Decreased melanin production, Increased transcriptional activity, Increased HPV18 LCR reporter activity, Increased NF-kappaB reporter expression, Negative genetic interaction between BLM-/- and BLM+/+, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0001525 GO:0010466 GO:0010469 GO:0010469 GO:0010469 GO:0010757 GO:0010951
ATF1 	ATF1 (Activating Transcription Factor 1) is a Protein Coding gene. Diseases associated with ATF1 include  CREB1	This gene encodes an activating transcription factor, which belongs to the ATF subfamily and bZIP (basic-region leucine zipper) family. It influences cellular physiologic processes by regulating the expression of downstream target genes, which are related to growth, survival, and other cellular activities. This protein is phosphorylated at serine 63 in its kinase-inducible domain by serine/threonine kinases, cAMP-dependent protein kinase A, calmodulin-dependent protein kinase I/II, mitogen- and stress-activated protein kinase and cyclin-dependent kinase 3 (cdk-3). Its phosphorylation enhances its transactivation and transcriptional activities, and enhances cell transformation. Fusion of this gene and FUS on chromosome 16 or EWSR1 on chromosome 22 induced by translocation generates chimeric proteins in angiomatoid fibrous histiocytoma and clear cell sarcoma. This gene has a pseudogene on chromosome 6. [provided by RefSeq, Aug 2010]	This gene encodes an activating transcription factor, which belongs to the ATF subfamily and bZIP (basic-region leucine zipper) family. It influences cellular physiologic processes by regulating the expression of downstream target genes, which are related to growth, survival, and other cellular activities. This protein is phosphorylated at serine 63 in its kinase-inducible domain by serine/threonine kinases, cAMP-dependent protein kinase A, calmodulin-dependent protein kinase I/II, mitogen- and stress-activated protein kinase and cyclin-dependent kinase 3 (cdk-3). Its phosphorylation enhances its transactivation and transcriptional activities, and enhances cell transformation. Fusion of this gene and FUS on chromosome 16 or EWSR1 on chromosome 22 induced by translocation generates chimeric proteins in angiomatoid fibrous histiocytoma and clear cell sarcoma. This gene has a pseudogene on chromosome 6. [provided by RefSeq, Aug 2010]	no effect, shRNA abundance &lt;= 50%, Increased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased viability (proliferation), Decreased shRNA abundance, Increased S DNA content, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357
VEGFC 	VEGFC (Vascular Endothelial Growth Factor C) is a Protein Coding gene. Diseases associated with VEGFC include  VEGFD	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors. [provided by RefSeq, Apr 2014]	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors. [provided by RefSeq, Apr 2014]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Decreased viability (cell death), Increased cell migration, Increased CFP-tsO45G cell surface transport, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0001934 GO:0001938 GO:0002040
SOD3 	SOD3 (Superoxide Dismutase 3) is a Protein Coding gene. Diseases associated with SOD3 include  Asbestosis SOD1	This gene encodes a member of the superoxide dismutase (SOD) protein family. SODs are antioxidant enzymes that catalyze the conversion of superoxide radicals into hydrogen peroxide and oxygen, which may protect the brain, lungs, and other tissues from oxidative stress. Proteolytic processing of the encoded protein results in the formation of two distinct homotetramers that differ in their ability to interact with the extracellular matrix (ECM). Homotetramers consisting of the intact protein, or type C subunit, exhibit high affinity for heparin and are anchored to the ECM. Homotetramers consisting of a proteolytically cleaved form of the protein, or type A subunit, exhibit low affinity for heparin and do not interact with the ECM. A mutation in this gene may be associated with increased heart disease risk. [provided by RefSeq, Oct 2015]	This gene encodes a member of the superoxide dismutase (SOD) protein family. SODs are antioxidant enzymes that catalyze the conversion of superoxide radicals into hydrogen peroxide and oxygen, which may protect the brain, lungs, and other tissues from oxidative stress. Proteolytic processing of the encoded protein results in the formation of two distinct homotetramers that differ in their ability to interact with the extracellular matrix (ECM). Homotetramers consisting of the intact protein, or type C subunit, exhibit high affinity for heparin and are anchored to the ECM. Homotetramers consisting of a proteolytically cleaved form of the protein, or type A subunit, exhibit low affinity for heparin and do not interact with the ECM. A mutation in this gene may be associated with increased heart disease risk. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Negative genetic interaction between BLM-/- and BLM+/+, Actin fiber cells, 	GO:0001666 GO:0006801 GO:0006801 GO:0006801 GO:0006979 GO:0006979 GO:0006979 GO:0019430 GO:0019430 GO:0019430
DUSP6 	DUSP6 (Dual Specificity Phosphatase 6) is a Protein Coding gene. Diseases associated with DUSP6 include  DUSP7	The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK2, is expressed in a variety of tissues with the highest levels in heart and pancreas, and unlike most other members of this family, is localized in the cytoplasm. Mutations in this gene have been associated with congenital hypogonadotropic hypogonadism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]	The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK2, is expressed in a variety of tissues with the highest levels in heart and pancreas, and unlike most other members of this family, is localized in the cytoplasm. Mutations in this gene have been associated with congenital hypogonadotropic hypogonadism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]	no effect, Decreased viability in colon lineage, Increased Nanog expression, Increased HPV18 LCR reporter activity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, Increased shRNA abundance, Fragmented cis-Golgi, fragmented trans-Golgi, Increased apoptosis, 	 
DLC1 	DLC1 (DLC1 Rho GTPase Activating Protein) is a Protein Coding gene. Diseases associated with DLC1 include  STARD13	This gene encodes a GTPase-activating protein (GAP) that is a member of the rhoGAP family of proteins which play a role in the regulation of small GTP-binding proteins. GAP family proteins participate in signaling pathways that regulate cell processes involved in cytoskeletal changes. This gene functions as a tumor suppressor gene in a number of common cancers, including prostate, lung, colorectal, and breast cancers. Multiple transcript variants due to alternative promoters and alternative splicing have been found for this gene.[provided by RefSeq, Apr 2010]	This gene encodes a GTPase-activating protein (GAP) that is a member of the rhoGAP family of proteins which play a role in the regulation of small GTP-binding proteins. GAP family proteins participate in signaling pathways that regulate cell processes involved in cytoskeletal changes. This gene functions as a tumor suppressor gene in a number of common cancers, including prostate, lung, colorectal, and breast cancers. Multiple transcript variants due to alternative promoters and alternative splicing have been found for this gene.[provided by RefSeq, Apr 2010]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in colon lineage, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Decreased viability, Reduced shRNA abundance in FBW7 KO line, 	GO:0001843 GO:0003007 GO:0003007 GO:0003007 GO:0006915 GO:0006915 GO:0006915 GO:0006919
SPHK1 	SPHK1 (Sphingosine Kinase 1) is a Protein Coding gene. Diseases associated with SPHK1 include  Glioblastoma SPHK2	The protein encoded by this gene catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Intracellularly, S1P regulates proliferation and survival, and extracellularly, it is a ligand for cell surface G protein-coupled receptors. This protein, and its product S1P, play a key role in TNF-alpha signaling and the NF-kappa-B activation pathway important in inflammatory, antiapoptotic, and immune processes. Phosphorylation of this protein alters its catalytic activity and promotes its translocation to the plasma membrane. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]	The protein encoded by this gene catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Intracellularly, S1P regulates proliferation and survival, and extracellularly, it is a ligand for cell surface G protein-coupled receptors. This protein, and its product S1P, play a key role in TNF-alpha signaling and the NF-kappa-B activation pathway important in inflammatory, antiapoptotic, and immune processes. Phosphorylation of this protein alters its catalytic activity and promotes its translocation to the plasma membrane. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, Strongly decreased CFP-tsO45G cell surface transport, No cells, Increased HPV18 LCR reporter activity, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Decreased Salmonella proliferation, Synthetic lethal with gemcitabine, Decreased simian virus 40 (SV40) infection, Increased apoptosis, Diffuse cis-Golgi, diffuse trans-Golgi, Decreased CYP1A1 activity after TCDD stimulation, 	 
CXCL2 	CXCL2 (C-X-C Motif Chemokine Ligand 2) is a Protein Coding gene. Diseases associated with CXCL2 include  Peritonitis Pneumonia CXCL1	This antimicrobial gene is part of a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CXC subfamily, is expressed at sites of inflammation and may suppress hematopoietic progenitor cell proliferation. [provided by RefSeq, Sep 2014]	This antimicrobial gene is part of a chemokine superfamily that encodes secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CXC subfamily, is expressed at sites of inflammation and may suppress hematopoietic progenitor cell proliferation. [provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Increased shRNA abundance (Z-score &gt; 2), Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, 	GO:0002237 GO:0006935 GO:0006952 GO:0006954 GO:0006954 GO:0006954
SPARCL1 	SPARCL1 (SPARC Like 1) is a Protein Coding gene. Diseases associated with SPARCL1 include  SPARC	Predicted to enable calcium ion binding activity; collagen binding activity; and extracellular matrix binding activity. Predicted to be involved in anatomical structure development and regulation of synapse organization. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable calcium ion binding activity; collagen binding activity; and extracellular matrix binding activity. Predicted to be involved in anatomical structure development and regulation of synapse organization. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability with paclitaxel, Large nuclei, Decreased transferrin (TF) endocytosis, 	GO:0007165 GO:0048856 GO:0048856 GO:0048856
AKT1S1 	AKT1S1 (AKT1 Substrate 1) is a Protein Coding gene. Diseases associated with AKT1S1 include 	AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]	AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]	no effect, Reduced mammosphere formation, Increased IL-8 secretion, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Increased hepcidin::fluc mRNA expression, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006469 GO:0032007 GO:0042981 GO:0043523 GO:0043523 GO:0043523 GO:0045792 GO:0045792 GO:0045792
SMURF1 	SMURF1 (SMAD Specific E3 Ubiquitin Protein Ligase 1) is a Protein Coding gene. Diseases associated with SMURF1 include  Geotrichosis SMURF2	This gene encodes a ubiquitin ligase that is specific for receptor-regulated SMAD proteins in the bone morphogenetic protein (BMP) pathway. This protein plays a key roll in the regulation of cell motility, cell signalling, and cell polarity. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Dec 2010]	This gene encodes a ubiquitin ligase that is specific for receptor-regulated SMAD proteins in the bone morphogenetic protein (BMP) pathway. This protein plays a key roll in the regulation of cell motility, cell signalling, and cell polarity. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Dec 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, Increased homologous recombination repair frequency, Decreased shRNA abundance, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased cell death in HCT116 cells, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Increased cell number in G1, average or increased nuclei size in G1, 	GO:0000209 GO:0006511 GO:0006611 GO:0007398 GO:0016567
PLEKHA1 	PLEKHA1 (Pleckstrin Homology Domain Containing A1) is a Protein Coding gene. Diseases associated with PLEKHA1 include  Metabolism PLEKHA2	This gene encodes a pleckstrin homology domain-containing adapter protein. The encoded protein is localized to the plasma membrane where it specifically binds phosphatidylinositol 3,4-bisphosphate. This protein may be involved in the formation of signaling complexes in the plasma membrane. Polymorphisms in this gene are associated with age-related macular degeneration. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 5.[provided by RefSeq, Sep 2010]	This gene encodes a pleckstrin homology domain-containing adapter protein. The encoded protein is localized to the plasma membrane where it specifically binds phosphatidylinositol 3,4-bisphosphate. This protein may be involved in the formation of signaling complexes in the plasma membrane. Polymorphisms in this gene are associated with age-related macular degeneration. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 5.[provided by RefSeq, Sep 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Decreased melanin production, 	 
MAP4K2 	MAP4K2 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2) is a Protein Coding gene. Diseases associated with MAP4K2 include  MAP4K3	The protein encoded by this gene is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]	The protein encoded by this gene is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Increased G2M DNA content, increased 8N DNA content, Increased transcriptional activity, Increased homologous recombination repair frequency, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with vaccinia virus (VACV) infection, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell viability after pRB stimulation, Diffuse medial Golgi, 	GO:0000165 GO:0002376 GO:0002376 GO:0002376 GO:0006468 GO:0006468 GO:0006468 GO:0006903 GO:0006955 GO:0006955 GO:0006955
ZNF217 	ZNF217 (Zinc Finger Protein 217) is a Protein Coding gene. Diseases associated with ZNF217 include  Cystadenocarcinoma ZNF516	Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in mitochondrion and nuclear speck. Part of histone deacetylase complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in mitochondrion and nuclear speck. Part of histone deacetylase complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased cell death HMECs cells, 	GO:0000122 GO:0006355 GO:0045892
RAP1A 	RAP1A (RAP1A, Member Of RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAP1A include  RAP1B	This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	This gene encodes a member of the Ras family of small GTPases. The encoded protein undergoes a change in conformational state and activity, depending on whether it is bound to GTP or GDP. This protein is activated by several types of guanine nucleotide exchange factors (GEFs), and inactivated by two groups of GTPase-activating proteins (GAPs). The activation status of the encoded protein is therefore affected by the balance of intracellular levels of GEFs and GAPs. The encoded protein regulates signaling pathways that affect cell proliferation and adhesion, and may play a role in tumor malignancy. Pseudogenes of this gene have been defined on chromosomes 14 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased viability with SS1P at EC30, Synthetic lethal with imatinib mesylate, 	 
RORA 	RORA (RAR Related Orphan Receptor A) is a Protein Coding gene. Diseases associated with RORA include  RORB	The protein encoded by this gene is a member of the NR1 subfamily of nuclear hormone receptors. It can bind as a monomer or as a homodimer to hormone response elements upstream of several genes to enhance the expression of those genes. The encoded protein has been shown to interact with NM23-2, a nucleoside diphosphate kinase involved in organogenesis and differentiation, as well as with NM23-1, the product of a tumor metastasis suppressor candidate gene. Also, it has been shown to aid in the transcriptional regulation of some genes involved in circadian rhythm. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2014]	The protein encoded by this gene is a member of the NR1 subfamily of nuclear hormone receptors. It can bind as a monomer or as a homodimer to hormone response elements upstream of several genes to enhance the expression of those genes. The encoded protein has been shown to interact with NM23-2, a nucleoside diphosphate kinase involved in organogenesis and differentiation, as well as with NM23-1, the product of a tumor metastasis suppressor candidate gene. Also, it has been shown to aid in the transcriptional regulation of some genes involved in circadian rhythm. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2014]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Increased ionizing radiation sensitivity, Decreased shRNA abundance, 	GO:0001525 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006357
ESRRA 	ESRRA (Estrogen Related Receptor Alpha) is a Protein Coding gene. Diseases associated with ESRRA include  ESRRB	The protein encoded by this gene is a nuclear receptor that is most closely related to the estrogen receptor. This protein acts as a site-specific transcription factor and interacts with members of the PGC-1 family of transcription cofactors to regulate the expression of most genes involved in cellular energy production as well as in the process of mitochondrial biogenesis. A processed pseudogene of ESRRA is located on chromosome 13q12.1. [provided by RefSeq, Jun 2019]	The protein encoded by this gene is a nuclear receptor that is most closely related to the estrogen receptor. This protein acts as a site-specific transcription factor and interacts with members of the PGC-1 family of transcription cofactors to regulate the expression of most genes involved in cellular energy production as well as in the process of mitochondrial biogenesis. A processed pseudogene of ESRRA is located on chromosome 13q12.1. [provided by RefSeq, Jun 2019]	Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased Aire reporter expression, Increased Salmonella enterica Typhimurium invasion, Decreased viability after ionizing radiation, 	GO:0006351 GO:0006355 GO:0006355 GO:0006355
HOXB2 	HOXB2 (Homeobox B2) is a Protein Coding gene. Diseases associated with HOXB2 include  HOXA2	This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with pancreatic cancer. This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with pancreatic cancer. no effect, Decreased vaccinia virus (VACV) infection, 	GO:0002011 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007399 GO:0007399 GO:0007399
SLIT3 	SLIT3 (Slit Guidance Ligand 3) is a Protein Coding gene. Diseases associated with SLIT3 include  SLIT2	The protein encoded by this gene is secreted, likely interacting with roundabout homolog receptors to effect cell migration. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]	The protein encoded by this gene is secreted, likely interacting with roundabout homolog receptors to effect cell migration. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in ovarian lineage, Increased IL-8 secretion, Increased NF-kappaB reporter expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0003180 GO:0003181 GO:0003181 GO:0003181 GO:0007399 GO:0007399 GO:0007399 GO:0007411 GO:0007411 GO:0007411
FERMT3 	FERMT3 (FERM Domain Containing Kindlin 3) is a Protein Coding gene. Diseases associated with FERMT3 include  Adhesion FERMT1	Kindlins are a small family of proteins that mediate protein-protein interactions involved in integrin activation and thereby have a role in cell adhesion, migration, differentiation, and proliferation. The protein encoded by this gene has a key role in the regulation of hemostasis and thrombosis. This protein may also help maintain the membrane skeleton of erythrocytes. Mutations in this gene cause the autosomal recessive leukocyte adhesion deficiency syndrome-III (LAD-III). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2010]	Kindlins are a small family of proteins that mediate protein-protein interactions involved in integrin activation and thereby have a role in cell adhesion, migration, differentiation, and proliferation. The protein encoded by this gene has a key role in the regulation of hemostasis and thrombosis. This protein may also help maintain the membrane skeleton of erythrocytes. Mutations in this gene cause the autosomal recessive leukocyte adhesion deficiency syndrome-III (LAD-III). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased epidermal growth factor (EGF) endocytosis, Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, 	GO:0007155 GO:0007159 GO:0007159 GO:0007159 GO:0007160 GO:0007229 GO:0030335
MAP1B 	MAP1B (Microtubule Associated Protein 1B) is a Protein Coding gene. Diseases associated with MAP1B include  MAP1A	This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1B heavy chain and LC1 light chain. Gene knockout studies of the mouse microtubule-associated protein 1B gene suggested an important role in development and function of the nervous system. This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1B heavy chain and LC1 light chain. Gene knockout studies of the mouse microtubule-associated protein 1B gene suggested an important role in development and function of the nervous system. Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability ratio, Increased HPV18 LCR reporter activity, Increased hepcidin::fluc mRNA expression, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0000226 GO:0001578 GO:0001764 GO:0001764 GO:0001764
FZD4 	FZD4 (Frizzled Class Receptor 4) is a Protein Coding gene. Diseases associated with FZD4 include  FZD10	This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence. This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This protein may play a role as a positive regulator of the Wingless type MMTV integration site signaling pathway. A transcript variant retaining intronic sequence and encoding a shorter isoform has been described, however, its expression is not supported by other experimental evidence. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased ionizing radiation sensitivity, Increased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), 	 
FGFR1 	FGFR1 (Fibroblast Growth Factor Receptor 1) is a Protein Coding gene. Diseases associated with FGFR1 include  FGFR2	The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Decreased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Condensed medial Golgi, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Transferrin accumulation in small spots in the cell periphery, 	GO:0000165 GO:0001501 GO:0001764 GO:0001837 GO:0006468
EBF2 	EBF2 (EBF Transcription Factor 2) is a Protein Coding gene. Diseases associated with EBF2 include  EBF3	The protein encoded by this gene belongs to the COE (Collier/Olf/EBF) family of non-basic, helix-loop-helix transcription factors that have a well conserved DNA binding domain. The COE family proteins play an important role in variety of developmental processes. Studies in mouse suggest that this gene may be involved in the differentiation of osteoblasts. [provided by RefSeq, Oct 2011]	The protein encoded by this gene belongs to the COE (Collier/Olf/EBF) family of non-basic, helix-loop-helix transcription factors that have a well conserved DNA binding domain. The COE family proteins play an important role in variety of developmental processes. Studies in mouse suggest that this gene may be involved in the differentiation of osteoblasts. [provided by RefSeq, Oct 2011]	no effect, Decreased viability, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, 	GO:0001709 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
MAPT 	MAPT (Microtubule Associated Protein Tau) is a Protein Coding gene. Diseases associated with MAPT include  MAP2	This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer\'s disease, Pick\'s disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer\'s disease, Pick\'s disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. no effect, Decreased viability, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0000226 GO:0001774 GO:0006475 GO:0006919 GO:0007267
PARVB 	PARVB (Parvin Beta) is a Protein Coding gene. Diseases associated with PARVB include  PARVA	This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]	This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased ionizing radiation sensitivity, Decreased HIV-LTR-beta-galactosidase protein expression, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Increased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0007155 GO:0007163 GO:0007163 GO:0007163 GO:0030031 GO:0030032 GO:0031532
ARHGDIA 	ARHGDIA (Rho GDP Dissociation Inhibitor Alpha) is a Protein Coding gene. Diseases associated with ARHGDIA include  ARHGDIB	This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]	This gene encodes a protein that plays a key role in the regulation of signaling through Rho GTPases. The encoded protein inhibits the disassociation of Rho family members from GDP (guanine diphosphate), thereby maintaining these factors in an inactive state. Activity of this protein is important in a variety of cellular processes, and expression of this gene may be altered in tumors. Mutations in this gene have been found in individuals with nephrotic syndrome, type 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]	Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, Decreased viability ratio, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased focal adhesion (FA) abundance, 	GO:0007162 GO:0007266 GO:0032880 GO:0035023 GO:0035023 GO:0035023 GO:0043066
ABCA1 	ABCA1 (ATP Binding Cassette Subfamily A Member 1) is a Protein Coding gene. Diseases associated with ABCA1 include  ABCA4	The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019]	The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Strongly decreased CFP-tsO45G cell surface transport, Increased HPV16-GFP infection, Decreased free cholesterol, 	 
TFPI 	TFPI (Tissue Factor Pathway Inhibitor) is a Protein Coding gene. Diseases associated with TFPI include  Thrombosis TFPI2	This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. This gene encodes multiple protein isoforms that differ in their inhibitory activity, specificity and cellular localization. This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. This gene encodes multiple protein isoforms that differ in their inhibitory activity, specificity and cellular localization. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Increased G1 DNA content, G0/1 arrest, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007596 GO:0007599 GO:0007599 GO:0007599 GO:0010466 GO:0010466 GO:0010466 GO:0030195 GO:0030195 GO:0030195 GO:0071383
COL4A4 	COL4A4 (Collagen Type IV Alpha 4 Chain) is a Protein Coding gene. Diseases associated with COL4A4 include  COL4A6	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3\' UTR. This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3\' UTR. no effect, Decreased POU5F1-GFP protein expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0030198 GO:0032836 GO:0032836 GO:0032836
VAV1 	VAV1 (Vav Guanine Nucleotide Exchange Factor 1) is a Protein Coding gene. Diseases associated with VAV1 include  VAV3	This gene is a member of the VAV gene family. The VAV proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases that activate pathways leading to actin cytoskeletal rearrangements and transcriptional alterations. The encoded protein is important in hematopoiesis, playing a role in T-cell and B-cell development and activation. The encoded protein has been identified as the specific binding partner of Nef proteins from HIV-1. Coexpression and binding of these partners initiates profound morphological changes, cytoskeletal rearrangements and the JNK/SAPK signaling cascade, leading to increased levels of viral transcription and replication. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2012]	This gene is a member of the VAV gene family. The VAV proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases that activate pathways leading to actin cytoskeletal rearrangements and transcriptional alterations. The encoded protein is important in hematopoiesis, playing a role in T-cell and B-cell development and activation. The encoded protein has been identified as the specific binding partner of Nef proteins from HIV-1. Coexpression and binding of these partners initiates profound morphological changes, cytoskeletal rearrangements and the JNK/SAPK signaling cascade, leading to increased levels of viral transcription and replication. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2012]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased S DNA content, 	 
FN1 	FN1 (Fibronectin 1) is a Protein Coding gene. Diseases associated with FN1 include  TNC	This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]	This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, 	GO:0001525 GO:0001932 GO:0001932 GO:0001932 GO:0006953 GO:0007044 GO:0007044 GO:0007044 GO:0007155
CACNA2D2 	CACNA2D2 (Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2) is a Protein Coding gene. Diseases associated with CACNA2D2 include  CACNA2D1	Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]	Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]	no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with imatinib mesylate, Downregulation of RLR pathway after Sendai virus (SeV) infection, 	 
RICTOR 	RICTOR (RPTOR Independent Companion Of MTOR Complex 2) is a Protein Coding gene. Diseases associated with RICTOR include  binding	RICTOR and MTOR (FRAP1; MIM 601231) are components of a protein complex that integrates nutrient- and growth factor-derived signals to regulate cell growth (Sarbassov et al., 2004 [PubMed 15268862]).[supplied by OMIM, Mar 2008]	RICTOR and MTOR (FRAP1; MIM 601231) are components of a protein complex that integrates nutrient- and growth factor-derived signals to regulate cell growth (Sarbassov et al., 2004 [PubMed 15268862]).[supplied by OMIM, Mar 2008]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased cell migration, Increased shRNA abundance (Z-score &gt; 2), Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001932 GO:0007010 GO:0007010 GO:0007010
GJB2 	GJB2 (Gap Junction Protein Beta 2) is a Protein Coding gene. Diseases associated with GJB2 include  GJB6	This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008]	This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	 
RAC3 	RAC3 (Rac Family Small GTPase 3) is a Protein Coding gene. Diseases associated with RAC3 include  RAC1	The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased centriole number, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell elongation, 	GO:0007015 GO:0007163 GO:0007264 GO:0008045 GO:0008045 GO:0008045 GO:0008360
COL4A6 	COL4A6 (Collagen Type IV Alpha 6 Chain) is a Protein Coding gene. Diseases associated with COL4A6 include  COL4A4	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased IL-8 secretion, Increased NF-kappaB reporter expression, 	GO:0007155 GO:0030198 GO:0030198 GO:0030198 GO:0038063
SLC16A3 	SLC16A3 (Solute Carrier Family 16 Member 3) is a Protein Coding gene. Diseases associated with SLC16A3 include  SLC16A8	Lactic acid and pyruvate transport across plasma membranes is catalyzed by members of the proton-linked monocarboxylate transporter (MCT) family, which has been designated solute carrier family-16. Each MCT appears to have slightly different substrate and inhibitor specificities and transport kinetics, which are related to the metabolic requirements of the tissues in which it is found. The MCTs, which include MCT1 (SLC16A1; MIM 600682) and MCT2 (SLC16A7; MIM 603654), are characterized by 12 predicted transmembrane domains (Price et al., 1998 [PubMed 9425115]).[supplied by OMIM, Mar 2008]	Lactic acid and pyruvate transport across plasma membranes is catalyzed by members of the proton-linked monocarboxylate transporter (MCT) family, which has been designated solute carrier family-16. Each MCT appears to have slightly different substrate and inhibitor specificities and transport kinetics, which are related to the metabolic requirements of the tissues in which it is found. The MCTs, which include MCT1 (SLC16A1; MIM 600682) and MCT2 (SLC16A7; MIM 603654), are characterized by 12 predicted transmembrane domains (Price et al., 1998 [PubMed 9425115]).[supplied by OMIM, Mar 2008]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability ratio, FOXO1 nuclear localization, Resistant to vaccinia virus (VACV-A4L) infection, Decreased cell number, Decreased POU5F1-GFP protein expression, Decreased viability in pancreas lineage, Dynamic nuclei (hole, folded or small irregular), Increased cell number in S and G2M, 	GO:0015718 GO:0030163 GO:0035873
KIF16B 	KIF16B (Kinesin Family Member 16B) is a Protein Coding gene. Diseases associated with KIF16B include  KIF1A	The protein encoded by this gene is a kinesin-like protein that may be involved in intracellular trafficking. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]	The protein encoded by this gene is a kinesin-like protein that may be involved in intracellular trafficking. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Effect on mitosis, Increased viability with MLN4924 (a NAE inhibitor), 	GO:0001704 GO:0001919 GO:0001919 GO:0001919 GO:0006895 GO:0007018 GO:0007018 GO:0007018 GO:0007173
AMOTL1 	AMOTL1 (Angiomotin Like 1) is a Protein Coding gene. Diseases associated with AMOTL1 include  AMOT	The protein encoded by this gene is a peripheral membrane protein that is a component of tight junctions or TJs. TJs form an apical junctional structure and act to control paracellular permeability and maintain cell polarity. This protein is related to angiomotin, an angiostatin binding protein that regulates endothelial cell migration and capillary formation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	The protein encoded by this gene is a peripheral membrane protein that is a component of tight junctions or TJs. TJs form an apical junctional structure and act to control paracellular permeability and maintain cell polarity. This protein is related to angiomotin, an angiostatin binding protein that regulates endothelial cell migration and capillary formation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Downregulation of NF-kappaB pathway after LMP1 stimulation, Inconclusive, Decreased influenza A virus infection, 	GO:0001525 GO:0003365 GO:0016055 GO:0030036 GO:0030036 GO:0030036 GO:0030334
PRR14 	PRR14 (Proline Rich 14) is a Protein Coding gene.    An important paralog of this gene is  PRR14L	The protein encoded by this gene tethers heterochromatin to the nuclear laminar scaffold by binding heterochromatin protein 1 (HP1) and the nuclear lamina. The tether is broken during mitosis and reforms quickly after mitosis, with the encoded protein first binding HP1 and then attaching to the nuclear lamina. This protein also has been shown to promote MyoD activity and skeletal myogenesis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Feb 2016]	The protein encoded by this gene tethers heterochromatin to the nuclear laminar scaffold by binding heterochromatin protein 1 (HP1) and the nuclear lamina. The tether is broken during mitosis and reforms quickly after mitosis, with the encoded protein first binding HP1 and then attaching to the nuclear lamina. This protein also has been shown to promote MyoD activity and skeletal myogenesis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Feb 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased IL-8 secretion, Inconclusive, 	 
TESK1 	TESK1 (Testis Associated Actin Remodelling Kinase 1) is a Protein Coding gene. Diseases associated with TESK1 include  TESK2	This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain and a C-terminal proline-rich domain. Its protein kinase domain is most closely related to those of the LIM motif-containing protein kinases (LIMKs). The encoded protein can phosphorylate myelin basic protein and histone in vitro. The testicular germ cell-specific expression and developmental pattern of expression of the mouse gene suggests that this gene plays an important role at and after the meiotic phase of spermatogenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]	This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain and a C-terminal proline-rich domain. Its protein kinase domain is most closely related to those of the LIM motif-containing protein kinases (LIMKs). The encoded protein can phosphorylate myelin basic protein and histone in vitro. The testicular germ cell-specific expression and developmental pattern of expression of the mouse gene suggests that this gene plays an important role at and after the meiotic phase of spermatogenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Increased Nanog expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased cell death in HCC-1954 cells, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Small cells, Fragmented cis-Golgi, fragmented trans-Golgi, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0001934
FGFR2 	FGFR2 (Fibroblast Growth Factor Receptor 2) is a Protein Coding gene. Diseases associated with FGFR2 include  FGFR1	The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]	The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]	no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased substrate adherent cell growth, Increased shRNA abundance, Moderately decreased NFAT1-GFP nuclear translocation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Polylobed nuclei, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Fragmented cis-Golgi, fragmented medial Golgi, fragmented trans-Golgi, Increased IL-10 protein expression, 	 
NOS2 	NOS2 (Nitric Oxide Synthase 2) is a Protein Coding gene. Diseases associated with NOS2 include  Malaria Glioblastoma NOS1	Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. Increased gamma-H2AX phosphorylation, Increased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0001666 GO:0001912 GO:0001912 GO:0001912 GO:0002227 GO:0006527
ETV6 	ETV6 (ETS Variant Transcription Factor 6) is a Protein Coding gene. Diseases associated with ETV6 include  ETV7	This gene encodes an ETS family transcription factor. The product of this gene contains two functional domains: a N-terminal pointed (PNT) domain that is involved in protein-protein interactions with itself and other proteins, and a C-terminal DNA-binding domain. Gene knockout studies in mice suggest that it is required for hematopoiesis and maintenance of the developing vascular network. This gene is known to be involved in a large number of chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. [provided by RefSeq, Sep 2008]	This gene encodes an ETS family transcription factor. The product of this gene contains two functional domains: a N-terminal pointed (PNT) domain that is involved in protein-protein interactions with itself and other proteins, and a C-terminal DNA-binding domain. Gene knockout studies in mice suggest that it is required for hematopoiesis and maintenance of the developing vascular network. This gene is known to be involved in a large number of chromosomal rearrangements associated with leukemia and congenital fibrosarcoma. [provided by RefSeq, Sep 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased HPV18 LCR reporter activity, Decreased viability with TRAIL, Increased G1 length, increased S length, Increased S length, 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357
FOSB 	FOSB (FosB Proto-Oncogene, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with FOSB include  Osteoblastoma FOS	The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), High actin ratio cells, 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357
ULK1 	ULK1 (Unc-51 Like Autophagy Activating Kinase 1) is a Protein Coding gene. Diseases associated with ULK1 include  Autophagy ULK2	Enables identical protein binding activity; protein serine/threonine kinase activity; and small GTPase binding activity. Involved in several processes, including autophagosome assembly; positive regulation by symbiont of host autophagy; and protein phosphorylation. Located in autophagosome; cytosol; and phagophore assembly site membrane. Is extrinsic component of autophagosome membrane; extrinsic component of omegasome membrane; and extrinsic component of phagophore assembly site membrane. Part of Atg1/ULK1 kinase complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables identical protein binding activity; protein serine/threonine kinase activity; and small GTPase binding activity. Involved in several processes, including autophagosome assembly; positive regulation by symbiont of host autophagy; and protein phosphorylation. Located in autophagosome; cytosol; and phagophore assembly site membrane. Is extrinsic component of autophagosome membrane; extrinsic component of omegasome membrane; and extrinsic component of phagophore assembly site membrane. Part of Atg1/ULK1 kinase complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased vesicular stomatitis virus (VSV) infection, Increased cell death HMECs cells, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cilium length after serum starvation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Transferrin accumulation in small spots in the cell periphery, 	GO:0000045 GO:0000422 GO:0006468 GO:0006468 GO:0006468
NCOA2 	NCOA2 (Nuclear Receptor Coactivator 2) is a Protein Coding gene. Diseases associated with NCOA2 include  NCOA3	The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), 	GO:0000122 GO:0006355 GO:0006355 GO:0006355
SNAI2 	SNAI2 (Snail Family Transcriptional Repressor 2) is a Protein Coding gene. Diseases associated with SNAI2 include  SNAI1	This gene encodes a member of the Snail family of C2H2-type zinc finger transcription factors. The encoded protein acts as a transcriptional repressor that binds to E-box motifs and is also likely to repress E-cadherin transcription in breast carcinoma. This protein is involved in epithelial-mesenchymal transitions and has antiapoptotic activity. Mutations in this gene may be associated with sporatic cases of neural tube defects. This gene encodes a member of the Snail family of C2H2-type zinc finger transcription factors. The encoded protein acts as a transcriptional repressor that binds to E-box motifs and is also likely to repress E-cadherin transcription in breast carcinoma. This protein is involved in epithelial-mesenchymal transitions and has antiapoptotic activity. Mutations in this gene may be associated with sporatic cases of neural tube defects. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability with paclitaxel, Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased Aire reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0000122 GO:0001649 GO:0001837 GO:0003180 GO:0003198
ADAMTS4 	ADAMTS4 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 4) is a Protein Coding gene. Diseases associated with ADAMTS4 include  Arthritis Chondrosarcoma ADAMTS1	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of this family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene lacks a C-terminal TS motif. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease is responsible for the degradation of aggrecan, a major proteoglycan of cartilage, and brevican, a brain-specific extracellular matrix protein. The expression of this gene is upregulated in arthritic disease and this may contribute to disease progression through the degradation of aggrecan. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of this family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene lacks a C-terminal TS motif. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease is responsible for the degradation of aggrecan, a major proteoglycan of cartilage, and brevican, a brain-specific extracellular matrix protein. The expression of this gene is upregulated in arthritic disease and this may contribute to disease progression through the degradation of aggrecan. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Polylobed nuclei, Proliferating cells, 	GO:0001501 GO:0006508 GO:0022617 GO:0022617 GO:0022617 GO:0030198 GO:0030198 GO:0030198
CXCL12 	CXCL12 (C-X-C Motif Chemokine Ligand 12) is a Protein Coding gene. Diseases associated with CXCL12 include  Ischemia	This antimicrobial gene encodes a stromal cell-derived alpha chemokine member of the intercrine family. The encoded protein functions as the ligand for the G-protein coupled receptor, chemokine (C-X-C motif) receptor 4, and plays a role in many diverse cellular functions, including embryogenesis, immune surveillance, inflammation response, tissue homeostasis, and tumor growth and metastasis. Mutations in this gene are associated with resistance to human immunodeficiency virus type 1 infections. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]	This antimicrobial gene encodes a stromal cell-derived alpha chemokine member of the intercrine family. The encoded protein functions as the ligand for the G-protein coupled receptor, chemokine (C-X-C motif) receptor 4, and plays a role in many diverse cellular functions, including embryogenesis, immune surveillance, inflammation response, tissue homeostasis, and tumor growth and metastasis. Mutations in this gene are associated with resistance to human immunodeficiency virus type 1 infections. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased free cholesterol, Decreased free cholesterol, Increased LDL uptake, 	GO:0001666 GO:0001764 GO:0001764 GO:0001764 GO:0001938 GO:0001938 GO:0001938 GO:0006874 GO:0006874 GO:0006874 GO:0006935
ZBTB17 	ZBTB17 (Zinc Finger And BTB Domain Containing 17) is a Protein Coding gene. Diseases associated with ZBTB17 include  ZNF407	This gene encodes a zinc finger protein involved in the regulation of c-myc. The symbol MIZ1 has also been associated with PIAS2 which is a different gene located on chromosome 18. This gene encodes a zinc finger protein involved in the regulation of c-myc. The symbol MIZ1 has also been associated with PIAS2 which is a different gene located on chromosome 18. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0000122 GO:0001702 GO:0001702 GO:0001702 GO:0001817 GO:0001817 GO:0001817 GO:0002682
PTK2 	PTK2 (Protein Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with PTK2 include  PTK2B	This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Decreased substrate adherent cell growth, Increased circadian period length, Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased simian virus 40 (SV40) infection, Diffuse trans-Golgi, Decreased viability with paclitaxel, Decreased viability in HMC1.1 cells, Decreased viability in CMK cells, 	GO:0001525 GO:0001890 GO:0001932 GO:0001934 GO:0003007
IL6 	IL6 (Interleukin 6) is a Protein Coding gene. Diseases associated with IL6 include 	This gene encodes a cytokine that functions in inflammation and the maturation of B cells. In addition, the encoded protein has been shown to be an endogenous pyrogen capable of inducing fever in people with autoimmune diseases or infections. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis. Elevated levels of the encoded protein have been found in virus infections, including COVID-19 (disease caused by SARS-CoV-2). [provided by RefSeq, Aug 2020]	This gene encodes a cytokine that functions in inflammation and the maturation of B cells. In addition, the encoded protein has been shown to be an endogenous pyrogen capable of inducing fever in people with autoimmune diseases or infections. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis. Elevated levels of the encoded protein have been found in virus infections, including COVID-19 (disease caused by SARS-CoV-2). [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability in esophageal squamous lineage, 	GO:0001781 GO:0002314 GO:0002384 GO:0002384 GO:0002384 GO:0002446 GO:0002548
DDR2 	DDR2 (Discoidin Domain Receptor Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with DDR2 include  DDR1	This gene encodes a member of the discoidin domain receptor subclass of the receptor tyrosine kinase (RTKs) protein family. RTKs play a key role in the communication of cells with their microenvironment. The encoded protein is a collagen-induced receptor that activates signal transduction pathways involved in cell adhesion, proliferation, and extracellular matrix remodeling. This protein is expressed in numerous cell types and may alos be involved in wound repair and regulate tumor growth and invasiveness. Mutations in this gene are the cause of short limb-hand type spondylometaepiphyseal dysplasia. [provided by RefSeq, Aug 2017]	This gene encodes a member of the discoidin domain receptor subclass of the receptor tyrosine kinase (RTKs) protein family. RTKs play a key role in the communication of cells with their microenvironment. The encoded protein is a collagen-induced receptor that activates signal transduction pathways involved in cell adhesion, proliferation, and extracellular matrix remodeling. This protein is expressed in numerous cell types and may alos be involved in wound repair and regulate tumor growth and invasiveness. Mutations in this gene are the cause of short limb-hand type spondylometaepiphyseal dysplasia. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased cell viability after pRB stimulation, Decreased viability in colon lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0001503 GO:0003416 GO:0003416 GO:0003416 GO:0006468 GO:0006468 GO:0006468 GO:0007155 GO:0007155 GO:0007155 GO:0007165
CCR7 	CCR7 (C-C Motif Chemokine Receptor 7) is a Protein Coding gene. Diseases associated with CCR7 include  CCR6	The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. Signals mediated by this receptor regulate T cell homeostasis in lymph nodes, and may also function in the activation and polarization of T cells, and in chronic inflammation pathogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014]	The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. Signals mediated by this receptor regulate T cell homeostasis in lymph nodes, and may also function in the activation and polarization of T cells, and in chronic inflammation pathogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014]	no effect, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), 	GO:0001768 GO:0001954 GO:0002407 GO:0002408
TNF 	TNF (Tumor Necrosis Factor) is a Protein Coding gene. Diseases associated with TNF include  Malaria Asthma TNFSF15	This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, psoriasis, rheumatoid arthritis ankylosing spondylitis, tuberculosis, autosomal dominant polycystic kidney disease, and cancer. Mutations in this gene affect susceptibility to cerebral malaria, septic shock, and Alzheimer disease. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Aug 2020]	This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, psoriasis, rheumatoid arthritis ankylosing spondylitis, tuberculosis, autosomal dominant polycystic kidney disease, and cancer. Mutations in this gene affect susceptibility to cerebral malaria, septic shock, and Alzheimer disease. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), 	GO:0000122 GO:0000165 GO:0001666 GO:0001774 GO:0001774 GO:0001774
SLC38A5 	SLC38A5 (Solute Carrier Family 38 Member 5) is a Protein Coding gene. Diseases associated with SLC38A5 include  SLC38A3	The protein encoded by this gene is a system N sodium-coupled amino acid transporter. The encoded protein transports glutamine, asparagine, histidine, serine, alanine, and glycine across the cell membrane, but does not transport charged amino acids, imino acids, or N-alkylated amino acids. Alternative splicing results in multiple transcript variants, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Aug 2013]	The protein encoded by this gene is a system N sodium-coupled amino acid transporter. The encoded protein transports glutamine, asparagine, histidine, serine, alanine, and glycine across the cell membrane, but does not transport charged amino acids, imino acids, or N-alkylated amino acids. Alternative splicing results in multiple transcript variants, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Aug 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased homologous recombination repair frequency, Decreased nuclei size in G2M, 	GO:0003333 GO:0006865 GO:0006865 GO:0006865 GO:0006867 GO:0006867 GO:0006867 GO:0006868 GO:0006868 GO:0006868 GO:0015804 GO:0015804 GO:0015804
GATA2 	GATA2 (GATA Binding Protein 2) is a Protein Coding gene. Diseases associated with GATA2 include  GATA3	This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]	This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in glioblastoma multiforme (GBM) lineage, Inconclusive, Negative genetic interaction between BLM-/- and BLM+/+, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0000122
RGS5 	RGS5 (Regulator Of G Protein Signaling 5) is a Protein Coding gene. Diseases associated with RGS5 include  RGS3	This locus represents naturally occurring readthrough transcription between the neighboring LOC127814295 (uncharacterized LOC127814295) and RGS5 (regulator of G-protein signaling 5) genes on chromosome 1. Some variants of the readthrough transcript encode novel proteins with unique N-termini. [provided by RefSeq, Nov 2022]	This locus represents naturally occurring readthrough transcription between the neighboring LOC127814295 (uncharacterized LOC127814295) and RGS5 (regulator of G-protein signaling 5) genes on chromosome 1. Some variants of the readthrough transcript encode novel proteins with unique N-termini. [provided by RefSeq, Nov 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased Salmonella enterica Typhimurium invasion, 	GO:0007186 GO:0008277 GO:0008277 GO:0008277
RALGDS 	RALGDS (Ral Guanine Nucleotide Dissociation Stimulator) is a Protein Coding gene. Diseases associated with RALGDS include  Rasopathy RGL1	Guanine nucleotide dissociation stimulators (GDSs, or exchange factors), such as RALGDS, are effectors of Ras-related GTPases (see MIM 190020) that participate in signaling for a variety of cellular processes.[supplied by OMIM, Nov 2010]	Guanine nucleotide dissociation stimulators (GDSs, or exchange factors), such as RALGDS, are effectors of Ras-related GTPases (see MIM 190020) that participate in signaling for a variety of cellular processes.[supplied by OMIM, Nov 2010]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance, Decreased OCT4 protein expression, Decreased NANOG protein expression, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0007265 GO:0007265 GO:0007265 GO:0043547
ARHGEF2 	ARHGEF2 (Rho/Rac Guanine Nucleotide Exchange Factor 2) is a Protein Coding gene. Diseases associated with ARHGEF2 include  ARHGEF28	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form complex with G proteins and stimulate rho-dependent signals. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Jun 2009]	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form complex with G proteins and stimulate rho-dependent signals. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Jun 2009]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased shRNA abundance, Increased virus production, 	GO:0000902 GO:0002376 GO:0006886 GO:0006886 GO:0006886 GO:0007015 GO:0007026
SSPN 	SSPN (Sarcospan) is a Protein Coding gene. Diseases associated with SSPN include 	This gene encodes a member of the dystrophin-glycoprotein complex (DGC). The DGC spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Two alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Oct 2008]	This gene encodes a member of the dystrophin-glycoprotein complex (DGC). The DGC spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Two alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Oct 2008]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, 	GO:0006936 GO:0007155
RAB13 	RAB13 (RAB13, Member RAS Oncogene Family) is a Protein Coding gene.  Among its related pathways are  RAB8B	This gene is a member of the Rab family of small G proteins and plays a role in regulating membrane trafficking between trans-Golgi network (TGN) and recycling endosomes (RE). The encoded protein is involved in the assembly of tight junctions, which are components of the apical junctional complex (AJC) of epithelial cells. The AJC plays a role in forming a barrier between luminal contents and the underlying tissue. Additional functions associated with the protein include endocytic recycling of occludin, regulation of epithelial cell scattering, neuronal regeneration and regulation of neurite outgrowth. Alternately spliced transcript variants have been observed for this gene. A pseudogene associated with this gene is located on chromosome 12. [provided by RefSeq, Jan 2013]	This gene is a member of the Rab family of small G proteins and plays a role in regulating membrane trafficking between trans-Golgi network (TGN) and recycling endosomes (RE). The encoded protein is involved in the assembly of tight junctions, which are components of the apical junctional complex (AJC) of epithelial cells. The AJC plays a role in forming a barrier between luminal contents and the underlying tissue. Additional functions associated with the protein include endocytic recycling of occludin, regulation of epithelial cell scattering, neuronal regeneration and regulation of neurite outgrowth. Alternately spliced transcript variants have been observed for this gene. A pseudogene associated with this gene is located on chromosome 12. [provided by RefSeq, Jan 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in ovarian lineage, Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability (cell death), Increased cell size, Decreased cilium length after serum starvation, 	GO:0006904 GO:0009306 GO:0010737 GO:0015031 GO:0016197 GO:0016197 GO:0016197
RPS6KB1 	RPS6KB1 (Ribosomal Protein S6 Kinase B1) is a Protein Coding gene. Diseases associated with RPS6KB1 include  Lymphangioleiomyomatosis RPS6KB2	This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]	This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased viability after ionizing radiation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Decreased viability with paclitaxel, Diffuse cis-Golgi, 	GO:0000082
SHANK2 	SHANK2 (SH3 And Multiple Ankyrin Repeat Domains 2) is a Protein Coding gene. Diseases associated with SHANK2 include  SHANK1	This gene encodes a protein that is a member of the Shank family of synaptic proteins that may function as molecular scaffolds in the postsynaptic density of excitatory synapses. Shank proteins contain multiple domains for protein-protein interaction, including ankyrin repeats, and an SH3 domain. This particular family member contains a PDZ domain, a consensus sequence for cortactin SH3 domain-binding peptides and a sterile alpha motif. The alternative splicing demonstrated in Shank genes has been suggested as a mechanism for regulating the molecular structure of Shank and the spectrum of Shank-interacting proteins in the postsynaptic densities of the adult and developing brain. Alterations in the encoded protein may be associated with susceptibility to autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	This gene encodes a protein that is a member of the Shank family of synaptic proteins that may function as molecular scaffolds in the postsynaptic density of excitatory synapses. Shank proteins contain multiple domains for protein-protein interaction, including ankyrin repeats, and an SH3 domain. This particular family member contains a PDZ domain, a consensus sequence for cortactin SH3 domain-binding peptides and a sterile alpha motif. The alternative splicing demonstrated in Shank genes has been suggested as a mechanism for regulating the molecular structure of Shank and the spectrum of Shank-interacting proteins in the postsynaptic densities of the adult and developing brain. Alterations in the encoded protein may be associated with susceptibility to autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Decreased viability after Maraba virus infection, Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), increased nuclear migration speed, 	GO:0007416 GO:0007420 GO:0007584 GO:0007584 GO:0007584 GO:0007612 GO:0007612 GO:0007612 GO:0008284
DDAH1 	DDAH1 (Dimethylarginine Dimethylaminohydrolase 1) is a Protein Coding gene. Diseases associated with DDAH1 include  Metabolism DDAH2	This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, FOXO1 nuclear localization, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with imatinib mesylate, 	GO:0000052 GO:0003073 GO:0006525 GO:0006525 GO:0006525 GO:0006527 GO:0007263
TH 	TH (Tyrosine Hydroxylase) is a Protein Coding gene. Diseases associated with TH include  PAH	The protein encoded by this gene is involved in the conversion of tyrosine to dopamine. It is the rate-limiting enzyme in the synthesis of catecholamines, hence plays a key role in the physiology of adrenergic neurons. Mutations in this gene have been associated with autosomal recessive Segawa syndrome. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. The protein encoded by this gene is involved in the conversion of tyrosine to dopamine. It is the rate-limiting enzyme in the synthesis of catecholamines, hence plays a key role in the physiology of adrenergic neurons. Mutations in this gene have been associated with autosomal recessive Segawa syndrome. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. no effect, Increased circadian period length, Increased homologous recombination repair frequency, Increased Nanog expression, 	GO:0001666 GO:0001963 GO:0001975 GO:0001975 GO:0001975 GO:0003007 GO:0003007 GO:0003007 GO:0006585
ARHGAP17 	ARHGAP17 (Rho GTPase Activating Protein 17) is a Protein Coding gene. Diseases associated with ARHGAP17 include  ARHGAP44	RICH1 is a GTPase-activating protein (GAP). GAPs stimulate the intrinsic GTP hydrolysis of small G proteins, such as RHOA (MIM 165390), RAC1 (MIM 602048), and CDC42 (MIM 116952).[supplied by OMIM, Apr 2004]	RICH1 is a GTPase-activating protein (GAP). GAPs stimulate the intrinsic GTP hydrolysis of small G proteins, such as RHOA (MIM 165390), RAC1 (MIM 602048), and CDC42 (MIM 116952).[supplied by OMIM, Apr 2004]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage, Two nuclei (binuclear), 	GO:0007015 GO:0007165 GO:0007165 GO:0007165 GO:0017156 GO:0017156 GO:0017156 GO:0032956 GO:0032956 GO:0032956 GO:0035020
ANGPTL4 	ANGPTL4 (Angiopoietin Like 4) is a Protein Coding gene. Diseases associated with ANGPTL4 include  ANGPTL3	This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]	This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability with paclitaxel, Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Decreased viability of wild-type and TP53 knockout cells, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased free cholesterol, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0006629 GO:0019216 GO:0019216 GO:0019216 GO:0043066 GO:0043066 GO:0043066
ATF4 	ATF4 (Activating Transcription Factor 4) is a Protein Coding gene. Diseases associated with ATF4 include  ATF5	This gene encodes a transcription factor that was originally identified as a widely expressed mammalian DNA binding protein that could bind a tax-responsive enhancer element in the LTR of HTLV-1. The encoded protein was also isolated and characterized as the cAMP-response element binding protein 2 (CREB-2). The protein encoded by this gene belongs to a family of DNA-binding proteins that includes the AP-1 family of transcription factors, cAMP-response element binding proteins (CREBs) and CREB-like proteins. These transcription factors share a leucine zipper region that is involved in protein-protein interactions, located C-terminal to a stretch of basic amino acids that functions as a DNA binding domain. Two alternative transcripts encoding the same protein have been described. Two pseudogenes are located on the X chromosome at q28 in a region containing a large inverted duplication. [provided by RefSeq, Sep 2011]	This gene encodes a transcription factor that was originally identified as a widely expressed mammalian DNA binding protein that could bind a tax-responsive enhancer element in the LTR of HTLV-1. The encoded protein was also isolated and characterized as the cAMP-response element binding protein 2 (CREB-2). The protein encoded by this gene belongs to a family of DNA-binding proteins that includes the AP-1 family of transcription factors, cAMP-response element binding proteins (CREBs) and CREB-like proteins. These transcription factors share a leucine zipper region that is involved in protein-protein interactions, located C-terminal to a stretch of basic amino acids that functions as a DNA binding domain. Two alternative transcripts encoding the same protein have been described. Two pseudogenes are located on the X chromosome at q28 in a region containing a large inverted duplication. [provided by RefSeq, Sep 2011]	Decreased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased shRNA abundance (Z-score &gt; 2), Increased cell death in HCT116 cells, 	GO:0000122 GO:0006094 GO:0006094 GO:0006094 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
PPP1CA 	PPP1CA (Protein Phosphatase 1 Catalytic Subunit Alpha) is a Protein Coding gene. Diseases associated with PPP1CA include  Encephalitis PPP1CC	The protein encoded by this gene is one of the three catalytic subunits of protein phosphatase 1 (PP1). This broadly expressed gene encodes the alpha subunit of the PP1 complex that associates with over 200 regulatory proteins to form holoenzymes which dephosphorylate their biological targets with high specificity. PP1 is a serine/threonine specific protein phosphatase known to be involved in the regulation of a variety of cellular processes, such as cell division, glycogen metabolism, muscle contractility, protein synthesis, and HIV-1 viral transcription. Increased PP1 activity has been observed in the end stage of heart failure. Studies suggest that PP1 is an important regulator of cardiac function and that PP1 deregulation is implicated in diabetes and multiple types of cancer. Three alternatively spliced transcript variants encoding different isoforms have been found for this gene.  The protein encoded by this gene is one of the three catalytic subunits of protein phosphatase 1 (PP1). This broadly expressed gene encodes the alpha subunit of the PP1 complex that associates with over 200 regulatory proteins to form holoenzymes which dephosphorylate their biological targets with high specificity. PP1 is a serine/threonine specific protein phosphatase known to be involved in the regulation of a variety of cellular processes, such as cell division, glycogen metabolism, muscle contractility, protein synthesis, and HIV-1 viral transcription. Increased PP1 activity has been observed in the end stage of heart failure. Studies suggest that PP1 is an important regulator of cardiac function and that PP1 deregulation is implicated in diabetes and multiple types of cancer. Three alternatively spliced transcript variants encoding different isoforms have been found for this gene.  no effect, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Nanog expression, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability after TNF/CHX stimulation, Increased apoptosis, Increased Erk phosphorylation after EGF stimulation, 	 
BNIP3L 	BNIP3L (BCL2 Interacting Protein 3 Like) is a Protein Coding gene. Diseases associated with BNIP3L include  BNIP3	This gene encodes a protein that belongs to the pro-apoptotic subfamily within the Bcl-2 family of proteins. The encoded protein binds to Bcl-2 and possesses the BH3 domain. The protein directly targets mitochondria and causes apoptotic changes, including loss of membrane potential and the release of cytochrome c. [provided by RefSeq, Feb 2015]	This gene encodes a protein that belongs to the pro-apoptotic subfamily within the Bcl-2 family of proteins. The encoded protein binds to Bcl-2 and possesses the BH3 domain. The protein directly targets mitochondria and causes apoptotic changes, including loss of membrane potential and the release of cytochrome c. [provided by RefSeq, Feb 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability in colon lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased proliferation, Increased the percentage of infected cells, 	GO:0006915 GO:0016239 GO:0016239 GO:0016239 GO:0019222 GO:0035694 GO:0035694 GO:0035694 GO:0043065
HOXB1 	HOXB1 (Homeobox B1) is a Protein Coding gene. Diseases associated with HOXB1 include  HOXA1	This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXB genes located in a cluster on chromosome 17. This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXB genes located in a cluster on chromosome 17. Increased vaccinia virus (VACV) infection, no effect, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0006355 GO:0006357 GO:0007389
EPHA7 	EPHA7 (EPH Receptor A7) is a Protein Coding gene. Diseases associated with EPHA7 include  EPHA5	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Transferrin accumulation in the perinuclear area, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability (proliferation), Increased cell death HMECs cells, Increased viability, Increased vesicular stomatitis virus (VSV) infection, 	 
SMAD6 	SMAD6 (SMAD Family Member 6) is a Protein Coding gene. Diseases associated with SMAD6 include  SMAD7	The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila \'mothers against decapentaplegic\' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]	The protein encoded by this gene belongs to the SMAD family of proteins, which are related to Drosophila \'mothers against decapentaplegic\' (Mad) and C. elegans Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions in the negative regulation of BMP and TGF-beta/activin-signalling. Multiple transcript variants have been found for this gene.[provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0001657 GO:0003148 GO:0003148 GO:0003148 GO:0003170 GO:0003170 GO:0003170 GO:0003180 GO:0003180 GO:0003180
CD2AP 	CD2AP (CD2 Associated Protein) is a Protein Coding gene. Diseases associated with CD2AP include  SH3KBP1	This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. no effect, Decreased viability, Decreased viability ratio, Increased replication of vaccinia virus (VACV), Decreased homologous recombination repair frequency, 	GO:0006930 GO:0007015 GO:0007049 GO:0007165 GO:0007165 GO:0007165
RNF187 	RNF187 (Ring Finger Protein 187) is a Protein Coding gene. Diseases associated with RNF187 include 	Enables ubiquitin-protein transferase activity. Involved in positive regulation of transcription, DNA-templated; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein ubiquitination. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables ubiquitin-protein transferase activity. Involved in positive regulation of transcription, DNA-templated; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein ubiquitination. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability, Increased IL-8 secretion, 	GO:0008284 GO:0010468 GO:0010468 GO:0010468 GO:0016567 GO:0016567 GO:0016567 GO:0043161 GO:0043161 GO:0043161
TIMP3 	TIMP3 (TIMP Metallopeptidase Inhibitor 3) is a Protein Coding gene. Diseases associated with TIMP3 include  TIMP4	This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby\'s fundus dystrophy. This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby\'s fundus dystrophy. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased virus production, 	GO:0007601 GO:0009725 GO:0009725 GO:0009725 GO:0010033 GO:0010466 GO:0010466 GO:0010466 GO:0010951 GO:0010951 GO:0010951
IRAK2 	IRAK2 (Interleukin 1 Receptor Associated Kinase 2) is a Protein Coding gene.  Among its related pathways are  IRAK1	IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB. IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability after Maraba virus infection, Increased Nanog expression, Decreased substrate adherent cell growth, Decreased NF-kappaB reporter expression, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Increased cell death HMECs cells, Decreased shRNA abundance, Decreased mitotic index, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, Decreased viability after gemcitabine stimulation, 	GO:0001959 GO:0002755 GO:0006468 GO:0006954 GO:0006954 GO:0006954
VHL 	VHL (Von Hippel-Lindau Tumor Suppressor) is a Protein Coding gene. Diseases associated with VHL include  VHLL	This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]	This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]	Increased gamma-H2AX phosphorylation, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Increased Nanog expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased cilium length after serum starvation, Increased sensitivity to paclitaxel, 	GO:0000902 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006508 GO:0008285
MAML1 	MAML1 (Mastermind Like Transcriptional Coactivator 1) is a Protein Coding gene. Diseases associated with MAML1 include  MAML3	This protein is the human homolog of mastermind, a Drosophila protein that plays a role in the Notch signaling pathway involved in cell-fate determination. There is in vitro evidence that the human homolog forms a complex with the intracellular portion of human Notch receptors and can increase expression of a Notch-induced gene. This evidence supports its proposed function as a transcriptional co-activator in the Notch signaling pathway. This protein is the human homolog of mastermind, a Drosophila protein that plays a role in the Notch signaling pathway involved in cell-fate determination. There is in vitro evidence that the human homolog forms a complex with the intracellular portion of human Notch receptors and can increase expression of a Notch-induced gene. This evidence supports its proposed function as a transcriptional co-activator in the Notch signaling pathway. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 25%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with imatinib mesylate, 	GO:0003162 GO:0006468 GO:0006468 GO:0006468 GO:0007219 GO:0007221 GO:0010831
ITGA2 	ITGA2 (Integrin Subunit Alpha 2) is a Protein Coding gene. Diseases associated with ITGA2 include  ITGA1	This gene encodes the alpha subunit of a transmembrane receptor for collagens and related proteins. The encoded protein forms a heterodimer with a beta subunit and mediates the adhesion of platelets and other cell types to the extracellular matrix. Loss of the encoded protein is associated with bleeding disorder platelet-type 9. Antibodies against this protein are found in several immune disorders, including neonatal alloimmune thrombocytopenia. This gene is located adjacent to a related alpha subunit gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	This gene encodes the alpha subunit of a transmembrane receptor for collagens and related proteins. The encoded protein forms a heterodimer with a beta subunit and mediates the adhesion of platelets and other cell types to the extracellular matrix. Loss of the encoded protein is associated with bleeding disorder platelet-type 9. Antibodies against this protein are found in several immune disorders, including neonatal alloimmune thrombocytopenia. This gene is located adjacent to a related alpha subunit gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	no effect, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Decreased viability, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased cell migration, Decreased shRNA abundance, 	GO:0001666 GO:0002687 GO:0002687 GO:0002687 GO:0006929 GO:0006929 GO:0006929 GO:0006971 GO:0007155 GO:0007155 GO:0007155
HNRNPA1 	HNRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) is a Protein Coding gene. Diseases associated with HNRNPA1 include  HNRNPA1L3	This gene encodes a member of a family of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), which are RNA-binding proteins that associate with pre-mRNAs in the nucleus and influence pre-mRNA processing, as well as other aspects of mRNA metabolism and transport. The protein encoded by this gene is one of the most abundant core proteins of hnRNP complexes and plays a key role in the regulation of alternative splicing. Mutations in this gene have been observed in individuals with amyotrophic lateral sclerosis 20. Multiple alternatively spliced transcript variants have been found. There are numerous pseudogenes of this gene distributed throughout the genome. [provided by RefSeq, Feb 2016]	This gene encodes a member of a family of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs), which are RNA-binding proteins that associate with pre-mRNAs in the nucleus and influence pre-mRNA processing, as well as other aspects of mRNA metabolism and transport. The protein encoded by this gene is one of the most abundant core proteins of hnRNP complexes and plays a key role in the regulation of alternative splicing. Mutations in this gene have been observed in individuals with amyotrophic lateral sclerosis 20. Multiple alternatively spliced transcript variants have been found. There are numerous pseudogenes of this gene distributed throughout the genome. [provided by RefSeq, Feb 2016]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Low eccentricity cells, Increased NF-kappaB reporter expression, Decreased centriole number, Proliferating cells, Increased SMN2 exon 7 inclusion, 	GO:0000381 GO:0000398 GO:0006397 GO:0006405 GO:0006405 GO:0006405
TRAF6 	TRAF6 (TNF Receptor Associated Factor 6) is a Protein Coding gene. Diseases associated with TRAF6 include  TRAF2	The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]	The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]	no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased G1 DNA content, Increased Nanog expression, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0000122 GO:0000209
ZFYVE9 	ZFYVE9 (Zinc Finger FYVE-Type Containing 9) is a Protein Coding gene. Diseases associated with ZFYVE9 include  Nanophthalmos	This gene encodes a double zinc finger motif-containing protein that participates in the transforming growth factor-beta (TGFB) signalling pathway. The encoded protein interacts directly with SMAD2 and SMAD3, and recruits SMAD2 to the TGFB receptor. There are multiple pseudogenes for this gene on chromosomes 2, 15, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]	This gene encodes a double zinc finger motif-containing protein that participates in the transforming growth factor-beta (TGFB) signalling pathway. The encoded protein interacts directly with SMAD2 and SMAD3, and recruits SMAD2 to the TGFB receptor. There are multiple pseudogenes for this gene on chromosomes 2, 15, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]	no effect, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0006897 GO:0007179 GO:0016197
MRAS 	MRAS (Muscle RAS Oncogene Homolog) is a Protein Coding gene. Diseases associated with MRAS include  RRAS2	This gene encodes a member of the Ras family of small GTPases. These membrane-associated proteins function as signal transducers in multiple processes including cell growth and differentiation, and dysregulation of Ras signaling has been associated with many types of cancer. The encoded protein may play a role in the tumor necrosis factor-alpha and MAP kinase signaling pathways. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	This gene encodes a member of the Ras family of small GTPases. These membrane-associated proteins function as signal transducers in multiple processes including cell growth and differentiation, and dysregulation of Ras signaling has been associated with many types of cancer. The encoded protein may play a role in the tumor necrosis factor-alpha and MAP kinase signaling pathways. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability (cell death), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased homologous recombination repair frequency, Decreased shRNA abundance, Increased free cholesterol, 	GO:0007165 GO:0007265 GO:0007265 GO:0007265
PTPN11 	PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11) is a Protein Coding gene. Diseases associated with PTPN11 include  PTPN6	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]	no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Increased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell number in G2M, increased number of polyploid cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0000077 GO:0006470 GO:0006470 GO:0006470
MAP3K11 	MAP3K11 (Mitogen-Activated Protein Kinase Kinase Kinase 11) is a Protein Coding gene.  Among its related pathways are  MAP3K9	The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase contains a SH3 domain and a leucine zipper-basic motif. This kinase preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway. This kinase can directly phosphorylate, and activates IkappaB kinase alpha and beta, and is found to be involved in the transcription activity of NF-kappaB mediated by Rho family GTPases and CDC42. The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase contains a SH3 domain and a leucine zipper-basic motif. This kinase preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway. This kinase can directly phosphorylate, and activates IkappaB kinase alpha and beta, and is found to be involved in the transcription activity of NF-kappaB mediated by Rho family GTPases and CDC42. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Increased circadian period length, Dynamic nuclei (hole, folded or small irregular), Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death in HCC-1954 cells, Decreased substrate adherent cell growth, Increased cell death in DLD-1 cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, Misorientated spindle, 	GO:0000165 GO:0006468 GO:0007017 GO:0007254
VEGFB 	VEGFB (Vascular Endothelial Growth Factor B) is a Protein Coding gene. Diseases associated with VEGFB include  VEGFA	This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011]	This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Decreased cell migration, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Altered focal adhesion (FA) or cell shape morphology, 	GO:0001666 GO:0001934 GO:0001938 GO:0002040
PAK5 	PAK5 (P21 (RAC1) Activated Kinase 5) is a Protein Coding gene. Diseases associated with PAK5 include  PAK4	The protein encoded by this gene is a member of the PAK family of Ser/Thr protein kinases. PAK family members are known to be effectors of Rac/Cdc42 GTPases, which have been implicated in the regulation of cytoskeletal dynamics, proliferation, and cell survival signaling. This kinase contains a CDC42/Rac1 interactive binding (CRIB) motif, and has been shown to bind CDC42 in the presence of GTP. This kinase is predominantly expressed in brain. It is capable of promoting neurite outgrowth, and thus may play a role in neurite development. This kinase is associated with microtubule networks and induces microtubule stabilization. The subcellular localization of this kinase is tightly regulated during cell cycle progression. Alternatively spliced transcript variants encoding the same protein have been described. The protein encoded by this gene is a member of the PAK family of Ser/Thr protein kinases. PAK family members are known to be effectors of Rac/Cdc42 GTPases, which have been implicated in the regulation of cytoskeletal dynamics, proliferation, and cell survival signaling. This kinase contains a CDC42/Rac1 interactive binding (CRIB) motif, and has been shown to bind CDC42 in the presence of GTP. This kinase is predominantly expressed in brain. It is capable of promoting neurite outgrowth, and thus may play a role in neurite development. This kinase is associated with microtubule networks and induces microtubule stabilization. The subcellular localization of this kinase is tightly regulated during cell cycle progression. Alternatively spliced transcript variants encoding the same protein have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Increased Nanog expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Decreased substrate adherent cell growth, Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased transferrin (TF) endocytosis, Increased mitotic index, Decreased Cdk9 T-loop phosphorylation, 	GO:0001558 GO:0006468 GO:0006915 GO:0007010 GO:0007165
GSC 	GSC (Goosecoid Homeobox) is a Protein Coding gene. Diseases associated with GSC include  Gastrulation GSC2	This gene encodes a member of the bicoid subfamily of the paired (PRD) homeobox family of proteins. The encoded protein acts as a transcription factor and may be autoregulatory. A similar protein in mice plays a role in craniofacial and rib cage development during embryogenesis. This gene encodes a member of the bicoid subfamily of the paired (PRD) homeobox family of proteins. The encoded protein acts as a transcription factor and may be autoregulatory. A similar protein in mice plays a role in craniofacial and rib cage development during embryogenesis. no effect, shRNA abundance &lt;= 50%, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased viability in pancreas lineage, Decreased viability, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, 	GO:0000122 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007369
AGTR1 	AGTR1 (Angiotensin II Receptor Type 1) is a Protein Coding gene. Diseases associated with AGTR1 include  AGTR2	Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed; however, it is now believed that there is only one type 1 receptor gene in humans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2020]	Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed; however, it is now believed that there is only one type 1 receptor gene in humans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2020]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Reduced mammosphere formation, Decreased viability ratio, Increased Nanog expression, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased G1 length, Increased G1 length, increased S length, Decreased shRNA abundance (Z-score &lt; -2), Increased S length, increased G2 length, Increased G1 length, increased S length, increased G2 length, 	GO:0001558 GO:0001822 GO:0002018 GO:0002034 GO:0003081
NR1I3 	NR1I3 (Nuclear Receptor Subfamily 1 Group I Member 3) is a Protein Coding gene. Diseases associated with NR1I3 include  Cholestasis NR1I2	This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene.  This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene.  no effect, Decreased ionizing radiation sensitivity, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance, 	GO:0000122
KCNJ3 	KCNJ3 (Potassium Inwardly Rectifying Channel Subfamily J Member 3) is a Protein Coding gene. Diseases associated with KCNJ3 include  Epilepsy KCNJ6	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and plays an important role in regulating heartbeat. It associates with three other G-protein-activated potassium channels to form a heteromultimeric pore-forming complex that also couples to neurotransmitter receptors in the brain and whereby channel activation can inhibit action potential firing by hyperpolarizing the plasma membrane. These multimeric G-protein-gated inwardly-rectifying potassium (GIRK) channels may play a role in the pathophysiology of epilepsy, addiction, Down\'s syndrome, ataxia, and Parkinson\'s disease. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, May 2012]	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and plays an important role in regulating heartbeat. It associates with three other G-protein-activated potassium channels to form a heteromultimeric pore-forming complex that also couples to neurotransmitter receptors in the brain and whereby channel activation can inhibit action potential firing by hyperpolarizing the plasma membrane. These multimeric G-protein-gated inwardly-rectifying potassium (GIRK) channels may play a role in the pathophysiology of epilepsy, addiction, Down\'s syndrome, ataxia, and Parkinson\'s disease. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, May 2012]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased HPV16-GFP infection, Increased ionizing radiation sensitivity, Decreased homologous recombination repair frequency, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0006811 GO:0006813 GO:0006813 GO:0006813 GO:0034220 GO:0034765 GO:0034765 GO:0034765
SRCAP 	SRCAP (Snf2 Related CREBBP Activator Protein) is a Protein Coding gene. Diseases associated with SRCAP include  EP400	This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]	This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 25%, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Negative genetic interaction between BLM-/- and BLM+/+, Increased Nanog expression, Increased CDKN1A mRNA expression, Increased BBC3 mRNA expression, 	GO:0006325 GO:0006338 GO:0006338 GO:0006338 GO:0006355 GO:0006355 GO:0006355 GO:0006357
SMOC1 	SMOC1 (SPARC Related Modular Calcium Binding 1) is a Protein Coding gene. Diseases associated with SMOC1 include  SMOC2	This gene encodes a multi-domain secreted protein that may have a critical role in ocular and limb development. Mutations in this gene are associated with microphthalmia and limb anomalies. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]	This gene encodes a multi-domain secreted protein that may have a critical role in ocular and limb development. Mutations in this gene are associated with microphthalmia and limb anomalies. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0001654 GO:0030154 GO:0030198 GO:0030198 GO:0030198 GO:0045667 GO:0060173
COL6A1 	COL6A1 (Collagen Type VI Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL6A1 include  COL5A1	The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Elongated cells with protrusions, 	GO:0001649 GO:0007155 GO:0035987 GO:0035987 GO:0035987
HSPA1A 	HSPA1A (Heat Shock Protein Family A (Hsp70) Member 1A) is a Protein Coding gene. Diseases associated with HSPA1A include  Ischemia HSPA1B	This intronless gene encodes a 70kDa heat shock protein which is a member of the heat shock protein 70 family. In conjuction with other heat shock proteins, this protein stabilizes existing proteins against aggregation and mediates the folding of newly translated proteins in the cytosol and in organelles. It is also involved in the ubiquitin-proteasome pathway through interaction with the AU-rich element RNA-binding protein 1. The gene is located in the major histocompatibility complex class III region, in a cluster with two closely related genes which encode similar proteins. This intronless gene encodes a 70kDa heat shock protein which is a member of the heat shock protein 70 family. In conjuction with other heat shock proteins, this protein stabilizes existing proteins against aggregation and mediates the folding of newly translated proteins in the cytosol and in organelles. It is also involved in the ubiquitin-proteasome pathway through interaction with the AU-rich element RNA-binding protein 1. The gene is located in the major histocompatibility complex class III region, in a cluster with two closely related genes which encode similar proteins. Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased viability in pancreas lineage, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000122 GO:0006402
DLX1 	DLX1 (Distal-Less Homeobox 1) is a Protein Coding gene. Diseases associated with DLX1 include  Autism DLX6	This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein is localized to the nucleus where it may function as a transcriptional regulator of signals from multiple TGF-{beta} superfamily members. The encoded protein may play a role in the control of craniofacial patterning and the differentiation and survival of inhibitory neurons in the forebrain. This gene is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 2. Alternatively spliced transcript variants encoding different isoforms have been described. This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein is localized to the nucleus where it may function as a transcriptional regulator of signals from multiple TGF-{beta} superfamily members. The encoded protein may play a role in the control of craniofacial patterning and the differentiation and survival of inhibitory neurons in the forebrain. This gene is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 2. Alternatively spliced transcript variants encoding different isoforms have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007219 GO:0007219 GO:0007219 GO:0009790 GO:0009790 GO:0009790
GJA9 	GJA9 (Gap Junction Protein Alpha 9) is a Protein Coding gene. Diseases associated with GJA9 include  GJA10	Connexins, such as GJA9, are involved in the formation of gap junctions, intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each of which contains 6 connexin subunits (Sohl et al., 2003 [PubMed 12881038]).[supplied by OMIM, Mar 2008]	Connexins, such as GJA9, are involved in the formation of gap junctions, intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each of which contains 6 connexin subunits (Sohl et al., 2003 [PubMed 12881038]).[supplied by OMIM, Mar 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	 
PAK3 	PAK3 (P21 (RAC1) Activated Kinase 3) is a Protein Coding gene. Diseases associated with PAK3 include  PAK1	The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]	The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]	no effect, Decreased viability, Decreased substrate adherent cell growth, Increased ionizing radiation sensitivity, Increased Nanog expression, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Fragmented cis-Golgi, fragmented medial Golgi, fragmented trans-Golgi, Decreased 12E8 tau but not total tau protein expression and decreased ratio of 12E8/total tau protein expression, 	GO:0000165 GO:0002223 GO:0002223 GO:0002223 GO:0006468 GO:0006468 GO:0006468
ETV4 	ETV4 (ETS Variant Transcription Factor 4) is a Protein Coding gene. Diseases associated with ETV4 include  Cakut ETV1	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of keratinocyte differentiation and positive regulation of transcription by RNA polymerase II. Located in chromosome and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of keratinocyte differentiation and positive regulation of transcription by RNA polymerase II. Located in chromosome and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0030154 GO:0045618 GO:0045944
HES1 	HES1 (Hes Family BHLH Transcription Factor 1) is a Protein Coding gene. Diseases associated with HES1 include  Medulloblastoma HES4	This protein belongs to the basic helix-loop-helix family of transcription factors. It is a transcriptional repressor of genes that require a bHLH protein for their transcription. The protein has a particular type of basic domain that contains a helix interrupting protein that binds to the N-box rather than the canonical E-box. This protein belongs to the basic helix-loop-helix family of transcription factors. It is a transcriptional repressor of genes that require a bHLH protein for their transcription. The protein has a particular type of basic domain that contains a helix interrupting protein that binds to the N-box rather than the canonical E-box. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased HIV-LTR-beta-galactosidase protein expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0000122
MINK1 	MINK1 (Misshapen Like Kinase 1) is a Protein Coding gene. Diseases associated with MINK1 include  TNIK	This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]	This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased cell death HMECs cells, Decreased cell migration, Decreased shRNA abundance (Z-score &lt; -2), Decreased homologous recombination repair frequency, Increased cell death in HCC-1954 cells, Decreased epidermal growth factor (EGF) endocytosis, Increased cell spreading, 	GO:0000165 GO:0001952 GO:0006468 GO:0007254 GO:0007254 GO:0007254
FBXO4 	FBXO4 (F-Box Protein 4) is a Protein Coding gene. Diseases associated with FBXO4 include 	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased hepcidin::fluc mRNA expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Multipolar spindles, Inhibition of centrosomal clustering, 	GO:0000209
TGFB1 	TGFB1 (Transforming Growth Factor Beta 1) is a Protein Coding gene. Diseases associated with TGFB1 include  TGFB3	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Increased HPV16-GFP infection, Decreased viability with paclitaxel, 	GO:0000122 GO:0000165 GO:0000165 GO:0000165
RBPJ 	RBPJ (Recombination Signal Binding Protein For Immunoglobulin Kappa J Region) is a Protein Coding gene. Diseases associated with RBPJ include  RBPJL	The protein encoded by this gene is a transcriptional regulator important in the Notch signaling pathway. The encoded protein acts as a repressor when not bound to Notch proteins and an activator when bound to Notch proteins. It is thought to function by recruiting chromatin remodeling complexes containing histone deacetylase or histone acetylase proteins to Notch signaling pathway genes. Several transcript variants encoding different isoforms have been found for this gene, and several pseudogenes of this gene exist on chromosome 9. [provided by RefSeq, Oct 2013]	The protein encoded by this gene is a transcriptional regulator important in the Notch signaling pathway. The encoded protein acts as a repressor when not bound to Notch proteins and an activator when bound to Notch proteins. It is thought to function by recruiting chromatin remodeling complexes containing histone deacetylase or histone acetylase proteins to Notch signaling pathway genes. Several transcript variants encoding different isoforms have been found for this gene, and several pseudogenes of this gene exist on chromosome 9. [provided by RefSeq, Oct 2013]	no effect, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	 
FNBP1 	FNBP1 (Formin Binding Protein 1) is a Protein Coding gene. Diseases associated with FNBP1 include  FNBP1L	The protein encoded by this gene is a member of the formin-binding-protein family. The protein contains an N-terminal Fer/Cdc42-interacting protein 4 (CIP4) homology (FCH) domain followed by a coiled-coil domain, a proline-rich motif, a second coiled-coil domain, a Rho family protein-binding domain (RBD), and a C-terminal SH3 domain. This protein binds sorting nexin 2 (SNX2), tankyrase (TNKS), and dynamin; an interaction between this protein and formin has not been demonstrated yet in human. The protein encoded by this gene is a member of the formin-binding-protein family. The protein contains an N-terminal Fer/Cdc42-interacting protein 4 (CIP4) homology (FCH) domain followed by a coiled-coil domain, a proline-rich motif, a second coiled-coil domain, a Rho family protein-binding domain (RBD), and a C-terminal SH3 domain. This protein binds sorting nexin 2 (SNX2), tankyrase (TNKS), and dynamin; an interaction between this protein and formin has not been demonstrated yet in human. no effect, Mildly decreased CFP-tsO45G cell surface transport, 	 
AR 	AR (Androgen Receptor) is a Protein Coding gene. Diseases associated with AR include  NR3C2	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy\'s disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]	The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy\'s disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]	no effect, Synthetic lethal with Ras, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Aire reporter expression, Decreased caspase 3/7 activity, 	GO:0000122
COL9A1 	COL9A1 (Collagen Type IX Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL9A1 include  COL4A5	This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased NF-kappaB reporter expression, Elongated cells, Decreased nuclei size in G2M, Increased caspase activity, 	GO:0009887 GO:0030198
RET 	RET (Ret Proto-Oncogene) is a Protein Coding gene. Diseases associated with RET include  ERBB4	This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]	This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased mitotic index, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased viability, Polylobed nuclei, dynamic nuclei (hole, folded or small irregular), 	GO:0000165 GO:0001657 GO:0001657 GO:0001657 GO:0001755 GO:0001755 GO:0001755 GO:0001838 GO:0001838 GO:0001838 GO:0006468 GO:0006468 GO:0006468
CLEC14A 	CLEC14A (C-Type Lectin Domain Containing 14A) is a Protein Coding gene.  Among its related pathways are  CD93	This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting. [provided by RefSeq, Jan 2012]	This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting. [provided by RefSeq, Jan 2012]	no effect, Decreased vaccinia virus (VACV) infection, Decreased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0001946 GO:0002040 GO:0002040 GO:0002040 GO:0002042 GO:0002042 GO:0002042 GO:0016477 GO:0016477 GO:0016477 GO:0036324
RACK1 	RACK1 (Receptor For Activated C Kinase 1) is a Protein Coding gene. Diseases associated with RACK1 include  Melanomatosis	Enables several functions, including cyclin binding activity; enzyme binding activity; and protein domain specific binding activity. Involved in several processes, including positive regulation of hydrolase activity; regulation of cellular protein metabolic process; and regulation of signal transduction. Located in several cellular components, including midbody; perinuclear region of cytoplasm; and phagocytic cup. Part of IRE1-RACK1-PP2A complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including cyclin binding activity; enzyme binding activity; and protein domain specific binding activity. Involved in several processes, including positive regulation of hydrolase activity; regulation of cellular protein metabolic process; and regulation of signal transduction. Located in several cellular components, including midbody; perinuclear region of cytoplasm; and phagocytic cup. Part of IRE1-RACK1-PP2A complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability ratio, Decreased replication of vaccinia virus (VACV), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased HPV16-GFP infection, Nuclear pre-40S maturation defects, Cytoplasmic 40S maturation defects, 	GO:0001934 GO:0002181
RIF1 	RIF1 (Replication Timing Regulatory Factor 1) is a Protein Coding gene. Diseases associated with RIF1 include  binding	This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]	This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Decreased NF-kappaB reporter expression, Decreased shRNA abundance, 	GO:0000122 GO:0000723 GO:0000723 GO:0000723 GO:0006281 GO:0006281 GO:0006281 GO:0006974 GO:0006974 GO:0006974
FURIN 	FURIN (Furin, Paired Basic Amino Acid Cleaving Enzyme) is a Protein Coding gene. Diseases associated with FURIN include  Diphtheria PCSK4	This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. It encodes a type 1 membrane bound protease that is expressed in many tissues, including neuroendocrine, liver, gut, and brain. The encoded protein undergoes an initial autocatalytic processing event in the ER and then sorts to the trans-Golgi network through endosomes where a second autocatalytic event takes place and the catalytic activity is acquired. Like other members of this convertase family, the product of this gene specifically cleaves substrates at single or paired basic residues. Some of its substrates include proparathyroid hormone, transforming growth factor beta 1 precursor, proalbumin, pro-beta-secretase, membrane type-1 matrix metalloproteinase, beta subunit of pro-nerve growth factor and von Willebrand factor. It is thought to be one of the proteases responsible for the activation of HIV envelope glycoproteins gp160 and gp140, and may play a role in tumor progression. Unlike SARS-CoV and other coronaviruses, the spike protein of SARS-CoV-2 is thought to be uniquely cleaved by this protease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]	This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. It encodes a type 1 membrane bound protease that is expressed in many tissues, including neuroendocrine, liver, gut, and brain. The encoded protein undergoes an initial autocatalytic processing event in the ER and then sorts to the trans-Golgi network through endosomes where a second autocatalytic event takes place and the catalytic activity is acquired. Like other members of this convertase family, the product of this gene specifically cleaves substrates at single or paired basic residues. Some of its substrates include proparathyroid hormone, transforming growth factor beta 1 precursor, proalbumin, pro-beta-secretase, membrane type-1 matrix metalloproteinase, beta subunit of pro-nerve growth factor and von Willebrand factor. It is thought to be one of the proteases responsible for the activation of HIV envelope glycoproteins gp160 and gp140, and may play a role in tumor progression. Unlike SARS-CoV and other coronaviruses, the spike protein of SARS-CoV-2 is thought to be uniquely cleaved by this protease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Sindbis virus (SINV) infection, Increased viability with SS1P at EC90, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with gemcitabine, 	 
TIAM1 	TIAM1 (TIAM Rac1 Associated GEF 1) is a Protein Coding gene. Diseases associated with TIAM1 include  TIAM2	This gene encodes a RAC1-specific guanine nucleotide exchange factor (GEF). GEFs mediate the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP). The binding of GTP induces a conformational change in RAC1 that allows downstream effectors to bind and transduce a signal. This gene thus regulates RAC1 signaling pathways that affect cell shape, migration, adhesion, growth, survival, and polarity, as well as influencing actin cytoskeletal formation, endocytosis, and membrane trafficking. This gene thus plays an important role in cell invasion, metastasis, and carcinogenesis. In addition to RAC1, the encoded protein activates additional Rho-like GTPases such as CDC42, RAC2, RAC3 and RHOA. This gene encodes multiple protein isoforms that experience a diverse array of intramolecular, protein-protein, and phosphorylation interactions as well as phosphoinositide binding. Both the longer and shorter isoforms have C-terminal Dbl homology (DH) and pleckstrin homology (PH) domains while only the longer isoforms of this gene have the N-terminal myristoylation site and the downstream N-terminal PH domain, ras-binding domain (RBD), and PSD-95/DlgA/ZO-1 (PDZ) domain. [provided by RefSeq, Jul 2017]	This gene encodes a RAC1-specific guanine nucleotide exchange factor (GEF). GEFs mediate the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP). The binding of GTP induces a conformational change in RAC1 that allows downstream effectors to bind and transduce a signal. This gene thus regulates RAC1 signaling pathways that affect cell shape, migration, adhesion, growth, survival, and polarity, as well as influencing actin cytoskeletal formation, endocytosis, and membrane trafficking. This gene thus plays an important role in cell invasion, metastasis, and carcinogenesis. In addition to RAC1, the encoded protein activates additional Rho-like GTPases such as CDC42, RAC2, RAC3 and RHOA. This gene encodes multiple protein isoforms that experience a diverse array of intramolecular, protein-protein, and phosphorylation interactions as well as phosphoinositide binding. Both the longer and shorter isoforms have C-terminal Dbl homology (DH) and pleckstrin homology (PH) domains while only the longer isoforms of this gene have the N-terminal myristoylation site and the downstream N-terminal PH domain, ras-binding domain (RBD), and PSD-95/DlgA/ZO-1 (PDZ) domain. [provided by RefSeq, Jul 2017]	no effect, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased cell migration, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt pathway, 	GO:0007160 GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0008284 GO:0010717
CDH1 	CDH1 (Cadherin 1) is a Protein Coding gene. Diseases associated with CDH1 include  CDH2	This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]	This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased G1 DNA content, G0/1 arrest, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased viability in glioblastoma multiforme (GBM) lineage, Effect on mitosis, Increased ionizing radiation sensitivity, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000902 GO:0007043 GO:0007155 GO:0007156 GO:0007156 GO:0007156 GO:0007275
RAC2 	RAC2 (Rac Family Small GTPase 2) is a Protein Coding gene. Diseases associated with RAC2 include  RAC1	This gene encodes a member of the Ras superfamily of small guanosine triphosphate (GTP)-metabolizing proteins. The encoded protein localizes to the plasma membrane, where it regulates diverse processes, such as secretion, phagocytosis, and cell polarization. Activity of this protein is also involved in the generation of reactive oxygen species. Mutations in this gene are associated with neutrophil immunodeficiency syndrome. There is a pseudogene for this gene on chromosome 6. [provided by RefSeq, Jul 2013]	This gene encodes a member of the Ras superfamily of small guanosine triphosphate (GTP)-metabolizing proteins. The encoded protein localizes to the plasma membrane, where it regulates diverse processes, such as secretion, phagocytosis, and cell polarization. Activity of this protein is also involved in the generation of reactive oxygen species. Mutations in this gene are associated with neutrophil immunodeficiency syndrome. There is a pseudogene for this gene on chromosome 6. [provided by RefSeq, Jul 2013]	Mitotic spindle defects, no effect, Decreased viability, Effect on mitosis, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell death HMECs cells, Synthetic lethal with vaccinia virus (VACV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Altered focal adhesion (FA) or cell shape morphology, 	GO:0006935 GO:0007015 GO:0007015 GO:0007015 GO:0007163 GO:0007165 GO:0007165 GO:0007165
HSPA9 	HSPA9 (Heat Shock Protein Family A (Hsp70) Member 9) is a Protein Coding gene. Diseases associated with HSPA9 include  HSPA8	This gene encodes a member of the heat shock protein 70 gene family. The encoded protein is primarily localized to the mitochondria but is also found in the endoplasmic reticulum, plasma membrane and cytoplasmic vesicles. This protein is a heat-shock cognate protein. This protein plays a role in cell proliferation, stress response and maintenance of the mitochondria. A pseudogene of this gene is found on chromosome 2.[provided by RefSeq, May 2010]	This gene encodes a member of the heat shock protein 70 gene family. The encoded protein is primarily localized to the mitochondria but is also found in the endoplasmic reticulum, plasma membrane and cytoplasmic vesicles. This protein is a heat-shock cognate protein. This protein plays a role in cell proliferation, stress response and maintenance of the mitochondria. A pseudogene of this gene is found on chromosome 2.[provided by RefSeq, May 2010]	no effect, Decreased viability, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Wnt reporter downregulated, Increased ionizing radiation sensitivity, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased proliferation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased viability after ionizing radiation, Increased 8N DNA content, Decreased vesicular stomatitis virus (VSV) infection, Decreased human parainfluenza virus type 3 (HPIV3) infection, 	GO:0006457 GO:0006611 GO:0006611 GO:0006611 GO:0006886 GO:0006886 GO:0006886 GO:0007007 GO:0016226
NUMBL 	NUMBL (NUMB Like Endocytic Adaptor Protein) is a Protein Coding gene. Diseases associated with NUMBL include  NUMB	Involved in cytokine-mediated signaling pathway and protein metabolic process. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Involved in cytokine-mediated signaling pathway and protein metabolic process. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Reduced mammosphere formation, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Inconclusive, Decreased shRNA abundance (Z-score &lt; -2), Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased HIV-1 infection, 	GO:0007399 GO:0007405 GO:0007409 GO:0007409 GO:0007409 GO:0019221 GO:0019221 GO:0019221 GO:0019538
ARX 	ARX (Aristaless Related Homeobox) is a Protein Coding gene. Diseases associated with ARX include  ALX4	This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability with paclitaxel, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Negative genetic interaction between BLM-/- and BLM+/+, Decreased Salmonella proliferation, Increased cell number in G2M, increased number of polyploid cells, 	GO:0000122 GO:0001764 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
TGFBI 	TGFBI (Transforming Growth Factor Beta Induced) is a Protein Coding gene. Diseases associated with TGFBI include  POSTN	This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased NF-kappaB reporter expression, Increased HPV18 LCR reporter activity, Increased S DNA content, 	GO:0001525 GO:0002062 GO:0007155 GO:0007155 GO:0007155 GO:0007162
TLN1 	TLN1 (Talin 1) is a Protein Coding gene. Diseases associated with TLN1 include  TLN2	This gene encodes a cytoskeletal protein that is concentrated in areas of cell-substratum and cell-cell contacts. The encoded protein plays a significant role in the assembly of actin filaments and in spreading and migration of various cell types, including fibroblasts and osteoclasts. It codistributes with integrins in the cell surface membrane in order to assist in the attachment of adherent cells to extracellular matrices and of lymphocytes to other cells. The N-terminus of this protein contains elements for localization to cell-extracellular matrix junctions. The C-terminus contains binding sites for proteins such as beta-1-integrin, actin, and vinculin. [provided by RefSeq, Feb 2009]	This gene encodes a cytoskeletal protein that is concentrated in areas of cell-substratum and cell-cell contacts. The encoded protein plays a significant role in the assembly of actin filaments and in spreading and migration of various cell types, including fibroblasts and osteoclasts. It codistributes with integrins in the cell surface membrane in order to assist in the attachment of adherent cells to extracellular matrices and of lymphocytes to other cells. The N-terminus of this protein contains elements for localization to cell-extracellular matrix junctions. The C-terminus contains binding sites for proteins such as beta-1-integrin, actin, and vinculin. [provided by RefSeq, Feb 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability ratio, FOXO1 nuclear localization, Decreased cell migration, Increased focal adhesion (FA) area, decreased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, decreased cell spreading, 	GO:0007010 GO:0007043 GO:0007043 GO:0007043
SPAG9 	SPAG9 (Sperm Associated Antigen 9) is a Protein Coding gene. Diseases associated with SPAG9 include  MAPK8IP3	This gene encodes a member of the cancer testis antigen gene family. The encoded protein functions as a scaffold protein that structurally organizes mitogen-activated protein kinases and mediates c-Jun-terminal kinase signaling. This protein also binds to kinesin-1 and may be involved in microtubule-based membrane transport. This protein may play a role in tumor growth and development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]	This gene encodes a member of the cancer testis antigen gene family. The encoded protein functions as a scaffold protein that structurally organizes mitogen-activated protein kinases and mediates c-Jun-terminal kinase signaling. This protein also binds to kinesin-1 and may be involved in microtubule-based membrane transport. This protein may play a role in tumor growth and development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased homologous recombination repair frequency, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased viability of wild-type and TP53 knockout cells, 	GO:0001933 GO:0016192 GO:0016192 GO:0016192 GO:0030335 GO:0032418 GO:0042147
COL11A2 	COL11A2 (Collagen Type XI Alpha 2 Chain) is a Protein Coding gene. Diseases associated with COL11A2 include  COL5A1	This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]	This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability after Maraba virus infection, Wnt reporter downregulated, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased caspase activity, 	GO:0001501 GO:0001649 GO:0001894 GO:0001894 GO:0001894 GO:0002062 GO:0002062 GO:0002062 GO:0007605 GO:0007605 GO:0007605
NOG 	NOG (Noggin) is a Protein Coding gene. Diseases associated with NOG include 	The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple joint fusion as their principal feature, and map to the same region (17q22) as this gene. All of these mutations altered evolutionarily conserved amino acid residues. The amino acid sequence of this human gene is highly homologous to that of Xenopus, rat and mouse. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Inconclusive, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Big cells, 	GO:0000122 GO:0001501 GO:0001501 GO:0001501 GO:0001649
GGA3 	GGA3 (Golgi Associated, Gamma Adaptin Ear Containing, ARF Binding Protein 3) is a Protein Coding gene. Diseases associated with GGA3 include  GGA1	This gene encodes a member of the Golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) family. This family includes ubiquitous coat proteins that regulate the trafficking of proteins between the trans-Golgi network and the lysosome. These proteins share an amino-terminal VHS domain which mediates sorting of the mannose 6-phosphate receptors at the trans-Golgi network. They also contain a carboxy-terminal region with homology to the ear domain of gamma-adaptins. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]	This gene encodes a member of the Golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) family. This family includes ubiquitous coat proteins that regulate the trafficking of proteins between the trans-Golgi network and the lysosome. These proteins share an amino-terminal VHS domain which mediates sorting of the mannose 6-phosphate receptors at the trans-Golgi network. They also contain a carboxy-terminal region with homology to the ear domain of gamma-adaptins. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability ratio, Decreased viability in colon lineage, Decreased NF-kappaB reporter expression, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0006622 GO:0006886 GO:0006893
FSTL3 	FSTL3 (Follistatin Like 3) is a Protein Coding gene. Diseases associated with FSTL3 include  FST	Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis. Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Low eccentricity cells, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0001503 GO:0002244 GO:0002244 GO:0002244 GO:0006357 GO:0007275 GO:0022409
WDR26 	WDR26 (WD Repeat Domain 26) is a Protein Coding gene. Diseases associated with WDR26 include  WDR13	This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Two transcript variants encoding two different isoforms have been found for this gene. This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Two transcript variants encoding two different isoforms have been found for this gene. Increased gamma-H2AX phosphorylation, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, FOXO1 nuclear localization, Decreased homologous recombination repair frequency, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased G1 length, Increased G1 length, increased S length, Increased S length, Polylobed nuclei, dynamic nuclei (hole, folded or small irregular), 	GO:0043161
ALDOA 	ALDOA (Aldolase, Fructose-Bisphosphate A) is a Protein Coding gene. Diseases associated with ALDOA include  ALDOC	This gene encodes a member of the class I fructose-bisphosphate aldolase protein family. The encoded protein is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Three aldolase isozymes (A, B, and C), encoded by three different genes, are differentially expressed during development. Mutations in this gene have been associated with Glycogen Storage Disease XII, an autosomal recessive disorder associated with hemolytic anemia. Disruption of this gene also plays a role in the progression of multiple types of cancers. Related pseudogenes have been identified on chromosomes 3 and 10. [provided by RefSeq, Sep 2017]	This gene encodes a member of the class I fructose-bisphosphate aldolase protein family. The encoded protein is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Three aldolase isozymes (A, B, and C), encoded by three different genes, are differentially expressed during development. Mutations in this gene have been associated with Glycogen Storage Disease XII, an autosomal recessive disorder associated with hemolytic anemia. Disruption of this gene also plays a role in the progression of multiple types of cancers. Related pseudogenes have been identified on chromosomes 3 and 10. [provided by RefSeq, Sep 2017]	no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage, Increased HPV18 LCR reporter activity, Polylobed nuclei, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0006000 GO:0006096 GO:0006754 GO:0006941 GO:0007015
APPL1 	APPL1 (Adaptor Protein, Phosphotyrosine Interacting With PH Domain And Leucine Zipper 1) is a Protein Coding gene. Diseases associated with APPL1 include  APPL2	The protein encoded by this gene has been shown to be involved in the regulation of cell proliferation, and in the crosstalk between the adiponectin signalling and insulin signalling pathways. The encoded protein binds many other proteins, including RAB5A, DCC, AKT2, PIK3CA, adiponectin receptors, and proteins of the NuRD/MeCP1 complex. This protein is found associated with endosomal membranes, but can be released by EGF and translocated to the nucleus. The protein encoded by this gene has been shown to be involved in the regulation of cell proliferation, and in the crosstalk between the adiponectin signalling and insulin signalling pathways. The encoded protein binds many other proteins, including RAB5A, DCC, AKT2, PIK3CA, adiponectin receptors, and proteins of the NuRD/MeCP1 complex. This protein is found associated with endosomal membranes, but can be released by EGF and translocated to the nucleus. Increased vaccinia virus (VACV) infection, Decreased viability, Increased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased homologous recombination repair frequency, Decreased telomerase activity, 	GO:0006606 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0007179 GO:0008286
NOTCH3 	NOTCH3 (Notch Receptor 3) is a Protein Coding gene. Diseases associated with NOTCH3 include  NOTCH1	This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0000122 GO:0006355 GO:0006355 GO:0006355 GO:0007219 GO:0007219 GO:0007219 GO:0007275 GO:0007411 GO:0007411 GO:0007411
GDI2 	GDI2 (GDP Dissociation Inhibitor 2) is a Protein Coding gene.  Among its related pathways are  GDI1	GDP dissociation inhibitors are proteins that regulate the GDP-GTP exchange reaction of members of the rab family, small GTP-binding proteins of the ras superfamily, that are involved in vesicular trafficking of molecules between cellular organelles. GDIs slow the rate of dissociation of GDP from rab proteins and release GDP from membrane-bound rabs. GDI2 is ubiquitously expressed. The GDI2 gene contains many repetitive elements indicating that it may be prone to inversion/deletion rearrangements. Alternative splicing results in multiple transcript variants encoding distinct isoforms. GDP dissociation inhibitors are proteins that regulate the GDP-GTP exchange reaction of members of the rab family, small GTP-binding proteins of the ras superfamily, that are involved in vesicular trafficking of molecules between cellular organelles. GDIs slow the rate of dissociation of GDP from rab proteins and release GDP from membrane-bound rabs. GDI2 is ubiquitously expressed. The GDI2 gene contains many repetitive elements indicating that it may be prone to inversion/deletion rearrangements. Alternative splicing results in multiple transcript variants encoding distinct isoforms. no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Dynamic nuclei (hole, folded or small irregular), Increased HPV18 LCR reporter activity, Increased G2M DNA content, Synthetic lethal with cisplatin, Decreased BPV1 E2 protein expression, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0015031 GO:0015031 GO:0015031 GO:0016192 GO:0016192 GO:0016192 GO:1902018
FABP7 	FABP7 (Fatty Acid Binding Protein 7) is a Protein Coding gene. Diseases associated with FABP7 include  FABP3	The gene encodes a small, highly conserved cytoplasmic protein that bind long-chain fatty acids and other hydrophobic ligands. The encoded protein is important in the establishment of the radial glial fiber in the developing brain. Alternative splicing and promoter usage results in multiple transcript variants encoding different isoforms. Pseudogenes of this gene are found on multiple chromosomes. [provided by RefSeq, Jan 2016]	The gene encodes a small, highly conserved cytoplasmic protein that bind long-chain fatty acids and other hydrophobic ligands. The encoded protein is important in the establishment of the radial glial fiber in the developing brain. Alternative splicing and promoter usage results in multiple transcript variants encoding different isoforms. Pseudogenes of this gene are found on multiple chromosomes. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, 	GO:0007399 GO:0008285 GO:0015908
LAMB2 	LAMB2 (Laminin Subunit Beta 2) is a Protein Coding gene. Diseases associated with LAMB2 include  LAMB1	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5\' splice site (gc) in the 5\' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011]	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5\' splice site (gc) in the 5\' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Increased shRNA abundance, 	 
LIMD1 	LIMD1 (LIM Domain Containing 1) is a Protein Coding gene. Diseases associated with LIMD1 include  WTIP	Predicted to enable transcription corepressor activity. Involved in several processes, including negative regulation of hippo signaling; regulation of gene expression; and response to hypoxia. Acts upstream of or within P-body assembly and gene silencing by miRNA. Located in several cellular components, including P-body; adherens junction; and focal adhesion. Part of RISC complex. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable transcription corepressor activity. Involved in several processes, including negative regulation of hippo signaling; regulation of gene expression; and response to hypoxia. Acts upstream of or within P-body assembly and gene silencing by miRNA. Located in several cellular components, including P-body; adherens junction; and focal adhesion. Part of RISC complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased viability in pancreas lineage, Decreased shRNA abundance (Z-score &lt; -2), Decreased replication of vaccinia virus (VACV), 	GO:0001666 GO:0002076 GO:0006355 GO:0006355 GO:0006355 GO:0007010 GO:0008360
HSPA5 	HSPA5 (Heat Shock Protein Family A (Hsp70) Member 5) is a Protein Coding gene. Diseases associated with HSPA5 include  Mucormycosis HSPA8	The protein encoded by this gene is a member of the heat shock protein 70 (HSP70) family. This protein localizes to the lumen of the endoplasmic reticulum (ER) where it operates as a typical HSP70 chaperone involved in the folding and assembly of proteins in the ER and is a master regulator of ER homeostasis. During cellular stress, as during viral infection or tumorogenesis, this protein interacts with the transmembrane stress sensor proteins PERK (protein kinase R-like endoplasmic reticulum kinase), IRE1 (inositol-requiring kinase 1), and ATF6 (activating transcription factor 6) where it acts as a repressor of the unfolded protein response (UPR) and also plays a role in cellular apoptosis and senescence. Elevated expression and atypical translocation of this protein to the cell surface has been reported in viral infections and some types of cancer cells. At the cell surface this protein may facilitate viral attachment and entry to host cells. This gene is a therapeutic target for the treatment of coronavirus diseases and chemoresistant cancers.  The protein encoded by this gene is a member of the heat shock protein 70 (HSP70) family. This protein localizes to the lumen of the endoplasmic reticulum (ER) where it operates as a typical HSP70 chaperone involved in the folding and assembly of proteins in the ER and is a master regulator of ER homeostasis. During cellular stress, as during viral infection or tumorogenesis, this protein interacts with the transmembrane stress sensor proteins PERK (protein kinase R-like endoplasmic reticulum kinase), IRE1 (inositol-requiring kinase 1), and ATF6 (activating transcription factor 6) where it acts as a repressor of the unfolded protein response (UPR) and also plays a role in cellular apoptosis and senescence. Elevated expression and atypical translocation of this protein to the cell surface has been reported in viral infections and some types of cancer cells. At the cell surface this protein may facilitate viral attachment and entry to host cells. This gene is a therapeutic target for the treatment of coronavirus diseases and chemoresistant cancers.  Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Increased IL-8 secretion, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased shRNA abundance, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	 
PDK1 	PDK1 (Pyruvate Dehydrogenase Kinase 1) is a Protein Coding gene. Diseases associated with PDK1 include  PDK2	Pyruvate dehydrogenase (PDH) is a mitochondrial multienzyme complex that catalyzes the oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the regulation of homeostasis of carbohydrate fuels in mammals. The enzymatic activity is regulated by a phosphorylation/dephosphorylation cycle. Phosphorylation of PDH by a specific pyruvate dehydrogenase kinase (PDK) results in inactivation. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2013]	Pyruvate dehydrogenase (PDH) is a mitochondrial multienzyme complex that catalyzes the oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the regulation of homeostasis of carbohydrate fuels in mammals. The enzymatic activity is regulated by a phosphorylation/dephosphorylation cycle. Phosphorylation of PDH by a specific pyruvate dehydrogenase kinase (PDK) results in inactivation. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2013]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Increased Nanog expression, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Increased NF-kappaB reporter expression, Decreased viability, Decreased viability of wild-type and TP53 knockout cells, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Polylobed nuclei, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Increased viability with tamoxifen, Misorientated spindle, 	GO:0005975 GO:0006006 GO:0006006 GO:0006006 GO:0006468 GO:0006468 GO:0006468 GO:0008283 GO:0008631
CCM2 	CCM2 (CCM2 Scaffold Protein) is a Protein Coding gene. Diseases associated with CCM2 include  CCM2L	This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]	This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability after Maraba virus infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased transcriptional activity, 	GO:0001568 GO:0001570 GO:0001570 GO:0001570
PECAM1 	PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with PECAM1 include  Angiosarcoma Hemangioma FCRL5	The protein encoded by this gene is found on the surface of platelets, monocytes, neutrophils, and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions. The encoded protein is a member of the immunoglobulin superfamily and is likely involved in leukocyte migration, angiogenesis, and integrin activation. [provided by RefSeq, May 2010]	The protein encoded by this gene is found on the surface of platelets, monocytes, neutrophils, and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions. The encoded protein is a member of the immunoglobulin superfamily and is likely involved in leukocyte migration, angiogenesis, and integrin activation. [provided by RefSeq, May 2010]	no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, 	GO:0001934 GO:0006909 GO:0007155 GO:0007156 GO:0007156 GO:0007156 GO:0007159
RHOA 	RHOA (Ras Homolog Family Member A) is a Protein Coding gene. Diseases associated with RHOA include  RHOC	This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. Overexpression of this gene is associated with tumor cell proliferation and metastasis. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. Overexpression of this gene is associated with tumor cell proliferation and metastasis. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	Increased gamma-H2AX phosphorylation, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased homologous recombination repair frequency, Increased cell migration, Increased Salmonella enterica Typhimurium invasion, Decreased OCT4 protein expression, Decreased NANOG protein expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased nuclear migration speed, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	 
EHD1 	EHD1 (EH Domain Containing 1) is a Protein Coding gene. Diseases associated with EHD1 include  EHD3	This gene belongs to a highly conserved gene family encoding EPS15 homology (EH) domain-containing proteins. The protein-binding EH domain was first noted in EPS15, a substrate for the epidermal growth factor receptor. The EH domain has been shown to be an important motif in proteins involved in protein-protein interactions and in intracellular sorting. The protein encoded by this gene is thought to play a role in the endocytosis of IGF1 receptors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2013]	This gene belongs to a highly conserved gene family encoding EPS15 homology (EH) domain-containing proteins. The protein-binding EH domain was first noted in EPS15, a substrate for the epidermal growth factor receptor. The EH domain has been shown to be an important motif in proteins involved in protein-protein interactions and in intracellular sorting. The protein encoded by this gene is thought to play a role in the endocytosis of IGF1 receptors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2013]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0006886 GO:0006897
LAMB1 	LAMB1 (Laminin Subunit Beta 1) is a Protein Coding gene. Diseases associated with LAMB1 include  LAMB2	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 1. The beta 1 chain has 7 structurally distinct domains which it shares with other beta chain isomers. The C-terminal helical region containing domains I and II are separated by domain alpha, domains III and V contain several EGF-like repeats, and domains IV and VI have a globular conformation. Laminin, beta 1 is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin 1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. A sequence in the beta 1 chain that is involved in cell attachment, chemotaxis, and binding to the laminin receptor was identified and shown to have the capacity to inhibit metastasis. [provided by RefSeq, Aug 2011]	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 1. The beta 1 chain has 7 structurally distinct domains which it shares with other beta chain isomers. The C-terminal helical region containing domains I and II are separated by domain alpha, domains III and V contain several EGF-like repeats, and domains IV and VI have a globular conformation. Laminin, beta 1 is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin 1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. A sequence in the beta 1 chain that is involved in cell attachment, chemotaxis, and binding to the laminin receptor was identified and shown to have the capacity to inhibit metastasis. [provided by RefSeq, Aug 2011]	Increased gamma-H2AX phosphorylation, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Wnt reporter upregulated, 	GO:0007155 GO:0009887 GO:0009888 GO:0009888 GO:0009888 GO:0016477 GO:0016477 GO:0016477 GO:0021812 GO:0021812 GO:0021812
CDC25C 	CDC25C (Cell Division Cycle 25C) is a Protein Coding gene. Diseases associated with CDC25C include  CDC25B	This gene encodes a conserved protein that plays a key role in the regulation of cell division. The encoded protein directs dephosphorylation of cyclin B-bound CDC2 and triggers entry into mitosis. It also suppresses p53-induced growth arrest. Multiple alternatively spliced transcript variants of this gene have been described. [provided by RefSeq, Dec 2015]	This gene encodes a conserved protein that plays a key role in the regulation of cell division. The encoded protein directs dephosphorylation of cyclin B-bound CDC2 and triggers entry into mitosis. It also suppresses p53-induced growth arrest. Multiple alternatively spliced transcript variants of this gene have been described. [provided by RefSeq, Dec 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased viability after Maraba virus infection, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Downregulation of NF-kappaB pathway after LMP1 stimulation, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, decreased cell spreading, 	GO:0000079 GO:0000086 GO:0006470 GO:0006470 GO:0006470 GO:0007049 GO:0007049 GO:0007049 GO:0007088 GO:0007088 GO:0007088
IRF1 	IRF1 (Interferon Regulatory Factor 1) is a Protein Coding gene. Diseases associated with IRF1 include  IRF2	The protein encoded by this gene is a transcriptional regulator and tumor suppressor, serving as an activator of genes involved in both innate and acquired immune responses. The encoded protein activates the transcription of genes involved in the body\'s response to viruses and bacteria, playing a role in cell proliferation, apoptosis, the immune response, and DNA damage response. This protein represses the transcription of several other genes. As a tumor suppressor, it both suppresses tumor cell growth and stimulates an immune response against tumor cells. Defects in this gene have been associated with gastric cancer, myelogenous leukemia, and lung cancer. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a transcriptional regulator and tumor suppressor, serving as an activator of genes involved in both innate and acquired immune responses. The encoded protein activates the transcription of genes involved in the body\'s response to viruses and bacteria, playing a role in cell proliferation, apoptosis, the immune response, and DNA damage response. This protein represses the transcription of several other genes. As a tumor suppressor, it both suppresses tumor cell growth and stimulates an immune response against tumor cells. Defects in this gene have been associated with gastric cancer, myelogenous leukemia, and lung cancer. [provided by RefSeq, Aug 2017]	no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Synthetic lethal with vaccinia virus (VACV) infection, Increased proliferation, Elongated cells, 	GO:0002376 GO:0002819 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
NCOR1 	NCOR1 (Nuclear Receptor Corepressor 1) is a Protein Coding gene. Diseases associated with NCOR1 include  NCOR2	This gene encodes a protein that mediates ligand-independent transcription repression of thyroid-hormone and retinoic-acid receptors by promoting chromatin condensation and preventing access of the transcription machinery. It is part of a complex which also includes histone deacetylases and transcriptional regulators similar to the yeast protein Sin3p. This gene is located between the Charcot-Marie-Tooth and Smith-Magenis syndrome critical regions on chromosome 17. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 17 and 20.[provided by RefSeq, Jun 2010]	This gene encodes a protein that mediates ligand-independent transcription repression of thyroid-hormone and retinoic-acid receptors by promoting chromatin condensation and preventing access of the transcription machinery. It is part of a complex which also includes histone deacetylases and transcriptional regulators similar to the yeast protein Sin3p. This gene is located between the Charcot-Marie-Tooth and Smith-Magenis syndrome critical regions on chromosome 17. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 17 and 20.[provided by RefSeq, Jun 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased viability (cell death), Increased ionizing radiation sensitivity, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Reduced shRNA abundance in FBW7 KO line, 	GO:0000122 GO:0006325 GO:0006357 GO:0006357 GO:0006357 GO:0045475 GO:0045475 GO:0045475 GO:0045820 GO:0045820 GO:0045820
ESR1 	ESR1 (Estrogen Receptor 1) is a Protein Coding gene. Diseases associated with ESR1 include  ESR2	This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain.  This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain.  Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Decreased Aire reporter expression, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell number in G1, small nuclei in G1, 	GO:0000122 GO:0001547 GO:0002064 GO:0002064 GO:0002064 GO:0006338 GO:0006338 GO:0006338
FOXO3 	FOXO3 (Forkhead Box O3) is a Protein Coding gene. Diseases associated with FOXO3 include  Aging Rhabdomyosarcoma FOXO1	This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. This gene likely functions as a trigger for apoptosis through expression of genes necessary for cell death. Translocation of this gene with the MLL gene is associated with secondary acute leukemia. Alternatively spliced transcript variants encoding the same protein have been observed. This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. This gene likely functions as a trigger for apoptosis through expression of genes necessary for cell death. Translocation of this gene with the MLL gene is associated with secondary acute leukemia. Alternatively spliced transcript variants encoding the same protein have been observed. no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability in ovarian lineage, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006390 GO:0006390 GO:0006390 GO:0006417
FGD1 	FGD1 (FYVE, RhoGEF And PH Domain Containing 1) is a Protein Coding gene. Diseases associated with FGD1 include  FGD4	This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]	This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), No cells, Decreased IL-8 secretion, Inconclusive, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), 	GO:0007010 GO:0007165 GO:0007165 GO:0007165 GO:0008360 GO:0009887 GO:0009887 GO:0009887 GO:0030036
HSPB1 	HSPB1 (Heat Shock Protein Family B (Small) Member 1) is a Protein Coding gene. Diseases associated with HSPB1 include  CRYAB	This gene encodes a member of the small heat shock protein (HSP20) family of proteins. In response to environmental stress, the encoded protein translocates from the cytoplasm to the nucleus and functions as a molecular chaperone that promotes the correct folding of other proteins. This protein plays an important role in the differentiation of a wide variety of cell types. Expression of this gene is correlated with poor clinical outcome in multiple human cancers, and the encoded protein may promote cancer cell proliferation and metastasis, while protecting cancer cells from apoptosis. Mutations in this gene have been identified in human patients with Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. [provided by RefSeq, Aug 2017]	This gene encodes a member of the small heat shock protein (HSP20) family of proteins. In response to environmental stress, the encoded protein translocates from the cytoplasm to the nucleus and functions as a molecular chaperone that promotes the correct folding of other proteins. This protein plays an important role in the differentiation of a wide variety of cell types. Expression of this gene is correlated with poor clinical outcome in multiple human cancers, and the encoded protein may promote cancer cell proliferation and metastasis, while protecting cancer cells from apoptosis. Mutations in this gene have been identified in human patients with Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. [provided by RefSeq, Aug 2017]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Increased HPV18 LCR reporter activity, 	GO:0001895 GO:0001932 GO:0006446 GO:0006469 GO:0006986 GO:0006986 GO:0006986
FGF2 	FGF2 (Fibroblast Growth Factor 2) is a Protein Coding gene. Diseases associated with FGF2 include  FGF1	The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased Hepatitis C virus replication, Increased nuclear migration speed, 	GO:0001525 GO:0001649 GO:0001649 GO:0001649 GO:0001658 GO:0001658 GO:0001658 GO:0001759 GO:0001934 GO:0001934 GO:0001934
UNC5B 	UNC5B (Unc-5 Netrin Receptor B) is a Protein Coding gene.  Among its related pathways are  UNC5C	This gene encodes a member of the netrin family of receptors. This particular protein mediates the repulsive effect of netrin-1 and is a vascular netrin receptor. This encoded protein is also in a group of proteins called dependence receptors (DpRs) which are involved in pro- and anti-apoptotic processes. Many DpRs are involved in embryogenesis and in cancer progression. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]	This gene encodes a member of the netrin family of receptors. This particular protein mediates the repulsive effect of netrin-1 and is a vascular netrin receptor. This encoded protein is also in a group of proteins called dependence receptors (DpRs) which are involved in pro- and anti-apoptotic processes. Many DpRs are involved in embryogenesis and in cancer progression. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased HPV16-GFP infection, Increased transcriptional activity, Increased cell number in G1, average or increased nuclei size in G1, 	GO:0001525 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007165 GO:0007165 GO:0007411 GO:0007411 GO:0007411 GO:0014068 GO:0014068 GO:0014068
LRP1 	LRP1 (LDL Receptor Related Protein 1) is a Protein Coding gene. Diseases associated with LRP1 include  LRP1B	This gene encodes a member of the low-density lipoprotein receptor family of proteins. The encoded preproprotein is proteolytically processed by furin to generate 515 kDa and 85 kDa subunits that form the mature receptor (PMID: 8546712). This receptor is involved in several cellular processes, including intracellular signaling, lipid homeostasis, and clearance of apoptotic cells. In addition, the encoded protein is necessary for the alpha 2-macroglobulin-mediated clearance of secreted amyloid precursor protein and beta-amyloid, the main component of amyloid plaques found in Alzheimer patients. Expression of this gene decreases with age and has been found to be lower than controls in brain tissue from Alzheimer\'s disease patients. [provided by RefSeq, Oct 2015]	This gene encodes a member of the low-density lipoprotein receptor family of proteins. The encoded preproprotein is proteolytically processed by furin to generate 515 kDa and 85 kDa subunits that form the mature receptor (PMID: 8546712). This receptor is involved in several cellular processes, including intracellular signaling, lipid homeostasis, and clearance of apoptotic cells. In addition, the encoded protein is necessary for the alpha 2-macroglobulin-mediated clearance of secreted amyloid precursor protein and beta-amyloid, the main component of amyloid plaques found in Alzheimer patients. Expression of this gene decreases with age and has been found to be lower than controls in brain tissue from Alzheimer\'s disease patients. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased replication of vaccinia virus (VACV), Two nuclei (binuclear), Increased HPV18 LCR reporter activity, Increased NF-kappaB reporter expression, 	GO:0001523 GO:0002265 GO:0002265 GO:0002265 GO:0006629 GO:0006629 GO:0006629
AXIN2 	AXIN2 (Axin 2) is a Protein Coding gene. Diseases associated with AXIN2 include  AXIN1	The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability in colon lineage, Wnt reporter downregulated, Increased shRNA abundance (Z-score &gt; 2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt pathway, 	GO:0001649 GO:0001756 GO:0001756 GO:0001756 GO:0001934 GO:0001934 GO:0001934
TFAP2B 	TFAP2B (Transcription Factor AP-2 Beta) is a Protein Coding gene. Diseases associated with TFAP2B include  TFAP2A	This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. no effect, Reduced mammosphere formation, Increased Nanog expression, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability in pancreas lineage, Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with imatinib mesylate, 	GO:0000122 GO:0001822 GO:0006006 GO:0006006 GO:0006006 GO:0006355 GO:0006357 GO:0006357 GO:0006357
FNBP1L 	FNBP1L (Formin Binding Protein 1 Like) is a Protein Coding gene. Diseases associated with FNBP1L include  FNBP1	The protein encoded by this gene binds to both CDC42 and N-WASP. This protein promotes CDC42-induced actin polymerization by activating the N-WASP-WIP complex and, therefore, is involved in a pathway that links cell surface signals to the actin cytoskeleton. Alternative splicing results in multiple transcript variants encoding different isoforms. The protein encoded by this gene binds to both CDC42 and N-WASP. This protein promotes CDC42-induced actin polymerization by activating the N-WASP-WIP complex and, therefore, is involved in a pathway that links cell surface signals to the actin cytoskeleton. Alternative splicing results in multiple transcript variants encoding different isoforms. no effect, Decreased viability, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), 	GO:0006897 GO:0006900 GO:0006900 GO:0006900 GO:0006914 GO:0007165 GO:0007165 GO:0007165 GO:0010324 GO:0010324 GO:0010324
MAP3K1 	MAP3K1 (Mitogen-Activated Protein Kinase Kinase Kinase 1) is a Protein Coding gene. Diseases associated with MAP3K1 include  MAP3K19	The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]	The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Upregulation of NF-kappaB pathway after LMP1 stimulation, Decreased viability, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased telomerase activity, Decreased OCT4 protein expression, Decreased NANOG protein expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Synthetic lethal with gemcitabine, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased apoptosis, Misorientated spindle, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0016310 GO:0038095 GO:0038095 GO:0038095 GO:0071260 GO:0071260 GO:0071260
FGA 	FGA (Fibrinogen Alpha Chain) is a Protein Coding gene. Diseases associated with FGA include  FN1	This gene encodes the alpha subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Following vascular injury, the encoded preproprotein is proteolytically processed by thrombin during the conversion of fibrinogen to fibrin. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. [provided by RefSeq, Jan 2016]	This gene encodes the alpha subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Following vascular injury, the encoded preproprotein is proteolytically processed by thrombin during the conversion of fibrinogen to fibrin. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Reduced shRNA abundance in FBW7 KO line, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0007160 GO:0007160 GO:0007160
ACTN1 	ACTN1 (Actinin Alpha 1) is a Protein Coding gene. Diseases associated with ACTN1 include  ACTN4	Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, cytoskeletal, alpha actinin isoform and maps to the same site as the structurally similar erythroid beta spectrin gene. Three transcript variants encoding different isoforms have been found for this gene. Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, cytoskeletal, alpha actinin isoform and maps to the same site as the structurally similar erythroid beta spectrin gene. Three transcript variants encoding different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, Decreased NF-kappaB reporter expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Increased CFP-tsO45G cell surface transport, 	GO:0007015 GO:0030036 GO:0030168 GO:0030220 GO:0036344
TGFB3 	TGFB3 (Transforming Growth Factor Beta 3) is a Protein Coding gene. Diseases associated with TGFB3 include  TGFB2	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. This protein is involved in embryogenesis and cell differentiation, and may play a role in wound healing. Mutations in this gene are a cause of aortic aneurysms and dissections, as well as familial arrhythmogenic right ventricular dysplasia 1. [provided by RefSeq, Aug 2016]	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. This protein is involved in embryogenesis and cell differentiation, and may play a role in wound healing. Mutations in this gene are a cause of aortic aneurysms and dissections, as well as familial arrhythmogenic right ventricular dysplasia 1. [provided by RefSeq, Aug 2016]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased cell death HMECs cells, Decreased shRNA abundance, Upregulation of Wnt pathway, Decreased viability with paclitaxel, 	GO:0001666 GO:0001701 GO:0007165 GO:0007165 GO:0007165 GO:0007179 GO:0007179 GO:0007179 GO:0007435
DLL3 	DLL3 (Delta Like Canonical Notch Ligand 3) is a Protein Coding gene. Diseases associated with DLL3 include  Gastrulation DLK2	This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, 	GO:0001501
RNF180 	RNF180 (Ring Finger Protein 180) is a Protein Coding gene.   Gene Ontology (GO) annotations related to this gene include  RNF114	Predicted to enable ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Predicted to be involved in norepinephrine metabolic process; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and serotonin metabolic process. Predicted to act upstream of or within several processes, including adult behavior; positive regulation of protein ubiquitination; and protein polyubiquitination. Predicted to be located in nuclear envelope. Predicted to be integral component of membrane. Predicted to be intrinsic component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Predicted to be involved in norepinephrine metabolic process; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and serotonin metabolic process. Predicted to act upstream of or within several processes, including adult behavior; positive regulation of protein ubiquitination; and protein polyubiquitination. Predicted to be located in nuclear envelope. Predicted to be integral component of membrane. Predicted to be intrinsic component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Decreased viability, Decreased IL-8 secretion, Moderately decreased NFAT1-GFP nuclear translocation, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0000209 GO:0016567 GO:0016567 GO:0016567 GO:0030534 GO:0030534 GO:0030534 GO:0031398 GO:0031398 GO:0031398 GO:0032436 GO:0032436 GO:0032436
BAIAP2 	BAIAP2 (BAR/IMD Domain Containing Adaptor Protein 2) is a Protein Coding gene. Diseases associated with BAIAP2 include  BAIAP2L1	The protein encoded by this gene has been identified as a brain-specific angiogenesis inhibitor (BAI1)-binding protein. This adaptor protein links membrane bound G-proteins to cytoplasmic effector proteins. This protein functions as an insulin receptor tyrosine kinase substrate and suggests a role for insulin in the central nervous system. It also associates with a downstream effector of Rho small G proteins, which is associated with the formation of stress fibers and cytokinesis. This protein is involved in lamellipodia and filopodia formation in motile cells and may affect neuronal growth-cone guidance. This protein has also been identified as interacting with the dentatorubral-pallidoluysian atrophy gene, which is associated with an autosomal dominant neurodegenerative disease. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]	The protein encoded by this gene has been identified as a brain-specific angiogenesis inhibitor (BAI1)-binding protein. This adaptor protein links membrane bound G-proteins to cytoplasmic effector proteins. This protein functions as an insulin receptor tyrosine kinase substrate and suggests a role for insulin in the central nervous system. It also associates with a downstream effector of Rho small G proteins, which is associated with the formation of stress fibers and cytokinesis. This protein is involved in lamellipodia and filopodia formation in motile cells and may affect neuronal growth-cone guidance. This protein has also been identified as interacting with the dentatorubral-pallidoluysian atrophy gene, which is associated with an autosomal dominant neurodegenerative disease. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Wnt reporter downregulated, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased influenza A/WSN/33 replication, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0007009 GO:0007409 GO:0007409 GO:0007409 GO:0007420 GO:0008286 GO:0008286 GO:0008286
CD44 	CD44 (CD44 Molecule (Indian Blood Group)) is a Protein Coding gene. Diseases associated with CD44 include  LYVE1	The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. Increased vaccinia virus (VACV) infection, Reduced mammosphere formation, no effect, Decreased viability in ovarian lineage, Decreased viability, Decreased shRNA abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Increased the percentage of infected cells, 	GO:0006954 GO:0007155 GO:0007160 GO:0016477
ADAM17 	ADAM17 (ADAM Metallopeptidase Domain 17) is a Protein Coding gene. Diseases associated with ADAM17 include  ADAM10	This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn\'s disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]	This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn\'s disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]	Decreased viability, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Increased cell migration, Decreased shRNA abundance (Z-score &lt; -2), Polylobed nuclei, 	GO:0001666 GO:0001934 GO:0002446 GO:0002467 GO:0002690
DVL2 	DVL2 (Dishevelled Segment Polarity Protein 2) is a Protein Coding gene. Diseases associated with DVL2 include  DVL3	This gene encodes a member of the dishevelled (dsh) protein family. The vertebrate dsh proteins have approximately 40% amino acid sequence similarity with Drosophila dsh. This gene encodes a 90-kD protein that undergoes posttranslational phosphorylation to form a 95-kD cytoplasmic protein, which may play a role in the signal transduction pathway mediated by multiple Wnt proteins. The mechanisms of dishevelled function in Wnt signaling are likely to be conserved among metazoans. This gene encodes a member of the dishevelled (dsh) protein family. The vertebrate dsh proteins have approximately 40% amino acid sequence similarity with Drosophila dsh. This gene encodes a 90-kD protein that undergoes posttranslational phosphorylation to form a 95-kD cytoplasmic protein, which may play a role in the signal transduction pathway mediated by multiple Wnt proteins. The mechanisms of dishevelled function in Wnt signaling are likely to be conserved among metazoans. no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased cell number, Increased HPV18 LCR reporter activity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), Decreased shRNA abundance, Increased shRNA abundance, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Downregulation of Wnt pathway after Wnt3A stimulation, Increased viability with TRAIL, Synthetic lethal with gemcitabine, 	GO:0001843 GO:0001934 GO:0001934 GO:0001934
S1PR1 	S1PR1 (Sphingosine-1-Phosphate Receptor 1) is a Protein Coding gene. Diseases associated with S1PR1 include  S1PR3	The protein encoded by this gene is structurally similar to G protein-coupled receptors and is highly expressed in endothelial cells. It binds the ligand sphingosine-1-phosphate with high affinity and high specificity, and suggested to be involved in the processes that regulate the differentiation of endothelial cells. Activation of this receptor induces cell-cell adhesion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	The protein encoded by this gene is structurally similar to G protein-coupled receptors and is highly expressed in endothelial cells. It binds the ligand sphingosine-1-phosphate with high affinity and high specificity, and suggested to be involved in the processes that regulate the differentiation of endothelial cells. Activation of this receptor induces cell-cell adhesion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	Increased gamma-H2AX phosphorylation, no effect, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, 	GO:0001525 GO:0001955 GO:0003245 GO:0003245 GO:0003245 GO:0003376 GO:0003376 GO:0003376
MAPK13 	MAPK13 (Mitogen-Activated Protein Kinase 13) is a Protein Coding gene.  Among its related pathways are  MAPK12	This gene encodes a member of the mitogen-activated protein (MAP) kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The encoded protein is a p38 MAP kinase and is activated by proinflammatory cytokines and cellular stress. Substrates of the encoded protein include the transcription factor ATF2 and the microtubule dynamics regulator stathmin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]	This gene encodes a member of the mitogen-activated protein (MAP) kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The encoded protein is a p38 MAP kinase and is activated by proinflammatory cytokines and cellular stress. Substrates of the encoded protein include the transcription factor ATF2 and the microtubule dynamics regulator stathmin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Wnt reporter downregulated, Increased replication of vaccinia virus (VACV), Decreased substrate adherent cell growth, Decreased viability, Decreased shRNA abundance, Increased cell viability after pRB stimulation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased mitotic index, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, toxic, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0006970 GO:0006970 GO:0006970
PRKAR1A 	PRKAR1A (Protein Kinase CAMP-Dependent Type I Regulatory Subunit Alpha) is a Protein Coding gene. Diseases associated with PRKAR1A include  PRKAR1B	cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]	cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]	no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased transferrin (TF) endocytosis, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased cell migration, Decreased viability, Downregulation of Wnt pathway after Wnt3A stimulation, Increased cell number in S and G2M, Decreased viability after gemcitabine stimulation, Increased cilium length after serum starvation, 	GO:0001707 GO:0001932 GO:0001932 GO:0001932 GO:0006357 GO:0006357 GO:0006357
SUSD3 	SUSD3 (Sushi Domain Containing 3) is a Protein Coding gene. Diseases associated with SUSD3 include  CSMD2	Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	 
STAT1 	STAT1 (Signal Transducer And Activator Of Transcription 1) is a Protein Coding gene. Diseases associated with STAT1 include  STAT4	The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]	The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]	Increased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability in colon lineage, Increased Nanog expression, Increased transcriptional activity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000122 GO:0001937 GO:0001937 GO:0001937 GO:0002053 GO:0002230 GO:0002230 GO:0002230
CCND3 	CCND3 (Cyclin D3) is a Protein Coding gene. Diseases associated with CCND3 include  Retinoblastoma CCND2	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activtiy is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. The CDK4 activity associated with this cyclin was reported to be necessary for cell cycle progression through G2 phase into mitosis after UV radiation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activtiy is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. The CDK4 activity associated with this cyclin was reported to be necessary for cell cycle progression through G2 phase into mitosis after UV radiation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased cell number in G1, small nuclei in G1, Decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0000079 GO:0000082 GO:0000122 GO:0001934 GO:0001934 GO:0001934
IL11 	IL11 (Interleukin 11) is a Protein Coding gene. Diseases associated with IL11 include  Plasmacytoma	The protein encoded by this gene is a member of the gp130 family of cytokines. These cytokines drive the assembly of multisubunit receptor complexes, all of which contain at least one molecule of the transmembrane signaling receptor IL6ST (gp130). This cytokine is shown to stimulate the T-cell-dependent development of immunoglobulin-producing B cells. It is also found to support the proliferation of hematopoietic stem cells and megakaryocyte progenitor cells. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2012]	The protein encoded by this gene is a member of the gp130 family of cytokines. These cytokines drive the assembly of multisubunit receptor complexes, all of which contain at least one molecule of the transmembrane signaling receptor IL6ST (gp130). This cytokine is shown to stimulate the T-cell-dependent development of immunoglobulin-producing B cells. It is also found to support the proliferation of hematopoietic stem cells and megakaryocyte progenitor cells. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased cell death HMECs cells, 	GO:0007165 GO:0008283 GO:0008283 GO:0008283 GO:0008284 GO:0008284 GO:0008284 GO:0030183 GO:0030219
ESM1 	ESM1 (Endothelial Cell Specific Molecule 1) is a Protein Coding gene. Diseases associated with ESM1 include 	This gene encodes a secreted protein which is mainly expressed in the endothelial cells in human lung and kidney tissues. The expression of this gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. The transcript contains multiple polyadenylation and mRNA instability signals. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]	This gene encodes a secreted protein which is mainly expressed in the endothelial cells in human lung and kidney tissues. The expression of this gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. The transcript contains multiple polyadenylation and mRNA instability signals. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]	Increased viability, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, 	GO:0001525 GO:0002040 GO:0008284 GO:1902204
KCNJ2 	KCNJ2 (Potassium Inwardly Rectifying Channel Subfamily J Member 2) is a Protein Coding gene. Diseases associated with KCNJ2 include  KCNJ12	Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased HPV16-GFP infection, Decreased shRNA abundance (Z-score &lt; -2), Increased cell number in G2M, increased nuclei size in G2M, 	GO:0006811 GO:0006813 GO:0006813 GO:0006813 GO:0014861 GO:0015693 GO:0030007 GO:0030007 GO:0030007
KLB 	KLB (Klotho Beta) is a Protein Coding gene. Diseases associated with KLB include  KL	Enables fibroblast growth factor binding activity and fibroblast growth factor receptor binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway. Predicted to act upstream of or within positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway and positive regulation of cell population proliferation. Predicted to be located in plasma membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]	Enables fibroblast growth factor binding activity and fibroblast growth factor receptor binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway. Predicted to act upstream of or within positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway and positive regulation of cell population proliferation. Predicted to be located in plasma membrane. Predicted to be active in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Synthetic lethal with Ras, Decreased viability, Decreased centriole number, 	 
DCLK1 	DCLK1 (Doublecortin Like Kinase 1) is a Protein Coding gene. Diseases associated with DCLK1 include  DCLK2	This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.[provided by RefSeq, Sep 2010]	This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.[provided by RefSeq, Sep 2010]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability after Maraba virus infection, Wnt reporter downregulated, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0001764 GO:0006468 GO:0006468 GO:0006468 GO:0007399 GO:0007409 GO:0007417 GO:0007417 GO:0007417
FER 	FER (FER Tyrosine Kinase) is a Protein Coding gene. Diseases associated with FER include  Sarcoma FES	The protein encoded by this gene is a member of the FPS/FES family of non-transmembrane receptor tyrosine kinases. It regulates cell-cell adhesion and mediates signaling from the cell surface to the cytoskeleton via growth factor receptors. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome X. [provided by RefSeq, Apr 2015]	The protein encoded by this gene is a member of the FPS/FES family of non-transmembrane receptor tyrosine kinases. It regulates cell-cell adhesion and mediates signaling from the cell surface to the cytoskeleton via growth factor receptors. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome X. [provided by RefSeq, Apr 2015]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Decreased viability in colon lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with c-Myc after tamoxifen stimulation, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Negative genetic interaction between BLM-/- and BLM+/+, Decreased cell migration, Decreased viability, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Synthetic lethal with gemcitabine, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased apoptosis, Misorientated spindle, 	GO:0000226 GO:0001932 GO:0006468 GO:0006468 GO:0006468 GO:0006935 GO:0007155
PARVA 	PARVA (Parvin Alpha) is a Protein Coding gene. Diseases associated with PARVA include  PARVB	This gene encodes a member of the parvin family of actin-binding proteins. Parvins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. The encoded protein is part of the integrin-linked kinase signaling complex and plays a role in cell adhesion, motility and survival. [provided by RefSeq, Dec 2010]	This gene encodes a member of the parvin family of actin-binding proteins. Parvins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. The encoded protein is part of the integrin-linked kinase signaling complex and plays a role in cell adhesion, motility and survival. [provided by RefSeq, Dec 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased HIV-LTR-beta-galactosidase protein expression, Increased cell migration, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Increased cilium length after serum starvation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, Increased cilium length, 	 
ITGB3 	ITGB3 (Integrin Subunit Beta 3) is a Protein Coding gene. Diseases associated with ITGB3 include  ITGB5	The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. no effect, Decreased viability, shRNA abundance &lt;= 50%, Dynamic nuclei (hole, folded or small irregular), Decreased replication of vaccinia virus (VACV), Increased shRNA abundance, Increased G2M DNA content, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased cell spreading, 	GO:0001934 GO:0001938
KSR1 	KSR1 (Kinase Suppressor Of Ras 1) is a Protein Coding gene. Diseases associated with KSR1 include  Rasopathy KSR2	Enables 14-3-3 protein binding activity; ATP binding activity; and protein C-terminus binding activity. Involved in positive regulation of MAPK cascade. Located in endoplasmic reticulum and membrane. Part of protein-containing complex. Implicated in breast adenocarcinoma. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]	Enables 14-3-3 protein binding activity; ATP binding activity; and protein C-terminus binding activity. Involved in positive regulation of MAPK cascade. Located in endoplasmic reticulum and membrane. Part of protein-containing complex. Implicated in breast adenocarcinoma. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability in esophageal squamous lineage, Decreased viability, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Synthetic lethal with vaccinia virus (VACV) infection, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Increased vesicular stomatitis virus (VSV) infection, toxic, 	GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007265 GO:0007265 GO:0007265
GDF15 	GDF15 (Growth Differentiation Factor 15) is a Protein Coding gene. Diseases associated with GDF15 include  BMP6 . The protein is expressed in a broad range of cell types, acts as a pleiotropic cytokine and is involved in the stress response program of cells after cellular injury. Increased protein levels are associated with disease states such as tissue hypoxia, inflammation, acute injury and oxidative stress. [provided by RefSeq, Aug 2016] . The protein is expressed in a broad range of cell types, acts as a pleiotropic cytokine and is involved in the stress response program of cells after cellular injury. Increased protein levels are associated with disease states such as tissue hypoxia, inflammation, acute injury and oxidative stress. [provided by RefSeq, Aug 2016]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability with nutlin-3, 	GO:0002023 GO:0007165 GO:0007179 GO:0007267 GO:0010862
S100A4 	S100A4 (S100 Calcium Binding Protein A4) is a Protein Coding gene. Diseases associated with S100A4 include  S100A2	The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified. The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0001837 GO:0043123
NDRG2 	NDRG2 (NDRG Family Member 2) is a Protein Coding gene. Diseases associated with NDRG2 include  NDRG4	This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein that may play a role in neurite outgrowth. This gene may be involved in glioblastoma carcinogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]	This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein that may play a role in neurite outgrowth. This gene may be involved in glioblastoma carcinogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased G1 DNA content, G0/1 arrest, Increased hepcidin::fluc mRNA expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0001818 GO:0007165 GO:0007165 GO:0007165
MEIS1 	MEIS1 (Meis Homeobox 1) is a Protein Coding gene. Diseases associated with MEIS1 include  MEIS2	Homeobox genes, of which the most well-characterized category is represented by the HOX genes, play a crucial role in normal development. In addition, several homeoproteins are involved in neoplasia. This gene encodes a homeobox protein belonging to the TALE (\'three amino acid loop extension\') family of homeodomain-containing proteins. Homeobox genes, of which the most well-characterized category is represented by the HOX genes, play a crucial role in normal development. In addition, several homeoproteins are involved in neoplasia. This gene encodes a homeobox protein belonging to the TALE (\'three amino acid loop extension\') family of homeodomain-containing proteins. Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Increased Nanog expression, 	GO:0001525 GO:0001654
HFE 	HFE (Homeostatic Iron Regulator) is a Protein Coding gene. Diseases associated with HFE include 	The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. [provided by RefSeq, May 2022]	The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, 	GO:0001916 GO:0002474 GO:0002476 GO:0002486
CDC42EP3 	CDC42EP3 (CDC42 Effector Protein 3) is a Protein Coding gene. Diseases associated with CDC42EP3 include  CDC42EP2	This gene encodes a member of a small family of guanosine triphosphate (GTP) metabolizing proteins that contain a CRIB (Cdc42, Rac interactive binding) domain. Members of this family of proteins act as effectors of CDC42 function. The encoded protein is involved in actin cytoskeleton re-organization during cell shape changes, including pseudopodia formation. A pseudogene of this gene is found on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	This gene encodes a member of a small family of guanosine triphosphate (GTP) metabolizing proteins that contain a CRIB (Cdc42, Rac interactive binding) domain. Members of this family of proteins act as effectors of CDC42 function. The encoded protein is involved in actin cytoskeleton re-organization during cell shape changes, including pseudopodia formation. A pseudogene of this gene is found on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased NF-kappaB reporter expression, Dynamic nuclei (hole, folded or small irregular), Decreased HIV-1 infection, 	GO:0007165
ATF3 	ATF3 (Activating Transcription Factor 3) is a Protein Coding gene. Diseases associated with ATF3 include  Hypospadias JDP2	This gene encodes a member of the mammalian activation transcription factor/cAMP responsive element-binding (CREB) protein family of transcription factors. This gene is induced by a variety of signals, including many of those encountered by cancer cells, and is involved in the complex process of cellular stress response. Multiple transcript variants encoding different isoforms have been found for this gene. It is possible that alternative splicing of this gene may be physiologically important in the regulation of target genes. [provided by RefSeq, Apr 2011]	This gene encodes a member of the mammalian activation transcription factor/cAMP responsive element-binding (CREB) protein family of transcription factors. This gene is induced by a variety of signals, including many of those encountered by cancer cells, and is involved in the complex process of cellular stress response. Multiple transcript variants encoding different isoforms have been found for this gene. It is possible that alternative splicing of this gene may be physiologically important in the regulation of target genes. [provided by RefSeq, Apr 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased hepcidin::fluc mRNA expression, 	GO:0000122 GO:0006094 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
SYNJ1 	SYNJ1 (Synaptojanin 1) is a Protein Coding gene. Diseases associated with SYNJ1 include  SYNJ2	This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]	This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased shRNA abundance, Increased Salmonella enterica Typhimurium invasion, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium binding, Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0006629 GO:0006661 GO:0006661 GO:0006661 GO:0006836 GO:0006836 GO:0006836 GO:0006897 GO:0006897 GO:0006897 GO:0007420 GO:0007420 GO:0007420
LASP1 	LASP1 (LIM And SH3 Protein 1) is a Protein Coding gene. Diseases associated with LASP1 include  Medulloblastoma NEB	This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer. [provided by RefSeq, Oct 2012]	This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer. [provided by RefSeq, Oct 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased epidermal growth factor (EGF) endocytosis, Increased ionizing radiation sensitivity, Decreased shRNA abundance, Weakly decreased NFAT1-GFP nuclear translocation, 	 
DOCK7 	DOCK7 (Dedicator Of Cytokinesis 7) is a Protein Coding gene. Diseases associated with DOCK7 include  binding DOCK6	The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that plays a role in axon formation and neuronal polarization. The encoded protein displays GEF activity toward RAC1 and RAC3 Rho small GTPases but not toward CDC42. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]	The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that plays a role in axon formation and neuronal polarization. The encoded protein displays GEF activity toward RAC1 and RAC3 Rho small GTPases but not toward CDC42. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]	Increased vaccinia virus (VACV) infection, no effect, Increased G1 DNA content, Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), Increased free cholesterol, 	GO:0000226 GO:0007264 GO:0007399 GO:0007399 GO:0007399 GO:0007409 GO:0007409 GO:0007409
ARHGAP32 	ARHGAP32 (Rho GTPase Activating Protein 32) is a Protein Coding gene. Diseases associated with ARHGAP32 include  ARHGAP33	RICS is a neuron-associated GTPase-activating protein that may regulate dendritic spine morphology and strength by modulating Rho GTPase (see RHOA; MIM 165390) activity (Okabe et al., 2003 [PubMed 12531901]).[supplied by OMIM, Mar 2008]	RICS is a neuron-associated GTPase-activating protein that may regulate dendritic spine morphology and strength by modulating Rho GTPase (see RHOA; MIM 165390) activity (Okabe et al., 2003 [PubMed 12531901]).[supplied by OMIM, Mar 2008]	no effect, Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Strongly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Decreased shRNA abundance, Decreased p24 protein expression, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264
SYNPO 	SYNPO (Synaptopodin) is a Protein Coding gene. Diseases associated with SYNPO include  SYNPO2	Synaptopodin is an actin-associated protein that may play a role in actin-based cell shape and motility. The name synaptopodin derives from the protein\'s associations with postsynaptic densities and dendritic spines and with renal podocytes (Mundel et al., 1997 [PubMed 9314539]).[supplied by OMIM, Mar 2008]	Synaptopodin is an actin-associated protein that may play a role in actin-based cell shape and motility. The name synaptopodin derives from the protein\'s associations with postsynaptic densities and dendritic spines and with renal podocytes (Mundel et al., 1997 [PubMed 9314539]).[supplied by OMIM, Mar 2008]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased viability ratio, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0032233 GO:0051492 GO:0098886 GO:0098886 GO:0098886 GO:1905355
VPS25 	VPS25 (Vacuolar Protein Sorting 25 Homolog) is a Protein Coding gene. Diseases associated with VPS25 include 	This gene encodes a protein that is a subunit of the endosomal sorting complex required for transport II (ESCRT-II). This protein complex functions in sorting of ubiquitinated membrane proteins during endocytosis. A pseudogene of this gene is present on chromosome 1. [provided by RefSeq, Jul 2013]	This gene encodes a protein that is a subunit of the endosomal sorting complex required for transport II (ESCRT-II). This protein complex functions in sorting of ubiquitinated membrane proteins during endocytosis. A pseudogene of this gene is present on chromosome 1. [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased Sindbis virus (SINV) infection, 	GO:0007175 GO:0015031 GO:0016236 GO:0016236 GO:0016236 GO:0036258 GO:0043328
ATG14 	ATG14 (Autophagy Related 14) is a Protein Coding gene. Diseases associated with ATG14 include  Autophagy	Enables GTPase binding activity. Involved in several processes, including macroautophagy; regulation of phosphorylation; and response to mitochondrial depolarisation. Acts upstream of or within endosome to lysosome transport. Located in autophagosome and phagophore assembly site membrane. Is extrinsic component of omegasome membrane and extrinsic component of phagophore assembly site membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables GTPase binding activity. Involved in several processes, including macroautophagy; regulation of phosphorylation; and response to mitochondrial depolarisation. Acts upstream of or within endosome to lysosome transport. Located in autophagosome and phagophore assembly site membrane. Is extrinsic component of omegasome membrane and extrinsic component of phagophore assembly site membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Lamellipodia cells, Increased G1 DNA content, Increased number of mitotic cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0000045 GO:0000423 GO:0001932
ADAMTS5 	ADAMTS5 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 5) is a Protein Coding gene. Diseases associated with ADAMTS5 include  Osteoarthritis ADAMTS1	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs and functions as an aggrecanase that cleaves aggrecan, a major proteoglycan of cartilage, and may mediate cartilage destruction in osteoarthritis. [provided by RefSeq, Feb 2016]	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs and functions as an aggrecanase that cleaves aggrecan, a major proteoglycan of cartilage, and may mediate cartilage destruction in osteoarthritis. [provided by RefSeq, Feb 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased transferrin (TF) endocytosis, Two nuclei (binuclear), Decreased HIV-LTR-beta-galactosidase protein expression, Decreased Salmonella enterica Typhimurium invasion, Strongly decreased NFAT1-GFP nuclear translocation, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, 	 
CDK2 	CDK2 (Cyclin Dependent Kinase 2) is a Protein Coding gene. Diseases associated with CDK2 include  Retinoblastoma CDK3	This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	no effect, Decreased ionizing radiation sensitivity, Decreased viability ratio, Decreased viability in ovarian lineage, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased viability, Increased cell viability after pRB stimulation, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell proliferation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0000082 GO:0000086 GO:0000122 GO:0006260 GO:0006260 GO:0006260
KAT2B 	KAT2B (Lysine Acetyltransferase 2B) is a Protein Coding gene. Diseases associated with KAT2B include  KAT2A	CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation. no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Increased Nanog expression, Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), 	GO:0006094 GO:0006282 GO:0006282 GO:0006282 GO:0006338 GO:0006351 GO:0006355 GO:0006355 GO:0006355
GATA4 	GATA4 (GATA Binding Protein 4) is a Protein Coding gene. Diseases associated with GATA4 include  GATA6	This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]	This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Increased G2M DNA content, 	GO:0000122 GO:0001947 GO:0003162 GO:0003162 GO:0003162 GO:0003180
SOD2 	SOD2 (Superoxide Dismutase 2) is a Protein Coding gene. Diseases associated with SOD2 include 	This gene is a member of the iron/manganese superoxide dismutase family. It encodes a mitochondrial protein that forms a homotetramer and binds one manganese ion per subunit. This protein binds to the superoxide byproducts of oxidative phosphorylation and converts them to hydrogen peroxide and diatomic oxygen. Mutations in this gene have been associated with idiopathic cardiomyopathy (IDC), premature aging, sporadic motor neuron disease, and cancer. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 1. [provided by RefSeq, Apr 2016]	This gene is a member of the iron/manganese superoxide dismutase family. It encodes a mitochondrial protein that forms a homotetramer and binds one manganese ion per subunit. This protein binds to the superoxide byproducts of oxidative phosphorylation and converts them to hydrogen peroxide and diatomic oxygen. Mutations in this gene have been associated with idiopathic cardiomyopathy (IDC), premature aging, sporadic motor neuron disease, and cancer. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 1. [provided by RefSeq, Apr 2016]	no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased IL-8 secretion, Decreased shRNA abundance, Synthetic lethal with paclitaxel, 	GO:0000302 GO:0000303 GO:0000303 GO:0000303
SH2B1 	SH2B1 (SH2B Adaptor Protein 1) is a Protein Coding gene. Diseases associated with SH2B1 include  SH2B2	This gene encodes a member of the SH2-domain containing mediators family. The encoded protein mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular transformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]	This gene encodes a member of the SH2-domain containing mediators family. The encoded protein mediates activation of various kinases and may function in cytokine and growth factor receptor signaling and cellular transformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Strongly decreased CFP-tsO45G cell surface transport, Decreased infection with West Nile virus (WNV), Decreased Salmonella proliferation, 	GO:0007165 GO:0007169 GO:0007169 GO:0007169 GO:0030032 GO:0030032 GO:0030032 GO:0035556 GO:0035556 GO:0035556
MMP9 	MMP9 (Matrix Metallopeptidase 9) is a Protein Coding gene. Diseases associated with MMP9 include  MMP2	Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased Nanog expression, Decreased HIV-LTR-beta-galactosidase protein expression, Increased NF-kappaB reporter expression, Decreased shRNA abundance, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0001501 GO:0001503 GO:0001503 GO:0001503 GO:0001934 GO:0001934 GO:0001934 GO:0006508
NTN1 	NTN1 (Netrin 1) is a Protein Coding gene. Diseases associated with NTN1 include  NTN3	Netrin is included in a family of laminin-related secreted proteins.  The function of this gene has not yet been defined; however, netrin is thought to be involved in axon guidance and cell migration during development.  Mutations and loss of expression of netrin suggest that variation in netrin may be involved in cancer development. Netrin is included in a family of laminin-related secreted proteins.  The function of this gene has not yet been defined; however, netrin is thought to be involved in axon guidance and cell migration during development.  Mutations and loss of expression of netrin suggest that variation in netrin may be involved in cancer development. Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased cell number, Decreased NF-kappaB reporter expression, Increased transcriptional activity, Synthetic lethal with vaccinia virus (VACV) infection, Decreased HIV-1 infection, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0001764 GO:0006357 GO:0006357 GO:0006357
EDN1 	EDN1 (Endothelin 1) is a Protein Coding gene. Diseases associated with EDN1 include  EDN2	This gene encodes a preproprotein that is proteolytically processed to generate a secreted peptide that belongs to the endothelin/sarafotoxin family. This peptide is a potent vasoconstrictor and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of this gene may promote tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	This gene encodes a preproprotein that is proteolytically processed to generate a secreted peptide that belongs to the endothelin/sarafotoxin family. This peptide is a potent vasoconstrictor and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of this gene may promote tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased homologous recombination repair frequency, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000122 GO:0000165 GO:0001501 GO:0001501 GO:0001501 GO:0001516 GO:0001516 GO:0001516
GAS6 	GAS6 (Growth Arrest Specific 6) is a Protein Coding gene. Diseases associated with GAS6 include  MEGF6	This gene encodes a gamma-carboxyglutamic acid (Gla)-containing protein thought to be involved in the stimulation of cell proliferation. This gene is frequently overexpressed in many cancers and has been implicated as an adverse prognostic marker. Elevated protein levels are additionally associated with a variety of disease states, including venous thromboembolic disease, systemic lupus erythematosus, chronic renal failure, and preeclampsia. [provided by RefSeq, Aug 2014]	This gene encodes a gamma-carboxyglutamic acid (Gla)-containing protein thought to be involved in the stimulation of cell proliferation. This gene is frequently overexpressed in many cancers and has been implicated as an adverse prognostic marker. Elevated protein levels are additionally associated with a variety of disease states, including venous thromboembolic disease, systemic lupus erythematosus, chronic renal failure, and preeclampsia. [provided by RefSeq, Aug 2014]	Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased IL-8 secretion, Increased viability (proliferation), 	GO:0001764 GO:0001934 GO:0001934 GO:0001934 GO:0001961 GO:0001961 GO:0001961 GO:0003104 GO:0006468 GO:0006468 GO:0006468
SORBS1 	SORBS1 (Sorbin And SH3 Domain Containing 1) is a Protein Coding gene. Diseases associated with SORBS1 include  SORBS2	This gene encodes a CBL-associated protein which functions in the signaling and stimulation of insulin. Mutations in this gene may be associated with human disorders of insulin resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	This gene encodes a CBL-associated protein which functions in the signaling and stimulation of insulin. Mutations in this gene may be associated with human disorders of insulin resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with imatinib mesylate, Decreased viability, Decreased viability after ionizing radiation, Decreased cell migration, 	GO:0007160 GO:0008286 GO:0031589 GO:0031589 GO:0031589 GO:0032869
CNGB1 	CNGB1 (Cyclic Nucleotide Gated Channel Subunit Beta 1) is a Protein Coding gene. Diseases associated with CNGB1 include  CNGB3	In humans, the rod photoreceptor cGMP-gated cation channel helps regulate ion flow into the rod photoreceptor outer segment in response to light-induced alteration of the levels of intracellular cGMP. This channel consists of two subunits, alpha and beta, with the protein encoded by this gene representing the beta subunit. Defects in this gene are a cause of cause of retinitis pigmentosa type 45. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]	In humans, the rod photoreceptor cGMP-gated cation channel helps regulate ion flow into the rod photoreceptor outer segment in response to light-induced alteration of the levels of intracellular cGMP. This channel consists of two subunits, alpha and beta, with the protein encoded by this gene representing the beta subunit. Defects in this gene are a cause of cause of retinitis pigmentosa type 45. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]	Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Two nuclei (binuclear), No cells, Decreased influenza A/WSN/33 replication, Decreased shRNA abundance (Z-score &lt; -2), Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), 	GO:0001895 GO:0006811 GO:0006812 GO:0006812 GO:0006812 GO:0007601
NES 	NES (Nestin) is a Protein Coding gene. Diseases associated with NES include  SYNM	This gene encodes a member of the intermediate filament protein family and is expressed primarily in nerve cells. [provided by RefSeq, Sep 2011]	This gene encodes a member of the intermediate filament protein family and is expressed primarily in nerve cells. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Lamellipodia cells, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000086 GO:0007399 GO:0007417 GO:0007417 GO:0007417
IGFBP3 	IGFBP3 (Insulin Like Growth Factor Binding Protein 3) is a Protein Coding gene. Diseases associated with IGFBP3 include  IGFBP5	This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, 	GO:0000165 GO:0001558 GO:0001558 GO:0001558 GO:0001649 GO:0001649 GO:0001649 GO:0001933 GO:0001933 GO:0001933 GO:0006468
LATS1 	LATS1 (Large Tumor Suppressor Kinase 1) is a Protein Coding gene. Diseases associated with LATS1 include  Tetraploidy LATS2	The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]	The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased substrate adherent cell growth, Decreased cell migration, Decreased viability, Increased CFP-tsO45G cell surface transport, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Decreased sensitivity to paclitaxel, 	GO:0000082 GO:0000086 GO:0000278 GO:0000819 GO:0000819 GO:0000819
YWHAZ 	YWHAZ (Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta) is a Protein Coding gene. Diseases associated with YWHAZ include  Autism YWHAB	This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and sheep orthologs. The encoded protein interacts with IRS1 protein, suggesting a role in regulating insulin sensitivity. Several transcript variants that differ in the 5\' UTR but that encode the same protein have been identified for this gene. [provided by RefSeq, Oct 2008]	This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and sheep orthologs. The encoded protein interacts with IRS1 protein, suggesting a role in regulating insulin sensitivity. Several transcript variants that differ in the 5\' UTR but that encode the same protein have been identified for this gene. [provided by RefSeq, Oct 2008]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Increased G1 DNA content, G0/1 arrest, Increased IL-8 secretion, Increased ionizing radiation sensitivity, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased viability of wild-type and TP53 knockout cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased cell number and increased metaphase cell number, Decreased viability with paclitaxel, 	GO:0000122 GO:0001525 GO:0003016 GO:0003016 GO:0003016 GO:0006468 GO:0006468 GO:0006468
PIK3CG 	PIK3CG (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma) is a Protein Coding gene. Diseases associated with PIK3CG include  binding PIK3CA	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I catalytic subunit of PI3K. Like other class I catalytic subunits (p110-alpha p110-beta, and p110-delta), the encoded protein binds a p85 regulatory subunit to form PI3K. This gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2015]	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I catalytic subunit of PI3K. Like other class I catalytic subunits (p110-alpha p110-beta, and p110-delta), the encoded protein binds a p85 regulatory subunit to form PI3K. This gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2015]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Two nuclei (binuclear), Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Increased cell death HMECs cells, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, Decreased cilium length after serum starvation, Decreased viability after gemcitabine stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Decreased cilium length, 	GO:0001525 GO:0001819 GO:0001819 GO:0001819 GO:0001932 GO:0002250 GO:0002250 GO:0002250
ARHGEF6 	ARHGEF6 (Rac/Cdc42 Guanine Nucleotide Exchange Factor 6) is a Protein Coding gene. Diseases associated with ARHGEF6 include  ARHGEF7	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability (cell death), No cells, 	GO:0006915 GO:0007254
S100A1 	S100A1 (S100 Calcium Binding Protein A1) is a Protein Coding gene. Diseases associated with S100A1 include  Myoepithelioma S100Z	The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies. The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability in ovarian lineage, Wnt reporter downregulated, Decreased HIV-LTR-beta-galactosidase protein expression, Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased Hepatitis C virus replication, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0008016 GO:0021762 GO:0035556 GO:0051000 GO:1903672
CXCR4 	CXCR4 (C-X-C Motif Chemokine Receptor 4) is a Protein Coding gene. Diseases associated with CXCR4 include  Macroglobulinemia CXCR3	This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, shRNA abundance &lt;= 50%, Decreased viability ratio, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with imatinib mesylate, Decreased p24 protein expression, 	GO:0001666 GO:0001764 GO:0002064 GO:0002064 GO:0002064 GO:0002407 GO:0002407 GO:0002407 GO:0006915
RAF1 	RAF1 (Raf-1 Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with RAF1 include  ARAF	This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased simian virus 40 (SV40) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased cell death in HCT116 cells, Increased mitotic index, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Increased viability, Increased IL-10 protein expression, 	GO:0000165 GO:0001678 GO:0001678 GO:0001678 GO:0001934 GO:0001934 GO:0001934 GO:0006468 GO:0006468 GO:0006468 GO:0006915 GO:0006915 GO:0006915
NUSAP1 	NUSAP1 (Nucleolar And Spindle Associated Protein 1) is a Protein Coding gene. Diseases associated with NUSAP1 include 	NUSAP1 is a nucleolar-spindle-associated protein that plays a role in spindle microtubule organization (Raemaekers et al., 2003 [PubMed 12963707]).[supplied by OMIM, Jun 2009]	NUSAP1 is a nucleolar-spindle-associated protein that plays a role in spindle microtubule organization (Raemaekers et al., 2003 [PubMed 12963707]).[supplied by OMIM, Jun 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability after Maraba virus infection, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Increased replication of vaccinia virus (VACV), 	GO:0000070 GO:0000226 GO:0000281 GO:0000281 GO:0000281 GO:0007049 GO:0007076 GO:0007076 GO:0007076
SH3GL2 	SH3GL2 (SH3 Domain Containing GRB2 Like 2, Endophilin A1) is a Protein Coding gene. Diseases associated with SH3GL2 include  SH3GL1	Enables identical protein binding activity. Involved in negative regulation of blood-brain barrier permeability; negative regulation of gene expression; and negative regulation of protein phosphorylation. Located in perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables identical protein binding activity. Involved in negative regulation of blood-brain barrier permeability; negative regulation of gene expression; and negative regulation of protein phosphorylation. Located in perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased circadian period length, 	GO:0001933 GO:0006897 GO:0007165 GO:0007165 GO:0007165 GO:0007417 GO:0010629
MAP3K3 	MAP3K3 (Mitogen-Activated Protein Kinase Kinase Kinase 3) is a Protein Coding gene. Diseases associated with MAP3K3 include  MAP3K2	This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. no effect, Decreased viability, Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased substrate adherent cell growth, Decreased viability in pancreas lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Decreased cell proliferation, Increased cell death in DLD-1 cells, Decreased cell viability after pRB stimulation, 	GO:0000165 GO:0001568 GO:0006468 GO:0006468 GO:0006468 GO:0016310 GO:0016310 GO:0016310 GO:0035556 GO:0035556 GO:0035556
HMOX1 	HMOX1 (Heme Oxygenase 1) is a Protein Coding gene. Diseases associated with HMOX1 include  Inflammasomes HMOX2	Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. no effect, shRNA abundance &lt;= 50%, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0001525 GO:0001666 GO:0001935 GO:0001935 GO:0001935 GO:0002246 GO:0002686
MMP1 	MMP1 (Matrix Metallopeptidase 1) is a Protein Coding gene. Diseases associated with MMP1 include  MMP8	This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down the interstitial collagens, including types I, II, and III. The gene is part of a cluster of MMP genes on chromosome 11. Mutations in this gene are associated with chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down the interstitial collagens, including types I, II, and III. The gene is part of a cluster of MMP genes on chromosome 11. Mutations in this gene are associated with chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased IL-8 secretion, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased NF-kappaB reporter expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006508 GO:0019538 GO:0022617 GO:0022617 GO:0022617 GO:0030198 GO:0030198 GO:0030198
LAMC1 	LAMC1 (Laminin Subunit Gamma 1) is a Protein Coding gene. Diseases associated with LAMC1 include  LAMC3	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 1. The gamma 1 chain, formerly thought to be a beta chain, contains structural domains similar to beta chains, however, lacks the short alpha region separating domains I and II. The structural organization of this gene also suggested that it had diverged considerably from the beta chain genes. Embryos of transgenic mice in which both alleles of the gamma 1 chain gene were inactivated by homologous recombination, lacked basement membranes, indicating that laminin, gamma 1 chain is necessary for laminin heterotrimer assembly. It has been inferred by analogy with the strikingly similar 3\' UTR sequence in mouse laminin gamma 1 cDNA, that multiple polyadenylation sites are utilized in human to generate the 2 different sized mRNAs (5.5 and 7.5 kb) seen on Northern analysis. [provided by RefSeq, Aug 2011]	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 1. The gamma 1 chain, formerly thought to be a beta chain, contains structural domains similar to beta chains, however, lacks the short alpha region separating domains I and II. The structural organization of this gene also suggested that it had diverged considerably from the beta chain genes. Embryos of transgenic mice in which both alleles of the gamma 1 chain gene were inactivated by homologous recombination, lacked basement membranes, indicating that laminin, gamma 1 chain is necessary for laminin heterotrimer assembly. It has been inferred by analogy with the strikingly similar 3\' UTR sequence in mouse laminin gamma 1 cDNA, that multiple polyadenylation sites are utilized in human to generate the 2 different sized mRNAs (5.5 and 7.5 kb) seen on Northern analysis. [provided by RefSeq, Aug 2011]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased number of mitotic cells, Increased S DNA content, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0007155 GO:0007492 GO:0009887 GO:0009888 GO:0009888 GO:0009888 GO:0016477 GO:0016477 GO:0016477
SHH 	SHH (Sonic Hedgehog Signaling Molecule) is a Protein Coding gene. Diseases associated with SHH include  Gastrulation IHH	This gene encodes a protein that is instrumental in patterning the early embryo. It has been implicated as the key inductive signal in patterning of the ventral neural tube, the anterior-posterior limb axis, and the ventral somites. Of three human proteins showing sequence and functional similarity to the sonic hedgehog protein of Drosophila, this protein is the most similar. The protein is made as a precursor that is autocatalytically cleaved; the N-terminal portion is soluble and contains the signalling activity while the C-terminal portion is involved in precursor processing. More importantly, the C-terminal product covalently attaches a cholesterol moiety to the N-terminal product, restricting the N-terminal product to the cell surface and preventing it from freely diffusing throughout the developing embryo. Defects in this protein or in its signalling pathway are a cause of holoprosencephaly (HPE), a disorder in which the developing forebrain fails to correctly separate into right and left hemispheres. HPE is manifested by facial deformities. It is also thought that mutations in this gene or in its signalling pathway may be responsible for VACTERL syndrome, which is characterized by vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, radial and renal dysplasia, cardiac anomalies, and limb abnormalities. Additionally, mutations in a long range enhancer located approximately 1 megabase upstream of this gene disrupt limb patterning and can result in preaxial polydactyly. This gene encodes a protein that is instrumental in patterning the early embryo. It has been implicated as the key inductive signal in patterning of the ventral neural tube, the anterior-posterior limb axis, and the ventral somites. Of three human proteins showing sequence and functional similarity to the sonic hedgehog protein of Drosophila, this protein is the most similar. The protein is made as a precursor that is autocatalytically cleaved; the N-terminal portion is soluble and contains the signalling activity while the C-terminal portion is involved in precursor processing. More importantly, the C-terminal product covalently attaches a cholesterol moiety to the N-terminal product, restricting the N-terminal product to the cell surface and preventing it from freely diffusing throughout the developing embryo. Defects in this protein or in its signalling pathway are a cause of holoprosencephaly (HPE), a disorder in which the developing forebrain fails to correctly separate into right and left hemispheres. HPE is manifested by facial deformities. It is also thought that mutations in this gene or in its signalling pathway may be responsible for VACTERL syndrome, which is characterized by vertebral defects, anal atresia, tracheoesophageal fistula with esophageal atresia, radial and renal dysplasia, cardiac anomalies, and limb abnormalities. Additionally, mutations in a long range enhancer located approximately 1 megabase upstream of this gene disrupt limb patterning and can result in preaxial polydactyly. no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased Salmonella enterica Typhimurium invasion, Decreased shRNA abundance, 	 
ADAM12 	ADAM12 (ADAM Metallopeptidase Domain 12) is a Protein Coding gene. Diseases associated with ADAM12 include  ADAM19	This gene encodes a member of a family of proteins that are structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. Expression of this gene has been used as a maternal serum marker for pre-natal development. Alternative splicing results in multiple transcript variants encoding different isoforms. Shorter isoforms are secreted, while longer isoforms are membrane-bound form. [provided by RefSeq, Jan 2014]	This gene encodes a member of a family of proteins that are structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. Expression of this gene has been used as a maternal serum marker for pre-natal development. Alternative splicing results in multiple transcript variants encoding different isoforms. Shorter isoforms are secreted, while longer isoforms are membrane-bound form. [provided by RefSeq, Jan 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Increased homologous recombination repair frequency, 	GO:0006508 GO:0007155 GO:0007155 GO:0007155 GO:0007229 GO:0007229 GO:0007229 GO:0007520 GO:0007520 GO:0007520 GO:0045766
ECT2 	ECT2 (Epithelial Cell Transforming 2) is a Protein Coding gene. Diseases associated with ECT2 include 	The protein encoded by this gene is a guanine nucleotide exchange factor and transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of this gene is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2017]	The protein encoded by this gene is a guanine nucleotide exchange factor and transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of this gene is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2017]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Decreased viability in pancreas lineage, Increased ionizing radiation sensitivity, Increased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased HPV16-GFP infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Cell division defect, Increased 8N DNA content, Multipolar spindles, Two nuclei (binuclear), polylobed nuclei, Inhibition of centrosomal clustering, 	GO:0000281 GO:0000902 GO:0007049 GO:0007049 GO:0007049 GO:0007399 GO:0007399 GO:0007399
STRAP 	STRAP (Serine/Threonine Kinase Receptor Associated Protein) is a Protein Coding gene. Diseases associated with STRAP include 	Enables RNA binding activity. Involved in maintenance of gastrointestinal epithelium; negative regulation of transforming growth factor beta receptor signaling pathway; and spliceosomal snRNP assembly. Located in cytosol. Part of SMN complex. Implicated in adenocarcinoma; colorectal carcinoma; large cell carcinoma; lung carcinoma; and squamous cell neoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables RNA binding activity. Involved in maintenance of gastrointestinal epithelium; negative regulation of transforming growth factor beta receptor signaling pathway; and spliceosomal snRNP assembly. Located in cytosol. Part of SMN complex. Implicated in adenocarcinoma; colorectal carcinoma; large cell carcinoma; lung carcinoma; and squamous cell neoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased IL-8 secretion, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0000122 GO:0000380 GO:0000380 GO:0000380 GO:0000387 GO:0000387 GO:0000387
TLR4 	TLR4 (Toll Like Receptor 4) is a Protein Coding gene. Diseases associated with TLR4 include  Pertussis TLR7	The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]	The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]	no effect, Decreased viability, Decreased viability ratio, Decreased viability in colon lineage, Inconclusive, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased viability with 4OH tamoxifen, 	GO:0002218 GO:0002224 GO:0002224 GO:0002224
RB1 	RB1 (RB Transcriptional Corepressor 1) is a Protein Coding gene. Diseases associated with RB1 include  Retinoblastoma RBL1	The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased NF-kappaB reporter expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0000082 GO:0000122 GO:0000122 GO:0000122
TCF3 	TCF3 (Transcription Factor 3) is a Protein Coding gene. Diseases associated with TCF3 include  TCF12	This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1;19), with PBX1), childhood leukemia (t(19;19), with TFPT) and acute leukemia (t(12;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Sep 2011]	This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1;19), with PBX1), childhood leukemia (t(19;19), with TFPT) and acute leukemia (t(12;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Sep 2011]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased nuclear migration distance, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased influenza A/WSN/33 replication, Increased shRNA abundance (Z-score &gt; 2), Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, 	GO:0000122 GO:0002326 GO:0006355 GO:0006357
ETS1 	ETS1 (ETS Proto-Oncogene 1, Transcription Factor) is a Protein Coding gene. Diseases associated with ETS1 include  ETS2	This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]	This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]	no effect, Increased Nanog expression, Increased virus production, 	GO:0002376 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006366 GO:0006955 GO:0006955 GO:0006955
ITGA3 	ITGA3 (Integrin Subunit Alpha 3) is a Protein Coding gene. Diseases associated with ITGA3 include  ITGA6	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function as cell surface adhesion molecules. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 3 subunit. This subunit joins with a beta 1 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. Expression of this gene may be correlated with breast cancer metastasis. [provided by RefSeq, Oct 2015]	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function as cell surface adhesion molecules. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 3 subunit. This subunit joins with a beta 1 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. Expression of this gene may be correlated with breast cancer metastasis. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased HPV18 LCR reporter activity, Increased hepcidin::fluc mRNA expression, Decreased cell migration, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Decreased viability with paclitaxel, Decreased Sindbis virus (SINV) infection, Large nuclei, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001764 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229
CYFIP2 	CYFIP2 (Cytoplasmic FMR1 Interacting Protein 2) is a Protein Coding gene. Diseases associated with CYFIP2 include  CYFIP1	Predicted to enable small GTPase binding activity. Involved in activation of cysteine-type endopeptidase activity; apoptotic process; and cell-cell adhesion. Located in perinuclear region of cytoplasm and synapse. Part of SCAR complex. Implicated in developmental and epileptic encephalopathy 65. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable small GTPase binding activity. Involved in activation of cysteine-type endopeptidase activity; apoptotic process; and cell-cell adhesion. Located in perinuclear region of cytoplasm and synapse. Part of SCAR complex. Implicated in developmental and epileptic encephalopathy 65. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0000902 GO:0006915 GO:0007155 GO:0007411 GO:0007411 GO:0007411 GO:0030031
GABARAP 	GABARAP (GABA Type A Receptor-Associated Protein) is a Protein Coding gene. Diseases associated with GABARAP include  GABARAPL1	Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. This gene encodes GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton. Gamma-aminobutyric acid A receptors [GABA(A) receptors] are ligand-gated chloride channels that mediate inhibitory neurotransmission. This gene encodes GABA(A) receptor-associated protein, which is highly positively charged in its N-terminus and shares sequence similarity with light chain-3 of microtubule-associated proteins 1A and 1B. This protein clusters neurotransmitter receptors by mediating interaction with the cytoskeleton. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Decreased HIV-LTR-beta-galactosidase protein expression, Increased NF-kappaB reporter expression, 	GO:0000045 GO:0000226 GO:0000422 GO:0000422 GO:0000422 GO:0006605
TUBB 	TUBB (Tubulin Beta Class I) is a Protein Coding gene. Diseases associated with TUBB include  TUBB4B	This gene encodes a beta tubulin protein. This protein forms a dimer with alpha tubulin and acts as a structural component of microtubules. Mutations in this gene cause cortical dysplasia, complex, with other brain malformations 6. Alternative splicing results in multiple splice variants. There are multiple pseudogenes for this gene on chromosomes 1, 6, 7, 8, 9, and 13. [provided by RefSeq, Jun 2014]	This gene encodes a beta tubulin protein. This protein forms a dimer with alpha tubulin and acts as a structural component of microtubules. Mutations in this gene cause cortical dysplasia, complex, with other brain malformations 6. Alternative splicing results in multiple splice variants. There are multiple pseudogenes for this gene on chromosomes 1, 6, 7, 8, 9, and 13. [provided by RefSeq, Jun 2014]	Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Increased number of mitotic cells, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Dynamic nuclei (hole, folded or small irregular), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell number, increased S DNA content, increased G2M DNA content, 	GO:0000226 GO:0000278
ZBTB7B 	ZBTB7B (Zinc Finger And BTB Domain Containing 7B) is a Protein Coding gene. Diseases associated with ZBTB7B include  ZBTB49	This gene encodes a zinc finger-containing transcription factor that acts as a key regulator of lineage commitment of immature T-cell precursors. It is necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. It also functions as a transcriptional repressor of type I collagen genes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]	This gene encodes a zinc finger-containing transcription factor that acts as a key regulator of lineage commitment of immature T-cell precursors. It is necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. It also functions as a transcriptional repressor of type I collagen genes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]	no effect, Decreased viability, shRNA abundance &lt;= 25%, Weakly decreased NFAT1-GFP nuclear translocation, 	GO:0000122 GO:0001865 GO:0001865 GO:0001865 GO:0006357 GO:0006357 GO:0006357 GO:0006366 GO:0007398
IQGAP1 	IQGAP1 (IQ Motif Containing GTPase Activating Protein 1) is a Protein Coding gene. Diseases associated with IQGAP1 include  IQGAP3	This gene encodes a member of the IQGAP family. The protein contains four IQ domains, one calponin homology domain, one Ras-GAP domain and one WW domain. It interacts with components of the cytoskeleton, with cell adhesion molecules, and with several signaling molecules to regulate cell morphology and motility. Expression of the protein is upregulated by gene amplification in two gastric cancer cell lines. This gene encodes a member of the IQGAP family. The protein contains four IQ domains, one calponin homology domain, one Ras-GAP domain and one WW domain. It interacts with components of the cytoskeleton, with cell adhesion molecules, and with several signaling molecules to regulate cell morphology and motility. Expression of the protein is upregulated by gene amplification in two gastric cancer cell lines. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased Salmonella enterica Typhimurium invasion, Decreased Hepatitis C virus replication, Decreased Salmonella enterica Typhimurium binding, Increased cell number in G1, small nuclei in G1, Altered focal adhesion (FA) or cell shape morphology, Decreased viability with paclitaxel, 	GO:0001817 GO:0007165 GO:0007165 GO:0007165 GO:0007173 GO:0007346
NODAL 	NODAL (Nodal Growth Differentiation Factor) is a Protein Coding gene. Diseases associated with NODAL include  GDF6	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which regulates early embryonic development. This protein is required for maintenance of human embryonic stem cell pluripotency and may play a role in human placental development. Mutations in this gene are associated with heterotaxy, a condition characterized by random orientation of visceral organs with respect to the left-right axis. [provided by RefSeq, Aug 2016]	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which regulates early embryonic development. This protein is required for maintenance of human embryonic stem cell pluripotency and may play a role in human placental development. Mutations in this gene are associated with heterotaxy, a condition characterized by random orientation of visceral organs with respect to the left-right axis. [provided by RefSeq, Aug 2016]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability ratio, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), 	 
GRIA1 	GRIA1 (Glutamate Ionotropic Receptor AMPA Type Subunit 1) is a Protein Coding gene. Diseases associated with GRIA1 include  GRIA2	Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes with multiple subunits, each possessing transmembrane regions, and all arranged to form a ligand-gated ion channel. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. This gene belongs to a family of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes with multiple subunits, each possessing transmembrane regions, and all arranged to form a ligand-gated ion channel. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. This gene belongs to a family of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. no effect, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability with SS1P at EC30, 	GO:0006811 GO:0007165 GO:0007165 GO:0007165
DACT1 	DACT1 (Dishevelled Binding Antagonist Of Beta Catenin 1) is a Protein Coding gene. Diseases associated with DACT1 include  Craniorachischisis DACT3	The protein encoded by this gene belongs to the dapper family, characterized by the presence of PDZ-binding motif at the C-terminus. It interacts with, and positively regulates dishevelled-mediated signaling pathways during development. Depletion of this mRNA from xenopus embryos resulted in loss of notochord and head structures, and mice lacking this gene died shortly after birth from severe posterior malformations. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]	The protein encoded by this gene belongs to the dapper family, characterized by the presence of PDZ-binding motif at the C-terminus. It interacts with, and positively regulates dishevelled-mediated signaling pathways during development. Depletion of this mRNA from xenopus embryos resulted in loss of notochord and head structures, and mice lacking this gene died shortly after birth from severe posterior malformations. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased IL-8 secretion, Decreased shRNA abundance, Decreased homologous recombination repair frequency, Increased Sindbis virus (SINV) infection, 	GO:0000122 GO:0007399 GO:0009968 GO:0009968 GO:0009968 GO:0016055 GO:0016055 GO:0016055 GO:0021915 GO:0021915 GO:0021915
E2F3 	E2F3 (E2F Transcription Factor 3) is a Protein Coding gene. Diseases associated with E2F3 include  Retinoblastoma E2F2	This gene encodes a member of a small family of transcription factors that function through binding of DP interaction partner proteins. The encoded protein recognizes a specific sequence motif in DNA and interacts directly with the retinoblastoma protein (pRB) to regulate the expression of genes involved in the cell cycle. Altered copy number and activity of this gene have been observed in a number of human cancers. There are pseudogenes for this gene on chromosomes 2 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]	This gene encodes a member of a small family of transcription factors that function through binding of DP interaction partner proteins. The encoded protein recognizes a specific sequence motif in DNA and interacts directly with the retinoblastoma protein (pRB) to regulate the expression of genes involved in the cell cycle. Altered copy number and activity of this gene have been observed in a number of human cancers. There are pseudogenes for this gene on chromosomes 2 and 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), Effect on mitosis, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), 	GO:0000082 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006367 GO:0006606
GDNF 	GDNF (Glial Cell Derived Neurotrophic Factor) is a Protein Coding gene. Diseases associated with GDNF include  NRTN . The recombinant form of this protein, a highly conserved neurotrophic factor, was shown to promote the survival and differentiation of dopaminergic neurons in culture, and was able to prevent apoptosis of motor neurons induced by axotomy. This protein is a ligand for the product of the RET (rearranged during transfection) protooncogene. Mutations in this gene may be associated with Hirschsprung disease and Tourette syndrome. This gene encodes multiple protein isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016] . The recombinant form of this protein, a highly conserved neurotrophic factor, was shown to promote the survival and differentiation of dopaminergic neurons in culture, and was able to prevent apoptosis of motor neurons induced by axotomy. This protein is a ligand for the product of the RET (rearranged during transfection) protooncogene. Mutations in this gene may be associated with Hirschsprung disease and Tourette syndrome. This gene encodes multiple protein isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]	no effect, Decreased vaccinia virus (VACV) infection, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0001656 GO:0001657 GO:0001657 GO:0001657 GO:0001658 GO:0001658 GO:0001658 GO:0001755 GO:0001755 GO:0001755
TAB3 	TAB3 (TGF-Beta Activated Kinase 1 (MAP3K7) Binding Protein 3) is a Protein Coding gene.  Among its related pathways are  TAB2	The product of this gene functions in the NF-kappaB signal transduction pathway. The encoded protein, and the similar and functionally redundant protein MAP3K7IP2/TAB2, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor. The human genome contains a related pseudogene. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. The product of this gene functions in the NF-kappaB signal transduction pathway. The encoded protein, and the similar and functionally redundant protein MAP3K7IP2/TAB2, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor. The human genome contains a related pseudogene. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability in pancreas lineage, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0010507 GO:0043123
DNM2 	DNM2 (Dynamin 2) is a Protein Coding gene. Diseases associated with DNM2 include  DNM1	Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]	Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Strongly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased Sindbis virus (SINV) infection, Increased viability with SS1P at EC90, Decreased HIV-1 infection, 	GO:0000086 GO:0002031 GO:0006355 GO:0006355 GO:0006355
GDF6 	GDF6 (Growth Differentiation Factor 6) is a Protein Coding gene. Diseases associated with GDF6 include  GDF5 . This protein is required for normal formation of some bones and joints in the limbs, skull, and axial skeleton. Mutations in this gene are associated with Klippel-Feil syndrome, microphthalmia, and Leber congenital amaurosis. [provided by RefSeq, Sep 2016] . This protein is required for normal formation of some bones and joints in the limbs, skull, and axial skeleton. Mutations in this gene are associated with Klippel-Feil syndrome, microphthalmia, and Leber congenital amaurosis. [provided by RefSeq, Sep 2016]	Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, 	GO:0001656 GO:0006915 GO:0010862 GO:0010862 GO:0010862 GO:0030509 GO:0032332
PTK2B 	PTK2B (Protein Tyrosine Kinase 2 Beta) is a Protein Coding gene. Diseases associated with PTK2B include  Osteopetrosis Osteoporosis PTK2	This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased IL-8 secretion, Decreased substrate adherent cell growth, Decreased Salmonella enterica Typhimurium invasion, Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability of wild-type and TP53 knockout cells, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased viability in HMC1.1 cells, Decreased viability in CMK cells, Increased IL-13 protein expression, 	 
CDKN1B 	CDKN1B (Cyclin Dependent Kinase Inhibitor 1B) is a Protein Coding gene. Diseases associated with CDKN1B include  CDKN1C	This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4). [provided by RefSeq, Apr 2014]	This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4). [provided by RefSeq, Apr 2014]	no effect, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability in pancreas lineage, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Decreased viability, Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Increased cell number in G2M, increased nuclei size in G2M, Decreased influenza A H1N1 (A/WSN/33) virus numbers, Condensed medial Golgi, Increased cell growth, 	GO:0000079
MAX 	MAX (MYC Associated Factor X) is a Protein Coding gene. Diseases associated with MAX include  Pheochromocytoma	The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased cell number, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Decreased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Decreased Salmonella enterica Typhimurium ruffling, Increased Nanog expression, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357
HOXD10 	HOXD10 (Homeobox D10) is a Protein Coding gene. Diseases associated with HOXD10 include  HOXA10	This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox D genes located on chromosome 2. The encoded nuclear protein functions as a sequence-specific transcription factor that is expressed in the developing limb buds and is involved in differentiation and limb development. Mutations in this gene have been associated with Wilm\'s tumor and congenital vertical talus (also known as "rocker-bottom foot" deformity or congenital convex pes valgus) and/or a foot deformity resembling that seen in Charcot-Marie-Tooth disease. This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox D genes located on chromosome 2. The encoded nuclear protein functions as a sequence-specific transcription factor that is expressed in the developing limb buds and is involved in differentiation and limb development. Mutations in this gene have been associated with Wilm\'s tumor and congenital vertical talus (also known as "rocker-bottom foot" deformity or congenital convex pes valgus) and/or a foot deformity resembling that seen in Charcot-Marie-Tooth disease. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with vaccinia virus (VACV) infection, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0001501 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
TCF4 	TCF4 (Transcription Factor 4) is a Protein Coding gene. Diseases associated with TCF4 include  TCF12	This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor. The encoded protein recognizes an Ephrussi-box (\'E-box\') binding site (\'CANNTG\') - a motif first identified in immunoglobulin enhancers. This gene is broadly expressed, and may play an important role in nervous system development. Defects in this gene are a cause of Pitt-Hopkins syndrome. In addition, an intronic CTG repeat normally numbering 10-37 repeat units can expand to &gt;50 repeat units and cause Fuchs endothelial corneal dystrophy. Multiple alternatively spliced transcript variants that encode different proteins have been described. This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor. The encoded protein recognizes an Ephrussi-box (\'E-box\') binding site (\'CANNTG\') - a motif first identified in immunoglobulin enhancers. This gene is broadly expressed, and may play an important role in nervous system development. Defects in this gene are a cause of Pitt-Hopkins syndrome. In addition, an intronic CTG repeat normally numbering 10-37 repeat units can expand to &gt;50 repeat units and cause Fuchs endothelial corneal dystrophy. Multiple alternatively spliced transcript variants that encode different proteins have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Wnt reporter downregulated, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased cell death HMECs cells, Decreased shRNA abundance, Increased cell death in HCC-1954 cells, Increased viability with TRAIL, 	GO:0006357 GO:0007399 GO:0030154 GO:0030154 GO:0030154 GO:0045666 GO:0045666 GO:0045666 GO:0045893 GO:0045893 GO:0045893
EPAS1 	EPAS1 (Endothelial PAS Domain Protein 1) is a Protein Coding gene. Diseases associated with EPAS1 include  HIF1A	This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]	This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]	Increased viability, no effect, Decreased viability in esophageal squamous lineage, Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased circadian period length, Increased shRNA abundance (Z-score &gt; 2), Decreased HIV-1 infection, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666
CAMK2A 	CAMK2A (Calcium/Calmodulin Dependent Protein Kinase II Alpha) is a Protein Coding gene. Diseases associated with CAMK2A include  CAMK2B	The product of this gene belongs to the serine/threonine protein kinases family, and to the Ca(2+)/calmodulin-dependent protein kinases subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. This calcium calmodulin-dependent protein kinase is composed of four different chains: alpha, beta, gamma, and delta. The alpha chain encoded by this gene is required for hippocampal long-term potentiation (LTP) and spatial learning. In addition to its calcium-calmodulin (CaM)-dependent activity, this protein can undergo autophosphorylation, resulting in CaM-independent activity. Several transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2018]	The product of this gene belongs to the serine/threonine protein kinases family, and to the Ca(2+)/calmodulin-dependent protein kinases subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. This calcium calmodulin-dependent protein kinase is composed of four different chains: alpha, beta, gamma, and delta. The alpha chain encoded by this gene is required for hippocampal long-term potentiation (LTP) and spatial learning. In addition to its calcium-calmodulin (CaM)-dependent activity, this protein can undergo autophosphorylation, resulting in CaM-independent activity. Several transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2018]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased epidermal growth factor (EGF) endocytosis, Decreased cell migration, Decreased viability, Decreased telomerase activity, Decreased viability with paclitaxel, 	GO:0000082 GO:0002931 GO:0002931 GO:0002931 GO:0006468 GO:0006468 GO:0006468
LTBP4 	LTBP4 (Latent Transforming Growth Factor Beta Binding Protein 4) is a Protein Coding gene. Diseases associated with LTBP4 include  LTBP2	The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]	The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Increased homologous recombination repair frequency, 	GO:0001558 GO:0006457 GO:0007179 GO:0017015 GO:0017015 GO:0017015
BAD 	BAD (BCL2 Associated Agonist Of Cell Death) is a Protein Coding gene. Diseases associated with BAD include 	The protein encoded by this gene is a member of the BCL-2 family. BCL-2 family members are known to be regulators of programmed cell death. This protein positively regulates cell apoptosis by forming heterodimers with BCL-xL (B-cell lymphoma-extra large) and BCL-2, and reversing their death repressor activity. Proapoptotic activity of this protein is regulated through its phosphorylation. Protein kinases AKT and MAP kinase, as well as protein phosphatase calcineurin were found to be involved in the regulation of this protein. Alternative splicing of this gene results in two transcript variants which encode the same isoform. [provided by RefSeq, Dec 2019]	The protein encoded by this gene is a member of the BCL-2 family. BCL-2 family members are known to be regulators of programmed cell death. This protein positively regulates cell apoptosis by forming heterodimers with BCL-xL (B-cell lymphoma-extra large) and BCL-2, and reversing their death repressor activity. Proapoptotic activity of this protein is regulated through its phosphorylation. Protein kinases AKT and MAP kinase, as well as protein phosphatase calcineurin were found to be involved in the regulation of this protein. Alternative splicing of this gene results in two transcript variants which encode the same isoform. [provided by RefSeq, Dec 2019]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability (cell death), Increased viability with MLN4924 (a NAE inhibitor), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Synthetic lethal with imatinib mesylate, Increased viability with nutlin-3, 	GO:0001666 GO:0001836 GO:0001836 GO:0001836 GO:0006007 GO:0006915 GO:0006915 GO:0006915
TBX2 	TBX2 (T-Box Transcription Factor 2) is a Protein Coding gene. Diseases associated with TBX2 include  TBX3	This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product is the human homolog of mouse Tbx2, and shares strong sequence similarity with Drosophila omb protein. Expression studies indicate that this gene may have a potential role in tumorigenesis as an immortalizing agent. Transcript heterogeneity due to alternative polyadenylation has been noted for this gene. This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product is the human homolog of mouse Tbx2, and shares strong sequence similarity with Drosophila omb protein. Expression studies indicate that this gene may have a potential role in tumorigenesis as an immortalizing agent. Transcript heterogeneity due to alternative polyadenylation has been noted for this gene. no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, Strongly decreased CFP-tsO45G cell surface transport, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0000122 GO:0001708
TRPV4 	TRPV4 (Transient Receptor Potential Cation Channel Subfamily V Member 4) is a Protein Coding gene. Diseases associated with TRPV4 include  TRPV1	This gene encodes a member of the OSM9-like transient receptor potential channel (OTRPC) subfamily in the transient receptor potential (TRP) superfamily of ion channels. The encoded protein is a Ca2+-permeable, nonselective cation channel that is thought to be involved in the regulation of systemic osmotic pressure. Mutations in this gene are the cause of spondylometaphyseal and metatropic dysplasia and hereditary motor and sensory neuropathy type IIC. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010]	This gene encodes a member of the OSM9-like transient receptor potential channel (OTRPC) subfamily in the transient receptor potential (TRP) superfamily of ion channels. The encoded protein is a Ca2+-permeable, nonselective cation channel that is thought to be involved in the regulation of systemic osmotic pressure. Mutations in this gene are the cause of spondylometaphyseal and metatropic dysplasia and hereditary motor and sensory neuropathy type IIC. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010]	no effect, Decreased ionizing radiation sensitivity, Decreased viability, Decreased viability in colon lineage, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), 	GO:0000122 GO:0002024 GO:0002024 GO:0002024 GO:0006811 GO:0006811 GO:0006811 GO:0006816 GO:0006816 GO:0006816 GO:0006874
MAPK3 	MAPK3 (Mitogen-Activated Protein Kinase 3) is a Protein Coding gene. Diseases associated with MAPK3 include  MAPK1	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. Increased gamma-H2AX phosphorylation, Increased viability, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased substrate adherent cell growth, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Increased CFP-tsO45G cell surface transport, Decreased viability with paclitaxel, Decreased focal adhesion (FA) abundance, increased cell elongation, decreased cell spreading, 	GO:0000165 GO:0001934 GO:0006351 GO:0006468 GO:0006468 GO:0006468
CD63 	CD63 (CD63 Molecule) is a Protein Coding gene. Diseases associated with CD63 include  TSPAN7	The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Deficiency of this protein is associated with Hermansky-Pudlak syndrome. Also this gene has been associated with tumor progression. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Apr 2012]	The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Deficiency of this protein is associated with Hermansky-Pudlak syndrome. Also this gene has been associated with tumor progression. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Apr 2012]	no effect, Decreased viability ratio, shRNA abundance &lt;= 25%, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased viability in non-small-cell lung cancer (NSCLC) lineage; decreased viability in pancreas lineage, 	GO:0002092 GO:0007160 GO:0015031 GO:0016477 GO:0016477 GO:0016477 GO:0035646
PDGFRL 	PDGFRL (Platelet Derived Growth Factor Receptor Like) is a Protein Coding gene. Diseases associated with PDGFRL include 	This gene encodes a protein with significant sequence similarity to the ligand binding domain of platelet-derived growth factor receptor beta. Mutations in this gene, or deletion of a chromosomal segment containing this gene, are associated with sporadic hepatocellular carcinomas, colorectal cancers, and non-small cell lung cancers. This suggests this gene product may function as a tumor suppressor. This gene encodes a protein with significant sequence similarity to the ligand binding domain of platelet-derived growth factor receptor beta. Mutations in this gene, or deletion of a chromosomal segment containing this gene, are associated with sporadic hepatocellular carcinomas, colorectal cancers, and non-small cell lung cancers. This suggests this gene product may function as a tumor suppressor. Increased vaccinia virus (VACV) infection, no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Decreased influenza A/WSN/33 replication, 	 
MRTFA 	MRTFA (Myocardin Related Transcription Factor A) is a Protein Coding gene. Diseases associated with MRTFA include  MRTFB	The protein encoded by this gene interacts with the transcription factor myocardin, a key regulator of smooth muscle cell differentiation. The encoded protein is predominantly nuclear and may help transduce signals from the cytoskeleton to the nucleus. This gene is involved in a specific translocation event that creates a fusion of this gene and the RNA-binding motif protein-15 gene. This translocation has been associated with acute megakaryocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]	The protein encoded by this gene interacts with the transcription factor myocardin, a key regulator of smooth muscle cell differentiation. The encoded protein is predominantly nuclear and may help transduce signals from the cytoskeleton to the nucleus. This gene is involved in a specific translocation event that creates a fusion of this gene and the RNA-binding motif protein-15 gene. This translocation has been associated with acute megakaryocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased circadian period length, Increased ionizing radiation sensitivity, Decreased nuclei size in G2M, 	GO:0006357 GO:0030036 GO:0030036 GO:0030036 GO:0044319 GO:0044319 GO:0044319 GO:0045944 GO:0051145
CEBPB 	CEBPB (CCAAT Enhancer Binding Protein Beta) is a Protein Coding gene. Diseases associated with CEBPB include  Retinoblastoma Med23 CEBPA	This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions. [provided by RefSeq, Oct 2013]	This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions. [provided by RefSeq, Oct 2013]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in pancreas lineage, Increased ionizing radiation sensitivity, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability after ionizing radiation, Increased cell number in G1, average or increased nuclei size in G1, Decreased BBC3 mRNA expression, 	GO:0000122
CD36 	CD36 (CD36 Molecule) is a Protein Coding gene. Diseases associated with CD36 include  SCARB2	The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]	The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, Increased hepcidin::fluc mRNA expression, Increased shRNA abundance, 	GO:0000122 GO:0000165 GO:0000165 GO:0000165 GO:0001954 GO:0001954 GO:0001954 GO:0002532 GO:0006629
NET1 	NET1 (Neuroepithelial Cell Transforming 1) is a Protein Coding gene. Diseases associated with NET1 include  ARHGEF3	This gene is part of the family of Rho guanine nucleotide exchange factors. Members of this family activate Rho proteins by catalyzing the exchange of GDP for GTP. The protein encoded by this gene interacts with RhoA within the cell nucleus and may play a role in repairing DNA damage after ionizing radiation. Pseudogenes of this gene are located on the long arms of chromosomes 1, 7 and 18. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012]	This gene is part of the family of Rho guanine nucleotide exchange factors. Members of this family activate Rho proteins by catalyzing the exchange of GDP for GTP. The protein encoded by this gene interacts with RhoA within the cell nucleus and may play a role in repairing DNA damage after ionizing radiation. Pseudogenes of this gene are located on the long arms of chromosomes 1, 7 and 18. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Increased transferrin (TF) endocytosis, Decreased IL-8 secretion, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	GO:0001558 GO:0007165 GO:0035025 GO:0035556 GO:0043065 GO:0043065 GO:0043065
CTTNBP2NL 	CTTNBP2NL (CTTNBP2 N-Terminal Like) is a Protein Coding gene.   Gene Ontology (GO) annotations related to this gene include  FILIP1	Enables protein phosphatase 2A binding activity. Acts upstream of or within negative regulation of transmembrane transport; negative regulation of transporter activity; and protein dephosphorylation. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]	Enables protein phosphatase 2A binding activity. Acts upstream of or within negative regulation of transmembrane transport; negative regulation of transporter activity; and protein dephosphorylation. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability after Maraba virus infection, Increased 8N DNA content, 	GO:0006470 GO:0032410 GO:0034763
HDAC5 	HDAC5 (Histone Deacetylase 5) is a Protein Coding gene. Diseases associated with HDAC5 include  HDAC4	Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to the class II histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. It coimmunoprecipitates only with HDAC3 family member and might form multicomplex proteins. It also interacts with myocyte enhancer factor-2 (MEF2) proteins, resulting in repression of MEF2-dependent genes. This gene is thought to be associated with colon cancer. Two transcript variants encoding different isoforms have been found for this gene. Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to the class II histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. It coimmunoprecipitates only with HDAC3 family member and might form multicomplex proteins. It also interacts with myocyte enhancer factor-2 (MEF2) proteins, resulting in repression of MEF2-dependent genes. This gene is thought to be associated with colon cancer. Two transcript variants encoding different isoforms have been found for this gene. no effect, Decreased viability, Negative genetic interaction between KRASG13D/+ and KRAS+/-, No cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000122 GO:0006325 GO:0006338 GO:0006476 GO:0006954
ITGB1BP1 	ITGB1BP1 (Integrin Subunit Beta 1 Binding Protein 1) is a Protein Coding gene. Diseases associated with ITGB1BP1 include 	The cytoplasmic domains of integrins are essential for cell adhesion. The protein encoded by this gene binds to the beta1 integrin cytoplasmic domain. The interaction between this protein and beta1 integrin is highly specific. Two isoforms of this protein are derived from alternatively spliced transcripts. The shorter form of this protein does not interact with the beta1 integrin cytoplasmic domain. The longer form is a phosphoprotein and the extent of its phosphorylation is regulated by the cell-matrix interaction, suggesting an important role of this protein during integrin-dependent cell adhesion. Several transcript variants, some protein-coding and some non-protein coding, have been found for this gene. [provided by RefSeq, Jan 2016]	The cytoplasmic domains of integrins are essential for cell adhesion. The protein encoded by this gene binds to the beta1 integrin cytoplasmic domain. The interaction between this protein and beta1 integrin is highly specific. Two isoforms of this protein are derived from alternatively spliced transcripts. The shorter form of this protein does not interact with the beta1 integrin cytoplasmic domain. The longer form is a phosphoprotein and the extent of its phosphorylation is regulated by the cell-matrix interaction, suggesting an important role of this protein during integrin-dependent cell adhesion. Several transcript variants, some protein-coding and some non-protein coding, have been found for this gene. [provided by RefSeq, Jan 2016]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased cell number, Decreased IL-8 secretion, Increased cell migration, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Polylobed nuclei, Decreased vaccinia virus (VACV-LREV ) gene expression, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, increased cell elongation, decreased cell spreading, 	GO:0001525 GO:0002043 GO:0002043 GO:0002043 GO:0006469
KDR 	KDR (Kinase Insert Domain Receptor) is a Protein Coding gene. Diseases associated with KDR include  FLT1	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]	Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased substrate adherent cell growth, Weakly decreased NFAT1-GFP nuclear translocation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, 	GO:0001525 GO:0001541 GO:0001569 GO:0001569 GO:0001569 GO:0001570 GO:0001934 GO:0001934 GO:0001934
AQP4 	AQP4 (Aquaporin 4) is a Protein Coding gene. Diseases associated with AQP4 include  AQP5	This gene encodes a member of the aquaporin family of intrinsic membrane proteins that function as water-selective channels in the plasma membranes of many cells. This protein is the predominant aquaporin found in brain and has an important role in brain water homeostasis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. Additional isoforms, resulting from the use of alternative in-frame translation initiation codons, have also been described. Recent studies provided evidence for translational readthrough in this gene, and expression of C-terminally extended isoforms via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]	This gene encodes a member of the aquaporin family of intrinsic membrane proteins that function as water-selective channels in the plasma membranes of many cells. This protein is the predominant aquaporin found in brain and has an important role in brain water homeostasis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. Additional isoforms, resulting from the use of alternative in-frame translation initiation codons, have also been described. Recent studies provided evidence for translational readthrough in this gene, and expression of C-terminally extended isoforms via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]	no effect, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, Decreased viability after Maraba virus infection, Increased nuclear migration distance, Increased homologous recombination repair frequency, Increased shRNA abundance, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased nuclei size in G2M, 	GO:0003091 GO:0006833 GO:0006833 GO:0006833
ETV2 	ETV2 (ETS Variant Transcription Factor 2) is a Protein Coding gene. Diseases associated with ETV2 include  ERG	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including cell surface receptor signaling pathway; positive regulation of endothelial cell differentiation; and positive regulation of macromolecule metabolic process. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in cell differentiation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including cell surface receptor signaling pathway; positive regulation of endothelial cell differentiation; and positive regulation of macromolecule metabolic process. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Increased IL-8 secretion, Increased NF-kappaB reporter expression, Increased cell number in G2M, increased nuclei size in G2M, 	 
UBE2L6 	UBE2L6 (Ubiquitin Conjugating Enzyme E2 L6) is a Protein Coding gene. Diseases associated with UBE2L6 include  UBE2L5	The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is highly similar in primary structure to the enzyme encoded by the UBE2L3 gene. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2011]	The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is highly similar in primary structure to the enzyme encoded by the UBE2L3 gene. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2011]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability after Maraba virus infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Weakly decreased NFAT1-GFP nuclear translocation, Decreased Salmonella proliferation, 	GO:0000209 GO:0006511 GO:0016567 GO:0019941 GO:0019941 GO:0019941 GO:0032020 GO:0032020 GO:0032020
ECM1 	ECM1 (Extracellular Matrix Protein 1) is a Protein Coding gene. Diseases associated with ECM1 include 	This gene encodes a soluble protein that is involved in endochondral bone formation, angiogenesis, and tumor biology. It also interacts with a variety of extracellular and structural proteins, contributing to the maintenance of skin integrity and homeostasis. Mutations in this gene are associated with lipoid proteinosis disorder (also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease) that is characterized by generalized thickening of skin, mucosae and certain viscera. Alternatively spliced transcript variants encoding distinct isoforms have been described for this gene. [provided by RefSeq, Feb 2011]	This gene encodes a soluble protein that is involved in endochondral bone formation, angiogenesis, and tumor biology. It also interacts with a variety of extracellular and structural proteins, contributing to the maintenance of skin integrity and homeostasis. Mutations in this gene are associated with lipoid proteinosis disorder (also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease) that is characterized by generalized thickening of skin, mucosae and certain viscera. Alternatively spliced transcript variants encoding distinct isoforms have been described for this gene. [provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Increased HPV18 LCR reporter activity, Increased homologous recombination repair frequency, Negative genetic interaction between BLM-/- and BLM+/+, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased homologous recombination repair frequency, 	GO:0001503 GO:0001525 GO:0001525 GO:0001525 GO:0001938 GO:0001938 GO:0001938
DAPK1 	DAPK1 (Death Associated Protein Kinase 1) is a Protein Coding gene. Diseases associated with DAPK1 include  DAPK3	Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death. DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites. It is a tumor suppressor candidate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death. DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites. It is a tumor suppressor candidate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Increased transcriptional activity, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Increased cell death in HCC-1954 cells, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Increased simian virus 40 (SV40) infection, Increased cell death in HCT116 cells, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Decreased cell viability after pRB stimulation, Decreased viability with RAF265, 	GO:0002357 GO:0002834 GO:0006417 GO:0006468 GO:0006468 GO:0006468 GO:0006915
SAV1 	SAV1 (Salvador Family WW Domain Containing Protein 1) is a Protein Coding gene. Diseases associated with SAV1 include  MAGI3	WW domain-containing proteins are found in all eukaryotes and play an important role in the regulation of a wide variety of cellular functions such as protein degradation, transcription, and RNA splicing. This gene encodes a protein with two WW domains, a SARAH domain, and a coiled-coil region and is ubiquitously expressed in adult tissues. This protein binds to MST1 (mammalian sterile 20-like kinase 1) and promotes MST1-induced apoptosis. It has also been shown to bind to HAX1 (hematopoietic cell-specific protein 1 (HS1)-associated protein X-1) and to attenuate the anti-apoptotic effects of HAX1. Studies in human and mouse suggest this gene acts as a tumor suppressor. [provided by RefSeq, Aug 2012]	WW domain-containing proteins are found in all eukaryotes and play an important role in the regulation of a wide variety of cellular functions such as protein degradation, transcription, and RNA splicing. This gene encodes a protein with two WW domains, a SARAH domain, and a coiled-coil region and is ubiquitously expressed in adult tissues. This protein binds to MST1 (mammalian sterile 20-like kinase 1) and promotes MST1-induced apoptosis. It has also been shown to bind to HAX1 (hematopoietic cell-specific protein 1 (HS1)-associated protein X-1) and to attenuate the anti-apoptotic effects of HAX1. Studies in human and mouse suggest this gene acts as a tumor suppressor. [provided by RefSeq, Aug 2012]	no effect, 	 
ATF2 	ATF2 (Activating Transcription Factor 2) is a Protein Coding gene. Diseases associated with ATF2 include  Retinoblastoma ATF7	This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions This protein binds to the cAMP-responsive element (CRE), an octameric palindrome. It forms a homodimer or a heterodimer with c-Jun and stimulates CRE-dependent transcription. This protein is also a histone acetyltransferase (HAT) that specifically acetylates histones H2B and H4 in vitro; thus it may represent a class of sequence-specific factors that activate transcription by direct effects on chromatin components. The encoded protein may also be involved in cell\'s DNA damage response independent of its role in transcriptional regulation. Several alternatively spliced transcript variants have been found for this gene [provided by RefSeq, Jan 2014]	This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions This protein binds to the cAMP-responsive element (CRE), an octameric palindrome. It forms a homodimer or a heterodimer with c-Jun and stimulates CRE-dependent transcription. This protein is also a histone acetyltransferase (HAT) that specifically acetylates histones H2B and H4 in vitro; thus it may represent a class of sequence-specific factors that activate transcription by direct effects on chromatin components. The encoded protein may also be involved in cell\'s DNA damage response independent of its role in transcriptional regulation. Several alternatively spliced transcript variants have been found for this gene [provided by RefSeq, Jan 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased IL-8 secretion, Decreased viability in pancreas lineage, Synthetic lethal with vaccinia virus (VACV) infection, Decreased homologous recombination repair frequency, 	GO:0000122
MYO10 	MYO10 (Myosin X) is a Protein Coding gene. Diseases associated with MYO10 include  Chondrocalcinosis MYH7	This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-10 (MYH10). Unconventional myosins contain the basic domains of conventional myosins and are further distinguished from class members by their tail domains. This gene functions as an actin-based molecular motor and plays a role in integration of F-actin and microtubule cytoskeletons during meiosis. [provided by RefSeq, Dec 2011]	This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional non-muscle myosin-10 (MYH10). Unconventional myosins contain the basic domains of conventional myosins and are further distinguished from class members by their tail domains. This gene functions as an actin-based molecular motor and plays a role in integration of F-actin and microtubule cytoskeletons during meiosis. [provided by RefSeq, Dec 2011]	no effect, Decreased viability, Increased IL-8 secretion, 	GO:0007165 GO:0008360 GO:0008360 GO:0008360 GO:0022409 GO:0030705 GO:0030705 GO:0030705 GO:0051489 GO:0051489 GO:0051489
CSPG4 	CSPG4 (Chondroitin Sulfate Proteoglycan 4) is a Protein Coding gene. Diseases associated with CSPG4 include  Melanoma	A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. Increased vaccinia virus (VACV) infection, no effect, Increased IL-8 secretion, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	 
TP53 	TP53 (Tumor Protein P53) is a Protein Coding gene. Diseases associated with TP53 include  TP73	This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]	This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability in pancreas lineage, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased viability with paclitaxel, Decreased viability of wild-type and TP53 knockout cells, Increased proliferation, Decreased CDKN1A mRNA expression, Decreased TP53 mRNA expression, Decreased BBC3 mRNA expression, Increased viability with nutlin-3, 	GO:0000122
PRDX1 	PRDX1 (Peroxiredoxin 1) is a Protein Coding gene. Diseases associated with PRDX1 include  PRDX2	This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jan 2011]	This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jan 2011]	Increased vaccinia virus (VACV) infection, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased shRNA abundance, 	GO:0000302 GO:0001501 GO:0001501 GO:0001501 GO:0001895 GO:0006979 GO:0008283
LTBP1 	LTBP1 (Latent Transforming Growth Factor Beta Binding Protein 1) is a Protein Coding gene. Diseases associated with LTBP1 include  LTBP2	The protein encoded by this gene belongs to the family of latent TGF-beta binding proteins (LTBPs). The secretion and activation of TGF-betas is regulated by their association with latency-associated proteins and with latent TGF-beta binding proteins. The product of this gene targets latent complexes of transforming growth factor beta to the extracellular matrix, where the latent cytokine is subsequently activated by several different mechanisms. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene belongs to the family of latent TGF-beta binding proteins (LTBPs). The secretion and activation of TGF-betas is regulated by their association with latency-associated proteins and with latent TGF-beta binding proteins. The product of this gene targets latent complexes of transforming growth factor beta to the extracellular matrix, where the latent cytokine is subsequently activated by several different mechanisms. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased viability, Increased transferrin (TF) endocytosis, Increased G1 DNA content, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0007178 GO:0035583 GO:0035583 GO:0035583 GO:1901388
BMP6 	BMP6 (Bone Morphogenetic Protein 6) is a Protein Coding gene. Diseases associated with BMP6 include  BMP5 . This protein regulates a wide range of biological processes including iron homeostasis, fat and bone development, and ovulation. Differential expression of this gene may be associated with progression of breast and prostate cancer. Mutations in this gene may be associated with iron overload in human patients.   . This protein regulates a wide range of biological processes including iron homeostasis, fat and bone development, and ovulation. Differential expression of this gene may be associated with progression of breast and prostate cancer. Mutations in this gene may be associated with iron overload in human patients. no effect, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000122 GO:0001501 GO:0001501 GO:0001501
GJD2 	GJD2 (Gap Junction Protein Delta 2) is a Protein Coding gene. Diseases associated with GJD2 include  GJC1	This gene encodes a member of the connexin protein family. Connexins are gap junction proteins which are arranged in groups of 6 around a central pore to form a connexon, a component of the gap junction intercellular channel. The channels formed by this protein allow cationic molecule exchange between human beta cells and may function in the regulation of insulin secretion. [provided by RefSeq, Oct 2012]	This gene encodes a member of the connexin protein family. Connexins are gap junction proteins which are arranged in groups of 6 around a central pore to form a connexon, a component of the gap junction intercellular channel. The channels formed by this protein allow cationic molecule exchange between human beta cells and may function in the regulation of insulin secretion. [provided by RefSeq, Oct 2012]	no effect, Reduced mammosphere formation, Decreased viability ratio, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, No cells, Decreased Hepatitis C virus replication, 	 
HSPA8 	HSPA8 (Heat Shock Protein Family A (Hsp70) Member 8) is a Protein Coding gene. Diseases associated with HSPA8 include  HSPA2	This gene encodes a member of the heat shock protein 70 family, which contains both heat-inducible and constitutively expressed members. This protein belongs to the latter group, which are also referred to as heat-shock cognate proteins. It functions as a chaperone, and binds to nascent polypeptides to facilitate correct folding. It also functions as an ATPase in the disassembly of clathrin-coated vesicles during transport of membrane components through the cell. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	This gene encodes a member of the heat shock protein 70 family, which contains both heat-inducible and constitutively expressed members. This protein belongs to the latter group, which are also referred to as heat-shock cognate proteins. It functions as a chaperone, and binds to nascent polypeptides to facilitate correct folding. It also functions as an ATPase in the disassembly of clathrin-coated vesicles during transport of membrane components through the cell. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	no effect, Decreased ionizing radiation sensitivity, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Increased shRNA abundance (Z-score &gt; 2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability of wild-type and TP53 knockout cells, 	GO:0000398 GO:0006397 GO:0006457 GO:0006457 GO:0006457 GO:0006986
MYB 	MYB (MYB Proto-Oncogene, Transcription Factor) is a Protein Coding gene. Diseases associated with MYB include  MYBL1	This gene encodes a protein with three HTH DNA-binding domains that functions as a transcription regulator. This protein plays an essential role in the regulation of hematopoiesis. This gene may be aberrently expressed or rearranged or undergo translocation in leukemias and lymphomas, and is considered to be an oncogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]	This gene encodes a protein with three HTH DNA-binding domains that functions as a transcription regulator. This protein plays an essential role in the regulation of hematopoiesis. This gene may be aberrently expressed or rearranged or undergo translocation in leukemias and lymphomas, and is considered to be an oncogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Strongly decreased CFP-tsO45G cell surface transport, Decreased viability, Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0000122 GO:0000278 GO:0006355 GO:0030218 GO:0045064
SIRT1 	SIRT1 (Sirtuin 1) is a Protein Coding gene. Diseases associated with SIRT1 include  Aging SIRT2	This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]	This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), High actin ratio cells, 	GO:0000012 GO:0000122 GO:0000183 GO:0000720 GO:0000720 GO:0000720
AGAP1 	AGAP1 (ArfGAP With GTPase Domain, Ankyrin Repeat And PH Domain 1) is a Protein Coding gene. Diseases associated with AGAP1 include  Autism AGAP3	This gene encodes a member of an ADP-ribosylation factor GTPase-activating protein family involved in membrane trafficking and cytoskeleton dynamics. This gene functions as a direct regulator of the adaptor-related protein complex 3 on endosomes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	This gene encodes a member of an ADP-ribosylation factor GTPase-activating protein family involved in membrane trafficking and cytoskeleton dynamics. This gene functions as a direct regulator of the adaptor-related protein complex 3 on endosomes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	no effect, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0015031 GO:0090630 GO:0090630 GO:0090630
HSP90AB1 	HSP90AB1 (Heat Shock Protein 90 Alpha Family Class B Member 1) is a Protein Coding gene. Diseases associated with HSP90AB1 include  Inflammasomes HSP90AA1	This gene encodes a member of the heat shock protein 90 family; these proteins are involved in signal transduction, protein folding and degradation and morphological evolution. This gene encodes the constitutive form of the cytosolic 90 kDa heat-shock protein and is thought to play a role in gastric apoptosis and inflammation. Alternative splicing results in multiple transcript variants. Pseudogenes have been identified on multiple chromosomes. [provided by RefSeq, Dec 2012]	This gene encodes a member of the heat shock protein 90 family; these proteins are involved in signal transduction, protein folding and degradation and morphological evolution. This gene encodes the constitutive form of the cytosolic 90 kDa heat-shock protein and is thought to play a role in gastric apoptosis and inflammation. Alternative splicing results in multiple transcript variants. Pseudogenes have been identified on multiple chromosomes. [provided by RefSeq, Dec 2012]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Strongly decreased CFP-tsO45G cell surface transport, Increased cell death HMECs cells, 	GO:0001890 GO:0006457 GO:0006457 GO:0006457 GO:0006986 GO:0007004
CCL21 	CCL21 (C-C Motif Chemokine Ligand 21) is a Protein Coding gene. Diseases associated with CCL21 include  Scrapie CX3CL1	This antimicrobial gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. Similar to other chemokines the protein encoded by this gene inhibits hemopoiesis and stimulates chemotaxis. This protein is chemotactic in vitro for thymocytes and activated T cells, but not for B cells, macrophages, or neutrophils. The cytokine encoded by this gene may also play a role in mediating homing of lymphocytes to secondary lymphoid organs. It is a high affinity functional ligand for chemokine receptor 7 that is expressed on T and B lymphocytes and a known receptor for another member of the cytokine family (small inducible cytokine A19). [provided by RefSeq, Sep 2014]	This antimicrobial gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. Similar to other chemokines the protein encoded by this gene inhibits hemopoiesis and stimulates chemotaxis. This protein is chemotactic in vitro for thymocytes and activated T cells, but not for B cells, macrophages, or neutrophils. The cytokine encoded by this gene may also play a role in mediating homing of lymphocytes to secondary lymphoid organs. It is a high affinity functional ligand for chemokine receptor 7 that is expressed on T and B lymphocytes and a known receptor for another member of the cytokine family (small inducible cytokine A19). [provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased shRNA abundance (Z-score &lt; -2), Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0001768 GO:0001771 GO:0001954 GO:0001954 GO:0001954 GO:0002407 GO:0002548
CXCL1 	CXCL1 (C-X-C Motif Chemokine Ligand 1) is a Protein Coding gene. Diseases associated with CXCL1 include  Tonsillitis CXCL2	This antimicrobial gene encodes a member of the CXC subfamily of chemokines. The encoded protein is a secreted growth factor that signals through the G-protein coupled receptor, CXC receptor 2. This protein plays a role in inflammation and as a chemoattractant for neutrophils. Aberrant expression of this protein is associated with the growth and progression of certain tumors. A naturally occurring processed form of this protein has increased chemotactic activity. Alternate splicing results in coding and non-coding variants of this gene. A pseudogene of this gene is found on chromosome 4. [provided by RefSeq, Sep 2014]	This antimicrobial gene encodes a member of the CXC subfamily of chemokines. The encoded protein is a secreted growth factor that signals through the G-protein coupled receptor, CXC receptor 2. This protein plays a role in inflammation and as a chemoattractant for neutrophils. Aberrant expression of this protein is associated with the growth and progression of certain tumors. A naturally occurring processed form of this protein has increased chemotactic activity. Alternate splicing results in coding and non-coding variants of this gene. A pseudogene of this gene is found on chromosome 4. [provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased viability in ovarian lineage, Decreased viability after Maraba virus infection, Decreased cell number, Decreased shRNA abundance (Z-score &lt; -2), Metaphase cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, 	GO:0006935 GO:0006952 GO:0006954 GO:0006954 GO:0006954 GO:0006955 GO:0007165 GO:0007165 GO:0007165
DAAM1 	DAAM1 (Dishevelled Associated Activator Of Morphogenesis 1) is a Protein Coding gene. Diseases associated with DAAM1 include  binding DAAM2	Cell motility, adhesion, cytokinesis, and other functions of the cell cortex are mediated by reorganization of the actin cytoskeleton and several formin homology (FH) proteins have been associated with these processes. The protein encoded by this gene contains two FH domains and belongs to a novel FH protein subfamily implicated in cell polarity. A key regulator of cytoskeletal architecture, the small GTPase Rho, is activated during development by Wnt/Fz signaling to control cell polarity and movement. The protein encoded by this gene is thought to function as a scaffolding protein for the Wnt-induced assembly of a disheveled (Dvl)-Rho complex. This protein also promotes the nucleation and elongation of new actin filaments and regulates cell growth through the stabilization of microtubules. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2012]	Cell motility, adhesion, cytokinesis, and other functions of the cell cortex are mediated by reorganization of the actin cytoskeleton and several formin homology (FH) proteins have been associated with these processes. The protein encoded by this gene contains two FH domains and belongs to a novel FH protein subfamily implicated in cell polarity. A key regulator of cytoskeletal architecture, the small GTPase Rho, is activated during development by Wnt/Fz signaling to control cell polarity and movement. The protein encoded by this gene is thought to function as a scaffolding protein for the Wnt-induced assembly of a disheveled (Dvl)-Rho complex. This protein also promotes the nucleation and elongation of new actin filaments and regulates cell growth through the stabilization of microtubules. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2012]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Inconclusive, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0016043 GO:0016055 GO:0016055 GO:0016055 GO:0030036 GO:0030036 GO:0030036 GO:0060071 GO:0060071 GO:0060071
ADRA1A 	ADRA1A (Adrenoceptor Alpha 1A) is a Protein Coding gene. Diseases associated with ADRA1A include  Ureterolithiasis Priapism ADRA1B	Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1A-adrenergic receptor. Alternative splicing of this gene generates four transcript variants, which encode four different isoforms with distinct C-termini but having similar ligand binding properties. Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1A-adrenergic receptor. Alternative splicing of this gene generates four transcript variants, which encode four different isoforms with distinct C-termini but having similar ligand binding properties. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability in ovarian lineage, Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Increased HPV16-GFP infection, Increased viability, 	GO:0000165 GO:0001985 GO:0001985 GO:0001985 GO:0001994 GO:0001994 GO:0001994 GO:0001996 GO:0001996 GO:0001996
HES5 	HES5 (Hes Family BHLH Transcription Factor 5) is a Protein Coding gene. Diseases associated with HES5 include  HES1	This gene encodes a member of a family of basic helix-loop-helix transcriptional repressors. The protein product of this gene, which is activated downstream of the Notch pathway, regulates cell differentiation in multiple tissues. Disruptions in the normal expression of this gene have been associated with developmental diseases and cancer. [provided by RefSeq, Dec 2008]	This gene encodes a member of a family of basic helix-loop-helix transcriptional repressors. The protein product of this gene, which is activated downstream of the Notch pathway, regulates cell differentiation in multiple tissues. Disruptions in the normal expression of this gene have been associated with developmental diseases and cancer. [provided by RefSeq, Dec 2008]	shRNA abundance &lt;= 50%, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased IL-8 secretion, Negative genetic interaction between BLM-/- and BLM+/+, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0000122 GO:0002062 GO:0002062 GO:0002062 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
YAP1 	YAP1 (Yes1 Associated Transcriptional Regulator) is a Protein Coding gene. Diseases associated with YAP1 include  WWTR1	This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2013]	This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2013]	no effect, Decreased ionizing radiation sensitivity, Decreased viability, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Decreased POU5F1-GFP protein expression, Increased shRNA abundance (Z-score &gt; 2), Increased viability with SS1P at EC90, Decreased viability of wild-type and TP53 knockout cells, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased OCT4 protein expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased NANOG protein expression, 	GO:0000122
DIXDC1 	DIXDC1 (DIX Domain Containing 1) is a Protein Coding gene. Diseases associated with DIXDC1 include  DVL1	The protein encoded by this gene is a positive regulator of the Wnt signaling pathway. The encoded protein is found associated with gamma tubulin at the centrosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2013]	The protein encoded by this gene is a positive regulator of the Wnt signaling pathway. The encoded protein is found associated with gamma tubulin at the centrosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2013]	Synthetic lethal with Ras, Decreased NF-kappaB reporter expression, 	 
PTGS2 	PTGS2 (Prostaglandin-Endoperoxide Synthase 2) is a Protein Coding gene. Diseases associated with PTGS2 include  Bursitis PTGS1	Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009]	Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009]	Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Increased Nanog expression, Inconclusive, Polylobed nuclei, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001516
GALNT3 	GALNT3 (Polypeptide N-Acetylgalactosaminyltransferase 3) is a Protein Coding gene. Diseases associated with GALNT3 include  Hyperphosphatemia GALNT6	This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases.  The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases.  The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Increased homologous recombination repair frequency, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0005975 GO:0006486 GO:0006493 GO:0006493 GO:0006493
ZFP36 	ZFP36 (ZFP36 Ring Finger Protein) is a Protein Coding gene. Diseases associated with ZFP36 include  ZFP36L2	Enables several functions, including 14-3-3 protein binding activity; heat shock protein binding activity; and mRNA 3\'-UTR AU-rich region binding activity. Involved in several processes, including cellular response to cytokine stimulus; cellular response to growth factor stimulus; and regulation of gene expression. Acts upstream of or within mRNA catabolic process. Located in cytoplasmic ribonucleoprotein granule; cytosol; and nucleus. Part of ribonucleoprotein complex. Colocalizes with RISC-loading complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including 14-3-3 protein binding activity; heat shock protein binding activity; and mRNA 3\'-UTR AU-rich region binding activity. Involved in several processes, including cellular response to cytokine stimulus; cellular response to growth factor stimulus; and regulation of gene expression. Acts upstream of or within mRNA catabolic process. Located in cytoplasmic ribonucleoprotein granule; cytosol; and nucleus. Part of ribonucleoprotein complex. Colocalizes with RISC-loading complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased Nanog expression, Decreased POU5F1-GFP protein expression, Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased hepcidin::fluc mRNA expression, Decreased OCT4 protein expression, Decreased NANOG protein expression, 	GO:0000122 GO:0000165 GO:0000288 GO:0000288 GO:0000288 GO:0000289
ITGA4 	ITGA4 (Integrin Subunit Alpha 4) is a Protein Coding gene. Diseases associated with ITGA4 include  ITGA9	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn\'s disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn\'s disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Large nuclei, Decreased Salmonella-containing vacuole maturation, 	GO:0002687 GO:0003366 GO:0003366 GO:0003366 GO:0007155 GO:0007159 GO:0007159 GO:0007159 GO:0007160
STK24 	STK24 (Serine/Threonine Kinase 24) is a Protein Coding gene. Diseases associated with STK24 include  STK26	This gene encodes a serine/threonine protein kinase that functions upstream of mitogen-activated protein kinase (MAPK) signaling. The encoded protein is cleaved into two chains by caspases; the N-terminal fragment (MST3/N) translocates to the nucleus and promotes programmed cells death. There is a pseudogene for this gene on chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]	This gene encodes a serine/threonine protein kinase that functions upstream of mitogen-activated protein kinase (MAPK) signaling. The encoded protein is cleaved into two chains by caspases; the N-terminal fragment (MST3/N) translocates to the nucleus and promotes programmed cells death. There is a pseudogene for this gene on chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, No cells, Negative genetic interaction between BLM-/- and BLM+/+, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased Hepatitis C virus replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006468 GO:0006915 GO:0007165 GO:0007165 GO:0007165 GO:0008631 GO:0009267
ID1 	ID1 (Inhibitor Of DNA Binding 1) is a Protein Coding gene. Diseases associated with ID1 include  Hemangioma ID4	The protein encoded by this gene is a helix-loop-helix (HLH) protein that can form heterodimers with members of the basic HLH family of transcription factors. The encoded protein has no DNA binding activity and therefore can inhibit the DNA binding and transcriptional activation ability of basic HLH proteins with which it interacts. This protein may play a role in cell growth, senescence, and differentiation. Two transcript variants encoding different isoforms have been found for this gene. The protein encoded by this gene is a helix-loop-helix (HLH) protein that can form heterodimers with members of the basic HLH family of transcription factors. The encoded protein has no DNA binding activity and therefore can inhibit the DNA binding and transcriptional activation ability of basic HLH proteins with which it interacts. This protein may play a role in cell growth, senescence, and differentiation. Two transcript variants encoding different isoforms have been found for this gene. no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0000122 GO:0001525 GO:0007179 GO:0007420 GO:0010621 GO:0010621 GO:0010621
EPS15 	EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15) is a Protein Coding gene. Diseases associated with EPS15 include  Vaccinia EPS15L1	This gene encodes a protein that is part of the EGFR pathway. The protein is present at clatherin-coated pits and is involved in receptor-mediated endocytosis of EGF. Notably, this gene is rearranged with the HRX/ALL/MLL gene in acute myelogeneous leukemias. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2009]	This gene encodes a protein that is part of the EGFR pathway. The protein is present at clatherin-coated pits and is involved in receptor-mediated endocytosis of EGF. Notably, this gene is rearranged with the HRX/ALL/MLL gene in acute myelogeneous leukemias. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability with TRAIL, 	GO:0006895 GO:0006897 GO:0015031 GO:0016050 GO:0016050 GO:0016050 GO:0016197
CIB1 	CIB1 (Calcium And Integrin Binding 1) is a Protein Coding gene. Diseases associated with CIB1 include  CIB4	This gene encodes a member of the EF-hand domain-containing calcium-binding superfamily. The encoded protein interacts with many other proteins, including the platelet integrin alpha-IIb-beta-3, DNA-dependent protein kinase, presenilin-2, focal adhesion kinase, p21 activated kinase, and protein kinase D. The encoded protein may be involved in cell survival and proliferation, and is associated with several disease states including cancer and Alzheimer\'s disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]	This gene encodes a member of the EF-hand domain-containing calcium-binding superfamily. The encoded protein interacts with many other proteins, including the platelet integrin alpha-IIb-beta-3, DNA-dependent protein kinase, presenilin-2, focal adhesion kinase, p21 activated kinase, and protein kinase D. The encoded protein may be involved in cell survival and proliferation, and is associated with several disease states including cancer and Alzheimer\'s disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability ratio, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	 
HTRA1 	HTRA1 (HtrA Serine Peptidase 1) is a Protein Coding gene. Diseases associated with HTRA1 include  HTRA3	This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Downregulation of Wnt pathway after Wnt3A stimulation, Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0001890 GO:0006508 GO:0006508 GO:0006508 GO:0012501 GO:0012501 GO:0012501
NAB2 	NAB2 (NGFI-A Binding Protein 2) is a Protein Coding gene. Diseases associated with NAB2 include  NAB1	This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance, 	GO:0001958 GO:0006351 GO:0006351 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0014037 GO:0016480 GO:0016480 GO:0016480
MSX1 	MSX1 (Msh Homeobox 1) is a Protein Coding gene. Diseases associated with MSX1 include  MSX2	This gene encodes a member of the muscle segment homeobox gene family. The encoded protein functions as a transcriptional repressor during embryogenesis through interactions with components of the core transcription complex and other homeoproteins. It may also have roles in limb-pattern formation, craniofacial development, particularly odontogenesis, and tumor growth inhibition. Mutations in this gene, which was once known as homeobox 7, have been associated with nonsyndromic cleft lip with or without cleft palate 5, Witkop syndrome, Wolf-Hirschom syndrome, and autosomoal dominant hypodontia. This gene encodes a member of the muscle segment homeobox gene family. The encoded protein functions as a transcriptional repressor during embryogenesis through interactions with components of the core transcription complex and other homeoproteins. It may also have roles in limb-pattern formation, craniofacial development, particularly odontogenesis, and tumor growth inhibition. Mutations in this gene, which was once known as homeobox 7, have been associated with nonsyndromic cleft lip with or without cleft palate 5, Witkop syndrome, Wolf-Hirschom syndrome, and autosomoal dominant hypodontia. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased replication of vaccinia virus (VACV), Decreased focal adhesion (FA) abundance, increased peripheral FA formation, Decreased cell migration, 	GO:0000122 GO:0000902 GO:0000902 GO:0000902
TNS1 	TNS1 (Tensin 1) is a Protein Coding gene. Diseases associated with TNS1 include  TNS3	The protein encoded by this gene localizes to focal adhesions, regions of the plasma membrane where the cell attaches to the extracellular matrix. This protein crosslinks actin filaments and contains a Src homology 2 (SH2) domain, which is often found in molecules involved in signal transduction. This protein is a substrate of calpain II. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]	The protein encoded by this gene localizes to focal adhesions, regions of the plasma membrane where the cell attaches to the extracellular matrix. This protein crosslinks actin filaments and contains a Src homology 2 (SH2) domain, which is often found in molecules involved in signal transduction. This protein is a substrate of calpain II. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased HPV16-GFP infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Downregulation of Wnt pathway after Wnt3A stimulation, Large nuclei, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased mitotic index, 	GO:0010761
SKIL 	SKIL (SKI Like Proto-Oncogene) is a Protein Coding gene. Diseases associated with SKIL include  SKI	The protein encoded by this gene is a component of the SMAD pathway, which regulates cell growth and differentiation through transforming growth factor-beta (TGFB). In the absence of ligand, the encoded protein binds to the promoter region of TGFB-responsive genes and recruits a nuclear repressor complex. TGFB signaling causes SMAD3 to enter the nucleus and degrade this protein, allowing these genes to be activated. Four transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	The protein encoded by this gene is a component of the SMAD pathway, which regulates cell growth and differentiation through transforming growth factor-beta (TGFB). In the absence of ligand, the encoded protein binds to the promoter region of TGFB-responsive genes and recruits a nuclear repressor complex. TGFB signaling causes SMAD3 to enter the nucleus and degrade this protein, allowing these genes to be activated. Four transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in colon lineage, Decreased viability after Maraba virus infection, Increased Nanog expression, Decreased HPV16-GFP infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), 	 
PREX1 	PREX1 (Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1) is a Protein Coding gene. Diseases associated with PREX1 include  PREX2	The protein encoded by this gene acts as a guanine nucleotide exchange factor for the RHO family of small GTP-binding proteins (RACs).  It has been shown to bind to and activate RAC1 by exchanging bound GDP for free GTP. The encoded protein, which is found mainly in the cytoplasm, is activated by phosphatidylinositol-3,4,5-trisphosphate and the beta-gamma subunits of heterotrimeric G proteins. The protein encoded by this gene acts as a guanine nucleotide exchange factor for the RHO family of small GTP-binding proteins (RACs).  It has been shown to bind to and activate RAC1 by exchanging bound GDP for free GTP. The encoded protein, which is found mainly in the cytoplasm, is activated by phosphatidylinositol-3,4,5-trisphosphate and the beta-gamma subunits of heterotrimeric G proteins. Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Increased G1 DNA content, Increased homologous recombination repair frequency, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0006801 GO:0007186 GO:0030041 GO:0030041 GO:0030041
CRK 	CRK (CRK Proto-Oncogene, Adaptor Protein) is a Protein Coding gene. Diseases associated with CRK include  Sarcoma CRKL	This gene encodes a member of an adapter protein family that binds to several tyrosine-phosphorylated proteins. The product of this gene has several SH2 and SH3 domains (src-homology domains) and is involved in several signaling pathways, recruiting cytoplasmic proteins in the vicinity of tyrosine kinase through SH2-phosphotyrosine interaction. The N-terminal SH2 domain of this protein functions as a positive regulator of transformation whereas the C-terminal SH3 domain functions as a negative regulator of transformation. Two alternative transcripts encoding different isoforms with distinct biological activity have been described. This gene encodes a member of an adapter protein family that binds to several tyrosine-phosphorylated proteins. The product of this gene has several SH2 and SH3 domains (src-homology domains) and is involved in several signaling pathways, recruiting cytoplasmic proteins in the vicinity of tyrosine kinase through SH2-phosphotyrosine interaction. The N-terminal SH2 domain of this protein functions as a positive regulator of transformation whereas the C-terminal SH3 domain functions as a negative regulator of transformation. Two alternative transcripts encoding different isoforms with distinct biological activity have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Decreased viability in ovarian lineage, Decreased cell number, Increased shRNA abundance (Z-score &gt; 2), Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	GO:0001764 GO:0001878 GO:0001878 GO:0001878 GO:0002685 GO:0002685 GO:0002685 GO:0006357 GO:0006357 GO:0006357
NPTX1 	NPTX1 (Neuronal Pentraxin 1) is a Protein Coding gene. Diseases associated with NPTX1 include  NPTX2	NPTX1 is a member of the neuronal pentraxin gene family. Neuronal pentraxin 1 is similar to the rat NP1 gene which encodes a binding protein for the snake venom toxin taipoxin. Human NPTX1 mRNA is exclusively localized to the nervous system. NPTX1 is a member of the neuronal pentraxin gene family. Neuronal pentraxin 1 is similar to the rat NP1 gene which encodes a binding protein for the snake venom toxin taipoxin. Human NPTX1 mRNA is exclusively localized to the nervous system. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, 	GO:0006839 GO:0007268 GO:0007268 GO:0007268 GO:0007417
MYL9 	MYL9 (Myosin Light Chain 9) is a Protein Coding gene. Diseases associated with MYL9 include  Microcolon MYL12B	Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene. Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene. no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased replication of vaccinia virus (VACV), 	GO:0006937 GO:0030239 GO:0070527
SRC 	SRC (SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with SRC include  YES1	This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. The protein encoded by this gene is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer. Two transcript variants encoding the same protein have been found for this gene. This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. The protein encoded by this gene is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer. Two transcript variants encoding the same protein have been found for this gene. no effect, Decreased viability, Paclitaxel antagonistic effect, Decreased simian virus 40 (SV40) infection, Decreased viability with paclitaxel, Decreased viability in HMC1.1 cells, Decreased viability in CMK cells, Increased telomerase activity, 	 
NID1 	NID1 (Nidogen 1) is a Protein Coding gene. Diseases associated with NID1 include  NID2	This gene encodes a member of the nidogen family of basement membrane glycoproteins. The protein interacts with several other components of basement membranes, and may play a role in cell interactions with the extracellular matrix. This gene encodes a member of the nidogen family of basement membrane glycoproteins. The protein interacts with several other components of basement membranes, and may play a role in cell interactions with the extracellular matrix. Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	 
PTPRZ1 	PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1) is a Protein Coding gene. Diseases associated with PTPRZ1 include  Glioblastoma PTPRG	This gene encodes a member of the receptor protein tyrosine phosphatase family. Expression of this gene is restricted to the central nervous system (CNS), and it may be involved in the regulation of specific developmental processes in the CNS. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]	This gene encodes a member of the receptor protein tyrosine phosphatase family. Expression of this gene is restricted to the central nervous system (CNS), and it may be involved in the regulation of specific developmental processes in the CNS. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]	no effect, shRNA abundance &lt;= 50%, Decreased viability, Increased ionizing radiation sensitivity, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased apoptosis, Decreased cell number and increased metaphase cell number, 	GO:0002244 GO:0006470 GO:0006470 GO:0006470 GO:0007409 GO:0007409 GO:0007409 GO:0007417 GO:0007417 GO:0007417
INSR 	INSR (Insulin Receptor) is a Protein Coding gene. Diseases associated with INSR include  IGF1R	This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell death in HCC-1954 cells, Decreased substrate adherent cell growth, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell viability after pRB stimulation, Paclitaxel antagonistic effect, Decreased viability in HMC1.1 cells, 	GO:0001934 GO:0002092 GO:0003007 GO:0005975 GO:0006355 GO:0006355 GO:0006355
KRAS 	KRAS (KRAS Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with KRAS include  NRAS	This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. Decreased viability, Increased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased replication of vaccinia virus (VACV), Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased shRNA abundance, Decreased viability in colon lineage; decreased viability in pancreas lineage, 	GO:0000165 GO:0001934 GO:0001934 GO:0001934 GO:0007165 GO:0007265 GO:0007265 GO:0007265
ARHGEF11 	ARHGEF11 (Rho Guanine Nucleotide Exchange Factor 11) is a Protein Coding gene. Diseases associated with ARHGEF11 include  ARHGEF12	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. A similar protein in rat interacts with glutamate transporter EAAT4 and modulates its glutamate transport activity. Expression of the rat protein induces the reorganization of the actin cytoskeleton and its overexpression induces the formation of membrane ruffling and filopodia. Two alternative transcripts encoding different isoforms have been described. Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. A similar protein in rat interacts with glutamate transporter EAAT4 and modulates its glutamate transport activity. Expression of the rat protein induces the reorganization of the actin cytoskeleton and its overexpression induces the formation of membrane ruffling and filopodia. Two alternative transcripts encoding different isoforms have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased melanin production, Decreased viability (cell death), Decreased cell migration, Polylobed nuclei, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001558 GO:0006941 GO:0007186 GO:0007266 GO:0030010
XIAP 	XIAP (X-Linked Inhibitor Of Apoptosis) is a Protein Coding gene. Diseases associated with XIAP include  BIRC3	This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]	This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Increased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Decreased influenza A virus infection, Increased cell death in HCT116 cells, Decreased HIV-1 infection, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Increased cilium length after serum starvation, Increased cilium length, 	GO:0006915 GO:0006974 GO:0006974 GO:0006974 GO:0010466 GO:0010804 GO:0010804 GO:0010804
EZH2 	EZH2 (Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit) is a Protein Coding gene. Diseases associated with EZH2 include  Lymphoma EZH1	This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011]	This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Increased ionizing radiation sensitivity, Increased hepcidin::fluc mRNA expression, Increased shRNA abundance (Z-score &gt; 2), 	GO:0000082 GO:0000122 GO:0000122 GO:0000122
MAST1 	MAST1 (Microtubule Associated Serine/Threonine Kinase 1) is a Protein Coding gene. Diseases associated with MAST1 include  MAST2	This gene is a member of the microtubule-associated serine/threonine kinase (MAST) family. The protein encoded by this gene has an N-terminal serine/threonine kinase domain followed by a postsynaptic density protein-95/discs large/zona occludens-1 (PDZ) domain. In mouse and rat, the orthologous protein associates with the cytoskeleton and can bind both beta-2-syntrophin and neuronal nitric oxide synthase (nNOS) through its PDZ domain. In mouse and rat, this protein also co-localizes with dystrophin- and utrophin-associated protein complexes (DAPC/UAPC) in the vascular endothelium of the central nervous system. [provided by RefSeq, May 2017]	This gene is a member of the microtubule-associated serine/threonine kinase (MAST) family. The protein encoded by this gene has an N-terminal serine/threonine kinase domain followed by a postsynaptic density protein-95/discs large/zona occludens-1 (PDZ) domain. In mouse and rat, the orthologous protein associates with the cytoskeleton and can bind both beta-2-syntrophin and neuronal nitric oxide synthase (nNOS) through its PDZ domain. In mouse and rat, this protein also co-localizes with dystrophin- and utrophin-associated protein complexes (DAPC/UAPC) in the vascular endothelium of the central nervous system. [provided by RefSeq, May 2017]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, shRNA abundance &lt;= 25%, Decreased substrate adherent cell growth, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Nanog expression, Decreased homologous recombination repair frequency, Moderately decreased NFAT1-GFP nuclear translocation, Elongated cells, Condensed cis-Golgi, condensed medial Golgi, 	GO:0006468 GO:0007010 GO:0007010 GO:0007010 GO:0007420 GO:0007420 GO:0007420 GO:0016310 GO:0018105 GO:0018105 GO:0018105
FRS2 	FRS2 (Fibroblast Growth Factor Receptor Substrate 2) is a Protein Coding gene. Diseases associated with FRS2 include  Liposarcoma FRS3	Enables fibroblast growth factor receptor binding activity and neurotrophin TRKA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within fibroblast growth factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	Enables fibroblast growth factor receptor binding activity and neurotrophin TRKA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within fibroblast growth factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased vesicular stomatitis virus (VSV) infection, Decreased lymphocytic choriomeningitis virus (LCMV) infection, 	 
SASH1 	SASH1 (SAM And SH3 Domain Containing 1) is a Protein Coding gene. Diseases associated with SASH1 include  SASH3	This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016]	This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased NF-kappaB reporter expression, 	GO:0000209 GO:0010595 GO:0010632 GO:0031666 GO:0043507
RAPGEF2 	RAPGEF2 (Rap Guanine Nucleotide Exchange Factor 2) is a Protein Coding gene. Diseases associated with RAPGEF2 include  RAPGEF6	Members of the RAS (see HRAS; MIM 190020) subfamily of GTPases function in signal transduction as GTP/GDP-regulated switches that cycle between inactive GDP- and active GTP-bound states. Guanine nucleotide exchange factors (GEFs), such as RAPGEF2, serve as RAS activators by promoting acquisition of GTP to maintain the active GTP-bound state and are the key link between cell surface receptors and RAS activation (Rebhun et al., 2000 [PubMed 10934204]).[supplied by OMIM, Mar 2008]	Members of the RAS (see HRAS; MIM 190020) subfamily of GTPases function in signal transduction as GTP/GDP-regulated switches that cycle between inactive GDP- and active GTP-bound states. Guanine nucleotide exchange factors (GEFs), such as RAPGEF2, serve as RAS activators by promoting acquisition of GTP to maintain the active GTP-bound state and are the key link between cell surface receptors and RAS activation (Rebhun et al., 2000 [PubMed 10934204]).[supplied by OMIM, Mar 2008]	Decreased viability, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased cell migration, Altered focal adhesion (FA) or cell shape morphology, 	GO:0000165
PPP1R14A 	PPP1R14A (Protein Phosphatase 1 Regulatory Inhibitor Subunit 14A) is a Protein Coding gene. Diseases associated with PPP1R14A include  PPP1R14C	The protein encoded by this gene belongs to the protein phosphatase 1 (PP1) inhibitor family. This protein is an inhibitor of smooth muscle myosin phosphatase, and has higher inhibitory activity when phosphorylated. Inhibition of myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Sep 2011]	The protein encoded by this gene belongs to the protein phosphatase 1 (PP1) inhibitor family. This protein is an inhibitor of smooth muscle myosin phosphatase, and has higher inhibitory activity when phosphorylated. Inhibition of myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Increased hepcidin::fluc mRNA expression, Increased cell number in G2M, increased nuclei size in G2M, 	 
THBD 	THBD (Thrombomodulin) is a Protein Coding gene. Diseases associated with THBD include 	The protein encoded by this intronless gene is an endothelial-specific type I membrane receptor that binds thrombin. This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations in this gene are a cause of thromboembolic disease, also known as inherited thrombophilia. The protein encoded by this intronless gene is an endothelial-specific type I membrane receptor that binds thrombin. This binding results in the activation of protein C, which degrades clotting factors Va and VIIIa and reduces the amount of thrombin generated. Mutations in this gene are a cause of thromboembolic disease, also known as inherited thrombophilia. Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, Increased cell number in G1, small nuclei in G1, 	GO:0006508 GO:0007565 GO:0007596 GO:0007596 GO:0007596
SPRY4 	SPRY4 (Sprouty RTK Signaling Antagonist 4) is a Protein Coding gene. Diseases associated with SPRY4 include  SPRY1	This gene encodes a member of a family of cysteine- and proline-rich proteins. The encoded protein is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. Activity of this protein impairs the formation of active GTP-RAS. Nucleotide variation in this gene has been associated with hypogonadotropic hypogonadism 17 with or without anosmia. Alternative splicing results in a multiple transcript variants. [provided by RefSeq, Jun 2014]	This gene encodes a member of a family of cysteine- and proline-rich proteins. The encoded protein is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. Activity of this protein impairs the formation of active GTP-RAS. Nucleotide variation in this gene has been associated with hypogonadotropic hypogonadism 17 with or without anosmia. Alternative splicing results in a multiple transcript variants. [provided by RefSeq, Jun 2014]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007275 GO:0009966 GO:0009966 GO:0009966 GO:0040037 GO:0040037 GO:0040037 GO:0043407 GO:0046580
MIF 	MIF (Macrophage Migration Inhibitory Factor) is a Protein Coding gene. Diseases associated with MIF include  DDT	This gene encodes a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation. It plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. This gene encodes a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation. It plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Dynamic nuclei (hole, folded or small irregular), Decreased shRNA abundance (Z-score &lt; -2), Proliferating cells, 	GO:0001516 GO:0001819
RUNX2 	RUNX2 (RUNX Family Transcription Factor 2) is a Protein Coding gene. Diseases associated with RUNX2 include  RUNX1	This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased epidermal growth factor (EGF) endocytosis, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Inconclusive, Increased caspase activity, 	GO:0001501 GO:0001503 GO:0001503 GO:0001503 GO:0001649
SDC1 	SDC1 (Syndecan 1) is a Protein Coding gene. Diseases associated with SDC1 include  Endometritis SDC3	The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. Altered syndecan-1 expression has been detected in several different tumor types. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same protein. The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. Altered syndecan-1 expression has been detected in several different tumor types. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same protein. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in ovarian lineage, Decreased HIV-LTR-beta-galactosidase protein expression, Decreased cell migration, 	 
ZNF703 	ZNF703 (Zinc Finger Protein 703) is a Protein Coding gene. Diseases associated with ZNF703 include  ZNF503	Predicted to enable DNA-binding transcription factor binding activity. Involved in several processes, including cellular response to estradiol stimulus; mammary gland epithelial cell differentiation; and positive regulation of mammary gland epithelial cell proliferation. Located in cytoplasm and nuclear matrix. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable DNA-binding transcription factor binding activity. Involved in several processes, including cellular response to estradiol stimulus; mammary gland epithelial cell differentiation; and positive regulation of mammary gland epithelial cell proliferation. Located in cytoplasm and nuclear matrix. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]	Mitotic spindle defects, Decreased viability, no effect, Increased transferrin (TF) endocytosis, Increased Nanog expression, Decreased NF-kappaB reporter expression, Strongly decreased NFAT1-GFP nuclear translocation, 	GO:0006355 GO:0008284 GO:0010718 GO:0017015 GO:0017015 GO:0017015
BCL2 	BCL2 (BCL2 Apoptosis Regulator) is a Protein Coding gene. Diseases associated with BCL2 include  BCL2L1	This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability (cell death), 	GO:0000082 GO:0000209 GO:0000209 GO:0000209
STMN1 	STMN1 (Stathmin 1) is a Protein Coding gene. Diseases associated with STMN1 include  Leukemia STMN2	This gene belongs to the stathmin family of genes. It encodes a ubiquitous cytosolic phosphoprotein proposed to function as an intracellular relay integrating regulatory signals of the cellular environment. The encoded protein is involved in the regulation of the microtubule filament system by destabilizing microtubules. It prevents assembly and promotes disassembly of microtubules. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]	This gene belongs to the stathmin family of genes. It encodes a ubiquitous cytosolic phosphoprotein proposed to function as an intracellular relay integrating regulatory signals of the cellular environment. The encoded protein is involved in the regulation of the microtubule filament system by destabilizing microtubules. It prevents assembly and promotes disassembly of microtubules. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]	no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0000281 GO:0007019 GO:0007052 GO:0007165
EPO 	EPO (Erythropoietin) is a Protein Coding gene. Diseases associated with EPO include 	This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. [provided by RefSeq, Aug 2017]	This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0000122
TMEM30A 	TMEM30A (Transmembrane Protein 30A) is a Protein Coding gene. Diseases associated with TMEM30A include  TMEM30B	Enables aminophospholipid flippase activity. Involved in several processes, including phospholipid transport; positive regulation of transport; and xenobiotic transmembrane transport. Located in endoplasmic reticulum and plasma membrane. Part of phospholipid-translocating ATPase complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables aminophospholipid flippase activity. Involved in several processes, including phospholipid transport; positive regulation of transport; and xenobiotic transmembrane transport. Located in endoplasmic reticulum and plasma membrane. Part of phospholipid-translocating ATPase complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance, 	GO:0006855 GO:0006869 GO:0010976 GO:0010976 GO:0010976 GO:0015914 GO:0015914 GO:0015914 GO:0015917 GO:0015917 GO:0015917
PGK1 	PGK1 (Phosphoglycerate Kinase 1) is a Protein Coding gene. Diseases associated with PGK1 include  PGK2	The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]	The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased vesicular stomatitis virus (VSV) infection, Increased epidermal growth factor (EGF) endocytosis, Decreased shRNA abundance, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased simian virus 40 (SV40) infection, Increased viability, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006094 GO:0006096 GO:0016310 GO:0016525 GO:0016525 GO:0016525 GO:0030855
JAK2 	JAK2 (Janus Kinase 2) is a Protein Coding gene. Diseases associated with JAK2 include  JAK3	This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.  This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.  no effect, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Wnt reporter downregulated, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased IL-8 secretion, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Decreased telomerase activity, Increased cell number in G1, small nuclei in G1, 	 
BMPR1B 	BMPR1B (Bone Morphogenetic Protein Receptor Type 1B) is a Protein Coding gene. Diseases associated with BMPR1B include  BMPR1A	This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]	This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Increased transferrin (TF) endocytosis, Decreased substrate adherent cell growth, Increased viability (proliferation), Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased viability, Increased shRNA abundance, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased S DNA content, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased simian virus 40 (SV40) infection, Diffuse trans-Golgi, 	GO:0001502 GO:0001550 GO:0001550 GO:0001550 GO:0001649 GO:0001649 GO:0001649
PJA1 	PJA1 (Praja Ring Finger Ubiquitin Ligase 1) is a Protein Coding gene. Diseases associated with PJA1 include  PJA2	This gene encodes an enzyme that has E2-dependent E3 ubiquitin-protein ligase activity. This enzyme belongs to a class of ubiquitin ligases that include a RING finger motif, and it can interact with the E2 ubiquitin-conjugating enzyme UbcH5B. This gene is located in an area of chromosome X where several X-linked cognitive disability disorders have been associated, and it has also been found as part of a contiguous gene deletion associated with craniofrontonasal syndrome, though a direct link to any disorder has yet to be demonstrated. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]	This gene encodes an enzyme that has E2-dependent E3 ubiquitin-protein ligase activity. This enzyme belongs to a class of ubiquitin ligases that include a RING finger motif, and it can interact with the E2 ubiquitin-conjugating enzyme UbcH5B. This gene is located in an area of chromosome X where several X-linked cognitive disability disorders have been associated, and it has also been found as part of a contiguous gene deletion associated with craniofrontonasal syndrome, though a direct link to any disorder has yet to be demonstrated. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]	no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability with paclitaxel, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Moderately decreased NFAT1-GFP nuclear translocation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	 
COL5A1 	COL5A1 (Collagen Type V Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL5A1 include  COL11A1	This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]	This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Decreased HIV-1 infection, 	GO:0001568 GO:0003007 GO:0003007 GO:0003007 GO:0007155 GO:0007155 GO:0007155 GO:0016477 GO:0030198
TAL1 	TAL1 (TAL BHLH Transcription Factor 1, Erythroid Differentiation Factor) is a Protein Coding gene. Diseases associated with TAL1 include  LYL1	Enables several functions, including DNA-binding transcription factor activity; E-box binding activity; and histone deacetylase binding activity. Involved in several processes, including myeloid cell differentiation; positive regulation of cellular component organization; and positive regulation of erythrocyte differentiation. Located in chromatin and nucleoplasm. Part of transcription regulator complex. Implicated in acute lymphoblastic leukemia. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including DNA-binding transcription factor activity; E-box binding activity; and histone deacetylase binding activity. Involved in several processes, including myeloid cell differentiation; positive regulation of cellular component organization; and positive regulation of erythrocyte differentiation. Located in chromatin and nucleoplasm. Part of transcription regulator complex. Implicated in acute lymphoblastic leukemia. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), 	 
TEK 	TEK (TEK Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with TEK include  TIE1	This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]	This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Increased mitotic index, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased viability after gemcitabine stimulation, 	GO:0001525 GO:0001934 GO:0001934 GO:0001934 GO:0001935 GO:0001938 GO:0001938 GO:0001938 GO:0002040
IQSEC1 	IQSEC1 (IQ Motif And Sec7 Domain ArfGEF 1) is a Protein Coding gene. Diseases associated with IQSEC1 include  IQSEC2	Predicted to enable protein kinase binding activity. Predicted to be involved in several processes, including positive regulation of focal adhesion disassembly; positive regulation of keratinocyte migration; and regulation of postsynaptic neurotransmitter receptor internalization. Located in nucleolus. Implicated in intellectual developmental disorder with short stature and behavioral abnormalities. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable protein kinase binding activity. Predicted to be involved in several processes, including positive regulation of focal adhesion disassembly; positive regulation of keratinocyte migration; and regulation of postsynaptic neurotransmitter receptor internalization. Located in nucleolus. Implicated in intellectual developmental disorder with short stature and behavioral abnormalities. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability, Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Increased cell size, Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased influenza A virus infection, Increased G2M DNA content, Increased caspase activity, 	GO:0030036
PDPK1 	PDPK1 (3-Phosphoinositide Dependent Protein Kinase 1) is a Protein Coding gene. Diseases associated with PDPK1 include  AKT3	Enables 3-phosphoinositide-dependent protein kinase activity; phospholipase activator activity; and phospholipase binding activity. Involved in several processes, including cell surface receptor signaling pathway; regulation of protein kinase activity; and regulation of signal transduction. Acts upstream of or within intracellular signal transduction. Located in cell projection; cytosol; and plasma membrane. Implicated in prostate cancer. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	Enables 3-phosphoinositide-dependent protein kinase activity; phospholipase activator activity; and phospholipase binding activity. Involved in several processes, including cell surface receptor signaling pathway; regulation of protein kinase activity; and regulation of signal transduction. Acts upstream of or within intracellular signal transduction. Located in cell projection; cytosol; and plasma membrane. Implicated in prostate cancer. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Decreased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased cell viability after pRB stimulation, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, toxic, 	GO:0003323 GO:0006468 GO:0006468 GO:0006468 GO:0006469 GO:0006972 GO:0007173 GO:0007173 GO:0007173
YY1 	YY1 (YY1 Transcription Factor) is a Protein Coding gene. Diseases associated with YY1 include  Insulinoma YY2	YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. The protein is involved in repressing and activating a diverse number of promoters.  YY1 may direct histone deacetylases and histone acetyltransferases to a promoter in order to activate or repress the promoter, thus implicating histone modification in the function of YY1. YY1 is a ubiquitously distributed transcription factor belonging to the GLI-Kruppel class of zinc finger proteins. The protein is involved in repressing and activating a diverse number of promoters.  YY1 may direct histone deacetylases and histone acetyltransferases to a promoter in order to activate or repress the promoter, thus implicating histone modification in the function of YY1. Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Increased Nanog expression, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased Aire reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Decreased OCT4 protein expression, Decreased NANOG protein expression, Increased epidermal growth factor (EGF) endosome number, increased epidermal growth factor (EGF) endosome elongation, 	GO:0000122 GO:0000723 GO:0000724 GO:0000724 GO:0000724 GO:0006275
PKD1 	PKD1 (Polycystin 1, Transient Receptor Potential Channel Interacting) is a Protein Coding gene. Diseases associated with PKD1 include  PKD1L1	This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]	This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased NF-kappaB reporter expression, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability, Decreased cell migration, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, increased cell elongation, 	 
HMGA2 	HMGA2 (High Mobility Group AT-Hook 2) is a Protein Coding gene. Diseases associated with HMGA2 include 	This gene encodes a protein that belongs to the non-histone chromosomal high mobility group (HMG) protein family. HMG proteins function as architectural factors and are essential components of the enhancesome. This protein contains structural DNA-binding domains and may act as a transcriptional regulating factor. Identification of the deletion, amplification, and rearrangement of this gene that are associated with myxoid liposarcoma suggests a role in adipogenesis and mesenchymal differentiation. A gene knock out study of the mouse counterpart demonstrated that this gene is involved in diet-induced obesity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene encodes a protein that belongs to the non-histone chromosomal high mobility group (HMG) protein family. HMG proteins function as architectural factors and are essential components of the enhancesome. This protein contains structural DNA-binding domains and may act as a transcriptional regulating factor. Identification of the deletion, amplification, and rearrangement of this gene that are associated with myxoid liposarcoma suggests a role in adipogenesis and mesenchymal differentiation. A gene knock out study of the mouse counterpart demonstrated that this gene is involved in diet-induced obesity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased Nanog expression, Increased HPV18 LCR reporter activity, Decreased CDKN1A mRNA expression, Decreased viability, Decreased TP53 mRNA expression, 	GO:0000122 GO:0001837 GO:0002062 GO:0003131 GO:0006284
COL4A3 	COL4A3 (Collagen Type IV Alpha 3 Chain) is a Protein Coding gene. Diseases associated with COL4A3 include  COL5A1	Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]	Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased hepcidin::fluc mRNA expression, 	GO:0006919 GO:0007155 GO:0007166 GO:0007166 GO:0007166 GO:0007605 GO:0008015
ARHGAP44 	ARHGAP44 (Rho GTPase Activating Protein 44) is a Protein Coding gene. Diseases associated with ARHGAP44 include  ARHGAP17	Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. [provided by Alliance of Genome Resources, Apr 2022]	Mitotic spindle defects, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased epidermal growth factor (EGF) endocytosis, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0006887 GO:0007165 GO:0007165 GO:0007165 GO:0032956 GO:0032956 GO:0032956 GO:0035020 GO:0035021 GO:0035021 GO:0035021
ELAVL1 	ELAVL1 (ELAV Like RNA Binding Protein 1) is a Protein Coding gene. Diseases associated with ELAVL1 include  ELAVL2	The protein encoded by this gene is a member of the ELAVL family of RNA-binding proteins that contain several RNA recognition motifs, and selectively bind AU-rich elements (AREs) found in the 3\' untranslated regions of mRNAs. AREs signal degradation of mRNAs as a means to regulate gene expression, thus by binding AREs, the ELAVL family of proteins play a role in stabilizing ARE-containing mRNAs. This gene has been implicated in a variety of biological processes and has been linked to a number of diseases, including cancer. It is highly expressed in many cancers, and could be potentially useful in cancer diagnosis, prognosis, and therapy. [provided by RefSeq, Sep 2012]	The protein encoded by this gene is a member of the ELAVL family of RNA-binding proteins that contain several RNA recognition motifs, and selectively bind AU-rich elements (AREs) found in the 3\' untranslated regions of mRNAs. AREs signal degradation of mRNAs as a means to regulate gene expression, thus by binding AREs, the ELAVL family of proteins play a role in stabilizing ARE-containing mRNAs. This gene has been implicated in a variety of biological processes and has been linked to a number of diseases, including cancer. It is highly expressed in many cancers, and could be potentially useful in cancer diagnosis, prognosis, and therapy. [provided by RefSeq, Sep 2012]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased G1 DNA content, Increased IL-8 secretion, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0006606 GO:0016441 GO:0016441 GO:0016441 GO:0045727 GO:0045727 GO:0045727 GO:0048255 GO:0051260
DLG4 	DLG4 (Discs Large MAGUK Scaffold Protein 4) is a Protein Coding gene. Diseases associated with DLG4 include  DLG1	This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Increased homologous recombination repair frequency, Decreased viability, Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Decreased telomerase activity, Decreased viability with paclitaxel, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with SS1P at EC90, 	GO:0002091 GO:0007165 GO:0007165 GO:0007165 GO:0007204 GO:0007268 GO:0007268 GO:0007268 GO:0007399
KIF3A 	KIF3A (Kinesin Family Member 3A) is a Protein Coding gene. Diseases associated with KIF3A include  KIF3B	Enables protein phosphatase binding activity; small GTPase binding activity; and spectrin binding activity. Involved in protein localization to cell junction and protein transport. Located in centriole and centrosome. Part of kinesin II complex. Colocalizes with spindle microtubule. [provided by Alliance of Genome Resources, Apr 2022]	Enables protein phosphatase binding activity; small GTPase binding activity; and spectrin binding activity. Involved in protein localization to cell junction and protein transport. Located in centriole and centrosome. Part of kinesin II complex. Colocalizes with spindle microtubule. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased G1 DNA content, G0/1 arrest, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased HIV-1 infection, 	GO:0006996 GO:0007018 GO:0008089 GO:0008089 GO:0008089 GO:0010457 GO:0015031 GO:0015031 GO:0015031
CDK1 	CDK1 (Cyclin Dependent Kinase 1) is a Protein Coding gene. Diseases associated with CDK1 include  Polyploidy Retinoblastoma CDK2	The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]	The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]	Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased viability with MLN4924 (a NAE inhibitor), Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased Nanog expression, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased G2M DNA content, FOXO1 nuclear localization, Increased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Increased cell number in G2M, increased nuclei size in G2M, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, G2 arrest, Fragmented cis-Golgi, diffuse trans-Golgi, 	GO:0000086 GO:0000226 GO:0000226 GO:0000226 GO:0000278 GO:0006260 GO:0006260 GO:0006260 GO:0006281
SH3BP5 	SH3BP5 (SH3 Domain Binding Protein 5) is a Protein Coding gene. Diseases associated with SH3BP5 include  SH3BP5L	Enables guanyl-nucleotide exchange factor activity and protein kinase inhibitor activity. Acts upstream of or within intracellular signal transduction. Located in cytoplasmic vesicle membrane and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Enables guanyl-nucleotide exchange factor activity and protein kinase inhibitor activity. Acts upstream of or within intracellular signal transduction. Located in cytoplasmic vesicle membrane and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased transferrin (TF) endocytosis, Increased HPV18 LCR reporter activity, Increased centriole number, Decreased centriole number, Upregulation of Wnt pathway, 	GO:0006469 GO:0007165 GO:0007165 GO:0007165 GO:0035556 GO:0061099
LCK 	LCK (LCK Proto-Oncogene, Src Family Tyrosine Kinase) is a Protein Coding gene. Diseases associated with LCK include  HCK	This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Aug 2016]	This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Aug 2016]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability, Decreased HPV16-GFP infection, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Effect on mitosis, decreased viability (cell death), Decreased viability (cell death), Increased apoptosis, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006468 GO:0006882 GO:0006919 GO:0007169 GO:0009410
CITED2 	CITED2 (Cbp/P300 Interacting Transactivator With Glu/Asp Rich Carboxy-Terminal Domain 2) is a Protein Coding gene. Diseases associated with CITED2 include  CITED1	The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]	The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]	no effect, Decreased viability, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased cell number in G2M, increased nuclei size in G2M, Downregulation of RLR pathway after Sendai virus (SeV) infection, Increased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0000122 GO:0001568 GO:0001570 GO:0001570 GO:0001570 GO:0001666 GO:0001666 GO:0001666
IRF3 	IRF3 (Interferon Regulatory Factor 3) is a Protein Coding gene. Diseases associated with IRF3 include  IRF5	This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes. The protein plays an important role in the innate immune response against DNA and RNA viruses. Mutations in this gene are associated with Encephalopathy, acute, infection-induced, herpes-specific, 7. [provided by RefSeq, Sep 2020]	This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes. The protein plays an important role in the innate immune response against DNA and RNA viruses. Mutations in this gene are associated with Encephalopathy, acute, infection-induced, herpes-specific, 7. [provided by RefSeq, Sep 2020]	no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased G1 DNA content, Increased shRNA abundance, Decreased interferon-beta reporter expression, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Big cells, Downregulation of RLR pathway after Sendai virus (SeV) infection, Increased Dengue infection, Increased infection with West Nile virus (WNV), Increased West Nile virus (WNV) infection, 	GO:0000122 GO:0001819 GO:0001819 GO:0001819 GO:0002376 GO:0002376 GO:0002376
NGFR 	NGFR (Nerve Growth Factor Receptor) is a Protein Coding gene. Diseases associated with NGFR include  TNFRSF1A	Nerve growth factor receptor contains an extracellular domain containing four 40-amino acid repeats with 6 cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain. Nerve growth factor receptor contains an extracellular domain containing four 40-amino acid repeats with 6 cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain. no effect, Increased number of mitotic cells, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased S DNA content, 	GO:0001678 GO:0001942 GO:0001942 GO:0001942 GO:0006886 GO:0006886 GO:0006886 GO:0006915 GO:0006915 GO:0006915 GO:0006919 GO:0006919 GO:0006919
PDE6D 	PDE6D (Phosphodiesterase 6D) is a Protein Coding gene. Diseases associated with PDE6D include 	This gene encodes the delta subunit of rod-specific photoreceptor phosphodiesterase (PDE), a key enzyme in the phototransduction cascade. A similar protein in cow functions in solubilizing membrane-bound PDE. In addition to its role in the PDE complex, the encoded protein is thought to bind to prenyl groups of proteins to target them to subcellular organelles called cilia. Mutations in this gene are associated with Joubert syndrome-22. Alternative splicing results in multiple splice variants. [provided by RefSeq, Mar 2014]	This gene encodes the delta subunit of rod-specific photoreceptor phosphodiesterase (PDE), a key enzyme in the phototransduction cascade. A similar protein in cow functions in solubilizing membrane-bound PDE. In addition to its role in the PDE complex, the encoded protein is thought to bind to prenyl groups of proteins to target them to subcellular organelles called cilia. Mutations in this gene are associated with Joubert syndrome-22. Alternative splicing results in multiple splice variants. [provided by RefSeq, Mar 2014]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance (Z-score &lt; -2), 	 
SPRY1 	SPRY1 (Sprouty RTK Signaling Antagonist 1) is a Protein Coding gene. Diseases associated with SPRY1 include  SPRY2	Involved in negative regulation of fibroblast growth factor receptor signaling pathway. Located in Golgi apparatus; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Involved in negative regulation of fibroblast growth factor receptor signaling pathway. Located in Golgi apparatus; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability ratio, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell spreading, 	 
FGG 	FGG (Fibrinogen Gamma Chain) is a Protein Coding gene. Diseases associated with FGG include  FGB	The protein encoded by this gene is the gamma component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]	The protein encoded by this gene is the gamma component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]	no effect, Decreased viability, Synthetic lethal with Ras, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007160 GO:0007596 GO:0007599 GO:0007599 GO:0007599 GO:0009306 GO:0009306 GO:0009306
KLF3 	KLF3 (KLF Transcription Factor 3) is a Protein Coding gene. Diseases associated with KLF3 include  KLF12	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, shRNA abundance &lt;= 25%, Decreased viability with paclitaxel, 	GO:0000122 GO:0006357 GO:0006357 GO:0006357 GO:0030097
PICK1 	PICK1 (Protein Interacting With PRKCA 1) is a Protein Coding gene. Diseases associated with PICK1 include  ARFIP2	The protein encoded by this gene contains a PDZ domain, through which it interacts with protein kinase C, alpha (PRKCA). This protein may function as an adaptor that binds to and organizes the subcellular localization of a variety of membrane proteins. It has been shown to interact with multiple glutamate receptor subtypes, monoamine plasma membrane transporters, as well as non-voltage gated sodium channels, and may target PRKCA to these membrane proteins and thus regulate their distribution and function. This protein has also been found to act as an anchoring protein that specifically targets PRKCA to mitochondria in a ligand-specific manner. Three transcript variants encoding the same protein have been found for this gene. The protein encoded by this gene contains a PDZ domain, through which it interacts with protein kinase C, alpha (PRKCA). This protein may function as an adaptor that binds to and organizes the subcellular localization of a variety of membrane proteins. It has been shown to interact with multiple glutamate receptor subtypes, monoamine plasma membrane transporters, as well as non-voltage gated sodium channels, and may target PRKCA to these membrane proteins and thus regulate their distribution and function. This protein has also been found to act as an anchoring protein that specifically targets PRKCA to mitochondria in a ligand-specific manner. Three transcript variants encoding the same protein have been found for this gene. no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased G1 DNA content, G0/1 arrest, Increased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0002092 GO:0006468 GO:0006468 GO:0006468 GO:0006886 GO:0006886 GO:0006886 GO:0006890 GO:0007205
DAPK3 	DAPK3 (Death Associated Protein Kinase 3) is a Protein Coding gene.  Among its related pathways are  DAPK1	Death-associated protein kinase 3 (DAPK3) induces morphological changes in apoptosis when overexpressed in mammalian cells.  These results suggest that DAPK3 may play a role in the induction of apoptosis. Death-associated protein kinase 3 (DAPK3) induces morphological changes in apoptosis when overexpressed in mammalian cells.  These results suggest that DAPK3 may play a role in the induction of apoptosis. Increased vaccinia virus (VACV) infection, Increased viability, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased substrate adherent cell growth, Decreased viability (cell death), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability with paclitaxel, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell viability after pRB stimulation, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0006325 GO:0006355 GO:0006355 GO:0006355 GO:0006417 GO:0006417 GO:0006417 GO:0006468 GO:0006468 GO:0006468 GO:0006915
MGMT 	MGMT (O-6-Methylguanine-DNA Methyltransferase) is a Protein Coding gene. Diseases associated with MGMT include  Oligodendroglioma Gliosarcoma	Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015]	Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0006266 GO:0006281
PFN1 	PFN1 (Profilin 1) is a Protein Coding gene. Diseases associated with PFN1 include  PFN2	This gene encodes a member of the profilin family of small actin-binding proteins. The encoded protein plays an important role in actin dynamics by regulating actin polymerization in response to extracellular signals. Deletion of this gene is associated with Miller-Dieker syndrome, and the encoded protein may also play a role in Huntington disease. Multiple pseudogenes of this gene are located on chromosome 1. [provided by RefSeq, Jul 2012]	This gene encodes a member of the profilin family of small actin-binding proteins. The encoded protein plays an important role in actin dynamics by regulating actin polymerization in response to extracellular signals. Deletion of this gene is associated with Miller-Dieker syndrome, and the encoded protein may also play a role in Huntington disease. Multiple pseudogenes of this gene are located on chromosome 1. [provided by RefSeq, Jul 2012]	no effect, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability (cell death), Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Decreased Salmonella enterica Typhimurium ruffling, Increased hepcidin::fluc mRNA expression, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Decreased nuclei size in G2M, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, 	GO:0001843 GO:0006357 GO:0006357 GO:0006357 GO:0010634 GO:0010634 GO:0010634
COL11A1 	COL11A1 (Collagen Type XI Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL11A1 include  COL5A1	This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]	This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased POU5F1-GFP protein expression, Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Decreased OCT4 protein expression, Decreased NANOG protein expression, 	 
ITGB4 	ITGB4 (Integrin Subunit Beta 4) is a Protein Coding gene. Diseases associated with ITGB4 include  ITGB1	Integrins are heterodimers comprised of alpha and beta subunits, that are noncovalently associated transmembrane glycoprotein receptors. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Integrins mediate cell-matrix or cell-cell adhesion, and transduced signals that regulate gene expression and cell growth. This gene encodes the integrin beta 4 subunit, a receptor for the laminins. This subunit tends to associate with alpha 6 subunit and is likely to play a pivotal role in the biology of invasive carcinoma. Mutations in this gene are associated with epidermolysis bullosa with pyloric atresia. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Integrins are heterodimers comprised of alpha and beta subunits, that are noncovalently associated transmembrane glycoprotein receptors. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Integrins mediate cell-matrix or cell-cell adhesion, and transduced signals that regulate gene expression and cell growth. This gene encodes the integrin beta 4 subunit, a receptor for the laminins. This subunit tends to associate with alpha 6 subunit and is likely to play a pivotal role in the biology of invasive carcinoma. Mutations in this gene are associated with epidermolysis bullosa with pyloric atresia. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Altered focal adhesion (FA) or cell shape morphology, 	GO:0006914 GO:0007154 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007229
FKBP14 	FKBP14 (FKBP Prolyl Isomerase 14) is a Protein Coding gene. Diseases associated with FKBP14 include  FKBP7	The protein encoded by this gene is a member of the FK506-binding protein family of peptidyl-prolyl cis-trans isomerases. The encoded protein is found in the lumen of the endoplasmic reticulum, where it is thought to accelerate protein folding. Defects in this gene are a cause of a type of Ehlers-Danlos syndrome (EDS). Both a protein-coding variant and noncoding variants are transcribed from this gene. [provided by RefSeq, Mar 2012]	The protein encoded by this gene is a member of the FK506-binding protein family of peptidyl-prolyl cis-trans isomerases. The encoded protein is found in the lumen of the endoplasmic reticulum, where it is thought to accelerate protein folding. Defects in this gene are a cause of a type of Ehlers-Danlos syndrome (EDS). Both a protein-coding variant and noncoding variants are transcribed from this gene. [provided by RefSeq, Mar 2012]	Increased viability, no effect, Decreased ionizing radiation sensitivity, Increased G1 DNA content, Increased NF-kappaB reporter expression, Increased virus production, Increased CFP-tsO45G cell surface transport, 	 
FGFR3 	FGFR3 (Fibroblast Growth Factor Receptor 3) is a Protein Coding gene. Diseases associated with FGFR3 include  Achondroplasia Hypochondroplasia FGFR2	This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. [provided by RefSeq, Aug 2017]	This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. [provided by RefSeq, Aug 2017]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased cell migration, Increased Nanog expression, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Decreased substrate adherent cell growth, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Large nuclei, decreased viability (cell death), Decreased cell spreading, 	GO:0000165 GO:0001501 GO:0001958 GO:0002062 GO:0003416
ABI1 	ABI1 (Abl Interactor 1) is a Protein Coding gene. Diseases associated with ABI1 include  Leukemia ABI2	This gene encodes a member of the Abelson-interactor family of adaptor proteins. These proteins facilitate signal transduction as components of several multiprotein complexes, and regulate actin polymerization and cytoskeletal remodeling through interactions with Abelson tyrosine kinases. The encoded protein plays a role in macropinocytosis as a component of the WAVE2 complex, and also forms a complex with EPS8 and SOS1 that mediates signal transduction from Ras to Rac. This gene may play a role in the progression of several malignancies including melanoma, colon cancer and breast cancer, and a t(10;11) chromosomal translocation involving this gene and the MLL gene has been associated with acute myeloid leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 14. [provided by RefSeq, Sep 2011]	This gene encodes a member of the Abelson-interactor family of adaptor proteins. These proteins facilitate signal transduction as components of several multiprotein complexes, and regulate actin polymerization and cytoskeletal remodeling through interactions with Abelson tyrosine kinases. The encoded protein plays a role in macropinocytosis as a component of the WAVE2 complex, and also forms a complex with EPS8 and SOS1 that mediates signal transduction from Ras to Rac. This gene may play a role in the progression of several malignancies including melanoma, colon cancer and breast cancer, and a t(10;11) chromosomal translocation involving this gene and the MLL gene has been associated with acute myeloid leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 14. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, 	GO:0001756 GO:0007169 GO:0007169 GO:0007169 GO:0008154 GO:0008285
GLMN 	GLMN (Glomulin, FKBP Associated Protein) is a Protein Coding gene. Diseases associated with GLMN include 	This gene encodes a phosphorylated protein that is a member of a Skp1-Cullin-F-box-like complex. The protein is essential for normal development of the vasculature and mutations in this gene have been associated with glomuvenous malformations, also called glomangiomas. Multiple splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]	This gene encodes a phosphorylated protein that is a member of a Skp1-Cullin-F-box-like complex. The protein is essential for normal development of the vasculature and mutations in this gene have been associated with glomuvenous malformations, also called glomangiomas. Multiple splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased G1 DNA content, Decreased HPV16-GFP infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Moderately decreased NFAT1-GFP nuclear translocation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001570 GO:0001819 GO:0001843 GO:0007166 GO:0007166 GO:0007166 GO:0008285
TSPAN1 	TSPAN1 (Tetraspanin 1) is a Protein Coding gene. Diseases associated with TSPAN1 include  TSPAN18	The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. no effect, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Strongly decreased CFP-tsO45G cell surface transport, Downregulation of Wnt pathway after Wnt3A stimulation, Weakly decreased NFAT1-GFP nuclear translocation, 	GO:0050821
DAB1 	DAB1 (DAB Adaptor Protein 1) is a Protein Coding gene. Diseases associated with DAB1 include  DAB2	The laminar organization of multiple neuronal types in the cerebral cortex is required for normal cognitive function. In mice, the disabled-1 gene plays a central role in brain development, directing the migration of cortical neurons past previously formed neurons to reach their proper layer. This gene is similar to disabled-1, and the protein encoded by this gene is thought to be a signal transducer that interacts with protein kinase pathways to regulate neuronal positioning in the developing brain. [provided by RefSeq, Jan 2017]	The laminar organization of multiple neuronal types in the cerebral cortex is required for normal cognitive function. In mice, the disabled-1 gene plays a central role in brain development, directing the migration of cortical neurons past previously formed neurons to reach their proper layer. This gene is similar to disabled-1, and the protein encoded by this gene is thought to be a signal transducer that interacts with protein kinase pathways to regulate neuronal positioning in the developing brain. [provided by RefSeq, Jan 2017]	no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased homologous recombination repair frequency, 	 
PTPRK 	PTPRK (Protein Tyrosine Phosphatase Receptor Type K) is a Protein Coding gene. Diseases associated with PTPRK include  PTPRM	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP was shown to mediate homophilic intercellular interaction, possibly through the interaction with beta- and gamma-catenin at adherens junctions. Expression of this gene was found to be stimulated by TGF-beta 1, which may be important for the inhibition of keratinocyte proliferation. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP was shown to mediate homophilic intercellular interaction, possibly through the interaction with beta- and gamma-catenin at adherens junctions. Expression of this gene was found to be stimulated by TGF-beta 1, which may be important for the inhibition of keratinocyte proliferation. no effect, Decreased ionizing radiation sensitivity, Increased transferrin (TF) endocytosis, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Upregulation of NF-kappaB pathway after LMP1 stimulation, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased apoptosis, 	GO:0006470 GO:0007155 GO:0007165 GO:0007179 GO:0008285
NFATC4 	NFATC4 (Nuclear Factor Of Activated T Cells 4) is a Protein Coding gene. Diseases associated with NFATC4 include  Leukostasis NFATC3	This gene encodes a member of the nuclear factor of activated T cells (NFAT) protein family. The encoded protein is part of a DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor stimulation and an inducible nuclear component. NFAT proteins are activated by the calmodulin-dependent phosphatase, calcineurin. The encoded protein plays a role in the inducible expression of cytokine genes in T cells, especially in the induction of interleukin-2 and interleukin-4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]	This gene encodes a member of the nuclear factor of activated T cells (NFAT) protein family. The encoded protein is part of a DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor stimulation and an inducible nuclear component. NFAT proteins are activated by the calmodulin-dependent phosphatase, calcineurin. The encoded protein plays a role in the inducible expression of cytokine genes in T cells, especially in the induction of interleukin-2 and interleukin-4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]	no effect, Decreased viability, Decreased viability in colon lineage, Decreased viability after Maraba virus infection, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0000122 GO:0001569 GO:0001569 GO:0001569 GO:0001816 GO:0001816 GO:0001816 GO:0006355 GO:0006357 GO:0006357 GO:0006357
CD40 	CD40 (CD40 Molecule) is a Protein Coding gene. Diseases associated with CD40 include  TNFRSF11A	This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]	This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Strongly decreased CFP-tsO45G cell surface transport, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0001934 GO:0002376 GO:0002637 GO:0002637 GO:0002637 GO:0002768 GO:0002768 GO:0002768 GO:0006874
ITGB1BP2 	ITGB1BP2 (Integrin Subunit Beta 1 Binding Protein 2) is a Protein Coding gene. Diseases associated with ITGB1BP2 include  CHORDC1	This gene encodes a protein with two cysteine and histidine-rich (CHORD) domains, PXXP motifs, YXXI/P motifs, putative SH2 and SH3 domain binding motifs, and an acidic region at the C-terminus that can bind calcium. Two hybrid analysis showed that this protein interacts with the cytoplasmic domain of the beta 1 integrin subunit and is thought to act as a chaperone protein. Studies in the mouse ortholog of this gene indicate that absence of this gene in mouse results in failed cardiac hypertrophy in response to mechanical stress. Alternative splicing results in multiple transcript variants encoding different isoforms, including an isoform that lacks several domains, including one of the CHORD domains. [provided by RefSeq, May 2017]	This gene encodes a protein with two cysteine and histidine-rich (CHORD) domains, PXXP motifs, YXXI/P motifs, putative SH2 and SH3 domain binding motifs, and an acidic region at the C-terminus that can bind calcium. Two hybrid analysis showed that this protein interacts with the cytoplasmic domain of the beta 1 integrin subunit and is thought to act as a chaperone protein. Studies in the mouse ortholog of this gene indicate that absence of this gene in mouse results in failed cardiac hypertrophy in response to mechanical stress. Alternative splicing results in multiple transcript variants encoding different isoforms, including an isoform that lacks several domains, including one of the CHORD domains. [provided by RefSeq, May 2017]	no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased transferrin (TF) endocytosis, Increased IL-8 secretion, Increased caspase activity, 	GO:0007165 GO:0007517
SMAD1 	SMAD1 (SMAD Family Member 1) is a Protein Coding gene. Diseases associated with SMAD1 include  Osteopoikilosis SMAD5	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased viability in pancreas lineage, Increased transcriptional activity, Increased homologous recombination repair frequency, Increased shRNA abundance, Increased cell number in S, High actin ratio cells, 	GO:0000165 GO:0001649 GO:0001649 GO:0001649
BMPER 	BMPER (BMP Binding Endothelial Regulator) is a Protein Coding gene. Diseases associated with BMPER include  Diaphanospondylodysostosis VWF	This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]	This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]	no effect, Decreased viability in esophageal squamous lineage, Mildly decreased CFP-tsO45G cell surface transport, Increased G1 DNA content, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Weakly decreased NFAT1-GFP nuclear translocation, Increased viability with neratinib, 	GO:0001568 GO:0001657 GO:0002043 GO:0002043 GO:0002043 GO:0007182 GO:0010594 GO:0010594 GO:0010594
GJA4 	GJA4 (Gap Junction Protein Alpha 4) is a Protein Coding gene. Diseases associated with GJA4 include  GJA1	This gene encodes a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene have been associated with atherosclerosis and a higher risk of myocardial infarction. This gene encodes a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene have been associated with atherosclerosis and a higher risk of myocardial infarction. no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Increased shRNA abundance (Z-score &gt; 2), Decreased cell number, increased S DNA content, 	GO:0001568 GO:0003158 GO:0003158 GO:0003158 GO:0006816 GO:0006816 GO:0006816 GO:0007043 GO:0007043 GO:0007043
SARM1 	SARM1 (Sterile Alpha And TIR Motif Containing 1) is a Protein Coding gene. Diseases associated with SARM1 include  binding	Enables NAD+ nucleotidase, cyclic ADP-ribose generating and identical protein binding activity. Involved in NAD catabolic process; positive regulation of neuron death; and response to axon injury. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]	Enables NAD+ nucleotidase, cyclic ADP-ribose generating and identical protein binding activity. Involved in NAD catabolic process; positive regulation of neuron death; and response to axon injury. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, FOXO1 nuclear localization, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased cell number, Decreased NF-kappaB reporter expression, Increased transcriptional activity, 	GO:0002376 GO:0007165 GO:0007165 GO:0007165 GO:0007399 GO:0007399 GO:0007399 GO:0009749 GO:0009749 GO:0009749 GO:0019677 GO:0019677 GO:0019677
PTPRG 	PTPRG (Protein Tyrosine Phosphatase Receptor Type G) is a Protein Coding gene. Diseases associated with PTPRG include  PTPRZ1	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this PTP contains a carbonic anhydrase-like (CAH) domain, which is also found in the extracellular region of PTPRBETA/ZETA. This gene is located in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma, thus is thought to be a candidate tumor suppressor gene. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this PTP contains a carbonic anhydrase-like (CAH) domain, which is also found in the extracellular region of PTPRBETA/ZETA. This gene is located in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma, thus is thought to be a candidate tumor suppressor gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased ionizing radiation sensitivity, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell death in DLD-1 cells, Increased apoptosis, 	GO:0006470 GO:0007169 GO:0007420 GO:0010633 GO:0010633 GO:0010633
COL7A1 	COL7A1 (Collagen Type VII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL7A1 include  COL27A1	This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased Salmonella enterica Typhimurium invasion, 	GO:0007155 GO:0008544 GO:0008544 GO:0008544 GO:0010466 GO:0030198 GO:0030198 GO:0030198 GO:0035987
APC 	APC (APC Regulator Of WNT Signaling Pathway) is a Protein Coding gene. Diseases associated with APC include  binding APC2	This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]	This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased POU5F1-GFP protein expression, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in esophageal squamous lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Upregulation of Wnt pathway, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell elongation, Downregulation of NFkappaB pathway, 	GO:0000281 GO:0001708 GO:0003170 GO:0003203 GO:0003203 GO:0003203 GO:0006974 GO:0006974 GO:0006974
MAPK8IP2 	MAPK8IP2 (Mitogen-Activated Protein Kinase 8 Interacting Protein 2) is a Protein Coding gene. Diseases associated with MAPK8IP2 include  MAPK8IP1	This gene encodes a scaffold protein that is thought to be involved in the regulation of the c-Jun amino-terminal kinase signaling pathway. This protein has been shown to interact with and regulate the activity of MAPK8/JNK1 and MAP2K7/MKK7 kinases. [provided by RefSeq, Jun 2017]	This gene encodes a scaffold protein that is thought to be involved in the regulation of the c-Jun amino-terminal kinase signaling pathway. This protein has been shown to interact with and regulate the activity of MAPK8/JNK1 and MAP2K7/MKK7 kinases. [provided by RefSeq, Jun 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased transferrin (TF) endocytosis, Decreased shRNA abundance, Decreased vesicular stomatitis virus (VSV) infection, Increased viability with 4OH tamoxifen, 	GO:0001662 GO:0007172 GO:0007172 GO:0007172
PIN1 	PIN1 (Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1) is a Protein Coding gene. Diseases associated with PIN1 include  PIN4	Peptidyl-prolyl cis/trans isomerases (PPIases) catalyze the cis/trans isomerization of peptidyl-prolyl peptide bonds. This gene encodes one of the PPIases, which specifically binds to phosphorylated ser/thr-pro motifs to catalytically regulate the post-phosphorylation conformation of its substrates. The conformational regulation catalyzed by this PPIase has a profound impact on key proteins involved in the regulation of cell growth, genotoxic and other stress responses, the immune response, induction and maintenance of pluripotency, germ cell development, neuronal differentiation, and survival. This enzyme also plays a key role in the pathogenesis of Alzheimer\'s disease and many cancers. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]	Peptidyl-prolyl cis/trans isomerases (PPIases) catalyze the cis/trans isomerization of peptidyl-prolyl peptide bonds. This gene encodes one of the PPIases, which specifically binds to phosphorylated ser/thr-pro motifs to catalytically regulate the post-phosphorylation conformation of its substrates. The conformational regulation catalyzed by this PPIase has a profound impact on key proteins involved in the regulation of cell growth, genotoxic and other stress responses, the immune response, induction and maintenance of pluripotency, germ cell development, neuronal differentiation, and survival. This enzyme also plays a key role in the pathogenesis of Alzheimer\'s disease and many cancers. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0000413 GO:0001666 GO:0001932 GO:0001934
TGIF1 	TGIF1 (TGFB Induced Factor Homeobox 1) is a Protein Coding gene. Diseases associated with TGIF1 include  TGIF2	The protein encoded by this gene is a member of the three-amino acid loop extension (TALE) superclass of atypical homeodomains. TALE homeobox proteins are highly conserved transcription regulators. This particular homeodomain binds to a previously characterized retinoid X receptor responsive element from the cellular retinol-binding protein II promoter. In addition to its role in inhibiting 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element, the protein is an active transcriptional co-repressor of SMAD2 and may participate in the transmission of nuclear signals during development and in the adult. Mutations in this gene are associated with holoprosencephaly type 4, which is a structural anomaly of the brain. Alternative splicing has been observed at this locus and multiple splice variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2013]	The protein encoded by this gene is a member of the three-amino acid loop extension (TALE) superclass of atypical homeodomains. TALE homeobox proteins are highly conserved transcription regulators. This particular homeodomain binds to a previously characterized retinoid X receptor responsive element from the cellular retinol-binding protein II promoter. In addition to its role in inhibiting 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element, the protein is an active transcriptional co-repressor of SMAD2 and may participate in the transmission of nuclear signals during development and in the adult. Mutations in this gene are associated with holoprosencephaly type 4, which is a structural anomaly of the brain. Alternative splicing has been observed at this locus and multiple splice variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2013]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), Elongated cells, Decreased Salmonella proliferation, 	GO:0000122
CD109 	CD109 (CD109 Molecule) is a Protein Coding gene. Diseases associated with CD109 include  A2M	This gene encodes a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signalling by transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]	This gene encodes a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signalling by transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]	no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, 	 
BMPR2 	BMPR2 (Bone Morphogenetic Protein Receptor Type 2) is a Protein Coding gene. Diseases associated with BMPR2 include  AMHR2	This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]	This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, May 2020]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Transferrin accumulation in the perinuclear area, Increased shRNA abundance (Z-score &gt; 2), Decreased interferon-beta reporter expression, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased simian virus 40 (SV40) infection, Increased nuclear migration speed, Increased G1 length, Increased G1 length, increased S length, Upregulation of Wnt pathway, Decreased cell viability after pRB stimulation, Increased S length, Decreased CYP1A1 activity after TCDD stimulation, Increased G1 length, increased S length, increased G2 length, 	GO:0001568 GO:0001649 GO:0001707 GO:0001893 GO:0001893 GO:0001893 GO:0001935 GO:0001935 GO:0001935
NID2 	NID2 (Nidogen 2) is a Protein Coding gene. Diseases associated with NID2 include  NID1	This gene encodes a member of the nidogen family of basement membrane proteins. This protein is a cell-adhesion protein that binds collagens I and IV and laminin and may be involved in maintaining the structure of the basement membrane.[provided by RefSeq, Jun 2010]	This gene encodes a member of the nidogen family of basement membrane proteins. This protein is a cell-adhesion protein that binds collagens I and IV and laminin and may be involved in maintaining the structure of the basement membrane.[provided by RefSeq, Jun 2010]	no effect, Decreased viability ratio, Decreased viability, 	GO:0007155 GO:0007160 GO:0071711
CA9 	CA9 (Carbonic Anhydrase 9) is a Protein Coding gene. Diseases associated with CA9 include  Oncocytoma CA12	Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jun 2014]	Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12. [provided by RefSeq, Jun 2014]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability after Maraba virus infection, Increased G1 DNA content, Decreased POU5F1-GFP protein expression, Decreased viability (cell death), Increased number of mitotic cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	 
ATF6 	ATF6 (Activating Transcription Factor 6) is a Protein Coding gene. Diseases associated with ATF6 include  Achromatopsia ATF6B	This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]	This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]	Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased hepcidin::fluc mRNA expression, Decreased circadian period length, 	GO:0001654 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006457
TCF12 	TCF12 (Transcription Factor 12) is a Protein Coding gene. Diseases associated with TCF12 include  TCF4	The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. Increased vaccinia virus (VACV) infection, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, 	GO:0006357 GO:0006955 GO:0007399 GO:0007517 GO:0007517 GO:0007517
FAF1 	FAF1 (Fas Associated Factor 1) is a Protein Coding gene. Diseases associated with FAF1 include  FAF2	Interaction of Fas ligand (TNFSF6) with the FAS antigen (TNFRSF6) mediates programmed cell death, also called apoptosis, in a number of organ systems. The protein encoded by this gene binds to FAS antigen and can initiate apoptosis or enhance apoptosis initiated through FAS antigen. Initiation of apoptosis by the protein encoded by this gene requires a ubiquitin-like domain but not the FAS-binding domain. Interaction of Fas ligand (TNFSF6) with the FAS antigen (TNFRSF6) mediates programmed cell death, also called apoptosis, in a number of organ systems. The protein encoded by this gene binds to FAS antigen and can initiate apoptosis or enhance apoptosis initiated through FAS antigen. Initiation of apoptosis by the protein encoded by this gene requires a ubiquitin-like domain but not the FAS-binding domain. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Increased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), 	GO:0006915 GO:0007253 GO:0007253 GO:0007253 GO:0008219 GO:0010942
TFRC 	TFRC (Transferrin Receptor) is a Protein Coding gene. Diseases associated with TFRC include  TFR2	This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased transferrin (TF) endocytosis, Increased cell death in HCT116 cells, Increased cell death in DLD-1 cells, 	GO:0001558 GO:0001666 GO:0001934 GO:0001934 GO:0001934 GO:0006826 GO:0006879
DUSP3 	DUSP3 (Dual Specificity Phosphatase 3) is a Protein Coding gene. Diseases associated with DUSP3 include  Vaccinia DUSP13	The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1. The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased viability in esophageal squamous lineage; decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in ovarian lineage, 	GO:0006470 GO:0016311 GO:0016311 GO:0016311 GO:0030336 GO:0035335 GO:0042059
FZD3 	FZD3 (Frizzled Class Receptor 3) is a Protein Coding gene. Diseases associated with FZD3 include  FZD6	This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. The function of this protein is unknown, although it may play a role in mammalian hair follicle development. Alternative splicing results in multiple transcript variants. This gene is a susceptibility locus for schizophrenia. [provided by RefSeq, Dec 2010]	This gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. The function of this protein is unknown, although it may play a role in mammalian hair follicle development. Alternative splicing results in multiple transcript variants. This gene is a susceptibility locus for schizophrenia. [provided by RefSeq, Dec 2010]	Decreased viability, no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), 	 
AJUBA 	AJUBA (Ajuba LIM Protein) is a Protein Coding gene.  Among its related pathways are  WTIP	Enables alpha-catenin binding activity and transcription corepressor activity. Involved in several processes, including negative regulation of hippo signaling; positive regulation of gene silencing by miRNA; and regulation of cellular response to hypoxia. Acts upstream of or within gene silencing by miRNA and positive regulation of protein-containing complex assembly. Located in several cellular components, including Golgi apparatus; P-body; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables alpha-catenin binding activity and transcription corepressor activity. Involved in several processes, including negative regulation of hippo signaling; positive regulation of gene silencing by miRNA; and regulation of cellular response to hypoxia. Acts upstream of or within gene silencing by miRNA and positive regulation of protein-containing complex assembly. Located in several cellular components, including Golgi apparatus; P-body; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Increased nuclear migration speed, Weakly decreased NFAT1-GFP nuclear translocation, 	GO:0000122 GO:0001666 GO:0001666 GO:0001666 GO:0006355 GO:0007010
TIMP2 	TIMP2 (TIMP Metallopeptidase Inhibitor 2) is a Protein Coding gene. Diseases associated with TIMP2 include  Conjunctivochalasis Fibrosarcoma TIMP4	This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased cell migration, Decreased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell death in HCT116 cells, Increased focal adhesion (FA) area, decreased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, 	GO:0009725 GO:0010033 GO:0010466 GO:0010466 GO:0010466 GO:0010951 GO:0010951 GO:0010951 GO:0034097
MELK 	MELK (Maternal Embryonic Leucine Zipper Kinase) is a Protein Coding gene.  Among its related pathways are  Neuroscience SIK1	Enables calcium ion binding activity; non-membrane spanning protein tyrosine kinase activity; and protein serine/threonine kinase activity. Involved in apoptotic process; cell population proliferation; and protein autophosphorylation. Located in cell cortex and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables calcium ion binding activity; non-membrane spanning protein tyrosine kinase activity; and protein serine/threonine kinase activity. Involved in apoptotic process; cell population proliferation; and protein autophosphorylation. Located in cell cortex and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased viability, no effect, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in ovarian lineage, Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, 	GO:0000086 GO:0006468 GO:0006915 GO:0007049 GO:0008283 GO:0008283 GO:0008283
NPM1 	NPM1 (Nucleophosmin 1) is a Protein Coding gene. Diseases associated with NPM1 include  NPM2	The protein encoded by this gene is involved in several cellular processes, including centrosome duplication, protein chaperoning, and cell proliferation. The encoded phosphoprotein shuttles between the nucleolus, nucleus, and cytoplasm, chaperoning ribosomal proteins and core histones from the nucleus to the cytoplasm. This protein is also known to sequester the tumor suppressor ARF in the nucleolus, protecting it from degradation until it is needed. Mutations in this gene are associated with acute myeloid leukemia. Dozens of pseudogenes of this gene have been identified. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is involved in several cellular processes, including centrosome duplication, protein chaperoning, and cell proliferation. The encoded phosphoprotein shuttles between the nucleolus, nucleus, and cytoplasm, chaperoning ribosomal proteins and core histones from the nucleus to the cytoplasm. This protein is also known to sequester the tumor suppressor ARF in the nucleolus, protecting it from degradation until it is needed. Mutations in this gene are associated with acute myeloid leukemia. Dozens of pseudogenes of this gene have been identified. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Mildly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), 	GO:0000055 GO:0000056 GO:0006281 GO:0006334 GO:0006338
SEMA4D 	SEMA4D (Semaphorin 4D) is a Protein Coding gene. Diseases associated with SEMA4D include  SEMA4B	Enables identical protein binding activity; semaphorin receptor binding activity; and transmembrane signaling receptor activity. Involved in several processes, including positive regulation of phosphatidylinositol 3-kinase signaling; regulation of neuron projection development; and regulation of phosphate metabolic process. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables identical protein binding activity; semaphorin receptor binding activity; and transmembrane signaling receptor activity. Involved in several processes, including positive regulation of phosphatidylinositol 3-kinase signaling; regulation of neuron projection development; and regulation of phosphate metabolic process. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Increased transferrin (TF) endocytosis, Increased G1 DNA content, Decreased transferrin (TF) endocytosis, 	GO:0000122 GO:0001755 GO:0001934 GO:0006955 GO:0007155
ARID3B 	ARID3B (AT-Rich Interaction Domain 3B) is a Protein Coding gene. Diseases associated with ARID3B include  Neuroblastoma ARID3A	This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA-binding proteins. The encoded protein is homologous with two proteins that bind to the retinoblastoma gene product, and also with the mouse Bright and Drosophila dead ringer proteins. A pseudogene on chromosome 1p31 exists for this gene. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and possibly in chromatin structure modification. This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA-binding proteins. The encoded protein is homologous with two proteins that bind to the retinoblastoma gene product, and also with the mouse Bright and Drosophila dead ringer proteins. A pseudogene on chromosome 1p31 exists for this gene. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and possibly in chromatin structure modification. Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Inconclusive, Increased Nanog expression, Decreased vesicular stomatitis virus (VSV) infection, 	GO:0006357
PLEKHM2 	PLEKHM2 (Pleckstrin Homology And RUN Domain Containing M2) is a Protein Coding gene. Diseases associated with PLEKHM2 include  ZFYVE26	This gene encodes a protein that binds the plus-end directed microtubule motor protein kinesin, together with the lysosomal GTPase Arl8, and is required for lysosomes to distribute away from the microtubule-organizing center. The encoded protein belongs to the multisubunit BLOC-one-related complex that regulates lysosome positioning. It binds a Salmonella effector protein called Salmonella induced filament A and is a critical host determinant in Salmonella pathogenesis. It has a domain architecture consisting of an N-terminal RPIP8, UNC-14, and NESCA (RUN) domain that binds kinesin-1 as well as the lysosomal GTPase Arl8, and a C-terminal pleckstrin homology domain that binds the Salmonella induced filament A effector protein. Naturally occurring mutations in this gene lead to abnormal localization of lysosomes, impaired autophagy flux and are associated with recessive dilated cardiomyopathy and left ventricular noncompaction. [provided by RefSeq, Feb 2017]	This gene encodes a protein that binds the plus-end directed microtubule motor protein kinesin, together with the lysosomal GTPase Arl8, and is required for lysosomes to distribute away from the microtubule-organizing center. The encoded protein belongs to the multisubunit BLOC-one-related complex that regulates lysosome positioning. It binds a Salmonella effector protein called Salmonella induced filament A and is a critical host determinant in Salmonella pathogenesis. It has a domain architecture consisting of an N-terminal RPIP8, UNC-14, and NESCA (RUN) domain that binds kinesin-1 as well as the lysosomal GTPase Arl8, and a C-terminal pleckstrin homology domain that binds the Salmonella induced filament A effector protein. Naturally occurring mutations in this gene lead to abnormal localization of lysosomes, impaired autophagy flux and are associated with recessive dilated cardiomyopathy and left ventricular noncompaction. [provided by RefSeq, Feb 2017]	Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, Strongly decreased CFP-tsO45G cell surface transport, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium ruffling, Increased hepcidin::fluc mRNA expression, Decreased homologous recombination repair frequency, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased Salmonella enterica Typhimurium binding, Decreased cell number, increased S DNA content, 	GO:0007030 GO:0032418 GO:0032880 GO:0042267 GO:1903527
TIFA 	TIFA (TRAF Interacting Protein With Forkhead Associated Domain) is a Protein Coding gene. Diseases associated with TIFA include  TIFAB	This gene encodes an adapter protein involved in adaptive and innate immunity. This protein includes a forkhead-associated (FHA) domain that specifically binds to phosphorylated serine and threonine residues. In response to bacterial infection, the encoded host cell protein undergoes an intermolecular interaction between the FHA domain and a phosphorylated threonine that leads to protein oligomerization and stimulation of the NF-kappa B and other downstream signaling pathways. This protein exhibits reduced expression in hepatocellular carcinoma and may suppress hepatocellular carcinoma progression. This protein may also play a role in the DNA damage response. [provided by RefSeq, Jun 2018]	This gene encodes an adapter protein involved in adaptive and innate immunity. This protein includes a forkhead-associated (FHA) domain that specifically binds to phosphorylated serine and threonine residues. In response to bacterial infection, the encoded host cell protein undergoes an intermolecular interaction between the FHA domain and a phosphorylated threonine that leads to protein oligomerization and stimulation of the NF-kappa B and other downstream signaling pathways. This protein exhibits reduced expression in hepatocellular carcinoma and may suppress hepatocellular carcinoma progression. This protein may also play a role in the DNA damage response. [provided by RefSeq, Jun 2018]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased viability ratio, Decreased POU5F1-GFP protein expression, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0002376 GO:0002753 GO:0002753 GO:0002753 GO:0007249 GO:0043123 GO:0045087
RAP2A 	RAP2A (RAP2A, Member Of RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAP2A include  RAP2C	Enables GTPase activity; guanyl ribonucleotide binding activity; and magnesium ion binding activity. Involved in several processes, including actin cytoskeleton reorganization; microvillus assembly; and positive regulation of protein autophosphorylation. Acts upstream of or within establishment of protein localization. Located in plasma membrane and recycling endosome membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables GTPase activity; guanyl ribonucleotide binding activity; and magnesium ion binding activity. Involved in several processes, including actin cytoskeleton reorganization; microvillus assembly; and positive regulation of protein autophosphorylation. Acts upstream of or within establishment of protein localization. Located in plasma membrane and recycling endosome membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased S DNA content, 	GO:0001934 GO:0007165 GO:0008104 GO:0008104 GO:0008104 GO:0030033 GO:0030336
CARM1 	CARM1 (Coactivator Associated Arginine Methyltransferase 1) is a Protein Coding gene. Diseases associated with CARM1 include  PRMT3	This gene belongs to the protein arginine methyltransferase (PRMT) family. The encoded enzyme catalyzes the methylation of guanidino nitrogens of arginyl residues of proteins. The enzyme acts specifically on histones and other chromatin-associated proteins and is involved in regulation of gene expression. The enzyme may act in association with other proteins or within multi-protein complexes and may play a role in cell type-specific functions and cell lineage specification. A related pseudogene is located on chromosome 9. [provided by RefSeq, Aug 2013]	This gene belongs to the protein arginine methyltransferase (PRMT) family. The encoded enzyme catalyzes the methylation of guanidino nitrogens of arginyl residues of proteins. The enzyme acts specifically on histones and other chromatin-associated proteins and is involved in regulation of gene expression. The enzyme may act in association with other proteins or within multi-protein complexes and may play a role in cell type-specific functions and cell lineage specification. A related pseudogene is located on chromosome 9. [provided by RefSeq, Aug 2013]	Increased gamma-H2AX phosphorylation, Synthetic lethal with Ras, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), shRNA abundance &lt;= 25%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased NF-kappaB reporter expression, Decreased Aire reporter expression, 	 
ICOS 	ICOS (Inducible T Cell Costimulator) is a Protein Coding gene. Diseases associated with ICOS include 	The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation. The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased homologous recombination repair frequency, 	GO:0002517 GO:0006955 GO:0031295 GO:0098609
COL9A2 	COL9A2 (Collagen Type IX Alpha 2 Chain) is a Protein Coding gene. Diseases associated with COL9A2 include  COL2A1	This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance, Decreased DCP1a protein expression and assembly in processing bodies after arsenite stimulation, 	GO:0001501 GO:0030198
AKT1 	AKT1 (AKT Serine/Threonine Kinase 1) is a Protein Coding gene. Diseases associated with AKT1 include  AKT3	This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene.  This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene.  no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Increased transferrin (TF) endocytosis, Increased Nanog expression, Wnt reporter downregulated, Strongly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Increased viability (proliferation), Decreased shRNA abundance (Z-score &lt; -2), Decreased HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, Increased cell viability after pRB stimulation, Decreased p24 protein expression, Increased viability with tamoxifen, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Decreased viability with TRAIL, Decreased simian virus 40 (SV40) infection, 	GO:0001649 GO:0001893 GO:0001893 GO:0001893 GO:0001934 GO:0001934 GO:0001934 GO:0001938 GO:0002042
VEGFD 	VEGFD (Vascular Endothelial Growth Factor D) is a Protein Coding gene. Diseases associated with VEGFD include  VEGFC	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011]	The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus. [provided by RefSeq, Feb 2011]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell elongation, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0001934 GO:0001938 GO:0002040
COL17A1 	COL17A1 (Collagen Type XVII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL17A1 include  COL5A1	This gene encodes the alpha chain of type XVII collagen. Unlike most collagens, collagen XVII is a transmembrane protein. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form. This gene encodes the alpha chain of type XVII collagen. Unlike most collagens, collagen XVII is a transmembrane protein. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, High actin ratio cells, 	GO:0007160 GO:0008544 GO:0030198 GO:0031581
BRD4 	BRD4 (Bromodomain Containing 4) is a Protein Coding gene. Diseases associated with BRD4 include  Disease BRD3	The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described. The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with c-Myc after tamoxifen stimulation, Increased Nanog expression, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased HPV18 LCR reporter activity, Increased cell death HMECs cells, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability of wild-type and TP53 knockout cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased nuclear migration distance, increased nuclear migration speed, Increased cell death in HCT116 cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, decreased cell spreading, Increased cilium length after serum starvation, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0000083
HIF1A 	HIF1A (Hypoxia Inducible Factor 1 Subunit Alpha) is a Protein Coding gene. Diseases associated with HIF1A include  EPAS1	This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]	This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased shRNA abundance, Decreased caspase 3/7 activity, 	GO:0000302 GO:0001525 GO:0001568 GO:0001568 GO:0001568 GO:0001666 GO:0001666 GO:0001666 GO:0001678
VCL 	VCL (Vinculin) is a Protein Coding gene. Diseases associated with VCL include  CTNNA1	Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased nuclear migration distance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability of wild-type and TP53 knockout cells, 	GO:0002009 GO:0007155 GO:0007160
CXCL8 	CXCL8 (C-X-C Motif Chemokine Ligand 8) is a Protein Coding gene. Diseases associated with CXCL8 include  Melanoma PPBP	The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]	The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]	no effect, Decreased viability, Synthetic lethal with Ras, Reduced mammosphere formation, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased interferon-beta reporter expression, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), 	GO:0001525 GO:0002237 GO:0006935 GO:0006952 GO:0006954 GO:0006954 GO:0006954
NGB 	NGB (Neuroglobin) is a Protein Coding gene. Diseases associated with NGB include  Ischemia	This gene encodes an oxygen-binding protein that is distantly related to members of the globin gene family. It is highly conserved among other vertebrates. It is expressed in the central and peripheral nervous system where it may be involved in increasing oxygen availability and providing protection under hypoxic/ischemic conditions. This gene encodes an oxygen-binding protein that is distantly related to members of the globin gene family. It is highly conserved among other vertebrates. It is expressed in the central and peripheral nervous system where it may be involved in increasing oxygen availability and providing protection under hypoxic/ischemic conditions. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, FOXO1 nuclear localization, 	GO:0001666 GO:0006915 GO:0015671 GO:0015671 GO:0015671
PPP2R5C 	PPP2R5C (Protein Phosphatase 2 Regulatory Subunit B\'Gamma) is a Protein Coding gene. Diseases associated with PPP2R5C include  binding PPP2R5D	The product of this gene belongs to the phosphatase 2A regulatory subunit B family. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a gamma isoform of the regulatory subunit B56 subfamily. Alternatively spliced transcript variants encoding different isoforms have been identified. The product of this gene belongs to the phosphatase 2A regulatory subunit B family. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a gamma isoform of the regulatory subunit B56 subfamily. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased transferrin (TF) endocytosis, Increased HPV16-GFP infection, Increased apoptosis, Increased Erk phosphorylation after EGF stimulation, Increased viability after TNF/CHX stimulation, 	GO:0006470 GO:0006977 GO:0007165 GO:0007165 GO:0007165 GO:0008285
SYVN1 	SYVN1 (Synoviolin 1) is a Protein Coding gene. Diseases associated with SYVN1 include  Arthropathy AMFR	This gene encodes a protein involved in endoplasmic reticulum (ER)-associated degradation. The encoded protein removes unfolded proteins, accumulated during ER stress, by retrograde transport to the cytosol from the ER. This protein also uses the ubiquitin-proteasome system for additional degradation of unfolded proteins. Sequence analysis identified two transcript variants that encode different isoforms. [provided by RefSeq, May 2011]	This gene encodes a protein involved in endoplasmic reticulum (ER)-associated degradation. The encoded protein removes unfolded proteins, accumulated during ER stress, by retrograde transport to the cytosol from the ER. This protein also uses the ubiquitin-proteasome system for additional degradation of unfolded proteins. Sequence analysis identified two transcript variants that encode different isoforms. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased NF-kappaB reporter expression, Increased ionizing radiation sensitivity, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased caspase activity, Decreased vesicular stomatitis virus (VSV) infection, Decreased lymphocytic choriomeningitis virus (LCMV) infection, 	GO:0002327 GO:0006511 GO:0006511 GO:0006511 GO:0016567 GO:0030433 GO:0030970
SPON1 	SPON1 (Spondin 1) is a Protein Coding gene. Diseases associated with SPON1 include  THSD7A	Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within positive regulation of protein binding activity; positive regulation of protein processing; and regulation of amyloid precursor protein catabolic process. Located in extracellular space. Colocalizes with collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within positive regulation of protein binding activity; positive regulation of protein processing; and regulation of amyloid precursor protein catabolic process. Located in extracellular space. Colocalizes with collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability after Maraba virus infection, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0007155
KIF14 	KIF14 (Kinesin Family Member 14) is a Protein Coding gene. Diseases associated with KIF14 include  KIF1B	This gene encodes a member of the kinesin-3 superfamily of microtubule motor proteins. These proteins are involved in numerous processes including vesicle transport, chromosome segregation, mitotic spindle formation, and cytokinesis. In human HeLa-S3 and 293T cells, this protein is localized to the cytoplasm during interphase, to the spindle poles and spindle microtubules during mitosis, and to the midbody during cytokinesis. An internal motor domain displays microtubule-dependent ATPase activity, consistent with its function as a microtubule motor protein. Knockdown of this gene results in failed cytokinesis with endoreplication, which results in multinucleated cells. This gene has been identified as a likely oncogene in breast, lung and ovarian cancers, as well as retinoblastomas and gliomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]	This gene encodes a member of the kinesin-3 superfamily of microtubule motor proteins. These proteins are involved in numerous processes including vesicle transport, chromosome segregation, mitotic spindle formation, and cytokinesis. In human HeLa-S3 and 293T cells, this protein is localized to the cytoplasm during interphase, to the spindle poles and spindle microtubules during mitosis, and to the midbody during cytokinesis. An internal motor domain displays microtubule-dependent ATPase activity, consistent with its function as a microtubule motor protein. Knockdown of this gene results in failed cytokinesis with endoreplication, which results in multinucleated cells. This gene has been identified as a likely oncogene in breast, lung and ovarian cancers, as well as retinoblastomas and gliomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, Decreased viability ratio, Two nuclei (binuclear), Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Synthetic lethal with vaccinia virus (VACV) infection, Increased 8N DNA content, Increased S length, 	GO:0001558 GO:0007018 GO:0007019 GO:0007080 GO:0007080 GO:0007080 GO:0008284
CDC25B 	CDC25B (Cell Division Cycle 25B) is a Protein Coding gene. Diseases associated with CDC25B include  Retinoblastoma CDC25A	CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist. CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist. no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, Decreased nuclei size in G2M, Decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in pancreas lineage, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell spreading, 	GO:0000086 GO:0000278 GO:0001556 GO:0006468 GO:0006468 GO:0006468
CNN1 	CNN1 (Calponin 1) is a Protein Coding gene. Diseases associated with CNN1 include  CNN3	Predicted to enable actin binding activity. Involved in negative regulation of vascular associated smooth muscle cell proliferation. Located in cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable actin binding activity. Involved in negative regulation of vascular associated smooth muscle cell proliferation. Located in cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, 	GO:0006940 GO:0031032 GO:1904706 GO:1904706 GO:1904706
ABL1 	ABL1 (ABL Proto-Oncogene 1, Non-Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with ABL1 include  ABL2	This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5\' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]	This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5\' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased viability with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased cell migration, Decreased viability, Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased circadian period length, Increased viability with tamoxifen, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Misorientated spindle, 	GO:0000278 GO:0001843 GO:0001922 GO:0001922 GO:0001922 GO:0001934 GO:0001934 GO:0001934
NCK1 	NCK1 (NCK Adaptor Protein 1) is a Protein Coding gene. Diseases associated with NCK1 include  Vaccinia NCK2	The protein encoded by this gene is one of the signaling and transforming proteins containing Src homology 2 and 3 (SH2 and SH3) domains. It is located in the cytoplasm and is an adaptor protein involved in transducing signals from receptor tyrosine kinases to downstream signal recipients such as RAS. Alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Jun 2010]	The protein encoded by this gene is one of the signaling and transforming proteins containing Src homology 2 and 3 (SH2 and SH3) domains. It is located in the cytoplasm and is an adaptor protein involved in transducing signals from receptor tyrosine kinases to downstream signal recipients such as RAS. Alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Jun 2010]	no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability ratio, Increased cell migration, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Increased focal adhesion (FA) area, decreased number of small and round FAs, increased peripheral FA formation, 	GO:0006417 GO:0006930 GO:0006930 GO:0006930 GO:0007015 GO:0007015 GO:0007015 GO:0007165 GO:0007165 GO:0007165 GO:0007172 GO:0007172 GO:0007172
DCAF1 	DCAF1 (DDB1 And CUL4 Associated Factor 1) is a Protein Coding gene. Diseases associated with DCAF1 include  Neurilemmomatosis	Enables estrogen receptor binding activity and histone kinase activity (H2A-T120 specific). Involved in cell competition in a multicellular organism; histone H2A-T120 phosphorylation; and negative regulation of transcription by RNA polymerase II. Located in fibrillar center and nucleoplasm. Part of Cul4-RING E3 ubiquitin ligase complex. Colocalizes with COP9 signalosome. [provided by Alliance of Genome Resources, Apr 2022]	Enables estrogen receptor binding activity and histone kinase activity (H2A-T120 specific). Involved in cell competition in a multicellular organism; histone H2A-T120 phosphorylation; and negative regulation of transcription by RNA polymerase II. Located in fibrillar center and nucleoplasm. Part of Cul4-RING E3 ubiquitin ligase complex. Colocalizes with COP9 signalosome. [provided by Alliance of Genome Resources, Apr 2022]	Synthetic lethal with Ras, Decreased viability, Increased IL-8 secretion, Decreased cell number, Inconclusive, Decreased shRNA abundance, Decreased viability of wild-type and TP53 knockout cells, Decreased homologous recombination repair frequency, Increased G1 length, Decreased p24 protein expression, 	GO:0000122
ID3 	ID3 (Inhibitor Of DNA Binding 3) is a Protein Coding gene. Diseases associated with ID3 include  ID2	The protein encoded by this gene is a helix-loop-helix (HLH) protein that can form heterodimers with other HLH proteins. However, the encoded protein lacks a basic DNA-binding domain and therefore inhibits the DNA binding of any HLH protein with which it interacts. [provided by RefSeq, Aug 2011]	The protein encoded by this gene is a helix-loop-helix (HLH) protein that can form heterodimers with other HLH proteins. However, the encoded protein lacks a basic DNA-binding domain and therefore inhibits the DNA binding of any HLH protein with which it interacts. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability with paclitaxel, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased viability (cell death), 	GO:0000122
NCOA1 	NCOA1 (Nuclear Receptor Coactivator 1) is a Protein Coding gene. Diseases associated with NCOA1 include  Rhabdomyosarcoma NCOA2	The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased viability, Decreased HPV16-GFP infection, Decreased viability in pancreas lineage, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell death HMECs cells, Increased cell death in HCC-1954 cells, Decreased viability with cisplatin, 	GO:0000435 GO:0002155 GO:0006355 GO:0006355 GO:0006355 GO:0016570 GO:0016570 GO:0016570 GO:0032870 GO:0032870 GO:0032870
RPS6KA3 	RPS6KA3 (Ribosomal Protein S6 Kinase A3) is a Protein Coding gene. Diseases associated with RPS6KA3 include  RPS6KA2	This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased melanin production, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability (proliferation), Dynamic nuclei (hole, folded or small irregular), Decreased HIV-LTR-beta-galactosidase protein expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability with paclitaxel, Increased mitotic index, 	GO:0001501
CEP63 	CEP63 (Centrosomal Protein 63) is a Protein Coding gene. Diseases associated with CEP63 include  DEUP1	This gene encodes a protein with six coiled-coil domains. The protein is localized to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. Several alternatively spliced transcript variants have been found, but their biological validity has not been determined. This gene encodes a protein with six coiled-coil domains. The protein is localized to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. Several alternatively spliced transcript variants have been found, but their biological validity has not been determined. Decreased hepcidin::fluc mRNA expression, no effect, Increased G1 DNA content, G0/1 arrest, Increased Nanog expression, 	 
PDE3B 	PDE3B (Phosphodiesterase 3B) is a Protein Coding gene. Diseases associated with PDE3B include  Impotence PDE3A	Enables 3\',5\'-cyclic-nucleotide phosphodiesterase activity. Involved in negative regulation of angiogenesis; negative regulation of cell adhesion; and negative regulation of lipid catabolic process. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables 3\',5\'-cyclic-nucleotide phosphodiesterase activity. Involved in negative regulation of angiogenesis; negative regulation of cell adhesion; and negative regulation of lipid catabolic process. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased IL-8 secretion, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with paclitaxel, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0001525 GO:0007162 GO:0007162 GO:0007162 GO:0007165 GO:0007186 GO:0007186 GO:0007186 GO:0016525 GO:0016525 GO:0016525
EEA1 	EEA1 (Early Endosome Antigen 1) is a Protein Coding gene. Diseases associated with EEA1 include 	Enables 1-phosphatidylinositol binding activity; GTP-dependent protein binding activity; and protein homodimerization activity. Involved in endocytosis; vesicle fusion; and viral RNA genome replication. Located in cytosol and early endosome. Is extrinsic component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Enables 1-phosphatidylinositol binding activity; GTP-dependent protein binding activity; and protein homodimerization activity. Involved in endocytosis; vesicle fusion; and viral RNA genome replication. Located in cytosol and early endosome. Is extrinsic component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Increased G2M DNA content, increased 8N DNA content, Cell division defect, Increased epidermal growth factor (EGF) endosome number, increased epidermal growth factor (EGF) endosome elongation, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0006897 GO:0006906 GO:0016189 GO:0044788 GO:0045022
S100A13 	S100A13 (S100 Calcium Binding Protein A13) is a Protein Coding gene. Diseases associated with S100A13 include  S100A5	The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is widely expressed in various types of tissues with a high expression level in thyroid gland. In smooth muscle cells, this protein co-expresses with other family members in the nucleus and in stress fibers, suggesting diverse functions in signal transduction. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein is widely expressed in various types of tissues with a high expression level in thyroid gland. In smooth muscle cells, this protein co-expresses with other family members in the nucleus and in stress fibers, suggesting diverse functions in signal transduction. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased NF-kappaB reporter expression, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Decreased Sindbis virus (SINV) infection, Increased Salmonella enterica Typhimurium invasion, 	GO:0001819 GO:0008284 GO:0015031 GO:0032730 GO:0032730 GO:0032730 GO:0043123
ROR1 	ROR1 (Receptor Tyrosine Kinase Like Orphan Receptor 1) is a Protein Coding gene. Diseases associated with ROR1 include  ROR2	This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012]	This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability (cell death), Decreased viability, Increased Salmonella enterica Typhimurium invasion, Decreased epidermal growth factor (EGF) endocytosis, Decreased substrate adherent cell growth, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased vesicular stomatitis virus (VSV) infection, Increased apoptosis, 	GO:0006468 GO:0007169 GO:0007169 GO:0007169 GO:0007275 GO:0007605 GO:0010976
NR4A1 	NR4A1 (Nuclear Receptor Subfamily 4 Group A Member 1) is a Protein Coding gene. Diseases associated with NR4A1 include  Pseudohypoaldosteronism Pyomyositis NR4A2	This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. Expression is induced by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. The encoded protein acts as a nuclear transcription factor. Translocation of the protein from the nucleus to mitochondria induces apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]	This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. Expression is induced by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. The encoded protein acts as a nuclear transcription factor. Translocation of the protein from the nucleus to mitochondria induces apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]	no effect, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Decreased caspase 3/7 activity, 	GO:0001938 GO:0001975 GO:0002042 GO:0002042 GO:0002042
ACVR2A 	ACVR2A (Activin A Receptor Type 2A) is a Protein Coding gene. Diseases associated with ACVR2A include  ACVR2B	This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]	This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Decreased viability in ovarian lineage, Decreased HPV16-GFP infection, Decreased substrate adherent cell growth, Increased viability (proliferation), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased viability after gemcitabine stimulation, Increased apoptosis, 	GO:0001702 GO:0001934 GO:0001934 GO:0001934 GO:0006468 GO:0007178
LYVE1 	LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1) is a Protein Coding gene. Diseases associated with LYVE1 include  Metabolism CD44	This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis. This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis. no effect, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Decreased HPV16-GFP infection, 	GO:0002693 GO:0006027 GO:0006898 GO:0006898 GO:0006898 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007160 GO:0007160
F3 	F3 (Coagulation Factor III, Tissue Factor) is a Protein Coding gene. Diseases associated with F3 include  IL20RA	This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]	This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased S DNA content, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001938 GO:0002541 GO:0002543 GO:0006919 GO:0007596
SCNN1B 	SCNN1B (Sodium Channel Epithelial 1 Subunit Beta) is a Protein Coding gene. Diseases associated with SCNN1B include  SCNN1G	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009]	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased HPV16-GFP infection, 	GO:0002269 GO:0002283 GO:0002283 GO:0002283 GO:0006811 GO:0006811 GO:0006811 GO:0006814 GO:0006814 GO:0006814 GO:0006883
ELK1 	ELK1 (ETS Transcription Factor ELK1) is a Protein Coding gene. Diseases associated with ELK1 include  Melanoma ELK3	This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum response element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade. This gene produces multiple isoforms by using alternative translational start codons and by alternative splicing. Related pseudogenes have been identified on chromosomes 7 and 14. [provided by RefSeq, Mar 2012]	This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) subfamily. Proteins of the TCF subfamily form a ternary complex by binding to the the serum response factor and the serum response element in the promoter of the c-fos proto-oncogene. The protein encoded by this gene is a nuclear target for the ras-raf-MAPK signaling cascade. This gene produces multiple isoforms by using alternative translational start codons and by alternative splicing. Related pseudogenes have been identified on chromosomes 7 and 14. [provided by RefSeq, Mar 2012]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased HPV16-GFP infection, Decreased Aire reporter expression, Decreased shRNA abundance, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0001889 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
CTTN 	CTTN (Cortactin) is a Protein Coding gene. Diseases associated with CTTN include  HCLS1	This gene is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Three splice variants that encode different isoforms have been identified for this gene. [provided by RefSeq, May 2010]	This gene is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Three splice variants that encode different isoforms have been identified for this gene. [provided by RefSeq, May 2010]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), Decreased vaccinia virus (VACV-LREV ) gene expression, 	GO:0006886 GO:0006897 GO:0006898 GO:0006898 GO:0006898 GO:0006930 GO:0006930 GO:0006930 GO:0007165 GO:0007165 GO:0007165
SOS2 	SOS2 (SOS Ras/Rho Guanine Nucleotide Exchange Factor 2) is a Protein Coding gene. Diseases associated with SOS2 include  SOS1	This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001782 GO:0002260 GO:0002260 GO:0002260 GO:0007264 GO:0007264 GO:0007264 GO:0007265 GO:0007265 GO:0007265
STIM1 	STIM1 (Stromal Interaction Molecule 1) is a Protein Coding gene. Diseases associated with STIM1 include  STIM2	This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3\' end of this gene situated 1.6 kb from the 5\' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]	This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3\' end of this gene situated 1.6 kb from the 5\' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Strongly decreased NFAT1-GFP nuclear translocation, 	GO:0002115 GO:0005513 GO:0006811 GO:0006816 GO:0006816 GO:0006816 GO:0006874 GO:0006874 GO:0006874
TRPM4 	TRPM4 (Transient Receptor Potential Cation Channel Subfamily M Member 4) is a Protein Coding gene. Diseases associated with TRPM4 include  TRPM5	The protein encoded by this gene is a calcium-activated nonselective ion channel that mediates transport of monovalent cations across membranes, thereby depolarizing the membrane. The activity of the encoded protein increases with increasing intracellular calcium concentration, but this channel does not transport calcium. [provided by RefSeq, Mar 2016]	The protein encoded by this gene is a calcium-activated nonselective ion channel that mediates transport of monovalent cations across membranes, thereby depolarizing the membrane. The activity of the encoded protein increases with increasing intracellular calcium concentration, but this channel does not transport calcium. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased circadian period length, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Increased caspase activity, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0002407 GO:0002407 GO:0002407 GO:0002724 GO:0002724 GO:0002724
FZD5 	FZD5 (Frizzled Class Receptor 5) is a Protein Coding gene. Diseases associated with FZD5 include  FZD8	 Members of the \'frizzled\' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD5 protein is believed to be the receptor for the Wnt5A ligand.  Members of the \'frizzled\' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD5 protein is believed to be the receptor for the Wnt5A ligand. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between BLM-/- and BLM+/+, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0000578 GO:0001525 GO:0001944 GO:0001944 GO:0001944 GO:0002071 GO:0002071 GO:0002071 GO:0002726 GO:0002726 GO:0002726
PRKCB 	PRKCB (Protein Kinase C Beta) is a Protein Coding gene. Diseases associated with PRKCB include  PRKCA	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase has been reported to be involved in many different cellular functions, such as B cell activation, apoptosis induction, endothelial cell proliferation, and intestinal sugar absorption. Studies in mice also suggest that this kinase may also regulate neuronal functions and correlate fear-induced conflict behavior after stress. Alternatively spliced transcript variants encoding distinct isoforms have been reported. Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase has been reported to be involved in many different cellular functions, such as B cell activation, apoptosis induction, endothelial cell proliferation, and intestinal sugar absorption. Studies in mice also suggest that this kinase may also regulate neuronal functions and correlate fear-induced conflict behavior after stress. Alternatively spliced transcript variants encoding distinct isoforms have been reported. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Increased Nanog expression, Decreased substrate adherent cell growth, No cells, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Decreased Sindbis virus (SINV) infection, Increased human cytomegalovirus (HCMV) strain AD169 replication, Large nuclei, Decreased viability after ionizing radiation, Increased cell number in G2M, increased nuclei size in G2M, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, increased cell spreading, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0006325 GO:0006325 GO:0006325 GO:0006357 GO:0006357 GO:0006357 GO:0006468
VPS37B 	VPS37B (VPS37B Subunit Of ESCRT-I) is a Protein Coding gene.  Among its related pathways are  VPS37C	Enables calcium-dependent protein binding activity. Involved in positive regulation of viral budding via host ESCRT complex. Located in endosome membrane; midbody; and plasma membrane. Part of ESCRT I complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables calcium-dependent protein binding activity. Involved in positive regulation of viral budding via host ESCRT complex. Located in endosome membrane; midbody; and plasma membrane. Part of ESCRT I complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability ratio, Decreased viability after Maraba virus infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Inconclusive, Increased nuclear migration speed, 	GO:0006612 GO:0006623
SHB 	SHB (SH2 Domain Containing Adaptor Protein B) is a Protein Coding gene. Diseases associated with SHB include  Sulfhemoglobinemia SHF	Enables phosphotyrosine residue binding activity. Predicted to be involved in several processes, including angiogenesis; apoptotic process; and signal transduction. Predicted to act upstream of or within several processes, including hematopoietic stem cell proliferation; negative regulation of oocyte maturation; and positive regulation of immune response. Located in cytoplasmic ribonucleoprotein granule; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables phosphotyrosine residue binding activity. Predicted to be involved in several processes, including angiogenesis; apoptotic process; and signal transduction. Predicted to act upstream of or within several processes, including hematopoietic stem cell proliferation; negative regulation of oocyte maturation; and positive regulation of immune response. Located in cytoplasmic ribonucleoprotein granule; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Increased G1 DNA content, Strongly decreased CFP-tsO45G cell surface transport, Increased viability with SS1P at EC90, 	GO:0001525 GO:0001568 GO:0001568 GO:0001568 GO:0006469 GO:0006469 GO:0006469 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007165 GO:0007165
CNN2 	CNN2 (Calponin 2) is a Protein Coding gene. Diseases associated with CNN2 include  CNN3	The protein encoded by this gene, which can bind actin, calmodulin, troponin C, and tropomyosin, may function in the structural organization of actin filaments. The encoded protein could play a role in smooth muscle contraction and cell adhesion. Several pseudogenes of this gene have been identified, and are present on chromosomes 1, 2, 3, 6, 9, 11, 13, 15, 16, 21 and 22. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2015]	The protein encoded by this gene, which can bind actin, calmodulin, troponin C, and tropomyosin, may function in the structural organization of actin filaments. The encoded protein could play a role in smooth muscle contraction and cell adhesion. Several pseudogenes of this gene have been identified, and are present on chromosomes 1, 2, 3, 6, 9, 11, 13, 15, 16, 21 and 22. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, High actin ratio cells, 	GO:0006909 GO:0007010 GO:0007010 GO:0007010
DIAPH3 	DIAPH3 (Diaphanous Related Formin 3) is a Protein Coding gene. Diseases associated with DIAPH3 include  binding DIAPH2	This gene encodes a member of the diaphanous subfamily of the formin family. Members of this family are involved in actin remodeling and regulate cell movement and adhesion. Mutations in this gene are associated with autosomal dominant auditory neuropathy 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]	This gene encodes a member of the diaphanous subfamily of the formin family. Members of this family are involved in actin remodeling and regulate cell movement and adhesion. Mutations in this gene are associated with autosomal dominant auditory neuropathy 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased IL-8 secretion, Increased hepcidin::fluc mRNA expression, Increased homologous recombination repair frequency, 	 
RNF213 	RNF213 (Ring Finger Protein 213) is a Protein Coding gene. Diseases associated with RNF213 include 	This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]	This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability in colon lineage, Increased G2M DNA content, Synthetic lethal with paclitaxel, G2 arrest, 	GO:0001525 GO:0002040 GO:0002376 GO:0006511 GO:0006511 GO:0006511
HSP90AA1 	HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1) is a Protein Coding gene. Diseases associated with HSP90AA1 include  Candidiasis HSP90AB1	The protein encoded by this gene is an inducible molecular chaperone that functions as a homodimer. The encoded protein aids in the proper folding of specific target proteins by use of an ATPase activity that is modulated by co-chaperones. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]	The protein encoded by this gene is an inducible molecular chaperone that functions as a homodimer. The encoded protein aids in the proper folding of specific target proteins by use of an ATPase activity that is modulated by co-chaperones. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased HPV16-GFP infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0001764 GO:0001934 GO:0001934 GO:0001934 GO:0002218 GO:0002230
PLD1 	PLD1 (Phospholipase D1) is a Protein Coding gene. Diseases associated with PLD1 include  PLD2	This gene encodes a phosphatidylcholine-specific phospholipase which catalyzes the hydrolysis of phosphatidylcholine in order to yield phosphatidic acid and choline. The enzyme may play a role in signal transduction and subcellular trafficking. Alternative splicing results in multiple transcript variants with both catalytic and regulatory properties. [provided by RefSeq, Sep 2011]	This gene encodes a phosphatidylcholine-specific phospholipase which catalyzes the hydrolysis of phosphatidylcholine in order to yield phosphatidic acid and choline. The enzyme may play a role in signal transduction and subcellular trafficking. Alternative splicing results in multiple transcript variants with both catalytic and regulatory properties. [provided by RefSeq, Sep 2011]	no effect, shRNA abundance &lt;= 50%, Decreased IL-8 secretion, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased viability, 	GO:0006629 GO:0006654 GO:0006654 GO:0006654 GO:0006935 GO:0006935 GO:0006935 GO:0007264 GO:0007264 GO:0007264
EPB41L5 	EPB41L5 (Erythrocyte Membrane Protein Band 4.1 Like 5) is a Protein Coding gene. Diseases associated with EPB41L5 include  EPB41L4B	Predicted to enable cytoskeletal protein binding activity and protein domain specific binding activity. Predicted to be involved in actomyosin structure organization. Predicted to act upstream of or within several processes, including chordate embryonic development; embryonic foregut morphogenesis; and mesoderm morphogenesis. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable cytoskeletal protein binding activity and protein domain specific binding activity. Predicted to be involved in actomyosin structure organization. Predicted to act upstream of or within several processes, including chordate embryonic development; embryonic foregut morphogenesis; and mesoderm morphogenesis. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	no effect, 	 
CTBP1 	CTBP1 (C-Terminal Binding Protein 1) is a Protein Coding gene. Diseases associated with CTBP1 include  CTBP2	This gene encodes a protein that binds to the C-terminus of adenovirus E1A proteins. This phosphoprotein is a transcriptional repressor and may play a role during cellular proliferation. This protein and the product of a second closely related gene, CTBP2, can dimerize. Both proteins can also interact with a polycomb group protein complex which participates in regulation of gene expression during development. Alternative splicing of transcripts from this gene results in multiple transcript variants. This gene encodes a protein that binds to the C-terminus of adenovirus E1A proteins. This phosphoprotein is a transcriptional repressor and may play a role during cellular proliferation. This protein and the product of a second closely related gene, CTBP2, can dimerize. Both proteins can also interact with a polycomb group protein complex which participates in regulation of gene expression during development. Alternative splicing of transcripts from this gene results in multiple transcript variants. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, shRNA abundance &lt;= 25%, Decreased viability in pancreas lineage, Decreased transferrin (TF) endocytosis, 	GO:0000122 GO:0006357 GO:0006468 GO:0008285 GO:0019079
SOSTDC1 	SOSTDC1 (Sclerostin Domain Containing 1) is a Protein Coding gene. Diseases associated with SOSTDC1 include  Sclerosteosis SOST	This gene is a member of the sclerostin family and encodes an N-glycosylated, secreted protein with a C-terminal cystine knot-like domain. This protein functions as a bone morphogenetic protein (BMP) antagonist. Specifically, it directly associates with BMPs, prohibiting them from binding their receptors, thereby regulating BMP signaling during cellular proliferation, differentiation, and programmed cell death. This gene is a member of the sclerostin family and encodes an N-glycosylated, secreted protein with a C-terminal cystine knot-like domain. This protein functions as a bone morphogenetic protein (BMP) antagonist. Specifically, it directly associates with BMPs, prohibiting them from binding their receptors, thereby regulating BMP signaling during cellular proliferation, differentiation, and programmed cell death. Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, 	GO:0007389 GO:0010454 GO:0010454 GO:0010454 GO:0016055 GO:0016055 GO:0016055 GO:0030178 GO:0030178 GO:0030178
ACTN4 	ACTN4 (Actinin Alpha 4) is a Protein Coding gene. Diseases associated with ACTN4 include  ACTN1	 Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins.  Alpha actinin is an actin-binding protein with multiple roles in different cell types.  In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane.  In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments.  This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes.  Mutations in this gene have been associated with focal and segmental glomerulosclerosis.  Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins.  Alpha actinin is an actin-binding protein with multiple roles in different cell types.  In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane.  In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments.  This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes.  Mutations in this gene have been associated with focal and segmental glomerulosclerosis. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0001666 GO:0015031 GO:0015031 GO:0015031 GO:0030036 GO:0030036 GO:0030036 GO:0030050 GO:0030335
MGP 	MGP (Matrix Gla Protein) is a Protein Coding gene. Diseases associated with MGP include 	This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia. [provided by RefSeq, Sep 2016]	This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia. [provided by RefSeq, Sep 2016]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased number of mitotic cells, Decreased shRNA abundance (Z-score &lt; -2), Increased G2M DNA content, 	GO:0001502
JAG1 	JAG1 (Jagged Canonical Notch Ligand 1) is a Protein Coding gene. Diseases associated with JAG1 include  JAG2	The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. no effect, Decreased viability ratio, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased G1 DNA content, Strongly decreased CFP-tsO45G cell surface transport, Decreased vaccinia virus (VACV-LREV ) gene expression, 	GO:0001525 GO:0001709 GO:0001953
RASGRP2 	RASGRP2 (RAS Guanyl Releasing Protein 2) is a Protein Coding gene. Diseases associated with RASGRP2 include  RASGRP3	The protein encoded by this gene is a brain-enriched nucleotide exchanged factor that contains an N-terminal GEF domain, 2 tandem repeats of EF-hand calcium-binding motifs, and a C-terminal diacylglycerol/phorbol ester-binding domain. This protein can activate small GTPases, including RAS and RAP1/RAS3. The nucleotide exchange activity of this protein can be stimulated by calcium and diacylglycerol. Four alternatively spliced transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]	The protein encoded by this gene is a brain-enriched nucleotide exchanged factor that contains an N-terminal GEF domain, 2 tandem repeats of EF-hand calcium-binding motifs, and a C-terminal diacylglycerol/phorbol ester-binding domain. This protein can activate small GTPases, including RAS and RAP1/RAS3. The nucleotide exchange activity of this protein can be stimulated by calcium and diacylglycerol. Four alternatively spliced transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased IL-8 secretion, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased caspase activity, 	GO:0001558 GO:0007165 GO:0007264 GO:0007265 GO:0007265 GO:0007265 GO:0043547
FLRT3 	FLRT3 (Fibronectin Leucine Rich Transmembrane Protein 3) is a Protein Coding gene. Diseases associated with FLRT3 include  FLRT1	This gene encodes a member of the fibronectin leucine rich transmembrane protein (FLRT) family. FLRTs may function in cell adhesion and/or receptor signalling. Their protein structures resemble small leucine-rich proteoglycans found in the extracellular matrix. This gene is expressed in many tissues. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2010]	This gene encodes a member of the fibronectin leucine rich transmembrane protein (FLRT) family. FLRTs may function in cell adhesion and/or receptor signalling. Their protein structures resemble small leucine-rich proteoglycans found in the extracellular matrix. This gene is expressed in many tissues. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2010]	no effect, Decreased viability ratio, Increased G1 DNA content, G0/1 arrest, Increased nuclear migration speed, 	 
CCND1 	CCND1 (Cyclin D1) is a Protein Coding gene. Diseases associated with CCND1 include  CCND2	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in pancreas lineage, Increased viability with MLN4924 (a NAE inhibitor), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0000079 GO:0000082 GO:0000122
NF1 	NF1 (Neurofibromin 1) is a Protein Coding gene. Diseases associated with NF1 include  binding RASA3	This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA&gt;UGA-&gt;Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA&gt;UGA-&gt;Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Increased cell migration, Increased shRNA abundance with PLX4720, Decreased shRNA abundance (Z-score &lt; -2), Increased cell number in G1, small nuclei in G1, Decreased sensitivity to paclitaxel, 	 
HGF 	HGF (Hepatocyte Growth Factor) is a Protein Coding gene. Diseases associated with HGF include  MST1	This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015]	This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased HPV16-GFP infection, Negative genetic interaction between BLM-/- and BLM+/+, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Increased centriole number, 	GO:0000278 GO:0000902 GO:0001837 GO:0001837 GO:0001837 GO:0001889 GO:0001934 GO:0001934 GO:0001934
PML 	PML (PML Nuclear Body Scaffold) is a Protein Coding gene. Diseases associated with PML include  Leukemia TRIM33	The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein\'s central and C-terminal regions; all variants encode the same N-terminus. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein\'s central and C-terminal regions; all variants encode the same N-terminus. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Increased S DNA content, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Two nuclei (binuclear), polylobed nuclei, 	GO:0001666 GO:0002230 GO:0002376 GO:0002376 GO:0002376 GO:0006355 GO:0006355 GO:0006355
FADD 	FADD (Fas Associated Via Death Domain) is a Protein Coding gene. Diseases associated with FADD include 	The protein encoded by this gene is an adaptor molecule that interacts with various cell surface receptors and mediates cell apoptotic signals. Through its C-terminal death domain, this protein can be recruited by TNFRSF6/Fas-receptor, tumor necrosis factor receptor, TNFRSF25, and TNFSF10/TRAIL-receptor, and thus it participates in the death signaling initiated by these receptors. Interaction of this protein with the receptors unmasks the N-terminal effector domain of this protein, which allows it to recruit caspase-8, and thereby activate the cysteine protease cascade. Knockout studies in mice also suggest the importance of this protein in early T cell development. The protein encoded by this gene is an adaptor molecule that interacts with various cell surface receptors and mediates cell apoptotic signals. Through its C-terminal death domain, this protein can be recruited by TNFRSF6/Fas-receptor, tumor necrosis factor receptor, TNFRSF25, and TNFSF10/TRAIL-receptor, and thus it participates in the death signaling initiated by these receptors. Interaction of this protein with the receptors unmasks the N-terminal effector domain of this protein, which allows it to recruit caspase-8, and thereby activate the cysteine protease cascade. Knockout studies in mice also suggest the importance of this protein in early T cell development. Mitotic spindle defects, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Negative genetic interaction between BLM-/- and BLM+/+, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability with paclitaxel, 	GO:0001822 GO:0001916 GO:0001916 GO:0001916 GO:0002376 GO:0002376 GO:0002376 GO:0002821 GO:0002821 GO:0002821 GO:0006915 GO:0006915 GO:0006915
RAC1 	RAC1 (Rac Family Small GTPase 1) is a Protein Coding gene. Diseases associated with RAC1 include  RAC3	The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]	The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]	no effect, Synthetic lethal with Ras, Decreased viability, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability (cell death), Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, Increased cell death HMECs cells, Decreased cell migration, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased telomerase activity, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0001764 GO:0001934 GO:0001934 GO:0001934 GO:0003376 GO:0006954 GO:0007015
NECTIN2 	NECTIN2 (Nectin Cell Adhesion Molecule 2) is a Protein Coding gene. Diseases associated with NECTIN2 include  PVR	This gene encodes a single-pass type I membrane glycoprotein with two Ig-like C2-type domains and an Ig-like V-type domain. This protein is one of the plasma membrane components of adherens junctions. It also serves as an entry for certain mutant strains of herpes simplex virus and pseudorabies virus, and it is involved in cell to cell spreading of these viruses. Variations in this gene have been associated with differences in the severity of multiple sclerosis. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene encodes a single-pass type I membrane glycoprotein with two Ig-like C2-type domains and an Ig-like V-type domain. This protein is one of the plasma membrane components of adherens junctions. It also serves as an entry for certain mutant strains of herpes simplex virus and pseudorabies virus, and it is involved in cell to cell spreading of these viruses. Variations in this gene have been associated with differences in the severity of multiple sclerosis. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in pancreas lineage, Increased HPV18 LCR reporter activity, Increased free cholesterol, Decreased cilium length after serum starvation, Increased LDL uptake, 	GO:0001675 GO:0002860 GO:0002891 GO:0007010
BAMBI 	BAMBI (BMP And Activin Membrane Bound Inhibitor) is a Protein Coding gene. Diseases associated with BAMBI include  CATIP	This gene encodes a transmembrane glycoprotein related to the type I receptors of the transforming growth factor-beta (TGF-beta) family, whose members play important roles in signal transduction in many developmental and pathological processes. The encoded protein however is a pseudoreceptor, lacking an intracellular serine/threonine kinase domain required for signaling. Similar proteins in frog, mouse and zebrafish function as negative regulators of TGF-beta, which has led to the suggestion that the encoded protein may function to limit the signaling range of the TGF-beta family during early embryogenesis. This gene encodes a transmembrane glycoprotein related to the type I receptors of the transforming growth factor-beta (TGF-beta) family, whose members play important roles in signal transduction in many developmental and pathological processes. The encoded protein however is a pseudoreceptor, lacking an intracellular serine/threonine kinase domain required for signaling. Similar proteins in frog, mouse and zebrafish function as negative regulators of TGF-beta, which has led to the suggestion that the encoded protein may function to limit the signaling range of the TGF-beta family during early embryogenesis. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, 	GO:0007179 GO:0008284 GO:0008360 GO:0010718 GO:0016477
TPX2 	TPX2 (TPX2 Microtubule Nucleation Factor) is a Protein Coding gene. Diseases associated with TPX2 include 	Enables importin-alpha family protein binding activity and protein kinase binding activity. Involved in activation of protein kinase activity; microtubule cytoskeleton organization; and negative regulation of microtubule depolymerization. Located in intercellular bridge; mitotic spindle; and nucleoplasm. Colocalizes with spindle pole. [provided by Alliance of Genome Resources, Apr 2022]	Enables importin-alpha family protein binding activity and protein kinase binding activity. Involved in activation of protein kinase activity; microtubule cytoskeleton organization; and negative regulation of microtubule depolymerization. Located in intercellular bridge; mitotic spindle; and nucleoplasm. Colocalizes with spindle pole. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Mitotic spindle defects, no effect, Decreased viability, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased cell number, Increased number of mitotic cells, Abundance of large cells with protrusions and bright nuclei, Inconclusive, Decreased homologous recombination repair frequency, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), polylobed nuclei, many micronuclei (grape), decreased viability (cell death), Cell division defect, Multipolar spindles, Inhibition of centrosomal clustering, Increased cell number in G2M, increased number of polyploid cells, increased number of cells with high perimeter-to-area ratio nuclei, Decreased cell number, increased G2M DNA content, increased 8N DNA content, 	GO:0000278 GO:0006915 GO:0007020 GO:0007020 GO:0007020 GO:0007026
LPAR1 	LPAR1 (Lysophosphatidic Acid Receptor 1) is a Protein Coding gene. Diseases associated with LPAR1 include  LPAR2	The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Many transcript variants encoding a few different isoforms have been identified for this gene. [provided by RefSeq, Oct 2020]	The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Many transcript variants encoding a few different isoforms have been identified for this gene. [provided by RefSeq, Oct 2020]	Increased gamma-H2AX phosphorylation, Increased viability, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased NF-kappaB reporter expression, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with paclitaxel, 	GO:0007165 GO:0007186 GO:0007186 GO:0007186 GO:0007189 GO:0007193 GO:0007193 GO:0007193 GO:0007202 GO:0007202 GO:0007202
JAK1 	JAK1 (Janus Kinase 1) is a Protein Coding gene. Diseases associated with JAK1 include  TYK2	This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants.  This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants.  no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, Decreased viability in colon lineage, Increased Nanog expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability (cell death), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased HIV-LTR-beta-galactosidase protein expression, Increased cell death HMECs cells, Decreased cell migration, Increased cell death in HCC-1954 cells, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in DLD-1 cells, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Decreased p24 protein expression, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Increased apoptosis, Decreased viability in HMC1.1 cells, Decreased viability in CMK cells, 	GO:0006468 GO:0007259 GO:0007260
BTK 	BTK (Bruton Tyrosine Kinase) is a Protein Coding gene. Diseases associated with BTK include  TEC	The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]	The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Increased cell viability after pRB stimulation, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, 	GO:0001780 GO:0001805 GO:0001805 GO:0001805 GO:0001812 GO:0001812 GO:0001812 GO:0001818 GO:0001818 GO:0001818 GO:0002250 GO:0002250 GO:0002250
ADD1 	ADD1 (Adducin 1) is a Protein Coding gene. Diseases associated with ADD1 include  ADD3	Adducins are a family of cytoskeletal proteins encoded by three genes (alpha, beta, and gamma). Adducin acts as a heterodimer of the related alpha, beta, or gamma subunits. The protein encoded by this gene represents the alpha subunit. Alpha- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. [provided by RefSeq, Aug 2017]	Adducins are a family of cytoskeletal proteins encoded by three genes (alpha, beta, and gamma). Adducin acts as a heterodimer of the related alpha, beta, or gamma subunits. The protein encoded by this gene represents the alpha subunit. Alpha- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. [provided by RefSeq, Aug 2017]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased cell number, Inconclusive, Increased shRNA abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased shRNA abundance (Z-score &lt; -2), 	 
CREG1 	CREG1 (Cellular Repressor Of E1A Stimulated Genes 1) is a Protein Coding gene. Diseases associated with CREG1 include  Ornithosis CREG2	The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation. The protein encoded by this gene antagonizes transcriptional activation and cellular transformation by E1A. This protein shares limited sequence similarity with E1A and binds both the general transcription factor TBP and the tumor suppressor pRb in vitro. This gene may contribute to the transcriptional control of cell growth and differentiation. The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation. The protein encoded by this gene antagonizes transcriptional activation and cellular transformation by E1A. This protein shares limited sequence similarity with E1A and binds both the general transcription factor TBP and the tumor suppressor pRb in vitro. This gene may contribute to the transcriptional control of cell growth and differentiation. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357
WAS 	WAS (WASP Actin Nucleation Promoting Factor) is a Protein Coding gene. Diseases associated with WAS include  WASL	 The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton.  The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins.  Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3.  Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene.  The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients.  A transcript variant arising as a result of alternative promoter usage, and containing a different 5\' UTR sequence, has been described, however, its full-length nature is not known.  The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton.  The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins.  Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3.  Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene.  The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients.  A transcript variant arising as a result of alternative promoter usage, and containing a different 5\' UTR sequence, has been described, however, its full-length nature is not known. no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, 	GO:0002625 GO:0006952 GO:0006955 GO:0007015 GO:0007266 GO:0007266 GO:0007266
GABARAPL1 	GABARAPL1 (GABA Type A Receptor Associated Protein Like 1) is a Protein Coding gene. Diseases associated with GABARAPL1 include  GABARAP	Enables Tat protein binding activity and ubiquitin protein ligase binding activity. Predicted to be involved in autophagosome assembly; autophagy of mitochondrion; and cellular response to nitrogen starvation. Located in autophagosome. Colocalizes with mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]	Enables Tat protein binding activity and ubiquitin protein ligase binding activity. Predicted to be involved in autophagosome assembly; autophagy of mitochondrion; and cellular response to nitrogen starvation. Located in autophagosome. Colocalizes with mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Increased number of mitotic cells, Increased ionizing radiation sensitivity, Increased homologous recombination repair frequency, Cell division defect, Decreased Salmonella proliferation, Increased 8N DNA content, 	GO:0000045 GO:0000422 GO:0006914 GO:0006995 GO:0006995 GO:0006995 GO:0016236
NFAT5 	NFAT5 (Nuclear Factor Of Activated T Cells 5) is a Protein Coding gene. Diseases associated with NFAT5 include  NFATC3	The product of this gene is a member of the nuclear factors of activated T cells family of transcription factors. Proteins belonging to this family play a central role in inducible gene transcription during the immune response. This protein regulates gene expression induced by osmotic stress in mammalian cells. Unlike monomeric members of this protein family, this protein exists as a homodimer and forms stable dimers with DNA elements. Multiple transcript variants encoding different isoforms have been found for this gene. The product of this gene is a member of the nuclear factors of activated T cells family of transcription factors. Proteins belonging to this family play a central role in inducible gene transcription during the immune response. This protein regulates gene expression induced by osmotic stress in mammalian cells. Unlike monomeric members of this protein family, this protein exists as a homodimer and forms stable dimers with DNA elements. Multiple transcript variants encoding different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased IL-8 secretion, Increased shRNA abundance (Z-score &gt; 2), Increased cell number in G1, average or increased nuclei size in G1, 	GO:0001816 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006366
GABRA5 	GABRA5 (Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha5) is a Protein Coding gene. Diseases associated with GABRA5 include  GABRA3	GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Strongly decreased CFP-tsO45G cell surface transport, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, 	GO:0001662 GO:0006811 GO:0006811 GO:0006811 GO:0006821 GO:0006821 GO:0006821 GO:0007165 GO:0007165 GO:0007165 GO:0007214
MST1 	MST1 (Macrophage Stimulating 1) is a Protein Coding gene. Diseases associated with MST1 include  HGF	The protein encoded by this gene contains four kringle domains and a serine protease domain, similar to that found in hepatic growth factor. Despite the presence of the serine protease domain, the encoded protein may not have any proteolytic activity. The receptor for this protein is RON tyrosine kinase, which upon activation stimulates ciliary motility of ciliated epithelial lung cells. This protein is secreted and cleaved to form an alpha chain and a beta chain bridged by disulfide bonds. [provided by RefSeq, Jan 2010]	The protein encoded by this gene contains four kringle domains and a serine protease domain, similar to that found in hepatic growth factor. Despite the presence of the serine protease domain, the encoded protein may not have any proteolytic activity. The receptor for this protein is RON tyrosine kinase, which upon activation stimulates ciliary motility of ciliated epithelial lung cells. This protein is secreted and cleaved to form an alpha chain and a beta chain bridged by disulfide bonds. [provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased HPV18 LCR reporter activity, Increased shRNA abundance, Decreased BPV1 E2 protein expression, 	 
SEMA3G 	SEMA3G (Semaphorin 3G) is a Protein Coding gene. Diseases associated with SEMA3G include  SEMA3E	The transcription of this gene is activated by PPAR-gamma, and the resulting protein product plays a role in endothelial cell migration. Expression of this gene also inhibits tumor cell migration and invasion. The transcription of this gene is activated by PPAR-gamma, and the resulting protein product plays a role in endothelial cell migration. Expression of this gene also inhibits tumor cell migration and invasion. Increased gamma-H2AX phosphorylation, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in pancreas lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased homologous recombination repair frequency, Increased Salmonella enterica Typhimurium invasion, 	GO:0001755 GO:0007411 GO:0030335 GO:0030517 GO:0048843 GO:0048843 GO:0048843
MYO18A 	MYO18A (Myosin XVIIIA) is a Protein Coding gene. Diseases associated with MYO18A include  MYO18B	The protein encoded by this gene can bind GOLPH3, linking the Golgi to the cytoskeleton and influencing Golgi membrane trafficking. The encoded protein is also part of a complex that assembles lamellar actomyosin bundles and may be required for cell migration. [provided by RefSeq, Oct 2016]	The protein encoded by this gene can bind GOLPH3, linking the Golgi to the cytoskeleton and influencing Golgi membrane trafficking. The encoded protein is also part of a complex that assembles lamellar actomyosin bundles and may be required for cell migration. [provided by RefSeq, Oct 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), 	GO:0006259 GO:0007030 GO:0007030 GO:0007030 GO:0016477 GO:0031032 GO:0043030
RAP1GAP 	RAP1GAP (RAP1 GTPase Activating Protein) is a Protein Coding gene. Diseases associated with RAP1GAP include  RAP1GAP2	This gene encodes a type of GTPase-activating-protein (GAP) that down-regulates the activity of the ras-related RAP1 protein. RAP1 acts as a molecular switch by cycling between an inactive GDP-bound form and an active GTP-bound form. The product of this gene, RAP1GAP, promotes the hydrolysis of bound GTP and hence returns RAP1 to the inactive state whereas other proteins, guanine nucleotide exchange factors (GEFs), act as RAP1 activators by facilitating the conversion of RAP1 from the GDP- to the GTP-bound form. In general, ras subfamily proteins, such as RAP1, play key roles in receptor-linked signaling pathways that control cell growth and differentiation. RAP1 plays a role in diverse processes such as cell proliferation, adhesion, differentiation, and embryogenesis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Aug 2011]	This gene encodes a type of GTPase-activating-protein (GAP) that down-regulates the activity of the ras-related RAP1 protein. RAP1 acts as a molecular switch by cycling between an inactive GDP-bound form and an active GTP-bound form. The product of this gene, RAP1GAP, promotes the hydrolysis of bound GTP and hence returns RAP1 to the inactive state whereas other proteins, guanine nucleotide exchange factors (GEFs), act as RAP1 activators by facilitating the conversion of RAP1 from the GDP- to the GTP-bound form. In general, ras subfamily proteins, such as RAP1, play key roles in receptor-linked signaling pathways that control cell growth and differentiation. RAP1 plays a role in diverse processes such as cell proliferation, adhesion, differentiation, and embryogenesis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Aug 2011]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability, Decreased viability in ovarian lineage, Increased Nanog expression, Decreased POU5F1-GFP protein expression, Increased circadian period length, Moderately decreased NFAT1-GFP nuclear translocation, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased proliferation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0002250 GO:0007165 GO:0007165 GO:0007165 GO:0043087 GO:0043547
DROSHA 	DROSHA (Drosha Ribonuclease III) is a Protein Coding gene. Diseases associated with DROSHA include 	This gene encodes a ribonuclease (RNase) III double-stranded RNA-specific ribonuclease and subunit of the microprocessor protein complex, which catalyzes the initial processing step of microRNA (miRNA) synthesis. The encoded protein cleaves the stem loop structure from the primary microRNA (pri-miRNA) in the nucleus, yielding the precursor miRNA (pre-miRNA), which is then exported to the cytoplasm for further processing. In a human cell line lacking a functional copy of this gene, canonical miRNA synthesis is reduced. Somatic mutations in this gene have been observed in human patients with kidney cancer. [provided by RefSeq, Sep 2016]	This gene encodes a ribonuclease (RNase) III double-stranded RNA-specific ribonuclease and subunit of the microprocessor protein complex, which catalyzes the initial processing step of microRNA (miRNA) synthesis. The encoded protein cleaves the stem loop structure from the primary microRNA (pri-miRNA) in the nucleus, yielding the precursor miRNA (pre-miRNA), which is then exported to the cytoplasm for further processing. In a human cell line lacking a functional copy of this gene, canonical miRNA synthesis is reduced. Somatic mutations in this gene have been observed in human patients with kidney cancer. [provided by RefSeq, Sep 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	 
ADAM10 	ADAM10 (ADAM Metallopeptidase Domain 10) is a Protein Coding gene. Diseases associated with ADAM10 include  ADAM17	Members of the ADAM family are cell surface proteins with a unique structure possessing both potential adhesion and protease domains. This gene encodes and ADAM family member that cleaves many proteins including TNF-alpha and E-cadherin. Alternate splicing results in multiple transcript variants encoding different proteins that may undergo similar processing. [provided by RefSeq, Feb 2016]	Members of the ADAM family are cell surface proteins with a unique structure possessing both potential adhesion and protease domains. This gene encodes and ADAM family member that cleaves many proteins including TNF-alpha and E-cadherin. Alternate splicing results in multiple transcript variants encoding different proteins that may undergo similar processing. [provided by RefSeq, Feb 2016]	no effect, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased Salmonella enterica Typhimurium invasion, Moderately decreased NFAT1-GFP nuclear translocation, Decreased Tat-dependent transcription, Decreased transferrin (TF) endocytosis, Decreased p24 protein expression, Decreased viability in colon lineage; decreased viability in glioblastoma multiforme (GBM) lineage, 	GO:0001701 GO:0006468 GO:0006468 GO:0006468 GO:0006508 GO:0006508 GO:0006508 GO:0006509 GO:0006509 GO:0006509 GO:0007162
TRIM33 	TRIM33 (Tripartite Motif Containing 33) is a Protein Coding gene. Diseases associated with TRIM33 include  TRIM66	The protein encoded by this gene is thought to be a transcriptional corepressor. However, molecules that interact with this protein have not yet been identified. The protein is a member of the tripartite motif family. This motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. Three alternatively spliced transcript variants for this gene have been described, however, the full-length nature of one variant has not been determined. The protein encoded by this gene is thought to be a transcriptional corepressor. However, molecules that interact with this protein have not yet been identified. The protein is a member of the tripartite motif family. This motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. Three alternatively spliced transcript variants for this gene have been described, however, the full-length nature of one variant has not been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased viability with SS1P at EC90, Increased S DNA content, Weakly decreased NFAT1-GFP nuclear translocation, Big cells, Wnt reporter upregulated, 	GO:0000122 GO:0016567 GO:0016567 GO:0016567 GO:0017015 GO:0017015 GO:0017015 GO:0030514 GO:0045892
NPHS1 	NPHS1 (NPHS1 Adhesion Molecule, Nephrin) is a Protein Coding gene. Diseases associated with NPHS1 include  KIRREL1	This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]	This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]	Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, 	 
PTPRM 	PTPRM (Protein Tyrosine Phosphatase Receptor Type M) is a Protein Coding gene. Diseases associated with PTPRM include  Schizophrenia PTPRT	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP has been shown to mediate cell-cell aggregation through the interaction with another molecule of this PTP on an adjacent cell. This PTP can interact with scaffolding protein RACK1/GNB2L1, which may be necessary for the downstream signaling in response to cell-cell adhesion. Alternative splicing results in multiple transcripts encoding distinct isoforms. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP mu (MAM) domain, an Ig-like domain and four fibronectin type III-like repeats. This PTP has been shown to mediate cell-cell aggregation through the interaction with another molecule of this PTP on an adjacent cell. This PTP can interact with scaffolding protein RACK1/GNB2L1, which may be necessary for the downstream signaling in response to cell-cell adhesion. Alternative splicing results in multiple transcripts encoding distinct isoforms. Increased vaccinia virus (VACV) infection, Decreased viability, Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased shRNA abundance (Z-score &lt; -2), Increased apoptosis, 	GO:0001937 GO:0006470 GO:0007155 GO:0007156 GO:0007156 GO:0007156 GO:0007165
PDGFA 	PDGFA (Platelet Derived Growth Factor Subunit A) is a Protein Coding gene. Diseases associated with PDGFA include  PDGFB	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit A, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit B. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit A, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit B. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0001775 GO:0001775 GO:0001775
ANXA2 	ANXA2 (Annexin A2) is a Protein Coding gene. Diseases associated with ANXA2 include  ANXA1	This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions as an autocrine factor which heightens osteoclast formation and bone resorption. This gene has three pseudogenes located on chromosomes 4, 9 and 10, respectively. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. Annexin A2 expression has been found to correlate with resistance to treatment against various cancer forms. [provided by RefSeq, Dec 2019]	This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions as an autocrine factor which heightens osteoclast formation and bone resorption. This gene has three pseudogenes located on chromosomes 4, 9 and 10, respectively. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. Annexin A2 expression has been found to correlate with resistance to treatment against various cancer forms. [provided by RefSeq, Dec 2019]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0001525 GO:0001765 GO:0001921 GO:0002091 GO:0006900
STRN 	STRN (Striatin) is a Protein Coding gene. Diseases associated with STRN include  STRN3	Enables armadillo repeat domain binding activity; estrogen receptor binding activity; and protein phosphatase 2A binding activity. Involved in Wnt signaling pathway and negative regulation of cell population proliferation. Located in bicellular tight junction. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables armadillo repeat domain binding activity; estrogen receptor binding activity; and protein phosphatase 2A binding activity. Involved in Wnt signaling pathway and negative regulation of cell population proliferation. Located in bicellular tight junction. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Increased homologous recombination repair frequency, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Two nuclei (binuclear), decreased viability (cell death), 	GO:0007626 GO:0008285 GO:0008285 GO:0008285 GO:0016055 GO:0016358 GO:0070830 GO:0070830 GO:0070830
VCP 	VCP (Valosin Containing Protein) is a Protein Coding gene. Diseases associated with VCP include  SPATA5	This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017]	This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased homologous recombination repair frequency, Decreased centriole number, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Mitotic arrest, spindle defect, 	GO:0006281 GO:0006302 GO:0006511 GO:0006734 GO:0006734 GO:0006734
NOD1 	NOD1 (Nucleotide Binding Oligomerization Domain Containing 1) is a Protein Coding gene. Diseases associated with NOD1 include  NOD2	This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients. [provided by RefSeq, Aug 2017]	This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Polylobed nuclei, 	GO:0002221 GO:0002376 GO:0002606 GO:0002606 GO:0002606 GO:0006915 GO:0006915 GO:0006915 GO:0006919 GO:0006919 GO:0006919
SOST 	SOST (Sclerostin) is a Protein Coding gene. Diseases associated with SOST include  SOSTDC1	Sclerostin is a secreted glycoprotein with a C-terminal cysteine knot-like (CTCK) domain and sequence similarity to the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. Loss-of-function mutations in this gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth. A deletion downstream of this gene, which causes reduced sclerostin expression, is associated with a milder form of the disorder called van Buchem disease. Sclerostin is a secreted glycoprotein with a C-terminal cysteine knot-like (CTCK) domain and sequence similarity to the DAN (differential screening-selected gene aberrative in neuroblastoma) family of bone morphogenetic protein (BMP) antagonists. Loss-of-function mutations in this gene are associated with an autosomal-recessive disorder, sclerosteosis, which causes progressive bone overgrowth. A deletion downstream of this gene, which causes reduced sclerostin expression, is associated with a milder form of the disorder called van Buchem disease. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased NF-kappaB reporter expression, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001503 GO:0009612 GO:0016055 GO:0030178 GO:0030178 GO:0030178 GO:0030279
RTKN2 	RTKN2 (Rhotekin 2) is a Protein Coding gene.    An important paralog of this gene is  RTKN	Involved in negative regulation of intrinsic apoptotic signaling pathway; positive regulation of NF-kappaB transcription factor activity; and positive regulation of NIK/NF-kappaB signaling. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Involved in negative regulation of intrinsic apoptotic signaling pathway; positive regulation of NF-kappaB transcription factor activity; and positive regulation of NIK/NF-kappaB signaling. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Polylobed nuclei, 	GO:0007165 GO:0008284 GO:0008284 GO:0008284 GO:0030097 GO:0051092 GO:1901224
ACVR1 	ACVR1 (Activin A Receptor Type 1) is a Protein Coding gene. Diseases associated with ACVR1 include  Epicanthus ACVRL1	Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased ionizing radiation sensitivity, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Increased cell migration, Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased IL-13 protein expression, 	 
HSP90B1 	HSP90B1 (Heat Shock Protein 90 Beta Family Member 1) is a Protein Coding gene. Diseases associated with HSP90B1 include  HSP90AB1	This gene encodes a member of a family of adenosine triphosphate(ATP)-metabolizing molecular chaperones with roles in stabilizing and folding other proteins. The encoded protein is localized to melanosomes and the endoplasmic reticulum. Expression of this protein is associated with a variety of pathogenic states, including tumor formation. There is a microRNA gene located within the 5\' exon of this gene. There are pseudogenes for this gene on chromosomes 1 and 15. [provided by RefSeq, Aug 2012]	This gene encodes a member of a family of adenosine triphosphate(ATP)-metabolizing molecular chaperones with roles in stabilizing and folding other proteins. The encoded protein is localized to melanosomes and the endoplasmic reticulum. Expression of this protein is associated with a variety of pathogenic states, including tumor formation. There is a microRNA gene located within the 5\' exon of this gene. There are pseudogenes for this gene on chromosomes 1 and 15. [provided by RefSeq, Aug 2012]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased transferrin (TF) endocytosis, Increased G1 DNA content, G0/1 arrest, Strongly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Synthetic lethal with vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001666 GO:0006457 GO:0015031 GO:0030433 GO:0030970
PDCD10 	PDCD10 (Programmed Cell Death 10) is a Protein Coding gene. Diseases associated with PDCD10 include 	This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), 	GO:0001525 GO:0003158 GO:0003158 GO:0003158 GO:0006915 GO:0008284 GO:0008284 GO:0008284 GO:0010628
NHERF2 	NHERF2 (NHERF Family PDZ Scaffold Protein 2) is a Protein Coding gene. Diseases associated with NHERF2 include  NHERF1	This gene encodes a member of the NHERF family of PDZ scaffolding proteins. These proteins mediate many cellular processes by binding to and regulating the membrane expression and protein-protein interactions of membrane receptors and transport proteins. The encoded protein plays a role in intestinal sodium absorption by regulating the activity of the sodium/hydrogen exchanger 3, and may also regulate the cystic fibrosis transmembrane regulator (CFTR) ion channel. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	This gene encodes a member of the NHERF family of PDZ scaffolding proteins. These proteins mediate many cellular processes by binding to and regulating the membrane expression and protein-protein interactions of membrane receptors and transport proteins. The encoded protein plays a role in intestinal sodium absorption by regulating the activity of the sodium/hydrogen exchanger 3, and may also regulate the cystic fibrosis transmembrane regulator (CFTR) ion channel. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability (cell death), Synthetic lethal with vaccinia virus (VACV) infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased nuclei size in G2M, 	GO:0006508 GO:0065003 GO:0065003 GO:0065003 GO:0072659
RAP1GDS1 	RAP1GDS1 (Rap1 GTPase-GDP Dissociation Stimulator 1) is a Protein Coding gene. Diseases associated with RAP1GDS1 include  binding	The smg GDP dissociation stimulator (smgGDS) protein is a stimulatory GDP/GTP exchange protein with GTPase activity (Riess et al., 1993 [PubMed 8262526]).[supplied by OMIM, Feb 2010]	The smg GDP dissociation stimulator (smgGDS) protein is a stimulatory GDP/GTP exchange protein with GTPase activity (Riess et al., 1993 [PubMed 8262526]).[supplied by OMIM, Feb 2010]	no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Strongly decreased CFP-tsO45G cell surface transport, Increased HPV18 LCR reporter activity, Increased hepcidin::fluc mRNA expression, Decreased homologous recombination repair frequency, Actin fiber cells, 	GO:0003300 GO:0010821 GO:0010821 GO:0010821 GO:0014829 GO:0031034 GO:0031034 GO:0031034 GO:0032471 GO:0032471 GO:0032471
CDK9 	CDK9 (Cyclin Dependent Kinase 9) is a Protein Coding gene. Diseases associated with CDK9 include  Retinoblastoma CDK12	The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS. The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Decreased substrate adherent cell growth, Decreased viability (cell death), Abundance of large cells with protrusions and bright nuclei, Increased circadian period length, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Metaphase cells, Increased cell death in HCT116 cells, Increased cell death in DLD-1 cells, Decreased cell migration, Decreased simian virus 40 (SV40) infection, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, Transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006281 GO:0006282 GO:0006282 GO:0006282 GO:0006366 GO:0006367
ADGRF5 	ADGRF5 (Adhesion G Protein-Coupled Receptor F5) is a Protein Coding gene. Diseases associated with ADGRF5 include  ADGRF1	Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and cell surface receptor signaling pathway. Predicted to act upstream of or within several processes, including glomerular filtration; pharyngeal arch artery morphogenesis; and surfactant homeostasis. Located in cell surface and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and cell surface receptor signaling pathway. Predicted to act upstream of or within several processes, including glomerular filtration; pharyngeal arch artery morphogenesis; and surfactant homeostasis. Located in cell surface and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022]	Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Negative genetic interaction between BLM-/- and BLM+/+, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0003094 GO:0006112 GO:0006112 GO:0006112 GO:0007165 GO:0007166 GO:0007166 GO:0007166 GO:0007186 GO:0007186 GO:0007186
ARHGAP29 	ARHGAP29 (Rho GTPase Activating Protein 29) is a Protein Coding gene. Diseases associated with ARHGAP29 include  ARHGAP45	Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016]	Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability, 	GO:0007165 GO:0007266 GO:0007266 GO:0007266 GO:0051056 GO:0090630 GO:0090630 GO:0090630
BMP1 	BMP1 (Bone Morphogenetic Protein 1) is a Protein Coding gene. Diseases associated with BMP1 include  TLL2	This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008]	This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased melanin production, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased homologous recombination repair frequency, Decreased HIV-1 infection, 	GO:0001501 GO:0001502
GPC1 	GPC1 (Glypican 1) is a Protein Coding gene. Diseases associated with GPC1 include  Omodysplasia GPC6	Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage.  These proteins may play a role in the control of cell division and growth regulation. Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage.  These proteins may play a role in the control of cell division and growth regulation. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, FOXO1 nuclear localization, Negative genetic interaction between BLM-/- and BLM+/+, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, 	GO:0009966 GO:0014037 GO:0014037 GO:0014037 GO:0016477 GO:0016477 GO:0016477 GO:0030200
GRIP1 	GRIP1 (Glutamate Receptor Interacting Protein 1) is a Protein Coding gene. Diseases associated with GRIP1 include  GRIP2	This gene encodes a member of the glutamate receptor interacting protein family. The encoded scaffold protein binds to and mediates the trafficking and membrane organization of a number of transmembrane proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, May 2010]	This gene encodes a member of the glutamate receptor interacting protein family. The encoded scaffold protein binds to and mediates the trafficking and membrane organization of a number of transmembrane proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, May 2010]	Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, 	GO:0016358 GO:0035556 GO:0035556 GO:0035556 GO:0098887
TFEB 	TFEB (Transcription Factor EB) is a Protein Coding gene. Diseases associated with TFEB include  Pycnodysostosis MITF	Enables DNA-binding transcription factor activity; enzyme binding activity; and transcription cis-regulatory region binding activity. Involved in several processes, including cellular response to amino acid starvation; lysosome localization; and positive regulation of autophagy. Located in cytosol; lysosomal membrane; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription factor activity; enzyme binding activity; and transcription cis-regulatory region binding activity. Involved in several processes, including cellular response to amino acid starvation; lysosome localization; and positive regulation of autophagy. Located in cytosol; lysosomal membrane; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, 	GO:0001892 GO:0002250 GO:0002250 GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0006355 GO:0006355 GO:0006355 GO:0006357
MAPK7 	MAPK7 (Mitogen-Activated Protein Kinase 7) is a Protein Coding gene. Diseases associated with MAPK7 include  MAPK6	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors. Four alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported. The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors. Four alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Synthetic lethal with Ras, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased substrate adherent cell growth, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Decreased viability with TRAIL, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007049 GO:0007049 GO:0007049 GO:0007165 GO:0007165 GO:0007165
CDK4 	CDK4 (Cyclin Dependent Kinase 4) is a Protein Coding gene. Diseases associated with CDK4 include  CDK6	The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), Decreased cell migration, Decreased shRNA abundance, Increased cell viability after pRB stimulation, Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, 	GO:0000082 GO:0006468 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0008284 GO:0008284 GO:0008284
AKT2 	AKT2 (AKT Serine/Threonine Kinase 2) is a Protein Coding gene. Diseases associated with AKT2 include  AKT1	This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, Decreased IL-8 secretion, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, Decreased viability, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), Increased cell viability after pRB stimulation, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Increased apoptosis, Increased cell transformation, 	 
ITGA5 	ITGA5 (Integrin Subunit Alpha 5) is a Protein Coding gene. Diseases associated with ITGA5 include  ITGA8	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 5 subunit. This subunit associates with the beta 1 subunit to form a fibronectin receptor. This integrin may promote tumor invasion, and higher expression of this gene may be correlated with shorter survival time in lung cancer patients. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 5 subunit. This subunit associates with the beta 1 subunit to form a fibronectin receptor. This integrin may promote tumor invasion, and higher expression of this gene may be correlated with shorter survival time in lung cancer patients. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell number in G1, small nuclei in G1, 	GO:0001525 GO:0007044 GO:0007155 GO:0007155 GO:0007155
MDC1 	MDC1 (Mediator Of DNA Damage Checkpoint 1) is a Protein Coding gene. Diseases associated with MDC1 include  PAXIP1	The protein encoded by this gene contains an N-terminal forkhead domain, two BRCA1 C-terminal (BRCT) motifs and a central domain with 13 repetitions of an approximately 41-amino acid sequence. The encoded protein is required to activate the intra-S phase and G2/M phase cell cycle checkpoints in response to DNA damage. This nuclear protein interacts with phosphorylated histone H2AX near sites of DNA double-strand breaks through its BRCT motifs, and facilitates recruitment of the ATM kinase and meiotic recombination 11 protein complex to DNA damage foci. The protein encoded by this gene contains an N-terminal forkhead domain, two BRCA1 C-terminal (BRCT) motifs and a central domain with 13 repetitions of an approximately 41-amino acid sequence. The encoded protein is required to activate the intra-S phase and G2/M phase cell cycle checkpoints in response to DNA damage. This nuclear protein interacts with phosphorylated histone H2AX near sites of DNA double-strand breaks through its BRCT motifs, and facilitates recruitment of the ATM kinase and meiotic recombination 11 protein complex to DNA damage foci. no effect, Decreased viability, Decreased viability ratio, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased shRNA abundance, 	GO:0006281 GO:0006974 GO:0006974 GO:0006974 GO:0007049 GO:0007049 GO:0007049 GO:0031573 GO:0031573 GO:0031573 GO:0060261
MEG3 	MEG3 (Maternally Expressed 3) is an RNA Gene, and is affiliated with the lncRNA class. Diseases associated with MEG3 include 	This gene is a maternally expressed imprinted gene. Multiple alternatively spliced transcript variants have been transcribed from this gene and all of them are long non-coding RNAs (lncRNAs). This gene is expressed in many normal tissues, but its expression is lost in multiple cancer cell lines of various tissue origins. It inhibits tumor cell proliferation in vitro. It also interacts with the tumor suppressor p53, and regulates p53 target gene expression. Its deletion enhances angiogenesis in vivo. Many experimental evidences demonstrate that this gene is a lncRNA tumor suppressor. [provided by RefSeq, Mar 2012]	This gene is a maternally expressed imprinted gene. Multiple alternatively spliced transcript variants have been transcribed from this gene and all of them are long non-coding RNAs (lncRNAs). This gene is expressed in many normal tissues, but its expression is lost in multiple cancer cell lines of various tissue origins. It inhibits tumor cell proliferation in vitro. It also interacts with the tumor suppressor p53, and regulates p53 target gene expression. Its deletion enhances angiogenesis in vivo. Many experimental evidences demonstrate that this gene is a lncRNA tumor suppressor. [provided by RefSeq, Mar 2012] 
SSH1 	SSH1 (Slingshot Protein Phosphatase 1) is a Protein Coding gene. Diseases associated with SSH1 include  Porokeratosis SSH2	The protein encoded by this gene belongs to the slingshot homolog (SSH) family of phosphatases, which regulate actin filament dynamics. The SSH proteins dephosphorylate and activate the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Cofilin is inactivated by kinases such as LIM domain kinase-1 (LIMK1), which may also be dephosphorylated and inactivated by SSH proteins. The SSH family thus appears to play a role in actin dynamics by reactivating cofilin proteins. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]	The protein encoded by this gene belongs to the slingshot homolog (SSH) family of phosphatases, which regulate actin filament dynamics. The SSH proteins dephosphorylate and activate the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Cofilin is inactivated by kinases such as LIM domain kinase-1 (LIMK1), which may also be dephosphorylated and inactivated by SSH proteins. The SSH family thus appears to play a role in actin dynamics by reactivating cofilin proteins. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, no effect, Inconclusive, Negative genetic interaction between BLM-/- and BLM+/+, Increased viability with SS1P at EC90, Decreased epidermal growth factor (EGF) endocytosis, Increased HPV16-GFP infection, 	GO:0000902 GO:0006470 GO:0016311 GO:0030036 GO:0030036 GO:0030036 GO:0030837
FYN 	FYN (FYN Proto-Oncogene, Src Family Tyrosine Kinase) is a Protein Coding gene. Diseases associated with FYN include  YES1	This gene is a member of the protein-tyrosine kinase oncogene family. It encodes a membrane-associated tyrosine kinase that has been implicated in the control of cell growth. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. This gene is a member of the protein-tyrosine kinase oncogene family. It encodes a membrane-associated tyrosine kinase that has been implicated in the control of cell growth. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, Decreased simian virus 40 (SV40) infection, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), (Transferrin accumulation in the perinuclear area), 	GO:0000304
CALM1 	CALM1 (Calmodulin 1) is a Protein Coding gene. Diseases associated with CALM1 include  CALM3	This gene encodes one of three calmodulin proteins which are members of the EF-hand calcium-binding protein family. Calcium-induced activation of calmodulin regulates and modulates the function of cardiac ion channels. Two pseudogenes have been identified on chromosome 7 and X. Multiple transcript variants encoding different isoforms have been found for this gene.A missense mutation in the CALM1 gene has been associated with ventricular tachycardia.[provided by RefSeq, May 2020]	This gene encodes one of three calmodulin proteins which are members of the EF-hand calcium-binding protein family. Calcium-induced activation of calmodulin regulates and modulates the function of cardiac ion channels. Two pseudogenes have been identified on chromosome 7 and X. Multiple transcript variants encoding different isoforms have been found for this gene.A missense mutation in the CALM1 gene has been associated with ventricular tachycardia.[provided by RefSeq, May 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Strongly decreased CFP-tsO45G cell surface transport, Increased G1 length, Synthetic lethal with imatinib mesylate, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Synthetic lethal with gemcitabine, 	GO:0000086 GO:0002027 GO:0002027 GO:0002027 GO:0005513 GO:0007186 GO:0010800
MSX2 	MSX2 (Msh Homeobox 2) is a Protein Coding gene. Diseases associated with MSX2 include  MSX1	This gene encodes a member of the muscle segment homeobox gene family. The encoded protein is a transcriptional repressor whose normal activity may establish a balance between survival and apoptosis of neural crest-derived cells required for proper craniofacial morphogenesis. The encoded protein may also have a role in promoting cell growth under certain conditions and may be an important target for the RAS signaling pathways. Mutations in this gene are associated with parietal foramina 1 and craniosynostosis type 2. This gene encodes a member of the muscle segment homeobox gene family. The encoded protein is a transcriptional repressor whose normal activity may establish a balance between survival and apoptosis of neural crest-derived cells required for proper craniofacial morphogenesis. The encoded protein may also have a role in promoting cell growth under certain conditions and may be an important target for the RAS signaling pathways. Mutations in this gene are associated with parietal foramina 1 and craniosynostosis type 2. Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased Aire reporter expression, 	 
CCL2 	CCL2 (C-C Motif Chemokine Ligand 2) is a Protein Coding gene. Diseases associated with CCL2 include  CCL7	This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS&amp;#8208;CoV&amp;#8208;2) infection. [provided by RefSeq, Aug 2020]	This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS&amp;#8208;CoV&amp;#8208;2) infection. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased POU5F1-GFP protein expression, Decreased NF-kappaB reporter expression, Decreased homologous recombination repair frequency, Decreased OCT4 protein expression, Decreased NANOG protein expression, 	GO:0000165 GO:0001525 GO:0002548 GO:0006468 GO:0006935
FGFRL1 	FGFRL1 (Fibroblast Growth Factor Receptor Like 1) is a Protein Coding gene. Diseases associated with FGFRL1 include  MCRIP2	The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. A marked difference between this gene product and the other family members is its lack of a cytoplasmic tyrosine kinase domain. The result is a transmembrane receptor that could interact with other family members and potentially inhibit signaling. Multiple alternatively spliced transcript variants encoding the same isoform have been found for this gene. The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. A marked difference between this gene product and the other family members is its lack of a cytoplasmic tyrosine kinase domain. The result is a transmembrane receptor that could interact with other family members and potentially inhibit signaling. Multiple alternatively spliced transcript variants encoding the same isoform have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Increased Nanog expression, 	 
RASSF1 	RASSF1 (Ras Association Domain Family Member 1) is a Protein Coding gene. Diseases associated with RASSF1 include  RASSF5	This gene encodes a protein similar to the RAS effector proteins. Loss or altered expression of this gene has been associated with the pathogenesis of a variety of cancers, which suggests the tumor suppressor function of this gene. The inactivation of this gene was found to be correlated with the hypermethylation of its CpG-island promoter region. The encoded protein was found to interact with DNA repair protein XPA. The protein was also shown to inhibit the accumulation of cyclin D1, and thus induce cell cycle arrest. Several alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, May 2011]	This gene encodes a protein similar to the RAS effector proteins. Loss or altered expression of this gene has been associated with the pathogenesis of a variety of cancers, which suggests the tumor suppressor function of this gene. The inactivation of this gene was found to be correlated with the hypermethylation of its CpG-island promoter region. The encoded protein was found to interact with DNA repair protein XPA. The protein was also shown to inhibit the accumulation of cyclin D1, and thus induce cell cycle arrest. Several alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, 	GO:0006974 GO:0007049 GO:0007049 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0007265 GO:0007265 GO:0007265
HBEGF 	HBEGF (Heparin Binding EGF Like Growth Factor) is a Protein Coding gene. Diseases associated with HBEGF include  Diphtheria AREG	Enables growth factor activity and heparin binding activity. Involved in several processes, including epidermal growth factor receptor signaling pathway; positive regulation of protein kinase B signaling; and positive regulation of wound healing. Located in cell surface and extracellular space. Implicated in glomerulosclerosis and perinatal necrotizing enterocolitis. [provided by Alliance of Genome Resources, Apr 2022]	Enables growth factor activity and heparin binding activity. Involved in several processes, including epidermal growth factor receptor signaling pathway; positive regulation of protein kinase B signaling; and positive regulation of wound healing. Located in cell surface and extracellular space. Implicated in glomerulosclerosis and perinatal necrotizing enterocolitis. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased replication of vaccinia virus (VACV), Decreased shRNA abundance, 	GO:0007165 GO:0007173 GO:0007517 GO:0008016 GO:0008284 GO:0008284 GO:0008284
NCAM1 	NCAM1 (Neural Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with NCAM1 include  NCAM2	This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]	This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Reduced mammosphere formation, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Increased hepcidin::fluc mRNA expression, Decreased shRNA abundance, Decreased viability, Decreased cell migration, Decreased cell number, increased G2M DNA content, 	 
ARAF 	ARAF (A-Raf Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with ARAF include  RAF1	This proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2012]	This proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2012]	Increased viability, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 25%, Increased G1 DNA content, G0/1 arrest, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Increased cell viability after pRB stimulation, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Misorientated spindle, Increased viability with 4OH tamoxifen, 	 
TBC1D14 	TBC1D14 (TBC1 Domain Family Member 14) is a Protein Coding gene. Diseases associated with TBC1D14 include  TBC1D12	Enables protein kinase binding activity. Involved in negative regulation of autophagy; recycling endosome to Golgi transport; and regulation of autophagosome assembly. Located in several cellular components, including Golgi apparatus; autophagosome; and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022]	Enables protein kinase binding activity. Involved in negative regulation of autophagy; recycling endosome to Golgi transport; and regulation of autophagosome assembly. Located in several cellular components, including Golgi apparatus; autophagosome; and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased cell size, Increased S DNA content, 	GO:0006914 GO:0010507 GO:0010507 GO:0010507 GO:0071955 GO:0090630 GO:1902017
FOS 	FOS (Fos Proto-Oncogene, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with FOS include  Osteoblastoma FOSL2	The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2.  These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1.  As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation.  In some cases, expression of the FOS gene has also been associated with apoptotic cell death. The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2.  These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1.  As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation.  In some cases, expression of the FOS gene has also been associated with apoptotic cell death. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased ionizing radiation sensitivity, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with vaccinia virus (VACV) infection, Increased Sindbis virus (SINV) infection, 	GO:0001661 GO:0006306 GO:0006306 GO:0006306 GO:0006355 GO:0006357 GO:0006357 GO:0006357
KCNQ1 	KCNQ1 (Potassium Voltage-Gated Channel Subfamily Q Member 1) is a Protein Coding gene. Diseases associated with KCNQ1 include  KCNQ5	This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]	This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, 	 
CDK5 	CDK5 (Cyclin Dependent Kinase 5) is a Protein Coding gene. Diseases associated with CDK5 include  Tauopathy CDK3	This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]	This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased Nanog expression, Wnt reporter downregulated, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Increased Salmonella enterica Typhimurium invasion, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Decreased substrate adherent cell growth, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased viability in non-small-cell lung cancer (NSCLC) lineage; decreased viability in pancreas lineage, 	GO:0000083 GO:0000226 GO:0001764
FBN1 	FBN1 (Fibrillin 1) is a Protein Coding gene. Diseases associated with FBN1 include  FBN2	This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]	This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, 	GO:0001501 GO:0001656 GO:0001822 GO:0001822 GO:0001822 GO:0007165 GO:0007165 GO:0007165 GO:0007507 GO:0007507 GO:0007507
ARHGEF1 	ARHGEF1 (Rho Guanine Nucleotide Exchange Factor 1) is a Protein Coding gene. Diseases associated with ARHGEF1 include  ARHGEF12	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form complex with G proteins and stimulate Rho-dependent signals. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been defined. Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form complex with G proteins and stimulate Rho-dependent signals. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been defined. no effect, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability with paclitaxel, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007186 GO:0007266
CBL 	CBL (Cbl Proto-Oncogene) is a Protein Coding gene. Diseases associated with CBL include  CBLB	This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5\' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5\' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased epidermal growth factor (EGF) endocytosis, Decreased viability, Increased shRNA abundance, Metaphase cells, Decreased cell migration, 	GO:0000209 GO:0006511 GO:0006511 GO:0006511 GO:0006513 GO:0006974 GO:0006974 GO:0006974 GO:0007165 GO:0007165 GO:0007165
VCAM1 	VCAM1 (Vascular Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with VCAM1 include  CHL1	This gene is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Dec 2010]	This gene is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Dec 2010]	no effect, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Increased epidermal growth factor (EGF) endocytosis, 	GO:0001666 GO:0002526 GO:0002526 GO:0002526 GO:0002544 GO:0002544 GO:0002544 GO:0007155 GO:0007155 GO:0007155 GO:0007157
HNRNPK 	HNRNPK (Heterogeneous Nuclear Ribonucleoprotein K) is a Protein Coding gene. Diseases associated with HNRNPK include  PCBP2	This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene is located in the nucleoplasm and has three repeats of KH domains that binds to RNAs. It is distinct among other hnRNP proteins in its binding preference; it binds tenaciously to poly(C). This protein is also thought to have a role during cell cycle progession. Several alternatively spliced transcript variants have been described for this gene, however, not all of them are fully characterized. This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene is located in the nucleoplasm and has three repeats of KH domains that binds to RNAs. It is distinct among other hnRNP proteins in its binding preference; it binds tenaciously to poly(C). This protein is also thought to have a role during cell cycle progession. Several alternatively spliced transcript variants have been described for this gene, however, not all of them are fully characterized. Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased cell number, Decreased NF-kappaB reporter expression, Increased number of mitotic cells, Decreased replication of vaccinia virus (VACV), Decreased homologous recombination repair frequency, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Increased G2M DNA content, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Cell division defect, Increased caspase activity, Decreased vesicular stomatitis virus (VSV) infection, Decreased lymphocytic choriomeningitis virus (LCMV) infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased viability with nutlin-3, 	GO:0000398 GO:0006357 GO:0006396 GO:0006397 GO:0007165 GO:0007165 GO:0007165
IQSEC2 	IQSEC2 (IQ Motif And Sec7 Domain ArfGEF 2) is a Protein Coding gene. Diseases associated with IQSEC2 include  Iqsec2 IQSEC1	This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]	This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, Decreased viability ratio, Increased NF-kappaB reporter expression, 	GO:0030036 GO:0032012 GO:0050804 GO:0050804 GO:0050804 GO:0098696
PRKAA2 	PRKAA2 (Protein Kinase AMP-Activated Catalytic Subunit Alpha 2) is a Protein Coding gene. Diseases associated with PRKAA2 include  Ischemia PRKAA1	The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. no effect, Decreased viability, Decreased viability ratio, Decreased HPV16-GFP infection, Decreased viability (cell death), Decreased vesicular stomatitis virus (VSV) infection, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), Increased cell viability after pRB stimulation, Increased viability with TRAIL, Decreased mitotic index, Increased caspase activity, Increased mitotic index, Decreased cilium length after serum starvation, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006325 GO:0006468 GO:0006468 GO:0006468
HOXB4 	HOXB4 (Homeobox B4) is a Protein Coding gene.  Among its related pathways are  HOXA4	This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Intracellular or ectopic expression of this protein expands hematopoietic stem and progenitor cells in vivo and in vitro, making it a potential candidate for therapeutic stem cell expansion. This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Intracellular or ectopic expression of this protein expands hematopoietic stem and progenitor cells in vivo and in vitro, making it a potential candidate for therapeutic stem cell expansion. Decreased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0000122 GO:0002011 GO:0002011 GO:0002011 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0009952
COL3A1 	COL3A1 (Collagen Type III Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL3A1 include  COL5A2	This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]	This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]	Increased gamma-H2AX phosphorylation, no effect, Reduced mammosphere formation, Negative genetic interaction between PTEN-/- and PTEN+/+, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased viability, Synthetic lethal with imatinib mesylate, 	 
EGLN2 	EGLN2 (Egl-9 Family Hypoxia Inducible Factor 2) is a Protein Coding gene. Diseases associated with EGLN2 include  Polycythemia EGLN1	The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]	The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Increased HPV18 LCR reporter activity, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium ruffling, Decreased shRNA abundance (Z-score &lt; -2), Decreased Salmonella enterica Typhimurium binding, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), dynamic nuclei (hole, folded or small irregular), 	GO:0001558 GO:0001666 GO:0018401 GO:0030520 GO:0043523
HDAC4 	HDAC4 (Histone Deacetylase 4) is a Protein Coding gene. Diseases associated with HDAC4 include  HDAC5	Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. This protein does not bind DNA directly, but through transcription factors MEF2C and MEF2D. It seems to interact in a multiprotein complex with RbAp48 and HDAC3. Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. This protein does not bind DNA directly, but through transcription factors MEF2C and MEF2D. It seems to interact in a multiprotein complex with RbAp48 and HDAC3. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Inconclusive, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Colony formation, 	GO:0000122
L1CAM 	L1CAM (L1 Cell Adhesion Molecule) is a Protein Coding gene. Diseases associated with L1CAM include  NRCAM	The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]	The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Decreased Salmonella enterica Typhimurium invasion, Decreased replication of vaccinia virus (VACV), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased cilium length after serum starvation, 	GO:0006935 GO:0007155 GO:0007156 GO:0007160 GO:0007399
EGLN3 	EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3) is a Protein Coding gene. Diseases associated with EGLN3 include  Polycythemia EGLN1	Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Moderately decreased NFAT1-GFP nuclear translocation, Decreased cilium length after serum starvation, Decreased viability in esophageal squamous lineage; decreased viability in ovarian lineage, 	GO:0001666 GO:0006915 GO:0006919 GO:0006974 GO:0018126 GO:0018126 GO:0018126
DLK1 	DLK1 (Delta Like Non-Canonical Notch Ligand 1) is a Protein Coding gene. Diseases associated with DLK1 include  PEAR1	This gene encodes a transmembrane protein that contains multiple epidermal growth factor repeats that functions as a regulator of cell growth. The encoded protein is involved in the differentiation of several cell types including adipocytes. This gene is located in a region of chromosome 14 frequently showing unparental disomy, and is imprinted and expressed from the paternal allele. A single nucleotide variant in this gene is associated with child and adolescent obesity and shows polar overdominance, where heterozygotes carrying an active paternal allele express the phenotype, while mutant homozygotes are normal. [provided by RefSeq, Nov 2015]	This gene encodes a transmembrane protein that contains multiple epidermal growth factor repeats that functions as a regulator of cell growth. The encoded protein is involved in the differentiation of several cell types including adipocytes. This gene is located in a region of chromosome 14 frequently showing unparental disomy, and is imprinted and expressed from the paternal allele. A single nucleotide variant in this gene is associated with child and adolescent obesity and shows polar overdominance, where heterozygotes carrying an active paternal allele express the phenotype, while mutant homozygotes are normal. [provided by RefSeq, Nov 2015]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Dynamic nuclei (hole, folded or small irregular), Decreased Hepatitis C virus replication, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0030154 GO:0045746 GO:0045746 GO:0045746
GJB1 	GJB1 (Gap Junction Protein Beta 1) is a Protein Coding gene. Diseases associated with GJB1 include  GJB6	This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]	This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased POU5F1-GFP protein expression, Polylobed nuclei, Decreased cell migration, Increased CFP-tsO45G cell surface transport, 	GO:0007154 GO:0007267 GO:0007267 GO:0007267 GO:0007399 GO:0007399 GO:0007399
MAP2K1 	MAP2K1 (Mitogen-Activated Protein Kinase Kinase 1) is a Protein Coding gene. Diseases associated with MAP2K1 include  MAP2K2	The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased vesicular stomatitis virus (VSV) infection, Decreased viability, Increased nuclear migration distance, increased nuclear migration speed, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Increased viability, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, Transferrin accumulation in small spots in the cell periphery, polarized transferrin accumulation in plasma membrane protrusions, 	GO:0000165 GO:0006468 GO:0006935 GO:0007165
PPP2R2B 	PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Bbeta) is a Protein Coding gene. Diseases associated with PPP2R2B include  PPP2R2C	The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a beta isoform of the regulatory subunit B55 subfamily. Defects in this gene cause autosomal dominant spinocerebellar ataxia 12 (SCA12), a disease caused by degeneration of the cerebellum, sometimes involving the brainstem and spinal cord, and in resulting in poor coordination of speech and body movements. Multiple alternatively spliced variants, which encode different isoforms, have been identified for this gene. The 5\' UTR of some of these variants includes a CAG trinucleotide repeat sequence (7-28 copies) that can be expanded to 55-78 copies in cases of SCA12. The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a beta isoform of the regulatory subunit B55 subfamily. Defects in this gene cause autosomal dominant spinocerebellar ataxia 12 (SCA12), a disease caused by degeneration of the cerebellum, sometimes involving the brainstem and spinal cord, and in resulting in poor coordination of speech and body movements. Multiple alternatively spliced variants, which encode different isoforms, have been identified for this gene. The 5\' UTR of some of these variants includes a CAG trinucleotide repeat sequence (7-28 copies) that can be expanded to 55-78 copies in cases of SCA12. no effect, Decreased viability, Two nuclei (binuclear), Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased apoptosis, Fragmented cis-Golgi, fragmented medial Golgi, fragmented trans-Golgi, 	 
GRAP2 	GRAP2 (GRB2 Related Adaptor Protein 2) is a Protein Coding gene. Diseases associated with GRAP2 include  GRB2	This gene encodes a member of the GRB2/Sem5/Drk family. This member is an adaptor-like protein involved in leukocyte-specific protein-tyrosine kinase signaling. Like its related family member, GRB2-related adaptor protein (GRAP), this protein contains an SH2 domain flanked by two SH3 domains. This protein interacts with other proteins, such as GRB2-associated binding protein 1 (GAB1) and the SLP-76 leukocyte protein (LCP2), through its SH3 domains. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]	This gene encodes a member of the GRB2/Sem5/Drk family. This member is an adaptor-like protein involved in leukocyte-specific protein-tyrosine kinase signaling. Like its related family member, GRB2-related adaptor protein (GRAP), this protein contains an SH2 domain flanked by two SH3 domains. This protein interacts with other proteins, such as GRB2-associated binding protein 1 (GAB1) and the SLP-76 leukocyte protein (LCP2), through its SH3 domains. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased S DNA content, Decreased Salmonella proliferation, 	GO:0007165 GO:0007265 GO:0007267 GO:0043408
MAP3K2 	MAP3K2 (Mitogen-Activated Protein Kinase Kinase Kinase 2) is a Protein Coding gene. Diseases associated with MAP3K2 include  MAP3K3	The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process. The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process. Increased viability, Reduced mammosphere formation, no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Two nuclei (binuclear), Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased circadian period length, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased telomerase activity, Increased the percentage of infected cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Increased viability with 4OH tamoxifen, Fragmented cis-Golgi, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0016310 GO:0016310 GO:0016310 GO:0035556 GO:0035556 GO:0035556 GO:0071260
PPP1R12A 	PPP1R12A (Protein Phosphatase 1 Regulatory Subunit 12A) is a Protein Coding gene. Diseases associated with PPP1R12A include  PPP1R12B	Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]	Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in pancreas lineage, Dynamic nuclei (hole, folded or small irregular), Increased cell death HMECs cells, Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased shRNA abundance, Increased Nanog expression, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell death in HCC-1954 cells, Increased G1 length, Increased cell death in HCT116 cells, Cell division defect, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased viability after TNF/CHX stimulation, Decreased viability, Decreased cell number, increased G2M DNA content, increased 8N DNA content, 	GO:0000278 GO:0006470 GO:0007098 GO:0007165 GO:0030155 GO:0030155 GO:0030155
GADD45A 	GADD45A (Growth Arrest And DNA Damage Inducible Alpha) is a Protein Coding gene. Diseases associated with GADD45A include  GADD45G	This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase. The DNA damage-induced transcription of this gene is mediated by both p53-dependent and -independent mechanisms. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Dec 2010]	This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase. The DNA damage-induced transcription of this gene is mediated by both p53-dependent and -independent mechanisms. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Dec 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Increased HPV18 LCR reporter activity, 	GO:0000079 GO:0000122 GO:0006281 GO:0006469 GO:0006915 GO:0006915 GO:0006915
MET 	MET (MET Proto-Oncogene, Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with MET include  MST1R	This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]	This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]	no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Decreased cell migration, Moderately decreased NFAT1-GFP nuclear translocation, Increased cell viability after pRB stimulation, Decreased telomerase activity, Increased simian virus 40 (SV40) infection, Increased mitotic index, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Transferrin accumulation in small spots in the cell periphery, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, 	GO:0001886 GO:0001889 GO:0006468 GO:0006909 GO:0006909 GO:0006909 GO:0007165
PDE5A 	PDE5A (Phosphodiesterase 5A) is a Protein Coding gene. Diseases associated with PDE5A include  Impotence Priapism PDE11A	This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5\'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5\'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. no effect, shRNA abundance &lt;= 50%, Increased transferrin (TF) endocytosis, Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, No cells, Decreased caspase 3/7 activity, 	 
ETV5 	ETV5 (ETS Variant Transcription Factor 5) is a Protein Coding gene. Diseases associated with ETV5 include  ETV1	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in cellular response to oxidative stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in cellular response to oxidative stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased Nanog expression, Increased hepcidin::fluc mRNA expression, Decreased epidermal growth factor (EGF) endocytosis, Elongated cells, 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0030154 GO:0034599
PLEKHA7 	PLEKHA7 (Pleckstrin Homology Domain Containing A7) is a Protein Coding gene. Diseases associated with PLEKHA7 include  PLEKHA5	Enables delta-catenin binding activity. Involved in epithelial cell-cell adhesion; pore complex assembly; and zonula adherens maintenance. Located in several cellular components, including centrosome; nucleoplasm; and zonula adherens. Part of pore complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables delta-catenin binding activity. Involved in epithelial cell-cell adhesion; pore complex assembly; and zonula adherens maintenance. Located in several cellular components, including centrosome; nucleoplasm; and zonula adherens. Part of pore complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Increased G1 DNA content, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0044331 GO:0045218 GO:0046931 GO:0090136
TAB1 	TAB1 (TGF-Beta Activated Kinase 1 (MAP3K7) Binding Protein 1) is a Protein Coding gene. Diseases associated with TAB1 include  PPM1A	The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, 	GO:0001701 GO:0003007 GO:0003007 GO:0003007 GO:0003279 GO:0003279 GO:0003279 GO:0006470 GO:0006470 GO:0006470
STK25 	STK25 (Serine/Threonine Kinase 25) is a Protein Coding gene. Diseases associated with STK25 include  STK24	This gene encodes a member of the germinal centre kinase III (GCK III) subfamily of the sterile 20 superfamily of kinases. The encoded enzyme plays a role in serine-threonine liver kinase B1 (LKB1) signaling pathway to regulate neuronal polarization and morphology of the Golgi apparatus. The protein is translocated from the Golgi apparatus to the nucleus in response to chemical anoxia and plays a role in regulation of cell death. A pseudogene associated with this gene is located on chromosome 18. Multiple alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]	This gene encodes a member of the germinal centre kinase III (GCK III) subfamily of the sterile 20 superfamily of kinases. The encoded enzyme plays a role in serine-threonine liver kinase B1 (LKB1) signaling pathway to regulate neuronal polarization and morphology of the Golgi apparatus. The protein is translocated from the Golgi apparatus to the nucleus in response to chemical anoxia and plays a role in regulation of cell death. A pseudogene associated with this gene is located on chromosome 18. Multiple alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, shRNA abundance &lt;= 50%, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased viability (proliferation), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Decreased cell proliferation, Increased virus production, Paclitaxel antagonistic effect, 	GO:0006468 GO:0006979 GO:0007163 GO:0007165 GO:0007165 GO:0007165
AP2A2 	AP2A2 (Adaptor Related Protein Complex 2 Subunit Alpha 2) is a Protein Coding gene.  Among its related pathways are  binding AP2A1	The protein encoded by this gene is a subunit of the AP-2 adaptor protein complex, which is involved in linking lipid and protein membrane components with the clathrin lattice. This interaction supports the formation of clathrin-coated vesicles, and the encoded subunit aids in the process by binding polyphosphoinositide-containing lipids in the cell membrane. [provided by RefSeq, Nov 2016]	The protein encoded by this gene is a subunit of the AP-2 adaptor protein complex, which is involved in linking lipid and protein membrane components with the clathrin lattice. This interaction supports the formation of clathrin-coated vesicles, and the encoded subunit aids in the process by binding polyphosphoinositide-containing lipids in the cell membrane. [provided by RefSeq, Nov 2016]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability with paclitaxel, Decreased viability after Maraba virus infection, Inconclusive, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0006886 GO:0006897 GO:0006897 GO:0006897 GO:0015031 GO:0015031 GO:0015031 GO:0016192 GO:0016192 GO:0016192 GO:0072583
GRB10 	GRB10 (Growth Factor Receptor Bound Protein 10) is a Protein Coding gene. Diseases associated with GRB10 include  GRB14	The product of this gene belongs to a small family of adapter proteins that are known to interact with a number of receptor tyrosine kinases and signaling molecules. This gene encodes a growth factor receptor-binding protein that interacts with insulin receptors and insulin-like growth-factor receptors. Overexpression of some isoforms of the encoded protein inhibits tyrosine kinase activity and results in growth suppression. This gene is imprinted in a highly isoform- and tissue-specific manner, with expression observed from the paternal allele in the brain, and from the maternal allele in the placental trophoblasts. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2010]	The product of this gene belongs to a small family of adapter proteins that are known to interact with a number of receptor tyrosine kinases and signaling molecules. This gene encodes a growth factor receptor-binding protein that interacts with insulin receptors and insulin-like growth-factor receptors. Overexpression of some isoforms of the encoded protein inhibits tyrosine kinase activity and results in growth suppression. This gene is imprinted in a highly isoform- and tissue-specific manner, with expression observed from the paternal allele in the brain, and from the maternal allele in the placental trophoblasts. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Increased ionizing radiation sensitivity, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0007165 GO:0008286 GO:0008286 GO:0008286 GO:0010467 GO:0030178 GO:0030178 GO:0030178 GO:0030949
MT2A 	MT2A (Metallothionein 2A) is a Protein Coding gene. Diseases associated with MT2A include  Scrapie MT1G	This gene is a member of the metallothionein family of genes. Proteins encoded by this gene family are low in molecular weight, are cysteine-rich, lack aromatic residues, and bind divalent heavy metal ions, altering the intracellular concentration of heavy metals in the cell. These proteins act as anti-oxidants, protect against hydroxyl free radicals, are important in homeostatic control of metal in the cell, and play a role in detoxification of heavy metals. The encoded protein interacts with the protein encoded by the homeobox containing 1 gene in some cell types, controlling intracellular zinc levels, affecting apoptotic and autophagy pathways. Some polymorphisms in this gene are associated with an increased risk of cancer. [provided by RefSeq, Sep 2017]	This gene is a member of the metallothionein family of genes. Proteins encoded by this gene family are low in molecular weight, are cysteine-rich, lack aromatic residues, and bind divalent heavy metal ions, altering the intracellular concentration of heavy metals in the cell. These proteins act as anti-oxidants, protect against hydroxyl free radicals, are important in homeostatic control of metal in the cell, and play a role in detoxification of heavy metals. The encoded protein interacts with the protein encoded by the homeobox containing 1 gene in some cell types, controlling intracellular zinc levels, affecting apoptotic and autophagy pathways. Some polymorphisms in this gene are associated with an increased risk of cancer. [provided by RefSeq, Sep 2017]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Dynamic nuclei (hole, folded or small irregular), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased circadian period length, Decreased HIV-1 infection, 	GO:0006878 GO:0006882 GO:0010273 GO:0010273 GO:0010273 GO:0036016 GO:0036016 GO:0036016 GO:0036018
KEAP1 	KEAP1 (Kelch Like ECH Associated Protein 1) is a Protein Coding gene. Diseases associated with KEAP1 include  KLHL20	This gene encodes a protein containing KELCH-1 like domains, as well as a BTB/POZ domain. Kelch-like ECH-associated protein 1 interacts with NF-E2-related factor 2 in a redox-sensitive manner and the dissociation of the proteins in the cytoplasm is followed by transportation of NF-E2-related factor 2 to the nucleus. This interaction results in the expression of the catalytic subunit of gamma-glutamylcysteine synthetase. Two alternatively spliced transcript variants encoding the same isoform have been found for this gene. This gene encodes a protein containing KELCH-1 like domains, as well as a BTB/POZ domain. Kelch-like ECH-associated protein 1 interacts with NF-E2-related factor 2 in a redox-sensitive manner and the dissociation of the proteins in the cytoplasm is followed by transportation of NF-E2-related factor 2 to the nucleus. This interaction results in the expression of the catalytic subunit of gamma-glutamylcysteine synthetase. Two alternatively spliced transcript variants encoding the same isoform have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Increased cell death HMECs cells, Decreased shRNA abundance, Weakly decreased NFAT1-GFP nuclear translocation, Polylobed nuclei, Elongated cells, 	GO:0001701 GO:0006355 GO:0006355 GO:0006355 GO:0006511 GO:0006511 GO:0006511 GO:0010506
PCNA 	PCNA (Proliferating Cell Nuclear Antigen) is a Protein Coding gene. Diseases associated with PCNA include 	The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome. The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome. Mitotic spindle defects, Decreased hepcidin::fluc mRNA expression, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability, Increased transferrin (TF) endocytosis, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased Nanog expression, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased S DNA content, Increased cell death in HCT116 cells, Increased cell death in DLD-1 cells, S arrest, Increased telomere dysfunction-induced foci (TIF) formation, 	GO:0000122 GO:0006260 GO:0006260 GO:0006260 GO:0006272 GO:0006272 GO:0006272
LAMA4 	LAMA4 (Laminin Subunit Alpha 4) is a Protein Coding gene. Diseases associated with LAMA4 include  LAMA3	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]	Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]	no effect, Decreased viability, Large nuclei, Decreased viability with paclitaxel, 	 
SOX18 	SOX18 (SRY-Box Transcription Factor 18) is a Protein Coding gene. Diseases associated with SOX18 include  SOX7	This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. This protein plays a role in hair, blood vessel, and lymphatic vessel development. Mutations in this gene have been associated with recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. This protein plays a role in hair, blood vessel, and lymphatic vessel development. Mutations in this gene have been associated with recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, 	GO:0000122 GO:0001525
RGS2 	RGS2 (Regulator Of G Protein Signaling 2) is a Protein Coding gene. Diseases associated with RGS2 include  Anxiety RGS3	Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis. [provided by RefSeq, Aug 2009]	Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis. [provided by RefSeq, Aug 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability in pancreas lineage, Increased mitotic index, 	 
TUBB2A 	TUBB2A (Tubulin Beta 2A Class IIa) is a Protein Coding gene. Diseases associated with TUBB2A include  TUBB2B	Microtubules, key participants in processes such as mitosis and intracellular transport, are composed of heterodimers of alpha- and beta-tubulins. The protein encoded by this gene is a beta-tubulin. Defects in this gene are associated with complex cortical dysplasia with other brain malformations-5. Two transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2015]	Microtubules, key participants in processes such as mitosis and intracellular transport, are composed of heterodimers of alpha- and beta-tubulins. The protein encoded by this gene is a beta-tubulin. Defects in this gene are associated with complex cortical dysplasia with other brain malformations-5. Two transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2015]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability ratio, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Inconclusive, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000226 GO:0000278
PIK3R1 	PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1) is a Protein Coding gene. Diseases associated with PIK3R1 include  PIK3R2	Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]	Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), No cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased transferrin (TF) endocytosis, Increased homologous recombination repair frequency, Decreased viability after gemcitabine stimulation, 	 
RHOJ 	RHOJ (Ras Homolog Family Member J) is a Protein Coding gene. Diseases associated with RHOJ include  Rhinosporidiosis RHOQ	This gene encodes one of the many small GTP-binding proteins in the Rho family shown to be associated with focal adhesions in endothelial cells (PMID: 21148427, 22103495). The encoded protein is activated by vascular endothelial growth factor and may regulate angiogenesis. [provided by RefSeq, Dec 2011]	This gene encodes one of the many small GTP-binding proteins in the Rho family shown to be associated with focal adhesions in endothelial cells (PMID: 21148427, 22103495). The encoded protein is activated by vascular endothelial growth factor and may regulate angiogenesis. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Decreased shRNA abundance (Z-score &lt; -2), Increased peripheral focal adhesion (FA) formation, 	GO:0001525 GO:0006897 GO:0006897 GO:0006897 GO:0007163
ADD2 	ADD2 (Adducin 2) is a Protein Coding gene. Diseases associated with ADD2 include  ADD3	Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2010]	Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased IL-8 secretion, 	GO:0007416 GO:0030036 GO:0030036 GO:0030036 GO:0030097 GO:0032092 GO:0032092 GO:0032092 GO:0050900
LAMA1 	LAMA1 (Laminin Subunit Alpha 1) is a Protein Coding gene. Diseases associated with LAMA1 include  Myopia LAMA2	This gene encodes one of the alpha 1 subunits of laminin. The laminins are a family of extracellular matrix glycoproteins that have a heterotrimeric structure consisting of an alpha, beta and gamma chain. These proteins make up a major component of the basement membrane and have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Mutations in this gene may be associated with Poretti-Boltshauser syndrome. [provided by RefSeq, Sep 2014]	This gene encodes one of the alpha 1 subunits of laminin. The laminins are a family of extracellular matrix glycoproteins that have a heterotrimeric structure consisting of an alpha, beta and gamma chain. These proteins make up a major component of the basement membrane and have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Mutations in this gene may be associated with Poretti-Boltshauser syndrome. [provided by RefSeq, Sep 2014]	no effect, Mildly decreased CFP-tsO45G cell surface transport, 	 
OXTR 	OXTR (Oxytocin Receptor) is a Protein Coding gene. Diseases associated with OXTR include  AVPR1B	The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. Increased gamma-H2AX phosphorylation, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in colon lineage, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Increased caspase activity, 	GO:0001967 GO:0001975 GO:0001975 GO:0001975 GO:0001992 GO:0001992 GO:0001992 GO:0006936
RBBP7 	RBBP7 (RB Binding Protein 7, Chromatin Remodeling Factor) is a Protein Coding gene. Diseases associated with RBBP7 include  Retinoblastoma RBBP4	This protein is a ubiquitously expressed nuclear protein and belongs to a highly conserved subfamily of WD-repeat proteins. It is found among several proteins that binds directly to retinoblastoma protein, which regulates cell proliferation. The encoded protein is found in many histone deacetylase complexes, including mSin3 co-repressor complex. It is also present in protein complexes involved in chromatin assembly. This protein can interact with BRCA1 tumor-suppressor gene and may have a role in the regulation of cell proliferation and differentiation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]	This protein is a ubiquitously expressed nuclear protein and belongs to a highly conserved subfamily of WD-repeat proteins. It is found among several proteins that binds directly to retinoblastoma protein, which regulates cell proliferation. The encoded protein is found in many histone deacetylase complexes, including mSin3 co-repressor complex. It is also present in protein complexes involved in chromatin assembly. This protein can interact with BRCA1 tumor-suppressor gene and may have a role in the regulation of cell proliferation and differentiation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Inconclusive, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, Increased G1 length, Increased G1 length, increased S length, Increased cell number in G1, average or increased nuclei size in G1, 	GO:0000122 GO:0006260 GO:0006325 GO:0006325 GO:0006325 GO:0006338 GO:0006338 GO:0006338 GO:0006355
SOCS1 	SOCS1 (Suppressor Of Cytokine Signaling 1) is a Protein Coding gene. Diseases associated with SOCS1 include  CISH	This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased telomerase activity, Decreased nuclei size in G2M, Decreased viability in colon lineage; decreased viability in glioblastoma multiforme (GBM) lineage, 	 
GDF11 	GDF11 (Growth Differentiation Factor 11) is a Protein Coding gene. Diseases associated with GDF11 include  MSTN . This protein plays a role in the development of the nervous and other organ systems, and may regulate aging. [provided by RefSeq, Aug 2016] . This protein plays a role in the development of the nervous and other organ systems, and may regulate aging. [provided by RefSeq, Aug 2016]	no effect, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance (Z-score &lt; -2), Decreased Salmonella enterica Typhimurium invasion, Decreased epidermal growth factor (EGF) endocytosis, Decreased homologous recombination repair frequency, 	GO:0001501 GO:0001656 GO:0001657 GO:0001657 GO:0001657 GO:0007165 GO:0007165 GO:0007165 GO:0007399 GO:0007399 GO:0007399
POSTN 	POSTN (Periostin) is a Protein Coding gene. Diseases associated with POSTN include  TGFBI	This gene encodes a secreted extracellular matrix protein that functions in tissue development and regeneration, including wound healing, and ventricular remodeling following myocardial infarction. The encoded protein binds to integrins to support adhesion and migration of epithelial cells. This protein plays a role in cancer stem cell maintenance and metastasis. Mice lacking this gene exhibit cardiac valve disease, and skeletal and dental defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015]	This gene encodes a secreted extracellular matrix protein that functions in tissue development and regeneration, including wound healing, and ventricular remodeling following myocardial infarction. The encoded protein binds to integrins to support adhesion and migration of epithelial cells. This protein plays a role in cancer stem cell maintenance and metastasis. Mice lacking this gene exhibit cardiac valve disease, and skeletal and dental defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Multipolar spindles, Inhibition of centrosomal clustering, 	GO:0007155 GO:0008593 GO:0009888 GO:0009888 GO:0009888 GO:0030198 GO:0030198 GO:0030198 GO:0071307
MAP4K3 	MAP4K3 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 3) is a Protein Coding gene.  Among its related pathways are  MAP4K5	This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]	This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCT116 cells, Increased mitotic index, Condensed cis-Golgi, condensed medial Golgi, condensed trans-Golgi, Increased viability, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, decreased cell spreading, Increased telomerase activity, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007254 GO:0009411
ADAMTS1 	ADAMTS1 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 1) is a Protein Coding gene. Diseases associated with ADAMTS1 include  Chondrosarcoma ADAMTS15	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene contains two disintegrin loops and three C-terminal TS motifs and has anti-angiogenic activity. The expression of this gene may be associated with various inflammatory processes as well as development of cancer cachexia. This gene is likely to be necessary for normal growth, fertility, and organ morphology and function. This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene contains two disintegrin loops and three C-terminal TS motifs and has anti-angiogenic activity. The expression of this gene may be associated with various inflammatory processes as well as development of cancer cachexia. This gene is likely to be necessary for normal growth, fertility, and organ morphology and function. Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased POU5F1-GFP protein expression, Inconclusive, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001542 GO:0001822 GO:0001822 GO:0001822 GO:0006508 GO:0006508 GO:0006508 GO:0007229 GO:0007229 GO:0007229 GO:0008285
KLF2 	KLF2 (KLF Transcription Factor 2) is a Protein Coding gene. Diseases associated with KLF2 include  KLF4	This gene encodes a protein that belongs to the Kruppel family of transcription factors. The encoded zinc finger protein is expressed early in mammalian development and is found in many different cell types. The protein acts to bind the CACCC box found in the promoter of target genes to activate their transcription. It plays a role in many processes during development and disease including adipogenesis, embryonic erythropoiesis, epithelial integrity, inflammation and t-cell viability. [provided by RefSeq, Mar 2017]	This gene encodes a protein that belongs to the Kruppel family of transcription factors. The encoded zinc finger protein is expressed early in mammalian development and is found in many different cell types. The protein acts to bind the CACCC box found in the promoter of target genes to activate their transcription. It plays a role in many processes during development and disease including adipogenesis, embryonic erythropoiesis, epithelial integrity, inflammation and t-cell viability. [provided by RefSeq, Mar 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased Nanog expression, Decreased HIV-LTR-beta-galactosidase protein expression, Negative genetic interaction between BLM-/- and BLM+/+, Decreased replication of vaccinia virus (VACV), Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0000122 GO:0000902 GO:0001701 GO:0001701 GO:0001701 GO:0006357 GO:0006357 GO:0006357
EGLN1 	EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1) is a Protein Coding gene. Diseases associated with EGLN1 include  EGLN2	The protein encoded by this gene catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. This protein functions as a cellular oxygen sensor, and under normal oxygen concentration, modification by prolyl hydroxylation is a key regulatory event that targets HIF subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Mutations in this gene are associated with erythrocytosis familial type 3 (ECYT3). [provided by RefSeq, Nov 2009]	The protein encoded by this gene catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. This protein functions as a cellular oxygen sensor, and under normal oxygen concentration, modification by prolyl hydroxylation is a key regulatory event that targets HIF subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Mutations in this gene are associated with erythrocytosis familial type 3 (ECYT3). [provided by RefSeq, Nov 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased S DNA content, Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), increased nuclear migration speed, 	GO:0001666 GO:0006879 GO:0018401 GO:0018401 GO:0018401 GO:0032364 GO:0043433
MBD1 	MBD1 (Methyl-CpG Binding Domain Protein 1) is a Protein Coding gene. Diseases associated with MBD1 include  MBD2	The protein encoded by this gene is a member of a family of nuclear proteins related by the presence of a methyl-CpG binding domain (MBD). These proteins are capable of binding specifically to methylated DNA, and some members can also repress transcription from methylated gene promoters. This protein contains multiple domains: MBD at the N-terminus that functions both in binding to methylated DNA and in protein interactions; several CXXC-type zinc finger domains that mediate binding to non-methylated CpG dinucleotides; transcriptional repression domain (TRD) at the C-terminus that is involved in transcription repression and in protein interactions. Numerous alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Feb 2011]	The protein encoded by this gene is a member of a family of nuclear proteins related by the presence of a methyl-CpG binding domain (MBD). These proteins are capable of binding specifically to methylated DNA, and some members can also repress transcription from methylated gene promoters. This protein contains multiple domains: MBD at the N-terminus that functions both in binding to methylated DNA and in protein interactions; several CXXC-type zinc finger domains that mediate binding to non-methylated CpG dinucleotides; transcriptional repression domain (TRD) at the C-terminus that is involved in transcription repression and in protein interactions. Numerous alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased shRNA abundance, Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0006366 GO:0045892
WASL 	WASL (WASP Like Actin Nucleation Promoting Factor) is a Protein Coding gene. Diseases associated with WASL include  WAS	This gene encodes a member of the Wiskott-Aldrich syndrome (WAS) protein family. Wiskott-Aldrich syndrome proteins share similar domain structure, and associate with a variety of signaling molecules to alter the actin cytoskeleton. The encoded protein is highly expressed in neural tissues, and interacts with several proteins involved in cytoskeletal organization, including cell division control protein 42 (CDC42) and the actin-related protein-2/3 (ARP2/3) complex. The encoded protein may be involved in the formation of long actin microspikes, and in neurite extension. [provided by RefSeq, Jul 2013]	This gene encodes a member of the Wiskott-Aldrich syndrome (WAS) protein family. Wiskott-Aldrich syndrome proteins share similar domain structure, and associate with a variety of signaling molecules to alter the actin cytoskeleton. The encoded protein is highly expressed in neural tissues, and interacts with several proteins involved in cytoskeletal organization, including cell division control protein 42 (CDC42) and the actin-related protein-2/3 (ARP2/3) complex. The encoded protein may be involved in the formation of long actin microspikes, and in neurite extension. [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell migration, 	GO:0006900 GO:0007015 GO:0007015 GO:0007015 GO:0007049 GO:0007049 GO:0007049 GO:0008154 GO:0008154 GO:0008154
SKI 	SKI (SKI Proto-Oncogene) is a Protein Coding gene. Diseases associated with SKI include  SKIL	This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]	This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Strongly decreased CFP-tsO45G cell surface transport, Increased Nanog expression, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased vaccinia virus (VACV-LREV ) gene expression, 	GO:0000122 GO:0001843 GO:0002089 GO:0002089 GO:0002089 GO:0006351 GO:0006351 GO:0006351 GO:0007179 GO:0007179 GO:0007179
PACSIN1 	PACSIN1 (Protein Kinase C And Casein Kinase Substrate In Neurons 1) is a Protein Coding gene.  Among its related pathways are  PACSIN2	Enables phospholipid binding activity. Involved in plasma membrane tubulation. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables phospholipid binding activity. Involved in plasma membrane tubulation. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Increased homologous recombination repair frequency, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability after ionizing radiation, 	GO:0006897 GO:0007010 GO:0007010 GO:0007010 GO:0007015 GO:0016310 GO:0016310 GO:0016310 GO:0030100 GO:0030100 GO:0030100
TAB2 	TAB2 (TGF-Beta Activated Kinase 1 (MAP3K7) Binding Protein 2) is a Protein Coding gene. Diseases associated with TAB2 include  TAB3	The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Dynamic nuclei (hole, folded or small irregular), Increased hepcidin::fluc mRNA expression, Decreased shRNA abundance, Decreased Sindbis virus (SINV) infection, Decreased Salmonella proliferation, Decreased viability after TNF/CHX stimulation, Synthetic lethal with gemcitabine, 	GO:0007507 GO:0010507 GO:0032496 GO:0043123 GO:0045860
FBXL15 	FBXL15 (F-Box And Leucine Rich Repeat Protein 15) is a Protein Coding gene. Diseases associated with FBXL15 include  FBXL20	Involved in G2/M transition of mitotic cell cycle; cellular protein metabolic process; and positive regulation of BMP signaling pathway. Located in cytoplasm. Part of SCF ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	Involved in G2/M transition of mitotic cell cycle; cellular protein metabolic process; and positive regulation of BMP signaling pathway. Located in cytoplasm. Part of SCF ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Wnt reporter downregulated, Increased cell death in HCC-1954 cells, 	GO:0000086 GO:0009953 GO:0016567 GO:0016567 GO:0016567 GO:0030282 GO:0030282 GO:0030282 GO:0030513 GO:0030513 GO:0030513
EPHA4 	EPHA4 (EPH Receptor A4) is a Protein Coding gene. Diseases associated with EPHA4 include  EPHA5	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Decreased telomerase activity, Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased viability, 	GO:0006468 GO:0007155 GO:0007155 GO:0007155 GO:0007162 GO:0007162 GO:0007162
TBC1D4 	TBC1D4 (TBC1 Domain Family Member 4) is a Protein Coding gene. Diseases associated with TBC1D4 include  TBC1D1	This gene is a member of the Tre-2/BUB2/CDC16 domain family. The protein encoded by this gene is a Rab-GTPase-activating protein, and contains two phopshotyrosine-binding domains (PTB1 and PTB2), a calmodulin-binding domain (CBD), a Rab-GTPase domain, and multiple AKT phosphomotifs. This protein is thought to play an important role in glucose homeostasis by regulating the insulin-dependent trafficking of the glucose transporter 4 (GLUT4), important for removing glucose from the bloodstream into skeletal muscle and fat tissues. Reduced expression of this gene results in an increase in GLUT4 levels at the plasma membrane, suggesting that this protein is important in intracellular retention of GLUT4 under basal conditions. When exposed to insulin, this protein is phosphorylated, dissociates from GLUT4 vesicles, resulting in increased GLUT4 at the cell surface, and enhanced glucose transport. Phosphorylation of this protein by AKT is required for proper translocation of GLUT4 to the cell surface. Individuals homozygous for a mutation in this gene are at higher risk for type 2 diabetes and have higher levels of circulating glucose and insulin levels after glucose ingestion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]	This gene is a member of the Tre-2/BUB2/CDC16 domain family. The protein encoded by this gene is a Rab-GTPase-activating protein, and contains two phopshotyrosine-binding domains (PTB1 and PTB2), a calmodulin-binding domain (CBD), a Rab-GTPase domain, and multiple AKT phosphomotifs. This protein is thought to play an important role in glucose homeostasis by regulating the insulin-dependent trafficking of the glucose transporter 4 (GLUT4), important for removing glucose from the bloodstream into skeletal muscle and fat tissues. Reduced expression of this gene results in an increase in GLUT4 levels at the plasma membrane, suggesting that this protein is important in intracellular retention of GLUT4 under basal conditions. When exposed to insulin, this protein is phosphorylated, dissociates from GLUT4 vesicles, resulting in increased GLUT4 at the cell surface, and enhanced glucose transport. Phosphorylation of this protein by AKT is required for proper translocation of GLUT4 to the cell surface. Individuals homozygous for a mutation in this gene are at higher risk for type 2 diabetes and have higher levels of circulating glucose and insulin levels after glucose ingestion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]	Decreased vaccinia virus (VACV) infection, Increased homologous recombination repair frequency, 	GO:0016192 GO:0031339 GO:0032869 GO:0032869 GO:0032869 GO:0090630
PDIA3 	PDIA3 (Protein Disulfide Isomerase Family A Member 3) is a Protein Coding gene. Diseases associated with PDIA3 include  PDIA4	This gene encodes a protein of the endoplasmic reticulum that interacts with lectin chaperones calreticulin and calnexin to modulate folding of newly synthesized glycoproteins. The protein was once thought to be a phospholipase; however, it has been demonstrated that the protein actually has protein disulfide isomerase activity. It is thought that complexes of lectins and this protein mediate protein folding by promoting formation of disulfide bonds in their glycoprotein substrates. This protein also functions as a molecular chaperone that prevents the formation of protein aggregates. [provided by RefSeq, Dec 2016]	This gene encodes a protein of the endoplasmic reticulum that interacts with lectin chaperones calreticulin and calnexin to modulate folding of newly synthesized glycoproteins. The protein was once thought to be a phospholipase; however, it has been demonstrated that the protein actually has protein disulfide isomerase activity. It is thought that complexes of lectins and this protein mediate protein folding by promoting formation of disulfide bonds in their glycoprotein substrates. This protein also functions as a molecular chaperone that prevents the formation of protein aggregates. [provided by RefSeq, Dec 2016]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased NF-kappaB reporter expression, Decreased HIV-LTR-beta-galactosidase protein expression, Increased viability with SS1P at EC90, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, 	GO:0002502 GO:0006457 GO:0034975 GO:0034976
STK11 	STK11 (Serine/Threonine Kinase 11) is a Protein Coding gene. Diseases associated with STK11 include  DCLK2	The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]	The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability, Wnt reporter downregulated, Decreased substrate adherent cell growth, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased caspase activity, Increased mitotic index, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Increased viability with 4OH tamoxifen, 	GO:0001558 GO:0001894 GO:0001894 GO:0001894 GO:0001944 GO:0001944 GO:0001944 GO:0006468 GO:0006468 GO:0006468 GO:0006470
FARP1 	FARP1 (FERM, ARH/RhoGEF And Pleckstrin Domain Protein 1) is a Protein Coding gene. Diseases associated with FARP1 include  FARP2	This gene encodes a protein containing a FERM (4.2, exrin, radixin, moesin) domain, a Dbl homology domain, and two pleckstrin homology domains. These domains are found in guanine nucleotide exchange factors and proteins that link the cytoskeleton to the cell membrane. The encoded protein functions in neurons to promote dendritic growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]	This gene encodes a protein containing a FERM (4.2, exrin, radixin, moesin) domain, a Dbl homology domain, and two pleckstrin homology domains. These domains are found in guanine nucleotide exchange factors and proteins that link the cytoskeleton to the cell membrane. The encoded protein functions in neurons to promote dendritic growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Increased G1 DNA content, G0/1 arrest, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Inconclusive, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased vaccinia virus (VACV-LREV ) gene expression, 	 
GJA8 	GJA8 (Gap Junction Protein Alpha 8) is a Protein Coding gene. Diseases associated with GJA8 include  GJA3	This gene encodes a transmembrane connexin protein that is necessary for lens growth and maturation of lens fiber cells. The encoded protein is a component of gap junction channels and functions in a calcium and pH-dependent manner. Mutations in this gene have been associated with zonular pulverulent cataracts, nuclear progressive cataracts, and cataract-microcornea syndrome. [provided by RefSeq, Dec 2009]	This gene encodes a transmembrane connexin protein that is necessary for lens growth and maturation of lens fiber cells. The encoded protein is a component of gap junction channels and functions in a calcium and pH-dependent manner. Mutations in this gene have been associated with zonular pulverulent cataracts, nuclear progressive cataracts, and cataract-microcornea syndrome. [provided by RefSeq, Dec 2009]	no effect, Decreased viability, Decreased POU5F1-GFP protein expression, Inconclusive, Decreased OCT4 protein expression, Decreased NANOG protein expression, Increased cell number in G2M, increased number of polyploid cells, 	 
STK3 	STK3 (Serine/Threonine Kinase 3) is a Protein Coding gene. Diseases associated with STK3 include  STK4	This gene encodes a serine/threonine protein kinase activated by proapoptotic molecules indicating the encoded protein functions as a growth suppressor. Cleavage of the protein product by caspase removes the inhibitory C-terminal portion. The N-terminal portion is transported to the nucleus where it homodimerizes to form the active kinase which promotes the condensation of chromatin during apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]	This gene encodes a serine/threonine protein kinase activated by proapoptotic molecules indicating the encoded protein functions as a growth suppressor. Cleavage of the protein product by caspase removes the inhibitory C-terminal portion. The N-terminal portion is transported to the nucleus where it homodimerizes to form the active kinase which promotes the condensation of chromatin during apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Negative genetic interaction between BLM-/- and BLM+/+, Increased cell viability after pRB stimulation, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Paclitaxel antagonistic effect, 	GO:0001841 GO:0003157 GO:0003157 GO:0003157 GO:0006468 GO:0006468 GO:0006468 GO:0006606 GO:0006915
CCN2 	CCN2 (Cellular Communication Network Factor 2) is a Protein Coding gene. Diseases associated with CCN2 include  CCN3	The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]	The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	 
SNX27 	SNX27 (Sorting Nexin 27) is a Protein Coding gene. Diseases associated with SNX27 include  SNX17	This gene encodes a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). A highly similar protein in mouse is responsible for the specific recruitment of an isoform of serotonin 5-hydroxytryptamine 4 receptor into early endosomes, suggesting the analogous role for the human protein. This gene encodes a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). A highly similar protein in mouse is responsible for the specific recruitment of an isoform of serotonin 5-hydroxytryptamine 4 receptor into early endosomes, suggesting the analogous role for the human protein. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased interferon-beta reporter expression, Decreased viability with paclitaxel, Weakly decreased NFAT1-GFP nuclear translocation, Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased viability in colon lineage; decreased viability in glioblastoma multiforme (GBM) lineage, 	GO:0001770 GO:0006886
MAP4K4 	MAP4K4 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4) is a Protein Coding gene. Diseases associated with MAP4K4 include  TNIK	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Large nuclei, Increased cell transformation, 	GO:0000165 GO:0001953 GO:0006468 GO:0016310 GO:0030033 GO:0030033 GO:0030033
COL6A2 	COL6A2 (Collagen Type VI Alpha 2 Chain) is a Protein Coding gene. Diseases associated with COL6A2 include  COL5A1	This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability after Maraba virus infection, 	 
NTF3 	NTF3 (Neurotrophin 3) is a Protein Coding gene. Diseases associated with NTF3 include  Hypochondriasis NGF	The protein encoded by this gene is a member of the neurotrophin family, that controls survival and differentiation of mammalian neurons. This protein is closely related to both nerve growth factor and brain-derived neurotrophic factor. It may be involved in the maintenance of the adult nervous system, and may affect development of neurons in the embryo when it is expressed in human placenta. NTF3-deficient mice generated by gene targeting display severe movement defects of the limbs. The mature peptide of this protein is identical in all mammals examined including human, pig, rat and mouse. The protein encoded by this gene is a member of the neurotrophin family, that controls survival and differentiation of mammalian neurons. This protein is closely related to both nerve growth factor and brain-derived neurotrophic factor. It may be involved in the maintenance of the adult nervous system, and may affect development of neurons in the embryo when it is expressed in human placenta. NTF3-deficient mice generated by gene targeting display severe movement defects of the limbs. The mature peptide of this protein is identical in all mammals examined including human, pig, rat and mouse. Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Inconclusive, Synthetic lethal with MLN4924 (a NAE inhibitor), Synthetic lethal with vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0002092 GO:0007165 GO:0007169 GO:0007267 GO:0007399
SCNN1G 	SCNN1G (Sodium Channel Epithelial 1 Subunit Gamma) is a Protein Coding gene. Diseases associated with SCNN1G include  SCNN1B	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]	Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]	no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability with TRAIL, Increased nuclear migration speed, 	GO:0006811 GO:0006814 GO:0006814 GO:0006814 GO:0006883 GO:0008217 GO:0035725
PAX6 	PAX6 (Paired Box 6) is a Protein Coding gene. Diseases associated with PAX6 include  PAX7	This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter\'s anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]	This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter\'s anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]	no effect, Decreased viability in esophageal squamous lineage, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability (cell death), Inconclusive, 	GO:0000122 GO:0000132 GO:0000132 GO:0000132 GO:0001568 GO:0001568 GO:0001568 GO:0001654
CNTF 	CNTF (Ciliary Neurotrophic Factor) is a Protein Coding gene. Diseases associated with CNTF include 	The protein encoded by this gene is a polypeptide hormone whose actions appear to be restricted to the nervous system where it promotes neurotransmitter synthesis and neurite outgrowth in certain neuronal populations. The protein is a potent survival factor for neurons and oligodendrocytes and may be relevant in reducing tissue destruction during inflammatory attacks. A mutation in this gene, which results in aberrant splicing, leads to ciliary neurotrophic factor deficiency, but this phenotype is not causally related to neurologic disease. A read-through transcript variant composed of the upstream ZFP91 gene and CNTF sequence has been identified, but it is thought to be non-coding. Read-through transcription of ZFP91 and CNTF has also been observed in mouse. [provided by RefSeq, Oct 2010]	The protein encoded by this gene is a polypeptide hormone whose actions appear to be restricted to the nervous system where it promotes neurotransmitter synthesis and neurite outgrowth in certain neuronal populations. The protein is a potent survival factor for neurons and oligodendrocytes and may be relevant in reducing tissue destruction during inflammatory attacks. A mutation in this gene, which results in aberrant splicing, leads to ciliary neurotrophic factor deficiency, but this phenotype is not causally related to neurologic disease. A read-through transcript variant composed of the upstream ZFP91 gene and CNTF sequence has been identified, but it is thought to be non-coding. Read-through transcription of ZFP91 and CNTF has also been observed in mouse. [provided by RefSeq, Oct 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased Hepatitis C virus replication, 	GO:0007165 GO:0007260 GO:0007399 GO:0007399 GO:0007399 GO:0008284 GO:0008284 GO:0008284 GO:0010628
RAMP1 	RAMP1 (Receptor Activity Modifying Protein 1) is a Protein Coding gene. Diseases associated with RAMP1 include  RAMP3	The protein encoded by this gene is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs are type I transmembrane proteins with an extracellular N terminus and a cytoplasmic C terminus. RAMPs are required to transport calcitonin-receptor-like receptor (CRLR) to the plasma membrane. CRLR, a receptor with seven transmembrane domains, can function as either a calcitonin-gene-related peptide (CGRP) receptor or an adrenomedullin receptor, depending on which members of the RAMP family are expressed. In the presence of this (RAMP1) protein, CRLR functions as a CGRP receptor. The RAMP1 protein is involved in the terminal glycosylation, maturation, and presentation of the CGRP receptor to the cell surface. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]	The protein encoded by this gene is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs are type I transmembrane proteins with an extracellular N terminus and a cytoplasmic C terminus. RAMPs are required to transport calcitonin-receptor-like receptor (CRLR) to the plasma membrane. CRLR, a receptor with seven transmembrane domains, can function as either a calcitonin-gene-related peptide (CGRP) receptor or an adrenomedullin receptor, depending on which members of the RAMP family are expressed. In the presence of this (RAMP1) protein, CRLR functions as a CGRP receptor. The RAMP1 protein is involved in the terminal glycosylation, maturation, and presentation of the CGRP receptor to the cell surface. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]	Mitotic spindle defects, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability, Decreased HPV16-GFP infection, Inconclusive, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Negative genetic interaction between BLM-/- and BLM+/+, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001525 GO:0006816 GO:0006886 GO:0007186 GO:0007186 GO:0007186 GO:0007189
DDB1 	DDB1 (Damage Specific DNA Binding Protein 1) is a Protein Coding gene. Diseases associated with DDB1 include  SF3B3	The protein encoded by this gene is the large subunit (p127) of the heterodimeric DNA damage-binding (DDB) complex while another protein (p48) forms the small subunit. This protein complex functions in nucleotide-excision repair and binds to DNA following UV damage. Defective activity of this complex causes the repair defect in patients with xeroderma pigmentosum complementation group E (XPE) - an autosomal recessive disorder characterized by photosensitivity and early onset of carcinomas. However, it remains for mutation analysis to demonstrate whether the defect in XPE patients is in this gene or the gene encoding the small subunit. In addition, Best vitelliform mascular dystrophy is mapped to the same region as this gene on 11q, but no sequence alternations of this gene are demonstrated in Best disease patients. The protein encoded by this gene also functions as an adaptor molecule for the cullin 4 (CUL4) ubiquitin E3 ligase complex by facilitating the binding of substrates to this complex and the ubiquitination of proteins. [provided by RefSeq, May 2012]	The protein encoded by this gene is the large subunit (p127) of the heterodimeric DNA damage-binding (DDB) complex while another protein (p48) forms the small subunit. This protein complex functions in nucleotide-excision repair and binds to DNA following UV damage. Defective activity of this complex causes the repair defect in patients with xeroderma pigmentosum complementation group E (XPE) - an autosomal recessive disorder characterized by photosensitivity and early onset of carcinomas. However, it remains for mutation analysis to demonstrate whether the defect in XPE patients is in this gene or the gene encoding the small subunit. In addition, Best vitelliform mascular dystrophy is mapped to the same region as this gene on 11q, but no sequence alternations of this gene are demonstrated in Best disease patients. The protein encoded by this gene also functions as an adaptor molecule for the cullin 4 (CUL4) ubiquitin E3 ligase complex by facilitating the binding of substrates to this complex and the ubiquitination of proteins. [provided by RefSeq, May 2012]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased homologous recombination repair frequency, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased G1 length, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Increased circadian rhythm amplitude, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased nuclei size in G2M, S arrest, Decreased cell number, increased G2M DNA content, Increased S length, increased G2 length, Increased telomere dysfunction-induced foci (TIF) formation, 	GO:0006281 GO:0006289 GO:0006511
ERBB2 	ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with ERBB2 include  EGFR	This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Increased cell viability after pRB stimulation, Decreased cell proliferation, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability with paclitaxel, 	GO:0001934 GO:0006468 GO:0006468 GO:0006468 GO:0007165 GO:0007166 GO:0007167
AKTIP 	AKTIP (AKT Interacting Protein) is a Protein Coding gene. Diseases associated with AKTIP include  UBE2H	The mouse homolog of this gene produces fused toes and thymic hyperplasia in heterozygous mutant animals while homozygous mutants die in early development. This gene may play a role in apoptosis as these morphological abnormalities are caused by altered patterns of programmed cell death. The protein encoded by this gene is similar to the ubiquitin ligase domain of other ubiquitin-conjugating enzymes but lacks the conserved cysteine residue that enables those enzymes to conjugate ubiquitin to the target protein. This protein interacts directly with serine/threonine kinase protein kinase B (PKB)/Akt and modulates PKB activity by enhancing the phosphorylation of PKB\'s regulatory sites. Alternative splicing results in two transcript variants encoding the same protein. The mouse homolog of this gene produces fused toes and thymic hyperplasia in heterozygous mutant animals while homozygous mutants die in early development. This gene may play a role in apoptosis as these morphological abnormalities are caused by altered patterns of programmed cell death. The protein encoded by this gene is similar to the ubiquitin ligase domain of other ubiquitin-conjugating enzymes but lacks the conserved cysteine residue that enables those enzymes to conjugate ubiquitin to the target protein. This protein interacts directly with serine/threonine kinase protein kinase B (PKB)/Akt and modulates PKB activity by enhancing the phosphorylation of PKB\'s regulatory sites. Alternative splicing results in two transcript variants encoding the same protein. Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0000209 GO:0001934 GO:0001934 GO:0001934 GO:0006915 GO:0007032 GO:0007032 GO:0007032 GO:0007040
PAK4 	PAK4 (P21 (RAC1) Activated Kinase 4) is a Protein Coding gene. Diseases associated with PAK4 include  PAK5	PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3 and PAK4. PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. They serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases. PAK4 is a mediator of filopodia formation and may play a role in the reorganization of the actin cytoskeleton. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3 and PAK4. PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. They serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases. PAK4 is a mediator of filopodia formation and may play a role in the reorganization of the actin cytoskeleton. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. Increased viability, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Decreased mitotic index, Decreased substrate adherent cell growth, (Transferrin accumulation in small spots in the cell periphery), Downregulation of NFkappaB pathway, Decreased viability after gemcitabine stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased vesicular stomatitis virus (VSV) infection, 	GO:0001558 GO:0006468 GO:0006915 GO:0007010
RAP1GAP2 	RAP1GAP2 (RAP1 GTPase Activating Protein 2) is a Protein Coding gene.  Among its related pathways are  RAP1GAP	This gene encodes a GTPase-activating protein that activates the small guanine-nucleotide-binding protein Rap1 in platelets. The protein interacts with synaptotagmin-like protein 1 and Rab27 and regulates secretion of dense granules from platelets at sites of endothelial damage. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	This gene encodes a GTPase-activating protein that activates the small guanine-nucleotide-binding protein Rap1 in platelets. The protein interacts with synaptotagmin-like protein 1 and Rab27 and regulates secretion of dense granules from platelets at sites of endothelial damage. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, 	GO:0002250 GO:0008361 GO:0008361 GO:0008361 GO:0051056 GO:0090630 GO:0090630 GO:0090630
DDX6 	DDX6 (DEAD-Box Helicase 6) is a Protein Coding gene. Diseases associated with DDX6 include  DDX43	This gene encodes a member of the DEAD box protein family. The protein is an RNA helicase found in P-bodies and stress granules, and functions in translation suppression and mRNA degradation. It is required for microRNA-induced gene silencing. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Mar 2012]	This gene encodes a member of the DEAD box protein family. The protein is an RNA helicase found in P-bodies and stress granules, and functions in translation suppression and mRNA degradation. It is required for microRNA-induced gene silencing. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, Decreased Aire reporter expression, Increased shRNA abundance (Z-score &gt; 2), Increased Nanog expression, 	GO:0006617 GO:0017148 GO:0017148 GO:0017148 GO:0019074
PAK6 	PAK6 (P21 (RAC1) Activated Kinase 6) is a Protein Coding gene.  Among its related pathways are  PAK5	This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased substrate adherent cell growth, Decreased viability (cell death), No cells, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased nuclei size in G2M, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased simian virus 40 (SV40) infection, toxic, 	GO:0006355 GO:0006468 GO:0006915 GO:0007010
SEMA3E 	SEMA3E (Semaphorin 3E) is a Protein Coding gene. Diseases associated with SEMA3E include  SEMA3G	Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]	Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]	Increased vaccinia virus (VACV) infection, Increased viability, Resistant to vaccinia virus (VACV-A4L) infection, 	GO:0001525 GO:0001569 GO:0001569 GO:0001569 GO:0001755 GO:0001755 GO:0001755
ITGB5 	ITGB5 (Integrin Subunit Beta 5) is a Protein Coding gene. Diseases associated with ITGB5 include  ITGB3	This gene encodes a beta subunit of integrin, which can combine with different alpha chains to form a variety of integrin heterodimers. Integrins are integral cell-surface receptors that participate in cell adhesion as well as cell-surface mediated signaling. The alphav beta5 integrin is involved in adhesion to vitronectin. [provided by RefSeq, Aug 2017]	This gene encodes a beta subunit of integrin, which can combine with different alpha chains to form a variety of integrin heterodimers. Integrins are integral cell-surface receptors that participate in cell adhesion as well as cell-surface mediated signaling. The alphav beta5 integrin is involved in adhesion to vitronectin. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Dynamic nuclei (hole, folded or small irregular), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Increased nuclear migration distance, increased nuclear migration speed, Increased Salmonella enterica Typhimurium binding, Decreased viability, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007179 GO:0007229 GO:0016477
PIK3CA 	PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha) is a Protein Coding gene. Diseases associated with PIK3CA include  PIK3CD	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]	Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]	Increased viability, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Decreased HPV16-GFP infection, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Increased cell death in HCT116 cells, Decreased cell migration, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0001525 GO:0001889 GO:0001889 GO:0001889 GO:0001932 GO:0001932 GO:0001932 GO:0001944 GO:0001944 GO:0001944
SIRT3 	SIRT3 (Sirtuin 3) is a Protein Coding gene. Diseases associated with SIRT3 include  Aging SIRT2	SIRT3 encodes a member of the sirtuin family of class III histone deacetylases, homologs to the yeast Sir2 protein. The encoded protein is found exclusively in mitochondria, where it can eliminate reactive oxygen species, inhibit apoptosis, and prevent the formation of cancer cells. SIRT3 has far-reaching effects on nuclear gene expression, cancer, cardiovascular disease, neuroprotection, aging, and metabolic control. [provided by RefSeq, May 2019]	SIRT3 encodes a member of the sirtuin family of class III histone deacetylases, homologs to the yeast Sir2 protein. The encoded protein is found exclusively in mitochondria, where it can eliminate reactive oxygen species, inhibit apoptosis, and prevent the formation of cancer cells. SIRT3 has far-reaching effects on nuclear gene expression, cancer, cardiovascular disease, neuroprotection, aging, and metabolic control. [provided by RefSeq, May 2019]	no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased CFP-tsO45G cell surface transport, Effect on mitosis, decreased viability (cell death), Decreased viability (cell death), 	GO:0006476 GO:0009060 GO:0016570 GO:0034983 GO:0034983 GO:0034983 GO:1901671 GO:1901671 GO:1901671
RGL1 	RGL1 (Ral Guanine Nucleotide Dissociation Stimulator Like 1) is a Protein Coding gene. Diseases associated with RGL1 include  RALGDS	Predicted to be involved in regulation of catalytic activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to be involved in regulation of catalytic activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Decreased IL-8 secretion, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0007265 GO:0043547
MICAL1 	MICAL1 (Microtubule Associated Monooxygenase, Calponin And LIM Domain Containing 1) is a Protein Coding gene. Diseases associated with MICAL1 include  MICAL3	This gene encodes an enzyme that oxidizes methionine residues on actin, thereby promoting depolymerization of actin filaments. This protein interacts with and regulates signalling by NEDD9/CAS-L (neural precursor cell expressed, developmentally down-regulated 9). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]	This gene encodes an enzyme that oxidizes methionine residues on actin, thereby promoting depolymerization of actin filaments. This protein interacts with and regulates signalling by NEDD9/CAS-L (neural precursor cell expressed, developmentally down-regulated 9). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased ionizing radiation sensitivity, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0001933 GO:0007010 GO:0007010 GO:0007010 GO:0007165 GO:0019417 GO:0030042 GO:0030042 GO:0030042
STRN3 	STRN3 (Striatin 3) is a Protein Coding gene.  Among its related pathways are  STRN	Enables armadillo repeat domain binding activity; protein phosphatase 2A binding activity; and small GTPase binding activity. Involved in negative regulation of transcription by RNA polymerase II and positive regulation of transcription by RNA polymerase II. Located in Golgi apparatus; nucleoplasm; and plasma membrane. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables armadillo repeat domain binding activity; protein phosphatase 2A binding activity; and small GTPase binding activity. Involved in negative regulation of transcription by RNA polymerase II and positive regulation of transcription by RNA polymerase II. Located in Golgi apparatus; nucleoplasm; and plasma membrane. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), FOXO1 nuclear localization, Increased IL-8 secretion, No cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	 
PTPRO 	PTPRO (Protein Tyrosine Phosphatase Receptor Type O) is a Protein Coding gene. Diseases associated with PTPRO include  PTPRB	This gene encodes a member of the R3 subtype family of receptor-type protein tyrosine phosphatases. These proteins are localized to the apical surface of polarized cells and may have tissue-specific functions through activation of Src family kinases. This gene contains two distinct promoters, and alternatively spliced transcript variants encoding multiple isoforms have been observed. The encoded proteins may have multiple isoform-specific and tissue-specific functions, including the regulation of osteoclast production and activity, inhibition of cell proliferation and facilitation of apoptosis. This gene is a candidate tumor suppressor, and decreased expression of this gene has been observed in several types of cancer. [provided by RefSeq, May 2011]	This gene encodes a member of the R3 subtype family of receptor-type protein tyrosine phosphatases. These proteins are localized to the apical surface of polarized cells and may have tissue-specific functions through activation of Src family kinases. This gene contains two distinct promoters, and alternatively spliced transcript variants encoding multiple isoforms have been observed. The encoded proteins may have multiple isoform-specific and tissue-specific functions, including the regulation of osteoclast production and activity, inhibition of cell proliferation and facilitation of apoptosis. This gene is a candidate tumor suppressor, and decreased expression of this gene has been observed in several types of cancer. [provided by RefSeq, May 2011]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in colon lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell migration, Increased apoptosis, 	GO:0000902 GO:0002548 GO:0002548 GO:0002548 GO:0003093 GO:0003105 GO:0003105 GO:0003105 GO:0006470 GO:0006470 GO:0006470
SGK1 	SGK1 (Serum/Glucocorticoid Regulated Kinase 1) is a Protein Coding gene. Diseases associated with SGK1 include  Pseudohypoaldosteronism SGK3	This gene encodes a serine/threonine protein kinase that plays an important role in cellular stress response. This kinase activates certain potassium, sodium, and chloride channels, suggesting an involvement in the regulation of processes such as cell survival, neuronal excitability, and renal sodium excretion. High levels of expression of this gene may contribute to conditions such as hypertension and diabetic nephropathy. Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]	This gene encodes a serine/threonine protein kinase that plays an important role in cellular stress response. This kinase activates certain potassium, sodium, and chloride channels, suggesting an involvement in the regulation of processes such as cell survival, neuronal excitability, and renal sodium excretion. High levels of expression of this gene may contribute to conditions such as hypertension and diabetic nephropathy. Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Increased transferrin (TF) endocytosis, Decreased viability in ovarian lineage, Strongly decreased CFP-tsO45G cell surface transport, Decreased vesicular stomatitis virus (VSV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased viability (proliferation), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased apoptosis, 	GO:0001558 GO:0006468 GO:0006814
FGL2 	FGL2 (Fibrinogen Like 2) is a Protein Coding gene. Diseases associated with FGL2 include  TNR	The protein encoded by this gene is a secreted protein that is similar to the beta- and gamma-chains of fibrinogen. The carboxyl-terminus of the encoded protein consists of the fibrinogen-related domains (FRED). The encoded protein forms a tetrameric complex which is stabilized by interchain disulfide bonds. This protein may play a role in physiologic functions at mucosal sites. The protein encoded by this gene is a secreted protein that is similar to the beta- and gamma-chains of fibrinogen. The carboxyl-terminus of the encoded protein consists of the fibrinogen-related domains (FRED). The encoded protein forms a tetrameric complex which is stabilized by interchain disulfide bonds. This protein may play a role in physiologic functions at mucosal sites. no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased shRNA abundance, 	 
CTNND1 	CTNND1 (Catenin Delta 1) is a Protein Coding gene. Diseases associated with CTNND1 include  binding ARVCF	This gene encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction. Multiple translation initiation codons and alternative splicing result in many different isoforms being translated. Not all of the full-length natures of the described transcript variants have been determined. Read-through transcription also exists between this gene and the neighboring upstream thioredoxin-related transmembrane protein 2 (TMX2) gene. [provided by RefSeq, Dec 2010]	This gene encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction. Multiple translation initiation codons and alternative splicing result in many different isoforms being translated. Not all of the full-length natures of the described transcript variants have been determined. Read-through transcription also exists between this gene and the neighboring upstream thioredoxin-related transmembrane protein 2 (TMX2) gene. [provided by RefSeq, Dec 2010]	no effect, Decreased vaccinia virus (VACV) infection, Increased epidermal growth factor (EGF) endocytosis, Increased shRNA abundance, Increased cell migration, Decreased focal adhesion (FA) abundance, decreased cell spreading, 	GO:0007043 GO:0007155 GO:0007420 GO:0007420 GO:0007420 GO:0016055 GO:0016055 GO:0016055 GO:0044331 GO:0044331 GO:0044331
ITCH 	ITCH (Itchy E3 Ubiquitin Protein Ligase) is a Protein Coding gene. Diseases associated with ITCH include  WWP1	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein plays a role in multiple cellular processes including erythroid and lymphoid cell differentiation and the regulation of immune responses. Mutations in this gene are a cause of syndromic multisystem autoimmune disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein plays a role in multiple cellular processes including erythroid and lymphoid cell differentiation and the regulation of immune responses. Mutations in this gene are a cause of syndromic multisystem autoimmune disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	no effect, Increased IL-8 secretion, No cells, Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell death in HCC-1954 cells, Decreased viability with paclitaxel, Synthetic lethal with imatinib mesylate, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0000209 GO:0001558 GO:0001558 GO:0001558
MARK4 	MARK4 (Microtubule Affinity Regulating Kinase 4) is a Protein Coding gene. Diseases associated with MARK4 include  MARK3	This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer\'s disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]	This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer\'s disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]	no effect, Decreased viability, Increased Nanog expression, Increased IL-8 secretion, Decreased viability (cell death), No cells, Increased cell death HMECs cells, Increased cell migration, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt pathway, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Fragmented cis-Golgi, fragmented medial Golgi, fragmented trans-Golgi, 	GO:0000226 GO:0001578 GO:0006468 GO:0007049 GO:0007399 GO:0007399 GO:0007399
PPARG 	PPARG (Peroxisome Proliferator Activated Receptor Gamma) is a Protein Coding gene. Diseases associated with PPARG include  PPARA	This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Decreased shRNA abundance, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in pancreas lineage, 	 
SH3RF1 	SH3RF1 (SH3 Domain Containing Ring Finger 1) is a Protein Coding gene.  Among its related pathways are  SH3RF3	This gene encodes a protein containing an N-terminus RING-finger, four SH3 domains, and a region implicated in binding of the Rho GTPase Rac. Via the RING-finger, the encoded protein has been shown to function as an ubiquitin-protein ligase involved in protein sorting at the trans-Golgi network. The encoded protein may also act as a scaffold for the c-Jun N-terminal kinase signaling pathway, facilitating the formation of a functional signaling module. This gene encodes a protein containing an N-terminus RING-finger, four SH3 domains, and a region implicated in binding of the Rho GTPase Rac. Via the RING-finger, the encoded protein has been shown to function as an ubiquitin-protein ligase involved in protein sorting at the trans-Golgi network. The encoded protein may also act as a scaffold for the c-Jun N-terminal kinase signaling pathway, facilitating the formation of a functional signaling module. Increased vaccinia virus (VACV) infection, no effect, Increased homologous recombination repair frequency, 	GO:0001764 GO:0009966 GO:0009966 GO:0009966 GO:0016567 GO:0016567 GO:0016567 GO:0032436 GO:0043066
NELL1 	NELL1 (Neural EGFL Like 1) is a Protein Coding gene. Diseases associated with NELL1 include  Craniosynostosis NELL2	This gene encodes a cytoplasmic protein that contains epidermal growth factor (EGF)-like repeats. The encoded heterotrimeric protein may be involved in cell growth regulation and differentiation. A similar protein in rodents is involved in craniosynostosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	This gene encodes a cytoplasmic protein that contains epidermal growth factor (EGF)-like repeats. The encoded heterotrimeric protein may be involved in cell growth regulation and differentiation. A similar protein in rodents is involved in craniosynostosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased G2M DNA content, 	GO:0007399 GO:0010468 GO:0030154 GO:0030501 GO:0030501 GO:0030501 GO:0033689
DUSP16 	DUSP16 (Dual Specificity Phosphatase 16) is a Protein Coding gene. Diseases associated with DUSP16 include  DUSP8	This gene encodes a mitogen-activated protein kinase phosphatase that is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. The encoded protein specifically regulates the c-Jun amino-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways.[provided by RefSeq, May 2010]	This gene encodes a mitogen-activated protein kinase phosphatase that is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. The encoded protein specifically regulates the c-Jun amino-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways.[provided by RefSeq, May 2010]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, shRNA abundance &lt;= 50%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, Decreased viability after Maraba virus infection, Upregulation of NF-kappaB pathway after LMP1 stimulation, Increased hepcidin::fluc mRNA expression, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Reduced shRNA abundance in FBW7 KO line, Weakly decreased NFAT1-GFP nuclear translocation, Decreased HIV-1 infection, 	GO:0006470 GO:0016311 GO:0043409 GO:0043508 GO:0045204
NCOA6 	NCOA6 (Nuclear Receptor Coactivator 6) is a Protein Coding gene. Diseases associated with NCOA6 include 	The protein encoded by this gene is a transcriptional coactivator that can interact with nuclear hormone receptors to enhance their transcriptional activator functions. This protein has been shown to be involved in the hormone-dependent coactivation of several receptors, including prostanoid, retinoid, vitamin D3, thyroid hormone, and steroid receptors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2011]	The protein encoded by this gene is a transcriptional coactivator that can interact with nuclear hormone receptors to enhance their transcriptional activator functions. This protein has been shown to be involved in the hormone-dependent coactivation of several receptors, including prostanoid, retinoid, vitamin D3, thyroid hormone, and steroid receptors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2011]	Increased viability, no effect, Decreased viability, Synthetic lethal with Ras, Increased ionizing radiation sensitivity, Decreased Hepatitis C virus replication, Polylobed nuclei, Decreased HIV-1 infection, 	GO:0006352 GO:0006974 GO:0007420 GO:0007507 GO:0007507 GO:0007507 GO:0009725 GO:0009725 GO:0009725
NF2 	NF2 (NF2, Moesin-Ezrin-Radixin Like (MERLIN) Tumor Suppressor) is a Protein Coding gene. Diseases associated with NF2 include  EZR	This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein\'s function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]	This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein\'s function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Increased viability, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, Decreased cell migration, Decreased Tat-dependent transcription, Increased proliferation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Decreased p24 protein expression, Synthetic lethal with cisplatin, 	GO:0000165 GO:0001707 GO:0001707 GO:0001707 GO:0001953 GO:0001953 GO:0001953
FGD5 	FGD5 (FYVE, RhoGEF And PH Domain Containing 5) is a Protein Coding gene. Diseases associated with FGD5 include  Gastroduodenitis FGD6	Predicted to enable guanyl-nucleotide exchange factor activity and small GTPase binding activity. Predicted to be involved in several processes, including filopodium assembly; regulation of GTPase activity; and regulation of cell shape. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable guanyl-nucleotide exchange factor activity and small GTPase binding activity. Predicted to be involved in several processes, including filopodium assembly; regulation of GTPase activity; and regulation of cell shape. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased cell number, Large nuclei, Increased epidermal growth factor receptor (EGFR) surface abundance, 	 
TRIP6 	TRIP6 (Thyroid Hormone Receptor Interactor 6) is a Protein Coding gene. Diseases associated with TRIP6 include  ZYX	This gene is a member of the zyxin family and encodes a protein with three LIM zinc-binding domains. This protein localizes to focal adhesion sites and along actin stress fibers. Recruitment of this protein to the plasma membrane occurs in a lysophosphatidic acid (LPA)-dependent manner and it regulates LPA-induced cell migration. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. This gene is a member of the zyxin family and encodes a protein with three LIM zinc-binding domains. This protein localizes to focal adhesion sites and along actin stress fibers. Recruitment of this protein to the plasma membrane occurs in a lysophosphatidic acid (LPA)-dependent manner and it regulates LPA-induced cell migration. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007155 GO:0007165 GO:0007165 GO:0007165 GO:0030335 GO:0030335 GO:0030335 GO:0043009 GO:0048041 GO:0048041 GO:0048041
NOTCH1 	NOTCH1 (Notch Receptor 1) is a Protein Coding gene. Diseases associated with NOTCH1 include  NOTCH2	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]	no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability, shRNA abundance &lt;= 25%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Synthetic lethal with cisplatin, 	 
EPHA2 	EPHA2 (EPH Receptor A2) is a Protein Coding gene. Diseases associated with EPHA2 include  Cataract EPHA5	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]	This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Decreased viability, Increased shRNA abundance, Increased cell death in HCC-1954 cells, Increased mitotic index, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Increased viability, 	 
CDC42EP2 	CDC42EP2 (CDC42 Effector Protein 2) is a Protein Coding gene. Diseases associated with CDC42EP2 include  CDC42EP3	CDC42, a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to, and negatively regulate the function of CDC42. Coexpression of this protein with CDC42 suggested a role of this protein in actin filament assembly and cell shape control. [provided by RefSeq, Aug 2011]	CDC42, a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to, and negatively regulate the function of CDC42. Coexpression of this protein with CDC42 suggested a role of this protein in actin filament assembly and cell shape control. [provided by RefSeq, Aug 2011]	no effect, Decreased viability ratio, Decreased viability, shRNA abundance &lt;= 25%, Decreased viability in colon lineage, Wnt reporter downregulated, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased homologous recombination repair frequency, 	GO:0007015 GO:0007266 GO:0008360 GO:0008360 GO:0008360 GO:0030036 GO:0030838
SPP1 	SPP1 (Secreted Phosphoprotein 1) is a Protein Coding gene. Diseases associated with SPP1 include 	The protein encoded by this gene is involved in the attachment of osteoclasts to the mineralized bone matrix. The encoded protein is secreted and binds hydroxyapatite with high affinity. The osteoclast vitronectin receptor is found in the cell membrane and may be involved in the binding to this protein. This protein is also a cytokine that upregulates expression of interferon-gamma and interleukin-12. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	The protein encoded by this gene is involved in the attachment of osteoclasts to the mineralized bone matrix. The encoded protein is secreted and binds hydroxyapatite with high affinity. The osteoclast vitronectin receptor is found in the cell membrane and may be involved in the binding to this protein. This protein is also a cytokine that upregulates expression of interferon-gamma and interleukin-12. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased viability with paclitaxel, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), polylobed nuclei, dynamic nuclei (hole, folded or small irregular), Decreased CXCL12 induced migration, 	GO:0001503 GO:0001649 GO:0001649 GO:0001649 GO:0006710 GO:0006954 GO:0007155 GO:0007155 GO:0007155
HOXA9 	HOXA9 (Homeobox A9) is a Protein Coding gene. Diseases associated with HOXA9 include  Leukemia HMX3	In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. This gene is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. This gene is highly similar to the abdominal-B (Abd-B) gene of Drosophila. A specific translocation event which causes a fusion between this gene and the NUP98 gene has been associated with myeloid leukemogenesis. Read-through transcription exists between this gene and the upstream homeobox A10 (HOXA10) gene.[provided by RefSeq, Mar 2011]	In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. This gene is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. This gene is highly similar to the abdominal-B (Abd-B) gene of Drosophila. A specific translocation event which causes a fusion between this gene and the NUP98 gene has been associated with myeloid leukemogenesis. Read-through transcription exists between this gene and the upstream homeobox A10 (HOXA10) gene.[provided by RefSeq, Mar 2011]	no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
RAPGEF1 	RAPGEF1 (Rap Guanine Nucleotide Exchange Factor 1) is a Protein Coding gene. Diseases associated with RAPGEF1 include  RAPGEF4	This gene encodes a human guanine nucleotide exchange factor. It transduces signals from CRK by binding the SH3 domain of CRK, and activating several members of the Ras family of GTPases. This signaling cascade that may be involved in apoptosis, integrin-mediated signal transduction, and cell transformation. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some variants has not been determined. This gene encodes a human guanine nucleotide exchange factor. It transduces signals from CRK by binding the SH3 domain of CRK, and activating several members of the Ras family of GTPases. This signaling cascade that may be involved in apoptosis, integrin-mediated signal transduction, and cell transformation. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some variants has not been determined. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), Decreased shRNA abundance (Z-score &lt; -2), Decreased p24 protein expression, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, decreased cell spreading, 	GO:0001568 GO:0007165 GO:0007165 GO:0007165 GO:0007169 GO:0007264 GO:0007265 GO:0007265 GO:0007265
NPNT 	NPNT (Nephronectin) is a Protein Coding gene. Diseases associated with NPNT include  EGFL6	Predicted to enable integrin binding activity. Predicted to be involved in several processes, including cell-cell adhesion mediated by integrin; positive regulation of ERK1 and ERK2 cascade; and positive regulation of osteoblast differentiation. Predicted to act upstream of or within positive regulation of transforming growth factor beta receptor signaling pathway. Located in extracellular exosome. Part of collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable integrin binding activity. Predicted to be involved in several processes, including cell-cell adhesion mediated by integrin; positive regulation of ERK1 and ERK2 cascade; and positive regulation of osteoblast differentiation. Predicted to act upstream of or within positive regulation of transforming growth factor beta receptor signaling pathway. Located in extracellular exosome. Part of collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]GO:0001657 GO:0001658 GO:0007155 GO:0007160 GO:0007160 GO:0007160
TSG101 	TSG101 (Tumor Susceptibility 101) is a Protein Coding gene. Diseases associated with TSG101 include  UEVLD	The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression. The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression. no effect, Reduced mammosphere formation, Increased G1 DNA content, G0/1 arrest, Increased Nanog expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability in glioblastoma multiforme (GBM) lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased ionizing radiation sensitivity, Increased NF-kappaB reporter expression, Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased homologous recombination repair frequency, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell death in HCC-1954 cells, 	GO:0000122 GO:0001558 GO:0001558 GO:0001558 GO:0006513 GO:0006513 GO:0006513 GO:0006858 GO:0006858 GO:0006858
GRIA2 	GRIA2 (Glutamate Ionotropic Receptor AMPA Type Subunit 2) is a Protein Coding gene. Diseases associated with GRIA2 include  GRIA3	Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG-&gt;CGG; Q-&gt;R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG-&gt;CGG; Q-&gt;R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Increased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), Increased circadian rhythm amplitude, 	GO:0006811 GO:0007165 GO:0007165 GO:0007165 GO:0007215 GO:0007268 GO:0007268 GO:0007268
ADAMTS12 	ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 12) is a Protein Coding gene. Diseases associated with ADAMTS12 include  ADAMTS7	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS-1) motif. Individual members of this family differ in the number of C-terminal TS-1 motifs, and some have unique C-terminal domains. The enzyme encoded by this gene contains eight TS-1 motifs. It may play roles in pulmonary cells during fetal development or in tumor processes through its proteolytic activity or as a molecule potentially involved in regulation of cell adhesion. This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS-1) motif. Individual members of this family differ in the number of C-terminal TS-1 motifs, and some have unique C-terminal domains. The enzyme encoded by this gene contains eight TS-1 motifs. It may play roles in pulmonary cells during fetal development or in tumor processes through its proteolytic activity or as a molecule potentially involved in regulation of cell adhesion. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased viability, 	GO:0001503 GO:0002062 GO:0002062 GO:0002062 GO:0006029 GO:0006029 GO:0006029 GO:0006508 GO:0006508 GO:0006508 GO:0007160 GO:0007160 GO:0007160
SMAD9 	SMAD9 (SMAD Family Member 9) is a Protein Coding gene. Diseases associated with SMAD9 include  SMAD1	The protein encoded by this gene is a member of the SMAD family, which transduces signals from TGF-beta family members. The encoded protein is activated by bone morphogenetic proteins and interacts with SMAD4. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	The protein encoded by this gene is a member of the SMAD family, which transduces signals from TGF-beta family members. The encoded protein is activated by bone morphogenetic proteins and interacts with SMAD4. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased NF-kappaB reporter expression, Decreased shRNA abundance, Increased S DNA content, increased G2M DNA content, Increased CFP-tsO45G cell surface transport, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007179 GO:0009653 GO:0030154
EIF4EBP1 	EIF4EBP1 (Eukaryotic Translation Initiation Factor 4E Binding Protein 1) is a Protein Coding gene. Diseases associated with EIF4EBP1 include  Rhabdomyosarcoma EIF4EBP2	This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5\' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation. This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5\' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation. Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased transcriptional activity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Increased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000082 GO:0006417 GO:0017148 GO:0017148 GO:0017148 GO:0031929 GO:0031929 GO:0031929 GO:0045931
CD47 	CD47 (CD47 Molecule) is a Protein Coding gene. Diseases associated with CD47 include 	This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]	This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased influenza A/WSN/33 replication, Synthetic lethal with gemcitabine, 	GO:0007155 GO:0007229 GO:0007229 GO:0007229 GO:0008284 GO:0016477 GO:0022409 GO:0022409 GO:0022409
VEGFA 	VEGFA (Vascular Endothelial Growth Factor A) is a Protein Coding gene. Diseases associated with VEGFA include  PGF	This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]	This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased Nanog expression, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0000122 GO:0001525 GO:0001541 GO:0001569 GO:0001569 GO:0001569 GO:0001570
VASP 	VASP (Vasodilator Stimulated Phosphoprotein) is a Protein Coding gene. Diseases associated with VASP include  Thrombosis ENAH	Vasodilator-stimulated phosphoprotein (VASP) is a member of the Ena-VASP protein family. Ena-VASP family members contain an EHV1 N-terminal domain that binds proteins containing E/DFPPPPXD/E motifs and targets Ena-VASP proteins to focal adhesions. In the mid-region of the protein, family members have a proline-rich domain that binds SH3 and WW domain-containing proteins. Their C-terminal EVH2 domain mediates tetramerization and binds both G and F actin. VASP is associated with filamentous actin formation and likely plays a widespread role in cell adhesion and motility. VASP may also be involved in the intracellular signaling pathways that regulate integrin-extracellular matrix interactions. VASP is regulated by the cyclic nucleotide-dependent kinases PKA and PKG. Vasodilator-stimulated phosphoprotein (VASP) is a member of the Ena-VASP protein family. Ena-VASP family members contain an EHV1 N-terminal domain that binds proteins containing E/DFPPPPXD/E motifs and targets Ena-VASP proteins to focal adhesions. In the mid-region of the protein, family members have a proline-rich domain that binds SH3 and WW domain-containing proteins. Their C-terminal EVH2 domain mediates tetramerization and binds both G and F actin. VASP is associated with filamentous actin formation and likely plays a widespread role in cell adhesion and motility. VASP may also be involved in the intracellular signaling pathways that regulate integrin-extracellular matrix interactions. VASP is regulated by the cyclic nucleotide-dependent kinases PKA and PKG. Increased vaccinia virus (VACV) infection, no effect, 	GO:0001843 GO:0007411 GO:0008154 GO:0030036 GO:0030036 GO:0030036 GO:0030838
ERG 	ERG (ETS Transcription Factor ERG) is a Protein Coding gene. Diseases associated with ERG include  FLI1	This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing\'s sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]	This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing\'s sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]	no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased Nanog expression, Increased shRNA abundance, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006468 GO:0007165 GO:0030154
PTPRR 	PTPRR (Protein Tyrosine Phosphatase Receptor Type R) is a Protein Coding gene. Diseases associated with PTPRR include  PTPN5	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single intracellular catalytic domain, and thus represents a receptor-type PTP. Silencing of this gene has been associated with colorectal cancer. Multiple transcript variants encoding different isoforms have been found for this gene. This gene shares a symbol (PTPRQ) with another gene, protein tyrosine phosphatase, receptor type, Q (GeneID 374462), which is also located on chromosome 12. [provided by RefSeq, May 2011]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single intracellular catalytic domain, and thus represents a receptor-type PTP. Silencing of this gene has been associated with colorectal cancer. Multiple transcript variants encoding different isoforms have been found for this gene. This gene shares a symbol (PTPRQ) with another gene, protein tyrosine phosphatase, receptor type, Q (GeneID 374462), which is also located on chromosome 12. [provided by RefSeq, May 2011]	Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability after Maraba virus infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0001701 GO:0006470 GO:0007165 GO:0010633
BRAF 	BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with BRAF include  RAF1	This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]	This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]	Decreased viability, no effect, Synthetic lethal with Ras, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability ratio, Decreased viability in colon lineage, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased viability with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Increased simian virus 40 (SV40) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Misorientated spindle, 	GO:0000165 GO:0001934 GO:0002318 GO:0002318 GO:0002318 GO:0006468 GO:0006468 GO:0006468
DAXX 	DAXX (Death Domain Associated Protein) is a Protein Coding gene. Diseases associated with DAXX include 	This gene encodes a multifunctional protein that resides in multiple locations in the nucleus and in the cytoplasm. It interacts with a wide variety of proteins, such as apoptosis antigen Fas, centromere protein C, and transcription factor erythroblastosis virus E26 oncogene homolog 1. In the nucleus, the encoded protein functions as a potent transcription repressor that binds to sumoylated transcription factors. Its repression can be relieved by the sequestration of this protein into promyelocytic leukemia nuclear bodies or nucleoli. This protein also associates with centromeres in G2 phase. In the cytoplasm, the encoded protein may function to regulate apoptosis. The subcellular localization and function of this protein are modulated by post-translational modifications, including sumoylation, phosphorylation and polyubiquitination. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]	This gene encodes a multifunctional protein that resides in multiple locations in the nucleus and in the cytoplasm. It interacts with a wide variety of proteins, such as apoptosis antigen Fas, centromere protein C, and transcription factor erythroblastosis virus E26 oncogene homolog 1. In the nucleus, the encoded protein functions as a potent transcription repressor that binds to sumoylated transcription factors. Its repression can be relieved by the sequestration of this protein into promyelocytic leukemia nuclear bodies or nucleoli. This protein also associates with centromeres in G2 phase. In the cytoplasm, the encoded protein may function to regulate apoptosis. The subcellular localization and function of this protein are modulated by post-translational modifications, including sumoylation, phosphorylation and polyubiquitination. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability, Negative genetic interaction between PTEN-/- and PTEN+/+, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased shRNA abundance, Increased G1 length, Increased G1 length, increased S length, Decreased caspase 3/7 activity, 	GO:0001934 GO:0006325 GO:0006334 GO:0006334 GO:0006334 GO:0006338 GO:0006355
MYL6 	MYL6 (Myosin Light Chain 6) is a Protein Coding gene. Diseases associated with MYL6 include  MYL6B	Myosin is a hexameric ATPase cellular motor protein. It is composed of two heavy chains, two nonphosphorylatable alkali light chains, and two phosphorylatable regulatory light chains. This gene encodes a myosin alkali light chain that is expressed in smooth muscle and non-muscle tissues. Genomic sequences representing several pseudogenes have been described and two transcript variants encoding different isoforms have been identified for this gene. Myosin is a hexameric ATPase cellular motor protein. It is composed of two heavy chains, two nonphosphorylatable alkali light chains, and two phosphorylatable regulatory light chains. This gene encodes a myosin alkali light chain that is expressed in smooth muscle and non-muscle tissues. Genomic sequences representing several pseudogenes have been described and two transcript variants encoding different isoforms have been identified for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased homologous recombination repair frequency, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, decreased peripheral FA formation, decreased cell spreading, 	GO:0006936 GO:0007519 GO:0030049
CFTR 	CFTR (CF Transmembrane Conductance Regulator) is a Protein Coding gene. Diseases associated with CFTR include  ABCC4	This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]	This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased Nanog expression, 	GO:0006695 GO:0006811 GO:0006811 GO:0006811 GO:0006821 GO:0006821 GO:0006821 GO:0006904 GO:0006904 GO:0006904 GO:0015701 GO:0015701 GO:0015701
ANKS1B 	ANKS1B (Ankyrin Repeat And Sterile Alpha Motif Domain Containing 1B) is a Protein Coding gene. Diseases associated with ANKS1B include  ANKS1A	This gene encodes a multi-domain protein that is predominantly expressed in brain and testis. This protein interacts with amyloid beta protein precursor (AbetaPP) and may have a role in normal brain development, and in the pathogenesis of Alzheimer\'s disease. Expression of this gene has been shown to be elevated in patients with pre-B cell acute lymphocytic leukemia associated with t(1;19) translocation. Alternatively spliced transcript variants encoding different isoforms (some with different subcellular localization, PMID:15004329) have been described for this gene. [provided by RefSeq, Aug 2011]	This gene encodes a multi-domain protein that is predominantly expressed in brain and testis. This protein interacts with amyloid beta protein precursor (AbetaPP) and may have a role in normal brain development, and in the pathogenesis of Alzheimer\'s disease. Expression of this gene has been shown to be elevated in patients with pre-B cell acute lymphocytic leukemia associated with t(1;19) translocation. Alternatively spliced transcript variants encoding different isoforms (some with different subcellular localization, PMID:15004329) have been described for this gene. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Inconclusive, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0048013
ARHGAP1 	ARHGAP1 (Rho GTPase Activating Protein 1) is a Protein Coding gene. Diseases associated with ARHGAP1 include  ARHGAP8	This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein contains a SRC homology 3 domain and interacts with Bcl-2-associated protein family members. [provided by RefSeq, Aug 2012]	This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein contains a SRC homology 3 domain and interacts with Bcl-2-associated protein family members. [provided by RefSeq, Aug 2012]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, G0/1 arrest, Increased IL-8 secretion, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased Sindbis virus (SINV) infection, Increased cell migration, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0007266 GO:0016197 GO:0033572
SOS1 	SOS1 (SOS Ras/Rac Guanine Nucleotide Exchange Factor 1) is a Protein Coding gene. Diseases associated with SOS1 include  SOS2	This gene encodes a protein that is a guanine nucleotide exchange factor for RAS proteins, membrane proteins that bind guanine nucleotides and participate in signal transduction pathways. GTP binding activates and GTP hydrolysis inactivates RAS proteins. The product of this gene may regulate RAS proteins by facilitating the exchange of GTP for GDP. Mutations in this gene are associated with gingival fibromatosis 1 and Noonan syndrome type 4. This gene encodes a protein that is a guanine nucleotide exchange factor for RAS proteins, membrane proteins that bind guanine nucleotides and participate in signal transduction pathways. GTP binding activates and GTP hydrolysis inactivates RAS proteins. The product of this gene may regulate RAS proteins by facilitating the exchange of GTP for GDP. Mutations in this gene are associated with gingival fibromatosis 1 and Noonan syndrome type 4. no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Increased hepcidin::fluc mRNA expression, Decreased cell migration, Decreased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), 	 
TSPAN8 	TSPAN8 (Tetraspanin 8) is a Protein Coding gene. Diseases associated with TSPAN8 include  TSPAN9	The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This gene is expressed in different carcinomas. The use of alternate polyadenylation sites has been found for this gene. The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This gene is expressed in different carcinomas. The use of alternate polyadenylation sites has been found for this gene. no effect, Decreased viability, Decreased epidermal growth factor (EGF) endocytosis, 	 
CDC42EP1 	CDC42EP1 (CDC42 Effector Protein 1) is a Protein Coding gene.  Among its related pathways are  CDC42EP4	CDC42 is a member of the Rho GTPase family that regulates multiple cellular activities, including actin polymerization. The protein encoded by this gene is a CDC42 binding protein that mediates actin cytoskeleton reorganization at the plasma membrane. This protein is secreted and is primarily found in bone marrow. CDC42 is a member of the Rho GTPase family that regulates multiple cellular activities, including actin polymerization. The protein encoded by this gene is a CDC42 binding protein that mediates actin cytoskeleton reorganization at the plasma membrane. This protein is secreted and is primarily found in bone marrow. no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Strongly decreased CFP-tsO45G cell surface transport, Downregulation of NF-kappaB pathway after LMP1 stimulation, Decreased NF-kappaB reporter expression, Decreased viability, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0007266 GO:0008360 GO:0008360 GO:0008360 GO:0030838 GO:0031274 GO:0031274 GO:0031274
LGALS1 	LGALS1 (Galectin 1) is a Protein Coding gene. Diseases associated with LGALS1 include  LGALS2	The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. This gene product may act as an autocrine negative growth factor that regulates cell proliferation. The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. This gene product may act as an autocrine negative growth factor that regulates cell proliferation. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability in pancreas lineage, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0002317 GO:0006915 GO:0006915 GO:0006915 GO:0031295 GO:0031295 GO:0031295 GO:0042981 GO:0042981 GO:0042981 GO:0043065
HAX1 	HAX1 (HCLS1 Associated Protein X-1) is a Protein Coding gene. Diseases associated with HAX1 include 	The protein encoded by this gene is known to associate with hematopoietic cell-specific Lyn substrate 1, a substrate of Src family tyrosine kinases. It also interacts with the product of the polycystic kidney disease 2 gene, mutations in which are associated with autosomal-dominant polycystic kidney disease, and with the F-actin-binding protein, cortactin. It was earlier thought that this gene product is mainly localized in the mitochondria, however, recent studies indicate it to be localized in the cell body. Mutations in this gene result in autosomal recessive severe congenital neutropenia, also known as Kostmann disease. Two transcript variants encoding different isoforms have been found for this gene. The protein encoded by this gene is known to associate with hematopoietic cell-specific Lyn substrate 1, a substrate of Src family tyrosine kinases. It also interacts with the product of the polycystic kidney disease 2 gene, mutations in which are associated with autosomal-dominant polycystic kidney disease, and with the F-actin-binding protein, cortactin. It was earlier thought that this gene product is mainly localized in the mitochondria, however, recent studies indicate it to be localized in the cell body. Mutations in this gene result in autosomal recessive severe congenital neutropenia, also known as Kostmann disease. Two transcript variants encoding different isoforms have been found for this gene. no effect, Decreased viability, Increased transferrin (TF) endocytosis, Decreased NF-kappaB reporter expression, Increased 8N DNA content, 	GO:0007005 GO:0014068 GO:0030833 GO:0030854 GO:0033138
ARHGAP5 	ARHGAP5 (Rho GTPase Activating Protein 5) is a Protein Coding gene. Diseases associated with ARHGAP5 include  TCERG1	Rho GTPase activating protein 5 negatively regulates RHO GTPases, a family which may mediate cytoskeleton changes by stimulating the hydrolysis of bound GTP. Two transcript variants encoding different isoforms have been found for this gene. Rho GTPase activating protein 5 negatively regulates RHO GTPases, a family which may mediate cytoskeleton changes by stimulating the hydrolysis of bound GTP. Two transcript variants encoding different isoforms have been found for this gene. no effect, shRNA abundance &lt;= 50%, Negative genetic interaction between KRASG13D/+ and KRAS+/-, No cells, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, Decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0007155 GO:0007165 GO:0007266 GO:0007266 GO:0007266 GO:0008361
MAZ 	MAZ (MYC Associated Zinc Finger Protein) is a Protein Coding gene. Diseases associated with MAZ include  Amyloidosis VEZF1	Enables DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in several processes, including regulation of gene expression; regulation of signal transduction; and transcription by RNA polymerase II. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in several processes, including regulation of gene expression; regulation of signal transduction; and transcription by RNA polymerase II. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased viability in colon lineage, Increased replication of vaccinia virus (VACV), Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Increased Nanog expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000122 GO:0006357 GO:0006367 GO:0006369 GO:0008284
PDGFRA 	PDGFRA (Platelet Derived Growth Factor Receptor Alpha) is a Protein Coding gene. Diseases associated with PDGFRA include  PDGFRB	This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]	This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Diffuse trans-Golgi, Decreased viability in ovarian lineage; decreased viability in pancreas lineage, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0001553 GO:0001701 GO:0001701 GO:0001701 GO:0001775 GO:0001775 GO:0001775
ACVR1B 	ACVR1B (Activin A Receptor Type 1B) is a Protein Coding gene. Diseases associated with ACVR1B include  TGFBR1	This gene encodes an activin A type IB receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. This protein is a type I receptor which is essential for signaling. Mutations in this gene are associated with pituitary tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jun 2010]	This gene encodes an activin A type IB receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. This protein is a type I receptor which is essential for signaling. Mutations in this gene are associated with pituitary tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jun 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Increased cell viability after pRB stimulation, 	GO:0000082 GO:0001701 GO:0001942 GO:0001942 GO:0001942 GO:0006355 GO:0006355 GO:0006355 GO:0006468
TCF21 	TCF21 (Transcription Factor 21) is a Protein Coding gene. Diseases associated with TCF21 include  MSC	TCF21 encodes a transcription factor of the basic helix-loop-helix family. The TCF21 product is mesoderm specific, and expressed in embryonic epicardium, mesenchyme-derived tissues of lung, gut, gonad, and both mesenchymal and glomerular epithelial cells in the kidney. Two transcript variants encoding the same protein have been found for this gene. TCF21 encodes a transcription factor of the basic helix-loop-helix family. The TCF21 product is mesoderm specific, and expressed in embryonic epicardium, mesenchyme-derived tissues of lung, gut, gonad, and both mesenchymal and glomerular epithelial cells in the kidney. Two transcript variants encoding the same protein have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased NF-kappaB reporter expression, Decreased viability with TRAIL, 	GO:0000122
PDGFRB 	PDGFRB (Platelet Derived Growth Factor Receptor Beta) is a Protein Coding gene. Diseases associated with PDGFRB include  PDGFRA	The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased NF-kappaB reporter expression, Decreased viability in pancreas lineage, Increased cell death HMECs cells, Decreased cell migration, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Decreased cell viability after pRB stimulation, Decreased viability with RAF265, 	GO:0001525 GO:0006024 GO:0006468 GO:0006468 GO:0006468 GO:0006935 GO:0006935 GO:0006935 GO:0007165 GO:0007165 GO:0007165
USP7 	USP7 (Ubiquitin Specific Peptidase 7) is a Protein Coding gene. Diseases associated with USP7 include  Hypotonia USP47	The protein encoded by this gene belongs to the peptidase C19 family, which includes ubiquitinyl hydrolases. This protein deubiquitinates target proteins such as p53 (a tumor suppressor protein) and WASH (essential for endosomal protein recycling), and regulates their activities by counteracting the opposing ubiquitin ligase activity of proteins such as HDM2 and TRIM27, involved in the respective process. Mutations in this gene have been implicated in a neurodevelopmental disorder. [provided by RefSeq, Mar 2016]	The protein encoded by this gene belongs to the peptidase C19 family, which includes ubiquitinyl hydrolases. This protein deubiquitinates target proteins such as p53 (a tumor suppressor protein) and WASH (essential for endosomal protein recycling), and regulates their activities by counteracting the opposing ubiquitin ligase activity of proteins such as HDM2 and TRIM27, involved in the respective process. Mutations in this gene have been implicated in a neurodevelopmental disorder. [provided by RefSeq, Mar 2016]	no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased shRNA abundance (Z-score &gt; 2), Increased cell death in HCT116 cells, 	GO:0006111 GO:0006281 GO:0006283 GO:0006283 GO:0006283
CRB2 	CRB2 (Crumbs Cell Polarity Complex Component 2) is a Protein Coding gene. Diseases associated with CRB2 include  SCARF2	This gene encodes a member of a family of proteins that are components of the Crumbs cell polarity complex. In mammals, members of this family are thought to play a role in many cellular processes in early embryonic development. A similar protein in Drosophila determines apicobasal polarity in embryonic epithelial cells. Mutations in this gene are associated with focal segmental glomerulosclerosis 9, and with ventriculomegaly with cystic kidney disease. [provided by RefSeq, Aug 2016]	This gene encodes a member of a family of proteins that are components of the Crumbs cell polarity complex. In mammals, members of this family are thought to play a role in many cellular processes in early embryonic development. A similar protein in Drosophila determines apicobasal polarity in embryonic epithelial cells. Mutations in this gene are associated with focal segmental glomerulosclerosis 9, and with ventriculomegaly with cystic kidney disease. [provided by RefSeq, Aug 2016]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Increased IL-8 secretion, Inconclusive, 	GO:0001707 GO:0001756 GO:0001756 GO:0001756 GO:0001895 GO:0001895 GO:0001895 GO:0007157 GO:0007157 GO:0007157
ROBO4 	ROBO4 (Roundabout Guidance Receptor 4) is a Protein Coding gene. Diseases associated with ROBO4 include  MXRA5	Predicted to enable cell-cell adhesion mediator activity. Involved in angiogenesis and establishment of endothelial barrier. Located in extracellular exosome. Implicated in aortic valve disease 3. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable cell-cell adhesion mediator activity. Involved in angiogenesis and establishment of endothelial barrier. Located in extracellular exosome. Implicated in aortic valve disease 3. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Increased IL-8 secretion, Increased NF-kappaB reporter expression, Increased viability with SS1P at EC90, Downregulation of NFkappaB pathway, Decreased vesicular stomatitis virus (VSV) infection, 	GO:0001525 GO:0007156 GO:0007411 GO:0030154 GO:0030334 GO:0030334 GO:0030334
PRKCD 	PRKCD (Protein Kinase C Delta) is a Protein Coding gene. Diseases associated with PRKCD include  PRKCQ	The protein encoded by this gene is a member of the protein kinase C family of serine- and threonine-specific protein kinases. The encoded protein is activated by diacylglycerol and is both a tumor suppressor and a positive regulator of cell cycle progression. Also, this protein can positively or negatively regulate apoptosis. Defects in this gene are a cause of autoimmune lymphoproliferative syndrome. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a member of the protein kinase C family of serine- and threonine-specific protein kinases. The encoded protein is activated by diacylglycerol and is both a tumor suppressor and a positive regulator of cell cycle progression. Also, this protein can positively or negatively regulate apoptosis. Defects in this gene are a cause of autoimmune lymphoproliferative syndrome. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased substrate adherent cell growth, Decreased viability (cell death), Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Increased viability with TRAIL, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Increased apoptosis, 	GO:0006468 GO:0006915 GO:0007049 GO:0007165 GO:0007165 GO:0007165 GO:0008631
GLIPR1 	GLIPR1 (GLI Pathogenesis Related 1) is a Protein Coding gene. Diseases associated with GLIPR1 include  Glioma Glioblastoma GLIPR1L2	This gene encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family. Increased expression of this gene is associated with myelomocytic differentiation in macrophage and decreased expression of this gene through gene methylation is associated with prostate cancer. The protein has proapoptotic activities in prostate and bladder cancer cells. This gene is a member of a cluster on chromosome 12 containing two other similar genes. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. This gene encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family. Increased expression of this gene is associated with myelomocytic differentiation in macrophage and decreased expression of this gene through gene methylation is associated with prostate cancer. The protein has proapoptotic activities in prostate and bladder cancer cells. This gene is a member of a cluster on chromosome 12 containing two other similar genes. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. no effect, Increased IL-8 secretion, Synthetic lethal with imatinib mesylate, 	 
MAP3K4 	MAP3K4 (Mitogen-Activated Protein Kinase Kinase Kinase 4) is a Protein Coding gene. Diseases associated with MAP3K4 include  MAP2K7	The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Several alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, May 2014]	The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Several alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased telomerase activity, Decreased cell proliferation, Increased cell death in DLD-1 cells, Increased apoptosis, 	GO:0000165 GO:0001890 GO:0006468 GO:0006468 GO:0006468 GO:0010225 GO:0010225 GO:0010225
MAP3K5 	MAP3K5 (Mitogen-Activated Protein Kinase Kinase Kinase 5) is a Protein Coding gene. Diseases associated with MAP3K5 include  MAP3K15	Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK. Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Decreased cell viability after pRB stimulation, Increased telomerase activity, 	GO:0000165 GO:0001934 GO:0002376 GO:0002376 GO:0002376 GO:0002931 GO:0002931 GO:0002931 GO:0006468 GO:0006468 GO:0006468
EPN1 	EPN1 (Epsin 1) is a Protein Coding gene. Diseases associated with EPN1 include  EPN2	This gene encodes a member of the epsin protein family. The encoded protein binds clathrin and is involved in the endocytosis of clathrin-coated vesicles. Loss of function of this gene is associated with reduced tumor growth and progression in certain cancer types. [provided by RefSeq, Mar 2016]	This gene encodes a member of the epsin protein family. The encoded protein binds clathrin and is involved in the endocytosis of clathrin-coated vesicles. Loss of function of this gene is associated with reduced tumor growth and progression in certain cancer types. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, 	GO:0001701 GO:0006897 GO:0006897 GO:0006897
TRAF4 	TRAF4 (TNF Receptor Associated Factor 4) is a Protein Coding gene. Diseases associated with TRAF4 include  TRAF2	This gene encodes a member of the TNF receptor associated factor (TRAF) family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. The encoded protein has been shown to interact with neurotrophin receptor, p75 (NTR/NTSR1), and negatively regulate NTR induced cell death and NF-kappa B activation. This protein has been found to bind to p47phox, a cytosolic regulatory factor included in a multi-protein complex known as NAD(P)H oxidase. This protein thus, is thought to be involved in the oxidative activation of MAPK8/JNK. Alternatively spliced transcript variants have been observed but the full-length nature of only one has been determined. This gene encodes a member of the TNF receptor associated factor (TRAF) family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. The encoded protein has been shown to interact with neurotrophin receptor, p75 (NTR/NTSR1), and negatively regulate NTR induced cell death and NF-kappa B activation. This protein has been found to bind to p47phox, a cytosolic regulatory factor included in a multi-protein complex known as NAD(P)H oxidase. This protein thus, is thought to be involved in the oxidative activation of MAPK8/JNK. Alternatively spliced transcript variants have been observed but the full-length nature of only one has been determined. Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Decreased Sindbis virus (SINV) infection, Increased shRNA abundance (Z-score &gt; 2), 	 
NEDD4 	NEDD4 (NEDD4 E3 Ubiquitin Protein Ligase) is a Protein Coding gene. Diseases associated with NEDD4 include  Pseudohypoaldosteronism NEDD4L	This gene is the founding member of the NEDD4 family of HECT ubiquitin ligases that function in the ubiquitin proteasome system of protein degradation. The encoded protein contains an N-terminal calcium and phospholipid binding C2 domain followed by multiple tryptophan-rich WW domains and, a C-terminal HECT ubiquitin ligase catalytic domain. It plays critical role in the regulation of a number of membrane receptors, endocytic machinery components and the tumor suppressor PTEN. This gene is the founding member of the NEDD4 family of HECT ubiquitin ligases that function in the ubiquitin proteasome system of protein degradation. The encoded protein contains an N-terminal calcium and phospholipid binding C2 domain followed by multiple tryptophan-rich WW domains and, a C-terminal HECT ubiquitin ligase catalytic domain. It plays critical role in the regulation of a number of membrane receptors, endocytic machinery components and the tumor suppressor PTEN. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Strongly decreased CFP-tsO45G cell surface transport, No cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased HIV-1 infection, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0000209 GO:0006511 GO:0006511 GO:0006511 GO:0006622 GO:0007041
STAT3 	STAT3 (Signal Transducer And Activator Of Transcription 3) is a Protein Coding gene. Diseases associated with STAT3 include  STAT1	The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. This gene also plays a role in regulating host response to viral and bacterial infections. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. [provided by RefSeq, Aug 2020]	The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. This gene also plays a role in regulating host response to viral and bacterial infections. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. [provided by RefSeq, Aug 2020]	Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in glioblastoma multiforme (GBM) lineage, Upregulation of NF-kappaB pathway after LMP1 stimulation, Increased NF-kappaB reporter expression, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000122 GO:0001659 GO:0001754 GO:0001754 GO:0001754 GO:0006355 GO:0006355 GO:0006355
MAP2K6 	MAP2K6 (Mitogen-Activated Protein Kinase Kinase 6) is a Protein Coding gene. Diseases associated with MAP2K6 include  MAP2K3	This gene encodes a member of the dual specificity protein kinase family, which functions as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein phosphorylates and activates p38 MAP kinase in response to inflammatory cytokines or environmental stress. As an essential component of p38 MAP kinase mediated signal transduction pathway, this gene is involved in many cellular processes such as stress induced cell cycle arrest, transcription activation and apoptosis. This gene encodes a member of the dual specificity protein kinase family, which functions as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein phosphorylates and activates p38 MAP kinase in response to inflammatory cytokines or environmental stress. As an essential component of p38 MAP kinase mediated signal transduction pathway, this gene is involved in many cellular processes such as stress induced cell cycle arrest, transcription activation and apoptosis. no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased viability (cell death), Decreased viability, Decreased homologous recombination repair frequency, Increased cell viability after pRB stimulation, Decreased viability with cisplatin, 	GO:0000165
ARF6 	ARF6 (ADP Ribosylation Factor 6) is a Protein Coding gene. Diseases associated with ARF6 include  Cholera ARF1	This gene encodes a member of the human ARF gene family, which is part of the RAS superfamily. The ARF genes encode small guanine nucleotide-binding proteins that stimulate the ADP-ribosyltransferase activity of cholera toxin and play a role in vesicular trafficking and as activators of phospholipase D. The product of this gene is localized to the plasma membrane, and regulates vesicular trafficking, remodelling of membrane lipids, and signaling pathways that lead to actin remodeling. A pseudogene of this gene is located on chromosome 7. This gene encodes a member of the human ARF gene family, which is part of the RAS superfamily. The ARF genes encode small guanine nucleotide-binding proteins that stimulate the ADP-ribosyltransferase activity of cholera toxin and play a role in vesicular trafficking and as activators of phospholipase D. The product of this gene is localized to the plasma membrane, and regulates vesicular trafficking, remodelling of membrane lipids, and signaling pathways that lead to actin remodeling. A pseudogene of this gene is located on chromosome 7. no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, 	GO:0001889 GO:0006886 GO:0006886 GO:0006886 GO:0007049 GO:0007155 GO:0007155 GO:0007155
JUN 	JUN (Jun Proto-Oncogene, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with JUN include  Sarcoma JUND	This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies. This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies. no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased viability in ovarian lineage, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased IL-8 secretion, Inconclusive, Increased cell death HMECs cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased influenza A/WSN/33 replication, Increased HPV16-GFP infection, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, Increased epidermal growth factor (EGF) endosome number, increased epidermal growth factor (EGF) endosome elongation, Decreased influenza A H1N1 (A/WSN/33) virus numbers, Increased TP53 mRNA expression, 	GO:0000122
ACVR2B 	ACVR2B (Activin A Receptor Type 2B) is a Protein Coding gene. Diseases associated with ACVR2B include  ACVR2A	Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased virus production, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased viability after TNF/CHX stimulation, Decreased IL-13 protein expression, Increased vesicular stomatitis virus (VSV) infection, Increased apoptosis, Decreased viability in esophageal squamous lineage; decreased viability in pancreas lineage, 	GO:0000122
MCL1 	MCL1 (MCL1 Apoptosis Regulator, BCL2 Family Member) is a Protein Coding gene. Diseases associated with MCL1 include  Chlamydia BCL2	This gene encodes an anti-apoptotic protein, which is a member of the Bcl-2 family. Alternative splicing results in multiple transcript variants. The longest gene product (isoform 1) enhances cell survival by inhibiting apoptosis while the alternatively spliced shorter gene products (isoform 2 and isoform 3) promote apoptosis and are death-inducing. [provided by RefSeq, Oct 2010]	This gene encodes an anti-apoptotic protein, which is a member of the Bcl-2 family. Alternative splicing results in multiple transcript variants. The longest gene product (isoform 1) enhances cell survival by inhibiting apoptosis while the alternatively spliced shorter gene products (isoform 2 and isoform 3) promote apoptosis and are death-inducing. [provided by RefSeq, Oct 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, G0/1 arrest, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased cell number, No cells, Increased number of mitotic cells, Increased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with paclitaxel, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Synthetic lethal with cisplatin, 	GO:0001709 GO:0001836 GO:0006915 GO:0008053 GO:0008053 GO:0008053 GO:0008630
GABPA 	GABPA (GA Binding Protein Transcription Factor Subunit Alpha) is a Protein Coding gene.  Among its related pathways are  ETS2	This gene encodes one of three GA-binding protein transcription factor subunits which functions as a DNA-binding subunit. Since this subunit shares identity with a subunit encoding the nuclear respiratory factor 2 gene, it is likely involved in activation of cytochrome oxidase expression and nuclear control of mitochondrial function. This subunit also shares identity with a subunit constituting the transcription factor E4TF1, responsible for expression of the adenovirus E4 gene. Because of its chromosomal localization and ability to form heterodimers with other polypeptides, this gene may play a role in the Down Syndrome phenotype. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2010]	This gene encodes one of three GA-binding protein transcription factor subunits which functions as a DNA-binding subunit. Since this subunit shares identity with a subunit encoding the nuclear respiratory factor 2 gene, it is likely involved in activation of cytochrome oxidase expression and nuclear control of mitochondrial function. This subunit also shares identity with a subunit constituting the transcription factor E4TF1, responsible for expression of the adenovirus E4 gene. Because of its chromosomal localization and ability to form heterodimers with other polypeptides, this gene may play a role in the Down Syndrome phenotype. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2010]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased viability with paclitaxel, Increased Nanog expression, 	GO:0000122 GO:0001701 GO:0001701 GO:0001701 GO:0001825 GO:0001825 GO:0001825 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
PFKFB3 	PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3) is a Protein Coding gene. Diseases associated with PFKFB3 include  PFKFB2	The protein encoded by this gene belongs to a family of bifunctional proteins that are involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate (F2,6BP), and a fructose-2,6-biphosphatase activity that catalyzes the degradation of F2,6BP. This protein is required for cell cycle progression and prevention of apoptosis. It functions as a regulator of cyclin-dependent kinase 1, linking glucose metabolism to cell proliferation and survival in tumor cells. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2016]	The protein encoded by this gene belongs to a family of bifunctional proteins that are involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate (F2,6BP), and a fructose-2,6-biphosphatase activity that catalyzes the degradation of F2,6BP. This protein is required for cell cycle progression and prevention of apoptosis. It functions as a regulator of cyclin-dependent kinase 1, linking glucose metabolism to cell proliferation and survival in tumor cells. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2016]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased cell migration, Decreased shRNA abundance (Z-score &lt; -2), Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Weakly decreased NFAT1-GFP nuclear translocation, Large nuclei, Decreased simian virus 40 (SV40) infection, Decreased 12E8 and total tau protein expression, 	GO:0006000 GO:0006003 GO:0006003 GO:0006003
HMOX2 	HMOX2 (Heme Oxygenase 2) is a Protein Coding gene. Diseases associated with HMOX2 include  Gastroparesis HMOX1	Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. Several alternatively spliced transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]	Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. Several alternatively spliced transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]	Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Decreased viability ratio, Decreased POU5F1-GFP protein expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001666 GO:0006788 GO:0006979 GO:0042167 GO:0055072
GIPC1 	GIPC1 (GIPC PDZ Domain Containing Family Member 1) is a Protein Coding gene. Diseases associated with GIPC1 include  GIPC2	GIPC1 is a scaffolding protein that regulates cell surface receptor expression and trafficking (Lee et al., 2008 [PubMed 18775991]).[supplied by OMIM, Apr 2009]	GIPC1 is a scaffolding protein that regulates cell surface receptor expression and trafficking (Lee et al., 2008 [PubMed 18775991]).[supplied by OMIM, Apr 2009]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased viability in esophageal squamous lineage; decreased viability in pancreas lineage, 	GO:0006605 GO:0007186 GO:0007186 GO:0007186
MAPK9 	MAPK9 (Mitogen-Activated Protein Kinase 9) is a Protein Coding gene. Diseases associated with MAPK9 include  MAPK10	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene\'s mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Sep 2008]	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene\'s mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Sep 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased nuclear migration speed, Increased mitotic index, Decreased simian virus 40 (SV40) infection, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007165 GO:0007254 GO:0007254 GO:0007254 GO:0010628
DACH1 	DACH1 (Dachshund Family Transcription Factor 1) is a Protein Coding gene. Diseases associated with DACH1 include  DACH2	This gene encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. The protein contains a Ski domain that is highly conserved from Drosophila to human. Expression of this gene is lost in some forms of metastatic cancer, and is correlated with poor prognosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	This gene encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. The protein contains a Ski domain that is highly conserved from Drosophila to human. Expression of this gene is lost in some forms of metastatic cancer, and is correlated with poor prognosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	no effect, Synthetic lethal with Ras, Decreased viability, Decreased viability (cell death), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased HPV18 LCR reporter activity, Moderately decreased NFAT1-GFP nuclear translocation, Synthetic lethal with vaccinia virus (VACV) infection, Increased BBC3 mRNA expression, 	GO:0000122
LDHA 	LDHA (Lactate Dehydrogenase A) is a Protein Coding gene. Diseases associated with LDHA include  Myoglobinuria LDHB	The protein encoded by this gene catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. Multiple transcript variants encoding different isoforms have been found for this gene. The human genome contains several non-transcribed pseudogenes of this gene. [provided by RefSeq, Sep 2008]	The protein encoded by this gene catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. The protein is found predominantly in muscle tissue and belongs to the lactate dehydrogenase family. Mutations in this gene have been linked to exertional myoglobinuria. Multiple transcript variants encoding different isoforms have been found for this gene. The human genome contains several non-transcribed pseudogenes of this gene. [provided by RefSeq, Sep 2008]	no effect, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), 	GO:0006089 GO:0006090 GO:0006090 GO:0006090 GO:0006096 GO:0006096 GO:0006096
SMAD5 	SMAD5 (SMAD Family Member 5) is a Protein Coding gene. Diseases associated with SMAD5 include  SMAD1	The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased nuclear migration distance, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased vesicular stomatitis virus (VSV) infection, 	 
TRIM9 	TRIM9 (Tripartite Motif Containing 9) is a Protein Coding gene. Diseases associated with TRIM9 include  Dementia TRIM67	The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. Its function has not been identified. Alternate splicing of this gene generates two transcript variants encoding different isoforms. The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. Its function has not been identified. Alternate splicing of this gene generates two transcript variants encoding different isoforms. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability of wild-type and TP53 knockout cells, 	GO:0016567 GO:0043161 GO:0043161 GO:0043161
ARHGAP18 	ARHGAP18 (Rho GTPase Activating Protein 18) is a Protein Coding gene. Diseases associated with ARHGAP18 include  ARHGAP28	ARHGAP18 belongs to a family of Rho (see MIM 165390) GTPase-activating proteins that modulate cell signaling (Potkin et al., 2009 [PubMed 19065146]).[supplied by OMIM, Apr 2010]	ARHGAP18 belongs to a family of Rho (see MIM 165390) GTPase-activating proteins that modulate cell signaling (Potkin et al., 2009 [PubMed 19065146]).[supplied by OMIM, Apr 2010]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability ratio, Decreased viability, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability with paclitaxel, Decreased viability in ovarian lineage, Increased IL-8 secretion, Inconclusive, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0008360 GO:0030833 GO:0032956
COL1A1 	COL1A1 (Collagen Type I Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL1A1 include  COL2A1	This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]	This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]	no effect, Synthetic lethal with Ras, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0001501 GO:0001503 GO:0001568
UBE2O 	UBE2O (Ubiquitin Conjugating Enzyme E2 O) is a Protein Coding gene. Diseases associated with UBE2O include  UBE2Z	Enables ubiquitin conjugating enzyme activity and ubiquitin protein ligase activity. Involved in positive regulation of BMP signaling pathway; protein ubiquitination; and retrograde transport, endosome to Golgi. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Enables ubiquitin conjugating enzyme activity and ubiquitin protein ligase activity. Involved in positive regulation of BMP signaling pathway; protein ubiquitination; and retrograde transport, endosome to Golgi. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, No cells, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0006513 GO:0016567 GO:0030513 GO:0030513 GO:0030513 GO:0042147
ELF1 	ELF1 (E74 Like ETS Transcription Factor 1) is a Protein Coding gene. Diseases associated with ELF1 include  Retinoblastoma ELF4	This gene encodes an E26 transformation-specific related transcription factor. The encoded protein is primarily expressed in lymphoid cells and acts as both an enhancer and a repressor to regulate transcription of various genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2009]	This gene encodes an E26 transformation-specific related transcription factor. The encoded protein is primarily expressed in lymphoid cells and acts as both an enhancer and a repressor to regulate transcription of various genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2009]	no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Resistant to vaccinia virus (VACV-A4L) infection, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001817 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0030154 GO:0045893
FAM20C 	FAM20C (FAM20C Golgi Associated Secretory Pathway Kinase) is a Protein Coding gene. Diseases associated with FAM20C include  Rickets FAM20A	This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]	This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]	Decreased viability, no effect, Increased IL-8 secretion, No cells, Downregulation of Wnt pathway after Wnt3A stimulation, 	GO:0001501 GO:0006468 GO:0006468 GO:0006468
SEMA3A 	SEMA3A (Semaphorin 3A) is a Protein Coding gene. Diseases associated with SEMA3A include  SEMA3D	This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer\'s disease. This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer\'s disease. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, 	GO:0001755 GO:0001764 GO:0006915 GO:0006915 GO:0006915 GO:0007399 GO:0007399 GO:0007399 GO:0007411 GO:0007411 GO:0007411
NANOG 	NANOG (Nanog Homeobox) is a Protein Coding gene. Diseases associated with NANOG include  Teratocarcinoma Gastrulation NANOGP8	The protein encoded by this gene is a DNA binding homeobox transcription factor involved in embryonic stem (ES) cell proliferation, renewal, and pluripotency. The encoded protein can block ES cell differentiation and can also autorepress its own expression in differentiating cells. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]	The protein encoded by this gene is a DNA binding homeobox transcription factor involved in embryonic stem (ES) cell proliferation, renewal, and pluripotency. The encoded protein can block ES cell differentiation and can also autorepress its own expression in differentiating cells. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased POU5F1-GFP protein expression, 	GO:0000122 GO:0001714 GO:0001714 GO:0001714 GO:0006355 GO:0006357 GO:0010468
SULF1 	SULF1 (Sulfatase 1) is a Protein Coding gene. Diseases associated with SULF1 include  SULF2	This gene encodes an extracellular heparan sulfate endosulfatase. The encoded enzyme selectively removes 6-O-sulfate groups from heparan sulfate chains of heparan sulfate proteoglycans (HSPGs). The enzyme is secreted through the Golgi and is subsequently localized to the cell surface. The expression of this gene may be down-regulated in several types of cancer, including hepatocellular (HCC), ovarian and breast cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]	This gene encodes an extracellular heparan sulfate endosulfatase. The encoded enzyme selectively removes 6-O-sulfate groups from heparan sulfate chains of heparan sulfate proteoglycans (HSPGs). The enzyme is secreted through the Golgi and is subsequently localized to the cell surface. The expression of this gene may be down-regulated in several types of cancer, including hepatocellular (HCC), ovarian and breast cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Downregulation of Wnt pathway after Wnt3A stimulation, Decreased nuclei size in G2M, 	GO:0001822 GO:0001937 GO:0001937 GO:0001937
TGFB1I1 	TGFB1I1 (Transforming Growth Factor Beta 1 Induced Transcript 1) is a Protein Coding gene. Diseases associated with TGFB1I1 include  PXN	This gene encodes a coactivator of the androgen receptor, a transcription factor which is activated by androgen and has a key role in male sexual differentiation. The encoded protein is thought to regulate androgen receptor activity and may have a role to play in the treatment of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	This gene encodes a coactivator of the androgen receptor, a transcription factor which is activated by androgen and has a key role in male sexual differentiation. The encoded protein is thought to regulate androgen receptor activity and may have a role to play in the treatment of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, Increased Sindbis virus (SINV) infection, Decreased cell migration, 	GO:0006351 GO:0007155 GO:0007155 GO:0007155 GO:0008285 GO:0010718
GDF5 	GDF5 (Growth Differentiation Factor 5) is a Protein Coding gene. Diseases associated with GDF5 include  GDF6 . This protein regulates the development of numerous tissue and cell types, including cartilage, joints, brown fat, teeth, and the growth of neuronal axons and dendrites. Mutations in this gene are associated with acromesomelic dysplasia, brachydactyly, chondrodysplasia, multiple synostoses syndrome, proximal symphalangism, and susceptibility to osteoarthritis. [provided by RefSeq, Aug 2016] . This protein regulates the development of numerous tissue and cell types, including cartilage, joints, brown fat, teeth, and the growth of neuronal axons and dendrites. Mutations in this gene are associated with acromesomelic dysplasia, brachydactyly, chondrodysplasia, multiple synostoses syndrome, proximal symphalangism, and susceptibility to osteoarthritis. [provided by RefSeq, Aug 2016]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased homologous recombination repair frequency, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, High actin ratio cells, 	GO:0002062 GO:0007178 GO:0007178 GO:0007178 GO:0007179 GO:0007179 GO:0007179 GO:0007267
HSF1 	HSF1 (Heat Shock Transcription Factor 1) is a Protein Coding gene. Diseases associated with HSF1 include  HSF2	The product of this gene is a transcription factor that is rapidly induced after temperature stress and binds heat shock promoter elements (HSE). This protein plays a role in the regulation of lifespan. Expression of this gene is repressed by phosphorylation, which promotes binding by heat shock protein 90. [provided by RefSeq, Jul 2017]	The product of this gene is a transcription factor that is rapidly induced after temperature stress and binds heat shock promoter elements (HSE). This protein plays a role in the regulation of lifespan. Expression of this gene is repressed by phosphorylation, which promotes binding by heat shock protein 90. [provided by RefSeq, Jul 2017]	Decreased viability, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased Nanog expression, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased Aire reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Decreased Hepatitis C virus replication, Decreased vaccinia virus (VACV-LREV ) gene expression, 	GO:0000122 GO:0000165 GO:0006281 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
PTPN14 	PTPN14 (Protein Tyrosine Phosphatase Non-Receptor Type 14) is a Protein Coding gene. Diseases associated with PTPN14 include  PTPN21	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, Decreased epidermal growth factor (EGF) endocytosis, Fragmented trans-Golgi, 	GO:0001946 GO:0006351 GO:0006470 GO:0006470 GO:0006470 GO:0008285 GO:0008285 GO:0008285
ABCG1 	ABCG1 (ATP Binding Cassette Subfamily G Member 1) is a Protein Coding gene. Diseases associated with ABCG1 include  Sitosterolemia ABCG4	The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. It is involved in macrophage cholesterol and phospholipids transport, and may regulate cellular lipid homeostasis in other cell types. Six alternative splice variants have been identified. The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. It is involved in macrophage cholesterol and phospholipids transport, and may regulate cellular lipid homeostasis in other cell types. Six alternative splice variants have been identified. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased viability with SS1P at EC90, 	GO:0006869 GO:0008203 GO:0008203 GO:0008203 GO:0010033 GO:0010745
NEUROG2 	NEUROG2 (Neurogenin 2) is a Protein Coding gene. Diseases associated with NEUROG2 include  DYRK1A NEUROG1	This gene encodes a neural-specific basic helix-loop-helix (bHLH) transcription factor that can specify a neuronal fate on ectodermal cells and is expressed in neural progenitor cells within the developing central and peripheral nervous systems. The protein product of this gene also plays a role in the differentiation and survival of midbrain dopaminergic neurons. [provided by RefSeq, Apr 2012]	This gene encodes a neural-specific basic helix-loop-helix (bHLH) transcription factor that can specify a neuronal fate on ectodermal cells and is expressed in neural progenitor cells within the developing central and peripheral nervous systems. The protein product of this gene also plays a role in the differentiation and survival of midbrain dopaminergic neurons. [provided by RefSeq, Apr 2012]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased shRNA abundance (Z-score &gt; 2), 	 
MYOD1 	MYOD1 (Myogenic Differentiation 1) is a Protein Coding gene. Diseases associated with MYOD1 include  MYF5	This gene encodes a nuclear protein that belongs to the basic helix-loop-helix family of transcription factors and the myogenic factors subfamily. It regulates muscle cell differentiation by inducing cell cycle arrest, a prerequisite for myogenic initiation. The protein is also involved in muscle regeneration. It activates its own transcription which may stabilize commitment to myogenesis. This gene encodes a nuclear protein that belongs to the basic helix-loop-helix family of transcription factors and the myogenic factors subfamily. It regulates muscle cell differentiation by inducing cell cycle arrest, a prerequisite for myogenic initiation. The protein is also involved in muscle regeneration. It activates its own transcription which may stabilize commitment to myogenesis. Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in glioblastoma multiforme (GBM) lineage, Negative genetic interaction between BLM-/- and BLM+/+, Decreased influenza A/WSN/33 replication, Increased HPV16-GFP infection, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0000381 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006366 GO:0006468 GO:0006468 GO:0006468
LIMS1 	LIMS1 (LIM Zinc Finger Domain Containing 1) is a Protein Coding gene. Diseases associated with LIMS1 include  LIMS3	The protein encoded by this gene is an adaptor protein which contains five LIM domains, or double zinc fingers. The protein is likely involved in integrin signaling through its LIM domain-mediated interaction with integrin-linked kinase, found in focal adhesion plaques. It is also thought to act as a bridge linking integrin-linked kinase to NCK adaptor protein 2, which is involved in growth factor receptor kinase signaling pathways. Its localization to the periphery of spreading cells also suggests that this protein may play a role in integrin-mediated cell adhesion or spreading. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]	The protein encoded by this gene is an adaptor protein which contains five LIM domains, or double zinc fingers. The protein is likely involved in integrin signaling through its LIM domain-mediated interaction with integrin-linked kinase, found in focal adhesion plaques. It is also thought to act as a bridge linking integrin-linked kinase to NCK adaptor protein 2, which is involved in growth factor receptor kinase signaling pathways. Its localization to the periphery of spreading cells also suggests that this protein may play a role in integrin-mediated cell adhesion or spreading. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]	no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, 	GO:0001837 GO:0010628 GO:0010811 GO:0033209 GO:0043547
BMP7 	BMP7 (Bone Morphogenetic Protein 7) is a Protein Coding gene. Diseases associated with BMP7 include  BMP5 , which plays a role in bone, kidney and brown adipose tissue development. Additionally, this protein induces ectopic bone formation and may promote fracture healing in human patients.   , which plays a role in bone, kidney and brown adipose tissue development. Additionally, this protein induces ectopic bone formation and may promote fracture healing in human patients. Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased HPV16-GFP infection, Decreased viability of wild-type and TP53 knockout cells, Decreased homologous recombination repair frequency, Decreased centriole number, Increased CFP-tsO45G cell surface transport, 	GO:0001501 GO:0001503 GO:0001654 GO:0001654 GO:0001654 GO:0001656 GO:0001656 GO:0001656
SIK2 	SIK2 (Salt Inducible Kinase 2) is a Protein Coding gene. Diseases associated with SIK2 include  SIK1	Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in intracellular signal transduction and protein autophosphorylation. Predicted to be located in nucleus. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in intracellular signal transduction and protein autophosphorylation. Predicted to be located in nucleus. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability in ovarian lineage, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased NF-kappaB reporter expression, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell proliferation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased cell death in DLD-1 cells, Decreased CYP1A1 activity after TCDD stimulation, 	GO:0006468 GO:0016310 GO:0035556 GO:0035556 GO:0035556
SCX 	SCX (Scleraxis BHLH Transcription Factor) is a Protein Coding gene. Diseases associated with SCX include  TCF15	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and bHLH transcription factor binding activity. Contributes to E-box binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleus. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables DNA-binding transcription activator activity, RNA polymerase II-specific and bHLH transcription factor binding activity. Contributes to E-box binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleus. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased vaccinia virus (VACV) infection, No cells, 	 
VAV2 	VAV2 (Vav Guanine Nucleotide Exchange Factor 2) is a Protein Coding gene.  Among its related pathways are  VAV3	VAV2 is the second member of the VAV guanine nucleotide exchange factor family of oncogenes. Unlike VAV1, which is expressed exclusively in hematopoietic cells, VAV2 transcripts were found in most tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	VAV2 is the second member of the VAV guanine nucleotide exchange factor family of oncogenes. Unlike VAV1, which is expressed exclusively in hematopoietic cells, VAV2 transcripts were found in most tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	Increased vaccinia virus (VACV) infection, no effect, Increased transferrin (TF) endocytosis, Increased viability (proliferation), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0001525 GO:0007165 GO:0007165 GO:0007165 GO:0007264 GO:0008361 GO:0008361 GO:0008361 GO:0016477
IQGAP2 	IQGAP2 (IQ Motif Containing GTPase Activating Protein 2) is a Protein Coding gene. Diseases associated with IQGAP2 include  IQGAP1	This gene encodes a member of the IQGAP family. The encoded protein contains three IQ domains, one calponin homology domain, one Ras-GAP domain and one WW domain. This protein interacts with components of the cytoskeleton, with cell adhesion molecules, and with several signaling molecules to regulate cell morphology and motility. It also acts as a tumor suppressor and has been found to play a role in regulating innate antiviral responses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]	This gene encodes a member of the IQGAP family. The encoded protein contains three IQ domains, one calponin homology domain, one Ras-GAP domain and one WW domain. This protein interacts with components of the cytoskeleton, with cell adhesion molecules, and with several signaling molecules to regulate cell morphology and motility. It also acts as a tumor suppressor and has been found to play a role in regulating innate antiviral responses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]	no effect, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0007165 GO:0032956 GO:0034314 GO:0043087 GO:0070493 GO:0070493 GO:0070493
HEY1 	HEY1 (Hes Related Family BHLH Transcription Factor With YRPW Motif 1) is a Protein Coding gene. Diseases associated with HEY1 include  HEY2	This gene encodes a nuclear protein belonging to the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcriptional repressors. Expression of this gene is induced by the Notch and c-Jun signal transduction pathways. Two similar and redundant genes in mouse are required for embryonic cardiovascular development, and are also implicated in neurogenesis and somitogenesis. Alternative splicing results in multiple transcript variants. This gene encodes a nuclear protein belonging to the hairy and enhancer of split-related (HESR) family of basic helix-loop-helix (bHLH)-type transcriptional repressors. Expression of this gene is induced by the Notch and c-Jun signal transduction pathways. Two similar and redundant genes in mouse are required for embryonic cardiovascular development, and are also implicated in neurogenesis and somitogenesis. Alternative splicing results in multiple transcript variants. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Reduced mammosphere formation, Decreased viability, 	GO:0000122 GO:0001525 GO:0001525 GO:0001525 GO:0003161
IGF1 	IGF1 (Insulin Like Growth Factor 1) is a Protein Coding gene. Diseases associated with IGF1 include  Acromegaly IGF2	The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015]	The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Increased IL-8 secretion, Decreased viability with paclitaxel, 	GO:0001501 GO:0001775 GO:0001837 GO:0001932 GO:0007165
NOS1 	NOS1 (Nitric Oxide Synthase 1) is a Protein Coding gene. Diseases associated with NOS1 include  Achalasia NOS3	The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5\' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]	The protein encoded by this gene belongs to the family of nitric oxide synthases, which synthesize nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biologic mediator in several processes, including neurotransmission, and antimicrobial and antitumoral activities. In the brain and peripheral nervous system, nitric oxide displays many properties of a neurotransmitter, and has been implicated in neurotoxicity associated with stroke and neurodegenerative diseases, neural regulation of smooth muscle, including peristalsis, and penile erection. This protein is ubiquitously expressed, with high level of expression in skeletal muscle. Multiple transcript variants that differ in the 5\' UTR have been described for this gene but the full-length nature of these transcripts is not known. Additionally, alternatively spliced transcript variants encoding different isoforms (some testis-specific) have been found for this gene.[provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased viability, shRNA abundance &lt;= 50%, Increased NF-kappaB reporter expression, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0001666 GO:0002028 GO:0006527 GO:0006527 GO:0006527 GO:0006809 GO:0006936
SIAH2 	SIAH2 (Siah E3 Ubiquitin Protein Ligase 2) is a Protein Coding gene. Diseases associated with SIAH2 include  SIAH1	This gene encodes a protein that is a member of the seven in absentia homolog (SIAH) family. The protein is an E3 ligase and is involved in ubiquitination and proteasome-mediated degradation of specific proteins. The activity of this ubiquitin ligase has been implicated in regulating cellular response to hypoxia. This gene encodes a protein that is a member of the seven in absentia homolog (SIAH) family. The protein is an E3 ligase and is involved in ubiquitination and proteasome-mediated degradation of specific proteins. The activity of this ubiquitin ligase has been implicated in regulating cellular response to hypoxia. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased caspase activity, 	GO:0006511 GO:0006915 GO:0006915 GO:0006915 GO:0007049 GO:0007049 GO:0007049 GO:0007264 GO:0007264 GO:0007264
NR2E1 	NR2E1 (Nuclear Receptor Subfamily 2 Group E Member 1) is a Protein Coding gene. Diseases associated with NR2E1 include  NR2E3	The protein encoded by this gene is an orphan receptor involved in retinal development. The encoded protein also regulates adult neural stem cell proliferation and may be involved in control of aggressive behavior. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]	The protein encoded by this gene is an orphan receptor involved in retinal development. The encoded protein also regulates adult neural stem cell proliferation and may be involved in control of aggressive behavior. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, G0/1 arrest, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, Synthetic lethal with cisplatin, Decreased viability with neratinib, 	GO:0000122
PF4 	PF4 (Platelet Factor 4) is a Protein Coding gene. Diseases associated with PF4 include  Erythromelalgia PF4V1	This gene encodes a member of the CXC chemokine family. This chemokine is released from the alpha granules of activated platelets in the form of a homotetramer which has high affinity for heparin and is involved in platelet aggregation. This protein is chemotactic for numerous other cell type and also functions as an inhibitor of hematopoiesis, angiogenesis and T-cell function. The protein also exhibits antimicrobial activity against Plasmodium falciparum. [provided by RefSeq, Oct 2014]	This gene encodes a member of the CXC chemokine family. This chemokine is released from the alpha granules of activated platelets in the form of a homotetramer which has high affinity for heparin and is involved in platelet aggregation. This protein is chemotactic for numerous other cell type and also functions as an inhibitor of hematopoiesis, angiogenesis and T-cell function. The protein also exhibits antimicrobial activity against Plasmodium falciparum. [provided by RefSeq, Oct 2014]	no effect, Decreased viability, Inconclusive, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0006935 GO:0006952 GO:0006952 GO:0006952 GO:0006954 GO:0006954 GO:0006954 GO:0006955 GO:0007189 GO:0007189 GO:0007189
E2F1 	E2F1 (E2F Transcription Factor 1) is a Protein Coding gene. Diseases associated with E2F1 include  Retinoblastoma E2F3	The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain.  This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain.  This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Decreased viability of wild-type and TP53 knockout cells, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased homologous recombination repair frequency, Decreased influenza A/WSN/33 replication, 	GO:0000077 GO:0000082 GO:0000083 GO:0000122
PLEKHA5 	PLEKHA5 (Pleckstrin Homology Domain Containing A5) is a Protein Coding gene. Diseases associated with PLEKHA5 include  Metabolism PLEKHA7	Predicted to enable phosphatidylinositol phosphate binding activity. Predicted to act upstream of or within reproductive system development. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable phosphatidylinositol phosphate binding activity. Predicted to act upstream of or within reproductive system development. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), 	 
MYOCD 	MYOCD (Myocardin) is a Protein Coding gene. Diseases associated with MYOCD include  MRTFB	This gene encodes a nuclear protein, which is expressed in heart, aorta, and in smooth muscle cell-containing tissues. It functions as a transcriptional co-activator of serum response factor (SRF) and modulates expression of cardiac and smooth muscle-specific SRF-target genes, and thus may play a crucial role in cardiogenesis and differentiation of the smooth muscle cell lineage. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]	This gene encodes a nuclear protein, which is expressed in heart, aorta, and in smooth muscle cell-containing tissues. It functions as a transcriptional co-activator of serum response factor (SRF) and modulates expression of cardiac and smooth muscle-specific SRF-target genes, and thus may play a crucial role in cardiogenesis and differentiation of the smooth muscle cell lineage. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]	no effect, Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Decreased influenza A virus infection, 	GO:0000122 GO:0001560 GO:0001560 GO:0001560 GO:0001570 GO:0001570 GO:0001570 GO:0001666 GO:0001666 GO:0001666
AMOT 	AMOT (Angiomotin) is a Protein Coding gene. Diseases associated with AMOT include  Papilloma AMOTL1	This gene belongs to the motin family of angiostatin binding proteins characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells toward growth factors during the formation of new blood vessels. Alternative splicing results in multiple transcript variants encoding different isoforms. This gene belongs to the motin family of angiostatin binding proteins characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells toward growth factors during the formation of new blood vessels. Alternative splicing results in multiple transcript variants encoding different isoforms. no effect, Decreased viability, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0001525 GO:0001570 GO:0001701 GO:0001701 GO:0001701 GO:0001702 GO:0001702 GO:0001702 GO:0003365 GO:0003365 GO:0003365
COL18A1 	COL18A1 (Collagen Type XVIII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL18A1 include  COL2A1	This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased Sindbis virus (SINV) infection, 	GO:0001501 GO:0001525 GO:0001886 GO:0001886 GO:0001886 GO:0007155 GO:0007155 GO:0007155 GO:0007601 GO:0007601 GO:0007601
MAP3K10 	MAP3K10 (Mitogen-Activated Protein Kinase Kinase Kinase 10) is a Protein Coding gene. Diseases associated with MAP3K10 include  MAP3K9	The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase has been shown to activate MAPK8/JNK and MKK4/SEK1, and this kinase itself can be phoshorylated, and thus activated by JNK kinases. This kinase functions preferentially on the JNK signaling pathway, and is reported to be involved in nerve growth factor (NGF) induced neuronal apoptosis. The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase has been shown to activate MAPK8/JNK and MKK4/SEK1, and this kinase itself can be phoshorylated, and thus activated by JNK kinases. This kinase functions preferentially on the JNK signaling pathway, and is reported to be involved in nerve growth factor (NGF) induced neuronal apoptosis. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased Nanog expression, Decreased substrate adherent cell growth, Increased number of mitotic cells, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased viability, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased S DNA content, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Cell division defect, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0006468 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007224 GO:0007254
LDLR 	LDLR (Low Density Lipoprotein Receptor) is a Protein Coding gene. Diseases associated with LDLR include  LRP8	The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]	The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]	no effect, Decreased viability, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased viability after borna disease (rVSV&#916;G*/BDVG) virus infection, Dynamic nuclei (hole, folded or small irregular), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased HPV16-GFP infection, Decreased free cholesterol, Decreased viability in esophageal squamous lineage; decreased viability in glioblastoma multiforme (GBM) lineage, Decreased LDL uptake, 	GO:0001920 GO:0006629 GO:0006869 GO:0006897 GO:0006897 GO:0006897 GO:0006898
FGB 	FGB (Fibrinogen Beta Chain) is a Protein Coding gene. Diseases associated with FGB include  TNR	The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Fibrinogen serves key roles in hemostasis and antimicrobial host defense. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency. [provided by RefSeq, Aug 2020]	The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Fibrinogen serves key roles in hemostasis and antimicrobial host defense. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability (cell death), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007160 GO:0007160
FEZ1 	FEZ1 (Fasciculation And Elongation Protein Zeta 1) is a Protein Coding gene. Diseases associated with FEZ1 include  Schizophrenia Neuroscience FEZ2	This gene is an ortholog of the C. elegans unc-76 gene, which is necessary for normal axonal bundling and elongation within axon bundles. Expression of this gene in C. elegans unc-76 mutants can restore to the mutants partial locomotion and axonal fasciculation, suggesting that it also functions in axonal outgrowth. The N-terminal half of the gene product is highly acidic. Alternatively spliced transcript variants encoding different isoforms of this protein have been described. This gene is an ortholog of the C. elegans unc-76 gene, which is necessary for normal axonal bundling and elongation within axon bundles. Expression of this gene in C. elegans unc-76 mutants can restore to the mutants partial locomotion and axonal fasciculation, suggesting that it also functions in axonal outgrowth. The N-terminal half of the gene product is highly acidic. Alternatively spliced transcript variants encoding different isoforms of this protein have been described. no effect, Decreased viability, Reduced mammosphere formation, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0007155 GO:0007399 GO:0007411
MARK2 	MARK2 (Microtubule Affinity Regulating Kinase 2) is a Protein Coding gene.  Among its related pathways are  MARK1	This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2009]	This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2009]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Increased transferrin (TF) endocytosis, Increased Nanog expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased hepcidin::fluc mRNA expression, Decreased cell migration, Increased cell migration, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Decreased 12E8 tau but not total tau protein expression and decreased ratio of 12E8/total tau protein expression, 	GO:0000226 GO:0000422 GO:0001764 GO:0006468 GO:0006468 GO:0006468 GO:0010976
PLD2 	PLD2 (Phospholipase D2) is a Protein Coding gene. Diseases associated with PLD2 include  PLD1	The protein encoded by this gene catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline. The activity of the encoded enzyme is enhanced by phosphatidylinositol 4,5-bisphosphate and ADP-ribosylation factor-1. This protein localizes to the peripheral membrane and may be involved in cytoskeletal organization, cell cycle control, transcriptional regulation, and/or regulated secretion. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]	The protein encoded by this gene catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline. The activity of the encoded enzyme is enhanced by phosphatidylinositol 4,5-bisphosphate and ADP-ribosylation factor-1. This protein localizes to the peripheral membrane and may be involved in cytoskeletal organization, cell cycle control, transcriptional regulation, and/or regulated secretion. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Decreased influenza A/WSN/33 replication, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0006629 GO:0006654 GO:0006654 GO:0006654 GO:0007010 GO:0007010 GO:0007010 GO:0007264 GO:0009395
TRAP1 	TRAP1 (TNF Receptor Associated Protein 1) is a Protein Coding gene. Diseases associated with TRAP1 include  Cakut HSP90AB1	This gene encodes a mitochondrial chaperone protein that is member of the heat shock protein 90 (HSP90) family. The encoded protein has ATPase activity and interacts with tumor necrosis factor type I. This protein may function in regulating cellular stress responses. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]	This gene encodes a mitochondrial chaperone protein that is member of the heat shock protein 90 (HSP90) family. The encoded protein has ATPase activity and interacts with tumor necrosis factor type I. This protein may function in regulating cellular stress responses. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]	no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased NF-kappaB reporter expression, Increased HPV18 LCR reporter activity, Decreased influenza A/WSN/33 replication, Increased G2M DNA content, 	GO:0006457 GO:0009386 GO:0061077 GO:1901856 GO:1903427
SIX1 	SIX1 (SIX Homeobox 1) is a Protein Coding gene. Diseases associated with SIX1 include  SIX2	The protein encoded by this gene is a homeobox protein that is similar to the Drosophila \'sine oculis\' gene product. This gene is found in a cluster of related genes on chromosome 14 and is thought to be involved in limb development. Defects in this gene are a cause of autosomal dominant deafness type 23 (DFNA23) and branchiootic syndrome type 3 (BOS3). The protein encoded by this gene is a homeobox protein that is similar to the Drosophila \'sine oculis\' gene product. This gene is found in a cluster of related genes on chromosome 14 and is thought to be involved in limb development. Defects in this gene are a cause of autosomal dominant deafness type 23 (DFNA23) and branchiootic syndrome type 3 (BOS3). Increased vaccinia virus (VACV) infection, no effect, Increased IL-8 secretion, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased Nanog expression, 	 
CD28 	CD28 (CD28 Molecule) is a Protein Coding gene. Diseases associated with CD28 include  CTLA4	The protein encoded by this gene is essential for T-cell proliferation and survival, cytokine production, and T-helper type-2 development. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]	The protein encoded by this gene is essential for T-cell proliferation and survival, cytokine production, and T-helper type-2 development. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Reduced mammosphere formation, Decreased viability after Maraba virus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased shRNA abundance, 	GO:0001819 GO:0002863 GO:0006366 GO:0006366 GO:0006366 GO:0006955 GO:0006955 GO:0006955 GO:0006959 GO:0006959 GO:0006959
BHLHE40 	BHLHE40 (Basic Helix-Loop-Helix Family Member E40) is a Protein Coding gene. Diseases associated with BHLHE40 include  BHLHE41	This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL\'s transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. [provided by RefSeq, Feb 2014]	This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with ARNTL or compete for E-box binding sites in the promoter of PER1 and repress CLOCK/ARNTL\'s transactivation of PER1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. [provided by RefSeq, Feb 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased transcriptional activity, Increased hepcidin::fluc mRNA expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability with TRAIL, 	GO:0000122 GO:0006355 GO:0006357 GO:0007623 GO:0009952
HAND2 	HAND2 (Heart And Neural Crest Derivatives Expressed 2) is a Protein Coding gene. Diseases associated with HAND2 include  HAND1	The protein encoded by this gene belongs to the basic helix-loop-helix family of transcription factors. This gene product is one of two closely related family members, the HAND proteins, which are asymmetrically expressed in the developing ventricular chambers and play an essential role in cardiac morphogenesis. Working in a complementary fashion, they function in the formation of the right ventricle and aortic arch arteries, implicating them as mediators of congenital heart disease. In addition, this transcription factor plays an important role in limb and branchial arch development. The protein encoded by this gene belongs to the basic helix-loop-helix family of transcription factors. This gene product is one of two closely related family members, the HAND proteins, which are asymmetrically expressed in the developing ventricular chambers and play an essential role in cardiac morphogenesis. Working in a complementary fashion, they function in the formation of the right ventricle and aortic arch arteries, implicating them as mediators of congenital heart disease. In addition, this transcription factor plays an important role in limb and branchial arch development. no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased HPV16-GFP infection, Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	 
VWF 	VWF (Von Willebrand Factor) is a Protein Coding gene. Diseases associated with VWF include  MUC5B	This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]	This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]	Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased HIV-1 infection, 	GO:0007155 GO:0007596 GO:0007599 GO:0009611 GO:0030168
MAP2K4 	MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4) is a Protein Coding gene. Diseases associated with MAP2K4 include  MAP2K7	This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Increased Nanog expression, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased mitotic index, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0000165 GO:0001934 GO:0006468 GO:0006468 GO:0006468 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007165 GO:0007165
CIT 	CIT (Citron Rho-Interacting Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with CIT include  CDC42BPB	This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]	This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]	no effect, Synthetic lethal with Ras, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Decreased cell number, Decreased substrate adherent cell growth, Decreased viability (cell death), Decreased cell migration, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Cell division defect, Increased viability with tamoxifen, Paclitaxel antagonistic effect, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), two nuclei (binuclear), polylobed nuclei, 	GO:0000086 GO:0000278 GO:0000278 GO:0000278 GO:0000281
COL4A5 	COL4A5 (Collagen Type IV Alpha 5 Chain) is a Protein Coding gene. Diseases associated with COL4A5 include  COL4A1	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]	no effect, Decreased viability, Reduced mammosphere formation, 	GO:0007528 GO:0030198 GO:0030198 GO:0030198
RHO 	RHO (Rhodopsin) is a Protein Coding gene. Diseases associated with RHO include  OPN1MW	The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in esophageal squamous lineage, Decreased viability ratio, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased Nanog expression, Decreased Sindbis virus (SINV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007186 GO:0007186 GO:0007186 GO:0007601 GO:0007602 GO:0007602 GO:0007602
MMP14 	MMP14 (Matrix Metallopeptidase 14) is a Protein Coding gene. Diseases associated with MMP14 include  MMP15	Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance, 	GO:0001501
EGFR 	EGFR (Epidermal Growth Factor Receptor) is a Protein Coding gene. Diseases associated with EGFR include  ERBB4	The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).  The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).  no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Increased cell viability after pRB stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased S DNA content, Decreased shRNA abundance (Z-score &lt; -2), Decreased p24 protein expression, Decreased cell migration, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, increased cell spreading, Decreased viability with paclitaxel, 	GO:0000165 GO:0000902 GO:0000902 GO:0000902 GO:0001503 GO:0001503 GO:0001503 GO:0001892 GO:0001934 GO:0001934 GO:0001934
JUND 	JUND (JunD Proto-Oncogene, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with JUND include  JUN	The protein encoded by this intronless gene is a member of the JUN family, and a functional component of the AP1 transcription factor complex. This protein has been proposed to protect cells from p53-dependent senescence and apoptosis. Alternative translation initiation site usage results in the production of different isoforms (PMID:12105216). [provided by RefSeq, Nov 2013]	The protein encoded by this intronless gene is a member of the JUN family, and a functional component of the AP1 transcription factor complex. This protein has been proposed to protect cells from p53-dependent senescence and apoptosis. Alternative translation initiation site usage results in the production of different isoforms (PMID:12105216). [provided by RefSeq, Nov 2013]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability in pancreas lineage, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased circadian period length, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased Aire reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased virus production, Actin fiber cells, 	GO:0000122 GO:0002076 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
VTN 	VTN (Vitronectin) is a Protein Coding gene. Diseases associated with VTN include  PRG4	The protein encoded by this gene functions in part as an adhesive glycoprotein. Differential expression of this protein can promote either cell adhesion or migration as it links cells to the extracellular matrix through a variety of ligands. These ligands include integrins, plasminogen activator inhibitor-1, and urokinase plasminogen activator receptor. This secreted protein can be present in the plasma as a monomer or dimer and forms a multimer in the extracellular matrix of several tissues. This protein also inhibits the membrane-damaging effect of the terminal cytolytic complement pathway and binds to several serpin serine protease inhibitors. This protein can also promote extracellular matrix degradation and thus plays a role in tumorigenesis. It is involved in a variety of other biological processes such as the regulation of the coagulation pathway, wound healing, and tissue remodeling. The heparin-binding domain of this protein give it anti-microbial properties. It is also a lipid binding protein that forms a principal component of high density lipoprotein. [provided by RefSeq, Aug 2020]	The protein encoded by this gene functions in part as an adhesive glycoprotein. Differential expression of this protein can promote either cell adhesion or migration as it links cells to the extracellular matrix through a variety of ligands. These ligands include integrins, plasminogen activator inhibitor-1, and urokinase plasminogen activator receptor. This secreted protein can be present in the plasma as a monomer or dimer and forms a multimer in the extracellular matrix of several tissues. This protein also inhibits the membrane-damaging effect of the terminal cytolytic complement pathway and binds to several serpin serine protease inhibitors. This protein can also promote extracellular matrix degradation and thus plays a role in tumorigenesis. It is involved in a variety of other biological processes such as the regulation of the coagulation pathway, wound healing, and tissue remodeling. The heparin-binding domain of this protein give it anti-microbial properties. It is also a lipid binding protein that forms a principal component of high density lipoprotein. [provided by RefSeq, Aug 2020]	no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Inconclusive, Decreased Salmonella proliferation, 	GO:0006897 GO:0006955 GO:0006955 GO:0006955 GO:0007155 GO:0007155 GO:0007155 GO:0007160
HDAC1 	HDAC1 (Histone Deacetylase 1) is a Protein Coding gene. Diseases associated with HDAC1 include  Retinoblastoma HDAC2	Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. The protein encoded by this gene belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation. Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis. Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. The protein encoded by this gene belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation. Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis. Increased gamma-H2AX phosphorylation, no effect, Decreased ionizing radiation sensitivity, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased NF-kappaB reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased HIV-1 infection, Decreased TP53 mRNA expression, 	GO:0000122 GO:0006325 GO:0006338 GO:0006346 GO:0006357
DYNLL1 	DYNLL1 (Dynein Light Chain LC8-Type 1) is a Protein Coding gene. Diseases associated with DYNLL1 include  DYNLL2	Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Increased G2M DNA content, Cell division defect, 	GO:0006915 GO:0007017 GO:0007017 GO:0007017 GO:0021762 GO:0021762 GO:0021762 GO:0035721 GO:0042326
NEUROD1 	NEUROD1 (Neuronal Differentiation 1) is a Protein Coding gene. Diseases associated with NEUROD1 include  NEUROD2	This gene encodes a member of the NeuroD family of basic helix-loop-helix (bHLH) transcription factors. The protein forms heterodimers with other bHLH proteins and activates transcription of genes that contain a specific DNA sequence known as the E-box. It regulates expression of the insulin gene, and mutations in this gene result in type II diabetes mellitus. This gene encodes a member of the NeuroD family of basic helix-loop-helix (bHLH) transcription factors. The protein forms heterodimers with other bHLH proteins and activates transcription of genes that contain a specific DNA sequence known as the E-box. It regulates expression of the insulin gene, and mutations in this gene result in type II diabetes mellitus. no effect, shRNA abundance &lt;= 50%, Decreased viability with paclitaxel, Decreased shRNA abundance, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), 	 
THSD1 	THSD1 (Thrombospondin Type 1 Domain Containing 1) is a Protein Coding gene. Diseases associated with THSD1 include 	The protein encoded by this gene contains a type 1 thrombospondin domain, which is found in a number of proteins involved in the complement pathway, as well as in extracellular matrix proteins. Alternatively spliced transcript variants encoding different isoforms have been observed for this gene. [provided by RefSeq, Jan 2009]	The protein encoded by this gene contains a type 1 thrombospondin domain, which is found in a number of proteins involved in the complement pathway, as well as in extracellular matrix proteins. Alternatively spliced transcript variants encoding different isoforms have been observed for this gene. [provided by RefSeq, Jan 2009]	Increased vaccinia virus (VACV) infection, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Large nuclei, 	GO:0048041
NRG1 	NRG1 (Neuregulin 1) is a Protein Coding gene. Diseases associated with NRG1 include  NRG2	The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]	The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Increased G1 DNA content, Increased shRNA abundance (Z-score &gt; 2), Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0003222 GO:0006351 GO:0007154 GO:0007154 GO:0007154
GDF7 	GDF7 (Growth Differentiation Factor 7) is a Protein Coding gene. Diseases associated with GDF7 include  Epicondylitis GDF6 . This protein may play a role in the differentiation of tendon cells and spinal cord interneurons. A mutation in this gene may be associated with increased risk for Barrett\'s esophagus and esophageal adenocarcinoma. [provided by RefSeq, Sep 2016] . This protein may play a role in the differentiation of tendon cells and spinal cord interneurons. A mutation in this gene may be associated with increased risk for Barrett\'s esophagus and esophageal adenocarcinoma. [provided by RefSeq, Sep 2016]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability after Maraba virus infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0007411 GO:0010628 GO:0010628 GO:0010628 GO:0010862 GO:0010862 GO:0010862
SERPINA3 	SERPINA3 (Serpin Family A Member 3) is a Protein Coding gene. Diseases associated with SERPINA3 include  SERPINA9	The protein encoded by this gene is a member of the serpin family of proteins, a group of proteins that inhibit serine proteases. This gene is one in a cluster of serpin genes located on the q arm of chromosome 14. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein\'s sequence have been implicated in Alzheimer\'s disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease. [provided by RefSeq, Jun 2020]	The protein encoded by this gene is a member of the serpin family of proteins, a group of proteins that inhibit serine proteases. This gene is one in a cluster of serpin genes located on the q arm of chromosome 14. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein\'s sequence have been implicated in Alzheimer\'s disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease. [provided by RefSeq, Jun 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 25%, 	GO:0006953 GO:0006954 GO:0006954 GO:0006954 GO:0010466 GO:0010951 GO:0010951 GO:0010951 GO:0019216
GJA5 	GJA5 (Gap Junction Protein Alpha 5) is a Protein Coding gene. Diseases associated with GJA5 include  GJA8	This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene may be associated with atrial fibrillation. Alternatively spliced transcript variants encoding the same isoform have been described. This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene may be associated with atrial fibrillation. Alternatively spliced transcript variants encoding the same isoform have been described. no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), two nuclei (binuclear), polylobed nuclei, Decreased focal adhesion (FA) area, decreased FA length, increased number of small and round FAs, increased cell elongation, 	GO:0001525 GO:0003105 GO:0003151 GO:0003151 GO:0003151
LTBP2 	LTBP2 (Latent Transforming Growth Factor Beta Binding Protein 2) is a Protein Coding gene. Diseases associated with LTBP2 include  LTBP1	The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Increased NF-kappaB reporter expression, Decreased shRNA abundance, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006605 GO:0007179 GO:0009306 GO:0097435
LAMA5 	LAMA5 (Laminin Subunit Alpha 5) is a Protein Coding gene. Diseases associated with LAMA5 include  LAMA3	This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]	This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, FOXO1 nuclear localization, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	 
FBLN1 	FBLN1 (Fibulin 1) is a Protein Coding gene. Diseases associated with FBLN1 include  FBLN2	Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. Four splice variants which differ in the 3\' end have been identified. Each variant encodes a different isoform, but no functional distinctions have been identified among the four variants. Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. Four splice variants which differ in the 3\' end have been identified. Each variant encodes a different isoform, but no functional distinctions have been identified among the four variants. no effect, Decreased viability, Decreased viability with carboplatin, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), High actin ratio cells, Decreased viability with paclitaxel, 	GO:0001933 GO:0007162 GO:0007229
ZNF580 	ZNF580 (Zinc Finger Protein 580) is a Protein Coding gene.    An important paralog of this gene is  ZNF581	Enables sequence-specific double-stranded DNA binding activity. Involved in several processes, including cellular response to hydrogen peroxide; positive regulation of cell migration; and positive regulation of interleukin-8 production. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables sequence-specific double-stranded DNA binding activity. Involved in several processes, including cellular response to hydrogen peroxide; positive regulation of cell migration; and positive regulation of interleukin-8 production. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability, no effect, shRNA abundance &lt;= 50%, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0001938 GO:0002690 GO:0006357
SHOC2 	SHOC2 (SHOC2 Leucine Rich Repeat Scaffold Protein) is a Protein Coding gene. Diseases associated with SHOC2 include  SCRIB	This gene encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. The protein may function as a scaffold linking RAS to downstream signal transducers in the RAS/ERK MAP kinase signaling cascade. Mutations in this gene have been associated with Noonan-like syndrome with loose anagen hair. [provided by RefSeq, May 2010]	This gene encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. The protein may function as a scaffold linking RAS to downstream signal transducers in the RAS/ERK MAP kinase signaling cascade. Mutations in this gene have been associated with Noonan-like syndrome with loose anagen hair. [provided by RefSeq, May 2010]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased ionizing radiation sensitivity, Reduced mammosphere formation, Increased homologous recombination repair frequency, 	GO:0007165 GO:0007265 GO:0007265 GO:0007265 GO:0008543 GO:0046579
ITGA9 	ITGA9 (Integrin Subunit Alpha 9) is a Protein Coding gene. Diseases associated with ITGA9 include  ITGA4	This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0007155 GO:0007160 GO:0007229 GO:0030593 GO:0033627 GO:0033627 GO:0033627
SELE 	SELE (Selectin E) is a Protein Coding gene. Diseases associated with SELE include  SELP	The protein encoded by this gene is found in cytokine-stimulated endothelial cells and is thought to be responsible for the accumulation of blood leukocytes at sites of inflammation by mediating the adhesion of cells to the vascular lining. It exhibits structural features such as the presence of lectin- and EGF-like domains followed by short consensus repeat (SCR) domains that contain 6 conserved cysteine residues. These proteins are part of the selectin family of cell adhesion molecules. Adhesion molecules participate in the interaction between leukocytes and the endothelium and appear to be involved in the pathogenesis of atherosclerosis. The protein encoded by this gene is found in cytokine-stimulated endothelial cells and is thought to be responsible for the accumulation of blood leukocytes at sites of inflammation by mediating the adhesion of cells to the vascular lining. It exhibits structural features such as the presence of lectin- and EGF-like domains followed by short consensus repeat (SCR) domains that contain 6 conserved cysteine residues. These proteins are part of the selectin family of cell adhesion molecules. Adhesion molecules participate in the interaction between leukocytes and the endothelium and appear to be involved in the pathogenesis of atherosclerosis. Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased IL-8 secretion, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased G2M DNA content, 	GO:0002092 GO:0002523 GO:0002687 GO:0006954 GO:0006954 GO:0006954
LEF1 	LEF1 (Lymphoid Enhancer Binding Factor 1) is a Protein Coding gene. Diseases associated with LEF1 include  TCF7L2	This gene encodes a transcription factor belonging to a family of proteins that share homology with the high mobility group protein-1. The protein encoded by this gene can bind to a functionally important site in the T-cell receptor-alpha enhancer, thereby conferring maximal enhancer activity. This transcription factor is involved in the Wnt signaling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in this gene have been found in somatic sebaceous tumors. This gene has also been linked to other cancers, including androgen-independent prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]	This gene encodes a transcription factor belonging to a family of proteins that share homology with the high mobility group protein-1. The protein encoded by this gene can bind to a functionally important site in the T-cell receptor-alpha enhancer, thereby conferring maximal enhancer activity. This transcription factor is involved in the Wnt signaling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in this gene have been found in somatic sebaceous tumors. This gene has also been linked to other cancers, including androgen-independent prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased Nanog expression, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased viability (cell death), Increased transferrin (TF) endocytosis (mild increase), increased transferrin (TF) endosome elongation, 	GO:0000122 GO:0001569 GO:0001649 GO:0001649 GO:0001649
NTN4 	NTN4 (Netrin 4) is a Protein Coding gene.  Among its related pathways are  LAMB1	This gene encodes a member of the netrin family of proteins, which function in various biological processes including axon guidance, tumorogenesis, and angiogenesis. Netrins are laminin-related proteins that have an N-terminal laminin-type domain, epidermal growth factor-like repeat domain, and a positively charged heparin-binding domain at the C-terminus. The protein encoded by this gene is involved in processes including neurite growth and migration, angiogenesis and mural cell adhesion to endothelial cells. Alternative splicing results in multiple transcript variants. This gene encodes a member of the netrin family of proteins, which function in various biological processes including axon guidance, tumorogenesis, and angiogenesis. Netrins are laminin-related proteins that have an N-terminal laminin-type domain, epidermal growth factor-like repeat domain, and a positively charged heparin-binding domain at the C-terminus. The protein encoded by this gene is involved in processes including neurite growth and migration, angiogenesis and mural cell adhesion to endothelial cells. Alternative splicing results in multiple transcript variants. no effect, Increased transferrin (TF) endocytosis, Increased ionizing radiation sensitivity, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, 	GO:0009887 GO:0009888 GO:0009888 GO:0009888 GO:0016322 GO:0016322 GO:0016322 GO:0016477 GO:0016477 GO:0016477 GO:0034446
SYN1 	SYN1 (Synapsin I) is a Protein Coding gene. Diseases associated with SYN1 include  SYN2	This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased HPV18 LCR reporter activity, Decreased shRNA abundance, 	GO:0007268 GO:0007269 GO:0046928
TRIM71 	TRIM71 (Tripartite Motif Containing 71) is a Protein Coding gene. Diseases associated with TRIM71 include  TRIM2	The protein encoded by this gene is an E3 ubiquitin-protein ligase that binds with miRNAs and maintains the growth and upkeep of embryonic stem cells. This gene also is involved in the G1-S phase transition of the cell cycle. [provided by RefSeq, Dec 2015]	The protein encoded by this gene is an E3 ubiquitin-protein ligase that binds with miRNAs and maintains the growth and upkeep of embryonic stem cells. This gene also is involved in the G1-S phase transition of the cell cycle. [provided by RefSeq, Dec 2015]	Decreased viability, Increased homologous recombination repair frequency, Increased caspase activity, 	GO:0000082 GO:0000209 GO:0000209 GO:0000209
PEA15 	PEA15 (Proliferation And Apoptosis Adaptor Protein 15) is a Protein Coding gene. Diseases associated with PEA15 include 	This gene encodes a death effector domain-containing protein that functions as a negative regulator of apoptosis. The encoded protein is an endogenous substrate for protein kinase C. This protein is also overexpressed in type 2 diabetes mellitus, where it may contribute to insulin resistance in glucose uptake. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]	This gene encodes a death effector domain-containing protein that functions as a negative regulator of apoptosis. The encoded protein is an endogenous substrate for protein kinase C. This protein is also overexpressed in type 2 diabetes mellitus, where it may contribute to insulin resistance in glucose uptake. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with c-Myc after tamoxifen stimulation, Strongly decreased CFP-tsO45G cell surface transport, Decreased Salmonella enterica Typhimurium invasion, Increased cell death HMECs cells, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased proliferation, Increased cell death in HCT116 cells, Increased circadian rhythm amplitude, 	 
FOXC2 	FOXC2 (Forkhead Box C2) is a Protein Coding gene. Diseases associated with FOXC2 include  Distichiasis FOXC1	This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased Nanog expression, Decreased TP53 mRNA expression, 	 
TCF7L2 	TCF7L2 (Transcription Factor 7 Like 2) is a Protein Coding gene. Diseases associated with TCF7L2 include  TCF7L1	This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]	This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Increased Nanog expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased S DNA content, Decreased CDKN1A mRNA expression, Upregulation of Wnt pathway after Wnt3A stimulation, 	GO:0000122 GO:0001568 GO:0006357 GO:0009749 GO:0010909
ELN 	ELN (Elastin) is a Protein Coding gene. Diseases associated with ELN include 	This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]	This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, 	GO:0003151 GO:0003180 GO:0007519 GO:0007519 GO:0007519 GO:0007585 GO:0007585 GO:0007585 GO:0008015
GNG3 	GNG3 (G Protein Subunit Gamma 3) is a Protein Coding gene. Diseases associated with GNG3 include  GNG2	Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The gamma subunit determines the specificity of which signaling pathways will be affected by this particular complex. The protein encoded by this gene represents the gamma subunit of both inhibitory and stimulatory complexes. [provided by RefSeq, Jan 2012]	Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The gamma subunit determines the specificity of which signaling pathways will be affected by this particular complex. The protein encoded by this gene represents the gamma subunit of both inhibitory and stimulatory complexes. [provided by RefSeq, Jan 2012]	no effect, Decreased viability, Increased IL-8 secretion, Synthetic lethal with MLN4924 (a NAE inhibitor), 	GO:0007165 GO:0007186 GO:0007186 GO:0007186
ITGAV 	ITGAV (Integrin Subunit Alpha V) is a Protein Coding gene. Diseases associated with ITGAV include  ITGA8	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, FOXO1 nuclear localization, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Dynamic nuclei (hole, folded or small irregular), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased homologous recombination repair frequency, Reduced shRNA abundance in FBW7 KO line, Increased Salmonella enterica Typhimurium invasion, Increased Salmonella-containing vacuole maturation, Increased Salmonella enterica Typhimurium effector injection, Increased Salmonella enterica Typhimurium ruffling, Increased Salmonella enterica Typhimurium membrane closure, Decreased viability of wild-type and TP53 knockout cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased nuclear migration speed, Increased Salmonella enterica Typhimurium binding, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0001525 GO:0001568 GO:0001570 GO:0001570 GO:0001570 GO:0007155 GO:0007155 GO:0007155 GO:0007160
MAP2 	MAP2 (Microtubule Associated Protein 2) is a Protein Coding gene. Diseases associated with MAP2 include  MAPT	This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The products of similar genes in rat and mouse are neuron-specific cytoskeletal proteins that are enriched in dentrites, implicating a role in determining and stabilizing dentritic shape during neuron development. A number of alternatively spliced variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2010]	This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The products of similar genes in rat and mouse are neuron-specific cytoskeletal proteins that are enriched in dentrites, implicating a role in determining and stabilizing dentritic shape during neuron development. A number of alternatively spliced variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Increased homologous recombination repair frequency, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000226 GO:0001578 GO:0001578 GO:0001578 GO:0016358 GO:0016358 GO:0016358 GO:0021954
TAGLN 	TAGLN (Transgelin) is a Protein Coding gene. Diseases associated with TAGLN include  TAGLN3	This gene encodes a shape change and transformation sensitive actin-binding protein which belongs to the calponin family. It is ubiquitously expressed in vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. The encoded protein is thought to be involved in calcium-independent smooth muscle contraction. It acts as a tumor suppressor, and the loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity. The encoded protein has a domain architecture consisting of an N-terminal calponin homology (CH) domain and a C-terminal calponin-like (CLIK) domain. Mice with a knockout of the orthologous gene are viable and fertile but their vascular smooth muscle cells exhibit alterations in the distribution of the actin filament and changes in cytoskeletal organization. [provided by RefSeq, Aug 2017]	This gene encodes a shape change and transformation sensitive actin-binding protein which belongs to the calponin family. It is ubiquitously expressed in vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. The encoded protein is thought to be involved in calcium-independent smooth muscle contraction. It acts as a tumor suppressor, and the loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity. The encoded protein has a domain architecture consisting of an N-terminal calponin homology (CH) domain and a C-terminal calponin-like (CLIK) domain. Mice with a knockout of the orthologous gene are viable and fertile but their vascular smooth muscle cells exhibit alterations in the distribution of the actin filament and changes in cytoskeletal organization. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability with carboplatin, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability (cell death), Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0007517 GO:0030855
CD74 	CD74 (CD74 Molecule) is a Protein Coding gene. Diseases associated with CD74 include 	The protein encoded by this gene associates with class II major histocompatibility complex (MHC) and is an important chaperone that regulates antigen presentation for immune response. It also serves as cell surface receptor for the cytokine macrophage migration inhibitory factor (MIF) which, when bound to the encoded protein, initiates survival pathways and cell proliferation. This protein also interacts with amyloid precursor protein (APP) and suppresses the production of amyloid beta (Abeta). Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]	The protein encoded by this gene associates with class II major histocompatibility complex (MHC) and is an important chaperone that regulates antigen presentation for immune response. It also serves as cell surface receptor for the cytokine macrophage migration inhibitory factor (MIF) which, when bound to the encoded protein, initiates survival pathways and cell proliferation. This protein also interacts with amyloid precursor protein (APP) and suppresses the production of amyloid beta (Abeta). Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased shRNA abundance, Weakly decreased NFAT1-GFP nuclear translocation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0001516 GO:0001934 GO:0001961 GO:0002250 GO:0002286 GO:0002286 GO:0002286
SP1 	SP1 (Sp1 Transcription Factor) is a Protein Coding gene. Diseases associated with SP1 include  Erythroleukemia SP4	The protein encoded by this gene is a zinc finger transcription factor that binds to GC-rich motifs of many promoters. The encoded protein is involved in many cellular processes, including cell differentiation, cell growth, apoptosis, immune responses, response to DNA damage, and chromatin remodeling. Post-translational modifications such as phosphorylation, acetylation, glycosylation, and proteolytic processing significantly affect the activity of this protein, which can be an activator or a repressor. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2014]	The protein encoded by this gene is a zinc finger transcription factor that binds to GC-rich motifs of many promoters. The encoded protein is involved in many cellular processes, including cell differentiation, cell growth, apoptosis, immune responses, response to DNA damage, and chromatin remodeling. Post-translational modifications such as phosphorylation, acetylation, glycosylation, and proteolytic processing significantly affect the activity of this protein, which can be an activator or a repressor. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Downregulation of NFkappaB pathway, Decreased viability with paclitaxel, 	GO:0006355 GO:0006357 GO:0010628
TPM1 	TPM1 (Tropomyosin 1) is a Protein Coding gene. Diseases associated with TPM1 include  TPM3	This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]	This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Increased IL-8 secretion, Decreased POU5F1-GFP protein expression, Decreased OCT4 protein expression, Decreased NANOG protein expression, Synthetic lethal with imatinib mesylate, 	GO:0003065 GO:0006936 GO:0006937 GO:0006937 GO:0006937 GO:0007010 GO:0007015
NOS3 	NOS3 (Nitric Oxide Synthase 3) is a Protein Coding gene. Diseases associated with NOS3 include  NOS1	Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]	Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased G1 DNA content, Increased IL-8 secretion, Increased nuclear migration distance, Decreased shRNA abundance, Decreased influenza A virus infection, Increased Sindbis virus (SINV) infection, 	 
CD34 	CD34 (CD34 Molecule) is a Protein Coding gene. Diseases associated with CD34 include 	The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]	Increased gamma-H2AX phosphorylation, no effect, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt pathway, 	GO:0001894 GO:0001935 GO:0003094 GO:0003158
ARHGAP22 	ARHGAP22 (Rho GTPase Activating Protein 22) is a Protein Coding gene. Diseases associated with ARHGAP22 include  ARHGAP24	This gene encodes a member of the GTPase activating protein family which activates a GTPase belonging to the RAS superfamily of small GTP-binding proteins. The encoded protein is insulin-responsive, is dependent on the kinase Akt and requires the Akt-dependent 14-3-3 binding protein which binds sequentially to two serine residues. The result of these interactions is regulation of cell motility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]	This gene encodes a member of the GTPase activating protein family which activates a GTPase belonging to the RAS superfamily of small GTP-binding proteins. The encoded protein is insulin-responsive, is dependent on the kinase Akt and requires the Akt-dependent 14-3-3 binding protein which binds sequentially to two serine residues. The result of these interactions is regulation of cell motility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Increased IL-8 secretion, Increased HPV18 LCR reporter activity, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0001525 GO:0007165 GO:0007165 GO:0007165 GO:0030154 GO:0030154 GO:0030154 GO:0051056 GO:0051056 GO:0051056 GO:0090630 GO:0090630 GO:0090630
CALR 	CALR (Calreticulin) is a Protein Coding gene. Diseases associated with CALR include  Myelofibrosis CALR3	Calreticulin is a highly conserved chaperone protein which resides primarily in the endoplasmic reticulum, and is involved in a variety of cellular processes, among them, cell adhesion. Additionally, it functions in protein folding quality control and calcium homeostasis. Calreticulin is also found in the nucleus, suggesting that it may have a role in transcription regulation. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin. Recurrent mutations in calreticulin have been linked to various neoplasms, including the myeloproliferative type.[provided by RefSeq, May 2020]	Calreticulin is a highly conserved chaperone protein which resides primarily in the endoplasmic reticulum, and is involved in a variety of cellular processes, among them, cell adhesion. Additionally, it functions in protein folding quality control and calcium homeostasis. Calreticulin is also found in the nucleus, suggesting that it may have a role in transcription regulation. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin. Recurrent mutations in calreticulin have been linked to various neoplasms, including the myeloproliferative type.[provided by RefSeq, May 2020]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability, 	GO:0000122 GO:0002502 GO:0006355 GO:0006457 GO:0006611
TIPRL 	TIPRL (TOR Signaling Pathway Regulator) is a Protein Coding gene. Diseases associated with TIPRL include 	TIPRL is an inhibitory regulator of protein phosphatase-2A (PP2A) (see PPP2CA; MIM 176915), PP4 (see PPP4C; MIM 602035), and PP6 (see PPP6C; MIM 612725) (McConnell et al., 2007 [PubMed 17384681]).[supplied by OMIM, Nov 2010]	TIPRL is an inhibitory regulator of protein phosphatase-2A (PP2A) (see PPP2CA; MIM 176915), PP4 (see PPP4C; MIM 602035), and PP6 (see PPP6C; MIM 612725) (McConnell et al., 2007 [PubMed 17384681]).[supplied by OMIM, Nov 2010]	Increased vaccinia virus (VACV) infection, no effect, Increased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), Increased homologous recombination repair frequency, 	GO:0000077 GO:0031929 GO:0032515 GO:0043666
PPP1R12C 	PPP1R12C (Protein Phosphatase 1 Regulatory Subunit 12C) is a Protein Coding gene. Diseases associated with PPP1R12C include  PPP1R12A	The gene encodes a subunit of myosin phosphatase. The encoded protein regulates the catalytic activity of protein phosphatase 1 delta and assembly of the actin cytoskeleton. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2012]	The gene encodes a subunit of myosin phosphatase. The encoded protein regulates the catalytic activity of protein phosphatase 1 delta and assembly of the actin cytoskeleton. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased HIV-1 infection, 	 
BDNF 	BDNF (Brain Derived Neurotrophic Factor) is a Protein Coding gene. Diseases associated with BDNF include  NTF3	This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer\'s, Parkinson\'s, and Huntington\'s disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015]	This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer\'s, Parkinson\'s, and Huntington\'s disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability in colon lineage, Increased NF-kappaB reporter expression, 	GO:0007165 GO:0007169 GO:0007169 GO:0007169 GO:0007399 GO:0007411 GO:0007416
FOSL1 	FOSL1 (FOS Like 1, AP-1 Transcription Factor Subunit) is a Protein Coding gene. Diseases associated with FOSL1 include  FOSL2	The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased HPV18 LCR reporter activity, Synthetic lethal with vaccinia virus (VACV) infection, Decreased viability with paclitaxel, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Synthetic lethal with imatinib mesylate, Decreased cell number and increased metaphase cell number, 	GO:0001701 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006935 GO:0006968
MAPK8IP1 	MAPK8IP1 (Mitogen-Activated Protein Kinase 8 Interacting Protein 1) is a Protein Coding gene. Diseases associated with MAPK8IP1 include  MAPK8IP2	This gene encodes a regulator of the pancreatic beta-cell function. It is highly similar to JIP-1, a mouse protein known to be a regulator of c-Jun amino-terminal kinase (Mapk8). This protein has been shown to prevent MAPK8 mediated activation of transcription factors, and to decrease IL-1 beta and MAP kinase kinase 1 (MEKK1) induced apoptosis in pancreatic beta cells. This protein also functions as a DNA-binding transactivator of the glucose transporter GLUT2. RE1-silencing transcription factor (REST) is reported to repress the expression of this gene in insulin-secreting beta cells. This gene is found to be mutated in a type 2 diabetes family, and thus is thought to be a susceptibility gene for type 2 diabetes. [provided by RefSeq, May 2011]	This gene encodes a regulator of the pancreatic beta-cell function. It is highly similar to JIP-1, a mouse protein known to be a regulator of c-Jun amino-terminal kinase (Mapk8). This protein has been shown to prevent MAPK8 mediated activation of transcription factors, and to decrease IL-1 beta and MAP kinase kinase 1 (MEKK1) induced apoptosis in pancreatic beta cells. This protein also functions as a DNA-binding transactivator of the glucose transporter GLUT2. RE1-silencing transcription factor (REST) is reported to repress the expression of this gene in insulin-secreting beta cells. This gene is found to be mutated in a type 2 diabetes family, and thus is thought to be a susceptibility gene for type 2 diabetes. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability in glioblastoma multiforme (GBM) lineage, Inconclusive, Decreased homologous recombination repair frequency, Increased Nanog expression, Increased cell number in S and G2M, 	 
ARHGEF12 	ARHGEF12 (Rho Guanine Nucleotide Exchange Factor 12) is a Protein Coding gene. Diseases associated with ARHGEF12 include  Leukemia ARHGEF11	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli working through G protein-coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein has been observed to form a myeloid/lymphoid fusion partner in acute myeloid leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli working through G protein-coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein has been observed to form a myeloid/lymphoid fusion partner in acute myeloid leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	no effect, Decreased ionizing radiation sensitivity, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased S DNA content, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased p24 protein expression, Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0007186
WDR5 	WDR5 (WD Repeat Domain 5) is a Protein Coding gene. Diseases associated with WDR5 include  WDR5B	This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This protein contains 7 WD repeats. Alternatively spliced transcript variants encoding the same protein have been identified. This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This protein contains 7 WD repeats. Alternatively spliced transcript variants encoding the same protein have been identified. Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Wnt reporter downregulated, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Inconclusive, Increased Nanog expression, Decreased viability of wild-type and TP53 knockout cells, Increased G1 length, Increased S length, 	 
TUBB3 	TUBB3 (Tubulin Beta 3 Class III) is a Protein Coding gene. Diseases associated with TUBB3 include  TUBB6	This gene encodes a class III member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is primarily expressed in neurons and may be involved in neurogenesis and axon guidance and maintenance. Mutations in this gene are the cause of congenital fibrosis of the extraocular muscles type 3. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Oct 2010]	This gene encodes a class III member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is primarily expressed in neurons and may be involved in neurogenesis and axon guidance and maintenance. Mutations in this gene are the cause of congenital fibrosis of the extraocular muscles type 3. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Oct 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased IL-8 secretion, Effect on mitosis, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased infection with West Nile virus (WNV), Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, 	GO:0000226 GO:0000278
NR2F2 	NR2F2 (Nuclear Receptor Subfamily 2 Group F Member 2) is a Protein Coding gene. Diseases associated with NR2F2 include  NR2F1	This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]	This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]	no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Decreased Aire reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Large nuclei, 	GO:0000122 GO:0001701 GO:0001764 GO:0001764 GO:0001764 GO:0001893 GO:0001893 GO:0001893 GO:0001937 GO:0001937 GO:0001937
BMPR1A 	BMPR1A (Bone Morphogenetic Protein Receptor Type 1A) is a Protein Coding gene. Diseases associated with BMPR1A include  BMPR1B	The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, Synthetic lethal with Ras, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in ovarian lineage, Decreased substrate adherent cell growth, Transferrin accumulation in the perinuclear area, Increased G2M DNA content, increased 8N DNA content, Increased NF-kappaB reporter expression, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased mitotic index, Decreased cell viability after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, decreased cell spreading, Polylobed nuclei, many micronuclei (grape), dynamic nuclei (hole, folded or small irregular), 	GO:0001525
MDM2 	MDM2 (MDM2 Proto-Oncogene) is a Protein Coding gene. Diseases associated with MDM2 include  MDM4	This gene encodes a nuclear-localized E3 ubiquitin ligase. The encoded protein can promote tumor formation by targeting tumor suppressor proteins, such as p53, for proteasomal degradation. This gene is itself transcriptionally-regulated by p53. Overexpression or amplification of this locus is detected in a variety of different cancers. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in a multitude of transcript variants, many of which may be expressed only in tumor cells. [provided by RefSeq, Jun 2013]	This gene encodes a nuclear-localized E3 ubiquitin ligase. The encoded protein can promote tumor formation by targeting tumor suppressor proteins, such as p53, for proteasomal degradation. This gene is itself transcriptionally-regulated by p53. Overexpression or amplification of this locus is detected in a variety of different cancers. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in a multitude of transcript variants, many of which may be expressed only in tumor cells. [provided by RefSeq, Jun 2013]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased ionizing radiation sensitivity, Increased cell death HMECs cells, Decreased influenza A/WSN/33 replication, Increased cell death in HCT116 cells, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000122 GO:0000209
APLN 	APLN (Apelin) is a Protein Coding gene. Diseases associated with APLN include 	This gene encodes a peptide that functions as an endogenous ligand for the G-protein coupled apelin receptor. The encoded preproprotein is proteolytically processed into biologically active C-terminal peptide fragments. These peptide fragments activate different tissue specific signaling pathways that regulate diverse biological functions including fluid homeostasis, cardiovascular function and insulin secretion. This protein also functions as a coreceptor for the human immunodeficiency virus 1. [provided by RefSeq, Feb 2016]	This gene encodes a peptide that functions as an endogenous ligand for the G-protein coupled apelin receptor. The encoded preproprotein is proteolytically processed into biologically active C-terminal peptide fragments. These peptide fragments activate different tissue specific signaling pathways that regulate diverse biological functions including fluid homeostasis, cardiovascular function and insulin secretion. This protein also functions as a coreceptor for the human immunodeficiency virus 1. [provided by RefSeq, Feb 2016]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Inconclusive, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0001525 GO:0006955 GO:0006955 GO:0006955 GO:0007165 GO:0007165 GO:0007165
CYFIP1 	CYFIP1 (Cytoplasmic FMR1 Interacting Protein 1) is a Protein Coding gene. Diseases associated with CYFIP1 include  CYFIP2	This gene encodes a protein that regulates cytoskeletal dynamics and protein translation. The encoded protein is a component of the WAVE regulatory complex (WRC), which promotes actin polymerization. This protein also interacts with the synaptic functional regulator FMR1 protein and translation initiation factor 4E to inhibit protein translation. A large chromosomal deletion including this gene is associated with increased risk of schizophrenia and epilepsy in human patients. Reduced expression of this gene has been observed in various human cancers and the encoded protein may inhibit tumor invasion. [provided by RefSeq, Mar 2022]	This gene encodes a protein that regulates cytoskeletal dynamics and protein translation. The encoded protein is a component of the WAVE regulatory complex (WRC), which promotes actin polymerization. This protein also interacts with the synaptic functional regulator FMR1 protein and translation initiation factor 4E to inhibit protein translation. A large chromosomal deletion including this gene is associated with increased risk of schizophrenia and epilepsy in human patients. Reduced expression of this gene has been observed in various human cancers and the encoded protein may inhibit tumor invasion. [provided by RefSeq, Mar 2022]	Increased gamma-H2AX phosphorylation, Decreased hepcidin::fluc mRNA expression, no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability, 	GO:0000902 GO:0006417 GO:0007399 GO:0007411 GO:0007411 GO:0007411
SPRED1 	SPRED1 (Sprouty Related EVH1 Domain Containing 1) is a Protein Coding gene. Diseases associated with SPRED1 include  Neurofibromatosis SPRED2	The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). The protein encoded by this gene is a member of the Sprouty family of proteins and is phosphorylated by tyrosine kinase in response to several growth factors. The encoded protein can act as a homodimer or as a heterodimer with SPRED2 to regulate activation of the MAP kinase cascade. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced shRNA abundance in FBW7 KO line, 	GO:0006469 GO:0007275 GO:0009966 GO:0009966 GO:0009966 GO:0010719 GO:0010719 GO:0010719 GO:0010801 GO:0010801 GO:0010801
TRIM24 	TRIM24 (Tripartite Motif Containing 24) is a Protein Coding gene. Diseases associated with TRIM24 include  TRIM33	The protein encoded by this gene mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. The protein localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. The protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains - a RING, a B-box type 1 and a B-box type 2 - and a coiled-coil region. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. The protein encoded by this gene mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. The protein localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. The protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains - a RING, a B-box type 1 and a B-box type 2 - and a coiled-coil region. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene. Decreased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability after Maraba virus infection, Increased IL-8 secretion, Decreased vesicular stomatitis virus (VSV) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased Sindbis virus (SINV) infection, Synthetic lethal with imatinib mesylate, Increased caspase activity, Decreased viability in colon lineage; decreased viability in pancreas lineage, 	GO:0006366 GO:0006468 GO:0010628 GO:0010628 GO:0010628 GO:0016567 GO:0016567 GO:0016567 GO:0030163 GO:0030163 GO:0030163
TIMP1 	TIMP1 (TIMP Metallopeptidase Inhibitor 1) is a Protein Coding gene. Diseases associated with TIMP1 include  Conjunctivochalasis TIMP2	This gene belongs to the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases (MMPs), a group of peptidases involved in degradation of the extracellular matrix. In addition to its inhibitory role against most of the known MMPs, the encoded protein is able to promote cell proliferation in a wide range of cell types, and may also have an anti-apoptotic function. Transcription of this gene is highly inducible in response to many cytokines and hormones. In addition, the expression from some but not all inactive X chromosomes suggests that this gene inactivation is polymorphic in human females. This gene is located within intron 6 of the synapsin I gene and is transcribed in the opposite direction. This gene belongs to the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases (MMPs), a group of peptidases involved in degradation of the extracellular matrix. In addition to its inhibitory role against most of the known MMPs, the encoded protein is able to promote cell proliferation in a wide range of cell types, and may also have an anti-apoptotic function. Transcription of this gene is highly inducible in response to many cytokines and hormones. In addition, the expression from some but not all inactive X chromosomes suggests that this gene inactivation is polymorphic in human females. This gene is located within intron 6 of the synapsin I gene and is transcribed in the opposite direction. no effect, Reduced mammosphere formation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, 	GO:0001775 GO:0002248 GO:0002248 GO:0002248 GO:0007165 GO:0007165 GO:0007165 GO:0007568 GO:0007568 GO:0007568 GO:0008284 GO:0008284 GO:0008284
EIF3I 	EIF3I (Eukaryotic Translation Initiation Factor 3 Subunit I) is a Protein Coding gene. Diseases associated with EIF3I include  Stomatitis Clonorchiasis	Contributes to translation initiation factor activity. Involved in translational initiation. Located in extracellular exosome. Part of eukaryotic translation initiation factor 3 complex. [provided by Alliance of Genome Resources, Apr 2022]	Contributes to translation initiation factor activity. Involved in translational initiation. Located in extracellular exosome. Part of eukaryotic translation initiation factor 3 complex. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased cell number, Nuclear 60S biogenesis defects, Inconclusive, Nucleolar pre-40S maturation defects, Decreased viability of wild-type and TP53 knockout cells, Decreased viability with SS1P at EC30, Increased S DNA content, S arrest, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased vesicular stomatitis virus (VSV) infection, Decreased lymphocytic choriomeningitis virus (LCMV) infection, Decreased human parainfluenza virus type 3 (HPIV3) infection, 	GO:0001732 GO:0002183 GO:0006412 GO:0006413 GO:0006413 GO:0006413
ARHGEF17 	ARHGEF17 (Rho Guanine Nucleotide Exchange Factor 17) is a Protein Coding gene. Diseases associated with ARHGEF17 include  ARHGEF10L	Enables guanyl-nucleotide exchange factor activity. Acts upstream of or within actin cytoskeleton organization. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	Enables guanyl-nucleotide exchange factor activity. Acts upstream of or within actin cytoskeleton organization. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, Polylobed nuclei, many micronuclei (grape), 	GO:0030036
RYR2 	RYR2 (Ryanodine Receptor 2) is a Protein Coding gene. Diseases associated with RYR2 include  RYR3	This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. no effect, Synthetic lethal with Ras, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Effect on mitosis, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0001666 GO:0002027 GO:0002027 GO:0002027
ARHGAP21 	ARHGAP21 (Rho GTPase Activating Protein 21) is a Protein Coding gene. Diseases associated with ARHGAP21 include  ARHGAP23	ARHGAP21 functions preferentially as a GTPase-activating protein (GAP) for CDC42 (MIM 116952) and regulates the ARP2/3 complex (MIM 604221) and F-actin dynamics at the Golgi through control of CDC42 activity (Dubois et al., 2005 [PubMed 15793564]).[supplied by OMIM, Mar 2008]	ARHGAP21 functions preferentially as a GTPase-activating protein (GAP) for CDC42 (MIM 116952) and regulates the ARP2/3 complex (MIM 604221) and F-actin dynamics at the Golgi through control of CDC42 activity (Dubois et al., 2005 [PubMed 15793564]).[supplied by OMIM, Mar 2008]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, 	GO:0007030 GO:0007165 GO:0051056 GO:0051056 GO:0051056 GO:0051645 GO:0051645 GO:0051645 GO:0051683
NUAK1 	NUAK1 (NUAK Family Kinase 1) is a Protein Coding gene. Diseases associated with NUAK1 include  Omphalocele NUAK2	Enables p53 binding activity and protein serine/threonine kinase activity. Involved in several processes, including protein phosphorylation; regulation of cellular senescence; and regulation of myosin-light-chain-phosphatase activity. Located in cytoplasm; microtubule cytoskeleton; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]	Enables p53 binding activity and protein serine/threonine kinase activity. Involved in several processes, including protein phosphorylation; regulation of cellular senescence; and regulation of myosin-light-chain-phosphatase activity. Located in cytoplasm; microtubule cytoskeleton; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased HPV16-GFP infection, Decreased substrate adherent cell growth, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased homologous recombination repair frequency, Decreased viability after TNF/CHX stimulation, Decreased simian virus 40 (SV40) infection, 	GO:0006468 GO:0006974 GO:0007155 GO:0007155 GO:0007155 GO:0016310 GO:0016310 GO:0016310 GO:0030155 GO:0030155 GO:0030155
KLHL20 	KLHL20 (Kelch Like Family Member 20) is a Protein Coding gene. Diseases associated with KLHL20 include  KLHL2	The protein encoded by this gene is a member of the kelch family of proteins, which is characterized by a 44-56 amino acid repeat motif. The kelch motif appears in many different polypeptide contexts and contains multiple potential protein-protein contact sites. Members of this family are present both throughout the cell and extracellularly, with diverse activities. The protein encoded by this gene is a member of the kelch family of proteins, which is characterized by a 44-56 amino acid repeat motif. The kelch motif appears in many different polypeptide contexts and contains multiple potential protein-protein contact sites. Members of this family are present both throughout the cell and extracellularly, with diverse activities. no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased shRNA abundance, Weakly decreased NFAT1-GFP nuclear translocation, 	GO:0006895 GO:0007010 GO:0015031 GO:0015031 GO:0015031 GO:0016567 GO:0016567 GO:0016567 GO:0035455
EPHB4 	EPHB4 (EPH Receptor B4) is a Protein Coding gene. Diseases associated with EPHB4 include  EPHB3	Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Increased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased cell death HMECs cells, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCT116 cells, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0001525 GO:0002042 GO:0002042 GO:0002042 GO:0003007 GO:0006468 GO:0006468 GO:0006468 GO:0007155 GO:0007155 GO:0007155
DLX2 	DLX2 (Distal-Less Homeobox 2) is a Protein Coding gene. Diseases associated with DLX2 include  DLX5	Many vertebrate homeo box-containing genes have been identified on the basis of their sequence similarity with Drosophila developmental genes. Members of the Dlx gene family contain a homeobox that is related to that of Distal-less (Dll), a gene expressed in the head and limbs of the developing fruit fly. The Distal-less (Dlx) family of genes comprises at least 6 different members, DLX1-DLX6. The DLX proteins are postulated to play a role in forebrain and craniofacial development. This gene is located in a tail-to-tail configuration with another member of the gene family on the long arm of chromosome 2. Many vertebrate homeo box-containing genes have been identified on the basis of their sequence similarity with Drosophila developmental genes. Members of the Dlx gene family contain a homeobox that is related to that of Distal-less (Dll), a gene expressed in the head and limbs of the developing fruit fly. The Distal-less (Dlx) family of genes comprises at least 6 different members, DLX1-DLX6. The DLX proteins are postulated to play a role in forebrain and craniofacial development. This gene is located in a tail-to-tail configuration with another member of the gene family on the long arm of chromosome 2. no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased viability, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased BBC3 mRNA expression, 	GO:0000122 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007219 GO:0007219 GO:0007219 GO:0007420 GO:0007420 GO:0007420
MMP2 	MMP2 (Matrix Metallopeptidase 2) is a Protein Coding gene. Diseases associated with MMP2 include  MMP9	This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]	Increased gamma-H2AX phosphorylation, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Decreased shRNA abundance (Z-score &lt; -2), Decreased nuclei size in G2M, 	GO:0001525 GO:0001541 GO:0001541 GO:0001541 GO:0001542 GO:0001542 GO:0001542 GO:0001553 GO:0001553 GO:0001553 GO:0001666 GO:0001666 GO:0001666
RPS6KA1 	RPS6KA1 (Ribosomal Protein S6 Kinase A1) is a Protein Coding gene. Diseases associated with RPS6KA1 include  Sarcoma RPS6KA3	This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Increased cell migration, Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Synthetic lethal with cisplatin, 	GO:0006468 GO:0006915 GO:0007049 GO:0007049 GO:0007049 GO:0007165 GO:0007165 GO:0007165
FGL1 	FGL1 (Fibrinogen Like 1) is a Protein Coding gene. Diseases associated with FGL1 include  FGG	Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene. Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0002250 GO:0002376 GO:0002376 GO:0002376 GO:0007160 GO:0007160 GO:0007160
PIK3CD 	PIK3CD (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta) is a Protein Coding gene. Diseases associated with PIK3CD include  PIK3CB	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]	Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Decreased Sindbis virus (SINV) infection, Decreased cell proliferation, Decreased viability after gemcitabine stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001779 GO:0001819 GO:0001938 GO:0002250
TRIM28 	TRIM28 (Tripartite Motif Containing 28) is a Protein Coding gene. Diseases associated with TRIM28 include  TRIM33	The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. Decreased hepcidin::fluc mRNA expression, no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Decreased viability ratio, Decreased viability after Maraba virus infection, Wnt reporter downregulated, Decreased vesicular stomatitis virus (VSV) infection, Decreased NF-kappaB reporter expression, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Decreased influenza A virus infection, Increased simian virus 40 (SV40) infection, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased viability, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, decreased cell spreading, 	GO:0000122 GO:0001701 GO:0001701 GO:0001701 GO:0001837 GO:0001837 GO:0001837 GO:0006281 GO:0006281 GO:0006281
DLGAP1 	DLGAP1 (DLG Associated Protein 1) is a Protein Coding gene. Diseases associated with DLGAP1 include  DLGAP2	Predicted to enable molecular adaptor activity. Predicted to be a structural constituent of postsynaptic density. Predicted to be involved in several processes, including aggresome assembly; regulation of postsynaptic neurotransmitter receptor activity; and regulation of proteasomal protein catabolic process. Predicted to be located in plasma membrane. Predicted to be part of postsynaptic density. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable molecular adaptor activity. Predicted to be a structural constituent of postsynaptic density. Predicted to be involved in several processes, including aggresome assembly; regulation of postsynaptic neurotransmitter receptor activity; and regulation of proteasomal protein catabolic process. Predicted to be located in plasma membrane. Predicted to be part of postsynaptic density. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Two nuclei (binuclear), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased Tat-dependent transcription, 	GO:0007268 GO:0023052 GO:0098962 GO:0098962 GO:0098962
OSM 	OSM (Oncostatin M) is a Protein Coding gene. Diseases associated with OSM include  Plasmacytoma	This gene encodes a member of the leukemia inhibitory factor/oncostatin-M (LIF/OSM) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a secreted cytokine and growth regulator that inhibits the proliferation of a number of tumor cell lines. This protein also regulates the production of other cytokines, including interleukin 6, granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in endothelial cells. This gene and the related gene, leukemia inhibitory factor, also present on chromosome 22, may have resulted from the duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes a member of the leukemia inhibitory factor/oncostatin-M (LIF/OSM) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a secreted cytokine and growth regulator that inhibits the proliferation of a number of tumor cell lines. This protein also regulates the production of other cytokines, including interleukin 6, granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in endothelial cells. This gene and the related gene, leukemia inhibitory factor, also present on chromosome 22, may have resulted from the duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Synthetic lethal with c-Myc after tamoxifen stimulation, Effect on mitosis, Decreased viability in pancreas lineage, Negative genetic interaction between BLM-/- and BLM+/+, Moderately decreased NFAT1-GFP nuclear translocation, Decreased homologous recombination repair frequency, 	GO:0002675 GO:0006955 GO:0008284 GO:0008284 GO:0008284 GO:0008285
CSF1R 	CSF1R (Colony Stimulating Factor 1 Receptor) is a Protein Coding gene. Diseases associated with CSF1R include  KIT	The protein encoded by this gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most if not all of the biological effects of this cytokine. Ligand binding activates the receptor kinase through a process of oligomerization and transphosphorylation. The encoded protein is a tyrosine kinase transmembrane receptor and member of the CSF1/PDGF receptor family of tyrosine-protein kinases. Mutations in this gene have been associated with a predisposition to myeloid malignancy. The first intron of this gene contains a transcriptionally inactive ribosomal protein L7 processed pseudogene oriented in the opposite direction. Alternative splicing results in multiple transcript variants. Expression of a splice variant from an LTR promoter has been found in Hodgkin lymphoma (HL), HL cell lines and anaplastic large cell lymphoma. [provided by RefSeq, Mar 2017]	The protein encoded by this gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most if not all of the biological effects of this cytokine. Ligand binding activates the receptor kinase through a process of oligomerization and transphosphorylation. The encoded protein is a tyrosine kinase transmembrane receptor and member of the CSF1/PDGF receptor family of tyrosine-protein kinases. Mutations in this gene have been associated with a predisposition to myeloid malignancy. The first intron of this gene contains a transcriptionally inactive ribosomal protein L7 processed pseudogene oriented in the opposite direction. Alternative splicing results in multiple transcript variants. Expression of a splice variant from an LTR promoter has been found in Hodgkin lymphoma (HL), HL cell lines and anaplastic large cell lymphoma. [provided by RefSeq, Mar 2017]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased viability in ovarian lineage, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Decreased NF-kappaB reporter expression, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased centriole number, Paclitaxel antagonistic effect, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, increased cell spreading, 	GO:0001934 GO:0002244 GO:0002376 GO:0002376 GO:0002376 GO:0002931 GO:0002931 GO:0002931
VIM 	VIM (Vimentin) is a Protein Coding gene. Diseases associated with VIM include  DES	This gene encodes a type III intermediate filament protein. Intermediate filaments, along with microtubules and actin microfilaments, make up the cytoskeleton. The encoded protein is responsible for maintaining cell shape and integrity of the cytoplasm, and stabilizing cytoskeletal interactions. This protein is involved in neuritogenesis and cholesterol transport and functions as an organizer of a number of other critical proteins involved in cell attachment, migration, and signaling. Bacterial and viral pathogens have been shown to attach to this protein on the host cell surface. Mutations in this gene are associated with congenital cataracts in human patients. [provided by RefSeq, Aug 2017]	This gene encodes a type III intermediate filament protein. Intermediate filaments, along with microtubules and actin microfilaments, make up the cytoskeleton. The encoded protein is responsible for maintaining cell shape and integrity of the cytoplasm, and stabilizing cytoskeletal interactions. This protein is involved in neuritogenesis and cholesterol transport and functions as an organizer of a number of other critical proteins involved in cell attachment, migration, and signaling. Bacterial and viral pathogens have been shown to attach to this protein on the host cell surface. Mutations in this gene are associated with congenital cataracts in human patients. [provided by RefSeq, Aug 2017]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability with paclitaxel, Increased shRNA abundance (Z-score &gt; 2), Decreased cell number, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Decreased Hepatitis C virus replication, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0010628 GO:0010977 GO:0010977 GO:0010977 GO:0014002 GO:0014002 GO:0014002 GO:0031175 GO:0031175 GO:0031175 GO:0032967 GO:0032967 GO:0032967
ZFYVE27 	ZFYVE27 (Zinc Finger FYVE-Type Containing 27) is a Protein Coding gene. Diseases associated with ZFYVE27 include  Paraplegia	This gene encodes a protein with several transmembrane domains, a Rab11-binding domain and a lipid-binding FYVE finger domain. The encoded protein appears to promote neurite formation. A mutation in this gene has been reported to be associated with hereditary spastic paraplegia, however the pathogenicity of the mutation, which may simply represent a polymorphism, is unclear. [provided by RefSeq, Mar 2010]	This gene encodes a protein with several transmembrane domains, a Rab11-binding domain and a lipid-binding FYVE finger domain. The encoded protein appears to promote neurite formation. A mutation in this gene has been reported to be associated with hereditary spastic paraplegia, however the pathogenicity of the mutation, which may simply represent a polymorphism, is unclear. [provided by RefSeq, Mar 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Increased IL-8 secretion, No cells, Decreased Sindbis virus (SINV) infection, Increased epidermal growth factor receptor (EGFR) surface abundance, Two nuclei (binuclear), large nuclei, 	GO:0016192 GO:0031175 GO:0045773 GO:0048011 GO:0048011 GO:0048011 GO:0071787 GO:0071787 GO:0071787
RAB5C 	RAB5C (RAB5C, Member RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAB5C include  RAB5A	Members of the Rab protein family are small GTPases of the Ras superfamily that are thought to ensure fidelity in the process of docking and/or fusion of vesicles with their correct acceptor compartment (Han et al., 1996 [PubMed 8646882]).[supplied by OMIM, Nov 2010]	Members of the Rab protein family are small GTPases of the Ras superfamily that are thought to ensure fidelity in the process of docking and/or fusion of vesicles with their correct acceptor compartment (Han et al., 1996 [PubMed 8646882]).[supplied by OMIM, Nov 2010]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium ruffling, Decreased shRNA abundance, Increased nuclear migration distance, increased nuclear migration speed, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, Downregulation of RLR pathway after Sendai virus (SeV) infection, Decreased vesicular stomatitis virus (VSV) infection, Decreased lymphocytic choriomeningitis virus (LCMV) infection, 	GO:0006886 GO:0006897 GO:0015031 GO:0015031 GO:0015031 GO:0030100 GO:0030100 GO:0030100 GO:0048227 GO:0048227 GO:0048227
ITGA2B 	ITGA2B (Integrin Subunit Alpha 2b) is a Protein Coding gene. Diseases associated with ITGA2B include  ITGA8	This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]	This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Inconclusive, Increased circadian period length, Dynamic nuclei (hole, folded or small irregular), 	GO:0001525 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229 GO:0033627
PTHLH 	PTHLH (Parathyroid Hormone Like Hormone) is a Protein Coding gene. Diseases associated with PTHLH include 	The protein encoded by this gene is a member of the parathyroid hormone family. This hormone, via its receptor, PTHR1, regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2). Alternatively spliced transcript variants have been found for this gene. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, downstream of the initiator AUG codon, resulting in nuclear forms of this hormone. [provided by RefSeq, Nov 2013]	The protein encoded by this gene is a member of the parathyroid hormone family. This hormone, via its receptor, PTHR1, regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. It is responsible for most cases of humoral hypercalcemia of malignancy, and mutations in this gene are associated with brachydactyly type E2 (BDE2). Alternatively spliced transcript variants have been found for this gene. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, downstream of the initiator AUG codon, resulting in nuclear forms of this hormone. [provided by RefSeq, Nov 2013]	no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0001501 GO:0002076 GO:0007165 GO:0007189 GO:0007189 GO:0007189 GO:0007267
AKAP12 	AKAP12 (A-Kinase Anchoring Protein 12) is a Protein Coding gene. Diseases associated with AKAP12 include 	The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. The encoded protein is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells. It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction. This protein and RII PKA colocalize at the cell periphery. This protein is a cell growth-related protein. Antibodies to this protein can be produced by patients with myasthenia gravis. Alternative splicing of this gene results in two transcript variants encoding different isoforms. The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. The encoded protein is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells. It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction. This protein and RII PKA colocalize at the cell periphery. This protein is a cell growth-related protein. Antibodies to this protein can be produced by patients with myasthenia gravis. Alternative splicing of this gene results in two transcript variants encoding different isoforms. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability, Increased G2M DNA content, Cell division defect, Increased epidermal growth factor (EGF) endosome number, increased epidermal growth factor (EGF) endosome elongation, Decreased viability after gemcitabine stimulation, 	GO:0007165 GO:0007186 GO:0007193 GO:0010738
FOXC1 	FOXC1 (Forkhead Box C1) is a Protein Coding gene. Diseases associated with FOXC1 include  FOXC2	This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain.  The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development.  Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain.  The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development.  Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability with paclitaxel, Decreased viability with carboplatin, 	 
TSC1 	TSC1 (TSC Complex Subunit 1) is a Protein Coding gene. Diseases associated with TSC1 include  Lymphangioleiomyomatosis binding	This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]	This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Strongly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased cell migration, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability of wild-type and TP53 knockout cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0001822 GO:0001843 GO:0001843 GO:0001843 GO:0001952 GO:0001952 GO:0001952 GO:0002250 GO:0006407 GO:0006407 GO:0006407
MYL12A 	MYL12A (Myosin Light Chain 12A) is a Protein Coding gene. Diseases associated with MYL12A include  MYL12B	This gene encodes a nonsarcomeric myosin regulatory light chain. This protein is activated by phosphorylation and regulates smooth muscle and non-muscle cell contraction. This protein may also be involved in DNA damage repair by sequestering the transcriptional regulator apoptosis-antagonizing transcription factor (AATF)/Che-1 which functions as a repressor of p53-driven apoptosis. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8.[provided by RefSeq, Dec 2014]	This gene encodes a nonsarcomeric myosin regulatory light chain. This protein is activated by phosphorylation and regulates smooth muscle and non-muscle cell contraction. This protein may also be involved in DNA damage repair by sequestering the transcriptional regulator apoptosis-antagonizing transcription factor (AATF)/Che-1 which functions as a repressor of p53-driven apoptosis. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8.[provided by RefSeq, Dec 2014]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), No cells, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0070527
SH3RF2 	SH3RF2 (SH3 Domain Containing Ring Finger 2) is a Protein Coding gene. Diseases associated with SH3RF2 include  SH3RF3	Enables protein phosphatase 1 binding activity and ubiquitin protein ligase activity. Involved in several processes, including positive regulation of JNK cascade; protein autoubiquitination; and regulation of cellular protein metabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables protein phosphatase 1 binding activity and ubiquitin protein ligase activity. Involved in several processes, including positive regulation of JNK cascade; protein autoubiquitination; and regulation of cellular protein metabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Increased HPV18 LCR reporter activity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0009966 GO:0016567 GO:0016567 GO:0016567 GO:0030335 GO:0031397 GO:0032436
CCND2 	CCND2 (Cyclin D2) is a Protein Coding gene. Diseases associated with CCND2 include  CCND1	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]	The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Synthetic lethal with Ras, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Inconclusive, Increased cell death HMECs cells, Negative genetic interaction between BLM-/- and BLM+/+, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell death in DLD-1 cells, 	GO:0000079 GO:0000082 GO:0001934
SFRP2 	SFRP2 (Secreted Frizzled Related Protein 2) is a Protein Coding gene. Diseases associated with SFRP2 include  SFRP5	This gene encodes a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. Methylation of this gene is a potential marker for the presence of colorectal cancer. This gene encodes a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. Methylation of this gene is a potential marker for the presence of colorectal cancer. Increased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Decreased cell number, Decreased DCP1a protein expression and assembly in processing bodies after arsenite stimulation, 	GO:0001569 GO:0001756 GO:0001756 GO:0001756 GO:0001843 GO:0001843 GO:0001843 GO:0002063 GO:0002063 GO:0002063 GO:0003151 GO:0003151 GO:0003151
SPRY2 	SPRY2 (Sprouty RTK Signaling Antagonist 2) is a Protein Coding gene. Diseases associated with SPRY2 include  SPRY1	This gene encodes a protein belonging to the sprouty family. The encoded protein contains a carboxyl-terminal cysteine-rich domain essential for the inhibitory activity on receptor tyrosine kinase signaling proteins and is required for growth factor stimulated translocation of the protein to membrane ruffles. In primary dermal endothelial cells this gene is transiently upregulated in response to fibroblast growth factor two. This protein is indirectly involved in the non-cell autonomous inhibitory effect on fibroblast growth factor two signaling. The protein interacts with Cas-Br-M (murine) ectropic retroviral transforming sequence, and can function as a bimodal regulator of epidermal growth factor receptor/mitogen-activated protein kinase signaling. This protein may play a role in alveoli branching during lung development as shown by a similar mouse protein. This gene encodes a protein belonging to the sprouty family. The encoded protein contains a carboxyl-terminal cysteine-rich domain essential for the inhibitory activity on receptor tyrosine kinase signaling proteins and is required for growth factor stimulated translocation of the protein to membrane ruffles. In primary dermal endothelial cells this gene is transiently upregulated in response to fibroblast growth factor two. This protein is indirectly involved in the non-cell autonomous inhibitory effect on fibroblast growth factor two signaling. The protein interacts with Cas-Br-M (murine) ectropic retroviral transforming sequence, and can function as a bimodal regulator of epidermal growth factor receptor/mitogen-activated protein kinase signaling. This protein may play a role in alveoli branching during lung development as shown by a similar mouse protein. no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability in ovarian lineage, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), 	 
CALD1 	CALD1 (Caldesmon 1) is a Protein Coding gene. Diseases associated with CALD1 include  Adenomyoma LSP1	This gene encodes a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. This gene encodes a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased IL-8 secretion, 	GO:0001525 GO:0006936 GO:0051017 GO:0051017 GO:0051017
CTNNB1 	CTNNB1 (Catenin Beta 1) is a Protein Coding gene. Diseases associated with CTNNB1 include  Pilomatrixoma binding JUP	The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]	The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Wnt reporter downregulated, Increased cell migration, Downregulation of Wnt pathway after Wnt3A stimulation, Large nuclei, Decreased influenza A/WSN/33 replication, Increased shRNA abundance (Z-score &gt; 2), Increased cell death in HCT116 cells, Increased cell death in DLD-1 cells, Increased focal adhesion (FA) area, decreased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0000122 GO:0000165 GO:0000165 GO:0000165 GO:0000209 GO:0000209 GO:0000209
NTRK1 	NTRK1 (Neurotrophic Receptor Tyrosine Kinase 1) is a Protein Coding gene. Diseases associated with NTRK1 include  NTRK3	This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Increased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased cell migration, Decreased telomerase activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased cell viability after pRB stimulation, 	GO:0001934 GO:0006468 GO:0007169 GO:0007275
CASK 	CASK (Calcium/Calmodulin Dependent Serine Protein Kinase) is a Protein Coding gene. Diseases associated with CASK include  MPP1	This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]	This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Decreased cell migration, Increased cell death in HCC-1954 cells, Decreased telomerase activity, Increased simian virus 40 (SV40) infection, Increased cell death in HCT116 cells, Decreased cilium length after serum starvation, Increased apoptosis, Polarized transferrin accumulation in plasma membrane protrusions, 	GO:0001953 GO:0006468 GO:0007155 GO:0007155 GO:0007155 GO:0010839
VEZF1 	VEZF1 (Vascular Endothelial Zinc Finger 1) is a Protein Coding gene. Diseases associated with VEZF1 include  MAZ	Transcriptional regulatory proteins containing tandemly repeated zinc finger domains are thought to be involved in both normal and abnormal cellular proliferation and differentiation. ZNF161 is a C2H2-type zinc finger protein (Koyano-Nakagawa et al., 1994 [PubMed 8035792]). See MIM 603971 for general information on zinc finger proteins.[supplied by OMIM, Sep 2008]	Transcriptional regulatory proteins containing tandemly repeated zinc finger domains are thought to be involved in both normal and abnormal cellular proliferation and differentiation. ZNF161 is a C2H2-type zinc finger protein (Koyano-Nakagawa et al., 1994 [PubMed 8035792]). See MIM 603971 for general information on zinc finger proteins.[supplied by OMIM, Sep 2008]	Decreased viability, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Large nuclei, decreased viability (cell death), 	GO:0001525 GO:0001885 GO:0001885 GO:0001885 GO:0006357 GO:0006357 GO:0006357 GO:0006968 GO:0045603
SRY 	SRY (Sex Determining Region Y) is a Protein Coding gene. Diseases associated with SRY include  SOX21	This intronless gene encodes a transcription factor that is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor (TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome. This intronless gene encodes a transcription factor that is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor (TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome. Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0000122 GO:0006355 GO:0007548 GO:0007548 GO:0007548 GO:0009653 GO:0009653 GO:0009653 GO:0010628
ZBTB18 	ZBTB18 (Zinc Finger And BTB Domain Containing 18) is a Protein Coding gene. Diseases associated with ZBTB18 include  ZBTB42	This gene encodes a C2H2-type zinc finger protein which acts a transcriptional repressor of genes involved in neuronal development. The encoded protein recognizes a specific sequence motif and recruits components of chromatin to target genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]	This gene encodes a C2H2-type zinc finger protein which acts a transcriptional repressor of genes involved in neuronal development. The encoded protein recognizes a specific sequence motif and recruits components of chromatin to target genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]	no effect, Decreased shRNA abundance (Z-score &lt; -2), Two nuclei (binuclear), Increased shRNA abundance (Z-score &gt; 2), 	GO:0000122 GO:0006357 GO:0006357 GO:0006357 GO:0007519 GO:0045892 GO:0045892 GO:0045892 GO:0045944 GO:0045944 GO:0045944
EPOR 	EPOR (Erythropoietin Receptor) is a Protein Coding gene. Diseases associated with EPOR include  Erythroleukemia CSF2RB	This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]	This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]	no effect, Reduced mammosphere formation, Decreased viability, Decreased viability after Maraba virus infection, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased interferon-beta reporter expression, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Reduced shRNA abundance in FBW7 KO line, 	GO:0007165 GO:0007420 GO:0007507 GO:0007507 GO:0007507 GO:0008284 GO:0008284 GO:0008284 GO:0019221
SPOP 	SPOP (Speckle Type BTB/POZ Protein) is a Protein Coding gene. Diseases associated with SPOP include  SPOPL	This gene encodes a protein that may modulate the transcriptional repression activities of death-associated protein 6 (DAXX), which interacts with histone deacetylase, core histones, and other histone-associated proteins. In mouse, the encoded protein binds to the putative leucine zipper domain of macroH2A1.2, a variant H2A histone that is enriched on inactivated X chromosomes. The BTB/POZ domain of this protein has been shown in other proteins to mediate transcriptional repression and to interact with components of histone deacetylase co-repressor complexes. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. This gene encodes a protein that may modulate the transcriptional repression activities of death-associated protein 6 (DAXX), which interacts with histone deacetylase, core histones, and other histone-associated proteins. In mouse, the encoded protein binds to the putative leucine zipper domain of macroH2A1.2, a variant H2A histone that is enriched on inactivated X chromosomes. The BTB/POZ domain of this protein has been shown in other proteins to mediate transcriptional repression and to interact with components of histone deacetylase co-repressor complexes. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, G0/1 arrest, Decreased cell number, 	GO:0000209 GO:0016567 GO:0030162 GO:0030162 GO:0030162 GO:0043161 GO:0051179
DIAPH1 	DIAPH1 (Diaphanous Related Formin 1) is a Protein Coding gene. Diseases associated with DIAPH1 include  DIAPH2	This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. no effect, Reduced mammosphere formation, Decreased viability, Inconclusive, Decreased Salmonella enterica Typhimurium effector injection, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0007010 GO:0007015 GO:0007015 GO:0007015 GO:0007605 GO:0007605 GO:0007605 GO:0008360 GO:0008360 GO:0008360
SOCS3 	SOCS3 (Suppressor Of Cytokine Signaling 3) is a Protein Coding gene. Diseases associated with SOCS3 include  Overnutrition CISH	This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene is induced by various cytokines, including IL6, IL10, and interferon (IFN)-gamma. The protein encoded by this gene can bind to JAK2 kinase, and inhibit the activity of JAK2 kinase. Studies of the mouse counterpart of this gene suggested the roles of this gene in the negative regulation of fetal liver hematopoiesis, and placental development. This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene is induced by various cytokines, including IL6, IL10, and interferon (IFN)-gamma. The protein encoded by this gene can bind to JAK2 kinase, and inhibit the activity of JAK2 kinase. Studies of the mouse counterpart of this gene suggested the roles of this gene in the negative regulation of fetal liver hematopoiesis, and placental development. Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Wnt reporter downregulated, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased interferon-beta reporter expression, Decreased viability with paclitaxel, 	 
TGFB2 	TGFB2 (Transforming Growth Factor Beta 2) is a Protein Coding gene. Diseases associated with TGFB2 include  TGFB3	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters\' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters\' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]	Increased gamma-H2AX phosphorylation, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased CFP-tsO45G cell surface transport, 	GO:0000902 GO:0001501 GO:0001654 GO:0001654 GO:0001654 GO:0001666
KLHL12 	KLHL12 (Kelch Like Family Member 12) is a Protein Coding gene. Diseases associated with KLHL12 include  KLHL4	This gene encodes a member of the KLHL (Kelch-like) family of proteins. This protein has been identified as an autoantigen in the autoimmune disease Sjogren\'s syndrome and as a potential biomarker in primary biliary cirrhosis. This protein may act as a substrate adaptor of the Cullin-3 ubiquitin ligase complex to promote substrate-specific ubiquitylation. Ubiquitylation by this complex has been shown to regulate the Wnt signaling pathway as well as COPII vesicle coat size. A pseudogene has been identified on chromosome 22. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	This gene encodes a member of the KLHL (Kelch-like) family of proteins. This protein has been identified as an autoantigen in the autoimmune disease Sjogren\'s syndrome and as a potential biomarker in primary biliary cirrhosis. This protein may act as a substrate adaptor of the Cullin-3 ubiquitin ligase complex to promote substrate-specific ubiquitylation. Ubiquitylation by this complex has been shown to regulate the Wnt signaling pathway as well as COPII vesicle coat size. A pseudogene has been identified on chromosome 22. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	no effect, Decreased viability, Increased G1 DNA content, Decreased infection with West Nile virus (WNV), Increased cilium length after serum starvation, 	GO:0006513 GO:0006888 GO:0014029 GO:0014032 GO:0016055
MAP3K7 	MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7) is a Protein Coding gene. Diseases associated with MAP3K7 include  PKDCC	The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, Downregulation of NF-kappaB pathway after LMP1 stimulation, Downregulation of NF-kappaB pathway after TNFalpha stimulation, Downregulation of NF-kappaB pathway after IL-1beta stimulation, Decreased HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell viability after pRB stimulation, Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with gemcitabine, Increased cell number in G1, small nuclei in G1, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, 	GO:0000165 GO:0002223 GO:0002726 GO:0002726 GO:0002726
NCKAP1L 	NCKAP1L (NCK Associated Protein 1 Like) is a Protein Coding gene. Diseases associated with NCKAP1L include  NCKAP1	This gene encodes a member of the HEM family of tissue-specific transmembrane proteins which are highly conserved from invertebrates through mammals. This gene is only expressed in hematopoietic cells. The encoded protein is a part of the Scar/WAVE complex which plays an important role in regulating cell shape in both metazoans and plants. Alternatively spliced transcript variants encoding different isoforms have been found.[provided by RefSeq, May 2010]	This gene encodes a member of the HEM family of tissue-specific transmembrane proteins which are highly conserved from invertebrates through mammals. This gene is only expressed in hematopoietic cells. The encoded protein is a part of the Scar/WAVE complex which plays an important role in regulating cell shape in both metazoans and plants. Alternatively spliced transcript variants encoding different isoforms have been found.[provided by RefSeq, May 2010]	no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased HPV18 LCR reporter activity, Decreased shRNA abundance, Decreased Hepatitis C virus replication, Increased S DNA content, Decreased BPV1 E2 protein expression, 	GO:0000902 GO:0001782 GO:0002262 GO:0002262 GO:0002262 GO:0002687 GO:0002687 GO:0002687 GO:0006935
COL15A1 	COL15A1 (Collagen Type XV Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL15A1 include  COL11A2	This gene encodes the alpha chain of type XV collagen, a member of the FACIT collagen family (fibril-associated collagens with interrupted helices). Type XV collagen has a wide tissue distribution but the strongest expression is localized to basement membrane zones so it may function to adhere basement membranes to underlying connective tissue stroma. The proteolytically produced C-terminal fragment of type XV collagen is restin, a potentially antiangiogenic protein that is closely related to endostatin. Mouse studies have shown that collagen XV deficiency is associated with muscle and microvessel deterioration. [provided by RefSeq, May 2013]	This gene encodes the alpha chain of type XV collagen, a member of the FACIT collagen family (fibril-associated collagens with interrupted helices). Type XV collagen has a wide tissue distribution but the strongest expression is localized to basement membrane zones so it may function to adhere basement membranes to underlying connective tissue stroma. The proteolytically produced C-terminal fragment of type XV collagen is restin, a potentially antiangiogenic protein that is closely related to endostatin. Mouse studies have shown that collagen XV deficiency is associated with muscle and microvessel deterioration. [provided by RefSeq, May 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased replication of vaccinia virus (VACV), Increased shRNA abundance, 	 
TFAM 	TFAM (Transcription Factor A, Mitochondrial) is a Protein Coding gene. Diseases associated with TFAM include  HMGB1	This gene encodes a key mitochondrial transcription factor containing two high mobility group motifs. The encoded protein also functions in mitochondrial DNA replication and repair. Sequence polymorphisms in this gene are associated with Alzheimer\'s and Parkinson\'s diseases. There are pseudogenes for this gene on chromosomes 6, 7, and 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	This gene encodes a key mitochondrial transcription factor containing two high mobility group motifs. The encoded protein also functions in mitochondrial DNA replication and repair. Sequence polymorphisms in this gene are associated with Alzheimer\'s and Parkinson\'s diseases. There are pseudogenes for this gene on chromosomes 6, 7, and 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	Increased vaccinia virus (VACV) infection, no effect, Resistant to vaccinia virus (VACV-A4L) infection, 	GO:0006390 GO:0006391 GO:0033108 GO:0045893 GO:0045893 GO:0045893
ARHGAP31 	ARHGAP31 (Rho GTPase Activating Protein 31) is a Protein Coding gene. Diseases associated with ARHGAP31 include  ARHGAP32	This gene encodes a GTPase-activating protein (GAP). A variety of cellular processes are regulated by Rho GTPases which cycle between an inactive form bound to GDP and an active form bound to GTP. This cycling between inactive and active forms is regulated by guanine nucleotide exchange factors and GAPs. The encoded protein is a GAP shown to regulate two GTPases involved in protein trafficking and cell growth. This gene encodes a GTPase-activating protein (GAP). A variety of cellular processes are regulated by Rho GTPases which cycle between an inactive form bound to GDP and an active form bound to GTP. This cycling between inactive and active forms is regulated by guanine nucleotide exchange factors and GAPs. The encoded protein is a GAP shown to regulate two GTPases involved in protein trafficking and cell growth. Increased vaccinia virus (VACV) infection, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage; decreased viability in pancreas lineage, 	GO:0007165 GO:0007264 GO:0007264 GO:0007264
FBXW7 	FBXW7 (F-Box And WD Repeat Domain Containing 7) is a Protein Coding gene. Diseases associated with FBXW7 include  BTRC	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene\'s potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene\'s potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased HPV16-GFP infection, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Increased cell death in HCT116 cells, Increased  Cyt C expression, Decreased CDKN1A mRNA expression, 	GO:0001570 GO:0001944 GO:0001944 GO:0001944 GO:0006281 GO:0006974 GO:0006974 GO:0006974 GO:0007062 GO:0007062 GO:0007062
LMO2 	LMO2 (LIM Domain Only 2) is a Protein Coding gene. Diseases associated with LMO2 include  LMO1	LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Nov 2008]	LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Nov 2008]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased HPV16-GFP infection, Increased epidermal growth factor (EGF) endocytosis, Proliferating cells, 	GO:0045944 GO:0097067
COL20A1 	COL20A1 (Collagen Type XX Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL20A1 include  COL4A5	Predicted to be located in endoplasmic reticulum lumen and extracellular region. Predicted to be part of collagen trimer. Predicted to be active in collagen-containing extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to be located in endoplasmic reticulum lumen and extracellular region. Predicted to be part of collagen trimer. Predicted to be active in collagen-containing extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, FOXO1 nuclear localization, Moderately decreased NFAT1-GFP nuclear translocation, HIV Rev nuclear localization, 	 
COL4A2 	COL4A2 (Collagen Type IV Alpha 2 Chain) is a Protein Coding gene. Diseases associated with COL4A2 include  COL4A1	This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased replication of vaccinia virus (VACV), 	GO:0001525 GO:0006351 GO:0006351 GO:0006351 GO:0007568 GO:0007568 GO:0007568 GO:0014823 GO:0014823 GO:0014823 GO:0016525 GO:0016525 GO:0016525
ID2 	ID2 (Inhibitor Of DNA Binding 2) is a Protein Coding gene. Diseases associated with ID2 include  Retinoblastoma ID4	The protein encoded by this gene belongs to the inhibitor of DNA binding family, members of which are transcriptional regulators that contain a helix-loop-helix (HLH) domain but not a basic domain. Members of the inhibitor of DNA binding family inhibit the functions of basic helix-loop-helix transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. This protein may play a role in negatively regulating cell differentiation. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Aug 2011]	The protein encoded by this gene belongs to the inhibitor of DNA binding family, members of which are transcriptional regulators that contain a helix-loop-helix (HLH) domain but not a basic domain. Members of the inhibitor of DNA binding family inhibit the functions of basic helix-loop-helix transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. This protein may play a role in negatively regulating cell differentiation. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Aug 2011]	Mitotic spindle defects, no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Decreased viability in pancreas lineage, Increased cell death HMECs cells, Increased shRNA abundance, Increased cell death in HCT116 cells, 	 
WDR81 	WDR81 (WD Repeat Domain 81) is a Protein Coding gene. Diseases associated with WDR81 include  COP1	This gene encodes a multi-domain transmembrane protein which is predominantly expressed in the brain and is thought to play a role in endolysosomal trafficking. Mutations in this gene are associated with an autosomal recessive form of a syndrome exhibiting cerebellar ataxia, cognitive disability, and disequilibrium (CAMRQ2). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]	This gene encodes a multi-domain transmembrane protein which is predominantly expressed in the brain and is thought to play a role in endolysosomal trafficking. Mutations in this gene are associated with an autosomal recessive form of a syndrome exhibiting cerebellar ataxia, cognitive disability, and disequilibrium (CAMRQ2). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Wnt reporter downregulated, Two nuclei (binuclear), Decreased viability, Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0006511 GO:0007005 GO:0035973 GO:0035973 GO:0035973 GO:0043551 GO:0045022
MAPKAPK5 	MAPKAPK5 (MAPK Activated Protein Kinase 5) is a Protein Coding gene. Diseases associated with MAPKAPK5 include  Dientamoebiasis MAPKAPK3	The protein encoded by this gene is a tumor suppressor and member of the serine/threonine kinase family. In response to cellular stress and proinflammatory cytokines, this kinase is activated through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38-alpha, and MAPK11/p38-beta. The encoded protein is found in the nucleus but translocates to the cytoplasm upon phosphorylation and activation. This kinase phosphorylates heat shock protein HSP27 at its physiologically relevant sites. Two alternately spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2012]	The protein encoded by this gene is a tumor suppressor and member of the serine/threonine kinase family. In response to cellular stress and proinflammatory cytokines, this kinase is activated through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38-alpha, and MAPK11/p38-beta. The encoded protein is found in the nucleus but translocates to the cytoplasm upon phosphorylation and activation. This kinase phosphorylates heat shock protein HSP27 at its physiologically relevant sites. Two alternately spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2012]	Decreased hepcidin::fluc mRNA expression, no effect, Synthetic lethal with Ras, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, shRNA abundance &lt;= 25%, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Increased transcriptional activity, Dynamic nuclei (hole, folded or small irregular), Increased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased shRNA abundance (Z-score &lt; -2), Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Increased cell death in DLD-1 cells, Fragmented cis-Golgi, 	GO:0000165 GO:0006417 GO:0006417 GO:0006417 GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007265
DCC 	DCC (DCC Netrin 1 Receptor) is a Protein Coding gene. Diseases associated with DCC include  NEO1	This gene encodes a netrin 1 receptor. The transmembrane protein is a member of the immunoglobulin superfamily of cell adhesion molecules, and mediates axon guidance of neuronal growth cones towards sources of netrin 1 ligand. The cytoplasmic tail interacts with the tyrosine kinases Src and focal adhesion kinase (FAK, also known as PTK2) to mediate axon attraction. The protein partially localizes to lipid rafts, and induces apoptosis in the absence of ligand. The protein functions as a tumor suppressor, and is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma. [provided by RefSeq, Oct 2009]	This gene encodes a netrin 1 receptor. The transmembrane protein is a member of the immunoglobulin superfamily of cell adhesion molecules, and mediates axon guidance of neuronal growth cones towards sources of netrin 1 ligand. The cytoplasmic tail interacts with the tyrosine kinases Src and focal adhesion kinase (FAK, also known as PTK2) to mediate axon attraction. The protein partially localizes to lipid rafts, and induces apoptosis in the absence of ligand. The protein functions as a tumor suppressor, and is frequently mutated or downregulated in colorectal cancer and esophageal carcinoma. [provided by RefSeq, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Synthetic lethal with c-Myc after tamoxifen stimulation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Increased HPV16-GFP infection, 	GO:0001764 GO:0006915 GO:0007399 GO:0007399 GO:0007399 GO:0007409 GO:0007409 GO:0007409 GO:0007411
MMP16 	MMP16 (Matrix Metallopeptidase 16) is a Protein Coding gene. Diseases associated with MMP16 include  Seminoma Melanoma MMP24	Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein activates MMP2 by cleavage. This gene was once referred to as MT-MMP2, but was renamed as MT-MMP3 or MMP16. [provided by RefSeq, Oct 2010]	Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP\'s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein activates MMP2 by cleavage. This gene was once referred to as MT-MMP2, but was renamed as MT-MMP3 or MMP16. [provided by RefSeq, Oct 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased shRNA abundance, Decreased epidermal growth factor (EGF) endocytosis, Upregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0001501 GO:0001503 GO:0001958 GO:0001958 GO:0001958 GO:0006508 GO:0006508 GO:0006508 GO:0016485
ACTC1 	ACTC1 (Actin Alpha Cardiac Muscle 1) is a Protein Coding gene. Diseases associated with ACTC1 include  ACTA2	Actins are highly conserved proteins that are involved in various types of cell motility. Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to four others. The protein encoded by this gene belongs to the actin family which is comprised of three main groups of actin isoforms, alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Defects in this gene have been associated with idiopathic dilated cardiomyopathy (IDC) and familial hypertrophic cardiomyopathy (FHC). Actins are highly conserved proteins that are involved in various types of cell motility. Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to four others. The protein encoded by this gene belongs to the actin family which is comprised of three main groups of actin isoforms, alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Defects in this gene have been associated with idiopathic dilated cardiomyopathy (IDC) and familial hypertrophic cardiomyopathy (FHC). Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, 	GO:0007015 GO:0010628 GO:0030048 GO:0030048 GO:0030048
CLDN5 	CLDN5 (Claudin 5) is a Protein Coding gene. Diseases associated with CLDN5 include  CLDN3	This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Mutations in this gene have been found in patients with velocardiofacial syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2018]	This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Mutations in this gene have been found in patients with velocardiofacial syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2018]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability with paclitaxel, 	GO:0003151 GO:0007043 GO:0007155 GO:0007179 GO:0007612
CDC42EP5 	CDC42EP5 (CDC42 Effector Protein 5) is a Protein Coding gene.  Among its related pathways are  CDC42EP4	Cell division control protein 42 (CDC42), a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg (binder of Rho GTPases) family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to CDC42 and regulate its function negatively. The encoded protein may inhibit c-Jun N-terminal kinase (JNK) independently of CDC42 binding. The protein may also play a role in septin organization and inducing pseudopodia formation in fibroblasts [provided by RefSeq, Jul 2013]	Cell division control protein 42 (CDC42), a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg (binder of Rho GTPases) family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to CDC42 and regulate its function negatively. The encoded protein may inhibit c-Jun N-terminal kinase (JNK) independently of CDC42 binding. The protein may also play a role in septin organization and inducing pseudopodia formation in fibroblasts [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Inconclusive, Negative genetic interaction between BLM-/- and BLM+/+, 	GO:0007254 GO:0007266 GO:0007266 GO:0007266 GO:0008360 GO:0008360 GO:0008360 GO:0030838 GO:0031274
MPRIP 	MPRIP (Myosin Phosphatase Rho Interacting Protein) is a Protein Coding gene. Diseases associated with MPRIP include  Disease TRIOBP	Enables cadherin binding activity. Predicted to be involved in actin filament organization. Located in actin cytoskeleton and cytosol. [provided by Alliance of Genome Resources, Apr 2022]	Enables cadherin binding activity. Predicted to be involved in actin filament organization. Located in actin cytoskeleton and cytosol. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, shRNA abundance &lt;= 25%, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Salmonella enterica Typhimurium invasion, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased Akt phosphorylation after EGF stimulation, 	 
KRIT1 	KRIT1 (KRIT1 Ankyrin Repeat Containing) is a Protein Coding gene. Diseases associated with KRIT1 include  FRMD8	This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]	This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased replication of vaccinia virus (VACV), Decreased shRNA abundance, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0001525 GO:0001937 GO:0001937 GO:0001937 GO:0003158 GO:0007264 GO:0010596
ROCK1 	ROCK1 (Rho Associated Coiled-Coil Containing Protein Kinase 1) is a Protein Coding gene. Diseases associated with ROCK1 include  ROCK2	This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]	This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]	Increased vaccinia virus (VACV) infection, no effect, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Decreased cell migration, Increased Nanog expression, Decreased viability, Increased cell viability after pRB stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased homologous recombination repair frequency, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Condensed cis-Golgi, Increased telomerase activity, 	GO:0000281 GO:0001837 GO:0003180 GO:0003180 GO:0003180 GO:0003383 GO:0003383 GO:0003383 GO:0006468 GO:0006468 GO:0006468
MAPK14 	MAPK14 (Mitogen-Activated Protein Kinase 14) is a Protein Coding gene. Diseases associated with MAPK14 include  Chlamydia MAPK11	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased ionizing radiation sensitivity, Increased cell migration, Increased cell viability after pRB stimulation, Decreased telomerase activity, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, High actin ratio cells, Decreased viability in colon lineage; decreased viability in pancreas lineage, toxic, 	 
RASSF5 	RASSF5 (Ras Association Domain Family Member 5) is a Protein Coding gene. Diseases associated with RASSF5 include  RASSF1	This gene is a member of the Ras association domain family. It functions as a tumor suppressor, and is inactivated in a variety of cancers. The encoded protein localizes to centrosomes and microtubules, and associates with the GTP-activated forms of Ras, Rap1, and several other Ras-like small GTPases. The protein regulates lymphocyte adhesion and suppresses cell growth in response to activated Rap1 or Ras. Multiple transcript variants encoding different isoforms have been found for this gene. This gene is a member of the Ras association domain family. It functions as a tumor suppressor, and is inactivated in a variety of cancers. The encoded protein localizes to centrosomes and microtubules, and associates with the GTP-activated forms of Ras, Rap1, and several other Ras-like small GTPases. The protein regulates lymphocyte adhesion and suppresses cell growth in response to activated Rap1 or Ras. Multiple transcript variants encoding different isoforms have been found for this gene. Decreased viability, no effect, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in glioblastoma multiforme (GBM) lineage; decreased viability in pancreas lineage, 	GO:0006915 GO:0007165 GO:0007165 GO:0007165
GJC1 	GJC1 (Gap Junction Protein Gamma 1) is a Protein Coding gene. Diseases associated with GJC1 include  GJC2	This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Alternatively spliced transcript variants encoding the same isoform have been described. This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Alternatively spliced transcript variants encoding the same isoform have been described. no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased hepcidin::fluc mRNA expression, Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0001570 GO:0006936 GO:0006936 GO:0006936 GO:0007043
PLXNB2 	PLXNB2 (Plexin B2) is a Protein Coding gene. Diseases associated with PLXNB2 include  PLXNB1	Members of the B class of plexins, such as PLXNB2 are transmembrane receptors that participate in axon guidance and cell migration in response to semaphorins (Perrot et al. (2002) [PubMed 12183458]).[supplied by OMIM, Mar 2008]	Members of the B class of plexins, such as PLXNB2 are transmembrane receptors that participate in axon guidance and cell migration in response to semaphorins (Perrot et al. (2002) [PubMed 12183458]).[supplied by OMIM, Mar 2008]	Increased gamma-H2AX phosphorylation, Increased shRNA abundance (Z-score &gt; 2), Increased epidermal growth factor (EGF) endocytosis, Dynamic nuclei (hole, folded or small irregular), 	GO:0001843 GO:0001932 GO:0001932 GO:0001932 GO:0007156 GO:0007156 GO:0007156 GO:0007162
MAP2K3 	MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3) is a Protein Coding gene. Diseases associated with MAP2K3 include  MAP2K6	The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Decreased substrate adherent cell growth, Decreased NF-kappaB reporter expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), Increased shRNA abundance (Z-score &gt; 2), Increased cell migration, Increased cell viability after pRB stimulation, Decreased influenza A/WSN/33 replication, Increased Sindbis virus (SINV) infection, Decreased IL-10 protein expression, 	GO:0000165
EZR 	EZR (Ezrin) is a Protein Coding gene. Diseases associated with EZR include  RDX	The cytoplasmic peripheral membrane protein encoded by this gene functions as a protein-tyrosine kinase substrate in microvilli. As a member of the ERM protein family, this protein serves as an intermediate between the plasma membrane and the actin cytoskeleton. This protein plays a key role in cell surface structure adhesion, migration and organization, and it has been implicated in various human cancers. A pseudogene located on chromosome 3 has been identified for this gene. Alternatively spliced variants have also been described for this gene. The cytoplasmic peripheral membrane protein encoded by this gene functions as a protein-tyrosine kinase substrate in microvilli. As a member of the ERM protein family, this protein serves as an intermediate between the plasma membrane and the actin cytoskeleton. This protein plays a key role in cell surface structure adhesion, migration and organization, and it has been implicated in various human cancers. A pseudogene located on chromosome 3 has been identified for this gene. Alternatively spliced variants have also been described for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Effect on mitosis, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased S DNA content, increased 8N DNA content, 	GO:0000122 GO:0001951 GO:0003376 GO:0003376 GO:0003376 GO:0007159 GO:0008360
CNTN2 	CNTN2 (Contactin 2) is a Protein Coding gene. Diseases associated with CNTN2 include  CNTN1	This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]	This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, 	 
ZNF385C 	ZNF385C (Zinc Finger Protein 385C) is a Protein Coding gene. Diseases associated with ZNF385C include  Fibrochondrogenesis ZNF385B	Predicted to enable nucleic acid binding activity and zinc ion binding activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable nucleic acid binding activity and zinc ion binding activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, 	 
COL14A1 	COL14A1 (Collagen Type XIV Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL14A1 include  COL12A1	This gene encodes the alpha chain of type XIV collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XIV collagen interacts with the fibril surface and is involved in the regulation of fibrillogenesis. [provided by RefSeq, Jan 2013]	This gene encodes the alpha chain of type XIV collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XIV collagen interacts with the fibril surface and is involved in the regulation of fibrillogenesis. [provided by RefSeq, Jan 2013]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased viability with SS1P at EC90, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0007155 GO:0030198 GO:0030198 GO:0030198 GO:0030199 GO:0098609
COL10A1 	COL10A1 (Collagen Type X Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL10A1 include  COL8A2	This gene encodes the alpha chain of type X collagen, a short chain collagen expressed by hypertrophic chondrocytes during endochondral ossification. Unlike type VIII collagen, the other short chain collagen, type X collagen is a homotrimer. Mutations in this gene are associated with Schmid type metaphyseal chondrodysplasia (SMCD) and Japanese type spondylometaphyseal dysplasia (SMD). This gene encodes the alpha chain of type X collagen, a short chain collagen expressed by hypertrophic chondrocytes during endochondral ossification. Unlike type VIII collagen, the other short chain collagen, type X collagen is a homotrimer. Mutations in this gene are associated with Schmid type metaphyseal chondrodysplasia (SMCD) and Japanese type spondylometaphyseal dysplasia (SMD). Mitotic spindle defects, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased cell number, Decreased IL-8 secretion, Inconclusive, Increased S DNA content, 	GO:0001501 GO:0030198
PPM1A 	PPM1A (Protein Phosphatase, Mg2+/Mn2+ Dependent 1A) is a Protein Coding gene. Diseases associated with PPM1A include  Osteopoikilosis PPM1B	The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. This phosphatase dephosphorylates, and negatively regulates the activities of, MAP kinases and MAP kinase kinases. It has been shown to inhibit the activation of p38 and JNK kinase cascades induced by environmental stresses. This phosphatase can also dephosphorylate cyclin-dependent kinases, and thus may be involved in cell cycle control. Overexpression of this phosphatase is reported to activate the expression of the tumor suppressor gene TP53/p53, which leads to G2/M cell cycle arrest and apoptosis. Three alternatively spliced transcript variants encoding distinct isoforms have been described. The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. This phosphatase dephosphorylates, and negatively regulates the activities of, MAP kinases and MAP kinase kinases. It has been shown to inhibit the activation of p38 and JNK kinase cascades induced by environmental stresses. This phosphatase can also dephosphorylate cyclin-dependent kinases, and thus may be involved in cell cycle control. Overexpression of this phosphatase is reported to activate the expression of the tumor suppressor gene TP53/p53, which leads to G2/M cell cycle arrest and apoptosis. Three alternatively spliced transcript variants encoding distinct isoforms have been described. no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased caspase 3/7 activity, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0000122 GO:0006470 GO:0006470 GO:0006470 GO:0006499 GO:0006611 GO:0006611 GO:0006611 GO:0010991 GO:0010991 GO:0010991
YES1 	YES1 (YES Proto-Oncogene 1, Src Family Tyrosine Kinase) is a Protein Coding gene. Diseases associated with YES1 include  Sarcoma SRC	This gene is the cellular homolog of the Yamaguchi sarcoma virus oncogene. The encoded protein has tyrosine kinase activity and belongs to the src family of proteins. This gene lies in close proximity to thymidylate synthase gene on chromosome 18, and a corresponding pseudogene has been found on chromosome 22. This gene is the cellular homolog of the Yamaguchi sarcoma virus oncogene. The encoded protein has tyrosine kinase activity and belongs to the src family of proteins. This gene lies in close proximity to thymidylate synthase gene on chromosome 18, and a corresponding pseudogene has been found on chromosome 22. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Synthetic lethal with Ras, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased cell migration, Decreased viability, Decreased shRNA abundance, Increased cell viability after pRB stimulation, Decreased telomerase activity, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased mitotic index, Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic index, 	GO:0002862 GO:0006468 GO:0006468 GO:0006468 GO:0007169 GO:0007169 GO:0007169
RDX 	RDX (Radixin) is a Protein Coding gene. Diseases associated with RDX include  MSN	Radixin is a cytoskeletal protein that may be important in linking actin to the plasma membrane. It is highly similar in sequence to both ezrin and moesin. The radixin gene has been localized by fluorescence in situ hybridization to 11q23. A truncated version representing a pseudogene (RDXP2) was assigned to Xp21.3. Another pseudogene that seemed to lack introns (RDXP1) was mapped to 11p by Southern and PCR analyses. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]	Radixin is a cytoskeletal protein that may be important in linking actin to the plasma membrane. It is highly similar in sequence to both ezrin and moesin. The radixin gene has been localized by fluorescence in situ hybridization to 11q23. A truncated version representing a pseudogene (RDXP2) was assigned to Xp21.3. Another pseudogene that seemed to lack introns (RDXP1) was mapped to 11p by Southern and PCR analyses. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]	no effect, Decreased viability in esophageal squamous lineage, Decreased viability, Decreased viability after Maraba virus infection, Decreased NF-kappaB reporter expression, Increased S DNA content, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased cell migration, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, 	GO:0008360 GO:0008361 GO:0010628 GO:0010737 GO:0030335 GO:0030335 GO:0030335
RIPK1 	RIPK1 (Receptor Interacting Serine/Threonine Kinase 1) is a Protein Coding gene. Diseases associated with RIPK1 include  MAP3K9	This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein plays a role in inflammation and cell death in response to tissue damage, pathogen recognition, and as part of developmental regulation. RIPK1/RIPK3 kinase-mediated necrosis is referred to as necroptosis. Genetic disruption of this gene in mice results in death shortly after birth. [provided by RefSeq, Aug 2017]	This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein plays a role in inflammation and cell death in response to tissue damage, pathogen recognition, and as part of developmental regulation. RIPK1/RIPK3 kinase-mediated necrosis is referred to as necroptosis. Genetic disruption of this gene in mice results in death shortly after birth. [provided by RefSeq, Aug 2017]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Increased mitotic index, Increased cell number in G2M, increased nuclei size in G2M, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, 	GO:0000165 GO:0001934 GO:0001934 GO:0001934 GO:0006468 GO:0006915 GO:0006915 GO:0006915
COL13A1 	COL13A1 (Collagen Type XIII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL13A1 include  COL7A1	This gene encodes the alpha chain of one of the nonfibrillar collagens. The function of this gene product is not known, however, it has been detected at low levels in all connective tissue-producing cells so it may serve a general function in connective tissues. Unlike most of the collagens, which are secreted into the extracellular matrix, collagen XIII contains a transmembrane domain and the protein has been localized to the plasma membrane. The transcripts for this gene undergo complex and extensive splicing involving at least eight exons. Like other collagens, collagen XIII is a trimer; it is not known whether this trimer is composed of one or more than one alpha chain isomer. A number of alternatively spliced transcript variants have been described, but the full length nature of some of them has not been determined. This gene encodes the alpha chain of one of the nonfibrillar collagens. The function of this gene product is not known, however, it has been detected at low levels in all connective tissue-producing cells so it may serve a general function in connective tissues. Unlike most of the collagens, which are secreted into the extracellular matrix, collagen XIII contains a transmembrane domain and the protein has been localized to the plasma membrane. The transcripts for this gene undergo complex and extensive splicing involving at least eight exons. Like other collagens, collagen XIII is a trimer; it is not known whether this trimer is composed of one or more than one alpha chain isomer. A number of alternatively spliced transcript variants have been described, but the full length nature of some of them has not been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased IL-8 secretion, Inconclusive, 	GO:0001501
BAX 	BAX (BCL2 Associated X, Apoptosis Regulator) is a Protein Coding gene. Diseases associated with BAX include  MCL1	The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]	The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]	no effect, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), 	 
FBLN5 	FBLN5 (Fibulin 5) is a Protein Coding gene. Diseases associated with FBLN5 include  EFEMP2	The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Polylobed nuclei, Decreased viability with paclitaxel, 	GO:0001558 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0034394 GO:0046903 GO:0046903 GO:0046903
SNX9 	SNX9 (Sorting Nexin 9) is a Protein Coding gene. Diseases associated with SNX9 include  SNX18	This gene encodes a member of the sorting nexin family. Members of this family contain a phosphoinositide binding domain, and are involved in intracellular trafficking. The encoded protein does not contain a coiled coil region, like some family members, but does contain a SRC homology domain near its N-terminus. The encoded protein is reported to have a variety of interaction partners, including of adaptor protein 2 , dynamin, tyrosine kinase non-receptor 2, Wiskott-Aldrich syndrome-like, and ARP3 actin-related protein 3. The encoded protein is implicated in several stages of intracellular trafficking, including endocytosis, macropinocytosis, and F-actin nucleation. [provided by RefSeq, Jul 2013]	This gene encodes a member of the sorting nexin family. Members of this family contain a phosphoinositide binding domain, and are involved in intracellular trafficking. The encoded protein does not contain a coiled coil region, like some family members, but does contain a SRC homology domain near its N-terminus. The encoded protein is reported to have a variety of interaction partners, including of adaptor protein 2 , dynamin, tyrosine kinase non-receptor 2, Wiskott-Aldrich syndrome-like, and ARP3 actin-related protein 3. The encoded protein is implicated in several stages of intracellular trafficking, including endocytosis, macropinocytosis, and F-actin nucleation. [provided by RefSeq, Jul 2013]	no effect, Decreased viability, Decreased ionizing radiation sensitivity, Decreased viability ratio, Decreased NF-kappaB reporter expression, Decreased viability of wild-type and TP53 knockout cells, Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, 	GO:0000278 GO:0000281 GO:0000281 GO:0000281 GO:0006886 GO:0006897 GO:0006898
FGF1 	FGF1 (Fibroblast Growth Factor 1) is a Protein Coding gene. Diseases associated with FGF1 include  Overnutrition FGF2	The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein functions as a modifier of endothelial cell migration and proliferation, as well as an angiogenic factor. It acts as a mitogen for a variety of mesoderm- and neuroectoderm-derived cells in vitro, thus is thought to be involved in organogenesis. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Jan 2009]	The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein functions as a modifier of endothelial cell migration and proliferation, as well as an angiogenic factor. It acts as a mitogen for a variety of mesoderm- and neuroectoderm-derived cells in vitro, thus is thought to be involved in organogenesis. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Jan 2009]	no effect, Decreased vaccinia virus (VACV) infection, Increased G1 DNA content, Increased IL-8 secretion, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased number of mitotic cells, 	GO:0001525 GO:0001759 GO:0001759 GO:0001759 GO:0001934 GO:0001934 GO:0001934 GO:0007165 GO:0008284
BRCA1 	BRCA1 (BRCA1 DNA Repair Associated) is a Protein Coding gene. Diseases associated with BRCA1 include 	This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]	This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased IL-8 secretion, Increased ionizing radiation sensitivity, Decreased HIV-LTR-beta-galactosidase protein expression, Increased cell death HMECs cells, Decreased viability, Decreased homologous recombination repair frequency, Decreased viability of wild-type and TP53 knockout cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased viability after ionizing radiation, Decreased viability with cisplatin, Synthetic lethal with cisplatin, 	GO:0000209 GO:0000724 GO:0006281 GO:0006282 GO:0006301
MYLK 	MYLK (Myosin Light Chain Kinase) is a Protein Coding gene. Diseases associated with MYLK include  DAPK1	This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3\' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3\' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Reduced mammosphere formation, Increased IL-8 secretion, Wnt reporter downregulated, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Increased NF-kappaB reporter expression, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell migration, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Transferrin accumulation in enlarged cytoplasmic structures, 	GO:0006468 GO:0006939 GO:0006939 GO:0006939 GO:0014820 GO:0014820 GO:0014820 GO:0016310 GO:0016310 GO:0016310 GO:0030335 GO:0030335 GO:0030335
RAB35 	RAB35 (RAB35, Member RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAB35 include  RAB1A	Enables GTPase activity; guanyl ribonucleotide binding activity; and phosphatidylinositol-4,5-bisphosphate binding activity. Involved in several processes, including endosomal transport; plasma membrane to endosome transport; and protein localization to endosome. Located in several cellular components, including clathrin-coated endocytic vesicle; clathrin-coated pit; and intercellular bridge. [provided by Alliance of Genome Resources, Apr 2022]	Enables GTPase activity; guanyl ribonucleotide binding activity; and phosphatidylinositol-4,5-bisphosphate binding activity. Involved in several processes, including endosomal transport; plasma membrane to endosome transport; and protein localization to endosome. Located in several cellular components, including clathrin-coated endocytic vesicle; clathrin-coated pit; and intercellular bridge. [provided by Alliance of Genome Resources, Apr 2022]	no effect, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased viability after Maraba virus infection, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Decreased cilium length after serum starvation, Decreased shRNA abundance (Z-score &lt; -2), Decreased cilium length, 	GO:0000281 GO:0008104 GO:0015031 GO:0016192 GO:0016192 GO:0016192 GO:0016197 GO:0016197 GO:0016197
IGF1R 	IGF1R (Insulin Like Growth Factor 1 Receptor) is a Protein Coding gene. Diseases associated with IGF1R include  INSR	This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]	This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability in colon lineage, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Strongly decreased NFAT1-GFP nuclear translocation, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased focal adhesion (FA) abundance, increased peripheral FA formation, decreased cell spreading, Condensed cis-Golgi, condensed medial Golgi, Decreased Cdk9 T-loop phosphorylation, 	GO:0003230 GO:0006468 GO:0006468 GO:0006468 GO:0006955 GO:0006955 GO:0006955 GO:0007165
MEF2C 	MEF2C (Myocyte Enhancer Factor 2C) is a Protein Coding gene. Diseases associated with MEF2C include  MEF2A	This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]	This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]	no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased nuclei size in G2M, 	GO:0000122 GO:0000165
NR3C1 	NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1) is a Protein Coding gene. Diseases associated with NR3C1 include  NR3C2	This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]	This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, No cells, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Increased cell death in HCC-1954 cells, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased caspase 3/7 activity, 	GO:0000122 GO:0006111 GO:0006325 GO:0006325 GO:0006325 GO:0006351 GO:0006351 GO:0006351 GO:0006355 GO:0006355 GO:0006355
IL1B 	IL1B (Interleukin 1 Beta) is a Protein Coding gene. Diseases associated with IL1B include  IL37	The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2.  The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2.  Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0000165 GO:0001660 GO:0001819 GO:0001819 GO:0001819 GO:0001934 GO:0001934 GO:0001934 GO:0002711
SOX2 	SOX2 (SRY-Box Transcription Factor 2) is a Protein Coding gene. Diseases associated with SOX2 include  SOX1	This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). This intronless gene encodes a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The product of this gene is required for stem-cell maintenance in the central nervous system, and also regulates gene expression in the stomach. Mutations in this gene have been associated with optic nerve hypoplasia and with syndromic microphthalmia, a severe form of structural eye malformation. This gene lies within an intron of another gene called SOX2 overlapping transcript (SOX2OT). Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Increased HPV18 LCR reporter activity, Decreased viability, 	GO:0000122 GO:0001649 GO:0001649 GO:0001649 GO:0001654 GO:0001714 GO:0006325
MUC1 	MUC1 (Mucin 1, Cell Surface Associated) is a Protein Coding gene. Diseases associated with MUC1 include  Syringoma	This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2011]	This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased IL-8 secretion, Increased NF-kappaB reporter expression, Increased virus production, Decreased focal adhesion (FA) area, decreased FA length, increased number of small and round FAs, 	GO:0006351 GO:0006977 GO:0006977 GO:0006977 GO:0006978 GO:0010944 GO:0033629
RAB8A 	RAB8A (RAB8A, Member RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAB8A include  RAB8B	The protein encoded by this gene is a member of the RAS superfamily which are small GTP/GDP-binding proteins with an average size of 200 amino acids. The RAS-related proteins of the RAB/YPT family may play a role in the transport of proteins from the endoplasmic reticulum to the Golgi and the plasma membrane. This protein shares 97%, 96%, and 51% similarity with the dog RAB8, mouse MEL, and mouse YPT1 proteins, respectively and contains the 4 GTP/GDP-binding sites that are present in all the RAS proteins. The putative effector-binding site of this protein is similar to that of the RAB/YPT proteins. However, this protein contains a C-terminal CAAX motif that is characteristic of many RAS superfamily members but which is not found in YPT1 and the majority of RAB proteins. Although this gene was isolated as a transforming gene from a melanoma cell line, no linkage between MEL and malignant melanoma has been demonstrable. This oncogene is located 800 kb distal to MY09B on chromosome 19p13.1. The protein encoded by this gene is a member of the RAS superfamily which are small GTP/GDP-binding proteins with an average size of 200 amino acids. The RAS-related proteins of the RAB/YPT family may play a role in the transport of proteins from the endoplasmic reticulum to the Golgi and the plasma membrane. This protein shares 97%, 96%, and 51% similarity with the dog RAB8, mouse MEL, and mouse YPT1 proteins, respectively and contains the 4 GTP/GDP-binding sites that are present in all the RAS proteins. The putative effector-binding site of this protein is similar to that of the RAB/YPT proteins. However, this protein contains a C-terminal CAAX motif that is characteristic of many RAS superfamily members but which is not found in YPT1 and the majority of RAB proteins. Although this gene was isolated as a transforming gene from a melanoma cell line, no linkage between MEL and malignant melanoma has been demonstrable. This oncogene is located 800 kb distal to MY09B on chromosome 19p13.1. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in glioblastoma multiforme (GBM) lineage, Two nuclei (binuclear), Decreased viability (cell death), Decreased HIV-LTR-beta-galactosidase protein expression, Decreased Hepatitis C virus replication, 	GO:0006904 GO:0006914 GO:0007030 GO:0007030 GO:0007030 GO:0007409 GO:0009306 GO:0009306 GO:0009306
PPP2R2A 	PPP2R2A (Protein Phosphatase 2 Regulatory Subunit Balpha) is a Protein Coding gene. Diseases associated with PPP2R2A include  PPP2R2D	The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes an alpha isoform of the regulatory subunit B55 subfamily. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]	The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes an alpha isoform of the regulatory subunit B55 subfamily. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]	Increased gamma-H2AX phosphorylation, no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Strongly decreased CFP-tsO45G cell surface transport, Effect on mitosis, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased Sindbis virus (SINV) infection, Increased cell death in HCC-1954 cells, Decreased Tat-dependent transcription, Increased S DNA content, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death in HCT116 cells, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased caspase activity, Increased Erk phosphorylation after EGF stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, decreased cell spreading, Increased mitotic exit time, 	GO:0006470
KALRN 	KALRN (Kalirin RhoGEF Kinase) is a Protein Coding gene. Diseases associated with KALRN include  TRIO	Huntington\'s disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]	Huntington\'s disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased substrate adherent cell growth, Decreased viability (cell death), Increased ionizing radiation sensitivity, Decreased homologous recombination repair frequency, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell viability after pRB stimulation, Decreased viability with TRAIL, Weakly decreased NFAT1-GFP nuclear translocation, Increased G1 length, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007399 GO:0007411 GO:0007411 GO:0007411
PPARA 	PPARA (Peroxisome Proliferator Activated Receptor Alpha) is a Protein Coding gene. Diseases associated with PPARA include  PPARD	Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. Increased vaccinia virus (VACV) infection, Decreased viability, no effect, shRNA abundance &lt;= 25%, Decreased cell number, Decreased viability (cell death), Decreased influenza A virus infection, 	GO:0000122
CCBE1 	CCBE1 (Collagen And Calcium Binding EGF Domains 1) is a Protein Coding gene. Diseases associated with CCBE1 include 	This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]	This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]	Decreased viability, no effect, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased cell number, Decreased NF-kappaB reporter expression, Increased number of mitotic cells, Decreased viability in esophageal squamous lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased cell number, increased G2M DNA content, increased 8N DNA content, 	 
CUL4A 	CUL4A (Cullin 4A) is a Protein Coding gene. Diseases associated with CUL4A include  CUL4B	CUL4A is the ubiquitin ligase component of a multimeric complex involved in the degradation of DNA damage-response proteins (Liu et al., 2009 [PubMed 19481525]).[supplied by OMIM, Oct 2009]	CUL4A is the ubiquitin ligase component of a multimeric complex involved in the degradation of DNA damage-response proteins (Liu et al., 2009 [PubMed 19481525]).[supplied by OMIM, Oct 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Strongly decreased CFP-tsO45G cell surface transport, Increased nuclear migration distance, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased cell death in HCT116 cells, Increased S length, 	GO:0000082 GO:0001701 GO:0006281 GO:0006281 GO:0006281 GO:0006511 GO:0006511 GO:0006511 GO:0006974 GO:0006974 GO:0006974
TGFBR1 	TGFBR1 (Transforming Growth Factor Beta Receptor 1) is a Protein Coding gene. Diseases associated with TGFBR1 include  ACVR1B	The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	no effect, Decreased viability, shRNA abundance &lt;= 25%, Increased G1 DNA content, G0/1 arrest, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Downregulation of Wnt pathway after Wnt3A stimulation, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased Salmonella proliferation, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Transferrin accumulation in small spots in the cell periphery, Increased vesicular stomatitis virus (VSV) infection, Condensed cis-Golgi, condensed trans-Golgi, 	 
ILK 	ILK (Integrin Linked Kinase) is a Protein Coding gene. Diseases associated with ILK include  LRRK2	This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]	This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Increased viability (proliferation), Increased cell death HMECs cells, Decreased shRNA abundance (Z-score &lt; -2), Decreased cell migration, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability with paclitaxel, Decreased caspase 3/7 activity, Synthetic lethal with paclitaxel, Increased mitotic index, Increased viability with tamoxifen, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, 	GO:0000902 GO:0001658 GO:0001934 GO:0001934 GO:0001934 GO:0003151 GO:0006468 GO:0006468 GO:0006468
NTRK2 	NTRK2 (Neurotrophic Receptor Tyrosine Kinase 2) is a Protein Coding gene. Diseases associated with NTRK2 include  NTRK3	This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased cell death HMECs cells, Increased Nanog expression, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Increased mitotic index, Decreased viability with cisplatin, Decreased cell viability after pRB stimulation, Increased senescence-associated beta-galactosidase protein expression after pRB stimulation, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0001570 GO:0001764 GO:0001764 GO:0001764 GO:0001934 GO:0001934 GO:0001934 GO:0006468 GO:0007169 GO:0007169 GO:0007169
LRRK2 	LRRK2 (Leucine Rich Repeat Kinase 2) is a Protein Coding gene. Diseases associated with LRRK2 include  TNNI3K	This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. Increased vaccinia virus (VACV) infection, Decreased viability, Decreased viability with paclitaxel, Increased Nanog expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell proliferation, 	GO:0000165 GO:0001933 GO:0001934 GO:0001934 GO:0001934 GO:0006468
NCKAP1 	NCKAP1 (NCK Associated Protein 1) is a Protein Coding gene. Diseases associated with NCKAP1 include  NCKAP1L	Contributes to small GTPase binding activity. Involved in Rac protein signal transduction; positive regulation of Arp2/3 complex-mediated actin nucleation; and positive regulation of lamellipodium assembly. Located in extracellular exosome and focal adhesion. Part of SCAR complex. [provided by Alliance of Genome Resources, Apr 2022]	Contributes to small GTPase binding activity. Involved in Rac protein signal transduction; positive regulation of Arp2/3 complex-mediated actin nucleation; and positive regulation of lamellipodium assembly. Located in extracellular exosome and focal adhesion. Part of SCAR complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability ratio, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Decreased Salmonella enterica Typhimurium ruffling, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased HIV-1 infection, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium binding, Decreased Salmonella enterica Typhimurium membrane closure, 	GO:0000902 GO:0006915 GO:0007417 GO:0010592 GO:0016477 GO:0016477 GO:0016477
C2 	C2 (Complement C2) is a Protein Coding gene. Diseases associated with C2 include  CFB	Component C2 is a serum glycoprotein that functions as part of the classical pathway of the complement system. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]	Component C2 is a serum glycoprotein that functions as part of the classical pathway of the complement system. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Negative genetic interaction between PTTG1-/- and PTTG1+/+, 	GO:0002376 GO:0006508 GO:0006508 GO:0006508 GO:0006956 GO:0006956 GO:0006956
PHLPP1 	PHLPP1 (PH Domain And Leucine Rich Repeat Protein Phosphatase 1) is a Protein Coding gene. Diseases associated with PHLPP1 include  PHLPP2	This gene encodes a member of the serine/threonine phosphatase family. The encoded protein promotes apoptosis by dephosphorylating and inactivating the serine/threonine kinase Akt, and functions as a tumor suppressor in multiple types of cancer. Increased expression of this gene may also play a role in obesity and type 2 diabetes by interfering with Akt-mediated insulin signaling. [provided by RefSeq, Dec 2011]	This gene encodes a member of the serine/threonine phosphatase family. The encoded protein promotes apoptosis by dephosphorylating and inactivating the serine/threonine kinase Akt, and functions as a tumor suppressor in multiple types of cancer. Increased expression of this gene may also play a role in obesity and type 2 diabetes by interfering with Akt-mediated insulin signaling. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability (cell death), Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0002667 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007165 GO:0007165 GO:0009649 GO:0009649 GO:0009649 GO:0042981 GO:0042981 GO:0042981
COL9A3 	COL9A3 (Collagen Type IX Alpha 3 Chain) is a Protein Coding gene. Diseases associated with COL9A3 include  COL4A1	This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]	This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]	Increased gamma-H2AX phosphorylation, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased nuclear migration speed, Decreased cell number and increased metaphase cell number, 	GO:0008584 GO:0008585 GO:0008585 GO:0008585 GO:0030198 GO:0030198 GO:0030198
EFEMP1 	EFEMP1 (EGF Containing Fibulin Extracellular Matrix Protein 1) is a Protein Coding gene. Diseases associated with EFEMP1 include  EFEMP2	This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq, Nov 2009]	This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq, Nov 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased Sindbis virus (SINV) infection, Increased cilium length after serum starvation, 	GO:0006355 GO:0007173 GO:0007601 GO:0018108 GO:0032331
GSK3B 	GSK3B (Glycogen Synthase Kinase 3 Beta) is a Protein Coding gene. Diseases associated with GSK3B include  Myocarditis GSK3A	The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased vesicular stomatitis virus (VSV) infection, Negative genetic interaction between BLM-/- and BLM+/+, Decreased viability, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased substrate adherent cell growth, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Decreased cell proliferation, Increased shRNA abundance (Z-score &gt; 2), 	GO:0001837 GO:0001954 GO:0003170 GO:0005975 GO:0005975 GO:0005975 GO:0005977 GO:0005977 GO:0005977
PDGFB 	PDGFB (Platelet Derived Growth Factor Subunit B) is a Protein Coding gene. Diseases associated with PDGFB include  PDGFA	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased substrate adherent cell growth, Increased cell death HMECs cells, 	GO:0001892 GO:0001938 GO:0001938 GO:0001938 GO:0002548 GO:0003104 GO:0006468 GO:0006468 GO:0006468
NEDD9 	NEDD9 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 9) is a Protein Coding gene. Diseases associated with NEDD9 include  Adhesion BCAR1	The protein encoded by this gene is a member of the CRK-associated substrates family. Members of this family are adhesion docking molecules that mediate protein-protein interactions for signal transduction pathways. This protein is a focal adhesion protein that acts as a scaffold to regulate signaling complexes important in cell attachment, migration and invasion as well as apoptosis and the cell cycle. This protein has also been reported to have a role in cancer metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	The protein encoded by this gene is a member of the CRK-associated substrates family. Members of this family are adhesion docking molecules that mediate protein-protein interactions for signal transduction pathways. This protein is a focal adhesion protein that acts as a scaffold to regulate signaling complexes important in cell attachment, migration and invasion as well as apoptosis and the cell cycle. This protein has also been reported to have a role in cancer metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased viability after Maraba virus infection, Increased nuclear migration speed, Increased virus production, 	GO:0007010 GO:0007049 GO:0007155 GO:0007155 GO:0007155 GO:0007165 GO:0007165 GO:0007165 GO:0007169
PARD3 	PARD3 (Par-3 Family Cell Polarity Regulator) is a Protein Coding gene. Diseases associated with PARD3 include  Anencephaly PARD3B	This gene encodes a member of the PARD protein family. PARD family members interact with other PARD family members and other proteins; they affect asymmetrical cell division and direct polarized cell growth. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]	This gene encodes a member of the PARD protein family. PARD family members interact with other PARD family members and other proteins; they affect asymmetrical cell division and direct polarized cell growth. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Increased S DNA content, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0000226 GO:0006612 GO:0007049 GO:0007049 GO:0007049 GO:0007155 GO:0007155 GO:0007155 GO:0007163
JAZF1 	JAZF1 (JAZF Zinc Finger 1) is a Protein Coding gene. Diseases associated with JAZF1 include 	This gene encodes a nuclear protein with three C2H2-type zinc fingers, and functions as a transcriptional repressor. Chromosomal aberrations involving this gene are associated with endometrial stromal tumors. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized This gene encodes a nuclear protein with three C2H2-type zinc fingers, and functions as a transcriptional repressor. Chromosomal aberrations involving this gene are associated with endometrial stromal tumors. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized no effect, Strongly decreased CFP-tsO45G cell surface transport, Nuclear 60S biogenesis defects, Increased circadian period length, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0000122
GSK3A 	GSK3A (Glycogen Synthase Kinase 3 Alpha) is a Protein Coding gene. Diseases associated with GSK3A include  Schizophrenia GSK3B	This gene encodes a multifunctional Ser/Thr protein kinase that is implicated in the control of several regulatory proteins including glycogen synthase, and transcription factors, such as JUN. It also plays a role in the WNT and PI3K signaling pathways, as well as regulates the production of beta-amyloid peptides associated with Alzheimer\'s disease. [provided by RefSeq, Oct 2011]	This gene encodes a multifunctional Ser/Thr protein kinase that is implicated in the control of several regulatory proteins including glycogen synthase, and transcription factors, such as JUN. It also plays a role in the WNT and PI3K signaling pathways, as well as regulates the production of beta-amyloid peptides associated with Alzheimer\'s disease. [provided by RefSeq, Oct 2011]	no effect, Increased shRNA abundance (Z-score &gt; 2), shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Decreased shRNA abundance, Decreased viability, Increased cell viability after pRB stimulation, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Decreased influenza A virus infection, Increased viability with TRAIL, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased shRNA abundance with PLX4720, Increased simian virus 40 (SV40) infection, 	 
MYC 	MYC (MYC Proto-Oncogene, BHLH Transcription Factor) is a Protein Coding gene. Diseases associated with MYC include  MYCN	This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017]	This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, G0/1 arrest, Decreased cell number, Decreased NF-kappaB reporter expression, Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium effector injection, Decreased Salmonella enterica Typhimurium ruffling, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell size, Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Moderately decreased NFAT1-GFP nuclear translocation, Increased viability with TRAIL, Decreased influenza A/WSN/33 replication, Increased cell death in DLD-1 cells, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0000082 GO:0000122 GO:0000165
PTENP1 	PTENP1 (Phosphatase And Tensin Homolog Pseudogene 1) is a Pseudogene. Diseases associated with PTENP1 include 	PTENP1 represents a highly homologous processed pseudogene of PTEN (phosphatase and tensin homolog), a protein that encodes a tumor suppressor that functions by negatively regulating the AKT/PKB signaling pathway. PTENP1 is found on chromosome 9 and regulates PTEN by both sense and antisense RNAs (Gene ID: 101243555). This long-noncoding RNA (lncRNA) acts as a decoy for PTEN targeting microRNAs and also exerts a tumor suppressive activity. [provided by RefSeq, Jun 2020]	PTENP1 represents a highly homologous processed pseudogene of PTEN (phosphatase and tensin homolog), a protein that encodes a tumor suppressor that functions by negatively regulating the AKT/PKB signaling pathway. PTENP1 is found on chromosome 9 and regulates PTEN by both sense and antisense RNAs (Gene ID: 101243555). This long-noncoding RNA (lncRNA) acts as a decoy for PTEN targeting microRNAs and also exerts a tumor suppressive activity. [provided by RefSeq, Jun 2020] 
COL19A1 	COL19A1 (Collagen Type XIX Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL19A1 include  Megaesophagus COL8A1	This gene encodes the alpha chain of type XIX collagen, a member of the FACIT collagen family (fibril-associated collagens with interrupted helices). Although the function of this collagen is not known, other members of this collagen family are found in association with fibril-forming collagens such as type I and II, and serve to maintain the integrity of the extracellular matrix. The transcript produced from this gene has an unusually large 3\' UTR which has not been completely sequenced. This gene encodes the alpha chain of type XIX collagen, a member of the FACIT collagen family (fibril-associated collagens with interrupted helices). Although the function of this collagen is not known, other members of this collagen family are found in association with fibril-forming collagens such as type I and II, and serve to maintain the integrity of the extracellular matrix. The transcript produced from this gene has an unusually large 3\' UTR which has not been completely sequenced. Increased vaccinia virus (VACV) infection, no effect, Decreased viability (cell death), 	GO:0001501 GO:0007155
SH3PXD2A 	SH3PXD2A (SH3 And PX Domains 2A) is a Protein Coding gene. Diseases associated with SH3PXD2A include  SH3PXD2B	Predicted to enable superoxide-generating NADPH oxidase activator activity. Involved in osteoclast fusion and superoxide metabolic process. Located in podosome. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable superoxide-generating NADPH oxidase activator activity. Involved in osteoclast fusion and superoxide metabolic process. Located in podosome. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability, Two nuclei (binuclear), Decreased IL-8 secretion, Inconclusive, Metaphase cells, 	GO:0001701 GO:0006801 GO:0006801 GO:0006801 GO:0042554 GO:0072593 GO:0072675 GO:0072675 GO:0072675
PRKCI 	PRKCI (Protein Kinase C Iota) is a Protein Coding gene. Diseases associated with PRKCI include  PRKCZ	This gene encodes a member of the protein kinase C (PKC) family of serine/threonine protein kinases. The PKC family comprises at least eight members, which are differentially expressed and are involved in a wide variety of cellular processes. This protein kinase is calcium-independent and phospholipid-dependent. It is not activated by phorbolesters or diacylglycerol. This kinase can be recruited to vesicle tubular clusters (VTCs) by direct interaction with the small GTPase RAB2, where this kinase phosphorylates glyceraldehyde-3-phosphate dehydrogenase (GAPD/GAPDH) and plays a role in microtubule dynamics in the early secretory pathway. This kinase is found to be necessary for BCL-ABL-mediated resistance to drug-induced apoptosis and therefore protects leukemia cells against drug-induced apoptosis. There is a single exon pseudogene mapped on chromosome X. This gene encodes a member of the protein kinase C (PKC) family of serine/threonine protein kinases. The PKC family comprises at least eight members, which are differentially expressed and are involved in a wide variety of cellular processes. This protein kinase is calcium-independent and phospholipid-dependent. It is not activated by phorbolesters or diacylglycerol. This kinase can be recruited to vesicle tubular clusters (VTCs) by direct interaction with the small GTPase RAB2, where this kinase phosphorylates glyceraldehyde-3-phosphate dehydrogenase (GAPD/GAPDH) and plays a role in microtubule dynamics in the early secretory pathway. This kinase is found to be necessary for BCL-ABL-mediated resistance to drug-induced apoptosis and therefore protects leukemia cells against drug-induced apoptosis. There is a single exon pseudogene mapped on chromosome X. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased circadian period length, Decreased cell migration, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability after gemcitabine stimulation, 	GO:0006468 GO:0006612 GO:0007010
MAGI1 	MAGI1 (Membrane Associated Guanylate Kinase, WW And PDZ Domain Containing 1) is a Protein Coding gene. Diseases associated with MAGI1 include  MAGI2	The protein encoded by this gene is a member of the membrane-associated guanylate kinase homologue (MAGUK) family. MAGUK proteins participate in the assembly of multiprotein complexes on the inner surface of the plasma membrane at regions of cell-cell contact. The product of this gene may play a role as scaffolding protein at cell-cell junctions. Alternatively spliced transcript variants encoding different isoforms have been identified. The protein encoded by this gene is a member of the membrane-associated guanylate kinase homologue (MAGUK) family. MAGUK proteins participate in the assembly of multiprotein complexes on the inner surface of the plasma membrane at regions of cell-cell contact. The product of this gene may play a role as scaffolding protein at cell-cell junctions. Alternatively spliced transcript variants encoding different isoforms have been identified. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Increased IL-8 secretion, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0007155 GO:0007165 GO:0007166 GO:0022409 GO:0065003
HECTD1 	HECTD1 (HECT Domain E3 Ubiquitin Protein Ligase 1) is a Protein Coding gene. Diseases associated with HECTD1 include  binding TRIP12	Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in anatomical structure development; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and protein K63-linked ubiquitination. Predicted to act upstream of or within several processes, including animal organ development; negative regulation of protein localization to plasma membrane; and protein autoubiquitination. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in anatomical structure development; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; and protein K63-linked ubiquitination. Predicted to act upstream of or within several processes, including animal organ development; negative regulation of protein localization to plasma membrane; and protein autoubiquitination. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased HPV18 LCR reporter activity, Increased homologous recombination repair frequency, 	 
WWP2 	WWP2 (WW Domain Containing E3 Ubiquitin Protein Ligase 2) is a Protein Coding gene. Diseases associated with WWP2 include  WWP1	This gene encodes a member of the Nedd4 family of E3 ligases, which play an important role in protein ubiquitination. The encoded protein contains four WW domains and may play a role in multiple processes including chondrogenesis and the regulation of oncogenic signaling pathways via interactions with Smad proteins and the tumor suppressor PTEN. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 10. [provided by RefSeq, Jul 2012]	This gene encodes a member of the Nedd4 family of E3 ligases, which play an important role in protein ubiquitination. The encoded protein contains four WW domains and may play a role in multiple processes including chondrogenesis and the regulation of oncogenic signaling pathways via interactions with Smad proteins and the tumor suppressor PTEN. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 10. [provided by RefSeq, Jul 2012]	Decreased viability, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, G0/1 arrest, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased homologous recombination repair frequency, Elongated cells, 	GO:0000122 GO:0000209 GO:0006366 GO:0006366 GO:0006366 GO:0006511 GO:0006511 GO:0006511 GO:0006858 GO:0006858 GO:0006858
TRPC3 	TRPC3 (Transient Receptor Potential Cation Channel Subfamily C Member 3) is a Protein Coding gene. Diseases associated with TRPC3 include  binding TRPC7	The protein encoded by this gene is a membrane protein that can form a non-selective channel permeable to calcium and other cations. The encoded protein appears to be induced to form channels by a receptor tyrosine kinase-activated phosphatidylinositol second messenger system and also by depletion of intracellular calcium stores. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	The protein encoded by this gene is a membrane protein that can form a non-selective channel permeable to calcium and other cations. The encoded protein appears to be induced to form channels by a receptor tyrosine kinase-activated phosphatidylinositol second messenger system and also by depletion of intracellular calcium stores. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Decreased shRNA abundance (Z-score &lt; -2), Decreased DCP1a protein expression and assembly in processing bodies after arsenite stimulation, 	GO:0006811 GO:0006816 GO:0006816 GO:0006816 GO:0007338 GO:0007602 GO:0010524
FGF21 	FGF21 (Fibroblast Growth Factor 21) is a Protein Coding gene. Diseases associated with FGF21 include  FGF19	Theis gene encodes a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. This protein is a secreted endocrine factor that functions as a major metabolic regulator. The encoded protein stimulates the uptake of glucose in adipose tissue. [provided by RefSeq, Mar 2016]	Theis gene encodes a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. This protein is a secreted endocrine factor that functions as a major metabolic regulator. The encoded protein stimulates the uptake of glucose in adipose tissue. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001934 GO:0007165 GO:0007267 GO:0008284 GO:0008543
CD19 	CD19 (CD19 Molecule) is a Protein Coding gene. Diseases associated with CD19 include 	This gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.  This gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms.  Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased shRNA abundance, Increased S DNA content, 	GO:0001923 GO:0002250 GO:0002250 GO:0002250 GO:0002322 GO:0002322 GO:0002322 GO:0002376 GO:0016064 GO:0016064 GO:0016064
PRKAA1 	PRKAA1 (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1) is a Protein Coding gene. Diseases associated with PRKAA1 include  PRKAA2	The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5\'-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5\'-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased HIV-LTR-beta-galactosidase protein expression, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased cell migration, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Increased viability, 	GO:0001666 GO:0006006 GO:0006325 GO:0006325 GO:0006325 GO:0006468 GO:0006468 GO:0006468
BCL10 	BCL10 (BCL10 Immune Signaling Adaptor) is a Protein Coding gene. Diseases associated with BCL10 include 	This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased HPV18 LCR reporter activity, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), 	GO:0001783 GO:0001819 GO:0001819 GO:0001819 GO:0001843 GO:0001843 GO:0001843 GO:0002224 GO:0002250
KIT 	KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with KIT include  CSF1R	This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020]	This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased cell viability after pRB stimulation, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Increased viability after TNF/CHX stimulation, Decreased viability in HMC1.1 cells, 	GO:0001541 GO:0002244 GO:0002244 GO:0002244
DAB2 	DAB2 (DAB Adaptor Protein 2) is a Protein Coding gene. Diseases associated with DAB2 include  Teratocarcinoma DAB1	This gene encodes a mitogen-responsive phosphoprotein. It is expressed in normal ovarian epithelial cells, but is down-regulated or absent from ovarian carcinoma cell lines, suggesting its role as a tumor suppressor. This protein binds to the SH3 domains of GRB2, an adaptor protein that couples tyrosine kinase receptors to SOS (a guanine nucleotide exchange factor for Ras), via its C-terminal proline-rich sequences, and may thus modulate growth factor/Ras pathways by competing with SOS for binding to GRB2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	This gene encodes a mitogen-responsive phosphoprotein. It is expressed in normal ovarian epithelial cells, but is down-regulated or absent from ovarian carcinoma cell lines, suggesting its role as a tumor suppressor. This protein binds to the SH3 domains of GRB2, an adaptor protein that couples tyrosine kinase receptors to SOS (a guanine nucleotide exchange factor for Ras), via its C-terminal proline-rich sequences, and may thus modulate growth factor/Ras pathways by competing with SOS for binding to GRB2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, 	GO:0000122 GO:0001934 GO:0006897 GO:0006898 GO:0006898 GO:0006898
LIMS2 	LIMS2 (LIM Zinc Finger Domain Containing 2) is a Protein Coding gene. Diseases associated with LIMS2 include  LIMS1	This gene encodes a member of a small family of focal adhesion proteins which interacts with ILK (integrin-linked kinase), a protein which effects protein-protein interactions with the extraceullar matrix. The encoded protein has five LIM domains, each domain forming two zinc fingers, which permit interactions which regulate cell shape and migration. A pseudogene of this gene is located on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]	This gene encodes a member of a small family of focal adhesion proteins which interacts with ILK (integrin-linked kinase), a protein which effects protein-protein interactions with the extraceullar matrix. The encoded protein has five LIM domains, each domain forming two zinc fingers, which permit interactions which regulate cell shape and migration. A pseudogene of this gene is located on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]	no effect, Decreased viability, Increased IL-8 secretion, 	GO:0007229 GO:0043066 GO:0043066 GO:0043066 GO:0045216 GO:0045216 GO:0045216 GO:0061351 GO:0098609 GO:0098609 GO:0098609
RIN2 	RIN2 (Ras And Rab Interactor 2) is a Protein Coding gene. Diseases associated with RIN2 include  Alopecia RIN3	The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]	The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]	no effect, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0006897 GO:0007165 GO:0007165 GO:0007165 GO:0007264 GO:0007264 GO:0007264 GO:0010595
MAPKAPK2 	MAPKAPK2 (MAPK Activated Protein Kinase 2) is a Protein Coding gene. Diseases associated with MAPKAPK2 include  MAPKAPK3	This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo. Two transcript variants encoding two different isoforms have been found for this gene. This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo. Two transcript variants encoding two different isoforms have been found for this gene. no effect, Decreased ionizing radiation sensitivity, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Increased ionizing radiation sensitivity, Decreased cell viability after pRB stimulation, Decreased viability with TRAIL, Synthetic lethal with gemcitabine, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0000165 GO:0002224 GO:0006468 GO:0006468 GO:0006468
RUFY3 	RUFY3 (RUN And FYVE Domain Containing 3) is a Protein Coding gene.    An important paralog of this gene is  RUFY2	This gene encodes a RPIP8, UNC-14, and NESCA domain-containing protein that is required for maintenance of neuronal polarity. In addition, it has been implicated in mediation of gastric cancer cell migration and invasion via interaction with P21-activated kinase-1, which promotes its expression. The encoded protein localizes to F-actin-enriched invadopodia to induce formation of protrusions, thereby facilitating cell migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]	This gene encodes a RPIP8, UNC-14, and NESCA domain-containing protein that is required for maintenance of neuronal polarity. In addition, it has been implicated in mediation of gastric cancer cell migration and invasion via interaction with P21-activated kinase-1, which promotes its expression. The encoded protein localizes to F-actin-enriched invadopodia to induce formation of protrusions, thereby facilitating cell migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Strongly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Aire reporter expression, 	GO:0007015 GO:0007399 GO:0007399 GO:0007399 GO:0030154 GO:0030154 GO:0030154 GO:0030335 GO:0030335 GO:0030335
IL6ST 	IL6ST (Interleukin 6 Cytokine Family Signal Transducer) is a Protein Coding gene. Diseases associated with IL6ST include  IL31RA	The protein encoded by this gene is a signal transducer shared by many cytokines, including interleukin 6 (IL6), ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), and oncostatin M (OSM). This protein functions as a part of the cytokine receptor complex. The activation of this protein is dependent upon the binding of cytokines to their receptors. vIL6, a protein related to IL6 and encoded by the Kaposi sarcoma-associated herpesvirus, can bypass the interleukin 6 receptor (IL6R) and directly activate this protein. Knockout studies in mice suggest that this gene plays a critical role in regulating myocyte apoptosis. Alternatively spliced transcript variants have been described. A related pseudogene has been identified on chromosome 17. [provided by RefSeq, May 2014]	The protein encoded by this gene is a signal transducer shared by many cytokines, including interleukin 6 (IL6), ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), and oncostatin M (OSM). This protein functions as a part of the cytokine receptor complex. The activation of this protein is dependent upon the binding of cytokines to their receptors. vIL6, a protein related to IL6 and encoded by the Kaposi sarcoma-associated herpesvirus, can bypass the interleukin 6 receptor (IL6R) and directly activate this protein. Knockout studies in mice suggest that this gene plays a critical role in regulating myocyte apoptosis. Alternatively spliced transcript variants have been described. A related pseudogene has been identified on chromosome 17. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0002675 GO:0002821 GO:0005977 GO:0007165 GO:0007165 GO:0007165 GO:0008284 GO:0008284 GO:0008284
PROX1 	PROX1 (Prospero Homeobox 1) is a Protein Coding gene. Diseases associated with PROX1 include  PROX2	The protein encoded by this gene is a member of the homeobox transcription factor family. Members of this family contain a homeobox domain that consists of a 60-amino acid helix-turn-helix structure that binds DNA and RNA. The protein encoded by this gene is conserved across vertebrates and may play an essential role during development. Altered levels of this protein have been reported in cancers of different organs, such as colon, brain, blood, breast, pancreas, liver and esophagus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	The protein encoded by this gene is a member of the homeobox transcription factor family. Members of this family contain a homeobox domain that consists of a 60-amino acid helix-turn-helix structure that binds DNA and RNA. The protein encoded by this gene is conserved across vertebrates and may play an essential role during development. Altered levels of this protein have been reported in cancers of different organs, such as colon, brain, blood, breast, pancreas, liver and esophagus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Dynamic nuclei (hole, folded or small irregular), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000122 GO:0001822 GO:0001889 GO:0001938
AGT 	AGT (Angiotensinogen) is a Protein Coding gene. Diseases associated with AGT include  SERPINF1	The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Increased transferrin (TF) endocytosis, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased shRNA abundance, 	GO:0001558 GO:0001819 GO:0001822 GO:0001974 GO:0002016
TRADD 	TRADD (TNFRSF1A Associated Via Death Domain) is a Protein Coding gene. Diseases associated with TRADD include 	The protein encoded by this gene is a death domain containing adaptor molecule that interacts with TNFRSF1A/TNFR1 and mediates programmed cell death signaling and NF-kappaB activation. This protein binds adaptor protein TRAF2, reduces the recruitment of inhibitor-of-apoptosis proteins (IAPs) by TRAF2, and thus suppresses TRAF2 mediated apoptosis. This protein can also interact with receptor TNFRSF6/FAS and adaptor protein FADD/MORT1, and is involved in the Fas-induced cell death pathway. The protein encoded by this gene is a death domain containing adaptor molecule that interacts with TNFRSF1A/TNFR1 and mediates programmed cell death signaling and NF-kappaB activation. This protein binds adaptor protein TRAF2, reduces the recruitment of inhibitor-of-apoptosis proteins (IAPs) by TRAF2, and thus suppresses TRAF2 mediated apoptosis. This protein can also interact with receptor TNFRSF6/FAS and adaptor protein FADD/MORT1, and is involved in the Fas-induced cell death pathway. no effect, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased IL-8 secretion, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0006915 GO:0007165 GO:0007169 GO:0008625 GO:0008625 GO:0008625 GO:0030335
DKK1 	DKK1 (Dickkopf WNT Signaling Pathway Inhibitor 1) is a Protein Coding gene. Diseases associated with DKK1 include 	This gene encodes a member of the dickkopf family of proteins. Members of this family are secreted proteins characterized by two cysteine-rich domains that mediate protein-protein interactions. The encoded protein binds to the LRP6 co-receptor and inhibits beta-catenin-dependent Wnt signaling. This gene plays a role in embryonic development and may be important in bone formation in adults. Elevated expression of this gene has been observed in numerous human cancers and this protein may promote proliferation, invasion and growth in cancer cell lines. [provided by RefSeq, Sep 2017]	This gene encodes a member of the dickkopf family of proteins. Members of this family are secreted proteins characterized by two cysteine-rich domains that mediate protein-protein interactions. The encoded protein binds to the LRP6 co-receptor and inhibits beta-catenin-dependent Wnt signaling. This gene plays a role in embryonic development and may be important in bone formation in adults. Elevated expression of this gene has been observed in numerous human cancers and this protein may promote proliferation, invasion and growth in cancer cell lines. [provided by RefSeq, Sep 2017]	Increased vaccinia virus (VACV) infection, no effect, Increased G1 DNA content, 	 
SMURF2 	SMURF2 (SMAD Specific E3 Ubiquitin Protein Ligase 2) is a Protein Coding gene. Diseases associated with SMURF2 include  SMURF1	Enables SMAD binding activity; identical protein binding activity; and ubiquitin-protein transferase activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of trophoblast cell migration; and ubiquitin-dependent SMAD protein catabolic process. Located in nuclear speck. Part of ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables SMAD binding activity; identical protein binding activity; and ubiquitin-protein transferase activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of trophoblast cell migration; and ubiquitin-dependent SMAD protein catabolic process. Located in nuclear speck. Part of ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Synthetic lethal with Ras, Decreased viability, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Resistant to vaccinia virus (VACV-A4L) infection, No cells, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased caspase activity, 	GO:0000122 GO:0000209 GO:0000209 GO:0000209 GO:0006511 GO:0006511 GO:0006511 GO:0016567 GO:0017015
PDE4B 	PDE4B (Phosphodiesterase 4B) is a Protein Coding gene. Diseases associated with PDE4B include  Schizophrenia PDE4D	This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]	This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability, Two nuclei (binuclear), Decreased shRNA abundance, Increased cell number in S and G2M, 	GO:0001780 GO:0006198 GO:0006198 GO:0006198 GO:0007165 GO:0007165 GO:0007165 GO:0030593 GO:0030593 GO:0030593 GO:0032729 GO:0032729 GO:0032729
LIF 	LIF (LIF Interleukin 6 Family Cytokine) is a Protein Coding gene. Diseases associated with LIF include  Leukemia	The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	Decreased viability, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Decreased POU5F1-GFP protein expression, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, Increased HDAC inhibitor resistance, 	 
BNIP3 	BNIP3 (BCL2 Interacting Protein 3) is a Protein Coding gene. Diseases associated with BNIP3 include  Leiomyomatosis BNIP3L	This gene is encodes a mitochondrial protein that contains a BH3 domain and acts as a pro-apoptotic factor. The encoded protein interacts with anti-apoptotic proteins, including the E1B 19 kDa protein and Bcl2. This gene is silenced in tumors by DNA methylation. [provided by RefSeq, Dec 2014]	This gene is encodes a mitochondrial protein that contains a BH3 domain and acts as a pro-apoptotic factor. The encoded protein interacts with anti-apoptotic proteins, including the E1B 19 kDa protein and Bcl2. This gene is silenced in tumors by DNA methylation. [provided by RefSeq, Dec 2014]	no effect, Decreased vaccinia virus (VACV) infection, Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0000422
CAMKK2 	CAMKK2 (Calcium/Calmodulin Dependent Protein Kinase Kinase 2) is a Protein Coding gene. Diseases associated with CAMKK2 include  CAMKK1	The product of this gene belongs to the Serine/Threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. The major isoform of this gene plays a role in the calcium/calmodulin-dependent (CaM) kinase cascade by phosphorylating the downstream kinases CaMK1 and CaMK4. Protein products of this gene also phosphorylate AMP-activated protein kinase (AMPK). This gene has its strongest expression in the brain and influences signalling cascades involved with learning and memory, neuronal differentiation and migration, neurite outgrowth, and synapse formation. Alternative splicing results in multiple transcript variants encoding distinct isoforms. The identified isoforms differ in their ability to undergo autophosphorylation and to phosphorylate downstream kinases. [provided by RefSeq, Jul 2012]	The product of this gene belongs to the Serine/Threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. The major isoform of this gene plays a role in the calcium/calmodulin-dependent (CaM) kinase cascade by phosphorylating the downstream kinases CaMK1 and CaMK4. Protein products of this gene also phosphorylate AMP-activated protein kinase (AMPK). This gene has its strongest expression in the brain and influences signalling cascades involved with learning and memory, neuronal differentiation and migration, neurite outgrowth, and synapse formation. Alternative splicing results in multiple transcript variants encoding distinct isoforms. The identified isoforms differ in their ability to undergo autophosphorylation and to phosphorylate downstream kinases. [provided by RefSeq, Jul 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased vesicular stomatitis virus (VSV) infection, Decreased HIV-LTR-beta-galactosidase protein expression, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased cell migration, Decreased viability, Increased cell death in HCC-1954 cells, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Increased cell death in DLD-1 cells, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Transferrin accumulation in enlarged cytoplasmic structures, 	GO:0000165 GO:0001934 GO:0006468
ITGB8 	ITGB8 (Integrin Subunit Beta 8) is a Protein Coding gene.  Among its related pathways are  ITGB6	This gene is a member of the integrin beta chain family and encodes a single-pass type I membrane protein with a VWFA domain and four cysteine-rich repeats. This protein noncovalently binds to an alpha subunit to form a heterodimeric integrin complex. In general, integrin complexes mediate cell-cell and cell-extracellular matrix interactions and this complex plays a role in human airway epithelial proliferation. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. This gene is a member of the integrin beta chain family and encodes a single-pass type I membrane protein with a VWFA domain and four cysteine-rich repeats. This protein noncovalently binds to an alpha subunit to form a heterodimeric integrin complex. In general, integrin complexes mediate cell-cell and cell-extracellular matrix interactions and this complex plays a role in human airway epithelial proliferation. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Increased IL-8 secretion, Dynamic nuclei (hole, folded or small irregular), 	GO:0001570 GO:0001573 GO:0006955 GO:0006955 GO:0006955 GO:0007155 GO:0007155 GO:0007155 GO:0007160
WWP1 	WWP1 (WW Domain Containing E3 Ubiquitin Protein Ligase 1) is a Protein Coding gene. Diseases associated with WWP1 include  WWP2	WW domain-containing proteins are found in all eukaryotes and play an important role in the regulation of a wide variety of cellular functions such as protein degradation, transcription, and RNA splicing. This gene encodes a protein which contains 4 tandem WW domains and a HECT (homologous to the E6-associated protein carboxyl terminus) domain. The encoded protein belongs to a family of NEDD4-like proteins, which are E3 ubiquitin-ligase molecules and regulate key trafficking decisions, including targeting of proteins to proteosomes or lysosomes. Alternative splicing of this gene generates at least 6 transcript variants; however, the full length nature of these transcripts has not been defined. WW domain-containing proteins are found in all eukaryotes and play an important role in the regulation of a wide variety of cellular functions such as protein degradation, transcription, and RNA splicing. This gene encodes a protein which contains 4 tandem WW domains and a HECT (homologous to the E6-associated protein carboxyl terminus) domain. The encoded protein belongs to a family of NEDD4-like proteins, which are E3 ubiquitin-ligase molecules and regulate key trafficking decisions, including targeting of proteins to proteosomes or lysosomes. Alternative splicing of this gene generates at least 6 transcript variants; however, the full length nature of these transcripts has not been defined. no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased viability in colon lineage, Increased number of mitotic cells, Increased S DNA content, 	GO:0000209 GO:0006511 GO:0006511 GO:0006511 GO:0007165 GO:0007165 GO:0007165 GO:0007417 GO:0016567
BCAR1 	BCAR1 (BCAR1 Scaffold Protein, Cas Family Member) is a Protein Coding gene. Diseases associated with BCAR1 include  NEDD9	The protein encoded by this gene is a member of the Crk-associated substrate (CAS) family of scaffold proteins, characterized by the presence of multiple protein-protein interaction domains and many serine and tyrosine phosphorylation sites. The encoded protein contains a Src-homology 3 (SH3) domain, a proline-rich domain, a substrate domain which contains 15 repeat of the YxxP consensus phosphorylation motif for Src family kinases, a serine-rich domain, and a bipartite Src-binding domain, which can bind both SH2 and SH3 domains. This adaptor protein functions in multiple cellular pathways, including in cell motility, apoptosis and cell cycle control. Dysregulation of this gene can have a wide range of effects, affecting different pathways, including cardiac development, vascular smooth muscle cells, liver and kidney function, endothelial migration, and cancer. [provided by RefSeq, Sep 2017]	The protein encoded by this gene is a member of the Crk-associated substrate (CAS) family of scaffold proteins, characterized by the presence of multiple protein-protein interaction domains and many serine and tyrosine phosphorylation sites. The encoded protein contains a Src-homology 3 (SH3) domain, a proline-rich domain, a substrate domain which contains 15 repeat of the YxxP consensus phosphorylation motif for Src family kinases, a serine-rich domain, and a bipartite Src-binding domain, which can bind both SH2 and SH3 domains. This adaptor protein functions in multiple cellular pathways, including in cell motility, apoptosis and cell cycle control. Dysregulation of this gene can have a wide range of effects, affecting different pathways, including cardiac development, vascular smooth muscle cells, liver and kidney function, endothelial migration, and cancer. [provided by RefSeq, Sep 2017]	no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Reduced mammosphere formation, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Dynamic nuclei (hole, folded or small irregular), decreased viability (cell death), Decreased cell migration, 	GO:0001558 GO:0007015 GO:0007155 GO:0007165 GO:0007165 GO:0007165 GO:0007169 GO:0007169 GO:0007169
MOB1A 	MOB1A (MOB Kinase Activator 1A) is a Protein Coding gene. Diseases associated with MOB1A include  MOB1B	The protein encoded by this gene is a component of the Hippo signaling pathway, which controls organ size and tumor growth by enhancing apoptosis. Loss of the encoded protein results in cell proliferation and cancer formation. The encoded protein is also involved in the control of microtubule stability during cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]	The protein encoded by this gene is a component of the Hippo signaling pathway, which controls organ size and tumor growth by enhancing apoptosis. Loss of the encoded protein results in cell proliferation and cancer formation. The encoded protein is also involved in the control of microtubule stability during cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Decreased NF-kappaB reporter expression, 	GO:0001934 GO:0007165 GO:0035329 GO:0035329 GO:0035329
WNK1 	WNK1 (WNK Lysine Deficient Protein Kinase 1) is a Protein Coding gene. Diseases associated with WNK1 include  WNK2	This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]	This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Decreased viability ratio, Decreased viability with paclitaxel, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased HIV-LTR-beta-galactosidase protein expression, Increased cell death HMECs cells, Decreased shRNA abundance, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased Tat-dependent transcription, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased cell proliferation, Decreased Salmonella proliferation, Decreased p24 protein expression, Transferrin accumulation in small spots in the cell periphery, Decreased viability in colon lineage; decreased viability in pancreas lineage, 	GO:0002028 GO:0003084 GO:0003084 GO:0003084 GO:0006468 GO:0006468 GO:0006468 GO:0006811 GO:0007165 GO:0007165 GO:0007165
DCN 	DCN (Decorin) is a Protein Coding gene. Diseases associated with DCN include  BGN	This gene encodes a member of the small leucine-rich proteoglycan family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. This protein plays a role in collagen fibril assembly. Binding of this protein to multiple cell surface receptors mediates its role in tumor suppression, including a stimulatory effect on autophagy and inflammation and an inhibitory effect on angiogenesis and tumorigenesis. This gene and the related gene biglycan are thought to be the result of a gene duplication. Mutations in this gene are associated with congenital stromal corneal dystrophy in human patients. [provided by RefSeq, Nov 2015]	This gene encodes a member of the small leucine-rich proteoglycan family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. This protein plays a role in collagen fibril assembly. Binding of this protein to multiple cell surface receptors mediates its role in tumor suppression, including a stimulatory effect on autophagy and inflammation and an inhibitory effect on angiogenesis and tumorigenesis. This gene and the related gene biglycan are thought to be the result of a gene duplication. Mutations in this gene are associated with congenital stromal corneal dystrophy in human patients. [provided by RefSeq, Nov 2015]	Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0009887 GO:0010508 GO:0010596 GO:0014068 GO:0016239
PTPRJ 	PTPRJ (Protein Tyrosine Phosphatase Receptor Type J) is a Protein Coding gene. Diseases associated with PTPRJ include  PTPRB	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. Increased gamma-H2AX phosphorylation, Increased viability, no effect, Decreased ionizing radiation sensitivity, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Inconclusive, Increased G2M DNA content, Decreased HIV-1 infection, Increased Erk phosphorylation after EGF stimulation, Increased Akt phosphorylation after EGF stimulation, Apoptosis resistance, 	GO:0006470 GO:0008285 GO:0010642
GREM1 	GREM1 (Gremlin 1, DAN Family BMP Antagonist) is a Protein Coding gene. Diseases associated with GREM1 include  GREM2	This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]	This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, 	GO:0000902 GO:0001525 GO:0002042 GO:0002042 GO:0002042 GO:0002092
BAIAP2L1 	BAIAP2L1 (BAR/IMD Domain Containing Adaptor Protein 2 Like 1) is a Protein Coding gene. Diseases associated with BAIAP2L1 include  BAIAP2	This gene encodes a member of the IMD (IRSp53/MIM homology domain) family. Members of this family can be subdivided in two groups, the IRSp53-like and MIM-like, based on the presence or absence of the SH3 (Src homology 3) domain. The protein encoded by this gene contains a conserved IMD, also known as F-actin bundling domain, at the N-terminus, and a canonical SH3 domain near the C-terminus, so it belongs to the IRSp53-like group. This protein is the substrate for insulin receptor tyrosine kinase and binds to the small GTPase Rac. It is involved in signal transduction pathways that link deformation of the plasma membrane and remodeling of the actin cytoskeleton. It also promotes actin assembly and membrane protrusions when overexpressed in mammalian cells, and is essential to the formation of a potent actin assembly complex during EHEC (Enterohemorrhagic Escherichia coli) pedestal formation. [provided by RefSeq, Oct 2009]	This gene encodes a member of the IMD (IRSp53/MIM homology domain) family. Members of this family can be subdivided in two groups, the IRSp53-like and MIM-like, based on the presence or absence of the SH3 (Src homology 3) domain. The protein encoded by this gene contains a conserved IMD, also known as F-actin bundling domain, at the N-terminus, and a canonical SH3 domain near the C-terminus, so it belongs to the IRSp53-like group. This protein is the substrate for insulin receptor tyrosine kinase and binds to the small GTPase Rac. It is involved in signal transduction pathways that link deformation of the plasma membrane and remodeling of the actin cytoskeleton. It also promotes actin assembly and membrane protrusions when overexpressed in mammalian cells, and is essential to the formation of a potent actin assembly complex during EHEC (Enterohemorrhagic Escherichia coli) pedestal formation. [provided by RefSeq, Oct 2009]	shRNA abundance &lt;= 50%, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased POU5F1-GFP protein expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, 	GO:0007009 GO:0009617 GO:0009617 GO:0009617 GO:0030833 GO:0030838 GO:0030838 GO:0030838
GATA3 	GATA3 (GATA Binding Protein 3) is a Protein Coding gene. Diseases associated with GATA3 include  GATA2	This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009]	This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009]	no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Increased replication of vaccinia virus (VACV), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0000122
CUL3 	CUL3 (Cullin 3) is a Protein Coding gene. Diseases associated with CUL3 include  CUL4A	This gene encodes a member of the cullin protein family. The encoded protein plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex. Complexes including the encoded protein may also play a role in late endosome maturation. Mutations in this gene are a cause of type 2E pseudohypoaldosteronism. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	This gene encodes a member of the cullin protein family. The encoded protein plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex. Complexes including the encoded protein may also play a role in late endosome maturation. Mutations in this gene are a cause of type 2E pseudohypoaldosteronism. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Increased G1 DNA content, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased shRNA abundance (Z-score &lt; -2), Effect on mitosis, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased HPV16-GFP infection, 	GO:0000082 GO:0000122 GO:0000209 GO:0000209 GO:0000209
DCAF13 	DCAF13 (DDB1 And CUL4 Associated Factor 13) is a Protein Coding gene.  Among its related pathways are 	Enables estrogen receptor binding activity. Predicted to be involved in maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Located in several cellular components, including centrosome; cytosol; and nuclear lumen. Part of Cul4-RING E3 ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables estrogen receptor binding activity. Predicted to be involved in maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Located in several cellular components, including centrosome; cytosol; and nuclear lumen. Part of Cul4-RING E3 ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, Nucleolar pre-40S maturation defects, Decreased shRNA abundance, Increased G1 length, Decreased circadian period length, Decreased Salmonella proliferation, Increased G1 length, increased G2 length, Decreased vesicular stomatitis virus (VSV) infection, Nuclear 40S maturation defects, Decreased lymphocytic choriomeningitis virus (LCMV) infection, Decreased human parainfluenza virus type 3 (HPIV3) infection, 	GO:0000462
FASN 	FASN (Fatty Acid Synthase) is a Protein Coding gene. Diseases associated with FASN include  OXSM	The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased cell death HMECs cells, Increased cell death in HCC-1954 cells, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001649 GO:0002068 GO:0006629 GO:0006629 GO:0006629 GO:0006631 GO:0006631 GO:0006631
FLNA 	FLNA (Filamin A) is a Protein Coding gene. Diseases associated with FLNA include  FLNC	The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]	The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]	no effect, Decreased viability, Reduced mammosphere formation, Decreased cell migration, 	 
KLF6 	KLF6 (KLF Transcription Factor 6) is a Protein Coding gene. Diseases associated with KLF6 include  Adipogenesis KLF7	This gene encodes a member of the Kruppel-like family of transcription factors. The zinc finger protein is a transcriptional activator, and functions as a tumor suppressor. Multiple transcript variants encoding different isoforms have been found for this gene, some of which are implicated in carcinogenesis. [provided by RefSeq, May 2009]	This gene encodes a member of the Kruppel-like family of transcription factors. The zinc finger protein is a transcriptional activator, and functions as a tumor suppressor. Multiple transcript variants encoding different isoforms have been found for this gene, some of which are implicated in carcinogenesis. [provided by RefSeq, May 2009]	no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased viability (cell death), Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Downregulation of RLR pathway after Sendai virus (SeV) infection, 	GO:0006357 GO:0030183 GO:0045893 GO:0045944
WDFY2 	WDFY2 (WD Repeat And FYVE Domain Containing 2) is a Protein Coding gene. Diseases associated with WDFY2 include  WDFY1	This gene encodes a protein that contains two WD domains and an FYVE zinc finger region. The function of this gene is unknown. An alternatively spliced transcript variant of this gene may exist. This gene encodes a protein that contains two WD domains and an FYVE zinc finger region. The function of this gene is unknown. An alternatively spliced transcript variant of this gene may exist. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased IL-8 secretion, Increased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0001934 GO:0045600
RUNX1 	RUNX1 (RUNX Family Transcription Factor 1) is a Protein Coding gene. Diseases associated with RUNX1 include  RUNX2	Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. no effect, Decreased viability, Reduced mammosphere formation, Decreased NF-kappaB reporter expression, Decreased replication of vaccinia virus (VACV), Decreased influenza A/WSN/33 replication, Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers, 	GO:0000122 GO:0001503 GO:0001503 GO:0001503 GO:0002062 GO:0002062 GO:0002062 GO:0002573 GO:0002573 GO:0002573
CD151 	CD151 (CD151 Molecule (Raph Blood Group)) is a Protein Coding gene. Diseases associated with CD151 include  TSPAN11	The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It is involved in cellular processes including cell adhesion and may regulate integrin trafficking and/or function. This protein enhances cell motility, invasion and metastasis of cancer cells. Multiple alternatively spliced transcript variants that encode the same protein have been described for this gene. The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It is involved in cellular processes including cell adhesion and may regulate integrin trafficking and/or function. This protein enhances cell motility, invasion and metastasis of cancer cells. Multiple alternatively spliced transcript variants that encode the same protein have been described for this gene. Increased gamma-H2AX phosphorylation, no effect, Decreased viability in esophageal squamous lineage, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Weakly decreased NFAT1-GFP nuclear translocation, 	GO:0007155 GO:0016477 GO:0030335 GO:0030335 GO:0030335 GO:0042098 GO:0044319 GO:0044319 GO:0044319
HEG1 	HEG1 (Heart Development Protein With EGF Like Domains 1) is a Protein Coding gene. Diseases associated with HEG1 include 	Predicted to enable calcium ion binding activity. Involved in several processes, including negative regulation of Rho protein signal transduction; negative regulation of Rho-dependent protein serine/threonine kinase activity; and negative regulation of membrane permeability. Located in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable calcium ion binding activity. Involved in several processes, including negative regulation of Rho protein signal transduction; negative regulation of Rho-dependent protein serine/threonine kinase activity; and negative regulation of membrane permeability. Located in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, FOXO1 nuclear localization, Decreased viability with paclitaxel, Decreased influenza A/WSN/33 replication, 	 
DDR1 	DDR1 (Discoidin Domain Receptor Tyrosine Kinase 1) is a Protein Coding gene. Diseases associated with DDR1 include  DDR2	Receptor tyrosine kinases play a key role in the communication of cells with their microenvironment. These kinases are involved in the regulation of cell growth, differentiation and metabolism. The protein encoded by this gene belongs to a subfamily of tyrosine kinase receptors with homology to Dictyostelium discoideum protein discoidin I in their extracellular domain, and that are activated by various types of collagen. Expression of this protein is restricted to epithelial cells, particularly in the kidney, lung, gastrointestinal tract, and brain. In addition, it has been shown to be significantly overexpressed in several human tumors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]	Receptor tyrosine kinases play a key role in the communication of cells with their microenvironment. These kinases are involved in the regulation of cell growth, differentiation and metabolism. The protein encoded by this gene belongs to a subfamily of tyrosine kinase receptors with homology to Dictyostelium discoideum protein discoidin I in their extracellular domain, and that are activated by various types of collagen. Expression of this protein is restricted to epithelial cells, particularly in the kidney, lung, gastrointestinal tract, and brain. In addition, it has been shown to be significantly overexpressed in several human tumors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]	no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased cell death HMECs cells, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased cell proliferation, Increased nuclear migration speed, Increased cell death in DLD-1 cells, Decreased cell migration, Synthetic lethal with cisplatin, Decreased viability in esophageal squamous lineage; decreased viability in pancreas lineage, 	GO:0001558 GO:0001952 GO:0001952 GO:0001952 GO:0006468 GO:0006468 GO:0006468 GO:0007155 GO:0007155 GO:0007155 GO:0007169
DLX5 	DLX5 (Distal-Less Homeobox 5) is a Protein Coding gene. Diseases associated with DLX5 include  DLX3	This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein may play a role in bone development and fracture healing. Mutation in this gene, which is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 7, may be associated with split-hand/split-foot malformation. This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein may play a role in bone development and fracture healing. Mutation in this gene, which is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 7, may be associated with split-hand/split-foot malformation. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased transcriptional activity, Increased NF-kappaB reporter expression, Increased hepcidin::fluc mRNA expression, Decreased shRNA abundance, Decreased nuclei size in G2M, Effect on mitosis, decreased viability (cell death), Decreased viability (cell death), 	GO:0001501
CXCR2 	CXCR2 (C-X-C Motif Chemokine Receptor 2) is a Protein Coding gene. Diseases associated with CXCR2 include  CXCR1	The protein encoded by this gene is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth. This receptor mediates neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal microvascular endothelial cells are found to be mediated by this receptor. Knockout studies in mice suggested that this receptor controls the positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. This gene, IL8RA, a gene encoding another high affinity IL8 receptor, as well as IL8RBP, a pseudogene of IL8RB, form a gene cluster in a region mapped to chromosome 2q33-q36. Alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]	The protein encoded by this gene is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth. This receptor mediates neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal microvascular endothelial cells are found to be mediated by this receptor. Knockout studies in mice suggested that this receptor controls the positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. This gene, IL8RA, a gene encoding another high affinity IL8 receptor, as well as IL8RBP, a pseudogene of IL8RB, form a gene cluster in a region mapped to chromosome 2q33-q36. Alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]	no effect, shRNA abundance &lt;= 50%, Decreased viability, Increased transferrin (TF) endocytosis, Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Weakly decreased NFAT1-GFP nuclear translocation, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0002407 GO:0002438 GO:0002690 GO:0002690 GO:0002690 GO:0006935 GO:0006935 GO:0006935 GO:0006954
IGFBP5 	IGFBP5 (Insulin Like Growth Factor Binding Protein 5) is a Protein Coding gene. Diseases associated with IGFBP5 include  IGFBP3	Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]	Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Multipolar spindles, 	GO:0001558 GO:0001649 GO:0001649 GO:0001649 GO:0007165 GO:0007165 GO:0007165
COL12A1 	COL12A1 (Collagen Type XII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL12A1 include  COL14A1	This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability ratio, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Reduced shRNA abundance in FBW7 KO line, Decreased centriole number, 	GO:0007155 GO:0030199 GO:0030199 GO:0030199 GO:0035987
MS 	MS (Multiple Sclerosis) is a Genetic Locus. Diseases associated with MS include  
A2M 	A2M (Alpha-2-Macroglobulin) is a Protein Coding gene. Diseases associated with A2M include  Mastitis PZP	The protein encoded by this gene is a protease inhibitor and cytokine transporter. It uses a bait-and-trap mechanism to inhibit a broad spectrum of proteases, including trypsin, thrombin and collagenase. It can also inhibit inflammatory cytokines, and it thus disrupts inflammatory cascades. Mutations in this gene are a cause of alpha-2-macroglobulin deficiency. This gene is implicated in Alzheimer\'s disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits. A related pseudogene, which is also located on the p arm of chromosome 12, has been identified. [provided by RefSeq, Nov 2016]	The protein encoded by this gene is a protease inhibitor and cytokine transporter. It uses a bait-and-trap mechanism to inhibit a broad spectrum of proteases, including trypsin, thrombin and collagenase. It can also inhibit inflammatory cytokines, and it thus disrupts inflammatory cascades. Mutations in this gene are a cause of alpha-2-macroglobulin deficiency. This gene is implicated in Alzheimer\'s disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits. A related pseudogene, which is also located on the p arm of chromosome 12, has been identified. [provided by RefSeq, Nov 2016]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Lamellipodia cells, Decreased viability with carboplatin, Decreased ionizing radiation sensitivity, Decreased viability in esophageal squamous lineage, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Reduced mammosphere formation, 	GO:0001553 GO:0001869 GO:0001869 GO:0001869
SPARC 	SPARC (Secreted Protein Acidic And Cysteine Rich) is a Protein Coding gene. Diseases associated with SPARC include  SPARCL1	This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]	This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0001937 GO:0010595 GO:0016525 GO:0022604 GO:0048856
NLGN1 	NLGN1 (Neuroligin 1) is a Protein Coding gene. Diseases associated with NLGN1 include  NLGN4X	This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0002087 GO:0006605 GO:0006605 GO:0006605 GO:0007155 GO:0007155 GO:0007155 GO:0007157 GO:0007157 GO:0007157 GO:0007158 GO:0007158 GO:0007158
ITGA1 	ITGA1 (Integrin Subunit Alpha 1) is a Protein Coding gene. Diseases associated with ITGA1 include  ITGA2	This gene encodes the alpha 1 subunit of integrin receptors. This protein heterodimerizes with the beta 1 subunit to form a cell-surface receptor for collagen and laminin. The heterodimeric receptor is involved in cell-cell adhesion and may play a role in inflammation and fibrosis. The alpha 1 subunit contains an inserted (I) von Willebrand factor type I domain which is thought to be involved in collagen binding. This gene encodes the alpha 1 subunit of integrin receptors. This protein heterodimerizes with the beta 1 subunit to form a cell-surface receptor for collagen and laminin. The heterodimeric receptor is involved in cell-cell adhesion and may play a role in inflammation and fibrosis. The alpha 1 subunit contains an inserted (I) von Willebrand factor type I domain which is thought to be involved in collagen binding. Increased vaccinia virus (VACV) infection, no effect, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Dynamic nuclei (hole, folded or small irregular), Elongated cells, Decreased vesicular stomatitis virus (VSV) infection, 	GO:0007155 GO:0007160 GO:0007160 GO:0007160 GO:0007229 GO:0008285
STAMBP 	STAMBP (STAM Binding Protein) is a Protein Coding gene. Diseases associated with STAMBP include  Deubiquitination STAMBPL1	Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. Increased gamma-H2AX phosphorylation, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Synthetic lethal with c-Myc after tamoxifen stimulation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0000281 GO:0006508 GO:0007259 GO:0007259 GO:0007259 GO:0008284 GO:0014067
FHL2 	FHL2 (Four And A Half LIM Domains 2) is a Protein Coding gene. Diseases associated with FHL2 include  Rhabdomyosarcoma Metabolism FHL5	This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]	This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell number in G1, average or increased nuclei size in G1, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0000122 GO:0001649 GO:0006351 GO:0006351 GO:0006351 GO:0006357 GO:0006357 GO:0006357 GO:0009725 GO:0009725 GO:0009725
TET2 	TET2 (Tet Methylcytosine Dioxygenase 2) is a Protein Coding gene. Diseases associated with TET2 include  TET3	The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]	The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Downregulation of Wnt pathway after Wnt3A stimulation, Increased cell number in G2M, increased number of polyploid cells, 	GO:0002521 GO:0006211 GO:0006325 GO:0006493 GO:0006493 GO:0006493
SERPINC1 	SERPINC1 (Serpin Family C Member 1) is a Protein Coding gene. Diseases associated with SERPINC1 include  Thrombosis SERPINB4	The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]	The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, Reduced mammosphere formation, Decreased viability after Maraba virus infection, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased replication of vaccinia virus (VACV), Decreased circadian period length, 	 
RTKN 	RTKN (Rhotekin) is a Protein Coding gene.  Among its related pathways are  RTKN2	This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased NF-kappaB reporter expression, Increased caspase activity, 	GO:0000281 GO:0000915 GO:0006915 GO:0007165 GO:0007165 GO:0007165 GO:0007266
SOD1 	SOD1 (Superoxide Dismutase 1) is a Protein Coding gene. Diseases associated with SOD1 include  CCS	The protein encoded by this gene binds copper and zinc ions and is one of two isozymes responsible for destroying free superoxide radicals in the body. The encoded isozyme is a soluble cytoplasmic protein, acting as a homodimer to convert naturally-occuring but harmful superoxide radicals to molecular oxygen and hydrogen peroxide. The other isozyme is a mitochondrial protein. In addition, this protein contains an antimicrobial peptide that displays antibacterial, antifungal, and anti-MRSA activity against E. coli, E. faecalis, S. aureus, S. aureus MRSA LPV+, S. agalactiae, and yeast C. krusei. Mutations in this gene have been implicated as causes of familial amyotrophic lateral sclerosis. Rare transcript variants have been reported for this gene.  The protein encoded by this gene binds copper and zinc ions and is one of two isozymes responsible for destroying free superoxide radicals in the body. The encoded isozyme is a soluble cytoplasmic protein, acting as a homodimer to convert naturally-occuring but harmful superoxide radicals to molecular oxygen and hydrogen peroxide. The other isozyme is a mitochondrial protein. In addition, this protein contains an antimicrobial peptide that displays antibacterial, antifungal, and anti-MRSA activity against E. coli, E. faecalis, S. aureus, S. aureus MRSA LPV+, S. agalactiae, and yeast C. krusei. Mutations in this gene have been implicated as causes of familial amyotrophic lateral sclerosis. Rare transcript variants have been reported for this gene.  Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Increased number of mitotic cells, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance, Increased G2M DNA content, Cell division defect, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0000302 GO:0000303 GO:0000303 GO:0000303 GO:0001541 GO:0001819 GO:0001819 GO:0001819 GO:0001890
GAB1 	GAB1 (GRB2 Associated Binding Protein 1) is a Protein Coding gene. Diseases associated with GAB1 include  GAB2	The protein encoded by this gene is a member of the IRS1-like multisubstrate docking protein family. It is an important mediator of branching tubulogenesis and plays a central role in cellular growth response, transformation and apoptosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	The protein encoded by this gene is a member of the IRS1-like multisubstrate docking protein family. It is an important mediator of branching tubulogenesis and plays a central role in cellular growth response, transformation and apoptosis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased transferrin (TF) endocytosis, Decreased viability in ovarian lineage, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Inconclusive, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0001525 GO:0007165 GO:0007173 GO:0008286 GO:0031532
APP 	APP (Amyloid Beta Precursor Protein) is a Protein Coding gene. Diseases associated with APP include  APLP2	This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]	This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability after Maraba virus infection, Increased hepcidin::fluc mRNA expression, Decreased viability with TRAIL, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased caspase 3/7 activity, 	GO:0000086 GO:0000278 GO:0000278 GO:0000278 GO:0001774 GO:0001774 GO:0001774 GO:0001934
CDC42 	CDC42 (Cell Division Cycle 42) is a Protein Coding gene. Diseases associated with CDC42 include  RAC1	The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]	The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]	Decreased viability, no effect, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased POU5F1-GFP protein expression, Dynamic nuclei (hole, folded or small irregular), Decreased Salmonella enterica Typhimurium invasion, Decreased Salmonella enterica Typhimurium ruffling, Decreased Hepatitis C virus replication, Decreased OCT4 protein expression, Decreased NANOG protein expression, Increased S DNA content, Decreased Salmonella-containing vacuole maturation, Decreased Salmonella enterica Typhimurium membrane closure, Increased cell elongation, decreased cell spreading, 	GO:0003161 GO:0003253 GO:0003253 GO:0003253 GO:0006468 GO:0006468 GO:0006468 GO:0006897 GO:0006897 GO:0006897 GO:0006911
NR4A2 	NR4A2 (Nuclear Receptor Subfamily 4 Group A Member 2) is a Protein Coding gene. Diseases associated with NR4A2 include  NR4A3	This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcription factor. Mutations in this gene have been associated with disorders related to dopaminergic dysfunction, including Parkinson disease, schizophernia, and manic depression. Misregulation of this gene may be associated with rheumatoid arthritis. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcription factor. Mutations in this gene have been associated with disorders related to dopaminergic dysfunction, including Parkinson disease, schizophernia, and manic depression. Misregulation of this gene may be associated with rheumatoid arthritis. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. no effect, Decreased viability, Decreased viability ratio, shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Increased G1 DNA content, G0/1 arrest, Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell size, Increased viability with MLN4924 (a NAE inhibitor), Decreased replication of vaccinia virus (VACV), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased centriole number, Increased cell number in G2M, increased nuclei size in G2M, 	GO:0000122 GO:0001666 GO:0001764 GO:0001764 GO:0001764 GO:0001975 GO:0006351 GO:0006351 GO:0006351
CENPJ 	CENPJ (Centromere Protein J) is a Protein Coding gene. Diseases associated with CENPJ include  TCP10L	This gene encodes a protein that belongs to the centromere protein family. During cell division, this protein plays a structural role in the maintenance of centrosome integrity and normal spindle morphology, and it is involved in microtubule disassembly at the centrosome. This protein can function as a transcriptional coactivator in the Stat5 signaling pathway, and also as a coactivator of NF-kappaB-mediated transcription, likely via its interaction with the coactivator p300/CREB-binding protein. Mutations in this gene are associated with primary autosomal recessive microcephaly, a disorder characterized by severely reduced brain size and cognitive disability. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2012]	This gene encodes a protein that belongs to the centromere protein family. During cell division, this protein plays a structural role in the maintenance of centrosome integrity and normal spindle morphology, and it is involved in microtubule disassembly at the centrosome. This protein can function as a transcriptional coactivator in the Stat5 signaling pathway, and also as a coactivator of NF-kappaB-mediated transcription, likely via its interaction with the coactivator p300/CREB-binding protein. Mutations in this gene are associated with primary autosomal recessive microcephaly, a disorder characterized by severely reduced brain size and cognitive disability. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2012]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased G1 DNA content, G0/1 arrest, Increased ionizing radiation sensitivity, 	GO:0007020 GO:0007099 GO:0007224 GO:0030954 GO:0030954 GO:0030954
CXCL10 	CXCL10 (C-X-C Motif Chemokine Ligand 10) is a Protein Coding gene. Diseases associated with CXCL10 include  Cryptosporidiosis CXCL9	This antimicrobial gene encodes a chemokine of the CXC subfamily and ligand for the receptor CXCR3. Binding of this protein to CXCR3 results in pleiotropic effects, including stimulation of monocytes, natural killer and T-cell migration, and modulation of adhesion molecule expression. This gene may also be a key regulator of the \'cytokine storm\' immune response to SARS-CoV-2 infection. [provided by RefSeq, Sep 2020]	This antimicrobial gene encodes a chemokine of the CXC subfamily and ligand for the receptor CXCR3. Binding of this protein to CXCR3 results in pleiotropic effects, including stimulation of monocytes, natural killer and T-cell migration, and modulation of adhesion molecule expression. This gene may also be a key regulator of the \'cytokine storm\' immune response to SARS-CoV-2 infection. [provided by RefSeq, Sep 2020]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Synthetic lethal with c-Myc after tamoxifen stimulation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Fragmented cis-Golgi, 	GO:0002690 GO:0006935 GO:0006935 GO:0006935 GO:0006952 GO:0006954 GO:0006954 GO:0006954
NFE2L2 	NFE2L2 (NFE2 Like BZIP Transcription Factor 2) is a Protein Coding gene. Diseases associated with NFE2L2 include  NFE2L1	This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]	This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased Aire reporter expression, Increased viability with MLN4924 (a NAE inhibitor), 	GO:0006355 GO:0006357 GO:0006357 GO:0006357
COL6A3 	COL6A3 (Collagen Type VI Alpha 3 Chain) is a Protein Coding gene. Diseases associated with COL6A3 include  COL6A6	This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]	This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased viability in colon lineage, Increased IL-8 secretion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability with paclitaxel, 	GO:0007155 GO:0007517 GO:0007517 GO:0007517
SGK3 	SGK3 (Serum/Glucocorticoid Regulated Kinase Family Member 3) is a Protein Coding gene. Diseases associated with SGK3 include  SGK1	This gene is a member of the Ser/Thr protein kinase family and encodes a phosphoprotein with a PX (phox homology) domain. The protein phosphorylates several target proteins and has a role in neutral amino acid transport and activation of potassium and chloride channels. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene is a member of the Ser/Thr protein kinase family and encodes a phosphoprotein with a PX (phox homology) domain. The protein phosphorylates several target proteins and has a role in neutral amino acid transport and activation of potassium and chloride channels. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. no effect, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Increased IL-8 secretion, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Increased cell death HMECs cells, Decreased cell migration, Decreased viability, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased homologous recombination repair frequency, Increased cell migration, Decreased shRNA abundance (Z-score &lt; -2), Decreased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, 	GO:0001558 GO:0006468 GO:0016310 GO:0018105 GO:0018105 GO:0018105 GO:0030334
CXCL16 	CXCL16 (C-X-C Motif Chemokine Ligand 16) is a Protein Coding gene. Diseases associated with CXCL16 include 	Enables chemokine activity. Involved in several processes, including positive regulation of cell growth; response to interferon-gamma; and response to tumor necrosis factor. Located in extracellular space. Biomarker of COVID-19 and systemic scleroderma. [provided by Alliance of Genome Resources, Apr 2022]	Enables chemokine activity. Involved in several processes, including positive regulation of cell growth; response to interferon-gamma; and response to tumor necrosis factor. Located in extracellular space. Biomarker of COVID-19 and systemic scleroderma. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Synthetic lethal with Ras, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, G0/1 arrest, Decreased shRNA abundance (Z-score &lt; -2), Inconclusive, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0006898 GO:0006935 GO:0007165 GO:0010818 GO:0010818 GO:0010818 GO:0030307
HJV 	HJV (Hemojuvelin BMP Co-Receptor) is a Protein Coding gene. Diseases associated with HJV include  RGMA	The product of this gene is involved in iron metabolism. It may be a component of the signaling pathway which activates hepcidin or it may act as a modulator of hepcidin expression. It could also represent the cellular receptor for hepcidin. Two uORFs in the 5\' UTR negatively regulate the expression and activity of the encoded protein. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. Defects in this gene are the cause of hemochromatosis type 2A, also called juvenile hemochromatosis (JH). JH is an early-onset autosomal recessive disorder due to severe iron overload resulting in hypogonadotrophic hypogonadism, hepatic fibrosis or cirrhosis and cardiomyopathy, occurring typically before age of 30. [provided by RefSeq, Oct 2015]	The product of this gene is involved in iron metabolism. It may be a component of the signaling pathway which activates hepcidin or it may act as a modulator of hepcidin expression. It could also represent the cellular receptor for hepcidin. Two uORFs in the 5\' UTR negatively regulate the expression and activity of the encoded protein. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. Defects in this gene are the cause of hemochromatosis type 2A, also called juvenile hemochromatosis (JH). JH is an early-onset autosomal recessive disorder due to severe iron overload resulting in hypogonadotrophic hypogonadism, hepatic fibrosis or cirrhosis and cardiomyopathy, occurring typically before age of 30. [provided by RefSeq, Oct 2015]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0000122 GO:0006366 GO:0006366 GO:0006366 GO:0006879 GO:0006879 GO:0006879 GO:0016540 GO:0016540 GO:0016540 GO:0030509
KCNH2 	KCNH2 (Potassium Voltage-Gated Channel Subfamily H Member 2) is a Protein Coding gene. Diseases associated with KCNH2 include  KCNH7	This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]	This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased shRNA abundance, 	GO:0003064
RAPGEF3 	RAPGEF3 (Rap Guanine Nucleotide Exchange Factor 3) is a Protein Coding gene. Diseases associated with RAPGEF3 include  RAPGEF4	Enables guanyl-nucleotide exchange factor activity and protein domain specific binding activity. Involved in several processes, including positive regulation of protein modification process; regulation of actin cytoskeleton organization; and regulation of syncytium formation by plasma membrane fusion. Located in filopodium; lamellipodium; and microvillus. Colocalizes with cortical actin cytoskeleton and plasma membrane. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2022]	Enables guanyl-nucleotide exchange factor activity and protein domain specific binding activity. Involved in several processes, including positive regulation of protein modification process; regulation of actin cytoskeleton organization; and regulation of syncytium formation by plasma membrane fusion. Located in filopodium; lamellipodium; and microvillus. Colocalizes with cortical actin cytoskeleton and plasma membrane. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased viability ratio, Decreased viability, shRNA abundance &lt;= 25%, Inconclusive, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Synthetic lethal with vaccinia virus (VACV) infection, Increased telomerase activity, 	GO:0001525 GO:0002250 GO:0002250 GO:0002250 GO:0007165 GO:0007165 GO:0007165 GO:0007264 GO:0007265 GO:0007265 GO:0007265
PTPN13 	PTPN13 (Protein Tyrosine Phosphatase Non-Receptor Type 13) is a Protein Coding gene. Diseases associated with PTPN13 include  PTPRB	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP is a large intracellular protein. It has a catalytic PTP domain at its C-terminus and two major structural domains: a region with five PDZ domains and a FERM domain that binds to plasma membrane and cytoskeletal elements. This PTP was found to interact with, and dephosphorylate, Fas receptor and IkappaBalpha through the PDZ domains. This suggests it has a role in Fas mediated programmed cell death. This PTP was also shown to interact with GTPase-activating protein, and thus may function as a regulator of Rho signaling pathways. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Oct 2008]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP is a large intracellular protein. It has a catalytic PTP domain at its C-terminus and two major structural domains: a region with five PDZ domains and a FERM domain that binds to plasma membrane and cytoskeletal elements. This PTP was found to interact with, and dephosphorylate, Fas receptor and IkappaBalpha through the PDZ domains. This suggests it has a role in Fas mediated programmed cell death. This PTP was also shown to interact with GTPase-activating protein, and thus may function as a regulator of Rho signaling pathways. Four alternatively spliced transcript variants, which encode distinct proteins, have been reported. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased G1 DNA content, G0/1 arrest, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Decreased viability, Increased transcriptional activity, Increased NF-kappaB reporter expression, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased shRNA abundance, Moderately decreased NFAT1-GFP nuclear translocation, Increased cell migration, Increased cell number in G1, small nuclei in G1, 	GO:0001933 GO:0006470 GO:0014066
ACTG1 	ACTG1 (Actin Gamma 1) is a Protein Coding gene. Diseases associated with ACTG1 include  ACTB	Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]	Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased cell migration, Increased focal adhesion (FA) abundance, 	GO:0001525 GO:0001738 GO:0001895 GO:0009612 GO:0010628 GO:0010628 GO:0010628
NFKB1 	NFKB1 (Nuclear Factor Kappa B Subunit 1) is a Protein Coding gene. Diseases associated with NFKB1 include  NFKB2	This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]	This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]	no effect, Decreased viability, Increased transferrin (TF) endocytosis, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased POU5F1-GFP protein expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased NF-kappaB reporter expression, Decreased HIV-LTR-beta-galactosidase protein expression, Increased shRNA abundance, Decreased OCT4 protein expression, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Large nuclei, decreased viability (cell death), Increased TP53 mRNA expression, 	GO:0000122 GO:0000165 GO:0001818 GO:0001818 GO:0001818 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
PLCG1 	PLCG1 (Phospholipase C Gamma 1) is a Protein Coding gene. Diseases associated with PLCG1 include  PLCG2	The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of receptor-mediated tyrosine kinase activators. For example, when activated by SRC, the encoded protein causes the Ras guanine nucleotide exchange factor RasGRP1 to translocate to the Golgi, where it activates Ras. Also, this protein has been shown to be a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Two transcript variants encoding different isoforms have been found for this gene. The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of receptor-mediated tyrosine kinase activators. For example, when activated by SRC, the encoded protein causes the Ras guanine nucleotide exchange factor RasGRP1 to translocate to the Golgi, where it activates Ras. Also, this protein has been shown to be a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Two transcript variants encoding different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, No cells, Decreased cell migration, Decreased shRNA abundance, Synthetic lethal with vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis (mild increase), increased transferrin (TF) endosome elongation, 	 
FOXO1 	FOXO1 (Forkhead Box O1) is a Protein Coding gene. Diseases associated with FOXO1 include  Glioma FOXO3	This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. Increased vaccinia virus (VACV) infection, no effect, Decreased viability with carboplatin, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability, Synthetic lethal with vaccinia virus (VACV) infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), 	GO:0000122 GO:0001568 GO:0001568 GO:0001568 GO:0001659 GO:0001659 GO:0001659 GO:0001678
TRAF2 	TRAF2 (TNF Receptor Associated Factor 2) is a Protein Coding gene. Diseases associated with TRAF2 include  TRAF3	The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Downregulation of NF-kappaB pathway after LMP1 stimulation, Inconclusive, Increased cell death HMECs cells, Decreased replication of vaccinia virus (VACV), 	GO:0002637 GO:0002726 GO:0002726 GO:0002726 GO:0006915 GO:0007165 GO:0007165 GO:0007165 GO:0007250
MAP3K14 	MAP3K14 (Mitogen-Activated Protein Kinase Kinase Kinase 14) is a Protein Coding gene. Diseases associated with MAP3K14 include  MINK1	This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased HIV-LTR-beta-galactosidase protein expression, Decreased viability, Reduced beta-catenin activity and colon cancer cell proliferation, Decreased Hepatitis C virus replication, Decreased substrate adherent cell growth, Decreased cell proliferation, Decreased shRNA abundance (Z-score &lt; -2), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased caspase 3/7 activity, Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression, Increased viability, Increased viability with 4OH tamoxifen, 	 
ENG 	
BCL2L11 
CREB1 	
ANKRD1 	
GPC3 	
SMAD3 	
COL16A1 
STXBP1 	
EIF4E 	
AMH 	
ANO1 	
GRIN2B 	
PKN2 	
LOX 	
NOTCH2 	
MMP15 	
MAFK 	
PTEN 	
KLF4 	
AXIN1 	
FLT1 	
TGFBR3 	
MMP3 	
ITSN1 	
FGF23 	FGF23 (Fibroblast Growth Factor 23) is a Protein Coding gene. Diseases associated with FGF23 include  FGF3	This gene encodes a member of the fibroblast growth factor family of proteins, which possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. The product of this gene regulates phosphate homeostasis and transport in the kidney. The full-length, functional protein may be deactivated via cleavage into N-terminal and C-terminal chains. Mutation of this cleavage site causes autosomal dominant hypophosphatemic rickets (ADHR). Mutations in this gene are also associated with hyperphosphatemic familial tumoral calcinosis (HFTC). [provided by RefSeq, Feb 2013]	This gene encodes a member of the fibroblast growth factor family of proteins, which possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. The product of this gene regulates phosphate homeostasis and transport in the kidney. The full-length, functional protein may be deactivated via cleavage into N-terminal and C-terminal chains. Mutation of this cleavage site causes autosomal dominant hypophosphatemic rickets (ADHR). Mutations in this gene are also associated with hyperphosphatemic familial tumoral calcinosis (HFTC). [provided by RefSeq, Feb 2013]	no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased melanin production, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Increased ionizing radiation sensitivity, Decreased G3BP1 protein expression and assembly in stress granules after arsenite stimulation, 	GO:0000165 GO:0001934 GO:0001934 GO:0001934 GO:0006796 GO:0008284 GO:0008284 GO:0008284 GO:0008543
HGS 	HGS (Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate) is a Protein Coding gene. Diseases associated with HGS include  STAM	The protein encoded by this gene regulates endosomal sorting and plays a critical role in the recycling and degradation of membrane receptors. The encoded protein sorts monoubiquitinated membrane proteins into the multivesicular body, targeting these proteins for lysosome-dependent degradation. [provided by RefSeq, Dec 2010]	The protein encoded by this gene regulates endosomal sorting and plays a critical role in the recycling and degradation of membrane receptors. The encoded protein sorts monoubiquitinated membrane proteins into the multivesicular body, targeting these proteins for lysosome-dependent degradation. [provided by RefSeq, Dec 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Decreased viability (cell death), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Increased cell death in HCC-1954 cells, Decreased Tat-dependent transcription, Decreased epidermal growth factor (EGF) endocytosis, Decreased viability after TNF/CHX stimulation, 	GO:0006622 GO:0007165 GO:0008285 GO:0010324 GO:0010628
ATR 	ATR (ATR Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with ATR include  binding PRKDC	The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in ovarian lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased viability (proliferation), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Decreased homologous recombination repair frequency, Increased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Increased viability with SS1P at EC90, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Increased cell death in HCT116 cells, Decreased viability with cisplatin, Synthetic lethal with cisplatin, Decreased viability after gemcitabine stimulation, Synthetic lethal with gemcitabine, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased apoptosis, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, increased cell elongation, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0000077 GO:0000723 GO:0006139 GO:0006260 GO:0006281 GO:0006281 GO:0006281
ADAMTS3 	ADAMTS3 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 3) is a Protein Coding gene. Diseases associated with ADAMTS3 include  ADAMTS2	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease, a member of the procollagen aminopropeptidase subfamily of proteins, may play a role in the processing of type II fibrillar collagen in articular cartilage. [provided by RefSeq, Feb 2016]	This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease, a member of the procollagen aminopropeptidase subfamily of proteins, may play a role in the processing of type II fibrillar collagen in articular cartilage. [provided by RefSeq, Feb 2016]	no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001701 GO:0006508 GO:0006508 GO:0006508 GO:0010573 GO:0010573 GO:0010573 GO:0016485 GO:0030198
EPHB1 	EPHB1 (EPH Receptor B1) is a Protein Coding gene. Diseases associated with EPHB1 include  EPHB2	Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members. Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, shRNA abundance &lt;= 50%, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased cell size, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Increased S DNA content, Increased mitotic index, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Synthetic lethal with gemcitabine, Condensed cis-Golgi, condensed medial Golgi, 	GO:0001525
HSPG2 	HSPG2 (Heparan Sulfate Proteoglycan 2) is a Protein Coding gene. Diseases associated with HSPG2 include  USH2A	This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]	This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]	Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Decreased Salmonella enterica Typhimurium invasion, Negative genetic interaction between BLM-/- and BLM+/+, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, 	GO:0001525 GO:0006629 GO:0006629 GO:0006629 GO:0006898 GO:0006954 GO:0006954 GO:0006954 GO:0007420
NRGN 	NRGN (Neurogranin) is a Protein Coding gene. Diseases associated with NRGN include  Hypothyroidism	Neurogranin (NRGN) is the human homolog of the neuron-specific rat RC3/neurogranin gene. This gene encodes a postsynaptic protein kinase substrate that binds calmodulin in the absence of calcium. The NRGN gene contains four exons and three introns. The exons 1 and 2 encode the protein and exons 3 and 4 contain untranslated sequences. It is suggested that the NRGN is a direct target for thyroid hormone in human brain, and that control of expression of this gene could underlay many of the consequences of hypothyroidism on mental states during development as well as in adult subjects. Neurogranin (NRGN) is the human homolog of the neuron-specific rat RC3/neurogranin gene. This gene encodes a postsynaptic protein kinase substrate that binds calmodulin in the absence of calcium. The NRGN gene contains four exons and three introns. The exons 1 and 2 encode the protein and exons 3 and 4 contain untranslated sequences. It is suggested that the NRGN is a direct target for thyroid hormone in human brain, and that control of expression of this gene could underlay many of the consequences of hypothyroidism on mental states during development as well as in adult subjects. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased cell number in G1, average or increased nuclei size in G1, 	GO:0007165 GO:0007399
LRRC32 	LRRC32 (Leucine Rich Repeat Containing 32) is a Protein Coding gene. Diseases associated with LRRC32 include  NRROS	This gene encodes a type I membrane protein which contains 20 leucine-rich repeats. Alterations in the chromosomal region 11q13-11q14 are involved in several pathologies. This gene encodes a type I membrane protein which contains 20 leucine-rich repeats. Alterations in the chromosomal region 11q13-11q14 are involved in several pathologies. no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Decreased viability, Inconclusive, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased ionizing radiation sensitivity, 	GO:0001818 GO:0007179 GO:0007179 GO:0007179
DLL4 	DLL4 (Delta Like Canonical Notch Ligand 4) is a Protein Coding gene. Diseases associated with DLL4 include  DLL1	This gene is a homolog of the Drosophila delta gene. The delta gene family encodes Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. This gene is a homolog of the Drosophila delta gene. The delta gene family encodes Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. no effect, Lamellipodia cells, Reduced mammosphere formation, Effect on mitosis, Decreased Aire reporter expression, 	GO:0000122 GO:0001525 GO:0001525 GO:0001525 GO:0001569 GO:0001569 GO:0001569 GO:0001974 GO:0001974 GO:0001974 GO:0003180 GO:0003180 GO:0003180
NOX4 	NOX4 (NADPH Oxidase 4) is a Protein Coding gene. Diseases associated with NOX4 include  CYBB	This gene encodes a member of the NOX-family of enzymes that functions as the catalytic subunit the NADPH oxidase complex. The encoded protein is localized to non-phagocytic cells where it acts as an oxygen sensor and catalyzes the reduction of molecular oxygen to various reactive oxygen species (ROS). The ROS generated by this protein have been implicated in numerous biological functions including signal transduction, cell differentiation and tumor cell growth. A pseudogene has been identified on the other arm of chromosome 11. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2009]	This gene encodes a member of the NOX-family of enzymes that functions as the catalytic subunit the NADPH oxidase complex. The encoded protein is localized to non-phagocytic cells where it acts as an oxygen sensor and catalyzes the reduction of molecular oxygen to various reactive oxygen species (ROS). The ROS generated by this protein have been implicated in numerous biological functions including signal transduction, cell differentiation and tumor cell growth. A pseudogene has been identified on the other arm of chromosome 11. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2009]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Dynamic nuclei (hole, folded or small irregular), Increased HPV18 LCR reporter activity, Decreased homologous recombination repair frequency, Decreased cell number and increased metaphase cell number, 	GO:0000902 GO:0003015 GO:0006801 GO:0006952 GO:0006954
CAV1 	CAV1 (Caveolin 1) is a Protein Coding gene. Diseases associated with CAV1 include  CAV3	The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]	The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]	no effect, Decreased viability with carboplatin, Reduced mammosphere formation, Decreased viability, Increased transferrin (TF) endocytosis, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, decreased cell spreading, 	 
MAPK10 	MAPK10 (Mitogen-Activated Protein Kinase 10) is a Protein Coding gene. Diseases associated with MAPK10 include  Pheochromocytoma MAPK8	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased viability ratio, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Dynamic nuclei (hole, folded or small irregular), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell viability after pRB stimulation, Increased viability with TRAIL, Increased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Synthetic lethal with gemcitabine, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0007165 GO:0007165 GO:0007165 GO:0007254
STC1 	STC1 (Stanniocalcin 1) is a Protein Coding gene. Diseases associated with STC1 include  Fibrosarcoma STC2	This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. The gene contains a 5\' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers. This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. The gene contains a 5\' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers. Increased vaccinia virus (VACV) infection, no effect, Strongly decreased CFP-tsO45G cell surface transport, Decreased human cytomegalovirus (HCMV) strain AD169 replication, 	GO:0001503 GO:0001886 GO:0001886 GO:0001886 GO:0003421 GO:0006874
G3BP1 	G3BP1 (G3BP Stress Granule Assembly Factor 1) is a Protein Coding gene. Diseases associated with G3BP1 include  Chikungunya Disease G3BP2	This gene encodes one of the DNA-unwinding enzymes which prefers partially unwound 3\'-tailed substrates and can also unwind partial RNA/DNA and RNA/RNA duplexes in an ATP-dependent fashion. This enzyme is a member of the heterogeneous nuclear RNA-binding proteins and is also an element of the Ras signal transduction pathway. It binds specifically to the Ras-GTPase-activating protein by associating with its SH3 domain. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. This gene encodes one of the DNA-unwinding enzymes which prefers partially unwound 3\'-tailed substrates and can also unwind partial RNA/DNA and RNA/RNA duplexes in an ATP-dependent fashion. This enzyme is a member of the heterogeneous nuclear RNA-binding proteins and is also an element of the Ras signal transduction pathway. It binds specifically to the Ras-GTPase-activating protein by associating with its SH3 domain. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. no effect, Synthetic lethal with Ras, Decreased viability, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), Increased viability with MLN4924 (a NAE inhibitor), 	GO:0002376 GO:0007265 GO:0007265 GO:0007265 GO:0032481 GO:0032508 GO:0034063 GO:0034063 GO:0034063
CREBBP 	CREBBP (CREB Binding Protein) is a Protein Coding gene. Diseases associated with CREBBP include  EP300	This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]	This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased viability, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased homologous recombination repair frequency, High actin ratio cells, 	GO:0000122 GO:0001666 GO:0002223 GO:0006351 GO:0006351 GO:0006351 GO:0006355 GO:0006355 GO:0006355
POU3F2 	POU3F2 (POU Class 3 Homeobox 2) is a Protein Coding gene. Diseases associated with POU3F2 include  Microphthalmia Melanoma POU3F3	This gene encodes a member of the POU-III class of neural transcription factors. The encoded protein is involved in neuronal differentiation and enhances the activation of corticotropin-releasing hormone regulated genes. Overexpression of this protein is associated with an increase in the proliferation of melanoma cells. [provided by RefSeq, Mar 2012]	This gene encodes a member of the POU-III class of neural transcription factors. The encoded protein is involved in neuronal differentiation and enhances the activation of corticotropin-releasing hormone regulated genes. Overexpression of this protein is associated with an increase in the proliferation of melanoma cells. [provided by RefSeq, Mar 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability ratio, Decreased Hepatitis C virus replication, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007399 GO:0007399 GO:0007399 GO:0007420 GO:0007420 GO:0007420 GO:0008284 GO:0008284 GO:0008284
IRAK1 	IRAK1 (Interleukin 1 Receptor Associated Kinase 1) is a Protein Coding gene. Diseases associated with IRAK1 include  Mumps IRAK2	This gene encodes the interleukin-1 receptor-associated kinase 1, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This gene is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. This gene encodes the interleukin-1 receptor-associated kinase 1, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This gene is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Decreased substrate adherent cell growth, Increased epidermal growth factor (EGF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased telomerase activity, Increased viability with TRAIL, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased nuclei size in G2M, Increased mitotic index, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Increased viability, 	GO:0001959 GO:0002224 GO:0002376 GO:0002376 GO:0002376 GO:0002755 GO:0002755 GO:0002755 GO:0006468
ADAMTS7 	ADAMTS7 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 7) is a Protein Coding gene. Diseases associated with ADAMTS7 include  Arthritis ADAMTS12	The protein encoded by this gene is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Members of this family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs and may regulate vascular smooth muscle cell (VSMC) migration. Mutations in this gene may be associated with susceptibility to coronary artery disease. [provided by RefSeq, Feb 2016]	The protein encoded by this gene is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Members of this family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs and may regulate vascular smooth muscle cell (VSMC) migration. Mutations in this gene may be associated with susceptibility to coronary artery disease. [provided by RefSeq, Feb 2016]	Decreased viability, no effect, shRNA abundance &lt;= 50%, Strongly decreased CFP-tsO45G cell surface transport, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, 	GO:0001503 GO:0002062 GO:0002062 GO:0002062 GO:0006029 GO:0006029 GO:0006029 GO:0006508 GO:0006508 GO:0006508 GO:0030198 GO:0030198 GO:0030198
STRN4 	STRN4 (Striatin 4) is a Protein Coding gene. Diseases associated with STRN4 include  STRN3	Enables armadillo repeat domain binding activity and protein phosphatase 2A binding activity. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	Enables armadillo repeat domain binding activity and protein phosphatase 2A binding activity. Part of FAR/SIN/STRIPAK complex. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Decreased viability after Maraba virus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	 
HDAC7 	HDAC7 (Histone Deacetylase 7) is a Protein Coding gene.  Among its related pathways are  HDAC4	Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to mouse HDAC7 gene whose protein promotes repression mediated via the transcriptional corepressor SMRT. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. no effect, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000122 GO:0001570 GO:0001570 GO:0001570 GO:0006325 GO:0006325 GO:0006325 GO:0006476 GO:0006476 GO:0006476
ANKRD37 	ANKRD37 (Ankyrin Repeat Domain 37) is a Protein Coding gene. Diseases associated with ANKRD37 include  ANKRD42	Located in cytosol; mitochondrion; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Located in cytosol; mitochondrion; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, 	 
ANGPT2 	ANGPT2 (Angiopoietin 2) is a Protein Coding gene. Diseases associated with ANGPT2 include  ANGPT1	This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020]	This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased ionizing radiation sensitivity, 	GO:0001525 GO:0001666 GO:0007165 GO:0007165 GO:0007165
PRL 	PRL (Prolactin) is a Protein Coding gene. Diseases associated with PRL include  CSHL1	This gene encodes the anterior pituitary hormone prolactin. This secreted hormone is a growth regulator for many tissues, including cells of the immune system. It may also play a role in cell survival by suppressing apoptosis, and it is essential for lactation. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011]	This gene encodes the anterior pituitary hormone prolactin. This secreted hormone is a growth regulator for many tissues, including cells of the immune system. It may also play a role in cell survival by suppressing apoptosis, and it is essential for lactation. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, 	GO:0001937 GO:0007165 GO:0007166 GO:0007166 GO:0007166 GO:0007565
WDR36 	WDR36 (WD Repeat Domain 36) is a Protein Coding gene. Diseases associated with WDR36 include  PRPF19	This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Mutations in this gene have been associated with adult-onset primary open-angle glaucoma (POAG). This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Mutations in this gene have been associated with adult-onset primary open-angle glaucoma (POAG). Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Negative genetic interaction between MUS81-/- and MUS81+/+, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Nucleolar pre-40S maturation defects, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Decreased homologous recombination repair frequency, Nuclear 40S maturation defects, 	GO:0001895 GO:0006364 GO:0006364 GO:0006364
CDKN2B 	CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) is a Protein Coding gene. Diseases associated with CDKN2B include  CDKN2A	This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported. This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported. no effect, Increased transferrin (TF) endocytosis, Decreased telomerase activity, Decreased cilium length after serum starvation, Increased cell number in G2M, increased nuclei size in G2M, Decreased cilium length, 	GO:0000079 GO:0001889 GO:0007049 GO:0007049 GO:0007049 GO:0007568 GO:0007568 GO:0007568 GO:0008285 GO:0008285 GO:0008285
NOTCH4 	NOTCH4 (Notch Receptor 4) is a Protein Coding gene. Diseases associated with NOTCH4 include  Schizophrenia JAG1	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor may play a role in vascular, renal and hepatic development. Mutations in this gene may be associated with schizophrenia. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor may play a role in vascular, renal and hepatic development. Mutations in this gene may be associated with schizophrenia. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	no effect, Decreased viability, Decreased viability ratio, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability (cell death), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0000122 GO:0001569 GO:0001709 GO:0001709 GO:0001709 GO:0001763 GO:0001837 GO:0001837 GO:0001837
GJA1 	GJA1 (Gap Junction Protein Alpha 1) is a Protein Coding gene. Diseases associated with GJA1 include  GJA3	This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. The encoded protein is the major protein of gap junctions in the heart that are thought to have a crucial role in the synchronized contraction of the heart and in embryonic development. A related intronless pseudogene has been mapped to chromosome 5. Mutations in this gene have been associated with oculodentodigital dysplasia, autosomal recessive craniometaphyseal dysplasia and heart malformations. [provided by RefSeq, May 2014]	This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. The encoded protein is the major protein of gap junctions in the heart that are thought to have a crucial role in the synchronized contraction of the heart and in embryonic development. A related intronless pseudogene has been mapped to chromosome 5. Mutations in this gene have been associated with oculodentodigital dysplasia, autosomal recessive craniometaphyseal dysplasia and heart malformations. [provided by RefSeq, May 2014]	no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased cell migration, Increased shRNA abundance (Z-score &gt; 2), Increased CFP-tsO45G cell surface transport, Decreased focal adhesion (FA) abundance, 	GO:0000132 GO:0003161 GO:0007154 GO:0007165 GO:0007165 GO:0007165 GO:0007267
GLRX 	GLRX (Glutaredoxin) is a Protein Coding gene. Diseases associated with GLRX include 	This gene encodes a member of the glutaredoxin family. The encoded protein is a cytoplasmic enzyme catalyzing the reversible reduction of glutathione-protein mixed disulfides. This enzyme highly contributes to the antioxidant defense system. It is crucial for several signalling pathways by controlling the S-glutathionylation status of signalling mediators. It is involved in beta-amyloid toxicity and Alzheimer\'s disease. Multiple alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2011]	This gene encodes a member of the glutaredoxin family. The encoded protein is a cytoplasmic enzyme catalyzing the reversible reduction of glutathione-protein mixed disulfides. This enzyme highly contributes to the antioxidant defense system. It is crucial for several signalling pathways by controlling the S-glutathionylation status of signalling mediators. It is involved in beta-amyloid toxicity and Alzheimer\'s disease. Multiple alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2011]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Resistant to vaccinia virus (VACV-A4L) infection, Two nuclei (binuclear), Decreased shRNA abundance, 	GO:0015949 GO:0045838 GO:0045838 GO:0045838 GO:0080058 GO:2000651
PLAT 	PLAT (Plasminogen Activator, Tissue Type) is a Protein Coding gene. Diseases associated with PLAT include  PLG	This gene encodes tissue-type plasminogen activator, a secreted serine protease that converts the proenzyme plasminogen to plasmin, a fibrinolytic enzyme. The encoded preproprotein is proteolytically processed by plasmin or trypsin to generate heavy and light chains. These chains associate via disulfide linkages to form the heterodimeric enzyme. This enzyme plays a role in cell migration and tissue remodeling. Increased enzymatic activity causes hyperfibrinolysis, which manifests as excessive bleeding, while decreased activity leads to hypofibrinolysis, which can result in thrombosis or embolism. Alternative splicing of this gene results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	This gene encodes tissue-type plasminogen activator, a secreted serine protease that converts the proenzyme plasminogen to plasmin, a fibrinolytic enzyme. The encoded preproprotein is proteolytically processed by plasmin or trypsin to generate heavy and light chains. These chains associate via disulfide linkages to form the heterodimeric enzyme. This enzyme plays a role in cell migration and tissue remodeling. Increased enzymatic activity causes hyperfibrinolysis, which manifests as excessive bleeding, while decreased activity leads to hypofibrinolysis, which can result in thrombosis or embolism. Alternative splicing of this gene results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]	Decreased viability, no effect, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased transferrin (TF) endocytosis, Decreased viability after Maraba virus infection, Increased G1 DNA content, Increased Sindbis virus (SINV) infection, 	GO:0001666 GO:0006508 GO:0006508 GO:0006508 GO:0006617 GO:0006617 GO:0006617 GO:0007596 GO:0007596 GO:0007596 GO:0010757
HDAC2 	HDAC2 (Histone Deacetylase 2) is a Protein Coding gene. Diseases associated with HDAC2 include  HDAC1	This gene product belongs to the histone deacetylase family. Histone deacetylases act via the formation of large multiprotein complexes, and are responsible for the deacetylation of lysine residues at the N-terminal regions of core histones (H2A, H2B, H3 and H4). This protein forms transcriptional repressor complexes by associating with many different proteins, including YY1, a mammalian zinc-finger transcription factor. Thus, it plays an important role in transcriptional regulation, cell cycle progression and developmental events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]	This gene product belongs to the histone deacetylase family. Histone deacetylases act via the formation of large multiprotein complexes, and are responsible for the deacetylation of lysine residues at the N-terminal regions of core histones (H2A, H2B, H3 and H4). This protein forms transcriptional repressor complexes by associating with many different proteins, including YY1, a mammalian zinc-finger transcription factor. Thus, it plays an important role in transcriptional regulation, cell cycle progression and developmental events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Decreased viability after Maraba virus infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased shRNA abundance with PLX4720, 	GO:0000122 GO:0001975 GO:0003300 GO:0003300 GO:0003300 GO:0006325 GO:0006325 GO:0006325 GO:0006338 GO:0006338 GO:0006338
PARD6A 	PARD6A (Par-6 Family Cell Polarity Regulator Alpha) is a Protein Coding gene.  Among its related pathways are  PARD6G	This gene is a member of the PAR6 family and encodes a protein with a PSD95/Discs-large/ZO1 (PDZ) domain and a semi-Cdc42/Rac interactive binding (CRIB) domain. This cell membrane protein is involved in asymmetrical cell division and cell polarization processes as a member of a multi-protein complex. The protein also has a role in the epithelial-to-mesenchymal transition (EMT) that characterizes the invasive phenotype associated with metastatic carcinomas. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene is a member of the PAR6 family and encodes a protein with a PSD95/Discs-large/ZO1 (PDZ) domain and a semi-Cdc42/Rac interactive binding (CRIB) domain. This cell membrane protein is involved in asymmetrical cell division and cell polarization processes as a member of a multi-protein complex. The protein also has a role in the epithelial-to-mesenchymal transition (EMT) that characterizes the invasive phenotype associated with metastatic carcinomas. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. no effect, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased IL-8 secretion, Increased circadian period length, 	GO:0001933 GO:0007049 GO:0007049 GO:0007049 GO:0007098 GO:0007098 GO:0007098 GO:0007163 GO:0016032
VDAC1 	VDAC1 (Voltage Dependent Anion Channel 1) is a Protein Coding gene. Diseases associated with VDAC1 include  VDAC2	This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Alternate splicing results in multiple transcript variants. Multiple pseudogenes of this gene are found on chromosomes 1, 2 3, 6, 9, 12, X and Y.[provided by RefSeq, Sep 2010]	This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Alternate splicing results in multiple transcript variants. Multiple pseudogenes of this gene are found on chromosomes 1, 2 3, 6, 9, 12, X and Y.[provided by RefSeq, Sep 2010]	no effect, Decreased viability, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, Increased G1 length, Increased S length, 	GO:0001662 GO:0006090 GO:0006090 GO:0006090 GO:0006811 GO:0006811 GO:0006811 GO:0006820 GO:0006820 GO:0006820 GO:0006915
STAM 	STAM (Signal Transducing Adaptor Molecule) is a Protein Coding gene. Diseases associated with STAM include  STAM2	This gene encodes a member of the signal-transducing adaptor molecule family. These proteins mediate downstream signaling of cytokine receptors and also play a role in ER to Golgi trafficking by interacting with the coat protein II complex. The encoded protein also associates with hepatocyte growth factor-regulated substrate to form the endosomal sorting complex required for transport-0 (ESCRT-0), which sorts ubiquitinated membrane proteins to the ESCRT-1 complex for lysosomal degradation. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Feb 2011]	This gene encodes a member of the signal-transducing adaptor molecule family. These proteins mediate downstream signaling of cytokine receptors and also play a role in ER to Golgi trafficking by interacting with the coat protein II complex. The encoded protein also associates with hepatocyte growth factor-regulated substrate to form the endosomal sorting complex required for transport-0 (ESCRT-0), which sorts ubiquitinated membrane proteins to the ESCRT-1 complex for lysosomal degradation. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Feb 2011]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased cell death HMECs cells, Moderately decreased NFAT1-GFP nuclear translocation, Decreased cell migration, 	GO:0007165 GO:0015031 GO:0016236 GO:0016236 GO:0016236 GO:0036258 GO:0043328
HIF1AN 	HIF1AN (Hypoxia Inducible Factor 1 Subunit Alpha Inhibitor) is a Protein Coding gene. Diseases associated with HIF1AN include  HSPBAP1	Enables several functions, including 2-oxoglutarate-dependent dioxygenase activity; NF-kappaB binding activity; and transition metal ion binding activity. Involved in several processes, including negative regulation of Notch signaling pathway; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; and protein hydroxylation. Located in cytosol; nucleoplasm; and perinuclear region of cytoplasm. Colocalizes with nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including 2-oxoglutarate-dependent dioxygenase activity; NF-kappaB binding activity; and transition metal ion binding activity. Involved in several processes, including negative regulation of Notch signaling pathway; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; and protein hydroxylation. Located in cytosol; nucleoplasm; and perinuclear region of cytoplasm. Colocalizes with nucleus. [provided by Alliance of Genome Resources, Apr 2022]	Decreased viability, no effect, Decreased ionizing radiation sensitivity, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Increased circadian period length, Decreased shRNA abundance, Increased viability with neratinib, 	GO:0036138 GO:0042264 GO:0043433 GO:0045663 GO:0045746
LIMK1 	LIMK1 (LIM Domain Kinase 1) is a Protein Coding gene. Diseases associated with LIMK1 include  LIMK2	There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Feb 2011]	There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Feb 2011]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Effect on mitosis, Increased circadian period length, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability with paclitaxel, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased mitotic index, 	GO:0006468 GO:0007165 GO:0007266 GO:0007399
NR2F1 	NR2F1 (Nuclear Receptor Subfamily 2 Group F Member 1) is a Protein Coding gene. Diseases associated with NR2F1 include  NR2F2	The protein encoded by this gene is a nuclear hormone receptor and transcriptional regulator. The encoded protein acts as a homodimer and binds to 5\'-AGGTCA-3\' repeats. Defects in this gene are a cause of Bosch-Boonstra optic atrophy syndrome (BBOAS). [provided by RefSeq, Apr 2014]	The protein encoded by this gene is a nuclear hormone receptor and transcriptional regulator. The encoded protein acts as a homodimer and binds to 5\'-AGGTCA-3\' repeats. Defects in this gene are a cause of Bosch-Boonstra optic atrophy syndrome (BBOAS). [provided by RefSeq, Apr 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Dynamic nuclei (hole, folded or small irregular), Decreased viability, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000122 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0007165 GO:0007165 GO:0007165
IQGAP3 	IQGAP3 (IQ Motif Containing GTPase Activating Protein 3) is a Protein Coding gene. Diseases associated with IQGAP3 include  IQGAP1	Enables calmodulin binding activity and myosin VI light chain binding activity. Predicted to be involved in regulation of actin cytoskeleton organization. Predicted to act upstream of or within several processes, including intracellular signal transduction; positive regulation of macromolecule metabolic process; and positive regulation of mammary gland epithelial cell proliferation. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables calmodulin binding activity and myosin VI light chain binding activity. Predicted to be involved in regulation of actin cytoskeleton organization. Predicted to act upstream of or within several processes, including intracellular signal transduction; positive regulation of macromolecule metabolic process; and positive regulation of mammary gland epithelial cell proliferation. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability with paclitaxel, Increased IL-8 secretion, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased virus production, 	 
CDK6 	CDK6 (Cyclin Dependent Kinase 6) is a Protein Coding gene. Diseases associated with CDK6 include  CDK4	The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Increased transferrin (TF) endocytosis, Decreased cell number, Decreased substrate adherent cell growth, Increased shRNA abundance (Z-score &gt; 2), Decreased IL-8 secretion, Increased circadian period length, Increased shRNA abundance, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Increased mitotic index, Decreased viability after gemcitabine stimulation, Increased apoptosis, Increased IL-10 protein expression, Decreased viability in Von Hippel-Lindau (VHL) (-/-) cell line, Decreased viability in colon lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage; decreased viability in pancreas lineage, 	GO:0000082 GO:0000122 GO:0001954 GO:0001954 GO:0001954 GO:0002244 GO:0003323 GO:0003323 GO:0003323
NLRP3 	NLRP3 (NLR Family Pyrin Domain Containing 3) is a Protein Coding gene. Diseases associated with NLRP3 include  Inflammasomes NLRP12	This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5\' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5\' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]	This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5\' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5\' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]	no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased viability of wild-type and TP53 knockout cells, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0002221 GO:0002526 GO:0002674 GO:0002674 GO:0002674
CXCR5 	CXCR5 (C-X-C Motif Chemokine Receptor 5) is a Protein Coding gene. Diseases associated with CXCR5 include  Lymphoma CXCR3	This gene encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. It is expressed in mature B-cells and Burkitt\'s lymphoma. This cytokine receptor binds to B-lymphocyte chemoattractant (BLC), and is involved in B-cell migration into B-cell follicles of spleen and Peyer patches. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]	This gene encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. It is expressed in mature B-cells and Burkitt\'s lymphoma. This cytokine receptor binds to B-lymphocyte chemoattractant (BLC), and is involved in B-cell migration into B-cell follicles of spleen and Peyer patches. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased viability with paclitaxel, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Abundance of large cells with protrusions and bright nuclei, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased shRNA abundance, 	GO:0006935 GO:0006955 GO:0006955 GO:0006955
EGFL7 	EGFL7 (EGF Like Domain Multiple 7) is a Protein Coding gene.   Gene Ontology (GO) annotations related to this gene include  EGFL8	This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]	This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased NF-kappaB reporter expression, Downregulation of Wnt pathway after Wnt3A stimulation, Polylobed nuclei, 	GO:0001525 GO:0001568 GO:0001568 GO:0001568 GO:0001570 GO:0001570 GO:0001570 GO:0001938 GO:0001938 GO:0001938
NELL2 	NELL2 (Neural EGFL Like 2) is a Protein Coding gene. Diseases associated with NELL2 include  NELL1	The protein encoded by this gene is a glycoprotein containing several von Willebrand factor C domains and epidermal growth factor (EGF)-like domains. The encoded protein acts as a homotrimer and is found in the cytoplasm. Several variants encoding a few different isoforms exist, and at least one isoform appears to be a secreted protein. Studies in mouse suggest that this protein plays a role in neural cell growth and differentiation as well as in oncogenesis. [provided by RefSeq, Feb 2009]	The protein encoded by this gene is a glycoprotein containing several von Willebrand factor C domains and epidermal growth factor (EGF)-like domains. The encoded protein acts as a homotrimer and is found in the cytoplasm. Several variants encoding a few different isoforms exist, and at least one isoform appears to be a secreted protein. Studies in mouse suggest that this protein plays a role in neural cell growth and differentiation as well as in oncogenesis. [provided by RefSeq, Feb 2009]	no effect, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Decreased POU5F1-GFP protein expression, Increased NF-kappaB reporter expression, Downregulation of RLR pathway after Sendai virus (SeV) infection, 	 
TIE1 	TIE1 (Tyrosine Kinase With Immunoglobulin Like And EGF Like Domains 1) is a Protein Coding gene. Diseases associated with TIE1 include  Angiosarcoma TEK	This gene encodes a member of the tyrosine protein kinase family. The encoded protein plays a critical role in angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Ectodomain cleavage of the encoded protein relieves inhibition of Tie2 and is mediated by multiple factors including vascular endothelial growth factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	This gene encodes a member of the tyrosine protein kinase family. The encoded protein plays a critical role in angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Ectodomain cleavage of the encoded protein relieves inhibition of Tie2 and is mediated by multiple factors including vascular endothelial growth factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 25%, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased vesicular stomatitis virus (VSV) infection, Decreased cell migration, Decreased interferon-beta reporter expression, Decreased viability, Increased cell death in HCC-1954 cells, Decreased Hepatitis C virus replication, Increased mitotic index, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	 
CDH2 	CDH2 (Cadherin 2) is a Protein Coding gene. Diseases associated with CDH2 include  CDH4	This gene encodes a classical cadherin and member of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein is proteolytically processed to generate a calcium-dependent cell adhesion molecule and glycoprotein. This protein plays a role in the establishment of left-right asymmetry, development of the nervous system and the formation of cartilage and bone. [provided by RefSeq, Nov 2015]	This gene encodes a classical cadherin and member of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein is proteolytically processed to generate a calcium-dependent cell adhesion molecule and glycoprotein. This protein plays a role in the establishment of left-right asymmetry, development of the nervous system and the formation of cartilage and bone. [provided by RefSeq, Nov 2015]	no effect, Decreased viability, Inconclusive, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Increased G2M DNA content, 	GO:0000902 GO:0003323 GO:0007043 GO:0007043 GO:0007043 GO:0007155 GO:0007155 GO:0007155 GO:0007156
SMAD4 	SMAD4 (SMAD Family Member 4) is a Protein Coding gene. Diseases associated with SMAD4 include  SMAD5	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in colon lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Increased transcriptional activity, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased S DNA content, increased G2M DNA content, S arrest, Increased mitotic index, Downregulation of NFkappaB pathway, Synthetic lethal with gemcitabine, Increased sensitivity to paclitaxel, 	GO:0000122 GO:0001541 GO:0001541 GO:0001541 GO:0001649 GO:0001649 GO:0001649 GO:0001658 GO:0001658 GO:0001658 GO:0001666 GO:0001666 GO:0001666
FOXA2 	FOXA2 (Forkhead Box A2) is a Protein Coding gene. Diseases associated with FOXA2 include  Gastrulation FOXA1	This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]	This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Decreased viability in ovarian lineage, Inconclusive, Increased HPV18 LCR reporter activity, Decreased shRNA abundance, Decreased Sindbis virus (SINV) infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased nuclei size in G2M, Increased CDKN1A mRNA expression, Decreased TP53 mRNA expression, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000432 GO:0001708 GO:0001708 GO:0001708 GO:0006325 GO:0006325 GO:0006325 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
RIPK3 	RIPK3 (Receptor Interacting Serine/Threonine Kinase 3) is a Protein Coding gene. Diseases associated with RIPK3 include  RIPK1	The product of this gene is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, and contains a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals. It is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor. The product of this gene is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, and contains a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals. It is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor. Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability in pancreas lineage, Increased simian virus 40 (SV40) infection, Increased mitotic index, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0001914 GO:0002819 GO:0002819 GO:0002819 GO:0006468 GO:0006468 GO:0006468 GO:0006915 GO:0006915 GO:0006915 GO:0007165 GO:0007165 GO:0007165
RAPGEF4 	RAPGEF4 (Rap Guanine Nucleotide Exchange Factor 4) is a Protein Coding gene. Diseases associated with RAPGEF4 include  RAPGEF3	Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane and regulation of postsynapse organization. Predicted to act upstream of or within adenylate cyclase-activating G protein-coupled receptor signaling pathway; regulation of exocytosis; and secretion by cell. Predicted to be located in plasma membrane. Predicted to be active in glutamatergic synapse; hippocampal mossy fiber to CA3 synapse; and postsynaptic density. Implicated in autistic disorder. [provided by Alliance of Genome Resources, Apr 2022]	Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane and regulation of postsynapse organization. Predicted to act upstream of or within adenylate cyclase-activating G protein-coupled receptor signaling pathway; regulation of exocytosis; and secretion by cell. Predicted to be located in plasma membrane. Predicted to be active in glutamatergic synapse; hippocampal mossy fiber to CA3 synapse; and postsynaptic density. Implicated in autistic disorder. [provided by Alliance of Genome Resources, Apr 2022]	no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability in glioblastoma multiforme (GBM) lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased shRNA abundance (Z-score &lt; -2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased viability, 	GO:0002250 GO:0006887 GO:0006887 GO:0006887 GO:0007186 GO:0007186 GO:0007186
NDRG1 	NDRG1 (N-Myc Downstream Regulated 1) is a Protein Coding gene. Diseases associated with NDRG1 include  NDRG3	This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation. The encoded protein is necessary for p53-mediated caspase activation and apoptosis. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4D, and expression of this gene may be a prognostic indicator for several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]	This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation. The encoded protein is necessary for p53-mediated caspase activation and apoptosis. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4D, and expression of this gene may be a prognostic indicator for several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Moderately decreased NFAT1-GFP nuclear translocation, Synthetic lethal with vaccinia virus (VACV) infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, 	GO:0007165 GO:0008285 GO:0010038 GO:0010038 GO:0010038 GO:0030330
SRF 	SRF (Serum Response Factor) is a Protein Coding gene. Diseases associated with SRF include  Myopericytoma MEF2C	This gene encodes a ubiquitous nuclear protein that stimulates both cell proliferation and differentiation. It is a member of the MADS (MCM1, Agamous, Deficiens, and SRF) box superfamily of transcription factors. This protein binds to the serum response element (SRE) in the promoter region of target genes. This protein regulates the activity of many immediate-early genes, for example c-fos, and thereby participates in cell cycle regulation, apoptosis, cell growth, and cell differentiation. This gene is the downstream target of many pathways; for example, the mitogen-activated protein kinase pathway (MAPK) that acts through the ternary complex factors (TCFs). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]	This gene encodes a ubiquitous nuclear protein that stimulates both cell proliferation and differentiation. It is a member of the MADS (MCM1, Agamous, Deficiens, and SRF) box superfamily of transcription factors. This protein binds to the serum response element (SRE) in the promoter region of target genes. This protein regulates the activity of many immediate-early genes, for example c-fos, and thereby participates in cell cycle regulation, apoptosis, cell growth, and cell differentiation. This gene is the downstream target of many pathways; for example, the mitogen-activated protein kinase pathway (MAPK) that acts through the ternary complex factors (TCFs). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Negative genetic interaction between PTEN-/- and PTEN+/+, Two nuclei (binuclear), Decreased viability (cell death), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0001569 GO:0001666 GO:0001666 GO:0001666
GJB6 	GJB6 (Gap Junction Protein Beta 6) is a Protein Coding gene. Diseases associated with GJB6 include  GJB2	Gap junctions allow the transport of ions and metabolites between the cytoplasm of adjacent cells. They are formed by two hemichannels, made up of six connexin proteins assembled in groups. Each connexin protein has four transmembrane segments, two extracellular loops, a cytoplasmic loop formed between the two inner transmembrane segments, and the N- and C-terminus both being in the cytoplasm. The specificity of the gap junction is determined by which connexin proteins comprise the hemichannel. In the past, connexin protein names were based on their molecular weight, however the new nomenclature uses sequential numbers based on which form (alpha or beta) of the gap junction is present. This gene encodes one of the connexin proteins. Mutations in this gene have been found in some forms of deafness and in some families with hidrotic ectodermal dysplasia. Gap junctions allow the transport of ions and metabolites between the cytoplasm of adjacent cells. They are formed by two hemichannels, made up of six connexin proteins assembled in groups. Each connexin protein has four transmembrane segments, two extracellular loops, a cytoplasmic loop formed between the two inner transmembrane segments, and the N- and C-terminus both being in the cytoplasm. The specificity of the gap junction is determined by which connexin proteins comprise the hemichannel. In the past, connexin protein names were based on their molecular weight, however the new nomenclature uses sequential numbers based on which form (alpha or beta) of the gap junction is present. This gene encodes one of the connexin proteins. Mutations in this gene have been found in some forms of deafness and in some families with hidrotic ectodermal dysplasia. Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased IL-8 secretion, 	GO:0003163
NFKBIA 	NFKBIA (NFKB Inhibitor Alpha) is a Protein Coding gene. Diseases associated with NFKBIA include  NFKBIB	This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]	This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]	Mitotic spindle defects, no effect, shRNA abundance &lt;= 25%, Decreased shRNA abundance (Z-score &lt; -2), Decreased NF-kappaB reporter expression, Upregulation of NF-kappaB pathway after LMP1 stimulation, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased Nanog expression, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased nuclei size in G2M, 	GO:0006606 GO:0006915 GO:0006915 GO:0006915 GO:0007219 GO:0007249 GO:0007249 GO:0007249 GO:0007253
PKN1 	PKN1 (Protein Kinase N1) is a Protein Coding gene. Diseases associated with PKN1 include  PKN2	The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased viability ratio, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Decreased shRNA abundance, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased cell death in HCC-1954 cells, Decreased shRNA abundance (Z-score &lt; -2), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased cell death in DLD-1 cells, Decreased cell viability after pRB stimulation, Decreased viability after gemcitabine stimulation, 	 
EHD2 	EHD2 (EH Domain Containing 2) is a Protein Coding gene.  Among its related pathways are  EHD3	This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway. This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, Negative genetic interaction between PTEN-/- and PTEN+/+, Two nuclei (binuclear), Moderately decreased NFAT1-GFP nuclear translocation, 	GO:0006897 GO:0016197 GO:0030036 GO:0030036 GO:0030036 GO:0030866 GO:0030866 GO:0030866 GO:0032456 GO:0032456 GO:0032456
PGF 	PGF (Placental Growth Factor) is a Protein Coding gene. Diseases associated with PGF include  VEGFA	This gene encodes a growth factor found in placenta which is homologous to vascular endothelial growth factor. Alternatively spliced transcripts encoding different isoforms have been found for this gene.[provided by RefSeq, Jun 2011]	This gene encodes a growth factor found in placenta which is homologous to vascular endothelial growth factor. Alternatively spliced transcripts encoding different isoforms have been found for this gene.[provided by RefSeq, Jun 2011]	Increased vaccinia virus (VACV) infection, no effect, Increased G1 DNA content, Decreased viability in glioblastoma multiforme (GBM) lineage, Strongly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), 	GO:0001525 GO:0001666 GO:0001666 GO:0001666 GO:0001934 GO:0001938 GO:0002040
PXN 	PXN (Paxillin) is a Protein Coding gene. Diseases associated with PXN include  TGFB1I1	This gene encodes a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. These isoforms exhibit different expression pattern, and have different biochemical, as well as physiological properties (PMID:9054445). [provided by RefSeq, Aug 2011]	This gene encodes a cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. These isoforms exhibit different expression pattern, and have different biochemical, as well as physiological properties (PMID:9054445). [provided by RefSeq, Aug 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased POU5F1-GFP protein expression, Decreased shRNA abundance, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased cell migration, 	GO:0006351 GO:0007155 GO:0007155 GO:0007155 GO:0007160 GO:0007165 GO:0007165 GO:0007165 GO:0007172
TGFBR2 	TGFBR2 (Transforming Growth Factor Beta Receptor 2) is a Protein Coding gene. Diseases associated with TGFBR2 include  ACVR2A	The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]	no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased substrate adherent cell growth, Decreased viability in pancreas lineage, Increased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell viability after pRB stimulation, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased mitotic index, Increased mitotic index, Decreased viability after gemcitabine stimulation, Increased apoptosis, 	GO:0001568
RHOB 	RHOB (Ras Homolog Family Member B) is a Protein Coding gene. Diseases associated with RHOB include  RHOA	Predicted to enable GTP binding activity; GTPase activity; and protein kinase binding activity. Involved in several processes, including cellular response to hydrogen peroxide; cellular response to ionizing radiation; and regulation of cell migration. Located in cleavage furrow and endosome membrane. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable GTP binding activity; GTPase activity; and protein kinase binding activity. Involved in several processes, including cellular response to hydrogen peroxide; cellular response to ionizing radiation; and regulation of cell migration. Located in cleavage furrow and endosome membrane. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Negative genetic interaction between BLM-/- and BLM+/+, Increased shRNA abundance, Decreased cell migration, 	GO:0000281 GO:0001525 GO:0006886 GO:0006886 GO:0006886 GO:0006915 GO:0006915 GO:0006915
GJA3 	GJA3 (Gap Junction Protein Alpha 3) is a Protein Coding gene. Diseases associated with GJA3 include  GJA8	The protein encoded by this gene is a connexin and is a component of lens fiber gap junctions. Defects in this gene are a cause of zonular pulverulent cataract type 3 (CZP3). [provided by RefSeq, Jan 2010]	The protein encoded by this gene is a connexin and is a component of lens fiber gap junctions. Defects in this gene are a cause of zonular pulverulent cataract type 3 (CZP3). [provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance, Decreased influenza A virus infection, Increased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Increased cell number in G1, average or increased nuclei size in G1, 	GO:0007154 GO:0007267 GO:0007267 GO:0007267 GO:0007601 GO:0007601 GO:0007601 GO:0055085 GO:0055085 GO:0055085 GO:1990349 GO:1990349 GO:1990349
FZD7 	FZD7 (Frizzled Class Receptor 7) is a Protein Coding gene. Diseases associated with FZD7 include  FZD1	 Members of the \'frizzled\' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD7 protein contains an N-terminal signal sequence, 10 cysteine residues typical of the cysteine-rich extracellular domain of Fz family members, 7 putative transmembrane domains, and an intracellular C-terminal tail with a PDZ domain-binding motif.  FZD7 gene expression may downregulate APC function and enhance beta-catenin-mediated signals in poorly differentiated human esophageal carcinomas.  Members of the \'frizzled\' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD7 protein contains an N-terminal signal sequence, 10 cysteine residues typical of the cysteine-rich extracellular domain of Fz family members, 7 putative transmembrane domains, and an intracellular C-terminal tail with a PDZ domain-binding motif.  FZD7 gene expression may downregulate APC function and enhance beta-catenin-mediated signals in poorly differentiated human esophageal carcinomas. no effect, Decreased viability in esophageal squamous lineage, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased number of mitotic cells, Increased cell death HMECs cells, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Decreased substrate adherent cell growth, Increased G2M DNA content, 	GO:0006355 GO:0007165 GO:0007166 GO:0007166 GO:0007166 GO:0007186 GO:0007186 GO:0007186 GO:0010812 GO:0010812 GO:0010812
CDC37 	CDC37 (Cell Division Cycle 37, HSP90 Cochaperone) is a Protein Coding gene. Diseases associated with CDC37 include  CDC37L1	The protein encoded by this gene is highly similar to Cdc 37, a cell division cycle control protein of Sacchromyces cerevisiae. This protein is a molecular chaperone with specific function in cell signal transduction. It has been shown to form complex with Hsp90 and a variety of protein kinases including CDK4, CDK6, SRC, RAF-1, MOK, as well as eIF2 alpha kinases. It is thought to play a critical role in directing Hsp90 to its target kinases. The protein encoded by this gene is highly similar to Cdc 37, a cell division cycle control protein of Sacchromyces cerevisiae. This protein is a molecular chaperone with specific function in cell signal transduction. It has been shown to form complex with Hsp90 and a variety of protein kinases including CDK4, CDK6, SRC, RAF-1, MOK, as well as eIF2 alpha kinases. It is thought to play a critical role in directing Hsp90 to its target kinases. Increased gamma-H2AX phosphorylation, Decreased hepcidin::fluc mRNA expression, no effect, Decreased viability, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Strongly decreased CFP-tsO45G cell surface transport, Synthetic lethal with vaccinia virus (VACV) infection, 	GO:0000079 GO:0006457 GO:0006605
ADM 	ADM (Adrenomedullin) is a Protein Coding gene. Diseases associated with ADM include  Pheochromocytoma ADM2	The protein encoded by this gene is a preprohormone which is cleaved to form two biologically active peptides, adrenomedullin and proadrenomedullin N-terminal 20 peptide. Adrenomedullin is a 52 aa peptide with several functions, including vasodilation, regulation of hormone secretion, promotion of angiogenesis, and antimicrobial activity. The antimicrobial activity is antibacterial, as the peptide has been shown to kill E. coli and S. aureus at low concentration. [provided by RefSeq, Aug 2014]	The protein encoded by this gene is a preprohormone which is cleaved to form two biologically active peptides, adrenomedullin and proadrenomedullin N-terminal 20 peptide. Adrenomedullin is a 52 aa peptide with several functions, including vasodilation, regulation of hormone secretion, promotion of angiogenesis, and antimicrobial activity. The antimicrobial activity is antibacterial, as the peptide has been shown to kill E. coli and S. aureus at low concentration. [provided by RefSeq, Aug 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability after Maraba virus infection, Decreased HPV16-GFP infection, Decreased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased shRNA abundance, 	GO:0001570 GO:0001666 GO:0001843 GO:0001843 GO:0001843 GO:0002026 GO:0002026 GO:0002026 GO:0002031 GO:0002031 GO:0002031
BMI1 	BMI1 (BMI1 Proto-Oncogene, Polycomb Ring Finger) is a Protein Coding gene. Diseases associated with BMI1 include  Leukemia PCGF2	This gene encodes a ring finger protein that is major component of the polycomb group complex 1 (PRC1). This complex functions through chromatin remodeling as an essential epigenetic repressor of multiple regulatory genes involved in embryonic development and self-renewal in somatic stem cells. This protein also plays a central role in DNA damage repair. This gene is an oncogene and aberrant expression is associated with numerous cancers and is associated with resistance to certain chemotherapies. A pseudogene of this gene is found on chromosome X. Read-through transcription also exists between this gene and the upstream COMM domain containing 3 (COMMD3) gene. [provided by RefSeq, Sep 2015]	This gene encodes a ring finger protein that is major component of the polycomb group complex 1 (PRC1). This complex functions through chromatin remodeling as an essential epigenetic repressor of multiple regulatory genes involved in embryonic development and self-renewal in somatic stem cells. This protein also plays a central role in DNA damage repair. This gene is an oncogene and aberrant expression is associated with numerous cancers and is associated with resistance to certain chemotherapies. A pseudogene of this gene is found on chromosome X. Read-through transcription also exists between this gene and the upstream COMM domain containing 3 (COMMD3) gene. [provided by RefSeq, Sep 2015]	no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Increased G1 DNA content, Increased viability with MLN4924 (a NAE inhibitor), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased cell death in HCT116 cells, 	GO:0000122
SIPA1L1 	SIPA1L1 (Signal Induced Proliferation Associated 1 Like 1) is a Protein Coding gene. Diseases associated with SIPA1L1 include  SIPA1L2	Predicted to enable GTPase activator activity; actin filament binding activity; and protein kinase binding activity. Predicted to be involved in several processes, including actin cytoskeleton organization; activation of GTPase activity; and regulation of postsynapse organization. Located in actin cytoskeleton and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable GTPase activator activity; actin filament binding activity; and protein kinase binding activity. Predicted to be involved in several processes, including actin cytoskeleton organization; activation of GTPase activity; and regulation of postsynapse organization. Located in actin cytoskeleton and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, 	 
TPM4 	TPM4 (Tropomyosin 4) is a Protein Coding gene. Diseases associated with TPM4 include  TPM2	This gene encodes a member of the tropomyosin family of actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosins are dimers of coiled-coil proteins that polymerize end-to-end along the major groove in most actin filaments. They provide stability to the filaments and regulate access of other actin-binding proteins. In muscle cells, they regulate muscle contraction by controlling the binding of myosin heads to the actin filament. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2009]	This gene encodes a member of the tropomyosin family of actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosins are dimers of coiled-coil proteins that polymerize end-to-end along the major groove in most actin filaments. They provide stability to the filaments and regulate access of other actin-binding proteins. In muscle cells, they regulate muscle contraction by controlling the binding of myosin heads to the actin filament. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2009]	no effect, Decreased viability, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased cell migration, 	GO:0001649 GO:0006936 GO:0007015
MAP2K2 	MAP2K2 (Mitogen-Activated Protein Kinase Kinase 2) is a Protein Coding gene. Diseases associated with MAP2K2 include  MAP2K1	The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. no effect, Decreased viability ratio, shRNA abundance &lt;= 25%, Decreased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased cell migration, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased substrate adherent cell growth, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0000165 GO:0006468 GO:0007507 GO:0007507 GO:0007507 GO:0010628 GO:0010628 GO:0010628
TMEM176B 	TMEM176B (Transmembrane Protein 176B) is a Protein Coding gene.    An important paralog of this gene is  TMEM176A	Predicted to be involved in negative regulation of dendritic cell differentiation. Predicted to be located in nuclear membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to be involved in negative regulation of dendritic cell differentiation. Predicted to be located in nuclear membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Strongly decreased CFP-tsO45G cell surface transport, Decreased homologous recombination repair frequency, Decreased viability with paclitaxel, 	GO:0009887 GO:0030154 GO:0097028 GO:0097028 GO:0097028 GO:2001199 GO:2001199 GO:2001199
NFATC1 	NFATC1 (Nuclear Factor Of Activated T Cells 1) is a Protein Coding gene. Diseases associated with NFATC1 include  Cherubism NFATC3	The product of this gene is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation, and an inducible nuclear component. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. The product of this gene is an inducible nuclear component. It functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Different isoforms of this protein may regulate inducible expression of different cytokine genes. [provided by RefSeq, Jul 2013]	The product of this gene is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation, and an inducible nuclear component. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. The product of this gene is an inducible nuclear component. It functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Different isoforms of this protein may regulate inducible expression of different cytokine genes. [provided by RefSeq, Jul 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in glioblastoma multiforme (GBM) lineage, Synthetic lethal with imatinib mesylate, Decreased viability, 	GO:0001816 GO:0003180 GO:0003184 GO:0003184 GO:0003184 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
RALBP1 	RALBP1 (RalA Binding Protein 1) is a Protein Coding gene. Diseases associated with RALBP1 include 	RALBP1 plays a role in receptor-mediated endocytosis and is a downstream effector of the small GTP-binding protein RAL (see RALA; MIM 179550). Small G proteins, such as RAL, have GDP-bound inactive and GTP-bound active forms, which shift from the inactive to the active state through the action of RALGDS (MIM 601619), which in turn is activated by RAS (see HRAS; MIM 190020) (summary by Feig, 2003 [PubMed 12888294]).[supplied by OMIM, Nov 2010]	RALBP1 plays a role in receptor-mediated endocytosis and is a downstream effector of the small GTP-binding protein RAL (see RALA; MIM 179550). Small G proteins, such as RAL, have GDP-bound inactive and GTP-bound active forms, which shift from the inactive to the active state through the action of RALGDS (MIM 601619), which in turn is activated by RAS (see HRAS; MIM 190020) (summary by Feig, 2003 [PubMed 12888294]).[supplied by OMIM, Nov 2010]	no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability, Increased G2M DNA content, Big cells, 	GO:0001934 GO:0006897 GO:0006935 GO:0007165 GO:0007264 GO:0007264 GO:0007264
AKAP9 	AKAP9 (A-Kinase Anchoring Protein 9) is a Protein Coding gene. Diseases associated with AKAP9 include  PCNT	The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]	The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]	Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Increased transferrin (TF) endocytosis, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased viability, 	GO:0007020 GO:0007165 GO:0007194 GO:0007194 GO:0007194 GO:0007268 GO:0007268 GO:0007268 GO:0031116
WDR82 	WDR82 (WD Repeat Domain 82) is a Protein Coding gene. Diseases associated with WDR82 include 	TMEM113 (WDR82) is a component of the mammalian SET1A (MIM 611052)/SET1B (MIM 611055) histone H3-Lys4 methyltransferase complexes (Lee and Skalnik, 2005 [PubMed 16253997]; Lee et al., 2007 [PubMed 17355966]).[supplied by OMIM, Jul 2010]	TMEM113 (WDR82) is a component of the mammalian SET1A (MIM 611052)/SET1B (MIM 611055) histone H3-Lys4 methyltransferase complexes (Lee and Skalnik, 2005 [PubMed 16253997]; Lee et al., 2007 [PubMed 17355966]).[supplied by OMIM, Jul 2010]	Increased vaccinia virus (VACV) infection, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased POU5F1-GFP protein expression, Increased ionizing radiation sensitivity, Decreased OCT4 protein expression, Decreased NANOG protein expression, Decreased viability after ionizing radiation, 	GO:0006353 GO:0032785 GO:0032785 GO:0032785 GO:0051568 GO:0071027 GO:0080182
FERMT2 	FERMT2 (FERM Domain Containing Kindlin 2) is a Protein Coding gene. Diseases associated with FERMT2 include  FERMT1	Enables several functions, including actin binding activity; phosphatidylinositol-3,4,5-trisphosphate binding activity; and type I transforming growth factor beta receptor binding activity. Involved in several processes, including cell surface receptor signaling pathway; positive regulation of cell differentiation; and positive regulation of cellular component biogenesis. Acts upstream of or within cell adhesion and protein localization to cell junction. Located in cytosol; focal adhesion; and nucleoplasm. Is extrinsic component of cytoplasmic side of plasma membrane. Part of adherens junction and plasma membrane. Biomarker of acute myeloid leukemia. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including actin binding activity; phosphatidylinositol-3,4,5-trisphosphate binding activity; and type I transforming growth factor beta receptor binding activity. Involved in several processes, including cell surface receptor signaling pathway; positive regulation of cell differentiation; and positive regulation of cellular component biogenesis. Acts upstream of or within cell adhesion and protein localization to cell junction. Located in cytosol; focal adhesion; and nucleoplasm. Is extrinsic component of cytoplasmic side of plasma membrane. Part of adherens junction and plasma membrane. Biomarker of acute myeloid leukemia. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, Negative genetic interaction between KRASG13D/+ and KRAS+/-, Dynamic nuclei (hole, folded or small irregular), Increased S DNA content, Increased caspase activity, 	GO:0007155 GO:0007160 GO:0007179 GO:0007179 GO:0007179 GO:0007229
MAPK8 	MAPK8 (Mitogen-Activated Protein Kinase 8) is a Protein Coding gene. Diseases associated with MAPK8 include  MAPK10	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrom c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Apr 2016]	The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrom c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Apr 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased transferrin (TF) endocytosis, Decreased vesicular stomatitis virus (VSV) infection, Increased circadian period length, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased homologous recombination repair frequency, Decreased shRNA abundance, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Decreased Hepatitis C virus replication, Increased S DNA content, Increased mitotic index, Decreased cell viability after pRB stimulation, Decreased simian virus 40 (SV40) infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, Increased viability after TNF/CHX stimulation, Increased telomerase activity, Increased IL-13 protein expression, 	GO:0000165 GO:0006468 GO:0006468 GO:0006468 GO:0006979 GO:0007165 GO:0007254 GO:0007254 GO:0007254
RBL2 	RBL2 (RB Transcriptional Corepressor Like 2) is a Protein Coding gene. Diseases associated with RBL2 include  Retinoblastoma RBL1	Enables promoter-specific chromatin binding activity. Involved in regulation of lipid kinase activity. Acts upstream of or within negative regulation of gene expression. Located in chromosome; cytosol; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]	Enables promoter-specific chromatin binding activity. Involved in regulation of lipid kinase activity. Acts upstream of or within negative regulation of gene expression. Located in chromosome; cytosol; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Increased G1 DNA content, G0/1 arrest, Decreased viability, 	GO:0006325 GO:0006357 GO:0006357 GO:0006357 GO:0007049 GO:0007049 GO:0007049 GO:0010629 GO:0010629 GO:0010629 GO:0030154
TGM2 	TGM2 (Transglutaminase 2) is a Protein Coding gene. Diseases associated with TGM2 include  TGM5	Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. Two transcript variants encoding different isoforms have been found for this gene. Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. Two transcript variants encoding different isoforms have been found for this gene. Increased vaccinia virus (VACV) infection, no effect, Increased transferrin (TF) endocytosis, 	GO:0006508 GO:0007200 GO:0007200 GO:0007200 GO:0016570 GO:0018149 GO:0018149 GO:0018149 GO:0018277
GNG2 	GNG2 (G Protein Subunit Gamma 2) is a Protein Coding gene.  Among its related pathways are  GNG4	This gene encodes one of the gamma subunits of a guanine nucleotide-binding protein. Such proteins are involved in signaling mechanisms across membranes. Various subunits forms heterodimers which then interact with the different signal molecules. [provided by RefSeq, Aug 2011]	This gene encodes one of the gamma subunits of a guanine nucleotide-binding protein. Such proteins are involved in signaling mechanisms across membranes. Various subunits forms heterodimers which then interact with the different signal molecules. [provided by RefSeq, Aug 2011]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Increased viability, Decreased viability ratio, Increased IL-8 secretion, Decreased melanin production, Decreased HPV16-GFP infection, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0007165 GO:0007186 GO:0007186 GO:0007186
PTPN12 	PTPN12 (Protein Tyrosine Phosphatase Non-Receptor Type 12) is a Protein Coding gene. Diseases associated with PTPN12 include  PTPN22	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains a C-terminal PEST motif, which serves as a protein-protein interaction domain, and may regulate protein intracellular half-life. This PTP was found to bind and dephosphorylate the product of the oncogene c-ABL and thus may play a role in oncogenesis. This PTP was also shown to interact with, and dephosphorylate, various products related to cytoskeletal structure and cell adhesion, such as p130 (Cas), CAKbeta/PTK2B, PSTPIP1, and paxillin. This suggests it has a regulatory role in controlling cell shape and mobility. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains a C-terminal PEST motif, which serves as a protein-protein interaction domain, and may regulate protein intracellular half-life. This PTP was found to bind and dephosphorylate the product of the oncogene c-ABL and thus may play a role in oncogenesis. This PTP was also shown to interact with, and dephosphorylate, various products related to cytoskeletal structure and cell adhesion, such as p130 (Cas), CAKbeta/PTK2B, PSTPIP1, and paxillin. This suggests it has a regulatory role in controlling cell shape and mobility. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]	no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased Nanog expression, Strongly decreased CFP-tsO45G cell surface transport, Increased ionizing radiation sensitivity, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0006470 GO:0016311 GO:0035335 GO:0035335 GO:0035335 GO:0042058
TNIK 	TNIK (TRAF2 And NCK Interacting Kinase) is a Protein Coding gene. Diseases associated with TNIK include  MAP4K4	Wnt signaling plays important roles in carcinogenesis and embryonic development. The protein encoded by this gene is a serine/threonine kinase that functions as an activator of the Wnt signaling pathway. Mutations in this gene are associated with an autosomal recessive form of cognitive disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]	Wnt signaling plays important roles in carcinogenesis and embryonic development. The protein encoded by this gene is a serine/threonine kinase that functions as an activator of the Wnt signaling pathway. Mutations in this gene are associated with an autosomal recessive form of cognitive disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]	Increased viability, Synthetic lethal with Ras, Mildly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Increased homologous recombination repair frequency, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Decreased viability, Decreased telomerase activity, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Strongly decreased NFAT1-GFP nuclear translocation, Decreased viability after sindbis virus (SIN) dsTE12Q infection, Fragmented cis-Golgi, fragmented trans-Golgi, Decreased vesicular stomatitis virus (VSV) infection, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance, increased cell spreading, 	GO:0000165 GO:0001934 GO:0006468 GO:0007010
PFKFB2 	PFKFB2 (6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 2) is a Protein Coding gene. Diseases associated with PFKFB2 include  PFKFB3	The protein encoded by this gene is involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate, and a fructose-2,6-biphosphatase activity that catalyzes the degradation of fructose-2,6-bisphosphate. This protein regulates fructose-2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as a homodimer. Two transcript variants encoding two different isoforms have been found for this gene. The protein encoded by this gene is involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate, and a fructose-2,6-biphosphatase activity that catalyzes the degradation of fructose-2,6-bisphosphate. This protein regulates fructose-2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as a homodimer. Two transcript variants encoding two different isoforms have been found for this gene. no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Negative genetic interaction between BLM-/- and BLM+/+, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability, Increased vesicular stomatitis virus (VSV) infection, Increased apoptosis, 	GO:0006000 GO:0006003 GO:0006003 GO:0006003
PAK2 	PAK2 (P21 (RAC1) Activated Kinase 2) is a Protein Coding gene. Diseases associated with PAK2 include  PAK1	The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. Increased vaccinia virus (VACV) infection, no effect, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Decreased substrate adherent cell growth, Increased cell death HMECs cells, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell viability after pRB stimulation, Increased cell number in G1, small nuclei in G1, Decreased 12E8 tau but not total tau protein expression and decreased ratio of 12E8/total tau protein expression, Transferrin accumulation in small spots in the cell periphery, transferrin accumulation in enlarged cytoplasmic structures, 	GO:0002223 GO:0003300 GO:0003300 GO:0003300 GO:0006468 GO:0006468 GO:0006468 GO:0006469
SOX9 	SOX9 (SRY-Box Transcription Factor 9) is a Protein Coding gene. Diseases associated with SOX9 include  SOX10	The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal. Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Decreased shRNA abundance (Z-score &lt; -2), Negative genetic interaction between PTEN-/- and PTEN+/+, Increased Nanog expression, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in pancreas lineage, Increased shRNA abundance (Z-score &gt; 2), Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0000122 GO:0001501
ARNT 	ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) is a Protein Coding gene. Diseases associated with ARNT include  Endometriosis ARNT2	This gene encodes a protein containing a basic helix-loop-helix domain and two characteristic PAS domains along with a PAC domain. The encoded protein binds to ligand-bound aryl hydrocarbon receptor and aids in the movement of this complex to the nucleus, where it promotes the expression of genes involved in xenobiotic metabolism. This protein is also a co-factor for transcriptional regulation by hypoxia-inducible factor 1. Chromosomal translocation of this locus with the ETV6 (ets variant 6) gene on chromosome 12 have been described in leukemias. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2013]	This gene encodes a protein containing a basic helix-loop-helix domain and two characteristic PAS domains along with a PAC domain. The encoded protein binds to ligand-bound aryl hydrocarbon receptor and aids in the movement of this complex to the nucleus, where it promotes the expression of genes involved in xenobiotic metabolism. This protein is also a co-factor for transcriptional regulation by hypoxia-inducible factor 1. Chromosomal translocation of this locus with the ETV6 (ets variant 6) gene on chromosome 12 have been described in leukemias. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2013]	no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Increased Nanog expression, Increased shRNA abundance (Z-score &gt; 2), 	GO:0001666 GO:0001892 GO:0001938 GO:0001938 GO:0001938 GO:0006355 GO:0006357 GO:0006357 GO:0006357
ICAM1 	ICAM1 (Intercellular Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with ICAM1 include  Malaria Leukostasis ICAM3	This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased NF-kappaB reporter expression, Increased viability with MLN4924 (a NAE inhibitor), Decreased cilium length after serum starvation, 	GO:0001910 GO:0002291 GO:0002693 GO:0007155 GO:0007157
RARA 	RARA (Retinoic Acid Receptor Alpha) is a Protein Coding gene. Diseases associated with RARA include  Leukemia RARB	This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010]	This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Wnt reporter downregulated, Increased cell death HMECs cells, Large nuclei, Synthetic lethal with imatinib mesylate, Increased BBC3 mRNA expression, Decreased TP53 mRNA expression, 	GO:0000122
RASGRF1 	RASGRF1 (Ras Protein Specific Guanine Nucleotide Releasing Factor 1) is a Protein Coding gene. Diseases associated with RASGRF1 include  RASGRF2	The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) similar to the Saccharomyces cerevisiae CDC25 gene product. Functional analysis has demonstrated that this protein stimulates the dissociation of GDP from RAS protein. The studies of the similar gene in mouse suggested that the Ras-GEF activity of this protein in brain can be activated by Ca2+ influx, muscarinic receptors, and G protein beta-gamma subunit. Mouse studies also indicated that the Ras-GEF signaling pathway mediated by this protein may be important for long-term memory. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Mar 2009]	The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) similar to the Saccharomyces cerevisiae CDC25 gene product. Functional analysis has demonstrated that this protein stimulates the dissociation of GDP from RAS protein. The studies of the similar gene in mouse suggested that the Ras-GEF activity of this protein in brain can be activated by Ca2+ influx, muscarinic receptors, and G protein beta-gamma subunit. Mouse studies also indicated that the Ras-GEF signaling pathway mediated by this protein may be important for long-term memory. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Mar 2009]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased NF-kappaB reporter expression, Decreased IL-8 secretion, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with vaccinia virus (VACV) infection, Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased Salmonella enterica Typhimurium binding, Increased Sindbis virus (SINV) infection, 	GO:0007165 GO:0007264 GO:0007265 GO:0007265 GO:0007265 GO:0007616
ZEB2 	ZEB2 (Zinc Finger E-Box Binding Homeobox 2) is a Protein Coding gene. Diseases associated with ZEB2 include  ZEB1	The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]	The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]	no effect, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between KRASG13D/+ and KRAS+/-, Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Increased ionizing radiation sensitivity, Decreased Aire reporter expression, Increased Nanog expression, 	GO:0000122 GO:0006351 GO:0006357 GO:0006357 GO:0006357 GO:0006807 GO:0007399 GO:0007399 GO:0007399
EGR1 	EGR1 (Early Growth Response 1) is a Protein Coding gene. Diseases associated with EGR1 include  Ischemia EGR2	The protein encoded by this gene belongs to the EGR family of C2H2-type zinc-finger proteins. It is a nuclear protein and functions as a transcriptional regulator. The products of target genes it activates are required for differentitation and mitogenesis. Studies suggest this is a cancer suppressor gene. [provided by RefSeq, Dec 2014]	The protein encoded by this gene belongs to the EGR family of C2H2-type zinc-finger proteins. It is a nuclear protein and functions as a transcriptional regulator. The products of target genes it activates are required for differentitation and mitogenesis. Studies suggest this is a cancer suppressor gene. [provided by RefSeq, Dec 2014]	no effect, shRNA abundance &lt;= 50%, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with c-Myc after tamoxifen stimulation, Decreased shRNA abundance (Z-score &lt; -2), Decreased shRNA abundance, 	GO:0000122 GO:0001666 GO:0001666 GO:0001666 GO:0002931 GO:0002931 GO:0002931 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
RIN3 	RIN3 (Ras And Rab Interactor 3) is a Protein Coding gene. Diseases associated with RIN3 include  RIN2	Summary: This protein encoded by this gene is a member of the RIN family of Ras interaction-interference proteins, which are binding partners to the RAB5 small GTPases. The protein functions as a guanine nucleotide exchange for RAB5B and RAB31. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	Summary: This protein encoded by this gene is a member of the RIN family of Ras interaction-interference proteins, which are binding partners to the RAB5 small GTPases. The protein functions as a guanine nucleotide exchange for RAB5B and RAB31. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	Decreased viability, no effect, Decreased viability in esophageal squamous lineage, Mildly decreased CFP-tsO45G cell surface transport, Increased transferrin (TF) endocytosis, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, 	GO:0002091 GO:0006897 GO:0007165 GO:0016192 GO:0016192 GO:0016192 GO:0060755 GO:0060755 GO:0060755
RASA3 	RASA3 (RAS P21 Protein Activator 3) is a Protein Coding gene. Diseases associated with RASA3 include  Poliomyelitis RASA2	This gene encodes a protein that binds inositol 1,3,4,5-tetrakisphosphate and stimulates the GTPase activity of Ras p21. This protein functions as a negative regulator of the Ras signalling pathway. It is localized to the cell membrane via a pleckstrin homology (PH) domain in the C-terminal region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	This gene encodes a protein that binds inositol 1,3,4,5-tetrakisphosphate and stimulates the GTPase activity of Ras p21. This protein functions as a negative regulator of the Ras signalling pathway. It is localized to the cell membrane via a pleckstrin homology (PH) domain in the C-terminal region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]	no effect, Decreased ionizing radiation sensitivity, Decreased viability ratio, Decreased shRNA abundance, Decreased viability, High actin ratio cells, Decreased epidermal growth factor receptor (EGFR) surface abundance, 	GO:0007165
FLT4 	FLT4 (Fms Related Receptor Tyrosine Kinase 4) is a Protein Coding gene. Diseases associated with FLT4 include  KDR	This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Decreased viability after Maraba virus infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased vesicular stomatitis virus (VSV) infection, Decreased Sindbis virus (SINV) infection, Decreased epidermal growth factor (EGF) endocytosis, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased mitotic index, Increased cilium length after serum starvation, Decreased simian virus 40 (SV40) infection, Decreased viability in colon lineage; decreased viability in pancreas lineage, 	GO:0001525 GO:0001934 GO:0001938
SLC2A1 	SLC2A1 (Solute Carrier Family 2 Member 1) is a Protein Coding gene. Diseases associated with SLC2A1 include  SLC2A4	This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]	This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]	Increased vaccinia virus (VACV) infection, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Inconclusive, Decreased shRNA abundance, Decreased viability with paclitaxel, 	GO:0001666 GO:0006970 GO:0006970 GO:0006970 GO:0007417 GO:0007417 GO:0007417
GSKIP 	GSKIP (GSK3B Interacting Protein) is a Protein Coding gene. Diseases associated with GSKIP include 	This gene encodes a protein that is involved as a negative regulator of GSK3-beta in the Wnt signaling pathway. The encoded protein may play a role in the retinoic acid signaling pathway by regulating the functional interactions between GSK3-beta, beta-catenin and cyclin D1, and it regulates the beta-catenin/N-cadherin pool. The encoded protein contains a GSK3-beta interacting domain (GID) in its C-terminus, which is similar to the GID of Axin. The protein also contains an evolutionarily conserved RII-binding domain, which facilitates binding with protein kinase-A and GSK3-beta, enabling its role as an A-kinase anchoring protein. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]	This gene encodes a protein that is involved as a negative regulator of GSK3-beta in the Wnt signaling pathway. The encoded protein may play a role in the retinoic acid signaling pathway by regulating the functional interactions between GSK3-beta, beta-catenin and cyclin D1, and it regulates the beta-catenin/N-cadherin pool. The encoded protein contains a GSK3-beta interacting domain (GID) in its C-terminus, which is similar to the GID of Axin. The protein also contains an evolutionarily conserved RII-binding domain, which facilitates binding with protein kinase-A and GSK3-beta, enabling its role as an A-kinase anchoring protein. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Inconclusive, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), 	GO:0006469 GO:0008631 GO:0030111 GO:0060828 GO:0090263 GO:0090263 GO:0090263
TSC2 	TSC2 (TSC Complex Subunit 2) is a Protein Coding gene. Diseases associated with TSC2 include  Lymphangioleiomyomatosis binding RALGAPA1	This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]	This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability (cell death), Increased shRNA abundance (Z-score &gt; 2), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001843 GO:0006469 GO:0006469 GO:0006469 GO:0006606 GO:0006606 GO:0006606 GO:0006897 GO:0006897 GO:0006897
PRKCG 	PRKCG (Protein Kinase C Gamma) is a Protein Coding gene. Diseases associated with PRKCG include  PRKCA	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	no effect, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased substrate adherent cell growth, Decreased viability, Increased cell viability after pRB stimulation, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability after Chlamydia trachomatis serovar L2 infection and TNF-alpha/CHX stimulation, Decreased cell viability after pRB stimulation, Increased viability, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	GO:0006468
CRKL 	CRKL (CRK Like Proto-Oncogene, Adaptor Protein) is a Protein Coding gene. Diseases associated with CRKL include  Sarcoma CRK	This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.[provided by RefSeq, Jan 2009]	This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.[provided by RefSeq, Jan 2009]	no effect, Decreased viability, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Reduced mammosphere formation, Decreased viability ratio, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Increased shRNA abundance, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	 
DNM1 	DNM1 (Dynamin 1) is a Protein Coding gene. Diseases associated with DNM1 include  DNM3	This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3\' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described. This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3\' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in glioblastoma multiforme (GBM) lineage, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0006897 GO:0006898 GO:0007032 GO:0016185 GO:0031623 GO:0031623 GO:0031623
GADD45B 	GADD45B (Growth Arrest And DNA Damage Inducible Beta) is a Protein Coding gene. Diseases associated with GADD45B include  GADD45A	This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The genes in this group respond to environmental stresses by mediating activation of the p38/JNK pathway.  This activation is mediated via their proteins binding and activating MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. The function of these genes or their protein products is involved in the regulation of growth and apoptosis. These genes are regulated by different mechanisms, but they are often coordinately expressed and can function cooperatively in inhibiting cell growth. This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents. The genes in this group respond to environmental stresses by mediating activation of the p38/JNK pathway.  This activation is mediated via their proteins binding and activating MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. The function of these genes or their protein products is involved in the regulation of growth and apoptosis. These genes are regulated by different mechanisms, but they are often coordinately expressed and can function cooperatively in inhibiting cell growth. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability in glioblastoma multiforme (GBM) lineage, Negative genetic interaction between BLM-/- and BLM+/+, Decreased epidermal growth factor (EGF) endocytosis, 	GO:0006469 GO:0006915 GO:0006915 GO:0006915 GO:0030154 GO:0030154 GO:0030154 GO:0043065 GO:0043065 GO:0043065
SDC4 	SDC4 (Syndecan 4) is a Protein Coding gene. Diseases associated with SDC4 include  SDC2	The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan that functions as a receptor in intracellular signaling. The encoded protein is found as a homodimer and is a member of the syndecan proteoglycan family. This gene is found on chromosome 20, while a pseudogene has been found on chromosome 22. The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan that functions as a receptor in intracellular signaling. The encoded protein is found as a homodimer and is a member of the syndecan proteoglycan family. This gene is found on chromosome 20, while a pseudogene has been found on chromosome 22. no effect, Decreased viability, Decreased transferrin (TF) endocytosis, decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0001657 GO:0001843 GO:0001843 GO:0001843 GO:0010762 GO:0010762 GO:0010762 GO:0016477 GO:0016477 GO:0016477
SMAD2 	SMAD2 (SMAD Family Member 2) is a Protein Coding gene. Diseases associated with SMAD2 include  SMAD3	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]	The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene \'mothers against decapentaplegic\' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, shRNA abundance &lt;= 50%, Increased shRNA abundance (Z-score &gt; 2), Two nuclei (binuclear), Decreased NF-kappaB reporter expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Moderately decreased NFAT1-GFP nuclear translocation, Synthetic lethal with vaccinia virus (VACV) infection, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Decreased shRNA abundance (Z-score &lt; -2), Increased mitotic index, Decreased vesicular stomatitis virus (VSV) infection, 	 
GIT1 	GIT1 (GIT ArfGAP 1) is a Protein Coding gene. Diseases associated with GIT1 include  GIT2	Enables gamma-tubulin binding activity. Involved in positive regulation of microtubule nucleation and regulation of cytokinesis. Located in several cellular components, including focal adhesion; microtubule cytoskeleton; and mitochondrion. Implicated in attention deficit hyperactivity disorder. Biomarker of Huntington\'s disease. [provided by Alliance of Genome Resources, Apr 2022]	Enables gamma-tubulin binding activity. Involved in positive regulation of microtubule nucleation and regulation of cytokinesis. Located in several cellular components, including focal adhesion; microtubule cytoskeleton; and mitochondrion. Implicated in attention deficit hyperactivity disorder. Biomarker of Huntington\'s disease. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased viability in colon lineage, Strongly decreased CFP-tsO45G cell surface transport, Inconclusive, Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, 	GO:0001957 GO:0007420 GO:0007420 GO:0007420 GO:0007626 GO:0008277 GO:0008277 GO:0008277 GO:0032012
PBX1 	PBX1 (PBX Homeobox 1) is a Protein Coding gene. Diseases associated with PBX1 include  PBX3	This gene encodes a nuclear protein that belongs to the PBX homeobox family of transcriptional factors. Studies in mice suggest that this gene may be involved in the regulation of osteogenesis and required for skeletal patterning and programming. A chromosomal translocation, t(1;19) involving this gene and TCF3/E2A gene, is associated with pre-B-cell acute lymphoblastic leukemia. The resulting fusion protein, in which the DNA binding domain of E2A is replaced by the DNA binding domain of this protein, transforms cells by constitutively activating transcription of genes regulated by the PBX protein family. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	This gene encodes a nuclear protein that belongs to the PBX homeobox family of transcriptional factors. Studies in mice suggest that this gene may be involved in the regulation of osteogenesis and required for skeletal patterning and programming. A chromosomal translocation, t(1;19) involving this gene and TCF3/E2A gene, is associated with pre-B-cell acute lymphoblastic leukemia. The resulting fusion protein, in which the DNA binding domain of E2A is replaced by the DNA binding domain of this protein, transforms cells by constitutively activating transcription of genes regulated by the PBX protein family. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2017]	no effect, Decreased viability, Increased IL-8 secretion, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased viability in glioblastoma multiforme (GBM) lineage, Synthetic lethal with vaccinia virus (VACV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0000086 GO:0001654 GO:0001654 GO:0001654
FHOD1 	FHOD1 (Formin Homology 2 Domain Containing 1) is a Protein Coding gene. Diseases associated with FHOD1 include  FHOD3	This gene encodes a protein which is a member of the formin/diaphanous family of proteins. The gene is ubiquitously expressed but is found in abundance in the spleen. The encoded protein has sequence homology to diaphanous and formin proteins within the Formin Homology (FH)1 and FH2 domains. It also contains a coiled-coil domain, a collagen-like domain, two nuclear localization signals, and several potential PKC and PKA phosphorylation sites. It is a predominantly cytoplasmic protein and is expressed in a variety of human cell lines. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	This gene encodes a protein which is a member of the formin/diaphanous family of proteins. The gene is ubiquitously expressed but is found in abundance in the spleen. The encoded protein has sequence homology to diaphanous and formin proteins within the Formin Homology (FH)1 and FH2 domains. It also contains a coiled-coil domain, a collagen-like domain, two nuclear localization signals, and several potential PKC and PKA phosphorylation sites. It is a predominantly cytoplasmic protein and is expressed in a variety of human cell lines. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]	Increased gamma-H2AX phosphorylation, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Decreased influenza A/WSN/33 replication, 	GO:0007097 GO:0030866 GO:0030866 GO:0030866 GO:0045944 GO:0051492 GO:0051496
GFAP 	GFAP (Glial Fibrillary Acidic Protein) is a Protein Coding gene. Diseases associated with GFAP include  VIM	This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]	This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability in esophageal squamous lineage, Increased circadian period length, 	 
ILKAP 	ILKAP (ILK Associated Serine/Threonine Phosphatase) is a Protein Coding gene.  Among its related pathways are  PPM1F	The protein encoded by this gene is a protein serine/threonine phosphatase of the PP2C family. This protein can interact with integrin-linked kinase (ILK/ILK1), a regulator of integrin mediated signaling, and regulate the kinase activity of ILK. Through the interaction with ILK, this protein may selectively affect the signaling process of ILK-mediated glycogen synthase kinase 3 beta (GSK3beta), and thus participate in Wnt signaling pathway. The protein encoded by this gene is a protein serine/threonine phosphatase of the PP2C family. This protein can interact with integrin-linked kinase (ILK/ILK1), a regulator of integrin mediated signaling, and regulate the kinase activity of ILK. Through the interaction with ILK, this protein may selectively affect the signaling process of ILK-mediated glycogen synthase kinase 3 beta (GSK3beta), and thus participate in Wnt signaling pathway. no effect, shRNA abundance &lt;= 50%, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased homologous recombination repair frequency, Increased cell migration, 	GO:0006470
ANGPT1 	ANGPT1 (Angiopoietin 1) is a Protein Coding gene. Diseases associated with ANGPT1 include  ANGPT2	This gene encodes a secreted glycoprotein that belongs to the angiopoietin family. Members of this family play important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The protein encoded by this gene is a secreted glycoprotein that activates the receptor by inducing its tyrosine phosphorylation. It plays a critical role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme and inhibits endothelial permeability. The protein also contributes to blood vessel maturation and stability, and may be involved in early development of the heart. Mutations in this gene are associated with hereditary angioedema. [provided by RefSeq, Aug 2020]	This gene encodes a secreted glycoprotein that belongs to the angiopoietin family. Members of this family play important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The protein encoded by this gene is a secreted glycoprotein that activates the receptor by inducing its tyrosine phosphorylation. It plays a critical role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme and inhibits endothelial permeability. The protein also contributes to blood vessel maturation and stability, and may be involved in early development of the heart. Mutations in this gene are associated with hereditary angioedema. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased IL-8 secretion, Inconclusive, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased shRNA abundance, Increased caspase activity, 	GO:0001525 GO:0001701 GO:0001933 GO:0001933 GO:0001933 GO:0001934 GO:0001934 GO:0001934 GO:0001936
TNFAIP3 	TNFAIP3 (TNF Alpha Induced Protein 3) is a Protein Coding gene. Diseases associated with TNFAIP3 include  OTUD7A	This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2012]	This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2012]	Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 25%, Decreased viability in glioblastoma multiforme (GBM) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased S DNA content, Actin fiber cells, Increased cell number in G2M, increased number of polyploid cells, increased number of cells with high perimeter-to-area ratio nuclei, 	GO:0001922 GO:0002237 GO:0002237 GO:0002237
TNC 	TNC (Tenascin C) is a Protein Coding gene. Diseases associated with TNC include  TNXB	This gene encodes an extracellular matrix protein with a spatially and temporally restricted tissue distribution. This protein is homohexameric with disulfide-linked subunits, and contains multiple EGF-like and fibronectin type-III domains. It is implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity, and neuronal regeneration. [provided by RefSeq, Jul 2011]	This gene encodes an extracellular matrix protein with a spatially and temporally restricted tissue distribution. This protein is homohexameric with disulfide-linked subunits, and contains multiple EGF-like and fibronectin type-III domains. It is implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity, and neuronal regeneration. [provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, no effect, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased IL-8 secretion, Increased viability (proliferation), Increased cell death HMECs cells, Decreased shRNA abundance, Decreased influenza A/WSN/33 replication, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), dynamic nuclei (hole, folded or small irregular), 	GO:0001558 GO:0001649
DUSP4 	DUSP4 (Dual Specificity Phosphatase 4) is a Protein Coding gene. Diseases associated with DUSP4 include  DUSP1	The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1, ERK2 and JNK, is expressed in a variety of tissues, and is localized in the nucleus. Two alternatively spliced transcript variants, encoding distinct isoforms, have been observed for this gene. In addition, multiple polyadenylation sites have been reported. The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1, ERK2 and JNK, is expressed in a variety of tissues, and is localized in the nucleus. Two alternatively spliced transcript variants, encoding distinct isoforms, have been observed for this gene. In addition, multiple polyadenylation sites have been reported. no effect, Decreased viability, Increased Nanog expression, Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased NF-kappaB reporter expression, Increased cell death in HCC-1954 cells, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, 	GO:0001706 GO:0006470 GO:0016311 GO:0016311 GO:0016311 GO:0043409 GO:0070373
CDKN2C 	CDKN2C (Cyclin Dependent Kinase Inhibitor 2C) is a Protein Coding gene. Diseases associated with CDKN2C include  CDKN2D	The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to interact with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. Ectopic expression of this gene was shown to suppress the growth of human cells in a manner that appears to correlate with the presence of a wild-type RB1 function. Studies in the knockout mice suggested the roles of this gene in regulating spermatogenesis, as well as in suppressing tumorigenesis. Two alternatively spliced transcript variants of this gene, which encode an identical protein, have been reported. The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to interact with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. Ectopic expression of this gene was shown to suppress the growth of human cells in a manner that appears to correlate with the presence of a wild-type RB1 function. Studies in the knockout mice suggested the roles of this gene in regulating spermatogenesis, as well as in suppressing tumorigenesis. Two alternatively spliced transcript variants of this gene, which encode an identical protein, have been reported. no effect, Decreased viability, Increased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased Nanog expression, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Strongly decreased CFP-tsO45G cell surface transport, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased viability, Paclitaxel antagonistic effect, 	GO:0000079 GO:0007049 GO:0008283 GO:0008283 GO:0008283 GO:0008285 GO:0008285 GO:0008285
OLIG2 	OLIG2 (Oligodendrocyte Transcription Factor 2) is a Protein Coding gene. Diseases associated with OLIG2 include  Oligodendroglioma OLIG3	This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. no effect, Decreased viability, Synthetic lethal with Ras, Inconclusive, Negative genetic interaction between BLM-/- and BLM+/+, 	 
CHRD 	CHRD (Chordin) is a Protein Coding gene. Diseases associated with CHRD include  Holoprosencephaly MUC5B	This gene encodes a secreted protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta-like bone morphogenetic proteins and sequestering them in latent complexes. The encoded protein may also have roles in organogenesis and during adulthood. It has been suggested that this gene could be a candidate gene for Cornelia de Lange syndrome. Reduced expression of this gene results in enhanced bone regeneration. Alternative splicing results in multiple transcript variants. Other alternative splice variants have been described but their full length sequence has not been determined. [provided by RefSeq, Jan 2015]	This gene encodes a secreted protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta-like bone morphogenetic proteins and sequestering them in latent complexes. The encoded protein may also have roles in organogenesis and during adulthood. It has been suggested that this gene could be a candidate gene for Cornelia de Lange syndrome. Reduced expression of this gene results in enhanced bone regeneration. Alternative splicing results in multiple transcript variants. Other alternative splice variants have been described but their full length sequence has not been determined. [provided by RefSeq, Jan 2015]	Increased vaccinia virus (VACV) infection, no effect, Decreased ionizing radiation sensitivity, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001501 GO:0002053
FSTL1 	FSTL1 (Follistatin Like 1) is a Protein Coding gene. Diseases associated with FSTL1 include  Arthritis FSTL4	This gene encodes a protein with similarity to follistatin, an activin-binding protein. It contains an FS module, a follistatin-like sequence containing 10 conserved cysteine residues. This gene product is thought to be an autoantigen associated with rheumatoid arthritis. This gene encodes a protein with similarity to follistatin, an activin-binding protein. It contains an FS module, a follistatin-like sequence containing 10 conserved cysteine residues. This gene product is thought to be an autoantigen associated with rheumatoid arthritis. Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, Increased IL-8 secretion, Low eccentricity cells, Decreased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0007275 GO:0030154 GO:0030510
ITGB1 	ITGB1 (Integrin Subunit Beta 1) is a Protein Coding gene. Diseases associated with ITGB1 include  ITGB2	Integrins are heterodimeric proteins made up of alpha and beta subunits. At least 18 alpha and 8 beta subunits have been described in mammals. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. This gene encodes a beta subunit. Multiple alternatively spliced transcript variants which encode different protein isoforms have been found for this gene. Integrins are heterodimeric proteins made up of alpha and beta subunits. At least 18 alpha and 8 beta subunits have been described in mammals. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. This gene encodes a beta subunit. Multiple alternatively spliced transcript variants which encode different protein isoforms have been found for this gene. no effect, Decreased HPV16-GFP infection, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in pancreas lineage, Increased G2M DNA content, increased 8N DNA content, Increased number of mitotic cells, Increased ionizing radiation sensitivity, Decreased cell migration, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased Salmonella enterica Typhimurium invasion, Increased the percentage of infected cells, Decreased shRNA abundance (Z-score &lt; -2), Synthetic lethal with imatinib mesylate, 	GO:0000082 GO:0000132 GO:0000132 GO:0000132
BMP4 	BMP4 (Bone Morphogenetic Protein 4) is a Protein Coding gene. Diseases associated with BMP4 include  BMP2 . This protein regulates heart development and adipogenesis. Mutations in this gene are associated with orofacial cleft and microphthalmia in human patients. The encoded protein may also be involved in the pathology of multiple cardiovascular diseases and human cancers.   . This protein regulates heart development and adipogenesis. Mutations in this gene are associated with orofacial cleft and microphthalmia in human patients. The encoded protein may also be involved in the pathology of multiple cardiovascular diseases and human cancers. no effect, Decreased viability, Decreased vaccinia virus (VACV) infection, Increased transferrin (TF) endocytosis, Decreased viability after Maraba virus infection, Increased circadian period length, Synthetic lethal with vaccinia virus (VACV) infection, Strongly decreased NFAT1-GFP nuclear translocation, Increased cell number in G2M, increased nuclei size in G2M, 	 
COL4A1 	COL4A1 (Collagen Type IV Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL4A1 include  COL4A5	This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]	Increased vaccinia virus (VACV) infection, Increased viability, no effect, Negative genetic interaction between MUS81-/- and MUS81+/+, Negative genetic interaction between PTEN-/- and PTEN+/+, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell death HMECs cells, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), 	GO:0001525 GO:0001569 GO:0001569 GO:0001569 GO:0007420 GO:0007528 GO:0030198 GO:0030198 GO:0030198
FST 	FST (Follistatin) is a Protein Coding gene. Diseases associated with FST include  FSTL3	 Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release.  The single FST gene encodes two isoforms, FST317 and FST344 containing 317 and 344 amino acids respectively, resulting from alternative splicing of the precursor mRNA.  In a study in which 37 candidate genes were tested for linkage and association with polycystic ovary syndrome (PCOS) or hyperandrogenemia in 150 families, evidence was found for linkage between PCOS and follistatin.  Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release.  The single FST gene encodes two isoforms, FST317 and FST344 containing 317 and 344 amino acids respectively, resulting from alternative splicing of the precursor mRNA.  In a study in which 37 candidate genes were tested for linkage and association with polycystic ovary syndrome (PCOS) or hyperandrogenemia in 150 families, evidence was found for linkage between PCOS and follistatin. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability after Maraba virus infection, Strongly decreased CFP-tsO45G cell surface transport, 	GO:0000122 GO:0001501 GO:0002244 GO:0002244 GO:0002244 GO:0007275
ATM 	ATM (ATM Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with ATM include  binding PRKDC	The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]	The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased substrate adherent cell growth, Decreased shRNA abundance (Z-score &lt; -2), Decreased IL-8 secretion, Increased ionizing radiation sensitivity, Decreased cell migration, Decreased viability, Decreased homologous recombination repair frequency, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased viability with poly (ADP&#8208;ribose)&#8208;polymerase&#8208;1 (PARP) inhibitor, Decreased viability after ionizing radiation, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased viability after gemcitabine stimulation, Decreased TP53 mRNA expression, Decreased simian virus 40 (SV40) infection, Transferrin accumulation in small spots in the cell periphery, Increased apoptosis, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, 	GO:0000077 GO:0000425 GO:0000723
AURKA 	AURKA (Aurora Kinase A) is a Protein Coding gene. Diseases associated with AURKA include  AURKB	The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. Increased gamma-H2AX phosphorylation, no effect, Decreased viability, FOXO1 nuclear localization, Increased Nanog expression, Decreased substrate adherent cell growth, Increased number of mitotic cells, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased Salmonella enterica Typhimurium invasion, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Synthetic lethal with vaccinia virus (VACV) infection, Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Increased cell viability after pRB stimulation, Decreased viability with SS1P at EC30, Increased human cytomegalovirus (HCMV) strain AD169 replication, Decreased cell proliferation, Increased cell death in HCT116 cells, Cell division defect, Decreased cell migration, Synthetic lethal with paclitaxel, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Synthetic lethal with gemcitabine, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), Decreased cell number, increased G2M DNA content, Transferrin accumulation in small spots in the cell periphery, Decreased viability in esophageal squamous lineage; decreased viability in glioblastoma multiforme (GBM) lineage, Effect on mitosis, increased viability (proliferation), Increased viability (proliferation), 	GO:0000086 GO:0000212 GO:0000212 GO:0000212 GO:0000226 GO:0000226 GO:0000226 GO:0000278 GO:0000278 GO:0000278 GO:0006468
DUSP1 	DUSP1 (Dual Specificity Phosphatase 1) is a Protein Coding gene. Diseases associated with DUSP1 include  DUSP4	The protein encoded by this gene is a phosphatase with dual specificity for tyrosine and threonine. The encoded protein can dephosphorylate MAP kinase MAPK1/ERK2, which results in its involvement in several cellular processes. This protein appears to play an important role in the human cellular response to environmental stress as well as in the negative regulation of cellular proliferation. Finally, the encoded protein can make some solid tumors resistant to both chemotherapy and radiotherapy, making it a target for cancer therapy. [provided by RefSeq, Aug 2017]	The protein encoded by this gene is a phosphatase with dual specificity for tyrosine and threonine. The encoded protein can dephosphorylate MAP kinase MAPK1/ERK2, which results in its involvement in several cellular processes. This protein appears to play an important role in the human cellular response to environmental stress as well as in the negative regulation of cellular proliferation. Finally, the encoded protein can make some solid tumors resistant to both chemotherapy and radiotherapy, making it a target for cancer therapy. [provided by RefSeq, Aug 2017]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Increased IL-8 secretion, Increased shRNA abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Decreased viability with paclitaxel, 	GO:0001706 GO:0006470 GO:0007049 GO:0007049 GO:0007049 GO:0007162 GO:0007162 GO:0007162
LGALS3 	LGALS3 (Galectin 3) is a Protein Coding gene. Diseases associated with LGALS3 include  LGALS9C	This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2014]	This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2014]	no effect, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability, Increased shRNA abundance, 	GO:0002376 GO:0002548 GO:0002548 GO:0002548
FABP4 	FABP4 (Fatty Acid Binding Protein 4) is a Protein Coding gene. Diseases associated with FABP4 include  PMP2	FABP4 encodes the fatty acid binding protein found in adipocytes.  Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. It is thought that FABPs roles include fatty acid uptake, transport, and metabolism. FABP4 encodes the fatty acid binding protein found in adipocytes.  Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. It is thought that FABPs roles include fatty acid uptake, transport, and metabolism. no effect, Synthetic lethal with Ras, Decreased viability ratio, Decreased viability, Strongly decreased CFP-tsO45G cell surface transport, Decreased IL-8 secretion, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, 	GO:0006469 GO:0009617 GO:0009617 GO:0009617 GO:0015908 GO:0015908 GO:0015908
CXXC5 	CXXC5 (CXXC Finger Protein 5) is a Protein Coding gene. Diseases associated with CXXC5 include  CXXC4	The protein encoded by this gene is a retinoid-inducible nuclear protein containing a CXXC-type zinc finger motif. The encoded protein is involved in myelopoiesis, is required for DNA damage-induced p53 activation, regulates the differentiation of C2C12 myoblasts into myocytes, and negatively regulates cutaneous wound healing. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Nov 2015]	The protein encoded by this gene is a retinoid-inducible nuclear protein containing a CXXC-type zinc finger motif. The encoded protein is involved in myelopoiesis, is required for DNA damage-induced p53 activation, regulates the differentiation of C2C12 myoblasts into myocytes, and negatively regulates cutaneous wound healing. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Nov 2015]	no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Increased ionizing radiation sensitivity, 	GO:0000122 GO:0043123
CYLD 	CYLD (CYLD Lysine 63 Deubiquitinase) is a Protein Coding gene. Diseases associated with CYLD include 	This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Upregulation of NF-kappaB pathway after LMP1 stimulation, Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Decreased shRNA abundance, Reduced shRNA abundance in FBW7 KO line, Decreased caspase 3/7 activity, Increased mitotic index, Increased ID2::GFP protein expression, Increased NF-kappaB reporter activity, 	GO:0002376 GO:0006508 GO:0006508 GO:0006508 GO:0006511 GO:0006511 GO:0006511 GO:0007049 GO:0007049 GO:0007049 GO:0007346 GO:0007346 GO:0007346
BMP10 	BMP10 (Bone Morphogenetic Protein 10) is a Protein Coding gene. Diseases associated with BMP10 include  GDF2	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which binds to the activin receptor-like kinase 1 (ALK1) and plays important roles in cardiovascular development including cardiomyocyte proliferation and regulation of heart size, closure of the ductus arteriosus, angiogenesis and ventricular trabeculation. [provided by RefSeq, Aug 2016]	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate the mature protein, which binds to the activin receptor-like kinase 1 (ALK1) and plays important roles in cardiovascular development including cardiomyocyte proliferation and regulation of heart size, closure of the ductus arteriosus, angiogenesis and ventricular trabeculation. [provided by RefSeq, Aug 2016]	Increased gamma-H2AX phosphorylation, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Decreased NF-kappaB reporter expression, Decreased shRNA abundance, 	GO:0001822 GO:0007155 GO:0007155 GO:0007155 GO:0007507 GO:0007507 GO:0007507 GO:0007512 GO:0007512 GO:0007512 GO:0010596
ZEB1 	ZEB1 (Zinc Finger E-Box Binding Homeobox 1) is a Protein Coding gene. Diseases associated with ZEB1 include  ZEB2	This gene encodes a zinc finger transcription factor. The encoded protein likely plays a role in transcriptional repression of interleukin 2. Mutations in this gene have been associated with posterior polymorphous corneal dystrophy-3 and late-onset Fuchs endothelial corneal dystrophy. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2010]	This gene encodes a zinc finger transcription factor. The encoded protein likely plays a role in transcriptional repression of interleukin 2. Mutations in this gene have been associated with posterior polymorphous corneal dystrophy-3 and late-onset Fuchs endothelial corneal dystrophy. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2010]	no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased viability, Decreased viability in ovarian lineage, Decreased NF-kappaB reporter expression, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased S DNA content, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0000122 GO:0006351 GO:0006357 GO:0006357 GO:0006357
FOXF1 	FOXF1 (Forkhead Box F1) is a Protein Coding gene. Diseases associated with FOXF1 include  Gastrulation FOXC1	This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in the regulation of pulmonary genes as well as embryonic development. This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain.  The specific function of this gene has not yet been determined; however, it may play a role in the regulation of pulmonary genes as well as embryonic development. no effect, Decreased viability, Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased circadian period length, 	GO:0000122 GO:0001568 GO:0001568 GO:0001568 GO:0001570 GO:0001701 GO:0001701 GO:0001701
BRSK2 	BRSK2 (BR Serine/Threonine Kinase 2) is a Protein Coding gene. Diseases associated with BRSK2 include  Neuroscience BRSK1	Enables several functions, including ATP binding activity; ATPase binding activity; and protein kinase activity. Involved in several processes, including cellular protein metabolic process; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; and regulation of insulin secretion involved in cellular response to glucose stimulus. Located in centrosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]	Enables several functions, including ATP binding activity; ATPase binding activity; and protein kinase activity. Involved in several processes, including cellular protein metabolic process; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; and regulation of insulin secretion involved in cellular response to glucose stimulus. Located in centrosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Decreased viability, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, 	GO:0000086 GO:0006468
SYNJ2 	SYNJ2 (Synaptojanin 2) is a Protein Coding gene. Diseases associated with SYNJ2 include  SYNJ1	The gene is a member of the inositol-polyphosphate 5-phosphatase family. The encoded protein interacts with the ras-related C3 botulinum toxin substrate 1, which causes translocation of the encoded protein to the plasma membrane where it inhibits clathrin-mediated endocytosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]	The gene is a member of the inositol-polyphosphate 5-phosphatase family. The encoded protein interacts with the ras-related C3 botulinum toxin substrate 1, which causes translocation of the encoded protein to the plasma membrane where it inhibits clathrin-mediated endocytosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]	Increased gamma-H2AX phosphorylation, no effect, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Increased cell number in S and G2M, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0006629 GO:0006661 GO:0006661 GO:0006661 GO:0007420 GO:0007420 GO:0007420
PTPRB 	PTPRB (Protein Tyrosine Phosphatase Receptor Type B) is a Protein Coding gene. Diseases associated with PTPRB include  PTPRJ	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability in ovarian lineage, Decreased viability after Maraba virus infection, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Increased Akt phosphorylation after EGF stimulation, 	GO:0001525 GO:0006470 GO:0006796 GO:0008347 GO:0016311 GO:0016311 GO:0016311
RECK 	RECK (Reversion Inducing Cysteine Rich Protein With Kazal Motifs) is a Protein Coding gene. Diseases associated with RECK include 	The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased hepcidin::fluc mRNA expression, Increased viability, no effect, Reduced mammosphere formation, Increased viability with MLN4924 (a NAE inhibitor), Synthetic lethal with MLN4924 (a NAE inhibitor), Synthetic lethal with vaccinia virus (VACV) infection, Decreased homologous recombination repair frequency, Increased caspase activity, 	GO:0001955 GO:0002040
EFNA1 	EFNA1 (Ephrin A1) is a Protein Coding gene. Diseases associated with EFNA1 include  EFNA5	This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin which binds to the EPHA2, EPHA4, EPHA5, EPHA6, and EPHA7 receptors. Two transcript variants that encode different isoforms were identified through sequence analysis. This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin which binds to the EPHA2, EPHA4, EPHA5, EPHA6, and EPHA7 receptors. Two transcript variants that encode different isoforms were identified through sequence analysis. no effect, Reduced mammosphere formation, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased shRNA abundance, 	GO:0000122 GO:0001525 GO:0001525 GO:0001525 GO:0001934 GO:0001934 GO:0001934
NUMB 	NUMB (NUMB Endocytic Adaptor Protein) is a Protein Coding gene. Diseases associated with NUMB include  NUMBL	The protein encoded by this gene plays a role in the determination of cell fates during development. The encoded protein, whose degradation is induced in a proteasome-dependent manner by MDM2, is a membrane-bound protein that has been shown to associate with EPS15, LNX1, and NOTCH1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	The protein encoded by this gene plays a role in the determination of cell fates during development. The encoded protein, whose degradation is induced in a proteasome-dependent manner by MDM2, is a membrane-bound protein that has been shown to associate with EPS15, LNX1, and NOTCH1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]	Decreased hepcidin::fluc mRNA expression, no effect, Synthetic lethal with Ras, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance (Z-score &lt; -2), 	 
ETV1 	ETV1 (ETS Variant Transcription Factor 1) is a Protein Coding gene. Diseases associated with ETV1 include  Sarcoma ETV5	This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5\'-CGGA[AT]-3\'. The protein encoded by this gene contains a conserved short acidic transactivation domain (TAD) in the N-terminal region, in addition to the ETS DNA-binding domain in the C-terminal region. This gene is involved in chromosomal translocations, which result in multiple fusion proteins including EWS-ETV1 in Ewing sarcoma and at least 10 ETV1 partners (see PMID: 19657377, Table 1) in prostate cancer. In addition to chromosomal rearrangement, this gene is overexpressed in prostate cancer, melanoma and gastrointestinal stromal tumor. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. This gene encodes a member of the ETS (E twenty-six) family of transcription factors. The ETS proteins regulate many target genes that modulate biological processes like cell growth, angiogenesis, migration, proliferation and differentiation. All ETS proteins contain an ETS DNA-binding domain that binds to DNA sequences containing the consensus 5\'-CGGA[AT]-3\'. The protein encoded by this gene contains a conserved short acidic transactivation domain (TAD) in the N-terminal region, in addition to the ETS DNA-binding domain in the C-terminal region. This gene is involved in chromosomal translocations, which result in multiple fusion proteins including EWS-ETV1 in Ewing sarcoma and at least 10 ETV1 partners (see PMID: 19657377, Table 1) in prostate cancer. In addition to chromosomal rearrangement, this gene is overexpressed in prostate cancer, melanoma and gastrointestinal stromal tumor. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased hepcidin::fluc mRNA expression, Negative genetic interaction between BLM-/- and BLM+/+, Increased viability with neratinib, 	GO:0006355 GO:0006357 GO:0006357 GO:0006357 GO:0006366
PRKCA 	PRKCA (Protein Kinase C Alpha) is a Protein Coding gene. Diseases associated with PRKCA include  Cryptosporidiosis PRKCB	Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. no effect, Decreased viability, shRNA abundance &lt;= 50%, Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased cell migration, Increased cell viability after pRB stimulation, Decreased epidermal growth factor (EGF) endocytosis, Increased human cytomegalovirus (HCMV) strain AD169 replication, Increased viability with tamoxifen, Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell spreading, Increased colony dispersion (increased number of colonies and decreased number of cells per colony), 	GO:0001525 GO:0001938 GO:0001938 GO:0001938 GO:0002159 GO:0006468
PAK1 	PAK1 (P21 (RAC1) Activated Kinase 1) is a Protein Coding gene. Diseases associated with PAK1 include  PAK3	This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]	This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Decreased substrate adherent cell growth, Increased cell death HMECs cells, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased cell proliferation, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Increased Salmonella enterica Typhimurium binding, Decreased cell migration, Increased virus production, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, Synthetic lethal with gemcitabine, Decreased simian virus 40 (SV40) infection, Increased vesicular stomatitis virus (VSV) infection, Fragmented cis-Golgi, fragmented medial Golgi, fragmented trans-Golgi, Decreased Cdk9 T-loop phosphorylation, 	GO:0000165 GO:0001934 GO:0002223 GO:0006338 GO:0006338 GO:0006338 GO:0006468
ITGA8 	ITGA8 (Integrin Subunit Alpha 8) is a Protein Coding gene. Diseases associated with ITGA8 include  ITGAV	Integrins are heterodimeric transmembrane receptor proteins that mediate numerous cellular processes including cell adhesion, cytoskeletal rearrangement, and activation of cell signaling pathways. Integrins are composed of alpha and beta subunits. This gene encodes the alpha 8 subunit of the heterodimeric integrin alpha8beta1 protein. The encoded protein is a single-pass type 1 membrane protein that contains multiple FG-GAP repeats. This repeat is predicted to fold into a beta propeller structure. This gene regulates the recruitment of mesenchymal cells into epithelial structures, mediates cell-cell interactions, and regulates neurite outgrowth of sensory and motor neurons. The integrin alpha8beta1 protein thus plays an important role in wound-healing and organogenesis. Mutations in this gene have been associated with renal hypodysplasia/aplasia-1 (RHDA1) and with several animal models of chronic kidney disease. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2014]	Integrins are heterodimeric transmembrane receptor proteins that mediate numerous cellular processes including cell adhesion, cytoskeletal rearrangement, and activation of cell signaling pathways. Integrins are composed of alpha and beta subunits. This gene encodes the alpha 8 subunit of the heterodimeric integrin alpha8beta1 protein. The encoded protein is a single-pass type 1 membrane protein that contains multiple FG-GAP repeats. This repeat is predicted to fold into a beta propeller structure. This gene regulates the recruitment of mesenchymal cells into epithelial structures, mediates cell-cell interactions, and regulates neurite outgrowth of sensory and motor neurons. The integrin alpha8beta1 protein thus plays an important role in wound-healing and organogenesis. Mutations in this gene have been associated with renal hypodysplasia/aplasia-1 (RHDA1) and with several animal models of chronic kidney disease. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2014]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability after Maraba virus infection, Decreased replication of vaccinia virus (VACV), Decreased epidermal growth factor (EGF) endocytosis, 	GO:0001656 GO:0001822 GO:0001822 GO:0001822 GO:0007155 GO:0007160 GO:0007160 GO:0007160
NCL 	NCL (Nucleolin) is a Protein Coding gene. Diseases associated with NCL include  RBM19	Nucleolin (NCL), a eukaryotic nucleolar phosphoprotein, is involved in the synthesis and maturation of ribosomes. It is located mainly in dense fibrillar regions of the nucleolus. Human NCL gene consists of 14 exons with 13 introns and spans approximately 11kb. The intron 11 of the NCL gene encodes a small nucleolar RNA, termed U20. Nucleolin (NCL), a eukaryotic nucleolar phosphoprotein, is involved in the synthesis and maturation of ribosomes. It is located mainly in dense fibrillar regions of the nucleolus. Human NCL gene consists of 14 exons with 13 introns and spans approximately 11kb. The intron 11 of the NCL gene encodes a small nucleolar RNA, termed U20. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Synthetic lethal with Ras, Reduced mammosphere formation, Decreased shRNA abundance (Z-score &lt; -2), G0/1 arrest, Decreased cell number, Increased shRNA abundance (Z-score &gt; 2), Inconclusive, Increased circadian period length, Decreased viability with TRAIL, Decreased viability of wild-type and TP53 knockout cells, decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), 	GO:0001525 GO:0017148 GO:0045944 GO:0046627 GO:0046627 GO:0046627 GO:0048026 GO:0048026 GO:0048026
CNTN1 	CNTN1 (Contactin 1) is a Protein Coding gene. Diseases associated with CNTN1 include  CNTN2	The protein encoded by this gene is a member of the immunoglobulin superfamily. It is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein that functions as a cell adhesion molecule. It may play a role in the formation of axon connections in the developing nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]	The protein encoded by this gene is a member of the immunoglobulin superfamily. It is a glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein that functions as a cell adhesion molecule. It may play a role in the formation of axon connections in the developing nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, 	GO:0007155 GO:0007219 GO:0007399 GO:0007399 GO:0007399 GO:0007411 GO:0007411 GO:0007411 GO:0007420
RAB11A 	RAB11A (RAB11A, Member RAS Oncogene Family) is a Protein Coding gene. Diseases associated with RAB11A include  RAB11B	The protein encoded by this gene belongs to the Rab family of the small GTPase superfamily. It is associated with both constitutive and regulated secretory pathways, and may be involved in protein transport. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	The protein encoded by this gene belongs to the Rab family of the small GTPase superfamily. It is associated with both constitutive and regulated secretory pathways, and may be involved in protein transport. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Strongly decreased CFP-tsO45G cell surface transport, Decreased viability, Increased homologous recombination repair frequency, Decreased shRNA abundance (Z-score &lt; -2), Increased cell number in S, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, increased cell spreading, 	GO:0006887 GO:0007049 GO:0007080 GO:0007080 GO:0007080 GO:0010634 GO:0010796
SKP2 	SKP2 (S-Phase Kinase Associated Protein 2) is a Protein Coding gene. Diseases associated with SKP2 include  FBXL7	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class; in addition to an F-box, this protein contains 10 tandem leucine-rich repeats. This protein is an essential element of the cyclin A-CDK2 S-phase kinase. It specifically recognizes phosphorylated cyclin-dependent kinase inhibitor 1B (CDKN1B, also referred to as p27 or KIP1) predominantly in S phase and interacts with S-phase kinase-associated protein 1 (SKP1 or p19). In addition, this gene is established as a protooncogene causally involved in the pathogenesis of lymphomas. Alternative splicing of this gene generates three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2011]	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class; in addition to an F-box, this protein contains 10 tandem leucine-rich repeats. This protein is an essential element of the cyclin A-CDK2 S-phase kinase. It specifically recognizes phosphorylated cyclin-dependent kinase inhibitor 1B (CDKN1B, also referred to as p27 or KIP1) predominantly in S phase and interacts with S-phase kinase-associated protein 1 (SKP1 or p19). In addition, this gene is established as a protooncogene causally involved in the pathogenesis of lymphomas. Alternative splicing of this gene generates three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased NF-kappaB reporter expression, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435), Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell number in G2M, increased number of polyploid cells, Increased mitotic index, 	 
NRP2 	NRP2 (Neuropilin 2) is a Protein Coding gene. Diseases associated with NRP2 include  Lymphangioma NRP1	This gene encodes a member of the neuropilin family of receptor proteins. The encoded transmembrane protein binds to SEMA3C protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C} and SEMA3F protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F}, and interacts with vascular endothelial growth factor (VEGF). This protein may play a role in cardiovascular development, axon guidance, and tumorigenesis. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Jul 2021]	This gene encodes a member of the neuropilin family of receptor proteins. The encoded transmembrane protein binds to SEMA3C protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C} and SEMA3F protein {sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F}, and interacts with vascular endothelial growth factor (VEGF). This protein may play a role in cardiovascular development, axon guidance, and tumorigenesis. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Jul 2021]	Increased viability, no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Increased HPV18 LCR reporter activity, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased peripheral FA formation, Decreased vesicular stomatitis virus (VSV) infection, 	GO:0001525 GO:0001764 GO:0001938 GO:0001938 GO:0001938 GO:0003148 GO:0007155 GO:0007155 GO:0007155
RHOD 	RHOD (Ras Homolog Family Member D) is a Protein Coding gene. Diseases associated with RHOD include  RHOF	Ras homolog, or Rho, proteins interact with protein kinases and may serve as targets for activated GTPase. They play a critical role in muscle differentiation. The protein encoded by this gene binds GTP and is a member of the small GTPase superfamily. It is involved in endosome dynamics and reorganization of the actin cytoskeleton, and it may coordinate membrane transport with the function of the cytoskeleton. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	Ras homolog, or Rho, proteins interact with protein kinases and may serve as targets for activated GTPase. They play a critical role in muscle differentiation. The protein encoded by this gene binds GTP and is a member of the small GTPase superfamily. It is involved in endosome dynamics and reorganization of the actin cytoskeleton, and it may coordinate membrane transport with the function of the cytoskeleton. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Dynamic nuclei (hole, folded or small irregular), Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased cell migration, 	GO:0007015 GO:0007163 GO:0007163 GO:0007163 GO:0007264 GO:0007264 GO:0007264 GO:0007266 GO:0007266 GO:0007266
SHC1 	SHC1 (SHC Adaptor Protein 1) is a Protein Coding gene. Diseases associated with SHC1 include  SHC3	This gene encodes three main isoforms that differ in activities and subcellular location. While all three are adapter proteins in signal transduction pathways, the longest (p66Shc) may be involved in regulating life span and the effects of reactive oxygen species. The other two isoforms, p52Shc and p46Shc, link activated receptor tyrosine kinases to the Ras pathway by recruitment of the GRB2/SOS complex. p66Shc is not involved in Ras activation. Unlike the other two isoforms, p46Shc is targeted to the mitochondrial matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]	This gene encodes three main isoforms that differ in activities and subcellular location. While all three are adapter proteins in signal transduction pathways, the longest (p66Shc) may be involved in regulating life span and the effects of reactive oxygen species. The other two isoforms, p52Shc and p46Shc, link activated receptor tyrosine kinases to the Ras pathway by recruitment of the GRB2/SOS complex. p66Shc is not involved in Ras activation. Unlike the other two isoforms, p46Shc is targeted to the mitochondrial matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]	no effect, Decreased viability, Reduced mammosphere formation, Resistant to vaccinia virus (VACV-A4L) infection, Increased shRNA abundance (Z-score &gt; 2), Dynamic nuclei (hole, folded or small irregular), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased Sindbis virus (SINV) infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased cell migration, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell elongation, 	GO:0001525 GO:0007165 GO:0007165 GO:0007165 GO:0007169 GO:0007169 GO:0007169 GO:0007173 GO:0007173 GO:0007173 GO:0007176
CD93 	CD93 (CD93 Molecule) is a Protein Coding gene.  Among its related pathways are  CD248	The protein encoded by this gene is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. The encoded protein was once thought to be a receptor for C1q, but now is thought to instead be involved in intercellular adhesion and in the clearance of apoptotic cells. The intracellular cytoplasmic tail of this protein has been found to interact with moesin, a protein known to play a role in linking transmembrane proteins to the cytoskeleton and in the remodelling of the cytoskeleton. The protein encoded by this gene is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. The encoded protein was once thought to be a receptor for C1q, but now is thought to instead be involved in intercellular adhesion and in the clearance of apoptotic cells. The intracellular cytoplasmic tail of this protein has been found to interact with moesin, a protein known to play a role in linking transmembrane proteins to the cytoskeleton and in the remodelling of the cytoskeleton. Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Increased IL-8 secretion, Decreased Sindbis virus (SIN) capsid and autophagosome LC3 protein colocalization, Decreased mitophagy mCherry-Parkin protein expression after carbonyl cyanide m-chlorphenylhydrazone (CCCP) stimulation, Synthetic lethal with imatinib mesylate, Decreased viability after sindbis virus (SIN) dsTE12Q infection, 	GO:0006909 GO:0007155 GO:0042116 GO:0042116 GO:0042116 GO:0098609
WNT1 	WNT1 (Wnt Family Member 1) is a Protein Coding gene. Diseases associated with WNT1 include  WNT4	The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It is very conserved in evolution, and the protein encoded by this gene is known to be 98% identical to the mouse Wnt1 protein at the amino acid level. The studies in mouse indicate that the Wnt1 protein functions in the induction of the mesencephalon and cerebellum. This gene was originally considered as a candidate gene for Joubert syndrome, an autosomal recessive disorder with cerebellar hypoplasia as a leading feature. However,  further studies suggested that the gene mutations might not have a significant role in Joubert syndrome. This gene is clustered with another family member, WNT10B, in the chromosome 12q13 region. The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It is very conserved in evolution, and the protein encoded by this gene is known to be 98% identical to the mouse Wnt1 protein at the amino acid level. The studies in mouse indicate that the Wnt1 protein functions in the induction of the mesencephalon and cerebellum. This gene was originally considered as a candidate gene for Joubert syndrome, an autosomal recessive disorder with cerebellar hypoplasia as a leading feature. However,  further studies suggested that the gene mutations might not have a significant role in Joubert syndrome. This gene is clustered with another family member, WNT10B, in the chromosome 12q13 region. Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Mildly decreased CFP-tsO45G cell surface transport, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Decreased p24 protein expression, 	 
LTBP3 	LTBP3 (Latent Transforming Growth Factor Beta Binding Protein 3) is a Protein Coding gene. Diseases associated with LTBP3 include  LTBP1	The protein encoded by this gene forms a complex with transforming growth factor beta (TGF-beta) proteins and may be involved in their subcellular localization. Activation of this complex requires removal of the encoded binding protein. This protein also may play a structural role in the extracellular matrix. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	The protein encoded by this gene forms a complex with transforming growth factor beta (TGF-beta) proteins and may be involved in their subcellular localization. Activation of this complex requires removal of the encoded binding protein. This protein also may play a structural role in the extracellular matrix. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased NF-kappaB reporter expression, Increased transcriptional activity, Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased shRNA abundance, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Weakly decreased NFAT1-GFP nuclear translocation, Elongated cells, 	 
DLG2 	DLG2 (Discs Large MAGUK Scaffold Protein 2) is a Protein Coding gene. Diseases associated with DLG2 include  Schizophrenia DLG1	This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. The encoded protein forms a heterodimer with a related family member that may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described, but their full-length nature is not known. [provided by RefSeq, Dec 2008]	This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. The encoded protein forms a heterodimer with a related family member that may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described, but their full-length nature is not known. [provided by RefSeq, Dec 2008]	Increased viability, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Decreased viability ratio, Resistant to vaccinia virus (VACV-A4L) infection, Negative genetic interaction between PTEN-/- and PTEN+/+, Decreased viability in ovarian lineage, Increased Nanog expression, Increased shRNA abundance (Z-score &gt; 2), Increased HPV18 LCR reporter activity, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Decreased telomerase activity, Decreased influenza A/WSN/33 replication, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), Decreased influenza A H1N1 (A/WSN/33) virus numbers, 	GO:0007268 GO:0035865 GO:0043113 GO:0043113 GO:0043113 GO:0045197 GO:0045197 GO:0045197
NEDD4L 	NEDD4L (NEDD4 Like E3 Ubiquitin Protein Ligase) is a Protein Coding gene. Diseases associated with NEDD4L include  NEDD4	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]	no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Mildly decreased CFP-tsO45G cell surface transport, shRNA abundance &lt;= 25%, Increased replication of vaccinia virus (VACV), Two nuclei (binuclear), Decreased viability, 	GO:0000209 GO:0003254 GO:0003254 GO:0003254 GO:0006511 GO:0016567
RIN1 	RIN1 (Ras And Rab Interactor 1) is a Protein Coding gene.  Among its related pathways are  RIN2	Predicted to enable small GTPase binding activity. Predicted to be involved in endocytosis; regulation of catalytic activity; and signal transduction. Predicted to act upstream of or within associative learning; memory; and negative regulation of synaptic plasticity. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable small GTPase binding activity. Predicted to be involved in endocytosis; regulation of catalytic activity; and signal transduction. Predicted to act upstream of or within associative learning; memory; and negative regulation of synaptic plasticity. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Increased transferrin (TF) endocytosis, Decreased POU5F1-GFP protein expression, 	 
C3 	C3 (Complement C3) is a Protein Coding gene. Diseases associated with C3 include  C5	Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]	Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]	Increased gamma-H2AX phosphorylation, no effect, Reduced mammosphere formation, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Decreased viability in pancreas lineage, Decreased shRNA abundance, Large nuclei, 	GO:0001798 GO:0001934 GO:0001934 GO:0001934
COL8A1 	COL8A1 (Collagen Type VIII Alpha 1 Chain) is a Protein Coding gene. Diseases associated with COL8A1 include  COL8A2	This gene encodes one of the two alpha chains of type VIII collagen. The gene product is a short chain collagen and a major component of the basement membrane of the corneal endothelium. The type VIII collagen fibril can be either a homo- or a heterotrimer. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Dec 2011]	This gene encodes one of the two alpha chains of type VIII collagen. The gene product is a short chain collagen and a major component of the basement membrane of the corneal endothelium. The type VIII collagen fibril can be either a homo- or a heterotrimer. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Dec 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Reduced mammosphere formation, Increased shRNA abundance (Z-score &gt; 2), Increased IL-8 secretion, Increased replication of vaccinia virus (VACV), Decreased viability in pancreas lineage, Increased shRNA abundance, Increased shRNA abundance with PLX4720, Decreased shRNA abundance (Z-score &lt; -2), 	GO:0001525 GO:0007155 GO:0007155 GO:0007155 GO:0010811 GO:0010811 GO:0010811 GO:0030198 GO:0030198 GO:0030198 GO:0035987
HMGB1 	HMGB1 (High Mobility Group Box 1) is a Protein Coding gene. Diseases associated with HMGB1 include  Endophthalmitis HMGB1P1	This gene encodes a protein that belongs to the High Mobility Group-box superfamily. The encoded non-histone, nuclear DNA-binding protein regulates transcription, and is involved in organization of DNA. This protein plays a role in several cellular processes, including inflammation, cell differentiation and tumor cell migration. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2015]	This gene encodes a protein that belongs to the High Mobility Group-box superfamily. The encoded non-histone, nuclear DNA-binding protein regulates transcription, and is involved in organization of DNA. This protein plays a role in several cellular processes, including inflammation, cell differentiation and tumor cell migration. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2015]	no effect, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased viability, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Synthetic lethal with MLN4924 (a NAE inhibitor), Synthetic lethal with vaccinia virus (VACV) infection, Decreased HIV-1 infection, 	GO:0000122 GO:0001773 GO:0002218 GO:0002218 GO:0002218
PPP2CA 	PPP2CA (Protein Phosphatase 2 Catalytic Subunit Alpha) is a Protein Coding gene. Diseases associated with PPP2CA include  PPP2CB	This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit. This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit. Increased vaccinia virus (VACV) infection, Increased viability, no effect, Increased shRNA abundance (Z-score &gt; 2), Decreased viability after Maraba virus infection, Decreased shRNA abundance (Z-score &lt; -2), Effect on mitosis, Increased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, Increased cell number in S and G2M, Decreased viability, Diffuse trans-Golgi, Increased apoptosis, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell spreading, Increased mitotic exit time, 	GO:0000278 GO:0001932 GO:0006275 GO:0006355 GO:0006470
UCHL1 	UCHL1 (Ubiquitin C-Terminal Hydrolase L1) is a Protein Coding gene. Diseases associated with UCHL1 include  UCHL3	The protein encoded by this gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease.[provided by RefSeq, Sep 2009]	The protein encoded by this gene belongs to the peptidase C12 family. This enzyme is a thiol protease that hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. This gene is specifically expressed in the neurons and in cells of the diffuse neuroendocrine system. Mutations in this gene may be associated with Parkinson disease.[provided by RefSeq, Sep 2009]	no effect, Decreased viability, shRNA abundance &lt;= 25%, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Dynamic nuclei (hole, folded or small irregular), Synthetic lethal with MLN4924 (a NAE inhibitor), Increased cell number in G2M, increased nuclei size in G2M, 	 
PINK1 	PINK1 (PTEN Induced Kinase 1) is a Protein Coding gene. Diseases associated with PINK1 include  PRAG1	This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. no effect, Decreased viability, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased vaccinia virus (VACV) infection, Negative genetic interaction between MUS81-/- and MUS81+/+, shRNA abundance &lt;= 50%, Decreased viability after Maraba virus infection, Wnt reporter downregulated, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Increased cell size, Negative genetic interaction between BLM-/- and BLM+/+, Decreased cell migration, Synthetic lethal with vaccinia virus (VACV) infection, Decreased human cytomegalovirus (HCMV) strain AD169 replication, Increased 8N DNA content, Condensed cis-Golgi, condensed medial Golgi, condensed trans-Golgi, Decreased viability in esophageal squamous lineage; decreased viability in glioblastoma multiforme (GBM) lineage, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), Increased cell spreading, 	GO:0000422 GO:0000423 GO:0001934 GO:0002082
GRB2 	GRB2 (Growth Factor Receptor Bound Protein 2) is a Protein Coding gene. Diseases associated with GRB2 include  GRAP	The protein encoded by this gene binds the epidermal growth factor receptor and contains one SH2 domain and two SH3 domains. Its two SH3 domains direct complex formation with proline-rich regions of other proteins, and its SH2 domain binds tyrosine phosphorylated sequences. This gene is similar to the Sem5 gene of C.elegans, which is involved in the signal transduction pathway. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene. The protein encoded by this gene binds the epidermal growth factor receptor and contains one SH2 domain and two SH3 domains. Its two SH3 domains direct complex formation with proline-rich regions of other proteins, and its SH2 domain binds tyrosine phosphorylated sequences. This gene is similar to the Sem5 gene of C.elegans, which is involved in the signal transduction pathway. Two alternatively spliced transcript variants encoding different isoforms have been found for this gene. Decreased hepcidin::fluc mRNA expression, Decreased viability, no effect, Reduced mammosphere formation, shRNA abundance &lt;= 25%, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased cell death HMECs cells, Decreased shRNA abundance, Decreased endosome-nucleus distance (endosomes clustered in the perinuclear region), Increased shRNA abundance, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased cell spreading, Upregulation of Wnt/beta-catenin pathway after WNT3A stimulation, 	GO:0007165 GO:0007173 GO:0007265 GO:0007568 GO:0008286 GO:0008286 GO:0008286
BMP2 	BMP2 (Bone Morphogenetic Protein 2) is a Protein Coding gene. Diseases associated with BMP2 include  BMP4 , which plays a role in bone and cartilage development. Duplication of a regulatory region downstream of this gene causes a form of brachydactyly characterized by a malformed index finger and second toe in human patients.   , which plays a role in bone and cartilage development. Duplication of a regulatory region downstream of this gene causes a form of brachydactyly characterized by a malformed index finger and second toe in human patients. no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased shRNA abundance (Z-score &lt; -2), Increased IL-8 secretion, Metaphase cells, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Cell division defect, Decreased cell number, increased G2M DNA content, 	GO:0000122 GO:0001501 GO:0001503 GO:0001649 GO:0001649 GO:0001649
ARHGEF7 	ARHGEF7 (Rho Guanine Nucleotide Exchange Factor 7) is a Protein Coding gene. Diseases associated with ARHGEF7 include  ARHGEF6	This gene encodes a protein that belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It forms a complex with the small GTP binding protein Rac1 and recruits Rac1 to membrane ruffles and to focal adhesions. Multiple alternatively spliced transcript variants encoding different isoforms have been observed for this gene. [provided by RefSeq, Mar 2016]	This gene encodes a protein that belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It forms a complex with the small GTP binding protein Rac1 and recruits Rac1 to membrane ruffles and to focal adhesions. Multiple alternatively spliced transcript variants encoding different isoforms have been observed for this gene. [provided by RefSeq, Mar 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability, Decreased viability in glioblastoma multiforme (GBM) lineage, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased Sindbis virus (SINV) infection, Increased nuclear migration speed, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Decreased nuclei size in G2M, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Increased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, 	GO:0002244 GO:0007030 GO:0007030 GO:0007030 GO:0007165 GO:0007399 GO:0010763 GO:0010763 GO:0010763
ROCK2 	ROCK2 (Rho Associated Coiled-Coil Containing Protein Kinase 2) is a Protein Coding gene. Diseases associated with ROCK2 include  ROCK1	The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. Increased vaccinia virus (VACV) infection, no effect, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection, Increased viability (proliferation), Increased HPV18 LCR reporter activity, Increased cell death HMECs cells, Decreased viability, Decreased telomerase activity, Increased endosome-nucleus distance (endosomes dispersed in the cell periphery), Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after direct virus infection, Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection after viral supernatant infection, Increased shRNA abundance (Z-score &gt; 2), Increased epidermal growth factor receptor (EGFR) surface abundance, Decreased cell viability after pRB stimulation, toxic, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased cell spreading, 	GO:0000281 GO:0001837 GO:0001934 GO:0001934 GO:0001934
ADAM9 	ADAM9 (ADAM Metallopeptidase Domain 9) is a Protein Coding gene. Diseases associated with ADAM9 include  ADAM19	This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010]	This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010]	Increased vaccinia virus (VACV) infection, no effect, Mildly decreased CFP-tsO45G cell surface transport, Decreased shRNA abundance (Z-score &lt; -2), Resistant to vaccinia virus (VACV-A4L) infection, Increased G1 DNA content, G0/1 arrest, Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Increased shRNA abundance (Z-score &gt; 2), Decreased caspase 3/7 activity, Increased viability with tamoxifen, 	GO:0006508 GO:0006509 GO:0006509 GO:0006509 GO:0007155 GO:0007160 GO:0007179
CD248 	CD248 (CD248 Molecule) is a Protein Coding gene. Diseases associated with CD248 include  CD93	Predicted to enable extracellular matrix binding activity and extracellular matrix protein binding activity. Predicted to be involved in cell migration. Predicted to act upstream of or within several processes, including anatomical structure regression; lymph node development; and positive regulation of endothelial cell apoptotic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]	Predicted to enable extracellular matrix binding activity and extracellular matrix protein binding activity. Predicted to be involved in cell migration. Predicted to act upstream of or within several processes, including anatomical structure regression; lymph node development; and positive regulation of endothelial cell apoptotic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Decreased viability ratio, Decreased viability in colon lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased shRNA abundance (Z-score &lt; -2), Decreased Salmonella enterica Typhimurium invasion, Decreased viability with TRAIL, Decreased Dengue Infection, Decreased infection with West Nile virus (WNV), Decreased West Nile virus (WNV) infection, Increased shRNA abundance (Z-score &gt; 2), Decreased Salmonella enterica Typhimurium binding, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), decreased viability (cell death), 	GO:0008150 GO:0010761 GO:0010761 GO:0010761 GO:0016477 GO:0016477 GO:0016477
DOCK2 	DOCK2 (Dedicator Of Cytokinesis 2) is a Protein Coding gene. Diseases associated with DOCK2 include  binding DOCK1	The protein encoded by this gene belongs to the CDM protein family. It is specifically expressed in hematopoietic cells and is predominantly expressed in peripheral blood leukocytes. The protein is involved in remodeling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signaling. It activates members of the Rho family of GTPases, for example RAC1 and RAC2, by acting as a guanine nucleotide exchange factor (GEF) to exchange bound GDP for free GTP. Mutations in this gene result in immunodeficiency 40 (IMD40), a combined form of immunodeficiency that affects T cell number and function, also with variable defects in B cell and NK cell function. [provided by RefSeq, May 2018]	The protein encoded by this gene belongs to the CDM protein family. It is specifically expressed in hematopoietic cells and is predominantly expressed in peripheral blood leukocytes. The protein is involved in remodeling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signaling. It activates members of the Rho family of GTPases, for example RAC1 and RAC2, by acting as a guanine nucleotide exchange factor (GEF) to exchange bound GDP for free GTP. Mutations in this gene result in immunodeficiency 40 (IMD40), a combined form of immunodeficiency that affects T cell number and function, also with variable defects in B cell and NK cell function. [provided by RefSeq, May 2018]	Increased vaccinia virus (VACV) infection, no effect, shRNA abundance &lt;= 50%, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased viability ratio, Increased IL-8 secretion, Effect on mitosis, Decreased mitotic index, 	 
PSEN1 	PSEN1 (Presenilin 1) is a Protein Coding gene. Diseases associated with PSEN1 include  PSEN2	Alzheimer\'s disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined. [provided by RefSeq, Aug 2008]	Alzheimer\'s disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined. [provided by RefSeq, Aug 2008]	Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased ionizing radiation sensitivity, Decreased viability, Reduced mammosphere formation, Increased replication of vaccinia virus (VACV), Decreased human papilloma virus 16 (HPV16) pseudovirus infection, Decreased shRNA abundance (Z-score &lt; -2), Decreased epidermal growth factor (EGF) endocytosis, increased transferrin (TF) endocytosis, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Increased shRNA abundance (Z-score &gt; 2), Increased centriole number, 	GO:0000045 GO:0000122 GO:0000122 GO:0000122
FBXO5 	FBXO5 (F-Box Protein 5) is a Protein Coding gene. Diseases associated with FBXO5 include  FBXO43	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. This protein is similar to xenopus early mitotic inhibitor-1 (Emi1), which is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Dec 2008]	This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. This protein is similar to xenopus early mitotic inhibitor-1 (Emi1), which is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Dec 2008]	no effect, Decreased viability, Synthetic lethal with MLN4924 (a NAE inhibitor), Decreased cell number, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in non-small-cell lung cancer (NSCLC) lineage, Increased cell death HMECs cells, Increased viability with MLN4924 (a NAE inhibitor), Increased cell death in HCC-1954 cells, Decreased viability of wild-type and TP53 knockout cells, Large nuclei, Strongly decreased NFAT1-GFP nuclear translocation, Cell division defect, Increased cell number in G2M, increased number of polyploid cells, Decreased shRNA abundance (Z-score &lt; -2), Increased 8N DNA content, Increased mitotic index, 	GO:0001556 GO:0006275 GO:0006275 GO:0006275 GO:0007049 GO:0007057 GO:0007057 GO:0007057 GO:0007088 GO:0007088 GO:0007088
NLRP1 	NLRP1 (NLR Family Pyrin Domain Containing 1) is a Protein Coding gene. Diseases associated with NLRP1 include  Inflammasomes NLRP12	This gene encodes a member of the Ced-4 family of apoptosis proteins. Ced-family members contain a caspase recruitment domain (CARD) and are known to be key mediators of programmed cell death. The encoded protein contains a distinct N-terminal pyrin-like motif, which is possibly involved in protein-protein interactions. This protein interacts strongly with caspase 2 and weakly with caspase 9. Overexpression of this gene was demonstrated to induce apoptosis in cells. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined. This gene encodes a member of the Ced-4 family of apoptosis proteins. Ced-family members contain a caspase recruitment domain (CARD) and are known to be key mediators of programmed cell death. The encoded protein contains a distinct N-terminal pyrin-like motif, which is possibly involved in protein-protein interactions. This protein interacts strongly with caspase 2 and weakly with caspase 9. Overexpression of this gene was demonstrated to induce apoptosis in cells. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined. Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased viability with MLN4924 (a NAE inhibitor), Decreased HIV-1 infection, 	GO:0002221 GO:0002376 GO:0006508 GO:0006508 GO:0006508 GO:0006915 GO:0006915 GO:0006915 GO:0006919
HNF4A 	HNF4A (Hepatocyte Nuclear Factor 4 Alpha) is a Protein Coding gene. Diseases associated with HNF4A include  HNF4G	The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]	The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Reduced mammosphere formation, Decreased viability, shRNA abundance &lt;= 25%, Increased G1 DNA content, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased shRNA abundance, Increased free cholesterol, Decreased viability in colon lineage; decreased viability in esophageal squamous lineage, 	GO:0003323 GO:0006351 GO:0006351 GO:0006351 GO:0006355 GO:0006355 GO:0006355 GO:0006357 GO:0006357 GO:0006357
SYNGAP1 	SYNGAP1 (Synaptic Ras GTPase Activating Protein 1) is a Protein Coding gene. Diseases associated with SYNGAP1 include  DAB2IP	This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]	This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]	Increased vaccinia virus (VACV) infection, no effect, Decreased viability ratio, Decreased viability, Increased S DNA content, 	 
NDEL1 	NDEL1 (NudE Neurodevelopment Protein 1 Like 1) is a Protein Coding gene. Diseases associated with NDEL1 include  Lissencephaly NDE1	This gene encodes a coiled-coil protein that plays a role in multiple processes including cytoskeletal organization, cell signaling and neuron migration, outgrowth and maintenance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome X. [provided by RefSeq, Mar 2012]	This gene encodes a coiled-coil protein that plays a role in multiple processes including cytoskeletal organization, cell signaling and neuron migration, outgrowth and maintenance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome X. [provided by RefSeq, Mar 2012]	no effect, Decreased viability, Reduced mammosphere formation, Decreased viability ratio, Increased IL-8 secretion, Increased mitotic delay (prometaphase or metaphase alignment problems, MAP), Weakly decreased NFAT1-GFP nuclear translocation, Decreased DCP1a protein expression and assembly in processing bodies after arsenite stimulation, Decreased BBC3 mRNA expression, 	GO:0000132 GO:0000226 GO:0001764 GO:0001764 GO:0001764 GO:0001833 GO:0001833 GO:0001833 GO:0007020 GO:0007020 GO:0007020
WNT5A 	WNT5A (Wnt Family Member 5A) is a Protein Coding gene. Diseases associated with WNT5A include  WNT5B	The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene encodes a member of the WNT family that signals through both the canonical and non-canonical WNT pathways. This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2. This protein plays an essential role in regulating developmental pathways during embryogenesis. This protein may also play a role in oncogenesis. Mutations in this gene are the cause of autosomal dominant Robinow syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]	The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene encodes a member of the WNT family that signals through both the canonical and non-canonical WNT pathways. This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2. This protein plays an essential role in regulating developmental pathways during embryogenesis. This protein may also play a role in oncogenesis. Mutations in this gene are the cause of autosomal dominant Robinow syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]	no effect, Decreased viability, Increased shRNA abundance (Z-score &gt; 2), Decreased viability in colon lineage, Decreased shRNA abundance (Z-score &lt; -2), Increased G1 DNA content, Synthetic lethal with imatinib mesylate, Increased BBC3 mRNA expression, 	GO:0001736 GO:0001756 GO:0001756 GO:0001756 GO:0001819 GO:0001819 GO:0001819 GO:0001822 GO:0001822 GO:0001822 GO:0001837 GO:0001837 GO:0001837
PFN2 	PFN2 (Profilin 2) is a Protein Coding gene. Diseases associated with PFN2 include  PFN1	The protein encoded by this gene is a ubiquitous actin monomer-binding protein belonging to the profilin family. It is thought to regulate actin polymerization in response to extracellular signals. There are two alternatively spliced transcript variants encoding different isoforms described for this gene. The protein encoded by this gene is a ubiquitous actin monomer-binding protein belonging to the profilin family. It is thought to regulate actin polymerization in response to extracellular signals. There are two alternatively spliced transcript variants encoding different isoforms described for this gene. no effect, Reduced mammosphere formation, Decreased viability, Resistant to vaccinia virus (VACV-A4L) infection, Increased G1 DNA content, G0/1 arrest, Inconclusive, Increased cell migration, Decreased focal adhesion (FA) abundance, increased peripheral FA formation, decreased cell spreading, 	GO:0010633 GO:0016043 GO:0030036 GO:0030036 GO:0030036 GO:0030833 GO:0030833 GO:0030833 GO:0030837
BAP1 	BAP1 (BRCA1 Associated Protein 1) is a Protein Coding gene. Diseases associated with BAP1 include  UCHL5	This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013]	This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, shRNA abundance &lt;= 50%, Increased IL-8 secretion, Synthetic lethal with MLN4924 (a NAE inhibitor), Increased NF-kappaB reporter expression, Increased cell death HMECs cells, Decreased shRNA abundance, Increased cell death in HCC-1954 cells, Increased S DNA content, Cell division defect, Decreased viability in esophageal squamous lineage; decreased viability in glioblastoma multiforme (GBM) lineage, 	GO:0000278 GO:0001558 GO:0001558 GO:0001558
RPS6KA5 	RPS6KA5 (Ribosomal Protein S6 Kinase A5) is a Protein Coding gene. Diseases associated with RPS6KA5 include  RPS6KA4	Enables ATP binding activity and protein serine/threonine kinase activity. Involved in several processes, including histone-serine phosphorylation; positive regulation of histone modification; and regulation of transcription, DNA-templated. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables ATP binding activity and protein serine/threonine kinase activity. Involved in several processes, including histone-serine phosphorylation; positive regulation of histone modification; and regulation of transcription, DNA-templated. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability, shRNA abundance &lt;= 50%, Mildly decreased CFP-tsO45G cell surface transport, Decreased substrate adherent cell growth, Decreased Salmonella enterica Typhimurium invasion, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased telomerase activity, Increased homologous recombination repair frequency, Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection, Decreased cell&#8211;culture&#8211;derived Hepatitis C virus (HCVcc; Luc&#8211;Jc1) infection, Decreased cell viability after pRB stimulation, Decreased viability with TRAIL, Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, decreased FA abundance, increased peripheral FA formation, increased cell elongation, 	GO:0001818 GO:0006355 GO:0006468
TCL1A 	TCL1A (TCL1 Family AKT Coactivator A) is a Protein Coding gene. Diseases associated with TCL1A include  Leukemia MTCP1	Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998 [PubMed 9520462]). In normal T cells TCL1 is expressed in CD4-/CD8- cells, but not in cells at later stages of differentiation. TCL1 functions as a coactivator of the cell survival kinase AKT (MIM 164730) (Laine et al., 2000 [PubMed 10983986]).[supplied by OMIM, Jul 2010]	Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998 [PubMed 9520462]). In normal T cells TCL1 is expressed in CD4-/CD8- cells, but not in cells at later stages of differentiation. TCL1 functions as a coactivator of the cell survival kinase AKT (MIM 164730) (Laine et al., 2000 [PubMed 10983986]).[supplied by OMIM, Jul 2010]	Increased gamma-H2AX phosphorylation, Increased vaccinia virus (VACV) infection, no effect, Decreased viability, Decreased viability in ovarian lineage, Increased shRNA abundance (Z-score &gt; 2), Decreased POU5F1-GFP protein expression, Decreased shRNA abundance (Z-score &lt; -2), Decreased OCT4 protein expression, Decreased NANOG protein expression, 	GO:0008284 GO:0010918 GO:0031334 GO:0033138 GO:0043066
ACTA1 	ACTA1 (Actin Alpha 1, Skeletal Muscle) is a Protein Coding gene. Diseases associated with ACTA1 include  ACTC1	The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause a variety of myopathies, including nemaline myopathy, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects with manifestations such as hypotonia. [provided by RefSeq, Sep 2019]	The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause a variety of myopathies, including nemaline myopathy, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects with manifestations such as hypotonia. [provided by RefSeq, Sep 2019]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability ratio, Decreased POU5F1-GFP protein expression, 	GO:0006936
NRN1 	NRN1 (Neuritin 1) is a Protein Coding gene. Diseases associated with NRN1 include  NRN1L	This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a consensus cleavage signal found in glycosylphoshatidylinositol (GPI)-anchored proteins. The encoded protein promotes neurite outgrowth and arborization, suggesting its role in promoting neuritogenesis. Overexpression of the encoded protein may be associated with astrocytoma progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a consensus cleavage signal found in glycosylphoshatidylinositol (GPI)-anchored proteins. The encoded protein promotes neurite outgrowth and arborization, suggesting its role in promoting neuritogenesis. Overexpression of the encoded protein may be associated with astrocytoma progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]	no effect, Elongated cells, 	GO:0007399 GO:1990138 GO:1990138 GO:1990138
EFNB2 	EFNB2 (Ephrin B2) is a Protein Coding gene. Diseases associated with EFNB2 include  EFNB1	This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNB class ephrin which binds to the EPHB4 and EPHA3 receptors. This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNB class ephrin which binds to the EPHB4 and EPHA3 receptors. Increased vaccinia virus (VACV) infection, no effect, Synthetic lethal with Ras, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Decreased IL-8 secretion, Inconclusive, Decreased TP53 protein expression ratio (wild-type / TP53 knockout cells), Decreased viability with paclitaxel, 	GO:0001525 GO:0001945 GO:0001945 GO:0001945 GO:0002042 GO:0002042 GO:0002042 GO:0007155 GO:0007267
KIF13B 	KIF13B (Kinesin Family Member 13B) is a Protein Coding gene. Diseases associated with KIF13B include  KIF13A	Enables 14-3-3 protein binding activity and protein kinase binding activity. Involved in regulation of axonogenesis. Located in axon and cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	Enables 14-3-3 protein binding activity and protein kinase binding activity. Involved in regulation of axonogenesis. Located in axon and cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]	no effect, Decreased viability, Decreased shRNA abundance (Z-score &lt; -2), Increased shRNA abundance (Z-score &gt; 2), Moderately decreased NFAT1-GFP nuclear translocation, Decreased nuclei size in G2M, 	GO:0006605 GO:0007018 GO:0007165 GO:0030705 GO:0042110
AKAP13 	AKAP13 (A-Kinase Anchoring Protein 13) is a Protein Coding gene. Diseases associated with AKAP13 include 	The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]	The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]	no effect, Decreased viability, Decreased viability ratio, Increased IL-8 secretion, Increased ionizing radiation sensitivity, Increased homologous recombination repair frequency, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Decreased viability in esophageal squamous lineage; decreased viability in non-small-cell lung cancer (NSCLC) lineage, Decreased HIV-1 infection, Increased epidermal growth factor receptor (EGFR) surface abundance, Increased viability, Increased apoptosis, Decreased 12E8 tau but not total tau protein expression and decreased ratio of 12E8/total tau protein expression, 	GO:0007186 GO:0007507 GO:0035023 GO:0035023 GO:0035023 GO:0035025 GO:0043123
CDCP1 	CDCP1 (CUB Domain Containing Protein 1) is a Protein Coding gene. Diseases associated with CDCP1 include  Adhesion	This gene encodes a transmembrane protein which contains three extracellular CUB domains and acts as a substrate for Src family kinases. The protein plays a role in the tyrosine phosphorylation-dependent regulation of cellular events that are involved in tumor invasion and metastasis. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, May 2013]	This gene encodes a transmembrane protein which contains three extracellular CUB domains and acts as a substrate for Src family kinases. The protein plays a role in the tyrosine phosphorylation-dependent regulation of cellular events that are involved in tumor invasion and metastasis. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, May 2013]	Increased vaccinia virus (VACV) infection, Decreased viability, no effect, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Negative genetic interaction between BLM-/- and BLM+/+, Decreased epidermal growth factor (EGF) endocytosis, decreased transferrin (TF) endocytosis, Downregulation of RLR pathway after Sendai virus (SeV) infection, 	 
MOB1B 	MOB1B (MOB Kinase Activator 1B) is a Protein Coding gene. Diseases associated with MOB1B include  MOB1A	The protein encoded by this gene is similar to the yeast Mob1 protein. Yeast Mob1 binds Mps1p, a protein kinase essential for spindle pole body duplication and mitotic checkpoint regulation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]	The protein encoded by this gene is similar to the yeast Mob1 protein. Yeast Mob1 binds Mps1p, a protein kinase essential for spindle pole body duplication and mitotic checkpoint regulation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]	Increased vaccinia virus (VACV) infection, no effect, Decreased vaccinia virus (VACV) infection, Decreased viability in ovarian lineage, Negative genetic interaction between PTTG1-/- and PTTG1+/+, Decreased viability, Decreased number of cells in monopolar arrest with EMD534085 (a Kinesin-5 inhibitor), 	GO:0001934 GO:0007165 GO:0031952 GO:0031952 GO:0031952 GO:0035329
CDH13 	
USP8 	
FBLIM1 	
LIMK2 	
ACTB 	
ETS2 	
PDGFD 	
ITGA7 	
FGFR4 	
RAPGEF6 
FGF9 	
FCHO1 	
MEOX2 	
KIF23 	
MAGI2 	
REST 	
BSG 	
CRIM1 	
MTOR 	
COL5A2 	
HUWE1 	
SERPINB2
KIF5B 	
CD81 	
CYP2J2 	
EGF 	
GDF2 	
COL1A2
RhoA-ROCK
Wnt/-catenin
MAPK/ERK
Notch
MAPK/ERK
mTOR
Hippo
TGF-
PI3K/AKT 
